We are tracking the following list of medications (and groups of medications) to assess for COVID-related shortages:
ATC | Description |
---|---|
ATC | Description |
C01CA | Adrenergics |
H01BA | Vasopressin and analogues |
M03AB01 | Succinylcholine (suxamethonium) |
M03AC | Muscle relaxants (e.g. paralytics) |
N01A | Anesthetics (includes opioid, ketamines) |
N05CD | Benzodiazepines |
N05CM18 | Dexmedetomidine |
C01BD01 | Amiodarone |
C03CA01 | Furosemide |
J05AR10 | Kaletra (anti-viral) |
N02BE01 | Acetaminophen (Paracetamol) |
P01BA02 | Hydroxychloroquine |
R01AA04 | Phenylephrine (nasal) |
R03AC | Respiratory Beta Agonists |
The following charts shows the availability of COVID-19 indicator medications since November 2019. Only medications (by ATC code) that have had a shortages will be shown.
ATC | Drug Name | Dose | Company | Status | Start | Duration (days) | Reason | View report | |
---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
ATC | Drug Name | Dose | Company | Status | Start | Duration (days) | Reason | View report | |
---|---|---|---|---|---|---|---|---|---|
6582 | L01CA02 | VINCRISTINE SULFATE INJECTION | 1MG | Teva Canada Limited | Anticipated | 2025-05-01 | 132 | Manufacturing distruption | 246267 |
6583 | V03AB24 | DIGIFAB | 40MG | Btg International Inc | Anticipated | 2025-05-01 | 53 | Demand increase | 250276 |
6584 | B05ZA | NXSTAGE PUREFLOW SOLUTION RFP-... | 5.552G 0.102G 1.1G 0.075G 0.221G 8.408G | Nxstage Medical Inc | Anticipated | 2025-05-01 | Manufacturing distruption | 251900 | |
6580 | J04AB04 | MYCOBUTIN | 150MG | Pfizer Canada Ulc | Anticipated | 2025-04-30 | 28 | Manufacturing distruption | 249824 |
6581 | B01AB01 | HEPARIN SODIUM INJECTION, USP | 10000UNIT | Fresenius Kabi Canada Ltd | Anticipated | 2025-04-30 | 33 | Manufacturing distruption | 253985 |
6579 | N06DA04 | MYLAN-GALANTAMINE ER | 24MG | Mylan Pharmaceuticals Ulc | Anticipated | 2025-04-29 | 42 | Demand increase | 253701 |
6577 | N02CC04 | MAXALT | 10MG | Organon Canada Inc. | Anticipated | 2025-04-25 | 70 | Shipping delay | 250947 |
6578 | N02AA01 | MORPHINE SULFATE INJECTION, US... | 10MG | Fresenius Kabi Canada Ltd | Anticipated | 2025-04-25 | 54 | Manufacturing distruption | 253988 |
6576 | C01EB10 | ADENOSINE INJECTION | 3MG | Fresenius Kabi Canada Ltd | Anticipated | 2025-04-23 | 69 | Manufacturing distruption | 252332 |
6575 | G03AA05 | BREVICON 0.5/35 TABLETS (21-DA... | 0.5MG 0.035MG | Pfizer Canada Ulc | Anticipated | 2025-04-19 | 90 | Manufacturing distruption | 253804 |
6574 | C09CA01 | LOSARTAN | 100MG | Sanis Health Inc | Anticipated | 2025-04-18 | 28 | Manufacturing distruption | 253781 |
6573 | C01BC03 | MYLAN-PROPAFENONE | 150MG | Mylan Pharmaceuticals Ulc | Anticipated | 2025-04-17 | 26 | Manufacturing distruption | 253696 |
6571 | B05CB01 | SODIUM CHLORIDE IRRIGATION USP | 9MG | Icu Medical Canada Inc | Anticipated | 2025-04-14 | 18 | Manufacturing distruption | 252852 |
6572 | H01CB02 | SANDOSTATIN LAR | 20MG | Novartis Pharmaceuticals Canada Inc | Anticipated | 2025-04-14 | 64 | Manufacturing distruption | 254019 |
6569 | J05AB01 | MYLAN-ACYCLOVIR | 400MG | Mylan Pharmaceuticals Ulc | Anticipated | 2025-04-11 | 32 | Manufacturing distruption | 251227 |
6570 | N06AB10 | ESCITALOPRAM | 20MG | Sanis Health Inc | Anticipated | 2025-04-11 | 49 | Manufacturing distruption | 253771 |
6568 | A11GA01 | VITAMIN C | 500MG | Mylan Pharmaceuticals Ulc | Anticipated | 2025-04-09 | 34 | Manufacturing distruption | 253704 |
6567 | H01CB02 | SANDOSTATIN LAR | 30MG | Novartis Pharmaceuticals Canada Inc | Anticipated | 2025-04-08 | 13 | Manufacturing distruption | 254013 |
6564 | H02AB04 | DEPO-MEDROL (WITH PRESERVATIVE... | 80MG | Pfizer Canada Ulc | Anticipated | 2025-04-07 | 53 | Manufacturing distruption | 253471 |
6565 | B05XA03 | SODIUM CHLORIDE INJECTION USP | 9MG | Icu Medical Canada Inc | Anticipated | 2025-04-07 | 11 | Manufacturing distruption | 252855 |
6566 | R03BA05 | FLOVENT DISKUS | 100MCG | Glaxosmithkline Inc | Anticipated | 2025-04-07 | 25 | Manufacturing distruption | 252624 |
6562 | N07CA01 | AURO-BETAHISTINE | 8MG | Auro Pharma Inc | Anticipated | 2025-04-04 | 26 | Demand increase | 254027 |
6563 | L02BX03 | MAR-ABIRATERONE | 250MG | Marcan Pharmaceuticals Inc | Anticipated | 2025-04-04 | 56 | Shipping delay | 254001 |
6560 | A10BX16 | MOUNJARO | 12.5MG | Eli Lilly Canada Inc | Anticipated | 2025-04-03 | Other | 249495 | |
6561 | A10BB09 | MYLAN-GLICLAZIDE MR | 30MG | Mylan Pharmaceuticals Ulc | Anticipated | 2025-04-03 | 40 | Demand increase | 251242 |
6555 | N05AB03 | PERPHENAZINE | 4MG | Aa Pharma Inc | Active | 2025-04-02 | 26 | Manufacturing distruption | 253975 |
6556 | B01AB01 | HEPARIN SODIUM INJECTION, USP | 10000UNIT | Fresenius Kabi Canada Ltd | Active | 2025-04-02 | 30 | Manufacturing distruption | 253982 |
6557 | S01ED51 | MYLAN-LATANOPROST/TIMOLOL | 50MCG 5MG | Mylan Pharmaceuticals Ulc | Active | 2025-04-02 | 20 | Demand increase | 251255 |
6558 | N03AB02 | PHENYTOIN SODIUM | 100MG | Aa Pharma Inc | Active | 2025-04-02 | 93 | Manufacturing distruption | 253689 |
6559 | B01AE06 | BIVALIRUDIN INJECTION | 5MG | Avir Pharma Inc. | Active | 2025-04-02 | 16 | Shipping delay | 253968 |
6545 | S01ED01 | TIMOPTIC-XE | 0.5% | Elvium Life Sciences | Active | 2025-04-01 | 10 | Demand increase | 253899 |
6546 | J01BA01 | CHLOROMYCETIN SUCCINATE INJECT... | 1G | Searchlight Pharma Inc | Active | 2025-04-01 | Manufacturing distruption | 246465 | |
6547 | C03CA01 | FUROSEMIDE | 20MG | Sanis Health Inc | Active | 2025-04-01 | 52 | Manufacturing distruption | 253774 |
6548 | N05AX08 | RISPERIDONE | 0.5MG | Sanis Health Inc | Active | 2025-04-01 | 24 | Manufacturing distruption | 253789 |
6549 | N04BC05 | PRAMIPEXOLE | 0.25MG | Sanis Health Inc | Active | 2025-04-01 | 24 | Manufacturing distruption | 253784 |
6550 | N05AH04 | TEVA-QUETIAPINE XR | 50MG | Teva Canada Limited | Active | 2025-04-01 | 10 | Manufacturing distruption | 253963 |
6551 | C01CA24 | EPINEPHRINE INJECTION USP | 1MG | Hikma Canada Limited | Active | 2025-04-01 | 44 | Ingredient shortage | 253333 |
6552 | N06DA04 | GALANTAMINE ER | 8MG | Sanis Health Inc | Active | 2025-04-01 | 52 | Manufacturing distruption | 253778 |
6553 | J01FA09 | CLARITHROMYCIN | 250MG | Sanis Health Inc | Active | 2025-04-01 | 31 | Manufacturing distruption | 253768 |
6554 | J01XA01 | VANCOMYCIN INJECTION USP IN 0.... | 1000MG | Baxter Corporation | Active | 2025-04-01 | 24 | Other | 253375 |
6530 | G03CA57 | PREMARIN VAGINAL CREAM | 0.625MG | Pfizer Canada Ulc | Active | 2025-03-31 | 25 | Manufacturing distruption | 252882 |
6531 | R03AC02 | PMS-SALBUTAMOL | 2MG | Pharmascience Inc | Active | 2025-03-31 | 42 | Manufacturing distruption | 253879 |
6532 | R03BB01 | PMS-IPRATROPIUM | 125MCG | Pharmascience Inc | Active | 2025-03-31 | 28 | Manufacturing distruption | 253873 |
6533 | G03FA01 | ESTALIS 140/50 MCG | 140MCG 50MCG | Sandoz Canada Incorporated | Active | 2025-03-31 | 60 | Manufacturing distruption | 253662 |
6534 | J01GB06 | AMIKACIN SULFATE INJECTION USP | 250MG | Sandoz Canada Incorporated | Active | 2025-03-31 | 11 | Demand increase | 253659 |
6535 | J07AX | BOOSTRIX | 2.5MCG 8MCG 8MCG 20UNIT 2UNIT | Glaxosmithkline Inc | Active | 2025-03-31 | Manufacturing distruption | 253611 | |
6536 | C07AG02 | APO-CARVEDILOL | 12.5MG | Apotex Inc | Active | 2025-03-31 | Manufacturing distruption | 215955 | |
6537 | N02CC01 | PMS-SUMATRIPTAN | 25MG | Pharmascience Inc | Active | 2025-03-31 | 39 | Manufacturing distruption | 253882 |
6538 | A02BC02 | SANDOZ PANTOPRAZOLE | 20MG | Sandoz Canada Incorporated | Active | 2025-03-31 | 4 | Shipping delay | 253671 |
6539 | N02AA05 | PMS-OXYCODONE | 20MG | Pharmascience Inc | Active | 2025-03-31 | 28 | Manufacturing distruption | 253876 |
6540 | C01BC03 | RYTHMOL | 300MG | Bgp Pharma Ulc | Active | 2025-03-31 | 15 | Manufacturing distruption | 253723 |
6541 | S01EE01 | SANDOZ LATANOPROST | 50MCG | Sandoz Canada Incorporated | Active | 2025-03-31 | 11 | Shipping delay | 253668 |
6542 | A10BA02 | METFORMIN FC | 500MG | Sivem Pharmaceuticals Ulc | Active | 2025-03-31 | 28 | Manufacturing distruption | 253801 |
6543 | J01DD02 | CEFTAZIDIME FOR INJECTION BP | 2G | Sterimax Inc | Active | 2025-03-31 | Manufacturing distruption | 249450 | |
6544 | N03AX18 | SANDOZ LACOSAMIDE | 100MG | Sandoz Canada Incorporated | Active | 2025-03-31 | 11 | Shipping delay | 253665 |
6529 | J01DC01 | CEFOXITIN FOR INJECTION | 1G | Teva Canada Limited | Active | 2025-03-30 | 31 | Manufacturing distruption | 253960 |
6528 | M01AB55 | ARTHROTEC 75 | 200MCG 75MG | Pfizer Canada Ulc | Active | 2025-03-27 | 34 | Demand increase | 245769 |
6521 | A07EC02 | TEVA-5 ASA | 400MG | Teva Canada Limited | Active | 2025-03-26 | 76 | Manufacturing distruption | 253568 |
6522 | N05AD01 | TEVA-HALOPERIDOL | 5MG | Teva Canada Limited | Active | 2025-03-26 | 45 | Manufacturing distruption | 253562 |
6523 | J01FA09 | BIAXIN | 250MG | Bgp Pharma Ulc | Active | 2025-03-26 | 27 | Demand increase | 253726 |
6525 | C07AA05 | TEVA-PROPRANOLOL | 20MG | Teva Canada Limited | Active | 2025-03-26 | 35 | Manufacturing distruption | 253565 |
6526 | M03AC11 | CISATRACURIUM BESYLATE INJECTI... | 2MG | Omega Laboratories Limited | Active | 2025-03-26 | 20 | Other | 253444 |
6527 | B05CB01 | 0.9% SODIUM CHLORIDE IRRIGATIO... | 900MG | Baxter Corporation | Active | 2025-03-26 | 96 | Manufacturing distruption | 253468 |
6524 | G03CA03 | CLIMARA 75 | 75MCG | Bayer Inc | Resolved | 2025-03-26 | 2 | Demand increase | 244256 |
6516 | C08DB01 | APO-DILTIAZ CD | 300MG | Apotex Inc | Active | 2025-03-25 | 10 | Manufacturing distruption | 253505 |
6517 | N06BA07 | APO-MODAFINIL | 100MG | Apotex Inc | Active | 2025-03-25 | 10 | Manufacturing distruption | 253502 |
6518 | A02BC03 | APO-LANSOPRAZOLE | 30MG | Apotex Inc | Active | 2025-03-25 | 24 | Manufacturing distruption | 253493 |
6519 | C09BA04 | APO-PERINDOPRIL-INDAPAMIDE | 1.25MG 4MG | Apotex Inc | Active | 2025-03-25 | 101 | Manufacturing distruption | 253496 |
6520 | B01AC04 | APO-CLOPIDOGREL | 300MG | Apotex Inc | Active | 2025-03-25 | 66 | Manufacturing distruption | 253499 |
6511 | R03AC02 | VENTOLIN DISKUS | 200MCG | Glaxosmithkline Inc | Active | 2025-03-24 | 39 | Manufacturing distruption | 252627 |
6512 | N01AH03 | SUFENTANIL CITRATE INJECTION U... | 50MCG | Sandoz Canada Incorporated | Active | 2025-03-24 | 60 | Demand increase | 253320 |
6513 | N03AX09 | MYLAN-LAMOTRIGINE | 150MG | Mylan Pharmaceuticals Ulc | Active | 2025-03-24 | 29 | Manufacturing distruption | 248758 |
6514 | C07AB02 | METOPROLOL-L | 25MG | Sivem Pharmaceuticals Ulc | Active | 2025-03-24 | 35 | Manufacturing distruption | 251744 |
6515 | B01AF02 | SANDOZ APIXABAN SDZ | 2.5MG | Sandoz Canada Incorporated | Active | 2025-03-24 | 11 | Demand increase | 253317 |
6507 | H05BA01 | CALCIMAR | 200UNIT | Sanofi-Aventis Canada Inc | Active | 2025-03-21 | Other | 252590 | |
6508 | C09AA03 | LISINOPRIL | 5MG | Sivem Pharmaceuticals Ulc | Active | 2025-03-21 | Ingredient shortage | 250137 | |
6509 | N03AX14 | ACH-LEVETIRACETAM | 250MG | Accord Healthcare Inc | Active | 2025-03-21 | Manufacturing practices | 253221 | |
6510 | J01FA09 | CLARITHROMYCIN | 250MG | Sivem Pharmaceuticals Ulc | Active | 2025-03-21 | 38 | Manufacturing distruption | 250134 |
6503 | G04BD07 | DETROL LA | 2MG | Bgp Pharma Ulc | Active | 2025-03-20 | 110 | Demand increase | 253456 |
6505 | N02AB03 | FENTORA | 800MCG | Teva Canada Limited | Active | 2025-03-20 | 41 | Demand increase | 251941 |
6506 | S01BA | DUREZOL | 0.05% | Novartis Pharmaceuticals Canada Inc | Active | 2025-03-20 | 36 | Demand increase | 250425 |
6502 | D06BB10 | ALDARA P | 5% | Bausch Health, Canada Inc. | Avoided | 2025-03-20 | 14 | Demand increase | 251325 |
6504 | V03AB33 | CYANOKIT | 5G | Serb S.a. | Resolved | 2025-03-20 | 4 | Other | 253207 |
6496 | N02AJ17 | TEVA-OXYCOCET | 325MG 5MG | Teva Canada Limited | Active | 2025-03-19 | 73 | Manufacturing distruption | 253150 |
6499 | A04AD11 | TEVA-NABILONE | 1.0MG | Teva Canada Limited | Active | 2025-03-19 | 32 | Manufacturing distruption | 253153 |
6500 | L01XX24 | ONCASPAR | 750UNIT | Servier Canada Inc | Active | 2025-03-19 | Manufacturing distruption | 241135 | |
6497 | S01ED51 | COSOPT | 5MG 20MG | Elvium Life Sciences | Resolved | 2025-03-19 | 2 | Shipping delay | 253012 |
6498 | S01ED51 | COSOPT PRESERVATIVE-FREE | 5MG 20MG | Elvium Life Sciences | Resolved | 2025-03-19 | 16 | Shipping delay | 252641 |
6501 | L01EX12 | VITRAKVI | 100MG | Bayer Inc | Resolved | 2025-03-19 | 9 | Demand increase | 250914 |
6478 | C09CA06 | APO-CANDESARTAN TABLETS | 16MG | Apotex Inc | Active | 2025-03-18 | 17 | Manufacturing distruption | 253078 |
6479 | R06AX | APO-BILASTINE TABLETS | 20MG | Apotex Inc | Active | 2025-03-18 | 17 | Manufacturing distruption | 253067 |
6480 | J01EE01 | SULFATRIM DS | 160MG 800MG | Aa Pharma Inc | Active | 2025-03-18 | 43 | Manufacturing distruption | 252438 |
6481 | C10AA02 | LOVASTATIN | 40MG | Aa Pharma Inc | Active | 2025-03-18 | 52 | Manufacturing distruption | 253032 |
6482 | S01EC01 | ACETAZOLAMIDE | 250MG | Aa Pharma Inc | Active | 2025-03-18 | 29 | Manufacturing distruption | 252435 |
6483 | J01CR02 | APO-AMOXI CLAV | 125MG 500MG | Apotex Inc | Active | 2025-03-18 | 87 | Manufacturing distruption | 253070 |
6485 | N06DA03 | APO-RIVASTIGMINE | 6MG | Apotex Inc | Active | 2025-03-18 | 164 | Manufacturing distruption | 253075 |
6486 | C10AA07 | MINT-ROSUVASTATIN | 5MG | Mint Pharmaceuticals Inc | Active | 2025-03-18 | 43 | Manufacturing distruption | 252950 |
6487 | C10AA07 | MINT-ROSUVASTATIN | 10MG | Mint Pharmaceuticals Inc | Active | 2025-03-18 | 43 | Manufacturing distruption | 252953 |
6488 | C10AA07 | MINT-ROSUVASTATIN | 20MG | Mint Pharmaceuticals Inc | Active | 2025-03-18 | 43 | Manufacturing distruption | 252956 |
6489 | C10AA07 | MINT-ROSUVASTATIN | 40MG | Mint Pharmaceuticals Inc | Active | 2025-03-18 | 43 | Manufacturing distruption | 252959 |
6490 | J01MA14 | APO-MOXIFLOXACIN | 400MG | Apotex Inc | Active | 2025-03-18 | 38 | Manufacturing distruption | 253064 |
6491 | N06DA03 | RIVASTIGMINE | 1.5MG | Pro Doc Limitee | Active | 2025-03-18 | Manufacturing distruption | 244187 | |
6492 | N07CA01 | AURO-BETAHISTINE | 24MG | Auro Pharma Inc | Active | 2025-03-18 | 43 | Demand increase | 252974 |
6493 | D06AX09 | STRAMUCIN | 2% | Glenmark Pharmaceuticals Canada Inc. | Active | 2025-03-18 | 33 | Demand increase | 252945 |
6494 | H05AA02 | APO-TERIPARATIDE INJECTION | 250MCG | Apotex Inc | Active | 2025-03-18 | Manufacturing distruption | 253081 | |
6495 | N01AH01 | FENTANYL CITRATE INJECTION, US... | 50MCG | Fresenius Kabi Canada Ltd | Active | 2025-03-18 | 28 | Shipping delay | 252529 |
6484 | N07BC51 | SUBOXONE | 0.5MG 2MG | Indivior Uk Limited | Resolved | 2025-03-18 | 15 | Other | 252977 |
6464 | A10BX16 | MOUNJARO | 10MG | Eli Lilly Canada Inc | Active | 2025-03-17 | Other | 249492 | |
6465 | B05BB01 | LACTATED RINGER'S INJECTION | 3.1MG 0.2MG 0.3MG 6MG | Icu Medical Canada Inc | Active | 2025-03-17 | 39 | Manufacturing distruption | 248846 |
6467 | S01ED01 | SANDOZ TIMOLOL | 0.5% | Sandoz Canada Incorporated | Active | 2025-03-17 | 32 | Demand increase | 252713 |
6468 | M01CC01 | CUPRIMINE | 250MG | Bausch Health, Canada Inc. | Active | 2025-03-17 | 90 | Shipping delay | 251954 |
6476 | N03AX18 | SANDOZ LACOSAMIDE | 150MG | Sandoz Canada Incorporated | Active | 2025-03-17 | 25 | Manufacturing distruption | 252692 |
6477 | N05AH04 | NRA-QUETIAPINE XR | 400MG | Nora Pharma Inc | Active | 2025-03-17 | Manufacturing distruption | 250818 | |
6470 | J02AC04 | POSANOL | 200MG | Merck Canada Inc | Avoided | 2025-03-17 | 4 | Demand increase | 250614 |
6466 | S01ED01 | TIMOPTIC-XE | 0.5% | Elvium Life Sciences | Resolved | 2025-03-17 | 4 | Shipping delay | 252828 |
6469 | V03AC01 | DEFEROXAMINE MESYLATE FOR INJE... | 500MG | Pfizer Canada Ulc | Resolved | 2025-03-17 | Manufacturing distruption | 243095 | |
6471 | N05AH03 | SANDOZ OLANZAPINE ODT | 10MG | Sandoz Canada Incorporated | Resolved | 2025-03-17 | 18 | Demand increase | 252695 |
6472 | C09CA07 | SANDOZ TELMISARTAN | 40MG | Sandoz Canada Incorporated | Resolved | 2025-03-17 | 4 | Manufacturing practices | 252710 |
6473 | C10AB05 | SANDOZ FENOFIBRATE E | 48.0MG | Sandoz Canada Incorporated | Resolved | 2025-03-17 | 4 | Manufacturing distruption | 252689 |
6474 | C10AB05 | SANDOZ FENOFIBRATE E | 145.0MG | Sandoz Canada Incorporated | Resolved | 2025-03-17 | 11 | Manufacturing distruption | 252686 |
6475 | N06DA03 | SANDOZ RIVASTIGMINE PATCH 10 | 9.5MG | Sandoz Canada Incorporated | Resolved | 2025-03-17 | 11 | Manufacturing practices | 252700 |
6461 | M01AH01 | PMSC-CELECOXIB | 100MG | Pharmascience Inc | Active | 2025-03-16 | 57 | Manufacturing distruption | 252757 |
6462 | N03AG01 | PMS-VALPROIC ACID | 250MG | Pharmascience Inc | Active | 2025-03-16 | 46 | Manufacturing distruption | 252745 |
6463 | C07AB02 | PMS-METOPROLOL-L | 50MG | Pharmascience Inc | Active | 2025-03-16 | 110 | Manufacturing distruption | 252749 |
6460 | B05XA03 | SODIUM CHLORIDE INJECTION USP | 9MG | Icu Medical Canada Inc | Active | 2025-03-14 | 28 | Manufacturing distruption | 251160 |
6459 | S01EC03 | TRUSOPT | 2% | Elvium Life Sciences | Resolved | 2025-03-14 | 10 | Shipping delay | 252634 |
6457 | C02DC01 | LONITEN 10MG | 10MG | Pfizer Canada Ulc | Active | 2025-03-13 | 48 | Demand increase | 251155 |
6458 | N01BB09 | ROPIVACAINE HYDROCHLORIDE INJE... | 2MG | Fresenius Kabi Canada Ltd | Resolved | 2025-03-13 | 19 | Shipping delay | 252534 |
6452 | C09AA05 | TEVA-RAMIPRIL | 5MG | Teva Canada Limited | Active | 2025-03-12 | 100 | Manufacturing distruption | 252578 |
6453 | C09AA05 | TEVA-RAMIPRIL | 10MG | Teva Canada Limited | Active | 2025-03-12 | 80 | Manufacturing distruption | 252581 |
6454 | N03AX11 | TEVA-TOPIRAMATE | 100MG | Teva Canada Limited | Active | 2025-03-12 | 69 | Manufacturing distruption | 252584 |
6455 | A10BA02 | TEVA-METFORMIN | 500MG | Teva Canada Limited | Active | 2025-03-12 | 100 | Manufacturing distruption | 252587 |
6451 | N02CC01 | IMITREX | 20MG | Glaxosmithkline Inc | Resolved | 2025-03-12 | 12 | Shipping delay | 252843 |
6456 | N07CA01 | AURO-BETAHISTINE | 16MG | Auro Pharma Inc | Resolved | 2025-03-12 | 5 | Demand increase | 252406 |
6448 | C07AB03 | APO-ATENOL TAB 100MG | 100MG | Apotex Inc | Active | 2025-03-11 | 24 | Manufacturing distruption | 252554 |
6449 | D06BB03 | APO-ACYCLOVIR OINTMENT | 5% | Apotex Inc | Active | 2025-03-11 | 31 | Manufacturing distruption | 252560 |
6450 | A10BD07 | APO-SITAGLIPTIN MALATE / METFO... | 1000MG 50MG | Apotex Inc | Active | 2025-03-11 | 73 | Manufacturing distruption | 252564 |
6447 | P01BA02 | APO-HYDROXYQUINE | 200MG | Apotex Inc | Resolved | 2025-03-11 | 24 | Manufacturing distruption | 252548 |
6438 | G03CA03 | ESTRADOT 25 | 25MCG | Sandoz Canada Incorporated | Active | 2025-03-10 | 39 | Demand increase | 252235 |
6440 | C10AA05 | SANDOZ ATORVASTATIN | 10MG | Sandoz Canada Incorporated | Active | 2025-03-10 | 39 | Manufacturing distruption | 252229 |
6443 | S01GX09 | SANDOZ OLOPATADINE 0.2% | 0.2% | Sandoz Canada Incorporated | Active | 2025-03-10 | 11 | Manufacturing distruption | 252238 |
6444 | N02BA01 | SNS-ASA EC | 80MG | Sanis Health Inc | Active | 2025-03-10 | Manufacturing distruption | 252288 | |
6446 | V03AE01 | SOLYSTAT | 250MG | Pendopharm Division Of Pharmascience Inc | Active | 2025-03-10 | 49 | Ingredient shortage | 252253 |
6439 | J01MA02 | SANDOZ CIPROFLOXACIN | 250MG | Sandoz Canada Incorporated | Resolved | 2025-03-10 | 4 | Manufacturing practices | 252232 |
6441 | N02CC04 | SANDOZ RIZATRIPTAN ODT | 10MG | Sandoz Canada Incorporated | Resolved | 2025-03-10 | 11 | Shipping delay | 252241 |
6442 | M05BA08 | ZOLEDRONIC ACID - Z | 4MG | Sandoz Canada Incorporated | Resolved | 2025-03-10 | 18 | Demand increase | 252244 |
6445 | J01XE01 | AURO-NITROFURANTOIN BID | 100MG | Auro Pharma Inc | Resolved | 2025-03-10 | Demand increase | 251209 | |
6437 | J01MA12 | LEVOFLOXACIN | 500MG | Pro Doc Limitee | Active | 2025-03-07 | 91 | Shipping delay | 251994 |
6435 | B05XA03 | SODIUM CHLORIDE INJECTION, USP | 234MG | Fresenius Kabi Canada Ltd | Resolved | 2025-03-06 | 26 | Manufacturing distruption | 250996 |
6436 | L04AC11 | SYLVANT | 400MG | Recordati Rare Diseases Canada Inc | Resolved | 2025-03-06 | 25 | Manufacturing practices | 252358 |
6418 | A10BH01 | TEVA-SITAGLIPTIN MALATE | 25MG | Teva Canada Limited | Active | 2025-03-05 | 219 | Manufacturing distruption | 252059 |
6419 | A10BH01 | TEVA-SITAGLIPTIN MALATE | 50MG | Teva Canada Limited | Active | 2025-03-05 | 219 | Manufacturing distruption | 252062 |
6420 | A10BH01 | TEVA-SITAGLIPTIN MALATE | 100MG | Teva Canada Limited | Active | 2025-03-05 | 219 | Manufacturing distruption | 252066 |
6421 | J01MA12 | LEVOFLOXACIN IN 5% DEXTROSE IN... | 5MG | Hikma Canada Limited | Active | 2025-03-05 | 88 | Demand increase | 251894 |
6422 | A10BX16 | MOUNJARO | 7.5MG | Eli Lilly Canada Inc | Active | 2025-03-05 | Other | 249489 | |
6423 | N05AA01 | TEVA-CHLORPROMAZINE | 50.0MG | Teva Canada Limited | Active | 2025-03-05 | 56 | Manufacturing distruption | 252069 |
6424 | A07EC02 | TEVA-5 ASA | 400MG | Teva Canada Limited | Active | 2025-03-05 | 36 | Manufacturing distruption | 252075 |
6425 | C07AB03 | TEVA-ATENOLOL | 50MG | Teva Canada Limited | Active | 2025-03-05 | 36 | Manufacturing distruption | 252056 |
6426 | C07AB03 | TEVA-ATENOLOL | 100MG | Teva Canada Limited | Active | 2025-03-05 | 46 | Manufacturing distruption | 252072 |
6428 | N02CC01 | TEVA-SUMATRIPTAN | 100MG | Teva Canada Limited | Active | 2025-03-05 | 66 | Manufacturing distruption | 252078 |
6430 | N06AB04 | TEVA-CITALOPRAM | 10MG | Teva Canada Limited | Active | 2025-03-05 | 97 | Manufacturing distruption | 252081 |
6431 | N06DA02 | TEVA-DONEPEZIL | 10MG | Teva Canada Limited | Active | 2025-03-05 | Manufacturing distruption | 252084 | |
6432 | C10AX09 | TARO-EZETIMIBE | 10MG | Sun Pharma Canada Inc | Active | 2025-03-05 | 51 | Manufacturing distruption | 252806 |
6433 | N01BB02 | LIDOCAINE HYDROCHLORIDE INJECT... | 20MG | Hikma Canada Limited | Active | 2025-03-05 | 44 | Shipping delay | 251897 |
6427 | D10BA01 | ACCUTANE ROCHE | 10MG | Hoffmann-La Roche Limited | Resolved | 2025-03-05 | Manufacturing distruption | 251978 | |
6429 | C10AA03 | TEVA-PRAVASTATIN | 40MG | Teva Canada Limited | Resolved | 2025-03-05 | Manufacturing distruption | 252053 | |
6434 | B01AF01 | TEVA-RIVAROXABAN | 10MG | Teva Canada Limited | Resolved | 2025-03-05 | 137 | Manufacturing distruption | 252087 |
6415 | G04BD04 | APO-OXYBUTYNIN | 5MG | Apotex Inc | Active | 2025-03-04 | Manufacturing distruption | 252151 | |
6416 | M01AE02 | APO-NAPROXEN | 500MG | Apotex Inc | Resolved | 2025-03-04 | 10 | Manufacturing distruption | 252148 |
6417 | J01DB01 | APO-CEPHALEX | 250MG | Apotex Inc | Resolved | 2025-03-04 | 24 | Manufacturing distruption | 252145 |
6371 | R06AE07 | JAMP CETIRIZINE TABLETS | 20MG | Jamp Pharma Corporation | Active | 2025-03-03 | 89 | Manufacturing distruption | 251891 |
6372 | C01CA17 | JAMP MIDODRINE | 2.5MG | Jamp Pharma Corporation | Active | 2025-03-03 | 58 | Manufacturing distruption | 251882 |
6373 | C01CA17 | JAMP MIDODRINE | 5MG | Jamp Pharma Corporation | Active | 2025-03-03 | 58 | Manufacturing distruption | 251885 |
6375 | S01EC03 | DORZOLAMIDE | 20MG | Jamp Pharma Corporation | Active | 2025-03-03 | 58 | Manufacturing distruption | 251844 |
6376 | C02AC02 | JAMP GUANFACINE XR | 1MG | Jamp Pharma Corporation | Active | 2025-03-03 | 58 | Manufacturing distruption | 251867 |
6377 | C02AC02 | JAMP GUANFACINE XR | 2MG | Jamp Pharma Corporation | Active | 2025-03-03 | 58 | Manufacturing distruption | 251870 |
6378 | C02AC02 | JAMP GUANFACINE XR | 3MG | Jamp Pharma Corporation | Active | 2025-03-03 | 58 | Manufacturing distruption | 251873 |
6379 | C02AC02 | JAMP GUANFACINE XR | 4MG | Jamp Pharma Corporation | Active | 2025-03-03 | 58 | Manufacturing distruption | 251876 |
6380 | J01EE01 | SULFAMETHOXAZOLE AND TRIMETHOP... | 16MG 80MG | Auro Pharma Inc | Active | 2025-03-03 | Demand increase | 251788 | |
6381 | C08DB01 | JAMP DILTIAZEM CD | 300MG | Jamp Pharma Corporation | Active | 2025-03-03 | 58 | Manufacturing distruption | 251864 |
6382 | M03AC09 | ROCURONIUM BROMIDE INJECTION | 10MG | Jamp Pharma Corporation | Active | 2025-03-03 | 39 | Manufacturing distruption | 251888 |
6383 | G03AA07 | AUDRINA 21 | 20MCG 100MCG | Jamp Pharma Corporation | Active | 2025-03-03 | 28 | Manufacturing distruption | 251835 |
6384 | G03AA07 | AUDRINA 28 | 20MCG 100MCG | Jamp Pharma Corporation | Active | 2025-03-03 | 28 | Manufacturing distruption | 251838 |
6385 | S01EC01 | ACETAZOLAMIDE FOR INJECTION US... | 500MG | Marcan Pharmaceuticals Inc | Active | 2025-03-03 | 89 | Shipping delay | 251983 |
6386 | G04CA04 | JAMP SILODOSIN | 8MG | Jamp Pharma Corporation | Active | 2025-03-03 | 58 | Manufacturing distruption | 251858 |
6387 | N06BA12 | SANDOZ LISDEXAMFETAMINE CAPSUL... | 40MG | Sandoz Canada Incorporated | Active | 2025-03-03 | 46 | Manufacturing distruption | 251578 |
6389 | A10BA02 | SANDOZ METFORMIN FC | 500MG | Sandoz Canada Incorporated | Active | 2025-03-03 | 18 | Manufacturing distruption | 251584 |
6390 | N04BC05 | PRAMIPEXOLE | 1.5MG | Pro Doc Limitee | Active | 2025-03-03 | 43 | Shipping delay | 251799 |
6392 | C09DA01 | SANDOZ LOSARTAN HCT | 12.5MG 100MG | Sandoz Canada Incorporated | Active | 2025-03-03 | 60 | Manufacturing distruption | 251581 |
6395 | N06AB03 | JAMP-FLUOXETINE | 20MG | Jamp Pharma Corporation | Active | 2025-03-03 | 119 | Manufacturing distruption | 251920 |
6396 | N05AH04 | JAMP QUETIAPINE FUMARATE | 100MG | Jamp Pharma Corporation | Active | 2025-03-03 | 28 | Manufacturing distruption | 251852 |
6397 | N05AH04 | JAMP QUETIAPINE FUMARATE | 200MG | Jamp Pharma Corporation | Active | 2025-03-03 | 28 | Manufacturing distruption | 251855 |
6398 | N05AH03 | JAMP OLANZAPINE ODT | 10MG | Jamp Pharma Corporation | Active | 2025-03-03 | 119 | Manufacturing distruption | 251923 |
6399 | N05AH03 | JAMP OLANZAPINE ODT | 15MG | Jamp Pharma Corporation | Active | 2025-03-03 | 119 | Manufacturing distruption | 251926 |
6400 | N05AH03 | JAMP OLANZAPINE ODT | 20MG | Jamp Pharma Corporation | Active | 2025-03-03 | 119 | Manufacturing distruption | 251929 |
6401 | S01ED01 | JAMP-TIMOLOL | 0.5% | Jamp Pharma Corporation | Active | 2025-03-03 | 39 | Manufacturing distruption | 251861 |
6404 | L01DC03 | MITOMYCIN FOR INJECTION USP | 20MG | Accord Healthcare Inc | Active | 2025-03-03 | 56 | Manufacturing distruption | 252114 |
6405 | N06BA09 | ATOMOXETINE | 100MG | Sanis Health Inc | Active | 2025-03-03 | 39 | Manufacturing distruption | 250598 |
6406 | J02AC02 | JAMP ITRACONAZOLE ORAL SOLUTIO... | 10MG | Jamp Pharma Corporation | Active | 2025-03-03 | 58 | Manufacturing distruption | 251879 |
6407 | N06DA03 | JAMP RIVASTIGMINE | 1.5MG | Jamp Pharma Corporation | Active | 2025-03-03 | 119 | Manufacturing distruption | 251932 |
6408 | N06DA03 | JAMP RIVASTIGMINE | 1.5MG | Jamp Pharma Corporation | Active | 2025-03-03 | 119 | Manufacturing distruption | 251935 |
6409 | N06DA03 | JAMP RIVASTIGMINE | 3MG | Jamp Pharma Corporation | Active | 2025-03-03 | 119 | Manufacturing distruption | 251938 |
6410 | N06DA03 | JAMP RIVASTIGMINE | 3MG | Jamp Pharma Corporation | Active | 2025-03-03 | 119 | Manufacturing distruption | 251944 |
6411 | N06DA03 | JAMP RIVASTIGMINE | 4.5MG | Jamp Pharma Corporation | Active | 2025-03-03 | 119 | Manufacturing distruption | 251947 |
6412 | N06DA03 | JAMP RIVASTIGMINE | 4.5MG | Jamp Pharma Corporation | Active | 2025-03-03 | 119 | Manufacturing distruption | 251950 |
6413 | A06AX05 | JAMP PRUCALOPRIDE | 1MG | Jamp Pharma Corporation | Active | 2025-03-03 | 89 | Manufacturing distruption | 251903 |
6414 | A06AX05 | JAMP PRUCALOPRIDE | 2MG | Jamp Pharma Corporation | Active | 2025-03-03 | 89 | Manufacturing distruption | 251911 |
6374 | L04AA06 | JAMP MYCOPHENOLIC ACID | 360MG | Jamp Pharma Corporation | Resolved | 2025-03-03 | 28 | Manufacturing distruption | 251847 |
6388 | C07AG01 | LABETALOL HYDROCHLORIDE INJECT... | 5MG | Sandoz Canada Incorporated | Resolved | 2025-03-03 | 32 | Manufacturing distruption | 251573 |
6391 | C09CA04 | SANDOZ IRBESARTAN | 75MG | Sandoz Canada Incorporated | Resolved | 2025-03-03 | 4 | Manufacturing distruption | 251570 |
6393 | A03FA03 | JAMP-DOMPERIDONE | 10MG | Jamp Pharma Corporation | Resolved | 2025-03-03 | 28 | Manufacturing distruption | 251841 |
6394 | N01AH01 | FENTANYL CITRATE INJECTION SDZ | 50MCG | Sandoz Canada Incorporated | Resolved | 2025-03-03 | 25 | Manufacturing practices | 251567 |
6402 | C01BC03 | MYLAN-PROPAFENONE | 150MG | Mylan Pharmaceuticals Ulc | Resolved | 2025-03-03 | 10 | Manufacturing distruption | 251913 |
6403 | A02BC05 | SANDOZ ESOMEPRAZOLE | 40MG | Sandoz Canada Incorporated | Resolved | 2025-03-03 | 18 | Demand increase | 251562 |
6370 | J05AG01 | MYLAN-NEVIRAPINE | 200MG | Mylan Pharmaceuticals Ulc | Resolved | 2025-03-02 | 16 | Shipping delay | 251220 |
6368 | N05CD08 | MIDAZOLAM INJECTION | 1MG | Fresenius Kabi Canada Ltd | Active | 2025-03-01 | 30 | Manufacturing distruption | 250999 |
6369 | N01BB02 | LIDOCAINE HYDROCHLORIDE INJECT... | 10MG | Hikma Canada Limited | Active | 2025-03-01 | 91 | Demand increase | 251173 |
6363 | J01GB01 | TOBI PODHALER | 28MG | Bgp Pharma Ulc | Active | 2025-02-28 | 130 | Manufacturing distruption | 251246 |
6364 | M01AE52 | MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 500MG | Mylan Pharmaceuticals Ulc | Active | 2025-02-28 | 46 | Manufacturing distruption | 250703 |
6366 | N02BF02 | ACH-PREGABALIN | 50MG | Accord Healthcare Inc | Active | 2025-02-28 | Manufacturing practices | 251430 | |
6367 | B05XA31 | MICRO+6 CONCENTRATE | 75MCG 60MCG 10MCG 55MCG 300MCG 5MG | Sandoz Canada Incorporated | Active | 2025-02-28 | 49 | Manufacturing practices | 252111 |
6365 | N07CA01 | AURO-BETAHISTINE | 16MG | Auro Pharma Inc | Resolved | 2025-02-28 | 0 | Demand increase | 251261 |
6361 | D07XC01 | TEVA-BETAMETHASONE/ CALCIPOTRI... | 50MCG 0.5MG | Teva Canada Limited | Active | 2025-02-27 | 42 | Manufacturing distruption | 251445 |
6362 | L01BC06 | TARO-CAPECITABINE | 500MG | Taro Pharmaceuticals Inc | Active | 2025-02-27 | 36 | Manufacturing distruption | 252803 |
6360 | H01AC01 | GENOTROPIN | 0.2MG | Pfizer Canada Ulc | Resolved | 2025-02-27 | Demand increase | 251328 | |
6357 | C09DA08 | OLMETEC PLUS | 12.5MG 40MG | Organon Canada Inc. | Active | 2025-02-26 | 100 | Demand increase | 251284 |
6358 | B01AF03 | LIXIANA | 15MG | Servier Canada Inc | Active | 2025-02-26 | Other | 251365 | |
6355 | S01ED01 | TIMOPTIC-XE | 0.5% | Elvium Life Sciences | Resolved | 2025-02-26 | 16 | Shipping delay | 251140 |
6356 | D10BA01 | CLARUS | 10MG | Mylan Pharmaceuticals Ulc | Resolved | 2025-02-26 | 26 | Manufacturing distruption | 248180 |
6359 | V03AE01 | SOLYSTAT | 250MG | Pendopharm Division Of Pharmascience Inc | Resolved | 2025-02-26 | 33 | Ingredient shortage | 251258 |
6348 | S03BA01 | DEXAMETHASONE | 0.1% | Pharma Stulln Inc. | Active | 2025-02-25 | Shipping delay | 251206 | |
6351 | N06BA01 | APO-AMPHETAMINE XR | 10MG | Apotex Inc | Active | 2025-02-25 | 143 | Manufacturing distruption | 251358 |
6352 | N06BA01 | APO-AMPHETAMINE XR | 20MG | Apotex Inc | Active | 2025-02-25 | 143 | Manufacturing distruption | 251361 |
6354 | B01AC24 | TARO-TICAGRELOR | 90MG | Taro Pharmaceuticals Inc | Active | 2025-02-25 | 31 | Manufacturing distruption | 252809 |
6353 | C01BC03 | MYLAN-PROPAFENONE | 150MG | Mylan Pharmaceuticals Ulc | Avoided | 2025-02-25 | 42 | Manufacturing distruption | 248186 |
6349 | J01XE01 | NITROFURANTOIN | 100MG | Aa Pharma Inc | Resolved | 2025-02-25 | 13 | Manufacturing distruption | 251339 |
6350 | L01BA01 | METHOTREXATE INJECTION USP | 25MG | Pfizer Canada Ulc | Resolved | 2025-02-25 | Shipping delay | 239727 | |
6342 | J01FA10 | SANDOZ AZITHROMYCIN | 250MG | Sandoz Canada Incorporated | Active | 2025-02-24 | 67 | Manufacturing distruption | 251110 |
6344 | A16AX06 | SANDOZ MIGLUSTAT | 100MG | Sandoz Canada Incorporated | Active | 2025-02-24 | 67 | Manufacturing practices | 251119 |
6346 | B01AF01 | SANDOZ RIVAROXABAN | 10MG | Sandoz Canada Incorporated | Active | 2025-02-24 | 53 | Shipping delay | 251126 |
6347 | B01AF02 | SANDOZ APIXABAN SDZ | 2.5MG | Sandoz Canada Incorporated | Active | 2025-02-24 | 39 | Demand increase | 251107 |
6340 | B01AD02 | CATHFLO | 2MG | Hoffmann-La Roche Limited | Resolved | 2025-02-24 | 18 | Manufacturing practices | 247639 |
6341 | G03CA03 | SANDOZ ESTRADIOL DERM 100 | 100MCG | Sandoz Canada Incorporated | Resolved | 2025-02-24 | 11 | Demand increase | 251113 |
6343 | A10BB09 | DIAMICRON MR | 60MG | Servier Canada Inc | Resolved | 2025-02-24 | Manufacturing practices | 251176 | |
6345 | D07AA02 | SANDOZ HYDROCORTISONE | 2.5% | Sandoz Canada Incorporated | Resolved | 2025-02-24 | Manufacturing distruption | 251131 | |
6339 | J01FA09 | CLARITHROMYCIN | 500MG | Sivem Pharmaceuticals Ulc | Active | 2025-02-21 | 66 | Manufacturing distruption | 250131 |
6338 | N05BA01 | DIASTAT | 10MG | Bausch Health, Canada Inc. | Resolved | 2025-02-21 | 35 | Other | 250259 |
6335 | C02AC02 | INTUNIV XR | 3MG | Takeda Canada Inc | Active | 2025-02-20 | 78 | Shipping delay | 250821 |
6337 | L01CD02 | DOCETAXEL INJECTION | 10MG | Sandoz Canada Incorporated | Active | 2025-02-20 | 69 | Ingredient shortage | 249508 |
6334 | J01GB01 | TOBI PODHALER | 28MG | Bgp Pharma Ulc | Avoided | 2025-02-20 | 61 | Manufacturing distruption | 250630 |
6336 | L01CD02 | DOCETAXEL INJECTION | 10MG | Sandoz Canada Incorporated | Avoided | 2025-02-20 | 69 | Ingredient shortage | 248843 |
6333 | G01AC05 | VABLYS | 10MG | Duchesnay Inc | Resolved | 2025-02-20 | 29 | Shipping delay | 250944 |
6325 | S01BA04 | TEVA-PREDNISOLONE | 1% | Teva Canada Limited | Active | 2025-02-19 | 40 | Manufacturing distruption | 250900 |
6326 | N03AX14 | TEVA-LEVETIRACETAM | 250MG | Teva Canada Limited | Active | 2025-02-19 | 111 | Manufacturing distruption | 250903 |
6327 | N02AB03 | TEVA-FENTANYL | 50MCG | Teva Canada Limited | Active | 2025-02-19 | 70 | Manufacturing distruption | 247782 |
6329 | C07AB02 | APO-METOPROLOL (TYPE L) | 50MG | Apotex Inc | Active | 2025-02-19 | 79 | Manufacturing distruption | 250935 |
6330 | N05AH04 | TEVA-QUETIAPINE XR | 150MG | Teva Canada Limited | Active | 2025-02-19 | 50 | Manufacturing distruption | 250906 |
6320 | N06AB03 | APO-FLUOXETINE | 10MG | Apotex Inc | Resolved | 2025-02-19 | Manufacturing distruption | 245456 | |
6321 | R05DA20 | TEVA-COTRIDIN | 10MG 30MG 2MG | Teva Canada Limited | Resolved | 2025-02-19 | 121 | Manufacturing distruption | 250897 |
6322 | L01BA01 | METHOTREXATE INJECTION USP | 25MG | Pfizer Canada Ulc | Resolved | 2025-02-19 | Shipping delay | 250770 | |
6323 | J01CR02 | APO-AMOXI CLAV | 125MG 500MG | Apotex Inc | Resolved | 2025-02-19 | 16 | Manufacturing distruption | 250941 |
6324 | N02BF01 | APO-GABAPENTIN | 400MG | Apotex Inc | Resolved | 2025-02-19 | 37 | Manufacturing distruption | 250930 |
6328 | A04AA01 | APO-ONDANSETRON | 4MG | Apotex Inc | Resolved | 2025-02-19 | 9 | Manufacturing distruption | 250938 |
6331 | G03AA12 | MYA | 0.02MG 3.00MG | Apotex Inc | Resolved | 2025-02-19 | 9 | Manufacturing distruption | 250925 |
6332 | N06AX12 | TEVA-BUPROPION XL | 150MG | Teva Canada Limited | Resolved | 2025-02-19 | 40 | Manufacturing distruption | 250909 |
6316 | J01MA14 | MOXIFLOXACIN | 400MG | Sanis Health Inc | Active | 2025-02-18 | 81 | Manufacturing distruption | 250601 |
6317 | R03BA05 | FLOVENT DISKUS | 500MCG | Glaxosmithkline Inc | Active | 2025-02-18 | 71 | Manufacturing distruption | 249839 |
6318 | S01ED51 | COSOPT PRESERVATIVE-FREE | 5MG 20MG | Elvium Life Sciences | Resolved | 2025-02-18 | 24 | Shipping delay | 250617 |
6319 | L04AC13 | TALTZ | 80MG | Eli Lilly Canada Inc | Resolved | 2025-02-18 | 13 | Shipping delay | 250993 |
6303 | B01AD02 | ACTIVASE RT-PA | 100ML 100MG | Hoffmann-La Roche Limited | Active | 2025-02-17 | 147 | Manufacturing distruption | 243681 |
6305 | N02AA05 | SUPEUDOL 20 | 20MG | Sandoz Canada Incorporated | Active | 2025-02-17 | 151 | Manufacturing practices | 250522 |
6306 | B01AC06 | PRAXIS ASA EC 81 MG DAILY LOW ... | 81MG | Pharmascience Inc | Active | 2025-02-17 | 46 | Manufacturing distruption | 250559 |
6307 | C10AA05 | SANDOZ ATORVASTATIN | 40MG | Sandoz Canada Incorporated | Active | 2025-02-17 | 81 | Manufacturing distruption | 250508 |
6308 | J01FA10 | SANDOZ AZITHROMYCIN | 200MG | Sandoz Canada Incorporated | Active | 2025-02-17 | 53 | Demand increase | 250512 |
6311 | A10BA02 | METFORMIN FC | 500MG | Sivem Pharmaceuticals Ulc | Active | 2025-02-17 | 69 | Manufacturing distruption | 250142 |
6312 | A10BA02 | METFORMIN FC | 500MG | Sivem Pharmaceuticals Ulc | Active | 2025-02-17 | 49 | Manufacturing distruption | 250145 |
6313 | G04BE08 | PMS-TADALAFIL | 5MG | Pharmascience Inc | Active | 2025-02-17 | 52 | Manufacturing distruption | 250574 |
6304 | R03AC02 | VENTOLIN DISKUS | 200MCG | Glaxosmithkline Inc | Avoided | 2025-02-17 | 11 | Demand increase | 249342 |
6302 | L04AX03 | PMS-METHOTREXATE INJECTION | 12.5MG | Pharmascience Inc | Resolved | 2025-02-17 | 28 | Manufacturing distruption | 250578 |
6309 | N05AH04 | PMS-QUETIAPINE | 50MG | Pharmascience Inc | Resolved | 2025-02-17 | 22 | Manufacturing distruption | 250563 |
6310 | N06BA09 | PMS-ATOMOXETINE | 10MG | Pharmascience Inc | Resolved | 2025-02-17 | 23 | Manufacturing distruption | 250566 |
6314 | C09CA08 | SANDOZ OLMESARTAN | 40MG | Sandoz Canada Incorporated | Resolved | 2025-02-17 | 4 | Shipping delay | 250516 |
6315 | C09BA04 | SANDOZ PERINDOPRIL ERBUMINE/ I... | 2.5MG 8MG | Sandoz Canada Incorporated | Resolved | 2025-02-17 | 39 | Shipping delay | 250519 |
6299 | N02AB03 | TEVA-FENTANYL | 75MCG | Teva Canada Limited | Active | 2025-02-15 | 74 | Manufacturing distruption | 247785 |
6300 | N06AB03 | FLUOXETINE | 10MG | Sivem Pharmaceuticals Ulc | Active | 2025-02-15 | Manufacturing distruption | 243937 | |
6301 | C07AB02 | METOPROLOL-L | 50MG | Sivem Pharmaceuticals Ulc | Active | 2025-02-15 | 51 | Manufacturing distruption | 251755 |
6295 | B03AC | FERRLECIT | 12.5MG | Sanofi-Aventis Canada Inc | Active | 2025-02-14 | Other | 250410 | |
6297 | C09CA04 | IRBESARTAN | 300MG | Sanis Health Inc | Active | 2025-02-14 | Manufacturing distruption | 243736 | |
6298 | M01AH01 | CELECOXIB | 100MG | Sanis Health Inc | Avoided | 2025-02-14 | 28 | Manufacturing distruption | 247534 |
6294 | L03AA02 | NEUPOGEN | 300MCG | Amgen Canada Inc | Resolved | 2025-02-14 | 38 | Other | 250477 |
6296 | N02CC06 | RELPAX | 40MG | Bgp Pharma Ulc | Resolved | 2025-02-14 | Other | 250228 | |
6293 | L01XX05 | MYLAN-HYDROXYUREA | 500MG | Mylan Pharmaceuticals Ulc | Avoided | 2025-02-13 | 13 | Manufacturing distruption | 248755 |
6287 | C03DA01 | TEVA-SPIRONOLACTONE | 100MG | Teva Canada Limited | Active | 2025-02-12 | 57 | Manufacturing distruption | 250384 |
6288 | D10AF51 | CLINDOXYL GEL | 1% 5% | Glaxosmithkline Inc | Active | 2025-02-12 | 93 | Demand increase | 250432 |
6289 | N05AH03 | TEVA-OLANZAPINE | 10MG | Teva Canada Limited | Active | 2025-02-12 | 77 | Manufacturing distruption | 250390 |
6292 | R01AD09 | TEVA-MOMETASONE | 50MCG | Teva Canada Limited | Active | 2025-02-12 | 67 | Manufacturing distruption | 250393 |
6285 | H02AB07 | TEVA-PREDNISONE | 50MG | Teva Canada Limited | Resolved | 2025-02-12 | 47 | Manufacturing distruption | 250387 |
6286 | V08AB02 | OMNIPAQUE 240 | 518MG | Ge Healthcare Canada Inc | Resolved | 2025-02-12 | 19 | Other | 248506 |
6290 | N06AB10 | TEVA-ESCITALOPRAM | 10MG | Teva Canada Limited | Resolved | 2025-02-12 | 26 | Manufacturing distruption | 250381 |
6291 | A10AB04 | HUMALOG 200 UNITS/ML KWIKPEN | 200UNIT | Eli Lilly Canada Inc | Resolved | 2025-02-12 | 33 | Shipping delay | 250474 |
6275 | J02AX05 | MYCAMINE | 50MG | Astellas Pharma Canada Inc | Active | 2025-02-11 | Demand increase | 250175 | |
6277 | N06DA03 | APO-RIVASTIGMINE | 1.5MG | Apotex Inc | Active | 2025-02-11 | 199 | Manufacturing distruption | 250310 |
6278 | C01BB01 | LIDOCAINE HYDROCHLORIDE INJECT... | 20MG | Pfizer Canada Ulc | Active | 2025-02-11 | Manufacturing distruption | 250245 | |
6280 | N06BA01 | APO-AMPHETAMINE XR | 5MG | Apotex Inc | Active | 2025-02-11 | 157 | Manufacturing distruption | 250325 |
6282 | N05AX12 | APO-ARIPIPRAZOLE | 5MG | Apotex Inc | Active | 2025-02-11 | 66 | Manufacturing distruption | 250322 |
6283 | N05AX12 | APO-ARIPIPRAZOLE | 10MG | Apotex Inc | Active | 2025-02-11 | 80 | Manufacturing distruption | 250307 |
6270 | M01AB15 | APO-KETOROLAC | 10MG | Apotex Inc | Resolved | 2025-02-11 | 45 | Manufacturing distruption | 250316 |
6271 | S01ED51 | COSOPT | 5MG 20MG | Elvium Life Sciences | Resolved | 2025-02-11 | 24 | Shipping delay | 250122 |
6272 | D07AD01 | TARO-CLOBETASOL CREAM USP, 0.0... | 0.05% | Taro Pharmaceuticals Inc | Resolved | 2025-02-11 | 24 | Manufacturing distruption | 250659 |
6273 | G03GA01 | CHORIONIC GONADOTROPIN FOR INJ... | 10000UNIT | Fresenius Kabi Canada Ltd | Resolved | 2025-02-11 | 34 | Shipping delay | 250170 |
6274 | A02BC03 | APO-LANSOPRAZOLE | 30MG | Apotex Inc | Resolved | 2025-02-11 | 10 | Manufacturing distruption | 250301 |
6276 | C02KX02 | VOLIBRIS | 10MG | Glaxosmithkline Inc | Resolved | 2025-02-11 | 13 | Manufacturing distruption | 250269 |
6279 | J02AC01 | FLUCONAZOLE 150 | 150MG | Apotex Inc | Resolved | 2025-02-11 | 52 | Manufacturing distruption | 250304 |
6281 | N05AX12 | APO-ARIPIPRAZOLE | 2MG | Apotex Inc | Resolved | 2025-02-11 | 38 | Manufacturing distruption | 250313 |
6284 | V03AC03 | APO-DEFERASIROX (TYPE J) | 180MG | Apotex Inc | Resolved | 2025-02-11 | 10 | Manufacturing distruption | 250319 |
6251 | G03DA04 | PROGESTERONE | 100MG | Sanis Health Inc | Active | 2025-02-10 | 74 | Manufacturing distruption | 249879 |
6253 | R03BB01 | JAMP IPRATROPIUM HFA | 20MCG | Jamp Pharma Corporation | Active | 2025-02-10 | 49 | Manufacturing distruption | 250065 |
6256 | J01FA09 | SANDOZ CLARITHROMYCIN | 250MG | Sandoz Canada Incorporated | Active | 2025-02-10 | 60 | Manufacturing distruption | 249977 |
6257 | N04BC05 | SANDOZ PRAMIPEXOLE | 0.5MG | Sandoz Canada Incorporated | Active | 2025-02-10 | 67 | Manufacturing practices | 249992 |
6260 | C09AA10 | SANDOZ TRANDOLAPRIL | 2MG | Sandoz Canada Incorporated | Active | 2025-02-10 | 60 | Manufacturing distruption | 249999 |
6264 | N05AH03 | OLANZAPINE | 7.5MG | Sanis Health Inc | Active | 2025-02-10 | 74 | Manufacturing distruption | 249876 |
6265 | R03AC02 | SALBUTAMOL HFA | 100MCG | Sanis Health Inc | Active | 2025-02-10 | 137 | Demand increase | 250070 |
6268 | A02BC05 | MYL-ESOMEPRAZOLE | 40MG | Mylan Pharmaceuticals Ulc | Active | 2025-02-10 | Manufacturing distruption | 248183 | |
6269 | C09DA08 | NRA-OLMESARTAN HCTZ | 40MG 25MG | Nora Pharma Inc | Active | 2025-02-10 | Manufacturing distruption | 248787 | |
6252 | J01CR05 | PIPERACILLIN AND TAZOBACTAM FO... | 4.5G 36G | Sandoz Canada Incorporated | Resolved | 2025-02-10 | 18 | Manufacturing practices | 249989 |
6254 | C09AA04 | COVERSYL | 2MG | Servier Canada Inc | Resolved | 2025-02-10 | 2 | Shipping delay | 250117 |
6255 | R05CB01 | ACETYLCYSTEINE SOLUTION | 200MG | Sandoz Canada Incorporated | Resolved | 2025-02-10 | 4 | Manufacturing distruption | 249961 |
6258 | M03AC09 | ROCURONIUM BROMIDE INJECTION | 10MG | Sandoz Canada Incorporated | Resolved | 2025-02-10 | 11 | Manufacturing distruption | 249996 |
6259 | C10AA05 | SANDOZ ATORVASTATIN | 20MG | Sandoz Canada Incorporated | Resolved | 2025-02-10 | 46 | Demand increase | 249965 |
6261 | C09CA06 | SANDOZ CANDESARTAN | 16MG | Sandoz Canada Incorporated | Resolved | 2025-02-10 | 32 | Manufacturing distruption | 249971 |
6262 | J01CR05 | PIPERACILLIN AND TAZOBACTAM FO... | 1.5G 12G | Sandoz Canada Incorporated | Resolved | 2025-02-10 | 18 | Manufacturing practices | 249983 |
6263 | N05AX08 | RISPERIDONE | 1MG | Sanis Health Inc | Resolved | 2025-02-10 | 53 | Manufacturing distruption | 249882 |
6266 | L01BC06 | SANDOZ CAPECITABINE | 500MG | Sandoz Canada Incorporated | Resolved | 2025-02-10 | 4 | Manufacturing distruption | 249974 |
6267 | A06AA02 | DOCUSATE SODIUM | 100MG | Sanis Health Inc | Resolved | 2025-02-10 | 39 | Manufacturing distruption | 249873 |
6245 | H01AC01 | NORDITROPIN FLEXPRO | 5MG | Novo Nordisk Canada Inc | Active | 2025-02-07 | Other | 248767 | |
6246 | R03AK06 | ADVAIR 250 DISKUS | 250MCG 50MCG | Glaxosmithkline Inc | Active | 2025-02-07 | Manufacturing distruption | 250266 | |
6247 | J01FA09 | TARO-CLARITHROMYCIN | 125MG | Taro Pharmaceuticals Inc | Active | 2025-02-07 | 77 | Manufacturing distruption | 249958 |
6249 | N06DA03 | RIVASTIGMINE | 3MG | Pro Doc Limitee | Active | 2025-02-07 | Manufacturing distruption | 244190 | |
6250 | B01AF02 | ACH-APIXABAN | 2.5MG | Accord Healthcare Inc | Active | 2025-02-07 | Manufacturing practices | 249777 | |
6244 | C09AA10 | TRANDOLAPRIL | 1MG | Sanis Health Inc | Avoided | 2025-02-07 | 14 | Manufacturing distruption | 247555 |
6248 | C10AA05 | MYLAN-ATORVASTATIN | 40MG | Mylan Pharmaceuticals Ulc | Resolved | 2025-02-07 | 46 | Demand increase | 250646 |
6243 | D07AC01 | DIPROSONE | 0.05% | Organon Canada Inc. | Active | 2025-02-06 | 134 | Demand increase | 210018 |
6242 | D10BA01 | ABSORICA LD | 16MG | Sun Pharmaceutical Industries Limited | Resolved | 2025-02-06 | 25 | Shipping delay | 250073 |
6234 | C09CA03 | TEVA-VALSARTAN | 160MG | Teva Canada Limited | Active | 2025-02-05 | 104 | Manufacturing distruption | 249728 |
6235 | C10AA07 | TARO-ROSUVASTATIN | 40MG | Sun Pharma Canada Inc | Active | 2025-02-05 | 79 | Manufacturing distruption | 250681 |
6236 | N05AH04 | TEVA-QUETIAPINE XR | 200MG | Teva Canada Limited | Active | 2025-02-05 | 64 | Manufacturing distruption | 249731 |
6237 | A02BC05 | TARO-ESOMEPRAZOLE | 40MG | Sun Pharma Canada Inc | Active | 2025-02-05 | 79 | Manufacturing distruption | 250013 |
6241 | B01AF01 | XARELTO | 103.4MG | Bayer Inc | Avoided | 2025-02-05 | 8 | Demand increase | 249406 |
6231 | N02CC01 | IMITREX | 5MG | Glaxosmithkline Inc | Resolved | 2025-02-05 | 15 | Manufacturing distruption | 249842 |
6232 | J05AB01 | MYLAN-ACYCLOVIR | 800MG | Mylan Pharmaceuticals Ulc | Resolved | 2025-02-05 | 5 | Manufacturing distruption | 246907 |
6233 | C10AA03 | TEVA-PRAVASTATIN | 20MG | Teva Canada Limited | Resolved | 2025-02-05 | Manufacturing distruption | 249734 | |
6238 | N02AX02 | TARO-TRAMADOL ER | 100MG | Taro Pharmaceuticals Inc | Resolved | 2025-02-05 | 23 | Manufacturing distruption | 250007 |
6239 | N02CD02 | EMGALITY | 100MG | Eli Lilly Canada Inc | Resolved | 2025-02-05 | 33 | Shipping delay | 250079 |
6240 | B01AF01 | XARELTO | 51.7MG | Bayer Inc | Resolved | 2025-02-05 | 8 | Demand increase | 249440 |
6218 | A02BX02 | APO-SUCRALFATE - TAB 1G | 1G | Apotex Inc | Active | 2025-02-04 | Manufacturing distruption | 249763 | |
6221 | N05AN01 | APO-LITHIUM CARBONATE | 300MG | Apotex Inc | Active | 2025-02-04 | Manufacturing distruption | 247458 | |
6222 | B01AC04 | APO-CLOPIDOGREL | 75MG | Apotex Inc | Active | 2025-02-04 | 94 | Manufacturing distruption | 249749 |
6225 | N03AX14 | PMS-LEVETIRACETAM | 750MG | Pharmascience Inc | Active | 2025-02-04 | 93 | Manufacturing distruption | 249577 |
6229 | A10BB09 | APO-GLICLAZIDE MR | 60MG | Apotex Inc | Active | 2025-02-04 | 66 | Manufacturing distruption | 249766 |
6230 | APO-MELOXICAM | 1.5G | Apotex Inc | Active | 2025-02-04 | 192 | Manufacturing distruption | 249746 | |
6217 | G03BA03 | TESTOSTERONE ENANTHATE INJECTI... | 200MG | Hikma Canada Limited | Resolved | 2025-02-04 | 45 | Demand increase | 249532 |
6219 | R03AC02 | PMS-SALBUTAMOL | 2MG | Pharmascience Inc | Resolved | 2025-02-04 | 27 | Manufacturing distruption | 249585 |
6220 | M01AG01 | MEFENAMIC | 250MG | Aa Pharma Inc | Resolved | 2025-02-04 | 41 | Manufacturing distruption | 249651 |
6223 | J01FA09 | APO-CLARITHROMYCIN | 500MG | Apotex Inc | Resolved | 2025-02-04 | 24 | Manufacturing distruption | 249760 |
6224 | A02BC03 | APO-LANSOPRAZOLE | 30MG | Apotex Inc | Resolved | 2025-02-04 | 17 | Manufacturing distruption | 249752 |
6226 | S01ED51 | APO-DORZO-TIMOP | 5MG 20MG | Apotex Inc | Resolved | 2025-02-04 | 45 | Manufacturing distruption | 249755 |
6227 | C09DA04 | PMS-IRBESARTAN-HCTZ | 12.5MG 150MG | Pharmascience Inc | Resolved | 2025-02-04 | 56 | Manufacturing distruption | 249588 |
6228 | N02CC04 | PMS-RIZATRIPTAN RDT | 10MG | Pharmascience Inc | Resolved | 2025-02-04 | 34 | Manufacturing distruption | 249580 |
6212 | S01ED01 | SANDOZ TIMOLOL | 0.25% | Sandoz Canada Incorporated | Active | 2025-02-03 | 74 | Demand increase | 249432 |
6214 | A10BA02 | SANDOZ METFORMIN FC | 500MG | Sandoz Canada Incorporated | Active | 2025-02-03 | 46 | Manufacturing distruption | 249420 |
6215 | J01DD02 | CEFTAZIDIME FOR INJECTION BP | 1G | Sterimax Inc | Active | 2025-02-03 | Manufacturing distruption | 249447 | |
6208 | G04BD11 | SANDOZ FESOTERODINE FUMARATE | 4MG | Sandoz Canada Incorporated | Resolved | 2025-02-03 | 11 | Shipping delay | 249417 |
6209 | L01EX01 | SANDOZ SUNITINIB | 12.5MG | Sandoz Canada Incorporated | Resolved | 2025-02-03 | 11 | Shipping delay | 249423 |
6210 | L01EX01 | SANDOZ SUNITINIB | 25MG | Sandoz Canada Incorporated | Resolved | 2025-02-03 | 11 | Shipping delay | 249426 |
6211 | L01EX01 | SANDOZ SUNITINIB | 50MG | Sandoz Canada Incorporated | Resolved | 2025-02-03 | 11 | Shipping delay | 249429 |
6213 | B05BA03 | DEXTROSE INJECTION USP | 50MG | Icu Medical Canada Inc | Resolved | 2025-02-03 | 39 | Manufacturing distruption | 246539 |
6216 | N01AH01 | FENTANYL INJECTION BP | 2500MCG | Sterimax Inc | Resolved | 2025-02-03 | 15 | Shipping delay | 249443 |
6206 | L01CA01 | VINBLASTINE SULPHATE INJECTION | 1MG | Teva Canada Limited | Active | 2025-02-02 | 148 | Manufacturing distruption | 245304 |
6207 | C09DA08 | NRA-OLMESARTAN HCTZ | 20MG 12.5MG | Nora Pharma Inc | Active | 2025-02-02 | Manufacturing distruption | 248781 | |
6205 | C09CA01 | SANDOZ LOSARTAN | 25MG | Sandoz Canada Incorporated | Resolved | 2025-02-02 | 47 | Manufacturing distruption | 251116 |
6200 | N02AB03 | TEVA-FENTANYL | 12MCG | Teva Canada Limited | Active | 2025-02-01 | 88 | Manufacturing distruption | 247779 |
6201 | N06AB03 | FLUOXETINE | 20MG | Sivem Pharmaceuticals Ulc | Active | 2025-02-01 | Manufacturing distruption | 243940 | |
6202 | N06AB03 | FLUOXETINE | 20MG | Sivem Pharmaceuticals Ulc | Active | 2025-02-01 | Manufacturing distruption | 243943 | |
6203 | N02CC04 | NRA-RIZATRIPTAN ODT | 10MG | Nora Pharma Inc | Active | 2025-02-01 | Manufacturing distruption | 248701 | |
6204 | B01AF02 | TARO-APIXABAN | 2.5MG | Sun Pharma Canada Inc | Active | 2025-02-01 | 69 | Manufacturing distruption | 250041 |
6198 | N07CA01 | NRA-BETAHISTINE | 24MG | Nora Pharma Inc | Resolved | 2025-02-01 | 74 | Demand increase | 248674 |
6199 | R03AC02 | PMS-SALBUTAMOL | 0.5MG | Pharmascience Inc | Resolved | 2025-02-01 | 72 | Manufacturing distruption | 249029 |
6195 | C10AA03 | TARO-PRAVASTATIN | 20MG | Sun Pharma Canada Inc | Active | 2025-01-31 | 56 | Manufacturing distruption | 250016 |
6197 | C03CA01 | FUROSEMIDE INJECTION USP | 20MG | Hikma Canada Limited | Active | 2025-01-31 | 213 | Ingredient shortage | 247669 |
6192 | J04AC01 | PDP-ISONIAZID | 50MG | Pendopharm Division Of Pharmascience Inc | Resolved | 2025-01-31 | 56 | Manufacturing distruption | 249056 |
6193 | D07AD01 | TARO-CLOBETASOL TOPICAL SOLUTI... | 0.05% | Taro Pharmaceuticals Inc | Resolved | 2025-01-31 | 35 | Manufacturing distruption | 250666 |
6194 | V03AC01 | DEFEROXAMINE MESYLATE FOR INJE... | 2G | Pfizer Canada Ulc | Resolved | 2025-01-31 | Manufacturing distruption | 243092 | |
6196 | J01CE08 | BICILLIN L-A | 1200000UNIT | Pfizer Canada Ulc | Resolved | 2025-01-31 | Manufacturing distruption | 248704 | |
6186 | L01CA02 | VINCRISTINE SULFATE INJECTION | 1MG | Teva Canada Limited | Active | 2025-01-30 | 60 | Manufacturing distruption | 249198 |
6189 | N06DA02 | TEVA-DONEPEZIL | 5MG | Teva Canada Limited | Active | 2025-01-30 | 131 | Manufacturing distruption | 249207 |
6190 | L01DB01 | DOXORUBICIN HYDROCHLORIDE INJE... | 2MG | Teva Canada Limited | Active | 2025-01-30 | 121 | Manufacturing distruption | 249210 |
6187 | N02BF01 | TEVA-GABAPENTIN | 800MG | Teva Canada Limited | Avoided | 2025-01-30 | 49 | Manufacturing distruption | 249201 |
6180 | L01BA04 | PEMETREXED FOR INJECTION | 25MG | Accord Healthcare Inc | Resolved | 2025-01-30 | 25 | Shipping delay | 249305 |
6181 | G04BE08 | ACH-TADALAFIL | 10MG | Accord Healthcare Inc | Resolved | 2025-01-30 | 15 | Shipping delay | 249308 |
6182 | G04BE08 | ACH-TADALAFIL | 20MG | Accord Healthcare Inc | Resolved | 2025-01-30 | 8 | Shipping delay | 249313 |
6183 | J01AA02 | TEVA-DOXYCYCLINE | 100MG | Teva Canada Limited | Resolved | 2025-01-30 | 54 | Manufacturing distruption | 249192 |
6184 | A05AA02 | NRA-URSODIOL | 500MG | Nora Pharma Inc | Resolved | 2025-01-30 | 76 | Demand increase | 248680 |
6185 | D07AD01 | TEVA-CLOBETASOL | 0.05% | Teva Canada Limited | Resolved | 2025-01-30 | 21 | Manufacturing distruption | 249195 |
6188 | C10AA05 | TEVA-ATORVASTATIN | 40MG | Teva Canada Limited | Resolved | 2025-01-30 | 44 | Manufacturing distruption | 249204 |
6191 | L01DB01 | DOXORUBICIN HYDROCHLORIDE INJE... | 2MG | Teva Canada Limited | Resolved | 2025-01-30 | 70 | Manufacturing distruption | 249213 |
6172 | D01AC01 | CLOTRIMADERM TOPICAL | 1% | Taro Pharmaceuticals Inc | Active | 2025-01-29 | 72 | Manufacturing distruption | 249980 |
6173 | J02AC01 | TEVA-FLUCONAZOLE | 50MG | Teva Canada Limited | Active | 2025-01-29 | Manufacturing distruption | 249185 | |
6176 | J05AR02 | TEVA-ABACAVIR/LAMIVUDINE | 300MG 600MG | Teva Canada Limited | Active | 2025-01-29 | Manufacturing distruption | 249179 | |
6174 | D01BA02 | ACT TERBINAFINE | 250MG | Teva Canada Limited | Resolved | 2025-01-29 | Manufacturing distruption | 249182 | |
6175 | N06AB10 | TARO-ESCITALOPRAM | 10MG | Sun Pharma Canada Inc | Resolved | 2025-01-29 | 31 | Manufacturing distruption | 250010 |
6177 | C09BA04 | TEVA-PERINDOPRIL/INDAPAMIDE | 2.5MG 8MG | Teva Canada Limited | Resolved | 2025-01-29 | 30 | Manufacturing distruption | 240069 |
6178 | G01AF02 | CLOTRIMADERM VAGINAL 3 | 2% | Taro Pharmaceuticals Inc | Resolved | 2025-01-29 | 44 | Manufacturing distruption | 249986 |
6179 | D10AD53 | TARO-ADAPALENE/BENZOYL PEROXID... | 2.5% 0.3% | Taro Pharmaceuticals Inc | Resolved | 2025-01-29 | 58 | Manufacturing distruption | 249955 |
6160 | J01MA12 | LEVOFLOXACIN IN 5% DEXTROSE IN... | 5MG | Hikma Canada Limited | Active | 2025-01-28 | 124 | Demand increase | 248804 |
6163 | J01EE01 | SULFATRIM | 80MG 400MG | Aa Pharma Inc | Active | 2025-01-28 | 92 | Manufacturing distruption | 248522 |
6164 | C09AA03 | APO-LISINOPRIL | 5MG | Apotex Inc | Active | 2025-01-28 | Ingredient shortage | 198528 | |
6166 | N01BB09 | NAROPIN | 2MG | Aspen Pharmacare Canada Inc. | Active | 2025-01-28 | Manufacturing distruption | 249032 | |
6168 | L01XX05 | APO-HYDROXYUREA | 500MG | Apotex Inc | Active | 2025-01-28 | 80 | Manufacturing distruption | 249096 |
6171 | N06BA01 | APO-AMPHETAMINE XR | 25MG | Apotex Inc | Active | 2025-01-28 | 171 | Manufacturing distruption | 249092 |
6161 | C09CA06 | APO-CANDESARTAN TABLETS | 8MG | Apotex Inc | Resolved | 2025-01-28 | 59 | Manufacturing distruption | 249077 |
6162 | N06AB03 | APO-FLUOXETINE | 20MG | Apotex Inc | Resolved | 2025-01-28 | Manufacturing distruption | 245459 | |
6165 | N05AB04 | PROCHLORAZINE | 10MG | Aa Pharma Inc | Resolved | 2025-01-28 | 28 | Manufacturing distruption | 249265 |
6167 | P01AB01 | APO-METRONIDAZOLE TABLETS | 250MG | Apotex Inc | Resolved | 2025-01-28 | 24 | Manufacturing distruption | 249080 |
6169 | N05AX08 | APO-RISPERIDONE | 0.50MG | Apotex Inc | Resolved | 2025-01-28 | 24 | Manufacturing distruption | 249089 |
6170 | A10BB09 | APO-GLICLAZIDE MR | 30MG | Apotex Inc | Resolved | 2025-01-28 | 66 | Manufacturing distruption | 249074 |
6154 | C09DA01 | SANDOZ LOSARTAN HCT | 12.5MG 50MG | Sandoz Canada Incorporated | Active | 2025-01-27 | 74 | Manufacturing distruption | 248645 |
6155 | C09DA04 | SANDOZ IRBESARTAN HCT | 12.5MG 300MG | Sandoz Canada Incorporated | Active | 2025-01-27 | 116 | Manufacturing distruption | 248642 |
6156 | C03CA01 | FUROSEMIDE INJECTION SDZ | 10MG | Sandoz Canada Incorporated | Active | 2025-01-27 | 81 | Manufacturing distruption | 248629 |
6157 | L02BG03 | MINT-ANASTROZOLE | 1MG | Mint Pharmaceuticals Inc | Active | 2025-01-27 | 124 | Manufacturing distruption | 248689 |
6158 | A04AA01 | ONDANSETRON ODT | 8MG | Sandoz Canada Incorporated | Active | 2025-01-27 | 81 | Manufacturing distruption | 248648 |
6152 | L01BA01 | METHOTREXATE INJECTION USP | 25MG | Pfizer Canada Ulc | Resolved | 2025-01-27 | Demand increase | 239730 | |
6153 | J05AB01 | MYLAN-ACYCLOVIR | 400MG | Mylan Pharmaceuticals Ulc | Resolved | 2025-01-27 | 15 | Manufacturing distruption | 248196 |
6159 | B01AF02 | SANDOZ APIXABAN SDZ | 5MG | Sandoz Canada Incorporated | Resolved | 2025-01-27 | 18 | Shipping delay | 248626 |
6142 | L01BC06 | CAPECITABINE | 500MG | Sanis Health Inc | Active | 2025-01-24 | Manufacturing distruption | 223361 | |
6143 | C01BA03 | RYTHMODAN | 100MG | Cheplapharm Arzneimittel Gmbh | Active | 2025-01-24 | 97 | Manufacturing distruption | 248525 |
6144 | D07AD01 | TARO-CLOBETASOL OINTMENT USP, ... | 0.05% | Taro Pharmaceuticals Inc | Active | 2025-01-24 | 70 | Manufacturing distruption | 249968 |
6145 | A10BA02 | PRO-METFORMIN | 850MG | Pro Doc Limitee | Active | 2025-01-24 | 111 | Shipping delay | 248533 |
6146 | A10BA02 | PRO-METFORMIN | 500MG | Pro Doc Limitee | Active | 2025-01-24 | 111 | Shipping delay | 248530 |
6147 | N06DA02 | TARO-DONEPEZIL | 5MG | Sun Pharma Canada Inc | Active | 2025-01-24 | 70 | Manufacturing distruption | 248915 |
6150 | N05AE05 | TARO-LURASIDONE | 80MG | Taro Pharmaceuticals Inc | Active | 2025-01-24 | 56 | Manufacturing distruption | 248951 |
6148 | D01AC20 | TARO-CLOTRIMAZOLE/BETAMETHASON... | 1% 0.05% | Taro Pharmaceuticals Inc | Resolved | 2025-01-24 | 42 | Manufacturing distruption | 250689 |
6149 | D01AC20 | TARO-CLOTRIMAZOLE/BETAMETHASON... | 1% 0.05% | Taro Pharmaceuticals Inc | Resolved | 2025-01-24 | 42 | Manufacturing distruption | 248927 |
6151 | D07AD01 | TARO-CLOBETASOL SHAMPOO | 0.05% | Taro Pharmaceuticals Inc | Resolved | 2025-01-24 | 14 | Manufacturing distruption | 248936 |
6141 | J01GB01 | TOBI PODHALER | 28MG | Bgp Pharma Ulc | Resolved | 2025-01-23 | 19 | Manufacturing distruption | 249040 |
6139 | A10BX16 | MOUNJARO | 15MG | Eli Lilly Canada Inc | Active | 2025-01-22 | Other | 248601 | |
6137 | C09BA04 | PERINDOPRIL/INDAPAMIDE | 2.5MG 8MG | Sanis Health Inc | Resolved | 2025-01-22 | 58 | Manufacturing distruption | 243716 |
6138 | C01CA17 | MIDODRINE | 5MG | Sanis Health Inc | Resolved | 2025-01-22 | 58 | Manufacturing distruption | 247543 |
6140 | N03AF01 | TEGRETOL CR | 400MG | Novartis Pharmaceuticals Canada Inc | Resolved | 2025-01-22 | 11 | Demand increase | 245118 |
6128 | C03BA04 | JAMP CHLORTHALIDONE | 12.5MG | Jamp Pharma Corporation | Active | 2025-01-21 | 130 | Manufacturing distruption | 248363 |
6129 | C03BA04 | JAMP CHLORTHALIDONE | 25MG | Jamp Pharma Corporation | Active | 2025-01-21 | 130 | Manufacturing distruption | 248369 |
6135 | N06DA03 | APO-RIVASTIGMINE | 4.5MG | Apotex Inc | Active | 2025-01-21 | 220 | Manufacturing distruption | 248492 |
6130 | L04AA32 | APO-APREMILAST | 30MG | Apotex Inc | Resolved | 2025-01-21 | 10 | Manufacturing distruption | 248558 |
6131 | N03AX23 | APO-BRIVARACETAM | 75MG | Apotex Inc | Resolved | 2025-01-21 | 31 | Manufacturing distruption | 248486 |
6132 | N02AA01 | KADIAN | 20MG | Bgp Pharma Ulc | Resolved | 2025-01-21 | 1 | Manufacturing distruption | 248177 |
6133 | M01AE02 | APO-NAPROXEN | 500MG | Apotex Inc | Resolved | 2025-01-21 | 59 | Manufacturing distruption | 248489 |
6134 | P01AB01 | APO-METRONIDAZOLE | 500MG | Apotex Inc | Resolved | 2025-01-21 | 52 | Manufacturing distruption | 248483 |
6136 | R03AK06 | WIXELA INHUB | 50MCG 100MCG | Mylan Pharmaceuticals Ulc | Resolved | 2025-01-21 | 2 | Manufacturing distruption | 248189 |
6111 | D06BB03 | TARO-ACYCLOVIR | 5% | Taro Pharmaceuticals Inc | Active | 2025-01-20 | 88 | Manufacturing distruption | 248996 |
6115 | C02AC01 | TEVA-CLONIDINE | 0.2MG | Teva Canada Limited | Active | 2025-01-20 | 90 | Manufacturing distruption | 248427 |
6118 | N04BC05 | SANDOZ PRAMIPEXOLE | 1MG | Sandoz Canada Incorporated | Active | 2025-01-20 | 88 | Manufacturing practices | 248135 |
6119 | J01MA12 | ACT LEVOFLOXACIN | 250MG | Teva Canada Limited | Active | 2025-01-20 | Manufacturing distruption | 248430 | |
6120 | J01MA12 | ACT LEVOFLOXACIN | 500MG | Teva Canada Limited | Active | 2025-01-20 | Manufacturing distruption | 248433 | |
6121 | C10AA05 | SANDOZ ATORVASTATIN | 40MG | Sandoz Canada Incorporated | Active | 2025-01-20 | 88 | Demand increase | 248125 |
6122 | C09CA04 | SANDOZ IRBESARTAN | 150MG | Sandoz Canada Incorporated | Active | 2025-01-20 | 95 | Manufacturing distruption | 248132 |
6123 | J05AR06 | TEVA-EFAVIRENZ/EMTRICITABINE/T... | 300MG 200MG 600MG | Teva Canada Limited | Active | 2025-01-20 | Manufacturing distruption | 248436 | |
6124 | J05AR03 | TEVA-EMTRICITABINE/TENOFOVIR | 300MG 200MG | Teva Canada Limited | Active | 2025-01-20 | 376 | Manufacturing distruption | 248439 |
6125 | L01XG01 | ACT BORTEZOMIB | 3.5MG | Teva Canada Limited | Active | 2025-01-20 | Manufacturing distruption | 248442 | |
6112 | A11CC03 | SANDOZ ALFACALCIDOL | 0.25MCG | Sandoz Canada Incorporated | Resolved | 2025-01-20 | 32 | Manufacturing practices | 248121 |
6113 | J06BD08 | BEYFORTUS | 50MG | Sanofi Pasteur Limited | Resolved | 2025-01-20 | 69 | Demand increase | 248064 |
6114 | S01GX05 | ALOMIDE | 0.1% | Novartis Pharmaceuticals Canada Inc | Resolved | 2025-01-20 | 58 | Demand increase | 247997 |
6116 | R05CB01 | ACETYLCYSTEINE SOLUTION | 200MG | Sandoz Canada Incorporated | Resolved | 2025-01-20 | 4 | Manufacturing distruption | 248117 |
6117 | L04AD01 | SANDOZ CYCLOSPORINE | 25MG | Sandoz Canada Incorporated | Resolved | 2025-01-20 | 4 | Shipping delay | 248128 |
6126 | N06AX12 | TEVA-BUPROPION XL | 300MG | Teva Canada Limited | Resolved | 2025-01-20 | 39 | Manufacturing distruption | 248445 |
6127 | J01DD04 | CEFTRIAXONE INJECTION, USP | 2000MG | Baxter Corporation | Resolved | 2025-01-20 | 11 | Manufacturing distruption | 247690 |
6109 | G03BA03 | DEPO-TESTOSTERONE INJ 100MG/ML | 100MG | Pfizer Canada Ulc | Active | 2025-01-17 | Manufacturing distruption | 247166 | |
6108 | C09BA04 | PERINDOPRIL/INDAPAMIDE | 2.5MG 8MG | Sanis Health Inc | Resolved | 2025-01-17 | 49 | Manufacturing distruption | 247546 |
6110 | L01DB03 | EPIRUBICIN FOR INJECTION | 2MG | Teva Canada Limited | Resolved | 2025-01-17 | Manufacturing distruption | 246254 | |
6106 | C07AB02 | PMS-METOPROLOL-L | 25MG | Pharmascience Inc | Active | 2025-01-16 | 102 | Manufacturing distruption | 248005 |
6104 | A10BK01 | PMS-DAPAGLIFLOZIN | 5MG | Pharmascience Inc | Resolved | 2025-01-16 | 39 | Manufacturing distruption | 248000 |
6105 | G04BD04 | PMS-OXYBUTYNIN | 5MG | Pharmascience Inc | Resolved | 2025-01-16 | 63 | Manufacturing distruption | 248010 |
6107 | H01CC03 | ORILISSA | 200MG | Abbvie Corporation | Resolved | 2025-01-16 | 67 | Other | 245420 |
6091 | S01HA04 | ALCAINE | 0.5% | Alcon Canada Inc | Active | 2025-01-15 | 135 | Ingredient shortage | 246560 |
6099 | L01AX03 | TARO-TEMOZOLOMIDE | 20MG | Taro Pharmaceuticals Inc | Active | 2025-01-15 | 65 | Manufacturing distruption | 250004 |
6102 | N04BD03 | ONSTRYV | 50MG | Valeo Pharma Inc | Active | 2025-01-15 | 105 | Demand increase | 244023 |
6103 | N04BD03 | ONSTRYV | 100MG | Valeo Pharma Inc | Active | 2025-01-15 | 105 | Demand increase | 244021 |
6092 | N06AB08 | LUVOX | 50MG | Bgp Pharma Ulc | Resolved | 2025-01-15 | Manufacturing distruption | 245725 | |
6093 | J01FA09 | BIAXIN | 125MG | Bgp Pharma Ulc | Resolved | 2025-01-15 | 47 | Manufacturing distruption | 248148 |
6094 | N02CC01 | MYLAN-SUMATRIPTAN | 100MG | Mylan Pharmaceuticals Ulc | Resolved | 2025-01-15 | 6 | Other | 247721 |
6095 | N05AH04 | PRO-QUETIAPINE | 25MG | Pro Doc Limitee | Resolved | 2025-01-15 | 59 | Shipping delay | 247812 |
6096 | N06DA03 | MYLAN-RIVASTIGMINE PATCH 10 | 9.5MG | Mylan Pharmaceuticals Ulc | Resolved | 2025-01-15 | 5 | Manufacturing distruption | 247724 |
6097 | N06DA03 | MYLAN-RIVASTIGMINE PATCH 10 | 9.5MG | Mylan Pharmaceuticals Ulc | Resolved | 2025-01-15 | 13 | Manufacturing distruption | 245476 |
6098 | A05AA02 | GLN-URSODIOL | 250MG | Glenmark Pharmaceuticals Canada Inc. | Resolved | 2025-01-15 | 37 | Demand increase | 247964 |
6100 | J01XE01 | AURO-NITROFURANTOIN BID | 100MG | Auro Pharma Inc | Resolved | 2025-01-15 | 23 | Demand increase | 244481 |
6101 | P02CF01 | STROMECTOL | 3MG | Merck Canada Inc | Resolved | 2025-01-15 | 9 | Demand increase | 247703 |
6087 | S01ED01 | APO-TIMOP | 0.5% | Apotex Inc | Active | 2025-01-14 | 339 | Manufacturing distruption | 247865 |
6081 | L01XA02 | CARBOPLATIN INJECTION BP | 10MG | Pfizer Canada Ulc | Avoided | 2025-01-14 | Manufacturing distruption | 243984 | |
6082 | J01DB05 | APO-CEFADROXIL | 500MG | Apotex Inc | Resolved | 2025-01-14 | 45 | Manufacturing distruption | 247862 |
6083 | A02BB01 | MISOPROSTOL | 200MCG | Aa Pharma Inc | Resolved | 2025-01-14 | 44 | Manufacturing distruption | 247821 |
6084 | N05AH03 | APO-OLANZAPINE ODT | 5MG | Apotex Inc | Resolved | 2025-01-14 | 38 | Manufacturing distruption | 247901 |
6085 | S01EE01 | MYLAN-LATANOPROST | 50MCG | Mylan Pharmaceuticals Ulc | Resolved | 2025-01-14 | 10 | Demand increase | 248163 |
6086 | N02CC04 | APO-RIZATRIPTAN | 5MG | Apotex Inc | Resolved | 2025-01-14 | 24 | Manufacturing distruption | 247859 |
6088 | N05CF02 | APO-ZOLPIDEM ODT | 10MG | Apotex Inc | Resolved | 2025-01-14 | 31 | Manufacturing distruption | 247880 |
6089 | N05AX12 | APO-ARIPIPRAZOLE | 15MG | Apotex Inc | Resolved | 2025-01-14 | 17 | Manufacturing distruption | 247894 |
6090 | N03AX18 | TEVA-LACOSAMIDE | 200MG | Teva Canada Limited | Resolved | 2025-01-14 | 65 | Manufacturing distruption | 247935 |
6073 | C03CA01 | FUROSEMIDE INJECTION SDZ | 10MG | Sandoz Canada Incorporated | Active | 2025-01-13 | 95 | Manufacturing distruption | 247601 |
6074 | J01MA14 | SANDOZ MOXIFLOXACIN | 400MG | Sandoz Canada Incorporated | Active | 2025-01-13 | 95 | Manufacturing practices | 247617 |
6076 | C08DB01 | DILTIAZEM CD | 300MG | Sanis Health Inc | Active | 2025-01-13 | 165 | Manufacturing distruption | 247537 |
6080 | V03AC03 | SANDOZ DEFERASIROX (TYPE J) | 180MG | Sandoz Canada Incorporated | Active | 2025-01-13 | 101 | Demand increase | 247593 |
6059 | G04CA01 | ALFUZOSIN | 10MG | Sanis Health Inc | Resolved | 2025-01-13 | 32 | Manufacturing distruption | 247528 |
6060 | C07AA05 | TEVA-PROPRANOLOL | 10MG | Teva Canada Limited | Resolved | 2025-01-13 | 46 | Manufacturing distruption | 247932 |
6061 | C07AG01 | LABETALOL HYDROCHLORIDE INJECT... | 5MG | Sandoz Canada Incorporated | Resolved | 2025-01-13 | 32 | Demand increase | 247608 |
6062 | N05AA02 | METHOPRAZINE | 5MG | Aa Pharma Inc | Resolved | 2025-01-13 | 56 | Manufacturing distruption | 247522 |
6063 | V08AB04 | ISOVUE MULTIPACK-370 | 76% | Bracco Imaging Canada | Resolved | 2025-01-13 | 7 | Shipping delay | 247223 |
6064 | N03AF01 | TARO-CARBAMAZEPINE CHEWABLE TA... | 100MG | Taro Pharmaceuticals Inc | Resolved | 2025-01-13 | 25 | Manufacturing distruption | 248918 |
6065 | N02AA01 | SANDOZ MORPHINE SR | 15MG | Sandoz Canada Incorporated | Resolved | 2025-01-13 | 11 | Manufacturing distruption | 247614 |
6066 | G04CB01 | SANDOZ FINASTERIDE | 5MG | Sandoz Canada Incorporated | Resolved | 2025-01-13 | Manufacturing distruption | 247627 | |
6067 | C09CA04 | SANDOZ IRBESARTAN | 300MG | Sandoz Canada Incorporated | Resolved | 2025-01-13 | 18 | Manufacturing distruption | 247605 |
6068 | J01FA10 | AZITHROMYCIN | 250MG | Sanis Health Inc | Resolved | 2025-01-13 | 32 | Manufacturing distruption | 247531 |
6069 | G04CA02 | SANDOZ TAMSULOSIN CR | 0.4MG | Sandoz Canada Incorporated | Resolved | 2025-01-13 | 46 | Manufacturing distruption | 247623 |
6070 | L02BG04 | SANDOZ LETROZOLE | 2.5MG | Sandoz Canada Incorporated | Resolved | 2025-01-13 | 46 | Shipping delay | 247611 |
6071 | N02CC04 | SANDOZ RIZATRIPTAN ODT | 5MG | Sandoz Canada Incorporated | Resolved | 2025-01-13 | 74 | Shipping delay | 247620 |
6072 | N05AX08 | RISPERIDONE | 0.5MG | Sanis Health Inc | Resolved | 2025-01-13 | 32 | Manufacturing distruption | 247549 |
6075 | C10AB05 | SANDOZ FENOFIBRATE E | 48.0MG | Sandoz Canada Incorporated | Resolved | 2025-01-13 | 18 | Demand increase | 247597 |
6077 | N06AB10 | ESCITALOPRAM | 20MG | Sanis Health Inc | Resolved | 2025-01-13 | 67 | Manufacturing distruption | 247540 |
6078 | M01AE52 | MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 500MG | Mylan Pharmaceuticals Ulc | Resolved | 2025-01-13 | 28 | Manufacturing distruption | 247737 |
6079 | G04BD08 | SOLIFENACIN | 5MG | Sanis Health Inc | Resolved | 2025-01-13 | 18 | Manufacturing distruption | 247552 |
6058 | C09DA08 | GLN-OLMESARTAN HCTZ | 12.5MG 20MG | Glenmark Pharmaceuticals Canada Inc. | Active | 2025-01-11 | 93 | Demand increase | 247976 |
6053 | N05BA01 | DIASTAT | 15MG | Bausch Health, Canada Inc. | Active | 2025-01-10 | 140 | Other | 247796 |
6054 | A11CC03 | ONE-ALPHA | 2MCG | Cheplapharm Arzneimittel Gmbh | Active | 2025-01-10 | 111 | Manufacturing distruption | 247425 |
6055 | R03AC02 | APO-SALBUTAMOL HFA | 100MCG | Apotex Inc | Active | 2025-01-10 | 84 | Demand increase | 247455 |
6056 | B05BA03 | 5% DEXTROSE INJECTION | 50MG | Fresenius Kabi Canada Ltd | Resolved | 2025-01-10 | 28 | Shipping delay | 247474 |
6057 | D06AX09 | STRAMUCIN | 2% | Glenmark Pharmaceuticals Canada Inc. | Resolved | 2025-01-10 | 38 | Demand increase | 247973 |
6050 | R03BA07 | ASMANEX TWISTHALER | 200MCG | Organon Canada Inc. | Resolved | 2025-01-09 | 22 | Shipping delay | 246865 |
6051 | C09CA09 | EDARBI | 40MG | Bausch Health, Canada Inc. | Resolved | 2025-01-09 | 7 | Other | 245958 |
6052 | G03AD01 | CONTINGENCY ONE | 1.5MG | Mylan Pharmaceuticals Ulc | Resolved | 2025-01-09 | 22 | Shipping delay | 246904 |
6032 | D01AC01 | CLOTRIMADERM TOPICAL | 1% | Taro Pharmaceuticals Inc | Active | 2025-01-08 | 93 | Manufacturing distruption | 249011 |
6037 | N01BB02 | XYLOCAINE 1% | 10MG | Aspen Pharmacare Canada Inc. | Active | 2025-01-08 | 265 | Manufacturing distruption | 247177 |
6038 | N01BB02 | XYLOCAINE 2% | 20MG | Aspen Pharmacare Canada Inc. | Active | 2025-01-08 | 265 | Manufacturing distruption | 247180 |
6040 | L01XA02 | CARBOPLATIN INJECTION BP | 10MG | Accord Healthcare Inc | Active | 2025-01-08 | Manufacturing practices | 244151 | |
6042 | L01CE01 | TOPOTECAN HYDROCHLORIDE FOR IN... | 1MG | Accord Healthcare Inc | Active | 2025-01-08 | Manufacturing practices | 247141 | |
6043 | A05AA02 | GLN-URSODIOL | 500MG | Glenmark Pharmaceuticals Canada Inc. | Active | 2025-01-08 | 112 | Demand increase | 247163 |
6044 | L01BB05 | FLUDARABINE PHOSPHATE INJECTIO... | 25MG | Accord Healthcare Inc | Active | 2025-01-08 | Manufacturing practices | 247144 | |
6045 | L01BA04 | PEMETREXED DISODIUM FOR INJECT... | 100MG | Accord Healthcare Inc | Active | 2025-01-08 | Manufacturing distruption | 247136 | |
6046 | L04AD02 | ACH-TACROLIMUS | 1MG | Accord Healthcare Inc | Active | 2025-01-08 | Manufacturing practices | 247409 | |
6047 | L01BC06 | TARO-CAPECITABINE | 150MG | Taro Pharmaceuticals Inc | Active | 2025-01-08 | 72 | Manufacturing distruption | 249014 |
6048 | L01BA01 | METHOTREXATE INJECTION BP | 25MG | Accord Healthcare Inc | Active | 2025-01-08 | 100 | Manufacturing distruption | 247127 |
6049 | L01BA01 | METHOTREXATE INJECTION BP | 25MG | Accord Healthcare Inc | Active | 2025-01-08 | 100 | Manufacturing distruption | 247130 |
6033 | V07AB | STERILE WATER FOR INJECTION, U... | 100% | Baxter Corporation | Resolved | 2025-01-08 | 65 | Shipping delay | 247433 |
6034 | B05BA03 | 70% DEXTROSE INJECTION USP | 70G | Baxter Corporation | Resolved | 2025-01-08 | 65 | Shipping delay | 247430 |
6035 | L01BA01 | METHOTREXATE INJECTION USP | 25MG | Pfizer Canada Ulc | Resolved | 2025-01-08 | Demand increase | 239736 | |
6036 | B05BA01 | 20% PROSOL | 0.05G 0.6G 1.02G 1.02G 1.34G 1.96G 2.06G 2.76G 0.32G 0.76G 0.98G 1G 1.08G 1.08G 1.18G 1.35G 1.44G | Baxter Corporation | Resolved | 2025-01-08 | 26 | Manufacturing distruption | 247510 |
6039 | N02CC01 | MYLAN-SUMATRIPTAN | 50MG | Mylan Pharmaceuticals Ulc | Resolved | 2025-01-08 | 13 | Shipping delay | 246893 |
6041 | N07XX02 | MYLAN-RILUZOLE | 50MG | Mylan Pharmaceuticals Ulc | Resolved | 2025-01-08 | 13 | Shipping delay | 246898 |
6013 | B05BB02 | POTASS CHLOR 40MEQ 5% DEX AND ... | 300MG 900MG 5G | Baxter Corporation | Active | 2025-01-07 | 113 | Manufacturing distruption | 247098 |
6016 | R03BB01 | TEVA-IPRATROPIUM STERINEBS | 250MCG | Teva Canada Limited | Active | 2025-01-07 | 144 | Manufacturing distruption | 247336 |
6017 | R06AX13 | APO-LORATADINE | 10MG | Apotex Inc | Active | 2025-01-07 | 101 | Manufacturing distruption | 247397 |
6018 | A11HA02 | PYRIDOXINE HYDROCHLORIDE INJEC... | 100MG | Mylan Pharmaceuticals Ulc | Active | 2025-01-07 | 140 | Manufacturing distruption | 246901 |
6019 | S01BA04 | TEVA-PREDNISOLONE | 1% | Teva Canada Limited | Active | 2025-01-07 | 113 | Manufacturing distruption | 247316 |
6021 | A04AA01 | TEVA-ONDANSETRON | 4MG | Teva Canada Limited | Active | 2025-01-07 | Manufacturing distruption | 247360 | |
6025 | J05AG03 | TEVA-EFAVIRENZ | 600MG | Teva Canada Limited | Active | 2025-01-07 | Manufacturing distruption | 247357 | |
6026 | N07BA03 | APO-VARENICLINE | 1MG | Apotex Inc | Active | 2025-01-07 | 101 | Manufacturing distruption | 247385 |
6030 | B01AF02 | ACH-APIXABAN | 5MG | Accord Healthcare Inc | Active | 2025-01-07 | Manufacturing practices | 247412 | |
6031 | H01CB02 | OCTREOTIDE FOR INJECTABLE SUSP... | 20MG | Teva Canada Limited | Active | 2025-01-07 | 133 | Manufacturing distruption | 247309 |
6012 | N03AX23 | APO-BRIVARACETAM | 50MG | Apotex Inc | Resolved | 2025-01-07 | 38 | Manufacturing distruption | 247388 |
6014 | C02DB02 | APO-HYDRALAZINE | 50MG | Apotex Inc | Resolved | 2025-01-07 | 31 | Manufacturing distruption | 247379 |
6015 | D07AD01 | TEVA-CLOBETASOL | 0.05% | Teva Canada Limited | Resolved | 2025-01-07 | 44 | Manufacturing distruption | 247319 |
6020 | H02AB02 | APO-DEXAMETHASONE | 4MG | Apotex Inc | Resolved | 2025-01-07 | 38 | Manufacturing distruption | 247382 |
6022 | N06BA09 | TEVA-ATOMOXETINE | 40MG | Teva Canada Limited | Resolved | 2025-01-07 | 34 | Manufacturing distruption | 247322 |
6023 | N06AB10 | TEVA-ESCITALOPRAM | 10MG | Teva Canada Limited | Resolved | 2025-01-07 | 52 | Manufacturing distruption | 247325 |
6024 | S01ED51 | MYLAN-LATANOPROST/TIMOLOL | 50MCG 5MG | Mylan Pharmaceuticals Ulc | Resolved | 2025-01-07 | 45 | Demand increase | 250637 |
6027 | C08CA02 | APO-FELODIPINE | 5MG | Apotex Inc | Resolved | 2025-01-07 | 24 | Manufacturing distruption | 247391 |
6028 | C08CA02 | APO-FELODIPINE | 10MG | Apotex Inc | Resolved | 2025-01-07 | 24 | Manufacturing distruption | 247394 |
6029 | N03AB02 | PHENYTOIN SODIUM | 100MG | Aa Pharma Inc | Resolved | 2025-01-07 | 13 | Manufacturing distruption | 247519 |
6010 | C09DA09 | EDARBYCLOR | 12.5MG 40MG | Bausch Health, Canada Inc. | Active | 2025-01-06 | 91 | Other | 247037 |
6008 | D10AD01 | RETIN-A | 0.05% | Bausch Health, Canada Inc. | Resolved | 2025-01-06 | 40 | Demand increase | 247032 |
6009 | J05AP01 | VIRAZOLE | 6G | Bausch Health, Canada Inc. | Resolved | 2025-01-06 | 32 | Demand increase | 247043 |
6011 | H04AA01 | BAQSIMI | 3MG | Amphastar Pharmaceuticals, Inc. | Resolved | 2025-01-06 | 68 | Other | 246858 |
6005 | C09CA04 | IRBESARTAN | 150MG | Sanis Health Inc | Active | 2025-01-03 | Manufacturing distruption | 243729 | |
6006 | M01AH01 | AURO-CELECOXIB | 100MG | Auro Pharma Inc | Active | 2025-01-03 | 118 | Demand increase | 237513 |
6007 | N05AE05 | TARO-LURASIDONE | 20MG | Taro Pharmaceuticals Inc | Resolved | 2025-01-03 | 42 | Manufacturing distruption | 248948 |
5997 | L04AF01 | TARO-TOFACITINIB | 5MG | Taro Pharmaceuticals Inc | Active | 2025-01-01 | 86 | Manufacturing distruption | 250059 |
5998 | B05XA19 | CALCIUM GLUCONATE INJECTION, U... | 100MG | Baxter Corporation | Active | 2025-01-01 | Ingredient shortage | 238556 | |
5999 | L01XA02 | CARBOPLATIN INJECTION BP | 10MG | Accord Healthcare Inc | Active | 2025-01-01 | Manufacturing practices | 227111 | |
6000 | J01FA09 | TARO-CLARITHROMYCIN | 500MG | Sun Pharma Canada Inc | Active | 2025-01-01 | 86 | Manufacturing distruption | 248912 |
6004 | B01AF02 | TARO-APIXABAN | 5MG | Sun Pharma Canada Inc | Active | 2025-01-01 | 86 | Manufacturing distruption | 248909 |
6001 | C09CA06 | AURO-CANDESARTAN | 16MG | Auro Pharma Inc | Resolved | 2025-01-01 | Demand increase | 78626 | |
6002 | G03XA | ORILISSA | 150MG | Abbvie Corporation | Resolved | 2025-01-01 | 24 | Other | 245357 |
6003 | L04AX04 | TARO-LENALIDOMIDE | 10MG | Taro Pharmaceuticals Inc | Resolved | 2025-01-01 | 65 | Manufacturing distruption | 250050 |
5995 | D10BA01 | CLARUS | 10MG | Mylan Pharmaceuticals Ulc | Resolved | 2024-12-30 | Manufacturing distruption | 244622 | |
5996 | N02AA01 | MORPHINE SULFATE INJECTION EPI... | 0.5MG | Sterimax Inc | Resolved | 2024-12-30 | 64 | Manufacturing distruption | 245804 |
5993 | N07CA01 | SERC | 16MG | Bgp Pharma Ulc | Active | 2024-12-27 | 123 | Demand increase | 247750 |
5994 | N07CA01 | SERC | 24MG | Bgp Pharma Ulc | Active | 2024-12-27 | 123 | Demand increase | 247753 |
5992 | A05AA02 | NRA-URSODIOL | 250MG | Nora Pharma Inc | Resolved | 2024-12-27 | 110 | Demand increase | 248677 |
5989 | S01EC05 | METHAZOLAMIDE | 50MG | Aa Pharma Inc | Active | 2024-12-24 | 171 | Manufacturing distruption | 245994 |
5988 | H01BA02 | DESMOPRESSIN SPRAY | 10MCG | Aa Pharma Inc | Resolved | 2024-12-24 | 27 | Manufacturing distruption | 245991 |
5990 | N02BA01 | PRO-AAS - 80 (CROQUABLE) | 80MG | Pro Doc Limitee | Resolved | 2024-12-24 | 66 | Shipping delay | 246441 |
5991 | M05BA07 | AA-RISEDRONATE DR | 35MG | Aa Pharma Inc | Resolved | 2024-12-24 | 76 | Manufacturing distruption | 245997 |
5954 | C03BA04 | JAMP CHLORTHALIDONE | 50MG | Jamp Pharma Corporation | Active | 2024-12-23 | 159 | Manufacturing distruption | 246792 |
5955 | J01CR02 | JAMP AMOXI CLAV SUSPENSION | 28.5MG 200MG | Jamp Pharma Corporation | Active | 2024-12-23 | 189 | Manufacturing distruption | 246750 |
5962 | L02BG03 | JAMP-ANASTROZOLE | 1MG | Jamp Pharma Corporation | Active | 2024-12-23 | 128 | Manufacturing distruption | 246756 |
5963 | L02BG03 | JAMP-ANASTROZOLE | 1MG | Jamp Pharma Corporation | Active | 2024-12-23 | 128 | Manufacturing distruption | 246759 |
5969 | C09CA01 | JAMP-LOSARTAN | 25MG | Jamp Pharma Corporation | Active | 2024-12-23 | 189 | Manufacturing distruption | 246694 |
5970 | N02CC03 | JAMP-ZOLMITRIPTAN | 2.5MG | Jamp Pharma Corporation | Active | 2024-12-23 | 210 | Manufacturing distruption | 246697 |
5971 | A10BB09 | JAMP GLICLAZIDE-MR | 30MG | Jamp Pharma Corporation | Active | 2024-12-23 | 98 | Demand increase | 246765 |
5972 | A10BB09 | JAMP GLICLAZIDE-MR | 60MG | Jamp Pharma Corporation | Active | 2024-12-23 | 98 | Demand increase | 246770 |
5973 | N06AB04 | CITALOPRAM | 20MG | Jamp Pharma Corporation | Active | 2024-12-23 | 98 | Manufacturing distruption | 246702 |
5974 | N06AB04 | CITALOPRAM | 40MG | Jamp Pharma Corporation | Active | 2024-12-23 | 159 | Manufacturing distruption | 246705 |
5975 | N06AB04 | CITALOPRAM | 40MG | Jamp Pharma Corporation | Active | 2024-12-23 | 159 | Manufacturing distruption | 246713 |
5977 | J01FA10 | JAMP-AZITHROMYCIN | 250MG | Jamp Pharma Corporation | Active | 2024-12-23 | 98 | Demand increase | 246777 |
5981 | M02AA15 | JAMP DICLOFENAC TOPICAL SOLUTI... | 1.5% | Jamp Pharma Corporation | Active | 2024-12-23 | 251 | Manufacturing distruption | 246728 |
5982 | N04BD02 | JAMP RASAGILINE | 0.5MG | Jamp Pharma Corporation | Active | 2024-12-23 | 128 | Manufacturing distruption | 246735 |
5983 | G04BD07 | JAMP TOLTERODINE | 1MG | Jamp Pharma Corporation | Active | 2024-12-23 | 128 | Demand increase | 246738 |
5984 | G04BD07 | JAMP TOLTERODINE | 2MG | Jamp Pharma Corporation | Active | 2024-12-23 | 189 | Demand increase | 246741 |
5985 | L01BC07 | AZACITIDINE FOR INJECTION | 100MG | Jamp Pharma Corporation | Active | 2024-12-23 | 373 | Manufacturing distruption | 246744 |
5986 | G04BD09 | JAMP TROSPIUM | 20MG | Jamp Pharma Corporation | Active | 2024-12-23 | 189 | Manufacturing distruption | 246747 |
5964 | C09CA07 | SANDOZ TELMISARTAN | 40MG | Sandoz Canada Incorporated | Avoided | 2024-12-23 | 18 | Shipping delay | 246360 |
5952 | B05CB01 | SODIUM CHLORIDE IRRIGATION USP | 9MG | Icu Medical Canada Inc | Resolved | 2024-12-23 | 46 | Manufacturing distruption | 246534 |
5953 | L02BX03 | SANDOZ ABIRATERONE | 500MG | Sandoz Canada Incorporated | Resolved | 2024-12-23 | 53 | Demand increase | 246341 |
5956 | C04AD03 | JAMP PENTOXIFYLLINE SR | 400MG | Jamp Pharma Corporation | Resolved | 2024-12-23 | 98 | Demand increase | 246753 |
5957 | N06BA12 | SANDOZ LISDEXAMFETAMINE CAPSUL... | 30MG | Sandoz Canada Incorporated | Resolved | 2024-12-23 | 18 | Manufacturing distruption | 246345 |
5958 | B05BC01 | MANNITOL INJECTION USP | 20% | Icu Medical Canada Inc | Resolved | 2024-12-23 | 1 | Manufacturing distruption | 240224 |
5959 | J02AC04 | POSANOL | 200MG | Merck Canada Inc | Resolved | 2024-12-23 | 53 | Demand increase | 244160 |
5960 | L04AA06 | SANDOZ MYCOPHENOLATE MOFETIL | 500MG | Sandoz Canada Incorporated | Resolved | 2024-12-23 | 18 | Demand increase | 246353 |
5961 | J01CR05 | PIPERACILLIN AND TAZOBACTAM FO... | 1.5G 12G | Sandoz Canada Incorporated | Resolved | 2024-12-23 | 39 | Manufacturing distruption | 246356 |
5965 | J01DH02 | MEROPENEM FOR INJECTION | 500MG | Sandoz Canada Incorporated | Resolved | 2024-12-23 | 18 | Manufacturing distruption | 246349 |
5966 | A10BA02 | JAMP METFORMIN | 500MG | Jamp Pharma Corporation | Resolved | 2024-12-23 | 82 | Demand increase | 246762 |
5967 | C05AA01 | JAMPZINC-HC | 0.5% 0.5% | Jamp Pharma Corporation | Resolved | 2024-12-23 | 82 | Manufacturing distruption | 246691 |
5968 | N05CF02 | SUBLINOX | 5MG | Bausch Health, Canada Inc. | Resolved | 2024-12-23 | 11 | Shipping delay | 240919 |
5976 | N02CC04 | RIZATRIPTAN ODT | 10MG | Sanis Health Inc | Resolved | 2024-12-23 | 67 | Manufacturing distruption | 246306 |
5978 | J01FA10 | JAMP-AZITHROMYCIN | 250MG | Jamp Pharma Corporation | Resolved | 2024-12-23 | 60 | Manufacturing distruption | 246780 |
5979 | C09CA08 | JAMP OLMESARTAN | 20MG | Jamp Pharma Corporation | Resolved | 2024-12-23 | 39 | Manufacturing distruption | 246786 |
5980 | C09CA08 | JAMP OLMESARTAN | 20MG | Jamp Pharma Corporation | Resolved | 2024-12-23 | 39 | Manufacturing distruption | 246783 |
5987 | N05BE01 | JAMP BUSPIRONE | 10MG | Jamp Pharma Corporation | Resolved | 2024-12-23 | 39 | Demand increase | 246789 |
5949 | J05AB01 | MYLAN-ACYCLOVIR | 400MG | Mylan Pharmaceuticals Ulc | Resolved | 2024-12-20 | 26 | Manufacturing distruption | 244619 |
5950 | A10AB04 | HUMALOG 200 UNITS/ML KWIKPEN | 200UNIT | Eli Lilly Canada Inc | Resolved | 2024-12-20 | 26 | Shipping delay | 246406 |
5951 | S01 | BEPREVE | 1.5% | Bausch & Lomb Inc | Resolved | 2024-12-20 | 26 | Other | 246290 |
5938 | H05BX01 | PMS-CINACALCET | 30MG | Pharmascience Inc | Active | 2024-12-19 | 377 | Manufacturing distruption | 246198 |
5939 | H05BX01 | PMS-CINACALCET | 60MG | Pharmascience Inc | Active | 2024-12-19 | 377 | Manufacturing distruption | 246205 |
5940 | H05BX01 | PMS-CINACALCET | 90MG | Pharmascience Inc | Active | 2024-12-19 | 377 | Manufacturing distruption | 246210 |
5941 | J06BD08 | BEYFORTUS | 100MG | Sanofi Pasteur Limited | Active | 2024-12-19 | 101 | Demand increase | 245452 |
5942 | G02AD02 | PROSTIN E2 TABLETS | 0.5MG | Pfizer Canada Ulc | Active | 2024-12-19 | 285 | Manufacturing distruption | 246051 |
5943 | R03BB01 | PMS-IPRATROPIUM | 21MCG | Pharmascience Inc | Resolved | 2024-12-19 | 27 | Manufacturing distruption | 246219 |
5944 | A02BC06 | DEXILANT | 60MG | Takeda Canada Inc | Resolved | 2024-12-19 | 22 | Demand increase | 245976 |
5945 | L01BA01 | METHOTREXATE INJECTION, BP | 7.5MG | Pharmascience Inc | Resolved | 2024-12-19 | 42 | Manufacturing distruption | 246222 |
5946 | C01CA24 | EPINEPHRINE INJECTION USP | 1MG | Pfizer Canada Ulc | Resolved | 2024-12-19 | Manufacturing distruption | 246001 | |
5947 | L04AH02 | PMS-EVEROLIMUS | 2.5MG | Pharmascience Inc | Resolved | 2024-12-19 | 36 | Manufacturing distruption | 246213 |
5948 | L04AH02 | PMS-EVEROLIMUS | 5MG | Pharmascience Inc | Resolved | 2024-12-19 | 36 | Manufacturing distruption | 246216 |
5924 | H03AA01 | ELTROXIN | 100MCG | Aspen Pharmacare Canada Inc. | Active | 2024-12-18 | 164 | Manufacturing distruption | 246460 |
5928 | D07AD01 | TARO-CLOBETASOL OINTMENT USP, ... | 0.05% | Taro Pharmaceuticals Inc | Active | 2024-12-18 | 93 | Manufacturing distruption | 248930 |
5934 | G04BD07 | TEVA-TOLTERODINE LA | 2MG | Teva Canada Limited | Active | 2024-12-18 | Manufacturing distruption | 246118 | |
5935 | L01BB02 | PURINETHOL | 50MG | Teva Canada Limited | Active | 2024-12-18 | 468 | Manufacturing distruption | 231946 |
5936 | B05ZB | REGIOCIT | 5.29G 5.03G | Vantive Ulc | Active | 2024-12-18 | 121 | Shipping delay | 245813 |
5922 | D07AC01 | TEVA-TOPISONE | 0.05% | Teva Canada Limited | Resolved | 2024-12-18 | 103 | Manufacturing distruption | 246098 |
5923 | A07EC02 | TEVA-5 ASA | 400MG | Teva Canada Limited | Resolved | 2024-12-18 | 54 | Manufacturing distruption | 247885 |
5925 | J01DB01 | TEVA-CEPHALEXIN 250 | 250MG | Teva Canada Limited | Resolved | 2024-12-18 | 64 | Manufacturing distruption | 246092 |
5926 | M01AE02 | TEVA-NAPROXEN | 500MG | Teva Canada Limited | Resolved | 2024-12-18 | 82 | Manufacturing distruption | 246095 |
5927 | N01BB03 | CARBOCAINE 2% | 20MG | Pfizer Canada Ulc | Resolved | 2024-12-18 | Manufacturing distruption | 245961 | |
5929 | D07AC13 | TEVA-MOMETASONE | 0.1% | Teva Canada Limited | Resolved | 2024-12-18 | 103 | Manufacturing distruption | 246104 |
5930 | B01AB01 | HEPARIN SODIUM INJECTION, USP | 1000UNIT | Fresenius Kabi Canada Ltd | Resolved | 2024-12-18 | 30 | Other | 245670 |
5931 | N06AB10 | TEVA-ESCITALOPRAM | 20MG | Teva Canada Limited | Resolved | 2024-12-18 | 82 | Manufacturing distruption | 246107 |
5932 | N05AH03 | OLANZAPINE ODT | 10MG | Sanis Health Inc | Resolved | 2024-12-18 | 114 | Manufacturing distruption | 243713 |
5933 | N02AB03 | FENTORA | 400MCG | Teva Canada Limited | Resolved | 2024-12-18 | 51 | Manufacturing distruption | 246115 |
5937 | C07AB02 | TEVA-METOPROLOL | 100MG | Teva Canada Limited | Resolved | 2024-12-18 | 82 | Manufacturing distruption | 246101 |
5914 | C03BA04 | APO-CHLORTHALIDONE | 50MG | Apotex Inc | Active | 2024-12-17 | 185 | Manufacturing distruption | 246071 |
5921 | D06BB03 | APO-ACYCLOVIR OINTMENT | 5% | Apotex Inc | Active | 2024-12-17 | 108 | Manufacturing distruption | 246067 |
5915 | N02BF01 | APO-GABAPENTIN | 100MG | Apotex Inc | Resolved | 2024-12-17 | 24 | Manufacturing distruption | 246059 |
5916 | V08CA08 | MULTIHANCE | 529MG | Bracco Imaging Canada | Resolved | 2024-12-17 | 59 | Manufacturing distruption | 246225 |
5917 | S01ED51 | COSOPT PRESERVATIVE-FREE | 5MG 20MG | Elvium Life Sciences | Resolved | 2024-12-17 | 59 | Demand increase | 245896 |
5918 | N05AX08 | APO-RISPERIDONE | 4.0MG | Apotex Inc | Resolved | 2024-12-17 | 66 | Manufacturing distruption | 246062 |
5919 | C09BA04 | APO-PERINDOPRIL-INDAPAMIDE | 1.25MG 4MG | Apotex Inc | Resolved | 2024-12-17 | 31 | Manufacturing distruption | 246056 |
5920 | A10BB09 | DIAMICRON MR | 60MG | Servier Canada Inc | Resolved | 2024-12-17 | Demand increase | 245899 | |
5911 | C07AB02 | METOPROLOL-L | 100MG | Sivem Pharmaceuticals Ulc | Active | 2024-12-16 | 133 | Manufacturing distruption | 243966 |
5913 | C09DA08 | NRA-OLMESARTAN HCTZ | 40MG 12.5MG | Nora Pharma Inc | Active | 2024-12-16 | Manufacturing distruption | 248784 | |
5906 | V08CA03 | OMNISCAN | 287MG | Ge Healthcare Canada Inc | Resolved | 2024-12-16 | 18 | Demand increase | 245818 |
5907 | G03CA03 | SANDOZ ESTRADIOL DERM 50 | 50MCG | Sandoz Canada Incorporated | Resolved | 2024-12-16 | 81 | Demand increase | 245839 |
5908 | C09CA04 | SANDOZ IRBESARTAN | 75MG | Sandoz Canada Incorporated | Resolved | 2024-12-16 | 39 | Manufacturing distruption | 245843 |
5909 | J01DH02 | MEROPENEM FOR INJECTION | 1G | Sandoz Canada Incorporated | Resolved | 2024-12-16 | 25 | Shipping delay | 245847 |
5910 | S01GX09 | SANDOZ OLOPATADINE 0.2% | 0.2% | Sandoz Canada Incorporated | Resolved | 2024-12-16 | 32 | Demand increase | 245851 |
5912 | N02AA03 | DILAUDID | 8MG | Purdue Pharma | Resolved | 2024-12-16 | 28 | Demand increase | 245810 |
5904 | N07CA01 | NRA-BETAHISTINE | 8MG | Nora Pharma Inc | Resolved | 2024-12-15 | Demand increase | 248494 | |
5905 | C07AB09 | BREVIBLOC PREMIXED INJECTION | 10MG | Baxter Corporation | Resolved | 2024-12-15 | 89 | Manufacturing distruption | 241095 |
5902 | D01BA02 | TERBINAFINE | 250MG | Sivem Pharmaceuticals Ulc | Active | 2024-12-14 | Manufacturing distruption | 250148 | |
5903 | D01BA02 | TERBINAFINE | 250MG | Sivem Pharmaceuticals Ulc | Active | 2024-12-14 | Manufacturing distruption | 250151 | |
5895 | C07AG02 | APO-CARVEDILOL | 3.125MG | Apotex Inc | Active | 2024-12-13 | Manufacturing distruption | 215958 | |
5896 | N05AH04 | ACH-QUETIAPINE | 100MG | Accord Healthcare Inc | Active | 2024-12-13 | Manufacturing practices | 245741 | |
5897 | N05AH04 | ACH-QUETIAPINE | 200MG | Accord Healthcare Inc | Active | 2024-12-13 | Manufacturing practices | 245744 | |
5898 | N05AH04 | ACH-QUETIAPINE | 300MG | Accord Healthcare Inc | Active | 2024-12-13 | Manufacturing practices | 245747 | |
5899 | N05AH04 | ACH-QUETIAPINE FUMARATE XR | 400MG | Accord Healthcare Inc | Active | 2024-12-13 | Manufacturing practices | 245750 | |
5900 | A03AB02 | GLYCOPYRROLATE INJECTION USP | 0.2MG | Sterimax Inc | Active | 2024-12-13 | 143 | Manufacturing practices | 244055 |
5901 | B01AF01 | XARELTO | 103.4MG | Bayer Inc | Resolved | 2024-12-13 | 49 | Demand increase | 242145 |
5892 | L01BC02 | EFUDEX | 5% | Bausch Health, Canada Inc. | Active | 2024-12-12 | 215 | Ingredient shortage | 239776 |
5890 | A07EC02 | TEVA-5 ASA | 400MG | Teva Canada Limited | Resolved | 2024-12-12 | 88 | Manufacturing distruption | 245601 |
5891 | J05AF05 | 3TC | 10MG | Viiv Healthcare Ulc | Resolved | 2024-12-12 | 69 | Manufacturing distruption | 245633 |
5893 | R03BA05 | FLOVENT DISKUS | 100MCG | Glaxosmithkline Inc | Resolved | 2024-12-12 | Demand increase | 245630 | |
5894 | C03BA11 | MYLAN-INDAPAMIDE | 1.25MG | Mylan Pharmaceuticals Ulc | Resolved | 2024-12-12 | 19 | Manufacturing distruption | 243383 |
5889 | G04BD07 | TEVA-TOLTERODINE LA | 4MG | Teva Canada Limited | Active | 2024-12-11 | Manufacturing distruption | 245615 | |
5884 | D07AC01 | TEVA-TOPILENE | 0.05% | Teva Canada Limited | Resolved | 2024-12-11 | 51 | Manufacturing distruption | 245595 |
5885 | V03AF03 | LEUCOVORIN CALCIUM INJECTION | 10MG | Teva Canada Limited | Resolved | 2024-12-11 | 80 | Manufacturing distruption | 245598 |
5886 | C10AA03 | TEVA-PRAVASTATIN | 10MG | Teva Canada Limited | Resolved | 2024-12-11 | Manufacturing distruption | 245606 | |
5887 | A04AD11 | TEVA-NABILONE | 0.25MG | Teva Canada Limited | Resolved | 2024-12-11 | 40 | Manufacturing distruption | 245609 |
5888 | N05AH04 | TEVA-QUETIAPINE XR | 50MG | Teva Canada Limited | Resolved | 2024-12-11 | 89 | Manufacturing distruption | 245612 |
5877 | N06AA09 | ELAVIL | 50MG | Aa Pharma Inc | Active | 2024-12-10 | Manufacturing distruption | 245442 | |
5880 | S01EE01 | APO-LATANOPROST | 50MCG | Apotex Inc | Active | 2024-12-10 | 171 | Manufacturing distruption | 245508 |
5883 | A03AB02 | GLYCOPYRROLATE INJECTION USP | 0.4MG | Sterimax Inc | Active | 2024-12-10 | 146 | Manufacturing practices | 245519 |
5872 | C02AC02 | APO-GUANFACINE XR | 1MG | Apotex Inc | Resolved | 2024-12-10 | 38 | Manufacturing distruption | 245496 |
5873 | C02AC02 | APO-GUANFACINE XR | 3MG | Apotex Inc | Resolved | 2024-12-10 | 38 | Manufacturing distruption | 245499 |
5874 | C09CA06 | APO-CANDESARTAN TABLETS | 16MG | Apotex Inc | Resolved | 2024-12-10 | 87 | Manufacturing distruption | 245502 |
5875 | N06AA10 | AVENTYL | 10MG | Aa Pharma Inc | Resolved | 2024-12-10 | 7 | Manufacturing distruption | 245448 |
5876 | J01AA08 | MINOCYCLINE | 50MG | Aa Pharma Inc | Resolved | 2024-12-10 | 10 | Manufacturing distruption | 245445 |
5878 | J01GB01 | TOBRAMYCIN FOR INJECTION | 1.2G | Fresenius Kabi Canada Ltd | Resolved | 2024-12-10 | 45 | Other | 245141 |
5879 | C10AA05 | APO-ATORVASTATIN | 10MG | Apotex Inc | Resolved | 2024-12-10 | 38 | Manufacturing distruption | 245505 |
5881 | N02CC04 | APO-RIZATRIPTAN | 10MG | Apotex Inc | Resolved | 2024-12-10 | 52 | Manufacturing distruption | 245511 |
5882 | A10BB09 | MYLAN-GLICLAZIDE MR | 30MG | Mylan Pharmaceuticals Ulc | Resolved | 2024-12-10 | 71 | Demand increase | 243790 |
5860 | B01AF01 | SANDOZ RIVAROXABAN | 2.5MG | Sandoz Canada Incorporated | Active | 2024-12-09 | 130 | Shipping delay | 245211 |
5866 | A04AA01 | ONDANSETRON INJECTION USP ... | 2MG | Sandoz Canada Incorporated | Active | 2024-12-09 | 130 | Manufacturing practices | 245205 |
5856 | N07CA01 | M-BETAHISTINE | 8MG | Mantra Pharma Inc | Resolved | 2024-12-09 | 81 | Shipping delay | 245390 |
5857 | N07CA01 | M-BETAHISTINE | 16MG | Mantra Pharma Inc | Resolved | 2024-12-09 | 81 | Shipping delay | 245393 |
5858 | N07CA01 | M-BETAHISTINE | 24MG | Mantra Pharma Inc | Resolved | 2024-12-09 | 81 | Shipping delay | 245396 |
5859 | C09AA10 | TRANDOLAPRIL | 2MG | Sanis Health Inc | Resolved | 2024-12-09 | 88 | Manufacturing distruption | 244304 |
5861 | N07CA01 | NRA-BETAHISTINE | 16MG | Nora Pharma Inc | Resolved | 2024-12-09 | 96 | Demand increase | 248671 |
5862 | L01X | VORANIGO | 10MG | Servier Canada Inc | Resolved | 2024-12-09 | Shipping delay | 245307 | |
5863 | D10AD01 | RETIN-A | 0.025% | Bausch Health, Canada Inc. | Resolved | 2024-12-09 | 49 | Other | 244980 |
5864 | S01BC03 | VOLTAREN OPHTHA | 0.1% | Novartis Pharmaceuticals Canada Inc | Resolved | 2024-12-09 | 65 | Shipping delay | 244108 |
5865 | A10BB09 | DIAMICRON MR | 30MG | Servier Canada Inc | Resolved | 2024-12-09 | Shipping delay | 245310 | |
5867 | J01CR05 | PIPERACILLIN AND TAZOBACTAM FO... | 0.25G 2G | Sandoz Canada Incorporated | Resolved | 2024-12-09 | 32 | Manufacturing distruption | 245208 |
5868 | C09AA10 | SANDOZ TRANDOLAPRIL | 1MG | Sandoz Canada Incorporated | Resolved | 2024-12-09 | 109 | Manufacturing practices | 245214 |
5869 | V09GA02 | MYOVIEW 30ML | 1.38MG | Ge Healthcare Canada Inc | Resolved | 2024-12-09 | 24 | Other | 245107 |
5870 | C10AA03 | SANDOZ PRAVASTATIN TABLETS | 10MG | Sandoz Canada Incorporated | Resolved | 2024-12-09 | Manufacturing distruption | 245217 | |
5871 | B01AF02 | SANDOZ APIXABAN SDZ | 5MG | Sandoz Canada Incorporated | Resolved | 2024-12-09 | 39 | Demand increase | 245202 |
5855 | N03AX09 | LAMOTRIGINE | 100MG | Sivem Pharmaceuticals Ulc | Resolved | 2024-12-07 | Manufacturing distruption | 243960 | |
5844 | A10BG03 | ACH-PIOGLITAZONE | 30MG | Accord Healthcare Inc | Active | 2024-12-06 | Manufacturing practices | 245052 | |
5845 | A10BG03 | ACH-PIOGLITAZONE | 45MG | Accord Healthcare Inc | Active | 2024-12-06 | Manufacturing practices | 245057 | |
5846 | M05BA04 | ALENDRONATE | 70MG | Sanis Health Inc | Active | 2024-12-06 | Manufacturing distruption | 223392 | |
5847 | G04CB01 | ACH-FINASTERIDE | 5MG | Accord Healthcare Inc | Active | 2024-12-06 | Manufacturing practices | 245060 | |
5848 | C09CA06 | ACH-CANDESARTAN | 8MG | Accord Healthcare Inc | Active | 2024-12-06 | Manufacturing practices | 245063 | |
5849 | C10AA03 | ACH-PRAVASTATIN | 10MG | Accord Healthcare Inc | Active | 2024-12-06 | Manufacturing practices | 245066 | |
5850 | C10AA03 | ACH-PRAVASTATIN | 40MG | Accord Healthcare Inc | Active | 2024-12-06 | Manufacturing practices | 245069 | |
5851 | N06AB03 | BIO-FLUOXETINE | 10MG | Biomed Pharma | Active | 2024-12-06 | 91 | Manufacturing practices | 245167 |
5843 | C09CA01 | COZAAR | 25MG | Organon Canada Inc. | Avoided | 2024-12-06 | 35 | Shipping delay | 238733 |
5852 | D06AX09 | STRAMUCIN | 2% | Glenmark Pharmaceuticals Canada Inc. | Resolved | 2024-12-06 | 73 | Ingredient shortage | 244858 |
5853 | V03AE02 | RENVELA | 2.4G | Sanofi-Aventis Canada Inc | Resolved | 2024-12-06 | 115 | Other | 240885 |
5854 | L04AH02 | SANDOZ EVEROLIMUS | 2.5MG | Sandoz Canada Incorporated | Resolved | 2024-12-06 | 7 | Manufacturing distruption | 245033 |
5841 | C09DA03 | AURO-VALSARTAN HCT | 12.5MG 160MG | Auro Pharma Inc | Active | 2024-12-05 | 131 | Demand increase | 235918 |
5837 | N02AA01 | M-ESLON | 200MG | Ethypharm Inc | Resolved | 2024-12-05 | 8 | Shipping delay | 244743 |
5838 | G04BE03 | SILDENAFIL | 50MG | Pharmascience Inc | Resolved | 2024-12-05 | 34 | Manufacturing distruption | 244902 |
5839 | J01XA01 | VANCOMYCIN HYDROCHLORIDE FOR I... | 1G | Sterimax Inc | Resolved | 2024-12-05 | 15 | Shipping delay | 244865 |
5840 | N05AH04 | PMS-QUETIAPINE | 50MG | Pharmascience Inc | Resolved | 2024-12-05 | 48 | Manufacturing distruption | 244899 |
5842 | N03AX18 | PHARMA-LACOSAMIDE | 50MG | Pharmascience Inc | Resolved | 2024-12-05 | 34 | Manufacturing distruption | 244890 |
5828 | N05AH03 | ZYPREXA ZYDIS | 10MG | Eli Lilly Canada Inc | Active | 2024-12-04 | 99 | Shipping delay | 243641 |
5835 | A16AX04 | MDK-NITISINONE | 5MG | Mendelikabs Inc | Active | 2024-12-04 | 362 | Ingredient shortage | 239658 |
5827 | R03BB01 | PMS-IPRATROPIUM | 250MCG | Pharmascience Inc | Resolved | 2024-12-04 | 35 | Manufacturing distruption | 244822 |
5829 | H02AB04 | DEPO-MEDROL 80 MG/ML | 80MG | Pfizer Canada Ulc | Resolved | 2024-12-04 | Manufacturing distruption | 242131 | |
5830 | C09CA04 | PMS-IRBESARTAN | 75MG | Pharmascience Inc | Resolved | 2024-12-04 | 33 | Manufacturing distruption | 244825 |
5831 | J01FA09 | TARO-CLARITHROMYCIN | 125MG | Taro Pharmaceuticals Inc | Resolved | 2024-12-04 | 58 | Manufacturing distruption | 248921 |
5832 | J01FA09 | TARO-CLARITHROMYCIN | 125MG | Taro Pharmaceuticals Inc | Resolved | 2024-12-04 | 44 | Manufacturing distruption | 245665 |
5833 | N01BB09 | ROPIVACAINE HYDROCHLORIDE INJE... | 2MG | Fresenius Kabi Canada Ltd | Resolved | 2024-12-04 | 68 | Manufacturing distruption | 243515 |
5834 | R03BA09 | ARNUITY ELLIPTA | 100MCG | Glaxosmithkline Inc | Resolved | 2024-12-04 | Shipping delay | 245072 | |
5836 | D07CB01 | VIADERM KC CRM | 100000UNIT 0.25MG 2.5MG 1MG | Taro Pharmaceuticals Inc | Resolved | 2024-12-04 | 79 | Manufacturing distruption | 249008 |
5824 | N07CA01 | BETAHISTINE | 24MG | Sanis Health Inc | Active | 2024-12-03 | Manufacturing distruption | 244732 | |
5815 | C02AC02 | APO-GUANFACINE XR | 3MG | Apotex Inc | Resolved | 2024-12-03 | 45 | Manufacturing distruption | 244922 |
5816 | A10BD15 | APO-DAPAGLIFLOZIN-METFORMIN | 850MG 5MG | Apotex Inc | Resolved | 2024-12-03 | 10 | Manufacturing distruption | 244918 |
5817 | R03DA04 | AA-THEO LA | 200MG | Aa Pharma Inc | Resolved | 2024-12-03 | 48 | Manufacturing distruption | 244126 |
5818 | N02BA01 | ASAPHEN | 80MG | Pharmascience Inc | Resolved | 2024-12-03 | 80 | Manufacturing distruption | 244817 |
5819 | J01CA04 | APO-AMOXI | 500MG | Apotex Inc | Resolved | 2024-12-03 | 38 | Manufacturing distruption | 244926 |
5820 | H01BA02 | APO-DESMOPRESSIN | 0.2MG | Apotex Inc | Resolved | 2024-12-03 | 59 | Manufacturing distruption | 244883 |
5821 | A02BC02 | APO-PANTOPRAZOLE | 40MG | Apotex Inc | Resolved | 2024-12-03 | 80 | Manufacturing distruption | 244896 |
5822 | M01AH01 | APO-CELECOXIB | 100MG | Apotex Inc | Resolved | 2024-12-03 | 66 | Manufacturing distruption | 244910 |
5823 | J02AC04 | POSANOL | 300MG | Merck Canada Inc | Resolved | 2024-12-03 | 45 | Demand increase | 244157 |
5825 | J01DE01 | APO-CEFEPIME | 1G | Apotex Inc | Resolved | 2024-12-03 | 73 | Manufacturing distruption | 244915 |
5826 | B01AE07 | APO-DABIGATRAN | 110MG | Apotex Inc | Resolved | 2024-12-03 | 52 | Manufacturing distruption | 244888 |
5799 | B03AE04 | PREGNANCY MULTIVITAMIN | 300MG 600UNIT 12MCG 1.1MG 15MG 50MG 35MG 0.15MG 2MG 13.8MG 120MG 10MG 5MG 20MG 3.4MG 3MG 1.6MG | Jamp Pharma Corporation | Active | 2024-12-02 | 394 | Manufacturing distruption | 244475 |
5800 | B03AE04 | PREGNANCY MULTIVITAMIN FOLIC 5 | 5MG 20MG 3.4MG 3MG 300MG 600UNIT 12MCG 15MG 50MG 0.15MG 2MG 120MG 10MG 35MG 13.8MG 5MG 1.6MG | Jamp Pharma Corporation | Active | 2024-12-02 | 394 | Manufacturing distruption | 244478 |
5802 | P02BA01 | BILTRICIDE | 600MG | Bayer Inc | Active | 2024-12-02 | Other | 237622 | |
5805 | J01MA12 | SANDOZ LEVOFLOXACIN | 500MG | Sandoz Canada Incorporated | Active | 2024-12-02 | 200 | Manufacturing distruption | 244440 |
5796 | N02CC06 | ELETRIPTAN | 20MG | Sanis Health Inc | Resolved | 2024-12-02 | 60 | Manufacturing distruption | 244298 |
5797 | S01EE01 | M-LATANOPROST | 50MCG | Mantra Pharma Inc | Resolved | 2024-12-02 | 88 | Shipping delay | 245405 |
5798 | S01ED51 | M-LATANOPROST-TIMOLOL | 5MG 50MCG | Mantra Pharma Inc | Resolved | 2024-12-02 | 88 | Shipping delay | 245408 |
5801 | D07AB08 | PDP-DESONIDE | 0.05% | Pendopharm Division Of Pharmascience Inc | Resolved | 2024-12-02 | 22 | Manufacturing distruption | 244645 |
5803 | S01GX08 | ZADITOR | 0.25MG | Laboratoires Thea | Resolved | 2024-12-02 | 17 | Shipping delay | 244275 |
5804 | G03CA03 | SANDOZ ESTRADIOL DERM 100 | 100MCG | Sandoz Canada Incorporated | Resolved | 2024-12-02 | 46 | Demand increase | 244437 |
5806 | C09AA10 | SANDOZ TRANDOLAPRIL | 4MG | Sandoz Canada Incorporated | Resolved | 2024-12-02 | 39 | Shipping delay | 244452 |
5807 | N06AX16 | VENLAFAXINE XR | 150MG | Sanis Health Inc | Resolved | 2024-12-02 | 46 | Manufacturing distruption | 244301 |
5808 | C09CA07 | SANDOZ TELMISARTAN | 40MG | Sandoz Canada Incorporated | Resolved | 2024-12-02 | 18 | Manufacturing distruption | 244449 |
5809 | G04BD07 | SANDOZ TOLTERODINE LA | 2MG | Sandoz Canada Incorporated | Resolved | 2024-12-02 | 18 | Manufacturing distruption | 244431 |
5810 | C09CA06 | SANDOZ CANDESARTAN | 32MG | Sandoz Canada Incorporated | Resolved | 2024-12-02 | 4 | Shipping delay | 244434 |
5811 | J01XX08 | SANDOZ LINEZOLID | 600MG | Sandoz Canada Incorporated | Resolved | 2024-12-02 | 11 | Manufacturing practices | 244443 |
5812 | V03AE01 | SOLYSTAT | 250MG | Pendopharm Division Of Pharmascience Inc | Resolved | 2024-12-02 | 81 | Manufacturing distruption | 244642 |
5813 | G04CA04 | SANDOZ SILODOSIN | 8MG | Sandoz Canada Incorporated | Resolved | 2024-12-02 | 116 | Manufacturing distruption | 244446 |
5814 | B01AF01 | TARO-RIVAROXABAN | 20MG | Taro Pharmaceuticals Inc | Resolved | 2024-12-02 | 81 | Manufacturing distruption | 248957 |
5787 | S01EA03 | IOPIDINE | 0.5% | Essential Pharma Switzerland Gmbh | Active | 2024-12-01 | 120 | Ingredient shortage | 243912 |
5789 | D07AD01 | DERMOVATE OINTMENT | .05% | Taropharma, A Division Of Taro Pharmaceuticals Inc. | Active | 2024-12-01 | 89 | Manufacturing distruption | 250686 |
5790 | C07AG02 | APO-CARVEDILOL | 6.25MG | Apotex Inc | Active | 2024-12-01 | Manufacturing distruption | 215961 | |
5791 | C09AA02 | TARO-ENALAPRIL | 2MG | Sun Pharma Canada Inc | Active | 2024-12-01 | 117 | Manufacturing distruption | 250675 |
5792 | C09AA02 | TARO-ENALAPRIL | 4MG | Sun Pharma Canada Inc | Active | 2024-12-01 | 117 | Manufacturing distruption | 250678 |
5794 | S02CA06 | TARO-CIPROFLOXACIN/DEXAMETHASO... | 0.1% 0.3% | Taro Pharmaceuticals Inc | Active | 2024-12-01 | 110 | Manufacturing distruption | 249020 |
5788 | B05XA08 | SODIUM ACETATE INJECTION USP | 328MG | Omega Laboratories Limited | Resolved | 2024-12-01 | 71 | Manufacturing distruption | 245319 |
5793 | N07CA01 | AURO-BETAHISTINE | 24MG | Auro Pharma Inc | Resolved | 2024-12-01 | 60 | Demand increase | 243121 |
5795 | N02AA01 | MORPHINE SULFATE INJECTION, US... | 2MG | Fresenius Kabi Canada Ltd | Resolved | 2024-12-01 | 36 | Manufacturing distruption | 243494 |
5786 | B03BA01 | CYANOCOBALAMIN INJECTION USP | 1000MCG | Hikma Canada Limited | Active | 2024-11-30 | 183 | Manufacturing distruption | 242881 |
5785 | D07AD01 | TARO-CLOBETASOL SPRAY | 0.05% | Taro Pharmaceuticals Inc | Active | 2024-11-29 | 140 | Manufacturing distruption | 248933 |
5782 | N05CM18 | PRECEDEX | 100MCG | Pfizer Canada Ulc | Resolved | 2024-11-29 | Manufacturing distruption | 244907 | |
5783 | L01FA01 | RITUXAN SC | 1400MG | Hoffmann-La Roche Limited | Resolved | 2024-11-29 | 14 | Manufacturing distruption | 243448 |
5784 | M01AE52 | MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 375MG | Mylan Pharmaceuticals Ulc | Resolved | 2024-11-29 | 104 | Manufacturing distruption | 242126 |
5780 | A05AA02 | PMS-URSODIOL C | 250MG | Pharmascience Inc | Resolved | 2024-11-28 | 22 | Manufacturing distruption | 244163 |
5781 | A05AA02 | PMS-URSODIOL C | 500MG | Pharmascience Inc | Resolved | 2024-11-28 | 22 | Manufacturing distruption | 244166 |
5769 | A04AA01 | ONDANSETRON ODT | 8MG | Sanis Health Inc | Active | 2024-11-27 | 212 | Manufacturing distruption | 240734 |
5771 | J01XE01 | NITROFURANTOIN | 50MG | Aa Pharma Inc | Active | 2024-11-27 | 163 | Manufacturing distruption | 244123 |
5772 | G03AA05 | SELECT 1/35 (28-DAY) | 0.035MG 1.0MG | Pfizer Canada Ulc | Active | 2024-11-27 | 163 | Manufacturing distruption | 243957 |
5774 | R03AC02 | VENTOLIN HFA | 100MCG | Glaxosmithkline Inc | Active | 2024-11-27 | 149 | Manufacturing distruption | 244223 |
5776 | L01AA09 | TREANDA | 100MG | Teva Canada Limited | Active | 2024-11-27 | 246 | Manufacturing distruption | 244075 |
5777 | G04BD07 | TEVA-TOLTERODINE LA | 2MG | Teva Canada Limited | Active | 2024-11-27 | Manufacturing distruption | 244078 | |
5779 | H01CB02 | OCTREOTIDE FOR INJECTABLE SUSP... | 30MG | Teva Canada Limited | Active | 2024-11-27 | 113 | Manufacturing distruption | 244081 |
5770 | J02AC01 | DIFLUCAN | 2MG | Pfizer Canada Ulc | Resolved | 2024-11-27 | Manufacturing distruption | 242857 | |
5773 | V08CA03 | OMNISCAN | 287MG | Ge Healthcare Canada Inc | Resolved | 2024-11-27 | 9 | Demand increase | 243409 |
5775 | R03AK09 | ZENHALE | 5MCG 200MCG | Organon Canada Inc. | Resolved | 2024-11-27 | 37 | Shipping delay | 243987 |
5778 | V03AB35 | BRIDION | 100MG | Merck Canada Inc | Resolved | 2024-11-27 | 12 | Shipping delay | 244003 |
5763 | N06DA03 | APO-RIVASTIGMINE | 3MG | Apotex Inc | Active | 2024-11-26 | 276 | Manufacturing distruption | 244209 |
5764 | C09CA04 | TARO-IRBESARTAN | 75MG | Sun Pharma Canada Inc | Active | 2024-11-26 | 122 | Manufacturing distruption | 248999 |
5758 | N05AN01 | CARBOLITH | 600MG | Bausch Health, Canada Inc. | Resolved | 2024-11-26 | 20 | Demand increase | 244145 |
5759 | R03AC02 | PMS-SALBUTAMOL | 1MG | Pharmascience Inc | Resolved | 2024-11-26 | 104 | Manufacturing distruption | 243924 |
5760 | N06AX12 | WELLBUTRIN XL | 150MG | Bausch Health, Canada Inc. | Resolved | 2024-11-26 | 17 | Demand increase | 244139 |
5761 | C01BC04 | APO-FLECAINIDE | 50MG | Apotex Inc | Resolved | 2024-11-26 | 17 | Manufacturing distruption | 244200 |
5762 | R03AC02 | TEVA-SALBUTAMOL HFA | 100MCG | Teva Canada Limited | Resolved | 2024-11-26 | 114 | Manufacturing distruption | 243894 |
5765 | M01AH01 | APO-CELECOXIB | 200MG | Apotex Inc | Resolved | 2024-11-26 | 17 | Manufacturing distruption | 244206 |
5766 | H05BX01 | APO-CINACALCET | 30MG | Apotex Inc | Resolved | 2024-11-26 | 38 | Manufacturing distruption | 244203 |
5767 | N03AX18 | PHARMA-LACOSAMIDE | 200MG | Pharmascience Inc | Resolved | 2024-11-26 | 43 | Manufacturing distruption | 243921 |
5768 | J01XA01 | VANCOMYCIN INJECTION USP IN 0.... | 1000MG | Baxter Corporation | Resolved | 2024-11-26 | 34 | Shipping delay | 243907 |
5745 | V08AB04 | ISOVUE 370 INJECTION | 76% | Bracco Imaging Canada | Active | 2024-11-25 | 144 | Demand increase | 243710 |
5748 | S01EC03 | TRUSOPT PRESERVATIVE-FREE | 2% | Elvium Life Sciences | Active | 2024-11-25 | 186 | Shipping delay | 243891 |
5754 | N02AX02 | TARO-TRAMADOL ER | 200MG | Taro Pharmaceuticals Inc | Active | 2024-11-25 | 123 | Manufacturing distruption | 248960 |
5755 | J01FA09 | CLARITHROMYCIN | 500MG | Sanis Health Inc | Active | 2024-11-25 | 165 | Manufacturing distruption | 243701 |
5757 | V03AC03 | SANDOZ DEFERASIROX (TYPE J) | 360MG | Sandoz Canada Incorporated | Active | 2024-11-25 | 151 | Manufacturing distruption | 243843 |
5743 | G04BD11 | SANDOZ FESOTERODINE FUMARATE | 4MG | Sandoz Canada Incorporated | Resolved | 2024-11-25 | 18 | Shipping delay | 243846 |
5744 | J05AF01 | RETROVIR (AZT) | 50MG | Viiv Healthcare Ulc | Resolved | 2024-11-25 | Shipping delay | 244220 | |
5746 | N02AA05 | OXY.IR | 10MG | Purdue Pharma | Resolved | 2024-11-25 | 4 | Demand increase | 243809 |
5747 | R03AC02 | VENTOLIN DISKUS | 200MCG | Glaxosmithkline Inc | Resolved | 2024-11-25 | Manufacturing distruption | 243684 | |
5749 | M03BX01 | BACLOFEN | 10MG | Sanis Health Inc | Resolved | 2024-11-25 | 46 | Manufacturing distruption | 243696 |
5750 | C10AA07 | SANDOZ ROSUVASTATIN | 20MG | Sandoz Canada Incorporated | Resolved | 2024-11-25 | 25 | Manufacturing distruption | 243854 |
5751 | N03AX14 | LEVETIRACETAM | 750MG | Sanis Health Inc | Resolved | 2024-11-25 | 81 | Manufacturing distruption | 243704 |
5752 | N06DA03 | SANDOZ RIVASTIGMINE PATCH 10 | 9.5MG | Sandoz Canada Incorporated | Resolved | 2024-11-25 | 11 | Manufacturing distruption | 243850 |
5753 | V03AB34 | FOMEPIZOLE FOR INJECTION | 1G | Sterimax Inc | Resolved | 2024-11-25 | 36 | Shipping delay | 243759 |
5756 | C09AA04 | PERINDOPRIL ERBUMINE | 4MG | Sanis Health Inc | Resolved | 2024-11-25 | 74 | Manufacturing distruption | 243707 |
5737 | B05XA02 | SODIUM BICARBONATE INJECTION U... | 84MG | Sterimax Inc | Avoided | 2024-11-22 | 10 | Shipping delay | 241709 |
5738 | D01AC01 | CLOTRIMADERM TOPICAL | 1% | Taro Pharmaceuticals Inc | Resolved | 2024-11-22 | 98 | Manufacturing distruption | 248942 |
5739 | B01AB01 | HEPARIN SODIUM IN 0.9% SODIUM ... | 2UNIT | Pfizer Canada Ulc | Resolved | 2024-11-22 | Manufacturing distruption | 243656 | |
5740 | B05AA55 | LMD 10% IN 0.9% SODIUM CHLORID... | 0.9% 10% | Pfizer Canada Ulc | Resolved | 2024-11-22 | Manufacturing distruption | 239954 | |
5741 | A09AA02 | CREON MINIMICROSPHERES 10 | 11200UNIT 10000UNIT 730UNIT | Bgp Pharma Ulc | Resolved | 2024-11-22 | 21 | Other | 245485 |
5742 | C10AX09 | EZETROL | 10MG | Organon Canada Inc. | Resolved | 2024-11-22 | 3 | Shipping delay | 236926 |
5732 | C09CA07 | BIO-TELMISARTAN | 80MG | Biomed Pharma | Active | 2024-11-21 | Other | 244148 | |
5733 | C09AA03 | PRO-LISINOPRIL - 5 | 5MG | Pro Doc Limitee | Active | 2024-11-21 | Manufacturing distruption | 239765 | |
5734 | C01BC03 | MYLAN-PROPAFENONE | 300MG | Mylan Pharmaceuticals Ulc | Resolved | 2024-11-21 | Manufacturing distruption | 242846 | |
5735 | B01AF03 | LIXIANA | 15MG | Servier Canada Inc | Resolved | 2024-11-21 | Manufacturing distruption | 243167 | |
5736 | J01FA10 | AZITHROMYCIN FOR INJECTION USP | 500MG | Sterimax Inc | Resolved | 2024-11-21 | 15 | Shipping delay | 243597 |
5730 | C10AA07 | TARO-ROSUVASTATIN | 40MG | Sun Pharma Canada Inc | Active | 2024-11-20 | 121 | Manufacturing distruption | 249017 |
5728 | V03AF03 | LEUCOVORIN CALCIUM INJECTION | 10MG | Teva Canada Limited | Resolved | 2024-11-20 | 0 | Manufacturing distruption | 243580 |
5729 | P01BB51 | TEVA-ATOVAQUONE PROGUANIL | 100MG 250MG | Teva Canada Limited | Resolved | 2024-11-20 | 72 | Manufacturing distruption | 243583 |
5731 | J01DH02 | MEROPENEM FOR INJECTION | 1G | Sterimax Inc | Resolved | 2024-11-20 | 23 | Shipping delay | 243594 |
5725 | N02BF01 | APO-GABAPENTIN | 800MG | Apotex Inc | Active | 2024-11-19 | 143 | Manufacturing distruption | 243620 |
5722 | A02BA01 | CIMETIDINE | 300MG | Aa Pharma Inc | Resolved | 2024-11-19 | 17 | Manufacturing distruption | 243589 |
5723 | N05AA02 | METHOPRAZINE | 25MG | Aa Pharma Inc | Resolved | 2024-11-19 | 28 | Manufacturing distruption | 242915 |
5724 | J02AC01 | APO-FLUCONAZOLE-150 | 150MG | Apotex Inc | Resolved | 2024-11-19 | 101 | Manufacturing distruption | 243626 |
5726 | B01AC04 | APO-CLOPIDOGREL | 300MG | Apotex Inc | Resolved | 2024-11-19 | 52 | Manufacturing distruption | 243623 |
5727 | N03AB02 | PHENYTOIN SODIUM | 100MG | Aa Pharma Inc | Resolved | 2024-11-19 | 10 | Manufacturing distruption | 243586 |
5706 | A04AA01 | ONDANSETRON ODT | 4MG | Sanis Health Inc | Active | 2024-11-18 | Manufacturing distruption | 243274 | |
5707 | D01AC01 | CLOTRIMADERM TOPICAL | 1% | Taro Pharmaceuticals Inc | Active | 2024-11-18 | 144 | Manufacturing distruption | 248939 |
5713 | C09DA04 | IRBESARTAN/HCTZ | 12.5MG 150MG | Sanis Health Inc | Active | 2024-11-18 | Manufacturing distruption | 243268 | |
5714 | B01AC06 | ASA EC | 81MG | Sanis Health Inc | Active | 2024-11-18 | Manufacturing distruption | 243262 | |
5715 | G04CA02 | TAMSULOSIN CR | 0.4MG | Sanis Health Inc | Active | 2024-11-18 | Manufacturing distruption | 243280 | |
5717 | C02KX01 | NAT-BOSENTAN | 62.5MG | Natco Pharma (Canada) Inc | Active | 2024-11-18 | 408 | Manufacturing distruption | 243351 |
5718 | C02KX01 | NAT-BOSENTAN | 125MG | Natco Pharma (Canada) Inc | Active | 2024-11-18 | 408 | Manufacturing distruption | 243354 |
5720 | G01AF02 | CLOTRIMADERM VAGINAL 6 | 1% | Taro Pharmaceuticals Inc | Active | 2024-11-18 | 144 | Manufacturing distruption | 248945 |
5721 | A02BC01 | OMEPRAZOLE MAGNESIUM DELAYED R... | 20MG | Sanis Health Inc | Active | 2024-11-18 | Manufacturing distruption | 223352 | |
5704 | G03DA04 | PROGESTERONE | 100MG | Sanis Health Inc | Resolved | 2024-11-18 | 60 | Manufacturing distruption | 243277 |
5705 | J05AE30 | PAXLOVID | 150MG 100MG | Pfizer Canada Ulc | Resolved | 2024-11-18 | Demand increase | 239553 | |
5708 | V08AB04 | ISOVUE 370 INJECTION | 76% | Bracco Imaging Canada | Resolved | 2024-11-18 | 18 | Demand increase | 243344 |
5709 | M05BA04 | SANDOZ ALENDRONATE | 70MG | Sandoz Canada Incorporated | Resolved | 2024-11-18 | 1 | Manufacturing practices | 243330 |
5710 | J01CR05 | PIPERACILLIN AND TAZOBACTAM FO... | 0.5G 4G | Sandoz Canada Incorporated | Resolved | 2024-11-18 | 11 | Manufacturing distruption | 243327 |
5711 | N02BF01 | GABAPENTIN | 300MG | Sanis Health Inc | Resolved | 2024-11-18 | 32 | Manufacturing distruption | 243265 |
5712 | A10BA02 | METFORMIN | 500MG | Sanis Health Inc | Resolved | 2024-11-18 | 32 | Manufacturing distruption | 243271 |
5716 | A04AA01 | ONDANSETRON INJECTION USP | 2MG | Sterimax Inc | Resolved | 2024-11-18 | 32 | Shipping delay | 241706 |
5719 | J01FA10 | M-AZITHROMYCIN | 250MG | Mantra Pharma Inc | Resolved | 2024-11-18 | 153 | Shipping delay | 245384 |
5699 | N03AX18 | LACOSAMIDE INJECTION, USP | 10MG | Hikma Canada Limited | Active | 2024-11-15 | Manufacturing practices | 241553 | |
5703 | C09DA08 | OLMESARTAN/HCTZ | 20MG 12.5MG | Sanis Health Inc | Active | 2024-11-15 | Manufacturing distruption | 223386 | |
5698 | A10BD15 | AURO-DAPAGLIFLOZIN / METFORMIN | 1000MG 5MG | Auro Pharma Inc | Resolved | 2024-11-15 | 74 | Demand increase | 243238 |
5700 | N06AG02 | MANERIX | 150MG | Bausch Health, Canada Inc. | Resolved | 2024-11-15 | 77 | Other | 240916 |
5701 | V08AB04 | ISOVUE MULTIPACK-370 | 76% | Bracco Imaging Canada | Resolved | 2024-11-15 | 7 | Other | 243285 |
5702 | N02AX02 | AURO-TRAMADOL | 50MG | Auro Pharma Inc | Resolved | 2024-11-15 | 56 | Demand increase | 242984 |
5689 | C10AA05 | AURO-ATORVASTATIN | 80MG | Auro Pharma Inc | Avoided | 2024-11-14 | 31 | Demand increase | 242929 |
5678 | A04AA01 | AURO-ONDANSETRON ODT | 4MG | Auro Pharma Inc | Resolved | 2024-11-14 | 47 | Demand increase | 242972 |
5679 | A04AA01 | AURO-ONDANSETRON ODT | 8MG | Auro Pharma Inc | Resolved | 2024-11-14 | 47 | Demand increase | 242969 |
5680 | A10BH01 | AURO-SITAGLIPTIN | 50MG | Auro Pharma Inc | Resolved | 2024-11-14 | 77 | Demand increase | 242981 |
5681 | A10BK01 | AURO-DAPAGLIFLOZIN | 5MG | Auro Pharma Inc | Resolved | 2024-11-14 | 78 | Demand increase | 242948 |
5682 | A10BK01 | AURO-DAPAGLIFLOZIN | 10MG | Auro Pharma Inc | Resolved | 2024-11-14 | 78 | Demand increase | 242951 |
5683 | A10BD15 | AURO-DAPAGLIFLOZIN / METFORMIN | 850MG 5MG | Auro Pharma Inc | Resolved | 2024-11-14 | 75 | Demand increase | 242954 |
5684 | N02BF01 | AURO-GABAPENTIN | 100MG | Auro Pharma Inc | Resolved | 2024-11-14 | 31 | Demand increase | 242957 |
5685 | J01DC10 | AURO-CEFPROZIL | 125MG | Auro Pharma Inc | Resolved | 2024-11-14 | Demand increase | 242935 | |
5686 | J01DC10 | AURO-CEFPROZIL | 125MG | Auro Pharma Inc | Resolved | 2024-11-14 | 28 | Demand increase | 242939 |
5687 | J01DC10 | AURO-CEFPROZIL | 250MG | Auro Pharma Inc | Resolved | 2024-11-14 | 28 | Demand increase | 242945 |
5688 | J01DC10 | AURO-CEFPROZIL | 250MG | Auro Pharma Inc | Resolved | 2024-11-14 | 28 | Demand increase | 242942 |
5690 | C09DA01 | AURO-LOSARTAN HCT | 12.5MG 50MG | Auro Pharma Inc | Resolved | 2024-11-14 | 97 | Demand increase | 242963 |
5691 | C09DA01 | AURO-LOSARTAN HCT | 12.5MG 100MG | Auro Pharma Inc | Resolved | 2024-11-14 | 77 | Demand increase | 242960 |
5692 | C09DA01 | AURO-LOSARTAN HCT | 25MG 100MG | Auro Pharma Inc | Resolved | 2024-11-14 | 77 | Demand increase | 242966 |
5693 | C10AA07 | AURO-ROSUVASTATIN | 5MG | Auro Pharma Inc | Resolved | 2024-11-14 | 16 | Demand increase | 242975 |
5694 | C10AA07 | AURO-ROSUVASTATIN | 40MG | Auro Pharma Inc | Resolved | 2024-11-14 | 4 | Demand increase | 242978 |
5695 | C01BC03 | MYLAN-PROPAFENONE | 150MG | Mylan Pharmaceuticals Ulc | Resolved | 2024-11-14 | 7 | Manufacturing distruption | 243386 |
5696 | J01CR02 | AURO-AMOXICLAV | 125MG 250MG | Auro Pharma Inc | Resolved | 2024-11-14 | 97 | Demand increase | 242987 |
5697 | J01CR02 | AURO-AMOXICLAV | 125MG 500MG | Auro Pharma Inc | Resolved | 2024-11-14 | 97 | Demand increase | 242926 |
5674 | N06BA01 | TEVA-AMPHETAMINE XR | 25MG | Teva Canada Limited | Active | 2024-11-13 | 301 | Manufacturing distruption | 243046 |
5675 | D10AF51 | TARO-CLINDAMYCIN/BENZOYL PEROX... | 1% 5% | Taro Pharmaceuticals Inc | Active | 2024-11-13 | 156 | Manufacturing distruption | 248924 |
5670 | N02CC04 | RIZATRIPTAN | 10MG | Sanis Health Inc | Resolved | 2024-11-13 | 37 | Manufacturing distruption | 240737 |
5671 | N02AA05 | OXY.IR | 5MG | Purdue Pharma | Resolved | 2024-11-13 | 16 | Demand increase | 242888 |
5672 | J01FA09 | BIAXIN | 250MG | Bgp Pharma Ulc | Resolved | 2024-11-13 | 110 | Demand increase | 239651 |
5673 | C09AA03 | TEVA-LISINOPRIL (TYPE Z) | 20MG | Teva Canada Limited | Resolved | 2024-11-13 | 89 | Manufacturing distruption | 243043 |
5676 | J01DH02 | MEROPENEM FOR INJECTION | 500MG | Sterimax Inc | Resolved | 2024-11-13 | 30 | Shipping delay | 242923 |
5677 | N01AH01 | FENTANYL INJECTION BP | 250MCG | Sterimax Inc | Resolved | 2024-11-13 | 121 | Manufacturing distruption | 242920 |
5662 | N02BF02 | APO-PREGABALIN | 50MG | Apotex Inc | Active | 2024-11-12 | Manufacturing distruption | 216738 | |
5663 | N02BF02 | APO-PREGABALIN | 225MG | Apotex Inc | Active | 2024-11-12 | Manufacturing distruption | 216729 | |
5664 | C09CA08 | APO-OLMESARTAN | 40MG | Apotex Inc | Active | 2024-11-12 | Manufacturing distruption | 216714 | |
5665 | C09DA08 | APO-OLMESARTAN/HCTZ | 12.5MG 40MG | Apotex Inc | Active | 2024-11-12 | Manufacturing distruption | 216723 | |
5666 | C09DA08 | APO-OLMESARTAN/HCTZ | 25MG 40MG | Apotex Inc | Active | 2024-11-12 | Manufacturing distruption | 216717 | |
5667 | N05AH04 | APO-QUETIAPINE XR | 50MG | Apotex Inc | Active | 2024-11-12 | Manufacturing distruption | 216687 | |
5668 | N05AH04 | APO-QUETIAPINE XR | 300MG | Apotex Inc | Active | 2024-11-12 | Manufacturing distruption | 216693 | |
5669 | B01AE07 | APO-DABIGATRAN | 110MG | Apotex Inc | Active | 2024-11-12 | Manufacturing distruption | 243170 | |
5654 | R03BA05 | APO-FLUTICASONE HFA | 125MCG | Apotex Inc | Resolved | 2024-11-12 | 38 | Manufacturing distruption | 243089 |
5655 | J01AA08 | MINOCYCLINE | 100MG | Aa Pharma Inc | Resolved | 2024-11-12 | 10 | Manufacturing distruption | 242912 |
5656 | M04AA01 | APO-ALLOPURINOL TABLETS | 300MG | Apotex Inc | Resolved | 2024-11-12 | 17 | Manufacturing distruption | 243187 |
5657 | J01DB05 | APO-CEFADROXIL | 500MG | Apotex Inc | Resolved | 2024-11-12 | 38 | Manufacturing distruption | 243086 |
5658 | A04AA01 | APO-ONDANSETRON | 4MG | Apotex Inc | Resolved | 2024-11-12 | 24 | Manufacturing distruption | 243181 |
5659 | C10AA07 | APO-ROSUVASTATIN | 40MG | Apotex Inc | Resolved | 2024-11-12 | 101 | Manufacturing distruption | 243190 |
5660 | L01EA01 | APO-IMATINIB | 100MG | Apotex Inc | Resolved | 2024-11-12 | 73 | Manufacturing distruption | 243083 |
5661 | G03AA07 | ALYSENA 28 | 20MCG 100MCG | Apotex Inc | Resolved | 2024-11-12 | 66 | Manufacturing distruption | 243184 |
5626 | N06AB04 | NAT-CITALOPRAM | 20MG | Natco Pharma (Canada) Inc | Active | 2024-11-11 | Other | 242436 | |
5627 | N06AB04 | NAT-CITALOPRAM | 20MG | Natco Pharma (Canada) Inc | Active | 2024-11-11 | Other | 242439 | |
5628 | N06AB04 | NAT-CITALOPRAM | 20MG | Natco Pharma (Canada) Inc | Active | 2024-11-11 | Other | 242394 | |
5629 | N06AB04 | NAT-CITALOPRAM | 40MG | Natco Pharma (Canada) Inc | Active | 2024-11-11 | Other | 242445 | |
5630 | N06AB04 | NAT-CITALOPRAM | 40MG | Natco Pharma (Canada) Inc | Active | 2024-11-11 | Other | 242448 | |
5631 | N06AB04 | NAT-CITALOPRAM | 40MG | Natco Pharma (Canada) Inc | Active | 2024-11-11 | Other | 242451 | |
5636 | B05XA18 | MICRO ZN | 5MG | Sandoz Canada Incorporated | Active | 2024-11-11 | Manufacturing distruption | 236151 | |
5637 | H03AA01 | ELTROXIN | 50MCG | Aspen Pharmacare Canada Inc. | Active | 2024-11-11 | 201 | Manufacturing distruption | 242441 |
5642 | A02BC02 | PANTOPRAZOLE | 40MG | Sanis Health Inc | Active | 2024-11-11 | Manufacturing distruption | 242416 | |
5646 | G04BD07 | SANDOZ TOLTERODINE LA | 2MG | Sandoz Canada Incorporated | Active | 2024-11-11 | 263 | Manufacturing practices | 242762 |
5652 | A02BC03 | M-LANSOPRAZOLE | 15MG | Mantra Pharma Inc | Active | 2024-11-11 | Shipping delay | 245399 | |
5653 | L01AA09 | BENDAMUSTINE HYDROCHLORIDE FOR... | 25MG | Accord Healthcare Inc | Active | 2024-11-11 | Manufacturing practices | 225238 | |
5632 | N02BE01 | ACETAMINOPHEN INJECTION | 10MG | Baxter Corporation | Resolved | 2024-11-11 | 58 | Demand increase | 241787 |
5633 | G04BD11 | SANDOZ FESOTERODINE FUMARATE | 8MG | Sandoz Canada Incorporated | Resolved | 2024-11-11 | 32 | Manufacturing distruption | 242755 |
5634 | C01BC04 | FLECAINIDE | 100MG | Sanis Health Inc | Resolved | 2024-11-11 | 74 | Manufacturing distruption | 242413 |
5635 | J01MA12 | LEVOFLOXACIN IN 5% DEXTROSE IN... | 5MG | Hikma Canada Limited | Resolved | 2024-11-11 | 46 | Shipping delay | 242878 |
5638 | A02BC02 | SANDOZ PANTOPRAZOLE | 20MG | Sandoz Canada Incorporated | Resolved | 2024-11-11 | 18 | Manufacturing practices | 242759 |
5639 | J01MA02 | CIPROFLOXACIN INTRAVENOUS INFU... | 2MG | Sandoz Canada Incorporated | Resolved | 2024-11-11 | 81 | Manufacturing distruption | 242747 |
5640 | C09BA02 | ENALAPRIL MALEATE/HCTZ | 25MG 10MG | Aa Pharma Inc | Resolved | 2024-11-11 | 30 | Manufacturing distruption | 242184 |
5641 | N04BC05 | PRAMIPEXOLE | 0.25MG | Sanis Health Inc | Resolved | 2024-11-11 | 67 | Manufacturing distruption | 242419 |
5643 | C07AB12 | BYSTOLIC | 5MG | Abbvie Corporation | Resolved | 2024-11-11 | 67 | Demand increase | 240134 |
5644 | N06AB04 | NATCO-CITALOPRAM | 10MG | Natco Pharma (Canada) Inc | Resolved | 2024-11-11 | Other | 242454 | |
5645 | N06AB04 | NATCO-CITALOPRAM | 10MG | Natco Pharma (Canada) Inc | Resolved | 2024-11-11 | Other | 242457 | |
5647 | A05AA02 | GLN-URSODIOL | 250MG | Glenmark Pharmaceuticals Canada Inc. | Resolved | 2024-11-11 | 140 | Demand increase | 252092 |
5648 | N02CC04 | RIZATRIPTAN ODT | 5MG | Sanis Health Inc | Resolved | 2024-11-11 | 109 | Manufacturing distruption | 242422 |
5649 | S01BC03 | SANDOZ DICLOFENAC OPHTHA | 0.1% | Sandoz Canada Incorporated | Resolved | 2024-11-11 | 11 | Manufacturing distruption | 242751 |
5650 | N06BA01 | SANDOZ AMPHETAMINE XR | 5MG | Sandoz Canada Incorporated | Resolved | 2024-11-11 | 4 | Shipping delay | 242743 |
5651 | D07CB01 | VIADERM KC CRM | 100000UNIT 0.25MG 2.5MG 1MG | Taro Pharmaceuticals Inc | Resolved | 2024-11-11 | 88 | Manufacturing distruption | 248993 |
5618 | N05AH04 | QUETIAPINE FUMARATE XR | 300MG | Sanis Health Inc | Active | 2024-11-08 | Manufacturing distruption | 223365 | |
5619 | C07AG01 | TRANDATE | 100MG | Paladin Pharma Inc. | Active | 2024-11-08 | Manufacturing distruption | 242860 | |
5620 | C07AG01 | TRANDATE | 200MG | Paladin Pharma Inc. | Active | 2024-11-08 | Manufacturing distruption | 242865 | |
5621 | L02BG06 | AROMASIN | 25MG | Pfizer Canada Ulc | Active | 2024-11-08 | 143 | Demand increase | 242796 |
5622 | N06AX11 | MIRTAZAPINE | 30MG | Sanis Health Inc | Active | 2024-11-08 | Manufacturing distruption | 240731 | |
5623 | V03AB33 | CYANOKIT | 5G | Serb S.a. | Resolved | 2024-11-08 | 53 | Shipping delay | 242390 |
5624 | N06AB10 | ACH-ESCITALOPRAM | 10MG | Accord Healthcare Inc | Resolved | 2024-11-08 | 112 | Manufacturing distruption | 242382 |
5625 | N06AB10 | ACH-ESCITALOPRAM | 20MG | Accord Healthcare Inc | Resolved | 2024-11-08 | 101 | Manufacturing distruption | 242385 |
5602 | C02AC01 | TEVA-CLONIDINE | 0.1MG | Teva Canada Limited | Active | 2024-11-07 | 154 | Manufacturing distruption | 242344 |
5608 | A02BC01 | TEVA-OMEPRAZOLE | 20MG | Teva Canada Limited | Active | 2024-11-07 | 164 | Manufacturing distruption | 242358 |
5609 | N04BC05 | ACT PRAMIPEXOLE | 1.5MG | Teva Canada Limited | Active | 2024-11-07 | 164 | Manufacturing distruption | 242361 |
5614 | C09CA04 | TARO-IRBESARTAN | 150MG | Sun Pharma Canada Inc | Active | 2024-11-07 | 141 | Manufacturing distruption | 249002 |
5615 | C09CA04 | TARO-IRBESARTAN | 300MG | Sun Pharma Canada Inc | Active | 2024-11-07 | 134 | Manufacturing distruption | 249005 |
5617 | C02KX01 | TARO-BOSENTAN | 125MG | Taro Pharmaceuticals Inc | Active | 2024-11-07 | 134 | Manufacturing distruption | 242501 |
5603 | S01EC03 | TRUSOPT | 2% | Elvium Life Sciences | Avoided | 2024-11-07 | 120 | Shipping delay | 242263 |
5604 | A07AA02 | TEVA-NYSTATIN | 100000UNIT | Teva Canada Limited | Resolved | 2024-11-07 | 144 | Manufacturing distruption | 242349 |
5605 | N02BF01 | TEVA-GABAPENTIN | 600MG | Teva Canada Limited | Resolved | 2024-11-07 | 54 | Manufacturing distruption | 242352 |
5606 | S01ED51 | COSOPT PRESERVATIVE-FREE | 5MG 20MG | Elvium Life Sciences | Resolved | 2024-11-07 | 43 | Shipping delay | 242258 |
5607 | C09AA02 | ACT ENALAPRIL | 2MG | Teva Canada Limited | Resolved | 2024-11-07 | 105 | Manufacturing distruption | 242355 |
5610 | N02AA01 | TEVA-MORPHINE SR | 200MG | Teva Canada Limited | Resolved | 2024-11-07 | 95 | Manufacturing distruption | 242364 |
5611 | C10AA05 | TEVA-ATORVASTATIN | 40MG | Teva Canada Limited | Resolved | 2024-11-07 | 23 | Manufacturing distruption | 242367 |
5612 | L04AA06 | TEVA-MYCOPHENOLATE | 500MG | Teva Canada Limited | Resolved | 2024-11-07 | 64 | Manufacturing distruption | 242370 |
5613 | L01AA09 | TREANDA | 25MG | Teva Canada Limited | Resolved | 2024-11-07 | 95 | Manufacturing distruption | 242338 |
5616 | M01AE02 | TEVA-NAPROXEN SODIUM | 275MG | Teva Canada Limited | Resolved | 2024-11-07 | 64 | Manufacturing distruption | 242341 |
5601 | M02AA15 | TARO-DICLOFENAC | 1.5% | Taro Pharmaceuticals Inc | Resolved | 2024-11-06 | 16 | Manufacturing distruption | 242533 |
5587 | N06AA09 | ELAVIL | 25MG | Aa Pharma Inc | Active | 2024-11-05 | Manufacturing distruption | 242166 | |
5588 | N06AA09 | ELAVIL | 25MG | Aa Pharma Inc | Active | 2024-11-05 | Manufacturing distruption | 242175 | |
5589 | N05BA01 | DIASTAT | 5MG | Bausch Health, Canada Inc. | Active | 2024-11-05 | 206 | Other | 242227 |
5594 | C09AA03 | PRO-LISINOPRIL - 10 | 10MG | Pro Doc Limitee | Active | 2024-11-05 | Manufacturing distruption | 239530 | |
5596 | D06BB10 | ZYCLARA | 3.75% | Bausch Health, Canada Inc. | Active | 2024-11-05 | 191 | Other | 237210 |
5598 | N07CA01 | BETAHISTINE | 16MG | Sanis Health Inc | Active | 2024-11-05 | Manufacturing distruption | 242791 | |
5583 | D06AX01 | TARO-FUSIDIC ACID | 2% | Taro Pharmaceuticals Inc | Resolved | 2024-11-05 | 10 | Manufacturing distruption | 242674 |
5584 | N02CC07 | FROVATRIPTAN | 2.5MG | Sanis Health Inc | Resolved | 2024-11-05 | 122 | Manufacturing distruption | 240728 |
5585 | R03DA04 | AA-THEO LA | 100MG | Aa Pharma Inc | Resolved | 2024-11-05 | 24 | Manufacturing distruption | 242159 |
5586 | N03AE01 | APO-CLONAZEPAM | 2MG | Apotex Inc | Resolved | 2024-11-05 | 101 | Manufacturing distruption | 242202 |
5590 | D07AD01 | TARO-CLOBETASOL OINTMENT USP, ... | 0.05% | Taro Pharmaceuticals Inc | Resolved | 2024-11-05 | 87 | Manufacturing distruption | 242522 |
5591 | R01AX03 | IPRAVENT | 42MCG | Aa Pharma Inc | Resolved | 2024-11-05 | 20 | Manufacturing distruption | 241652 |
5592 | N05AX08 | APO-RISPERIDONE | 1.0MG | Apotex Inc | Resolved | 2024-11-05 | 108 | Manufacturing distruption | 242214 |
5593 | C09AA04 | APO-PERINDOPRIL | 4MG | Apotex Inc | Resolved | 2024-11-05 | 24 | Manufacturing distruption | 242208 |
5595 | N06BA09 | APO-ATOMOXETINE | 25MG | Apotex Inc | Resolved | 2024-11-05 | 45 | Manufacturing distruption | 242211 |
5597 | C07AB02 | APO-METOPROLOL (TYPE L) | 50MG | Apotex Inc | Resolved | 2024-11-05 | 38 | Manufacturing distruption | 242205 |
5599 | N05AX12 | APO-ARIPIPRAZOLE | 15MG | Apotex Inc | Resolved | 2024-11-05 | 24 | Manufacturing distruption | 242199 |
5600 | H04AA01 | BAQSIMI | 3MG | Amphastar Pharmaceuticals, Inc. | Resolved | 2024-11-05 | 20 | Demand increase | 242464 |
5576 | M03AC09 | ROCURONIUM BROMIDE INJECTION | 10MG | Hikma Canada Limited | Active | 2024-11-04 | 158 | Ingredient shortage | 240847 |
5580 | S03CA01 | SOFRACORT | 0.05MG 0.5MG 5MG | Cheplapharm Arzneimittel Gmbh | Active | 2024-11-04 | 178 | Manufacturing distruption | 242064 |
5581 | A06AA02 | DOCUSATE SODIUM | 100MG | Pro Doc Limitee | Active | 2024-11-04 | Manufacturing distruption | 241984 | |
5582 | M03AC09 | ROCURONIUM BROMIDE INJECTION | 10MG | Juno Pharmaceuticals Corp. | Active | 2024-11-04 | 238 | Demand increase | 242057 |
5577 | H02AB04 | DEPO-MEDROL 40 MG/ML | 40MG | Pfizer Canada Ulc | Resolved | 2024-11-04 | Manufacturing distruption | 232321 | |
5578 | N01BB51 | SENSORCAINE WITH EPINEPHRINE | 5MCG 2.5MG | Aspen Pharmacare Canada Inc. | Resolved | 2024-11-04 | 26 | Demand increase | 237703 |
5579 | N03AF01 | TEGRETOL SUSPENSION | 100MG | Novartis Pharmaceuticals Canada Inc | Resolved | 2024-11-04 | 21 | Demand increase | 235981 |
5573 | N02BF01 | GLN-GABAPENTIN | 800MG | Glenmark Pharmaceuticals Canada Inc. | Resolved | 2024-11-02 | 107 | Demand increase | 242238 |
5574 | A05AA02 | GLN-URSODIOL | 250MG | Glenmark Pharmaceuticals Canada Inc. | Resolved | 2024-11-02 | 46 | Demand increase | 242232 |
5575 | A05AA02 | GLN-URSODIOL | 500MG | Glenmark Pharmaceuticals Canada Inc. | Resolved | 2024-11-02 | 46 | Demand increase | 242235 |
5553 | L01XX69 | ZEPZELCA | 4MG | Jazz Pharmaceuticals Ireland Limited | Active | 2024-11-01 | Other | 234751 | |
5554 | A10BB09 | GLICLAZIDE MR | 30MG | Sanis Health Inc | Active | 2024-11-01 | 333 | Manufacturing distruption | 241793 |
5555 | L04AH02 | NAT-EVEROLIMUS | 5MG | Natco Pharma (Canada) Inc | Active | 2024-11-01 | 241 | Manufacturing distruption | 241865 |
5556 | L04AH02 | NAT-EVEROLIMUS | 10MG | Natco Pharma (Canada) Inc | Active | 2024-11-01 | 241 | Manufacturing distruption | 241868 |
5558 | C09BA03 | ZESTORETIC | 12.5MG 20MG | Searchlight Pharma Inc | Active | 2024-11-01 | 150 | Manufacturing distruption | 244985 |
5560 | A11CC04 | ROCALTROL | 0.5MCG | Searchlight Pharma Inc | Active | 2024-11-01 | 180 | Manufacturing distruption | 244991 |
5562 | L02AE01 | SUPREFACT DEPOT 2 MONTHS | 6.3MG | Cheplapharm Arzneimittel Gmbh | Active | 2024-11-01 | Manufacturing distruption | 240203 | |
5565 | D10AD53 | TARO-ADAPALENE/BENZOYL PEROXID... | 2.5% 0.1% | Taro Pharmaceuticals Inc | Active | 2024-11-01 | 165 | Manufacturing distruption | 242477 |
5567 | V03AE01 | ODAN-SODIUM POLYSTYRENE SULFON... | 250MG | Odan Laboratories Ltd | Active | 2024-11-01 | Manufacturing distruption | 242931 | |
5568 | C09DA08 | GLN-OLMESARTAN HCTZ | 12.5MG 40MG | Glenmark Pharmaceuticals Canada Inc. | Active | 2024-11-01 | 164 | Demand increase | 242241 |
5569 | C09DA08 | GLN-OLMESARTAN HCTZ | 12.5MG 40MG | Glenmark Pharmaceuticals Canada Inc. | Active | 2024-11-01 | 164 | Demand increase | 242244 |
5570 | C09DA08 | GLN-OLMESARTAN HCTZ | 25MG 40MG | Glenmark Pharmaceuticals Canada Inc. | Active | 2024-11-01 | 164 | Demand increase | 242247 |
5571 | G03BA03 | TARO-TESTOSTERONE CYPIONATE IN... | 100MG | Taro Pharmaceuticals Inc | Active | 2024-11-01 | 147 | Manufacturing distruption | 242561 |
5572 | N01AH01 | FENTANYL INJECTION BP | 100MCG | Sterimax Inc | Active | 2024-11-01 | 165 | Manufacturing distruption | 241701 |
5557 | D01AC01 | CLOTRIMADERM TOPICAL | 1% | Taro Pharmaceuticals Inc | Resolved | 2024-11-01 | 60 | Manufacturing distruption | 242528 |
5559 | B05XA06 | POTASSIUM PHOSPHATES INJECTION... | 236MG 224MG | Fresenius Kabi Canada Ltd | Resolved | 2024-11-01 | 31 | Manufacturing distruption | 240890 |
5561 | N02CA01 | DIHYDROERGOTAMINE (DHE), 1MG/M... | 1MG | Sterimax Inc | Resolved | 2024-11-01 | 150 | Shipping delay | 239039 |
5563 | D10BA01 | CLARUS | 40MG | Mylan Pharmaceuticals Ulc | Resolved | 2024-11-01 | 130 | Manufacturing distruption | 241465 |
5564 | N02AJ13 | TARO-TRAMADOL/ACET | 37.5MG 325MG | Sun Pharma Canada Inc | Resolved | 2024-11-01 | 91 | Manufacturing distruption | 242702 |
5566 | J01MA14 | MOXIFLOXACIN | 400MG | Pro Doc Limitee | Resolved | 2024-11-01 | 148 | Shipping delay | 241981 |
5549 | L04AA06 | ACH-MYCOPHENOLATE | 500MG | Accord Healthcare Inc | Active | 2024-10-31 | Manufacturing practices | 241849 | |
5550 | N03AF04 | APTIOM | 800MG | Sumitomo Pharma Canada, Inc. | Avoided | 2024-10-31 | 30 | Shipping delay | 238559 |
5548 | D07AD01 | TARO-CLOBETASOL CREAM USP, 0.0... | 0.05% | Taro Pharmaceuticals Inc | Resolved | 2024-10-31 | 22 | Manufacturing distruption | 242517 |
5551 | L01AA03 | TARO-MELPHALAN | 10ML 50MG | Taro Pharmaceuticals Inc | Resolved | 2024-10-31 | 127 | Manufacturing distruption | 248954 |
5552 | H03AA01 | LEVOTHYROXINE SODIUM INJECTION | 100MCG | Fresenius Kabi Canada Ltd | Resolved | 2024-10-31 | 76 | Manufacturing distruption | 239468 |
5545 | H03BB02 | TAPAZOLE | 10MG | Paladin Pharma Inc. | Active | 2024-10-30 | Manufacturing distruption | 241872 | |
5546 | N06AB10 | TARO-ESCITALOPRAM | 20MG | Sun Pharma Canada Inc | Resolved | 2024-10-30 | 128 | Manufacturing distruption | 242605 |
5547 | C10AX09 | TARO-EZETIMIBE | 10MG | Sun Pharma Canada Inc | Resolved | 2024-10-30 | 16 | Manufacturing distruption | 242610 |
5536 | V08AB07 | OPTIRAY 320 (ULTRAJECT) | 68% | Liebel-Flarsheim Company Llc | Active | 2024-10-29 | Ingredient shortage | 241513 | |
5539 | L03AB11 | PEGASYS | 180MCG | Pharmaand Gmbh | Active | 2024-10-29 | 428 | Manufacturing distruption | 241524 |
5535 | M01AB05 | APO-DICLO SR | 75MG | Apotex Inc | Resolved | 2024-10-29 | 24 | Manufacturing distruption | 241685 |
5537 | N02BE01 | APO-ACETAMINOPHEN EXTRA STRENG... | 500MG | Apotex Inc | Resolved | 2024-10-29 | 31 | Manufacturing distruption | 241697 |
5538 | M01AE02 | APO-NAPROXEN | 500MG | Apotex Inc | Resolved | 2024-10-29 | 122 | Manufacturing distruption | 241688 |
5540 | C01BC04 | APO-FLECAINIDE | 100MG | Apotex Inc | Resolved | 2024-10-29 | 45 | Manufacturing distruption | 241691 |
5541 | R03DC03 | APO-MONTELUKAST | 10MG | Apotex Inc | Resolved | 2024-10-29 | 17 | Manufacturing distruption | 241694 |
5542 | A10BB09 | MYLAN-GLICLAZIDE MR | 30MG | Mylan Pharmaceuticals Ulc | Resolved | 2024-10-29 | 23 | Demand increase | 240838 |
5543 | N06AA12 | SINEQUAN | 10MG | Aa Pharma Inc | Resolved | 2024-10-29 | 81 | Manufacturing distruption | 240973 |
5544 | N02AA03 | DILAUDID | 8MG | Purdue Pharma | Resolved | 2024-10-29 | 31 | Demand increase | 241499 |
5511 | J01FA09 | SANDOZ CLARITHROMYCIN | 500MG | Sandoz Canada Incorporated | Active | 2024-10-28 | 165 | Manufacturing distruption | 241390 |
5520 | B05XA03 | 0.9% SODIUM CHLORIDE INJECTION | 900MG | Fresenius Kabi Canada Ltd | Active | 2024-10-28 | 22 | Shipping delay | 241158 |
5521 | C08CA01 | AURO-AMLODIPINE | 5MG | Auro Pharma Inc | Active | 2024-10-28 | 169 | Demand increase | 241310 |
5533 | J05AR03 | AURO-EMTRICITABINE-TENOFOVIR | 200MG 300MG | Auro Pharma Inc | Active | 2024-10-28 | 169 | Demand increase | 241328 |
5512 | J01MA02 | CIPROFLOXACIN INTRAVENOUS INFU... | 2MG | Sandoz Canada Incorporated | Avoided | 2024-10-28 | 64 | Manufacturing distruption | 236750 |
5509 | L01XX27 | ARSENIC TRIOXIDE FOR INJECTION | 10MG | Sandoz Canada Incorporated | Resolved | 2024-10-28 | 39 | Manufacturing distruption | 241359 |
5510 | A10AB01 | MYXREDLIN | 1UNIT | Baxter Corporation | Resolved | 2024-10-28 | 18 | Manufacturing distruption | 241104 |
5513 | N06DA03 | SANDOZ RIVASTIGMINE | 3MG | Sandoz Canada Incorporated | Resolved | 2024-10-28 | Manufacturing distruption | 241411 | |
5514 | V09GA02 | MYOVIEW | 0.23MG | Ge Healthcare Canada Inc | Resolved | 2024-10-28 | 2 | Other | 241364 |
5515 | J01CR05 | PIPERACILLIN AND TAZOBACTAM FO... | 1.5G 12G | Sandoz Canada Incorporated | Resolved | 2024-10-28 | 32 | Manufacturing distruption | 241403 |
5516 | C09DA04 | SANDOZ IRBESARTAN HCT | 12.5MG 150MG | Sandoz Canada Incorporated | Resolved | 2024-10-28 | 32 | Manufacturing distruption | 241396 |
5517 | C09DA04 | SANDOZ IRBESARTAN HCT | 12.5MG 300MG | Sandoz Canada Incorporated | Resolved | 2024-10-28 | 39 | Manufacturing distruption | 241400 |
5518 | J01DC10 | AURO-CEFPROZIL | 500MG | Auro Pharma Inc | Resolved | 2024-10-28 | 130 | Demand increase | 241325 |
5519 | C09AA05 | AURO-RAMIPRIL | 10MG | Auro Pharma Inc | Resolved | 2024-10-28 | 114 | Demand increase | 241331 |
5522 | M05BA07 | AURO-RISEDRONATE | 35MG | Auro Pharma Inc | Resolved | 2024-10-28 | 30 | Demand increase | 241337 |
5523 | G04BE03 | AURO-SILDENAFIL | 50MG | Auro Pharma Inc | Resolved | 2024-10-28 | 18 | Demand increase | 241342 |
5524 | A10BX02 | AURO-REPAGLINIDE | 1MG | Auro Pharma Inc | Resolved | 2024-10-28 | 18 | Demand increase | 241334 |
5525 | G04CA01 | AURO-ALFUZOSIN | 10MG | Auro Pharma Inc | Resolved | 2024-10-28 | 33 | Demand increase | 241307 |
5526 | G04BD08 | AURO-SOLIFENACIN | 10MG | Auro Pharma Inc | Resolved | 2024-10-28 | 33 | Demand increase | 241348 |
5527 | N07CA01 | AURO-BETAHISTINE | 24MG | Auro Pharma Inc | Resolved | 2024-10-28 | 94 | Demand increase | 241319 |
5528 | N06AX16 | AURO-VENLAFAXINE XR | 37.5MG | Auro Pharma Inc | Resolved | 2024-10-28 | 48 | Demand increase | 241354 |
5529 | N05AX12 | AURO-ARIPIPRAZOLE | 5MG | Auro Pharma Inc | Resolved | 2024-10-28 | 138 | Demand increase | 241316 |
5530 | J01DD08 | AURO-CEFIXIME | 100MG | Auro Pharma Inc | Resolved | 2024-10-28 | 114 | Demand increase | 241322 |
5531 | D07AA02 | SANDOZ HYDROCORTISONE | 2.5% | Sandoz Canada Incorporated | Resolved | 2024-10-28 | 46 | Manufacturing distruption | 241393 |
5532 | B01AF02 | AURO-APIXABAN | 2.5MG | Auro Pharma Inc | Resolved | 2024-10-28 | 63 | Demand increase | 241313 |
5534 | A10BD07 | SANDOZ SITAGLIPTIN-METFORMIN | 1000MG 50MG | Sandoz Canada Incorporated | Resolved | 2024-10-28 | 25 | Shipping delay | 241407 |
5508 | L01EA01 | IMATINIB | 400MG | Sanis Health Inc | Active | 2024-10-27 | Manufacturing distruption | 225714 | |
5507 | L01BA01 | METHOTREXATE INJECTION USP | 25MG | Pfizer Canada Ulc | Resolved | 2024-10-27 | Demand increase | 239733 | |
5501 | J01GB01 | TOBI PODHALER | 28MG | Bgp Pharma Ulc | Resolved | 2024-10-25 | 87 | Manufacturing distruption | 236492 |
5502 | N05AH04 | AURO-QUETIAPINE | 25MG | Auro Pharma Inc | Resolved | 2024-10-25 | 21 | Demand increase | 241221 |
5503 | A10AB05 | FIASP | 100UNIT | Novo Nordisk Canada Inc | Resolved | 2024-10-25 | 4 | Shipping delay | 241119 |
5504 | J01CR02 | AURO-AMOXICLAV | 125MG 875MG | Auro Pharma Inc | Resolved | 2024-10-25 | 51 | Demand increase | 241129 |
5505 | V03AE01 | SOLYSTAT | 250MG | Pendopharm Division Of Pharmascience Inc | Resolved | 2024-10-25 | 101 | Manufacturing distruption | 241582 |
5506 | J05AR06 | AURO-EFAVIRENZ-EMTRICITABINE-T... | 300MG 200MG 600MG | Auro Pharma Inc | Resolved | 2024-10-25 | 36 | Demand increase | 241174 |
5498 | A03BA01 | ATROPINE SULFATE INJECTION USP | 1MG | Pfizer Canada Ulc | Active | 2024-10-24 | 249 | Manufacturing distruption | 241114 |
5496 | N05AE05 | SANDOZ LURASIDONE | 60MG | Sandoz Canada Incorporated | Resolved | 2024-10-24 | 15 | Manufacturing distruption | 240809 |
5497 | C01DX22 | VERQUVO | 2.5MG | Bayer Inc | Resolved | 2024-10-24 | 29 | Demand increase | 241108 |
5499 | N02CC01 | IMITREX | 20MG | Glaxosmithkline Inc | Resolved | 2024-10-24 | 15 | Demand increase | 241216 |
5500 | A03AX04 | PINAVERIUM | 50MG | Aa Pharma Inc | Resolved | 2024-10-24 | 43 | Manufacturing distruption | 240656 |
5495 | C10AA05 | ATORVASTATIN | 40MG | Sanis Health Inc | Active | 2024-10-23 | 184 | Manufacturing distruption | 236988 |
5491 | J05AB01 | ACYCLOVIR SODIUM INJECTION | 50MG | Eugia Pharma Inc. | Resolved | 2024-10-23 | Demand increase | 240932 | |
5492 | D07AC13 | ELOCOM | 0.1% | Organon Canada Inc. | Resolved | 2024-10-23 | 121 | Shipping delay | 240685 |
5493 | D07AD01 | TARO-CLOBETASOL TOPICAL SOLUTI... | 0.05% | Taro Pharmaceuticals Inc | Resolved | 2024-10-23 | 23 | Manufacturing distruption | 242525 |
5494 | C09AA05 | TARO-RAMIPRIL | 10MG | Sun Pharma Canada Inc | Resolved | 2024-10-23 | 107 | Manufacturing distruption | 242632 |
5479 | N07CA01 | TEVA-BETAHISTINE | 16MG | Teva Canada Limited | Active | 2024-10-22 | Manufacturing distruption | 240877 | |
5480 | N07CA01 | TEVA-BETAHISTINE | 24MG | Teva Canada Limited | Active | 2024-10-22 | Manufacturing distruption | 240880 | |
5488 | B01AE07 | APO-DABIGATRAN | 150MG | Apotex Inc | Active | 2024-10-22 | Manufacturing distruption | 241059 | |
5475 | C08DB01 | APO-DILTIAZ CD | 300MG | Apotex Inc | Resolved | 2024-10-22 | 45 | Manufacturing distruption | 241075 |
5476 | C07AB02 | APO-METOPROLOL | 50MG | Apotex Inc | Resolved | 2024-10-22 | 73 | Manufacturing distruption | 241087 |
5477 | D06BB10 | ALDARA P | 5% | Bausch Health, Canada Inc. | Resolved | 2024-10-22 | 62 | Other | 237220 |
5478 | C07AB02 | APO-METOPROLOL | 25MG | Apotex Inc | Resolved | 2024-10-22 | 73 | Manufacturing distruption | 241090 |
5481 | N05AX08 | APO-RISPERIDONE | 2.0MG | Apotex Inc | Resolved | 2024-10-22 | 122 | Manufacturing distruption | 241072 |
5482 | N06BA07 | APO-MODAFINIL | 100MG | Apotex Inc | Resolved | 2024-10-22 | 52 | Manufacturing distruption | 241084 |
5483 | A02BC02 | APO-PANTOPRAZOLE | 20MG | Apotex Inc | Resolved | 2024-10-22 | 122 | Manufacturing distruption | 241069 |
5484 | G03AA07 | ALYSENA 21 | 20MCG 100MCG | Apotex Inc | Resolved | 2024-10-22 | 80 | Manufacturing distruption | 241066 |
5485 | M01AH01 | APO-CELECOXIB | 100MG | Apotex Inc | Resolved | 2024-10-22 | 38 | Manufacturing distruption | 241078 |
5486 | V09GA02 | MYOVIEW 30ML | 1.38MG | Ge Healthcare Canada Inc | Resolved | 2024-10-22 | 20 | Other | 240653 |
5487 | C09BA05 | TARO-RAMIPRIL HCTZ | 12.5MG 10MG | Sun Pharma Canada Inc | Resolved | 2024-10-22 | 24 | Manufacturing distruption | 242640 |
5489 | B01AC24 | APO-TICAGRELOR | 90MG | Apotex Inc | Resolved | 2024-10-22 | 87 | Manufacturing distruption | 241081 |
5490 | A10BH03 | APO-SAXAGLIPTIN | 5MG | Apotex Inc | Resolved | 2024-10-22 | 80 | Manufacturing distruption | 241063 |
5469 | C09DA01 | SANDOZ LOSARTAN HCT | 12.5MG 50MG | Sandoz Canada Incorporated | Active | 2024-10-21 | 165 | Manufacturing distruption | 240805 |
5474 | R03AL02 | IPRATROPIUM BROMIDE AND SALBUT... | 2.5MG 0.5MG | Juno Pharmaceuticals Corp. | Active | 2024-10-21 | 191 | Demand increase | 240750 |
5464 | B05XA18 | MICRO ZN | 5MG | Sandoz Canada Incorporated | Avoided | 2024-10-21 | Manufacturing distruption | 234797 | |
5465 | S01ED01 | TIMOPTIC-XE | 0.5% | Elvium Life Sciences | Resolved | 2024-10-21 | 123 | Shipping delay | 240755 |
5466 | R01AB01 | SOFRAMYCIN NASAL SPRAY | 2.5MG 0.05MG 12.5MG | Searchlight Pharma Inc | Resolved | 2024-10-21 | 71 | Ingredient shortage | 240758 |
5467 | J01CR05 | PIPERACILLIN AND TAZOBACTAM FO... | 0.5G 4G | Sandoz Canada Incorporated | Resolved | 2024-10-21 | 18 | Manufacturing distruption | 240813 |
5468 | J01MA02 | CIPROFLOXACIN INTRAVENOUS INFU... | 2MG | Sandoz Canada Incorporated | Resolved | 2024-10-21 | 81 | Manufacturing practices | 236746 |
5470 | N06AX16 | VENLAFAXINE XR | 75MG | Sanis Health Inc | Resolved | 2024-10-21 | Manufacturing distruption | 240725 | |
5471 | C09DA06 | CANDESARTAN/HCTZ | 12.5MG 16MG | Sanis Health Inc | Resolved | 2024-10-21 | Manufacturing distruption | 240722 | |
5472 | L01BC06 | SANDOZ CAPECITABINE | 150MG | Sandoz Canada Incorporated | Resolved | 2024-10-21 | 81 | Manufacturing distruption | 240799 |
5473 | V09FX01 | ULTRA-TECHNEKOW V4 | 19CI | Curium Canada Inc | Resolved | 2024-10-21 | 21 | Ingredient shortage | 240205 |
5463 | L01BA01 | METHOTREXATE TABLETS, USP | 10MG | Pfizer Canada Ulc | Active | 2024-10-20 | Manufacturing distruption | 237201 | |
5462 | H02AB04 | SOLU-MEDROL | 500MG | Pfizer Canada Ulc | Avoided | 2024-10-20 | Manufacturing distruption | 235236 | |
5456 | N06AA01 | DESIPRAMINE | 10MG | Aa Pharma Inc | Resolved | 2024-10-18 | 18 | Manufacturing distruption | 240621 |
5457 | N06AA01 | DESIPRAMINE | 50MG | Aa Pharma Inc | Resolved | 2024-10-18 | 18 | Manufacturing distruption | 240633 |
5458 | M01AG01 | MEFENAMIC | 250MG | Aa Pharma Inc | Resolved | 2024-10-18 | 54 | Manufacturing distruption | 240624 |
5459 | R03DA04 | THEO ER | 600MG | Aa Pharma Inc | Resolved | 2024-10-18 | 13 | Manufacturing distruption | 240630 |
5460 | C10AA07 | ACH-ROSUVASTATIN | 40MG | Accord Healthcare Inc | Resolved | 2024-10-18 | 32 | Demand increase | 240670 |
5461 | L04AX03 | METHOTREXATE SUBCUTANEOUS | 20MG | Accord Healthcare Inc | Resolved | 2024-10-18 | 10 | Shipping delay | 240673 |
5452 | J07BG01 | RABAVERT | 2.5UNIT | Bavarian Nordic As | Active | 2024-10-17 | 183 | Demand increase | 240661 |
5454 | A02BC01 | BIO-OMEPRAZOLE | 20MG | Biomed Pharma | Active | 2024-10-17 | Manufacturing practices | 241101 | |
5453 | J01FA09 | TARO-CLARITHROMYCIN | 250MG | Taro Pharmaceuticals Inc | Resolved | 2024-10-17 | 85 | Manufacturing distruption | 242514 |
5455 | B01AF03 | LIXIANA | 30MG | Servier Canada Inc | Resolved | 2024-10-17 | 18 | Shipping delay | 240569 |
5446 | C10AA05 | ATORVASTATIN | 10MG | Sanis Health Inc | Active | 2024-10-16 | 191 | Manufacturing distruption | 236985 |
5439 | N05BA08 | APO-BROMAZEPAM | 3MG | Apotex Inc | Resolved | 2024-10-16 | 9 | Manufacturing distruption | 240699 |
5440 | P01AX06 | MEPRON | 750MG | Glaxosmithkline Inc | Resolved | 2024-10-16 | Demand increase | 240697 | |
5441 | N02BE01 | APO-ACETAMINOPHEN | 325MG | Apotex Inc | Resolved | 2024-10-16 | 93 | Manufacturing distruption | 240635 |
5442 | R01AD01 | APO-BECLOMETHASONE NASAL SPRAY | 50MCG | Apotex Inc | Resolved | 2024-10-16 | 79 | Manufacturing distruption | 240613 |
5443 | B01AC04 | APO-CLOPIDOGREL | 75MG | Apotex Inc | Resolved | 2024-10-16 | 93 | Manufacturing distruption | 240616 |
5444 | J01FA10 | PMS-AZITHROMYCIN | 250MG | Pharmascience Inc | Resolved | 2024-10-16 | 65 | Manufacturing distruption | 240607 |
5445 | N05AX08 | APO-RISPERIDONE | 1.0MG | Apotex Inc | Resolved | 2024-10-16 | 128 | Manufacturing distruption | 240627 |
5447 | L02BG04 | APO-LETROZOLE | 2.5MG | Apotex Inc | Resolved | 2024-10-16 | 23 | Manufacturing distruption | 240694 |
5448 | C07AG02 | CARVEDILOL | 3.125MG | Sanis Health Inc | Resolved | 2024-10-16 | 44 | Manufacturing distruption | 238402 |
5449 | C07AB02 | APO-METOPROLOL (TYPE L) | 100MG | Apotex Inc | Resolved | 2024-10-16 | 51 | Manufacturing distruption | 240642 |
5450 | N02BF02 | TARO-PREGABALIN | 50MG | Sun Pharma Canada Inc | Resolved | 2024-10-16 | 30 | Manufacturing distruption | 242669 |
5451 | N05CF02 | APO-ZOLPIDEM ODT | 5MG | Apotex Inc | Resolved | 2024-10-16 | 9 | Manufacturing distruption | 240639 |
5432 | D01BA02 | TERBINAFINE | 250MG | Sanis Health Inc | Active | 2024-10-15 | 241 | Manufacturing distruption | 238399 |
5433 | C09CA06 | TEVA-CANDESARTAN | 16MG | Teva Canada Limited | Active | 2024-10-15 | 217 | Manufacturing distruption | 240519 |
5427 | N01BB02 | XYLOCAINE 1% | 10MG | Aspen Pharmacare Canada Inc. | Avoided | 2024-10-15 | 16 | Shipping delay | 229837 |
5418 | L04AX04 | SANDOZ LENALIDOMIDE | 5MG | Sandoz Canada Incorporated | Resolved | 2024-10-15 | 10 | Manufacturing practices | 240301 |
5419 | N06BA12 | SANDOZ LISDEXAMFETAMINE CAPSUL... | 10MG | Sandoz Canada Incorporated | Resolved | 2024-10-15 | 10 | Manufacturing practices | 240305 |
5420 | N07AB02 | DUVOID | 25MG | Paladin Pharma Inc. | Resolved | 2024-10-15 | 37 | Shipping delay | 241482 |
5421 | M03BX08 | TEVA-CYCLOBENZAPRINE | 10MG | Teva Canada Limited | Resolved | 2024-10-15 | 146 | Manufacturing distruption | 240513 |
5422 | H02AB02 | DEXAMETHASONE-OMEGA | 4MG | Omega Laboratories Limited | Resolved | 2024-10-15 | 55 | Manufacturing distruption | 240175 |
5423 | V03AC01 | DEFEROXAMINE MESYLATE FOR INJE... | 500MG | Pfizer Canada Ulc | Resolved | 2024-10-15 | Manufacturing distruption | 231893 | |
5424 | G03FA01 | ESTALIS 140/50 MCG | 140MCG 50MCG | Sandoz Canada Incorporated | Resolved | 2024-10-15 | 59 | Manufacturing distruption | 240297 |
5425 | V03AC01 | DEFEROXAMINE MESYLATE FOR INJE... | 2G | Pfizer Canada Ulc | Resolved | 2024-10-15 | Manufacturing distruption | 234768 | |
5426 | C09AA04 | APO-PERINDOPRIL | 2MG | Apotex Inc | Resolved | 2024-10-15 | 45 | Manufacturing distruption | 240586 |
5428 | C09CA01 | SANDOZ LOSARTAN | 100MG | Sandoz Canada Incorporated | Resolved | 2024-10-15 | 45 | Manufacturing distruption | 240311 |
5429 | J01MA12 | LEVOFLOXACIN IN 5% DEXTROSE IN... | 5MG | Pfizer Canada Ulc | Resolved | 2024-10-15 | Manufacturing distruption | 236630 | |
5430 | N06AB10 | TEVA-ESCITALOPRAM | 20MG | Teva Canada Limited | Resolved | 2024-10-15 | 36 | Manufacturing distruption | 240516 |
5431 | J01FA10 | AZITHROMYCIN | 250MG | Sanis Health Inc | Resolved | 2024-10-15 | 108 | Manufacturing distruption | 240137 |
5434 | N06BA07 | TEVA-MODAFINIL | 100MG | Teva Canada Limited | Resolved | 2024-10-15 | 46 | Manufacturing distruption | 240522 |
5435 | N05CF04 | LUNESTA | 3MG | Sumitomo Pharma Canada, Inc. | Resolved | 2024-10-15 | 66 | Shipping delay | 238550 |
5436 | B05XA01 | POTASSIUM CHLORIDE FOR INJECTI... | 200mEq | Omega Laboratories Limited | Resolved | 2024-10-15 | 23 | Demand increase | 240180 |
5437 | B01AF02 | SANDOZ APIXABAN SDZ | 2.5MG | Sandoz Canada Incorporated | Resolved | 2024-10-15 | 17 | Manufacturing practices | 240291 |
5438 | H01CB02 | OCTREOTIDE FOR INJECTABLE SUSP... | 10MG | Teva Canada Limited | Resolved | 2024-10-15 | 167 | Manufacturing distruption | 240525 |
5417 | C05AA01 | ANUSOL-HC SUPPOSITORIES | 10MG 10MG | Church & Dwight Canada Corp | Active | 2024-10-14 | Manufacturing distruption | 238280 | |
5416 | N05CM18 | DEXMEDETOMIDINE HYDROCHLORIDE ... | 100MCG | Baxter Corporation | Resolved | 2024-10-14 | 9 | Shipping delay | 239969 |
5412 | S01XA18 | RESTASIS MULTIDOSE | 0.05% | Abbvie Corporation | Active | 2024-10-11 | 182 | Other | 239176 |
5414 | J01FA10 | AURO-AZITHROMYCIN | 200MG | Auro Pharma Inc | Active | 2024-10-11 | 186 | Demand increase | 239864 |
5401 | G03BA03 | TESTOSTERONE ENANTHATE INJECTI... | 200MG | Hikma Canada Limited | Resolved | 2024-10-11 | 60 | Shipping delay | 238542 |
5402 | N02BF01 | AURO-GABAPENTIN | 300MG | Auro Pharma Inc | Resolved | 2024-10-11 | 65 | Demand increase | 239877 |
5403 | N06AB06 | AURO-SERTRALINE | 100MG | Auro Pharma Inc | Resolved | 2024-10-11 | 50 | Demand increase | 239963 |
5404 | C09AA03 | AURO-LISINOPRIL | 10MG | Auro Pharma Inc | Resolved | 2024-10-11 | 170 | Demand increase | 239957 |
5405 | J05AB11 | AURO-VALACYCLOVIR | 1000MG | Auro Pharma Inc | Resolved | 2024-10-11 | 66 | Demand increase | 239966 |
5406 | N04BC05 | AURO-PRAMIPEXOLE | 1.5MG | Auro Pharma Inc | Resolved | 2024-10-11 | 50 | Demand increase | 239960 |
5407 | J01DD08 | AURO-CEFIXIME | 400MG | Auro Pharma Inc | Resolved | 2024-10-11 | 35 | Demand increase | 239869 |
5408 | A03AX04 | PINAVERIUM | 100MG | Aa Pharma Inc | Resolved | 2024-10-11 | 56 | Manufacturing distruption | 239697 |
5409 | J01CR02 | AURO-AMOXICLAV | 125MG 500MG | Auro Pharma Inc | Resolved | 2024-10-11 | 131 | Demand increase | 239851 |
5410 | N03AX18 | AURO-LACOSAMIDE | 50MG | Auro Pharma Inc | Resolved | 2024-10-11 | 65 | Demand increase | 239891 |
5411 | N03AX18 | AURO-LACOSAMIDE | 100MG | Auro Pharma Inc | Resolved | 2024-10-11 | 65 | Demand increase | 239888 |
5413 | J01FA10 | AURO-AZITHROMYCIN | 100MG | Auro Pharma Inc | Resolved | 2024-10-11 | 130 | Demand increase | 239859 |
5415 | J05AE10 | AURO-DARUNAVIR | 600MG | Auro Pharma Inc | Resolved | 2024-10-11 | 106 | Demand increase | 239874 |
5381 | D07AC01 | TEVA-TOPILENE | 0.05% | Teva Canada Limited | Active | 2024-10-10 | 253 | Manufacturing distruption | 240072 |
5384 | D01BA02 | ACT TERBINAFINE | 250MG | Teva Canada Limited | Active | 2024-10-10 | Manufacturing distruption | 240028 | |
5385 | D01BA02 | ACT TERBINAFINE | 250MG | Teva Canada Limited | Active | 2024-10-10 | 172 | Manufacturing distruption | 240037 |
5388 | N07CA01 | TEVA-BETAHISTINE | 8MG | Teva Canada Limited | Active | 2024-10-10 | Manufacturing distruption | 240053 | |
5390 | L02BG04 | TEVA-LETROZOLE | 2.5MG | Teva Canada Limited | Active | 2024-10-10 | 151 | Manufacturing distruption | 240066 |
5400 | N06AB03 | NRA-FLUOXETINE | 20MG | Nora Pharma Inc | Active | 2024-10-10 | 183 | Manufacturing distruption | 248686 |
5380 | C02DB02 | HYDRALAZINE HYDROCHLORIDE INJE... | 20MG | Eugia Pharma Inc. | Resolved | 2024-10-10 | 128 | Demand increase | 241496 |
5382 | D07CB01 | TEVA-TRIACOMB | 0.25MG 2.5MG 100000UNIT 1MG | Teva Canada Limited | Resolved | 2024-10-10 | 92 | Manufacturing distruption | 240075 |
5383 | G04BD07 | DETROL LA | 2MG | Bgp Pharma Ulc | Resolved | 2024-10-10 | Demand increase | 246925 | |
5386 | S01ED51 | COSOPT PRESERVATIVE-FREE | 5MG 20MG | Elvium Life Sciences | Resolved | 2024-10-10 | 15 | Shipping delay | 239771 |
5387 | N06AX12 | WELLBUTRIN XL | 150MG | Bausch Health, Canada Inc. | Resolved | 2024-10-10 | 34 | Demand increase | 240257 |
5389 | C10AA05 | TEVA-ATORVASTATIN | 80MG | Teva Canada Limited | Resolved | 2024-10-10 | 21 | Manufacturing distruption | 240049 |
5391 | G04BD07 | TEVA-TOLTERODINE LA | 2MG | Teva Canada Limited | Resolved | 2024-10-10 | 31 | Manufacturing distruption | 240040 |
5392 | G04BD07 | TEVA-TOLTERODINE LA | 4MG | Teva Canada Limited | Resolved | 2024-10-10 | 20 | Manufacturing distruption | 240043 |
5393 | L01BC06 | TARO-CAPECITABINE | 500MG | Taro Pharmaceuticals Inc | Resolved | 2024-10-10 | 15 | Manufacturing distruption | 240428 |
5394 | N03AX18 | TEVA-LACOSAMIDE | 50MG | Teva Canada Limited | Resolved | 2024-10-10 | 151 | Manufacturing distruption | 240063 |
5395 | N03AX18 | TEVA-LACOSAMIDE | 100MG | Teva Canada Limited | Resolved | 2024-10-10 | 151 | Manufacturing distruption | 240057 |
5396 | N03AX18 | TEVA-LACOSAMIDE | 150MG | Teva Canada Limited | Resolved | 2024-10-10 | 161 | Manufacturing distruption | 240060 |
5397 | H04AA01 | BAQSIMI | 3MG | Amphastar Pharmaceuticals, Inc. | Resolved | 2024-10-10 | 18 | Other | 239831 |
5398 | N06AA04 | TARO-CLOMIPRAMINE | 50MG | Taro Pharmaceuticals Inc | Resolved | 2024-10-10 | 22 | Manufacturing distruption | 240457 |
5399 | H01CB02 | OCTREOTIDE FOR INJECTABLE SUSP... | 30MG | Teva Canada Limited | Resolved | 2024-10-10 | 12 | Manufacturing distruption | 240046 |
5376 | N06DA03 | RIVASTIGMINE | 4.5MG | Pro Doc Limitee | Active | 2024-10-09 | Manufacturing distruption | 236658 | |
5374 | R06AA11 | GRAVOL IM | 50MG | Church & Dwight Canada Corp | Resolved | 2024-10-09 | 44 | Other | 235248 |
5375 | R03AK06 | ADVAIR 100 DISKUS | 100MCG 50MCG | Glaxosmithkline Inc | Resolved | 2024-10-09 | 33 | Demand increase | 239741 |
5377 | N06AB10 | ESCITALOPRAM | 10MG | Sanis Health Inc | Resolved | 2024-10-09 | 86 | Manufacturing distruption | 238396 |
5378 | C09BA05 | TARO-RAMIPRIL HCTZ | 25MG 5MG | Sun Pharma Canada Inc | Resolved | 2024-10-09 | 128 | Manufacturing distruption | 240562 |
5379 | D07CB01 | VIADERM KC ONT | 2.5MG 1MG 100000UNIT 0.25MG | Taro Pharmaceuticals Inc | Resolved | 2024-10-09 | 72 | Manufacturing distruption | 240470 |
5362 | C09AA03 | ZESTRIL | 5MG | Searchlight Pharma Inc | Active | 2024-10-08 | 265 | Manufacturing distruption | 244988 |
5371 | A16AX04 | MDK-NITISINONE | 10MG | Mendelikabs Inc | Active | 2024-10-08 | 419 | Ingredient shortage | 239654 |
5360 | N02CC06 | APO-ELETRIPTAN TABLETS | 40MG | Apotex Inc | Resolved | 2024-10-08 | 45 | Manufacturing distruption | 239816 |
5361 | C09AA02 | APO-ENALAPRIL | 5MG | Apotex Inc | Resolved | 2024-10-08 | 31 | Manufacturing distruption | 239822 |
5363 | J01XE01 | NITROFURANTOIN | 100MG | Aa Pharma Inc | Resolved | 2024-10-08 | 20 | Manufacturing distruption | 239691 |
5364 | J01XE01 | NITROFURANTOIN | 50MG | Aa Pharma Inc | Resolved | 2024-10-08 | 51 | Manufacturing distruption | 239694 |
5365 | C02AB02 | METHYLDOPA | 500MG | Aa Pharma Inc | Resolved | 2024-10-08 | 58 | Manufacturing distruption | 239537 |
5366 | J05AB01 | MYLAN-ACYCLOVIR | 400MG | Mylan Pharmaceuticals Ulc | Resolved | 2024-10-08 | 1 | Manufacturing distruption | 238435 |
5367 | N05AX08 | APO-RISPERIDONE | 2.0MG | Apotex Inc | Resolved | 2024-10-08 | 129 | Manufacturing distruption | 239819 |
5368 | J05AB09 | APO-FAMCICLOVIR | 250MG | Apotex Inc | Resolved | 2024-10-08 | 73 | Manufacturing distruption | 239813 |
5369 | N06AA09 | APO-AMITRIPTYLINE | 25MG | Apotex Inc | Resolved | 2024-10-08 | Manufacturing distruption | 239828 | |
5370 | N06AX21 | APO-DULOXETINE | 30MG | Apotex Inc | Resolved | 2024-10-08 | Manufacturing distruption | 239825 | |
5372 | C01EB17 | LANCORA | 5MG | Servier Canada Inc | Resolved | 2024-10-08 | 6 | Shipping delay | 239700 |
5373 | N06AX23 | APO-DESVENLAFAXINE | 100MG | Apotex Inc | Resolved | 2024-10-08 | 24 | Manufacturing distruption | 239810 |
5349 | M01 | MYINFLA | 0.5MG | Pendopharm Division Of Pharmascience Inc | Active | 2024-10-07 | 225 | Ingredient shortage | 239848 |
5358 | C09DA04 | IRBESARTAN/HCTZ | 12.5MG 300MG | Sanis Health Inc | Active | 2024-10-07 | Manufacturing distruption | 239494 | |
5348 | N02CC06 | ELETRIPTAN | 20MG | Sanis Health Inc | Resolved | 2024-10-07 | 53 | Manufacturing distruption | 239491 |
5350 | L04AA06 | CELLCEPT | 250MG | Hoffmann-La Roche Limited | Resolved | 2024-10-07 | 37 | Manufacturing distruption | 237837 |
5351 | N05BE01 | PRO-BUSPIRONE | 10MG | Pro Doc Limitee | Resolved | 2024-10-07 | 24 | Shipping delay | 239526 |
5352 | J01CR05 | PIPERACILLIN AND TAZOBACTAM FO... | 0.375G 3G | Sandoz Canada Incorporated | Resolved | 2024-10-07 | 74 | Manufacturing practices | 239593 |
5353 | C09CA01 | SANDOZ LOSARTAN | 25MG | Sandoz Canada Incorporated | Resolved | 2024-10-07 | 46 | Manufacturing distruption | 239589 |
5354 | N04BC05 | SANDOZ PRAMIPEXOLE | 1MG | Sandoz Canada Incorporated | Resolved | 2024-10-07 | 25 | Shipping delay | 239597 |
5355 | S01EC03 | SANDOZ DORZOLAMIDE | 2% | Sandoz Canada Incorporated | Resolved | 2024-10-07 | 11 | Manufacturing distruption | 239585 |
5356 | A10BX02 | SANDOZ REPAGLINIDE | 0.5MG | Sandoz Canada Incorporated | Resolved | 2024-10-07 | 11 | Manufacturing practices | 239601 |
5357 | A10BX02 | SANDOZ REPAGLINIDE | 2MG | Sandoz Canada Incorporated | Resolved | 2024-10-07 | 11 | Manufacturing practices | 239604 |
5359 | A02BA04 | AXID | 150MG | Pendopharm Division Of Pharmascience Inc | Resolved | 2024-10-07 | 57 | Ingredient shortage | 239845 |
5347 | V09HX01 | GALLIUM (GA67) CITRATE INJECTI... | 74MBq | Curium Canada Inc | Resolved | 2024-10-06 | 8 | Manufacturing distruption | 239216 |
5340 | N05AH04 | QUETIAPINE FUMARATE XR | 200MG | Sanis Health Inc | Active | 2024-10-04 | Manufacturing distruption | 223380 | |
5341 | L01AC01 | THIOTEPA FOR INJECTION, BP | 15MG | Hikma Canada Limited | Resolved | 2024-10-04 | 14 | Demand increase | 238545 |
5342 | N03AF01 | TARO-CARBAMAZEPINE CHEWABLE TA... | 100MG | Taro Pharmaceuticals Inc | Resolved | 2024-10-04 | 49 | Manufacturing distruption | 240431 |
5343 | N06AX16 | VENLAFAXINE XR | 37.5MG | Sanis Health Inc | Resolved | 2024-10-04 | Manufacturing distruption | 236991 | |
5344 | C01EB17 | LANCORA | 7.5MG | Servier Canada Inc | Resolved | 2024-10-04 | 27 | Manufacturing practices | 239624 |
5345 | L01EA02 | TARO-DASATINIB | 50MG | Taro Pharmaceuticals Inc | Resolved | 2024-10-04 | 105 | Manufacturing distruption | 240463 |
5346 | G01AF02 | CLOTRIMADERM VAGINAL 3 | 2% | Taro Pharmaceuticals Inc | Resolved | 2024-10-04 | 28 | Manufacturing distruption | 240460 |
5336 | J01GB01 | TOBI | 300MG | Bgp Pharma Ulc | Active | 2024-10-03 | 194 | Demand increase | 239646 |
5333 | G03AA05 | BREVICON 1/35 TABLETS (21-DAY ... | 0.035MG 1MG | Pfizer Canada Ulc | Resolved | 2024-10-03 | 139 | Manufacturing distruption | 230652 |
5334 | G03CA03 | CLIMARA 50 | 50MCG | Bayer Inc | Resolved | 2024-10-03 | 39 | Other | 238095 |
5335 | A10AB01 | HUMULIN R | 100UNIT | Eli Lilly Canada Inc | Resolved | 2024-10-03 | 19 | Demand increase | 239183 |
5337 | L01XX05 | MYLAN-HYDROXYUREA | 500MG | Mylan Pharmaceuticals Ulc | Resolved | 2024-10-03 | 68 | Manufacturing distruption | 238425 |
5338 | A10BX02 | REPAGLINIDE | 0.5MG | Pro Doc Limitee | Resolved | 2024-10-03 | 18 | Shipping delay | 239378 |
5339 | A10BX02 | REPAGLINIDE | 2MG | Pro Doc Limitee | Resolved | 2024-10-03 | 18 | Shipping delay | 239381 |
5328 | M01AE02 | NAPROSYN | 750MG | Atnahs Pharma Uk Limited | Active | 2024-10-02 | 179 | Other | 239149 |
5332 | N05CF02 | SUBLINOX | 5MG | Bausch Health, Canada Inc. | Avoided | 2024-10-02 | 75 | Shipping delay | 238527 |
5326 | D10AD01 | RETIN-A | 0.05% | Bausch Health, Canada Inc. | Resolved | 2024-10-02 | 59 | Other | 237217 |
5327 | M01AB05 | VOLTAREN RAPIDE | 50MG | Novartis Pharmaceuticals Canada Inc | Resolved | 2024-10-02 | 69 | Demand increase | 233544 |
5329 | C04AD03 | PENTOXIFYLLINE SR | 400MG | Aa Pharma Inc | Resolved | 2024-10-02 | 93 | Manufacturing distruption | 239503 |
5330 | A11GA01 | VITAMIN C | 500MG | Mylan Pharmaceuticals Ulc | Resolved | 2024-10-02 | 104 | Manufacturing distruption | 238430 |
5331 | N03AF01 | SANDOZ-CARBAMAZEPINE CR | 200MG | Sandoz Canada Incorporated | Resolved | 2024-10-02 | 58 | Manufacturing distruption | 239131 |
5316 | L01BA01 | METHOTREXATE INJECTION BP | 25MG | Accord Healthcare Inc | Active | 2024-10-01 | Manufacturing practices | 225235 | |
5306 | N01AX10 | DIPRIVAN 1% | 10MG | Aspen Pharmacare Canada Inc. | Avoided | 2024-10-01 | 14 | Shipping delay | 232195 |
5307 | N01BB51 | SENSORCAINE WITH EPINEPHRINE | 5MCG 2.5MG | Aspen Pharmacare Canada Inc. | Avoided | 2024-10-01 | 30 | Manufacturing distruption | 233376 |
5308 | N01BB51 | SENSORCAINE WITH EPINEPHRINE | 5MCG 2.5MG | Aspen Pharmacare Canada Inc. | Avoided | 2024-10-01 | 30 | Manufacturing distruption | 232188 |
5314 | B01AD02 | CATHFLO | 2MG | Hoffmann-La Roche Limited | Avoided | 2024-10-01 | Manufacturing practices | 227997 | |
5303 | C09CA06 | APO-CANDESARTAN TABLETS | 4MG | Apotex Inc | Resolved | 2024-10-01 | 115 | Manufacturing distruption | 239355 |
5304 | C09CA06 | APO-CANDESARTAN TABLETS | 4MG | Apotex Inc | Resolved | 2024-10-01 | 66 | Manufacturing distruption | 239358 |
5305 | V03AC01 | DESFERAL 500MG | 500MG | Novartis Pharmaceuticals Canada Inc | Resolved | 2024-10-01 | Demand increase | 239097 | |
5309 | V08AD01 | LIPIODOL ULTRA FLUID | 380MG | Guerbet | Resolved | 2024-10-01 | Other | 237698 | |
5310 | P01AB01 | APO-METRONIDAZOLE TABLETS | 250MG | Apotex Inc | Resolved | 2024-10-01 | 45 | Manufacturing distruption | 239361 |
5311 | C08DB01 | APO-DILTIAZ CD | 240MG | Apotex Inc | Resolved | 2024-10-01 | 66 | Manufacturing distruption | 239367 |
5312 | D10BA01 | ACCUTANE ROCHE | 40MG | Hoffmann-La Roche Limited | Resolved | 2024-10-01 | 242 | Manufacturing distruption | 229983 |
5313 | D07AD01 | TARO-CLOBETASOL OINTMENT USP, ... | 0.05% | Taro Pharmaceuticals Inc | Resolved | 2024-10-01 | 52 | Manufacturing distruption | 239430 |
5315 | N03AF01 | TEGRETOL | 200MG | Novartis Pharmaceuticals Canada Inc | Resolved | 2024-10-01 | 15 | Demand increase | 235974 |
5317 | N03AF01 | TEGRETOL CR | 200MG | Novartis Pharmaceuticals Canada Inc | Resolved | 2024-10-01 | 62 | Demand increase | 235978 |
5318 | N03AF01 | TEGRETOL CR | 400MG | Novartis Pharmaceuticals Canada Inc | Resolved | 2024-10-01 | 34 | Demand increase | 239094 |
5319 | C07AB02 | APO-METOPROLOL (TYPE L) | 100MG | Apotex Inc | Resolved | 2024-10-01 | 73 | Manufacturing distruption | 239352 |
5320 | A10BB09 | APO-GLICLAZIDE MR | 60MG | Apotex Inc | Resolved | 2024-10-01 | 115 | Manufacturing distruption | 239373 |
5321 | N07XX06 | APO-TETRABENAZINE | 25MG | Apotex Inc | Resolved | 2024-10-01 | 171 | Manufacturing distruption | 239370 |
5322 | N05CF02 | APO-ZOLPIDEM ODT | 10MG | Apotex Inc | Resolved | 2024-10-01 | 73 | Manufacturing distruption | 239364 |
5323 | C03CA01 | FUROSEMIDE INJECTION USP | 10MG | Sterimax Inc | Resolved | 2024-10-01 | 21 | Shipping delay | 239042 |
5324 | N07XX07 | TARO-FAMPRIDINE | 10MG | Taro Pharmaceuticals Inc | Resolved | 2024-10-01 | 101 | Manufacturing distruption | 242536 |
5325 | J07BC01 | ENGERIX-B | 10MCG | Glaxosmithkline Inc | Resolved | 2024-10-01 | 27 | Demand increase | 239471 |
5302 | J05AR03 | MYLAN-EMTRICITABINE/TENOFOVIR ... | 200MG 300MG | Mylan Pharmaceuticals Ulc | Active | 2024-09-30 | 183 | Manufacturing distruption | 240350 |
5294 | B03BA01 | VITAMIN B12 | 1000MCG | Sandoz Canada Incorporated | Resolved | 2024-09-30 | 4 | Manufacturing distruption | 238955 |
5295 | D10BA01 | CLARUS | 10MG | Mylan Pharmaceuticals Ulc | Resolved | 2024-09-30 | 57 | Manufacturing distruption | 239457 |
5296 | M03BX01 | BACLOFEN | 10MG | Sanis Health Inc | Resolved | 2024-09-30 | 67 | Manufacturing distruption | 238928 |
5297 | N06AB10 | MYLAN-ESCITALOPRAM | 10MG | Mylan Pharmaceuticals Ulc | Resolved | 2024-09-30 | Manufacturing distruption | 236497 | |
5298 | N06AB04 | CITALOPRAM | 40MG | Sanis Health Inc | Resolved | 2024-09-30 | 39 | Manufacturing distruption | 238925 |
5299 | J01FF01 | CLINDAMYCIN IV INFUSION | 18MG | Sandoz Canada Incorporated | Resolved | 2024-09-30 | 63 | Manufacturing practices | 236743 |
5300 | G04BD07 | SANDOZ TOLTERODINE LA | 4MG | Sandoz Canada Incorporated | Resolved | 2024-09-30 | 81 | Manufacturing practices | 238952 |
5301 | S01EE03 | VISTITAN | 0.03% | Sandoz Canada Incorporated | Resolved | 2024-09-30 | 11 | Manufacturing distruption | 238948 |
5292 | R03BB01 | PMS-IPRATROPIUM | 250MCG | Pharmascience Inc | Resolved | 2024-09-29 | 57 | Manufacturing distruption | 238961 |
5293 | C09CA07 | PMS-TELMISARTAN | 80MG | Pharmascience Inc | Resolved | 2024-09-29 | 57 | Manufacturing distruption | 238968 |
5291 | L02BG04 | LETROZOLE | 2.5MG | Sanis Health Inc | Active | 2024-09-27 | Manufacturing distruption | 223376 | |
5284 | N05AX08 | RISPERIDONE | 1MG | Sanis Health Inc | Avoided | 2024-09-27 | Manufacturing distruption | 236979 | |
5283 | N06AX12 | WELLBUTRIN XL | 300MG | Bausch Health, Canada Inc. | Resolved | 2024-09-27 | 31 | Demand increase | 239779 |
5285 | C09AA05 | AURO-RAMIPRIL | 1.25MG | Auro Pharma Inc | Resolved | 2024-09-27 | 169 | Demand increase | 238649 |
5286 | C10AA01 | AURO-SIMVASTATIN | 5MG | Auro Pharma Inc | Resolved | 2024-09-27 | 64 | Demand increase | 238660 |
5287 | N02BF01 | AURO-GABAPENTIN TABLETS | 600MG | Auro Pharma Inc | Resolved | 2024-09-27 | 79 | Demand increase | 238598 |
5288 | N02BF01 | AURO-GABAPENTIN TABLETS | 800MG | Auro Pharma Inc | Resolved | 2024-09-27 | 79 | Demand increase | 238601 |
5289 | N02AX02 | TARO-TRAMADOL ER | 100MG | Taro Pharmaceuticals Inc | Resolved | 2024-09-27 | 126 | Manufacturing distruption | 242564 |
5290 | G03DA04 | AURO-PROGESTERONE | 100MG | Auro Pharma Inc | Resolved | 2024-09-27 | 33 | Demand increase | 238646 |
5280 | N05AN01 | CARBOLITH | 300MG | Bausch Health, Canada Inc. | Resolved | 2024-09-26 | 43 | Demand increase | 239782 |
5281 | N01BB02 | XYLOCAINE SPRAY | 10MG | Aspen Pharmacare Canada Inc. | Resolved | 2024-09-26 | 155 | Manufacturing distruption | 238553 |
5282 | J07BG01 | RABAVERT | 2.5UNIT | Bavarian Nordic As | Resolved | 2024-09-26 | 11 | Demand increase | 238561 |
5275 | L01EX01 | TARO-SUNITINIB | 12.5MG | Taro Pharmaceuticals Inc | Resolved | 2024-09-25 | 51 | Manufacturing distruption | 238726 |
5276 | C09AA10 | TRANDOLAPRIL | 2MG | Sanis Health Inc | Resolved | 2024-09-25 | 30 | Manufacturing distruption | 236982 |
5277 | N06AX12 | WELLBUTRIN XL | 300MG | Bausch Health, Canada Inc. | Resolved | 2024-09-25 | 6 | Demand increase | 238524 |
5278 | A02BC05 | TARO-ESOMEPRAZOLE | 20MG | Sun Pharma Canada Inc | Resolved | 2024-09-25 | 58 | Manufacturing distruption | 238721 |
5279 | A10AB05 | FIASP | 100UNIT | Novo Nordisk Canada Inc | Resolved | 2024-09-25 | 5 | Shipping delay | 238486 |
5265 | C09AA01 | APO-CAPTO TAB 25MG | 25MG | Apotex Inc | Active | 2024-09-24 | Manufacturing distruption | 238835 | |
5271 | D06BB10 | VYLOMA | 3.75% | Bausch Health, Canada Inc. | Active | 2024-09-24 | 233 | Other | 234357 |
5266 | C07AG01 | APO-LABETALOL | 100MG | Apotex Inc | Resolved | 2024-09-24 | 31 | Manufacturing distruption | 238826 |
5267 | C07AG01 | APO-LABETALOL | 200MG | Apotex Inc | Resolved | 2024-09-24 | 73 | Manufacturing distruption | 238829 |
5268 | A10BB09 | APO-GLICLAZIDE | 80MG | Apotex Inc | Resolved | 2024-09-24 | 73 | Manufacturing distruption | 238838 |
5269 | N05AX08 | APO-RISPERIDONE | 0.50MG | Apotex Inc | Resolved | 2024-09-24 | 150 | Manufacturing distruption | 238841 |
5270 | V09GA06 | ULTRATAG RBC | 20MCI | Curium Canada Inc | Resolved | 2024-09-24 | 13 | Other | 238405 |
5272 | B02AA02 | TRANEXAMIC ACID INJECTION | 100MG | Omega Laboratories Limited | Resolved | 2024-09-24 | 31 | Ingredient shortage | 238410 |
5273 | V03AC03 | APO-DEFERASIROX | 250MG | Apotex Inc | Resolved | 2024-09-24 | 87 | Manufacturing distruption | 238844 |
5274 | C08DA01 | APO-VERAP TABLET 120MG | 120MG | Apotex Inc | Resolved | 2024-09-24 | 52 | Manufacturing distruption | 238832 |
5255 | N02AA05 | SUPEUDOL 5 | 5MG | Sandoz Canada Incorporated | Active | 2024-09-23 | 200 | Manufacturing distruption | 238345 |
5257 | N02AA05 | SUPEUDOL 10 | 10MG | Sandoz Canada Incorporated | Active | 2024-09-23 | 200 | Manufacturing distruption | 238341 |
5253 | N06BA12 | SANDOZ LISDEXAMFETAMINE CAPSUL... | 40MG | Sandoz Canada Incorporated | Resolved | 2024-09-23 | 109 | Manufacturing distruption | 238331 |
5254 | N06BA12 | SANDOZ LISDEXAMFETAMINE CAPSUL... | 60MG | Sandoz Canada Incorporated | Resolved | 2024-09-23 | 109 | Manufacturing distruption | 238335 |
5256 | N05AB02 | FLUPHENAZINE | 5MG | Aa Pharma Inc | Resolved | 2024-09-23 | 8 | Manufacturing distruption | 238266 |
5258 | G03CA03 | SANDOZ ESTRADIOL DERM 75 | 75MCG | Sandoz Canada Incorporated | Resolved | 2024-09-23 | 165 | Demand increase | 238319 |
5259 | C09CA01 | SANDOZ LOSARTAN | 50MG | Sandoz Canada Incorporated | Resolved | 2024-09-23 | 60 | Manufacturing distruption | 238338 |
5260 | C09CA04 | SANDOZ IRBESARTAN | 75MG | Sandoz Canada Incorporated | Resolved | 2024-09-23 | 46 | Manufacturing distruption | 238323 |
5261 | V09HA02 | CERETEC | 0.5MG | Ge Healthcare Canada Inc | Resolved | 2024-09-23 | 4 | Manufacturing distruption | 238131 |
5262 | A02BC03 | TARO-LANSOPRAZOLE | 30MG | Sun Pharma Canada Inc | Resolved | 2024-09-23 | 32 | Manufacturing distruption | 240477 |
5263 | V03AE01 | SOLYSTAT | 250MG | Pendopharm Division Of Pharmascience Inc | Resolved | 2024-09-23 | 63 | Manufacturing distruption | 241585 |
5264 | N03AX18 | SANDOZ LACOSAMIDE | 150MG | Sandoz Canada Incorporated | Resolved | 2024-09-23 | 11 | Shipping delay | 238327 |
5252 | B01AF02 | ACH-APIXABAN | 5MG | Accord Healthcare Inc | Active | 2024-09-20 | Manufacturing practices | 238140 | |
5247 | M01AC06 | MELOXICAM | 7.5MG | Sanis Health Inc | Avoided | 2024-09-20 | 49 | Manufacturing distruption | 235468 |
5248 | N02BF01 | GABAPENTIN | 300MG | Sanis Health Inc | Avoided | 2024-09-20 | 14 | Manufacturing distruption | 235471 |
5245 | J05AE30 | PAXLOVID | 150MG 100MG | Pfizer Canada Ulc | Resolved | 2024-09-20 | 42 | Demand increase | 238109 |
5246 | D10AD01 | RETIN-A | 0.025% | Bausch Health, Canada Inc. | Resolved | 2024-09-20 | 5 | Other | 237223 |
5249 | N06AX16 | VENLAFAXINE XR | 37.5MG | Sanis Health Inc | Resolved | 2024-09-20 | Manufacturing distruption | 234210 | |
5250 | B05XA17 | POTASSIUM ACETATE INJECTION US... | 39.2% | Omega Laboratories Limited | Resolved | 2024-09-20 | 38 | Ingredient shortage | 237160 |
5251 | M01AE52 | MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 500MG | Mylan Pharmaceuticals Ulc | Resolved | 2024-09-20 | 91 | Manufacturing distruption | 237812 |
5243 | G02CB03 | DOSTINEX | 0.5MG | Pfizer Canada Ulc | Resolved | 2024-09-19 | 29 | Demand increase | 238507 |
5244 | H02AB04 | DEPO-MEDROL 80 MG/ML | 80MG | Pfizer Canada Ulc | Resolved | 2024-09-19 | Manufacturing distruption | 230203 | |
5240 | C10AA05 | ATORVASTATIN | 20MG | Sanis Health Inc | Active | 2024-09-18 | 219 | Manufacturing distruption | 234186 |
5241 | L02BG06 | ACT EXEMESTANE | 25MG | Teva Canada Limited | Active | 2024-09-18 | 224 | Manufacturing distruption | 237984 |
5242 | C09DA06 | TEVA-CANDESARTAN/HCTZ | 12.5MG 16MG | Teva Canada Limited | Active | 2024-09-18 | 265 | Manufacturing distruption | 237989 |
5236 | V07AB | STERILE WATER FOR INJECTION US... | 100% | Pfizer Canada Ulc | Resolved | 2024-09-18 | Manufacturing distruption | 200834 | |
5237 | A09AA02 | CREON MINIMICROSPHERES 10 | 730UNIT 11200UNIT 10000UNIT | Bgp Pharma Ulc | Resolved | 2024-09-18 | 55 | Other | 239643 |
5238 | G03AB04 | SYNPHASIC 28 TABLETS | 1.0MG 0.5MG 0.035MG | Pfizer Canada Ulc | Resolved | 2024-09-18 | 181 | Manufacturing distruption | 234221 |
5239 | N02CC02 | TEVA-NARATRIPTAN | 1MG | Teva Canada Limited | Resolved | 2024-09-18 | 53 | Manufacturing distruption | 237977 |
5229 | C09CA06 | APO-CANDESARTAN TABLETS | 16MG | Apotex Inc | Resolved | 2024-09-17 | 171 | Manufacturing distruption | 238233 |
5230 | N03AE01 | APO-CLONAZEPAM | 0.5MG | Apotex Inc | Resolved | 2024-09-17 | 157 | Manufacturing distruption | 238242 |
5231 | H01BA02 | APO-DESMOPRESSIN | 0.2MG | Apotex Inc | Resolved | 2024-09-17 | 52 | Manufacturing distruption | 238230 |
5232 | A02BC02 | APO-PANTOPRAZOLE | 20MG | Apotex Inc | Resolved | 2024-09-17 | 157 | Manufacturing distruption | 238236 |
5233 | N06DA03 | APO-RIVASTIGMINE | 6MG | Apotex Inc | Resolved | 2024-09-17 | 24 | Manufacturing distruption | 238239 |
5234 | A04AD | EMEND IV | 150MG | Merck Canada Inc | Resolved | 2024-09-17 | 6 | Demand increase | 237846 |
5235 | J01DE01 | APO-CEFEPIME | 1G | Apotex Inc | Resolved | 2024-09-17 | 52 | Manufacturing distruption | 238245 |
5228 | R03DC03 | M-MONTELUKAST | 10MG | Mantra Pharma Inc | Avoided | 2024-09-16 | 95 | Shipping delay | 245411 |
5211 | D10AD53 | SANDOZ ADAPALENE / BENZOYL PER... | 2.5% 0.3% | Sandoz Canada Incorporated | Resolved | 2024-09-16 | 74 | Manufacturing distruption | 237724 |
5212 | G04BD11 | SANDOZ FESOTERODINE FUMARATE | 8MG | Sandoz Canada Incorporated | Resolved | 2024-09-16 | Manufacturing practices | 237761 | |
5213 | N06BA12 | SANDOZ LISDEXAMFETAMINE CAPSUL... | 50MG | Sandoz Canada Incorporated | Resolved | 2024-09-16 | 116 | Manufacturing distruption | 237754 |
5214 | N05AN01 | CARBOLITH | 300MG | Bausch Health, Canada Inc. | Resolved | 2024-09-16 | 10 | Demand increase | 232669 |
5215 | B05CX10 | SORBITOL MANNITOL IRRIGATION | 5.4MG 27MG | Icu Medical Canada Inc | Resolved | 2024-09-16 | 32 | Manufacturing distruption | 238042 |
5216 | V08AB02 | OMNIPAQUE 240 | 518MG | Ge Healthcare Canada Inc | Resolved | 2024-09-16 | 8 | Demand increase | 237683 |
5217 | V08AB02 | OMNIPAQUE 240 | 518MG | Ge Healthcare Canada Inc | Resolved | 2024-09-16 | 14 | Demand increase | 237809 |
5218 | J01FA10 | SANDOZ AZITHROMYCIN | 250MG | Sandoz Canada Incorporated | Resolved | 2024-09-16 | 21 | Manufacturing distruption | 237740 |
5219 | G04CA01 | SANDOZ ALFUZOSIN | 10MG | Sandoz Canada Incorporated | Resolved | 2024-09-16 | 116 | Manufacturing distruption | 237728 |
5220 | N06DA03 | SANDOZ RIVASTIGMINE | 3MG | Sandoz Canada Incorporated | Resolved | 2024-09-16 | Manufacturing distruption | 237764 | |
5221 | N06DA03 | SANDOZ RIVASTIGMINE | 4.5MG | Sandoz Canada Incorporated | Resolved | 2024-09-16 | Manufacturing distruption | 237768 | |
5222 | C10AA05 | SANDOZ ATORVASTATIN | 20MG | Sandoz Canada Incorporated | Resolved | 2024-09-16 | 18 | Manufacturing distruption | 237736 |
5223 | C09CA06 | SANDOZ CANDESARTAN | 16MG | Sandoz Canada Incorporated | Resolved | 2024-09-16 | 60 | Manufacturing distruption | 237744 |
5224 | C09DA04 | SANDOZ IRBESARTAN HCT | 12.5MG 300MG | Sandoz Canada Incorporated | Resolved | 2024-09-16 | 32 | Manufacturing distruption | 237750 |
5225 | L01CD01 | PACLITAXEL INJECTION USP | 6MG | Accord Healthcare Inc | Resolved | 2024-09-16 | 64 | Manufacturing practices | 227105 |
5226 | G04BD07 | SANDOZ TOLTERODINE LA | 4MG | Sandoz Canada Incorporated | Resolved | 2024-09-16 | 95 | Manufacturing distruption | 237757 |
5227 | J01CR02 | SANDOZ AMOXI-CLAV TABLET | 125MG 500MG | Sandoz Canada Incorporated | Resolved | 2024-09-16 | 130 | Manufacturing distruption | 237732 |
5206 | M03AC09 | ROCURONIUM BROMIDE INJECTION | 10MG | Eugia Pharma Inc. | Active | 2024-09-15 | 196 | Demand increase | 240927 |
5208 | J02AX05 | MICAFUNGIN SODIUM FOR INJECTIO... | 100MG | Hikma Canada Limited | Active | 2024-09-15 | Manufacturing distruption | 237779 | |
5209 | N06AB03 | ACH-FLUOXETINE | 10MG | Accord Healthcare Inc | Active | 2024-09-15 | Manufacturing practices | 225241 | |
5210 | C09DA08 | APO-OLMESARTAN/HCTZ | 12.5MG 20MG | Apotex Inc | Active | 2024-09-15 | Manufacturing distruption | 216720 | |
5207 | J01CR05 | PIPERACILLIN AND TAZOBACTAM FO... | 0.5G 4G | Eugia Pharma Inc. | Resolved | 2024-09-15 | 81 | Demand increase | 240924 |
5191 | L03AC01 | PROLEUKIN | 22000000UNIT | Sterimax Inc | Active | 2024-09-13 | Other | 235968 | |
5194 | V09DA04 | CHOLETEC | 45MG | Bracco Imaging Canada | Active | 2024-09-13 | 214 | Manufacturing distruption | 237492 |
5200 | C07AB02 | METOPROLOL-L | 25MG | Sivem Pharmaceuticals Ulc | Active | 2024-09-13 | 227 | Manufacturing distruption | 243963 |
5202 | N05AX12 | AURO-ARIPIPRAZOLE | 2MG | Auro Pharma Inc | Active | 2024-09-13 | 214 | Demand increase | 237504 |
5189 | L01BA04 | PEMETREXED DISODIUM FOR INJECT... | 100MG | Auro Pharma Inc | Resolved | 2024-09-13 | Other | 237624 | |
5190 | H02AB09 | AURO-HYDROCORTISONE | 20MG | Auro Pharma Inc | Resolved | 2024-09-13 | 32 | Demand increase | 237519 |
5192 | A11DA01 | THIAMIJECT INJECTION - LIQ IM... | 100MG | Omega Laboratories Limited | Resolved | 2024-09-13 | 6 | Other | 237153 |
5193 | C03BA11 | MYLAN-INDAPAMIDE | 1.25MG | Mylan Pharmaceuticals Ulc | Resolved | 2024-09-13 | 39 | Manufacturing distruption | 232575 |
5195 | N03AX09 | AURO-LAMOTRIGINE | 100MG | Auro Pharma Inc | Resolved | 2024-09-13 | 47 | Demand increase | 237525 |
5196 | N03AX09 | AURO-LAMOTRIGINE | 150MG | Auro Pharma Inc | Resolved | 2024-09-13 | 47 | Demand increase | 237528 |
5197 | N06AB03 | AURO-FLUOXETINE | 10MG | Auro Pharma Inc | Resolved | 2024-09-13 | 47 | Demand increase | 237516 |
5198 | C10AA05 | AURO-ATORVASTATIN | 20MG | Auro Pharma Inc | Resolved | 2024-09-13 | 47 | Demand increase | 237507 |
5199 | C07AG02 | AURO-CARVEDILOL | 25MG | Auro Pharma Inc | Resolved | 2024-09-13 | 47 | Demand increase | 237510 |
5201 | C09CA08 | AURO-OLMESARTAN | 20MG | Auro Pharma Inc | Resolved | 2024-09-13 | 47 | Demand increase | 237531 |
5203 | C09AA10 | AURO-TRANDOLAPRIL | 0.5MG | Auro Pharma Inc | Resolved | 2024-09-13 | 124 | Demand increase | 237499 |
5204 | N03AX18 | AURO-LACOSAMIDE | 150MG | Auro Pharma Inc | Resolved | 2024-09-13 | 78 | Demand increase | 237522 |
5205 | A04AA01 | AURO-ONDANSETRON INJECTION | 2MG | Auro Pharma Inc | Resolved | 2024-09-13 | Other | 237631 | |
5187 | N05CM18 | DEXMEDETOMIDINE HYDROCHLORIDE ... | 100MCG | Auro Pharma Inc | Resolved | 2024-09-12 | Other | 237628 | |
5188 | L01DB01 | TARO-DOXORUBICIN LIPOSOMAL | 2MG | Taro Pharmaceuticals Inc | Resolved | 2024-09-12 | 110 | Manufacturing distruption | 237366 |
5181 | C09AA06 | PMS-QUINAPRIL | 40MG | Pharmascience Inc | Active | 2024-09-11 | 265 | Manufacturing distruption | 237391 |
5182 | C10AA05 | ATORVASTATIN | 80MG | Sanis Health Inc | Active | 2024-09-11 | 226 | Manufacturing distruption | 234189 |
5183 | M04AC01 | PMS-COLCHICINE | 0.6MG | Pharmascience Inc | Active | 2024-09-11 | 362 | Manufacturing distruption | 237385 |
5184 | L01BC01 | PMS-CYTARABINE | 100MG | Pharmascience Inc | Active | 2024-09-11 | 272 | Manufacturing distruption | 237388 |
5185 | N02CC03 | ZOLMITRIPTAN ODT | 2.5MG | Sanis Health Inc | Active | 2024-09-11 | 240 | Manufacturing distruption | 197629 |
5186 | C09CA07 | PMS-TELMISARTAN | 40MG | Pharmascience Inc | Resolved | 2024-09-11 | 75 | Manufacturing distruption | 237394 |
5171 | A02BC01 | TEVA-OMEPRAZOLE | 20MG | Teva Canada Limited | Active | 2024-09-10 | 222 | Manufacturing distruption | 237473 |
5176 | N06DA02 | DONEPEZIL | 5MG | Sivem Pharmaceuticals Ulc | Active | 2024-09-10 | 264 | Manufacturing distruption | 217980 |
5177 | N06DA02 | DONEPEZIL | 10MG | Sivem Pharmaceuticals Ulc | Active | 2024-09-10 | 264 | Manufacturing distruption | 217983 |
5180 | N02CC03 | NRA-ZOLMITRIPTAN | 2.5MG | Nora Pharma Inc | Active | 2024-09-10 | Manufacturing distruption | 248698 | |
5164 | N06AX23 | DESVENLAFAXINE | 100MG | Pro Doc Limitee | Resolved | 2024-09-10 | 51 | Shipping delay | 237179 |
5165 | S01EC01 | ACETAZOLAMIDE | 250MG | Aa Pharma Inc | Resolved | 2024-09-10 | 80 | Manufacturing distruption | 236684 |
5166 | M01AE02 | APO-NAPROXEN | 500MG | Apotex Inc | Resolved | 2024-09-10 | 80 | Manufacturing distruption | 237375 |
5167 | R01AD01 | APO-BECLOMETHASONE NASAL SPRAY | 50MCG | Apotex Inc | Resolved | 2024-09-10 | 17 | Manufacturing distruption | 237360 |
5168 | J01DB05 | APO-CEFADROXIL | 500MG | Apotex Inc | Resolved | 2024-09-10 | 31 | Manufacturing distruption | 237372 |
5169 | M01AC06 | APO-MELOXICAM | 7.5MG | Apotex Inc | Resolved | 2024-09-10 | 31 | Manufacturing distruption | 237357 |
5170 | N06AX11 | APO-MIRTAZAPINE | 45MG | Apotex Inc | Resolved | 2024-09-10 | 10 | Manufacturing distruption | 237369 |
5172 | J01DD04 | CEFTRIAXONE SODIUM FOR INJECTI... | 1G | Sterimax Inc | Resolved | 2024-09-10 | Shipping delay | 235270 | |
5173 | R03DC03 | APO-MONTELUKAST | 10MG | Apotex Inc | Resolved | 2024-09-10 | 45 | Manufacturing distruption | 237363 |
5174 | G03AA07 | ALYSENA 21 | 20MCG 100MCG | Apotex Inc | Resolved | 2024-09-10 | 17 | Manufacturing distruption | 237351 |
5175 | N07BA03 | APO-VARENICLINE | 1MG | Apotex Inc | Resolved | 2024-09-10 | 66 | Manufacturing distruption | 237348 |
5178 | C08CA02 | APO-FELODIPINE | 10MG | Apotex Inc | Resolved | 2024-09-10 | 31 | Manufacturing distruption | 237378 |
5179 | L01EA02 | APO-DASATINIB | 100MG | Apotex Inc | Resolved | 2024-09-10 | 17 | Manufacturing distruption | 237354 |
5156 | A02BC02 | TARO-PANTOPRAZOLE | 40MG | Sun Pharma Canada Inc | Active | 2024-09-09 | 193 | Manufacturing distruption | 238086 |
5160 | C09CA06 | CANDESARTAN | 16MG | Sanis Health Inc | Active | 2024-09-09 | Manufacturing distruption | 236967 | |
5162 | G04BD08 | SOLIFENACIN | 10MG | Sanis Health Inc | Active | 2024-09-09 | Manufacturing distruption | 236973 | |
5155 | C10BX03 | CADUET | 10MG 10MG | Bgp Pharma Ulc | Avoided | 2024-09-09 | Manufacturing distruption | 235519 | |
5150 | C09AA10 | TRANDOLAPRIL | 1MG | Sanis Health Inc | Resolved | 2024-09-09 | 102 | Manufacturing distruption | 236976 |
5151 | A11CC03 | SANDOZ ALFACALCIDOL | 1MCG | Sandoz Canada Incorporated | Resolved | 2024-09-09 | 81 | Manufacturing distruption | 237133 |
5152 | A11CC03 | SANDOZ ALFACALCIDOL | 1MCG | Sandoz Canada Incorporated | Resolved | 2024-09-09 | 165 | Manufacturing distruption | 248199 |
5153 | N06AA10 | AVENTYL | 10MG | Aa Pharma Inc | Resolved | 2024-09-09 | 46 | Manufacturing distruption | 236687 |
5154 | H02AB02 | DEXAMETHASONE-OMEGA | 4MG | Omega Laboratories Limited | Resolved | 2024-09-09 | 91 | Manufacturing distruption | 237157 |
5157 | C09AA05 | TARO-RAMIPRIL | 2.5MG | Sun Pharma Canada Inc | Resolved | 2024-09-09 | 42 | Manufacturing distruption | 237305 |
5158 | C03CA01 | FUROSEMIDE | 40MG | Sanis Health Inc | Resolved | 2024-09-09 | 81 | Manufacturing distruption | 236970 |
5159 | C09CA07 | SANDOZ TELMISARTAN | 80MG | Sandoz Canada Incorporated | Resolved | 2024-09-09 | 25 | Manufacturing distruption | 237137 |
5161 | P01BB51 | ATOVAQUONE PROGUANIL | 100MG 250MG | Sanis Health Inc | Resolved | 2024-09-09 | Manufacturing distruption | 236964 | |
5163 | B01AF01 | TARO-RIVAROXABAN | 10MG | Taro Pharmaceuticals Inc | Resolved | 2024-09-09 | 102 | Manufacturing distruption | 239396 |
5143 | N01AB06 | FORANE | 100% | Baxter Corporation | Resolved | 2024-09-06 | 46 | Manufacturing distruption | 236912 |
5144 | N01AB08 | SEVOFLURANE | 99.97% | Baxter Corporation | Resolved | 2024-09-06 | 46 | Manufacturing distruption | 236909 |
5145 | C10BX03 | CADUET | 80MG 5MG | Bgp Pharma Ulc | Resolved | 2024-09-06 | 42 | Manufacturing distruption | 234685 |
5146 | C01DA14 | PRO-ISMN - 60 | 60MG | Pro Doc Limitee | Resolved | 2024-09-06 | 175 | Manufacturing distruption | 236921 |
5147 | J01CR05 | PIPERACILLIN AND TAZOBACTAM FO... | 0.25G 2.00G | Sterimax Inc | Resolved | 2024-09-06 | Demand increase | 235134 | |
5148 | N04BC05 | PRAMIPEXOLE | 0.25MG | Sanis Health Inc | Resolved | 2024-09-06 | Manufacturing distruption | 234195 | |
5149 | AERRANE | 100% | Baxter Corporation | Resolved | 2024-09-06 | 46 | Manufacturing distruption | 236906 | |
5138 | C09AA02 | VASOTEC | 8MG | Organon Canada Inc. | Resolved | 2024-09-05 | 15 | Shipping delay | 236928 |
5139 | J01CR05 | PIPERACILLIN AND TAZOBACTAM FO... | 0.25G 2G | Auro Pharma Inc | Resolved | 2024-09-05 | Other | 236880 | |
5140 | C01EB17 | LANCORA | 5MG | Servier Canada Inc | Resolved | 2024-09-05 | 18 | Shipping delay | 237006 |
5141 | J01CA01 | AMPICILLIN SODIUM FOR INJECTIO... | 1G | Auro Pharma Inc | Resolved | 2024-09-05 | Other | 236753 | |
5142 | L01BA01 | ACH-METHOTREXATE | 2.5MG | Accord Healthcare Inc | Resolved | 2024-09-05 | 25 | Shipping delay | 236736 |
5122 | N02BA71 | TEVA-TECNAL | 330MG 40MG 50MG | Teva Canada Limited | Active | 2024-09-04 | 299 | Manufacturing distruption | 236799 |
5132 | L01DB06 | IDARUBICIN | 1MG | Pfizer Canada Ulc | Active | 2024-09-04 | Manufacturing distruption | 226805 | |
5133 | L01DB06 | IDARUBICIN | 1MG | Pfizer Canada Ulc | Active | 2024-09-04 | Manufacturing distruption | 226809 | |
5136 | N05AH04 | APO-QUETIAPINE FUMARATE | 100MG | Apotex Inc | Active | 2024-09-04 | Manufacturing distruption | 216702 | |
5137 | N05AH04 | APO-QUETIAPINE FUMARATE | 200MG | Apotex Inc | Active | 2024-09-04 | Manufacturing distruption | 216705 | |
5118 | M03AC09 | ROCURONIUM BROMIDE INJECTION | 10MG | Hikma Canada Limited | Resolved | 2024-09-04 | 21 | Shipping delay | 236607 |
5119 | A07EC02 | TEVA-5 ASA | 400MG | Teva Canada Limited | Resolved | 2024-09-04 | 16 | Manufacturing distruption | 236802 |
5120 | N05AN01 | CARBOLITH | 150MG | Bausch Health, Canada Inc. | Resolved | 2024-09-04 | 22 | Demand increase | 236883 |
5121 | C07AB02 | APO-METOPROLOL | 100MG | Apotex Inc | Resolved | 2024-09-04 | 121 | Manufacturing distruption | 236860 |
5123 | C02CA04 | TEVA-DOXAZOSIN | 1MG | Teva Canada Limited | Resolved | 2024-09-04 | 46 | Manufacturing distruption | 236805 |
5124 | C09AA05 | TEVA-RAMIPRIL | 5MG | Teva Canada Limited | Resolved | 2024-09-04 | 77 | Manufacturing distruption | 236808 |
5125 | C09AA04 | APO-PERINDOPRIL | 8MG | Apotex Inc | Resolved | 2024-09-04 | 23 | Manufacturing distruption | 236864 |
5126 | C10AA05 | APO-ATORVASTATIN | 80MG | Apotex Inc | Resolved | 2024-09-04 | 79 | Manufacturing distruption | 236875 |
5127 | C10AA05 | TEVA-ATORVASTATIN | 40MG | Teva Canada Limited | Resolved | 2024-09-04 | 16 | Manufacturing distruption | 236813 |
5128 | N06BA09 | APO-ATOMOXETINE | 25MG | Apotex Inc | Resolved | 2024-09-04 | 37 | Manufacturing distruption | 236872 |
5129 | N06BA09 | APO-ATOMOXETINE | 40MG | Apotex Inc | Resolved | 2024-09-04 | 30 | Manufacturing distruption | 234317 |
5130 | C09DA07 | TEVA-TELMISARTAN HCTZ | 25.0MG 80.0MG | Teva Canada Limited | Resolved | 2024-09-04 | 97 | Manufacturing distruption | 236816 |
5131 | G04BD08 | TEVA-SOLIFENACIN | 10MG | Teva Canada Limited | Resolved | 2024-09-04 | 149 | Manufacturing distruption | 236819 |
5134 | J01FA10 | APO-AZITHROMYCIN Z | 250MG | Apotex Inc | Resolved | 2024-09-04 | 58 | Manufacturing distruption | 236867 |
5135 | L01BA01 | METHOTREXATE INJECTION BP | 25MG | Accord Healthcare Inc | Resolved | 2024-09-04 | Manufacturing practices | 227108 | |
5108 | C07AA07 | PMS-SOTALOL - 160 MG | 160MG | Pharmascience Inc | Active | 2024-09-03 | 454 | Manufacturing distruption | 235789 |
5117 | A02BC03 | M-LANSOPRAZOLE | 30MG | Mantra Pharma Inc | Active | 2024-09-03 | Shipping delay | 245402 | |
5109 | C10AA05 | LIPITOR | 80MG | Bgp Pharma Ulc | Avoided | 2024-09-03 | Manufacturing distruption | 235514 | |
5103 | N05AB03 | PERPHENAZINE | 8MG | Aa Pharma Inc | Resolved | 2024-09-03 | 45 | Manufacturing distruption | 236201 |
5104 | N05AH01 | LOXAPAC IM | 50MG | Sandoz Canada Incorporated | Resolved | 2024-09-03 | 10 | Demand increase | 236567 |
5105 | N05AB04 | PROCHLORAZINE | 10MG | Aa Pharma Inc | Resolved | 2024-09-03 | 24 | Manufacturing distruption | 236204 |
5106 | A10AB01 | HUMULIN R | 100UNIT | Eli Lilly Canada Inc | Resolved | 2024-09-03 | 14 | Demand increase | 236640 |
5107 | N05BA01 | DIASTAT | 5MG | Bausch Health, Canada Inc. | Resolved | 2024-09-03 | 34 | Other | 236858 |
5110 | G03CA03 | ESTRADOT 100 | 100MCG | Sandoz Canada Incorporated | Resolved | 2024-09-03 | 45 | Manufacturing distruption | 236552 |
5111 | C09DA01 | SANDOZ LOSARTAN HCT | 12.5MG 50MG | Sandoz Canada Incorporated | Resolved | 2024-09-03 | 24 | Manufacturing distruption | 236563 |
5112 | C09DA01 | SANDOZ LOSARTAN HCT DS | 25MG 100MG | Sandoz Canada Incorporated | Resolved | 2024-09-03 | 87 | Manufacturing distruption | 236560 |
5113 | B05XA03 | 0.9% SODIUM CHLORIDE INJECTION | 900MG | Fresenius Kabi Canada Ltd | Resolved | 2024-09-03 | 35 | Manufacturing distruption | 236464 |
5114 | B05BA03 | 5% DEXTROSE INJECTION | 50MG | Fresenius Kabi Canada Ltd | Resolved | 2024-09-03 | 22 | Manufacturing distruption | 236461 |
5115 | N06DA03 | SANDOZ RIVASTIGMINE PATCH 5 | 4.6MG | Sandoz Canada Incorporated | Resolved | 2024-09-03 | 94 | Manufacturing practices | 236571 |
5116 | N03AX18 | SANDOZ LACOSAMIDE | 50MG | Sandoz Canada Incorporated | Resolved | 2024-09-03 | 45 | Manufacturing distruption | 236556 |
5101 | G03GA08 | OVIDREL | 250MCG | Emd Serono, A Division Of Emd Inc., Canada | Active | 2024-09-02 | 485 | Demand increase | 233582 |
5102 | G04BE09 | MYLAN-VARDENAFIL | 5MG | Mylan Pharmaceuticals Ulc | Active | 2024-09-02 | 267 | Ingredient shortage | 236014 |
5100 | M01AB55 | GD-DICLOFENAC/MISOPROSTOL 75 | 200MCG 75MG | Genmed A Division Of Pfizer Canada Ulc | Resolved | 2024-09-02 | 71 | Demand increase | 233196 |
5092 | C08CA01 | TARO-AMLODIPINE | 5MG | Sun Pharma Canada Inc | Active | 2024-09-01 | Manufacturing distruption | 242583 | |
5093 | C08CA01 | TARO-AMLODIPINE | 10MG | Sun Pharma Canada Inc | Active | 2024-09-01 | Manufacturing distruption | 242586 | |
5094 | N05AX08 | TARO-RISPERIDONE | 1MG | Sun Pharma Canada Inc | Active | 2024-09-01 | Manufacturing distruption | 242652 | |
5095 | N05AX08 | TARO-RISPERIDONE | 2MG | Sun Pharma Canada Inc | Active | 2024-09-01 | Manufacturing distruption | 242655 | |
5096 | N05AX08 | TARO-RISPERIDONE | 4MG | Sun Pharma Canada Inc | Active | 2024-09-01 | Manufacturing distruption | 242661 | |
5097 | L01EA01 | NAT-IMATINIB | 100MG | Natco Pharma (Canada) Inc | Active | 2024-09-01 | Manufacturing distruption | 236421 | |
5098 | L01EA01 | NAT-IMATINIB | 400MG | Natco Pharma (Canada) Inc | Active | 2024-09-01 | Manufacturing distruption | 236418 | |
5086 | N01BB51 | SENSORCAINE WITH EPINEPHRINE | 5MCG 5MG | Aspen Pharmacare Canada Inc. | Avoided | 2024-09-01 | 29 | Manufacturing distruption | 233373 |
5087 | N01BB51 | SENSORCAINE WITH EPINEPHRINE | 5MCG 5MG | Aspen Pharmacare Canada Inc. | Avoided | 2024-09-01 | 29 | Manufacturing distruption | 229816 |
5088 | G03AA05 | BREVICON 0.5/35 TABLETS (28-DA... | .5MG .035MG | Pfizer Canada Ulc | Avoided | 2024-09-01 | 136 | Manufacturing distruption | 233215 |
5090 | C01BB01 | XYLOCARD | 100MG | Aspen Pharmacare Canada Inc. | Avoided | 2024-09-01 | 29 | Manufacturing distruption | 222692 |
5089 | G03AA05 | BREVICON 1/35 TABLETS (28-DAY ... | 0.035MG 1MG | Pfizer Canada Ulc | Resolved | 2024-09-01 | Manufacturing distruption | 234129 | |
5091 | D10BA01 | ACCUTANE ROCHE | 10MG | Hoffmann-La Roche Limited | Resolved | 2024-09-01 | 60 | Manufacturing distruption | 229980 |
5099 | L01BC06 | TARO-CAPECITABINE | 500MG | Taro Pharmaceuticals Inc | Resolved | 2024-09-01 | 54 | Manufacturing distruption | 237232 |
5084 | L01XX27 | ARSENIC TRIOXIDE FOR INJECTION | 1MG | Sterimax Inc | Active | 2024-08-31 | 370 | Manufacturing distruption | 235163 |
5082 | R03DX05 | XOLAIR | 150MG | Novartis Pharmaceuticals Canada Inc | Avoided | 2024-08-31 | 30 | Shipping delay | 224781 |
5081 | B05XA06 | POTASSIUM PHOSPHATES INJECTION... | 236MG 224MG | Fresenius Kabi Canada Ltd | Resolved | 2024-08-31 | 93 | Manufacturing distruption | 11547 |
5083 | G04CA02 | TAMSULOSIN CR | 0.4MG | Pro Doc Limitee | Resolved | 2024-08-31 | 94 | Ingredient shortage | 215019 |
5085 | N01AH01 | FENTANYL CITRATE INJECTION, US... | 50MCG | Fresenius Kabi Canada Ltd | Resolved | 2024-08-31 | 16 | Shipping delay | 235827 |
5073 | N05AH04 | QUETIAPINE FUMARATE XR | 400MG | Sanis Health Inc | Active | 2024-08-30 | Manufacturing distruption | 223373 | |
5078 | C09CA06 | CANDESARTAN | 32MG | Sanis Health Inc | Active | 2024-08-30 | Manufacturing distruption | 232011 | |
5080 | C09DA08 | OLMESARTAN/HCTZ | 40MG 25MG | Sanis Health Inc | Active | 2024-08-30 | Manufacturing distruption | 223370 | |
5074 | A03AD01 | PAPAVERINE HYDROCHLORIDE INJEC... | 65MG | Sandoz Canada Incorporated | Avoided | 2024-08-30 | Manufacturing distruption | 234800 | |
5075 | J01FF01 | CLINDAMYCIN INJECTION USP | 150MG | Sandoz Canada Incorporated | Avoided | 2024-08-30 | Manufacturing distruption | 234803 | |
5076 | C03CA01 | FUROSEMIDE | 40MG | Sanis Health Inc | Avoided | 2024-08-30 | 28 | Manufacturing distruption | 232002 |
5077 | N05AH03 | OLANZAPINE ODT | 10MG | Sanis Health Inc | Avoided | 2024-08-30 | Manufacturing distruption | 232029 | |
5079 | N01AH01 | FENTANYL INJECTION BP | 1000MCG | Sterimax Inc | Resolved | 2024-08-30 | 17 | Shipping delay | 236211 |
5071 | N05AH04 | QUETIAPINE XR | 150MG | Sivem Pharmaceuticals Ulc | Active | 2024-08-29 | Manufacturing distruption | 217992 | |
5070 | P01AX06 | GLN-ATOVAQUONE | 750MG | Glenmark Pharmaceuticals Canada Inc. | Resolved | 2024-08-29 | 41 | Ingredient shortage | 236216 |
5072 | J01DD02 | CEFTAZIDIME FOR INJECTION BP | 6G | Sterimax Inc | Resolved | 2024-08-29 | 32 | Shipping delay | 236208 |
5053 | D07AC01 | TEVA-TOPILENE | 0.05% | Teva Canada Limited | Active | 2024-08-28 | 306 | Manufacturing distruption | 236356 |
5054 | J01FF01 | DALACIN C FLAVOURED GRANULES | 75MG | Pfizer Canada Ulc | Active | 2024-08-28 | 306 | Manufacturing distruption | 226793 |
5061 | G04BD08 | TEVA-SOLIFENACIN | 10MG | Teva Canada Limited | Active | 2024-08-28 | 337 | Manufacturing distruption | 236376 |
5064 | N06BA01 | TEVA-AMPHETAMINE XR | 5MG | Teva Canada Limited | Active | 2024-08-28 | 215 | Manufacturing distruption | 236392 |
5065 | N06BA01 | TEVA-AMPHETAMINE XR | 10MG | Teva Canada Limited | Active | 2024-08-28 | 255 | Manufacturing distruption | 236395 |
5066 | N06BA01 | TEVA-AMPHETAMINE XR | 15MG | Teva Canada Limited | Active | 2024-08-28 | 215 | Manufacturing distruption | 236398 |
5067 | N06BA01 | TEVA-AMPHETAMINE XR | 20MG | Teva Canada Limited | Active | 2024-08-28 | 225 | Manufacturing distruption | 236401 |
5068 | N06BA01 | TEVA-AMPHETAMINE XR | 30MG | Teva Canada Limited | Active | 2024-08-28 | 215 | Manufacturing distruption | 236404 |
5052 | N06AX23 | DESVENLAFAXINE | 50MG | Sanis Health Inc | Resolved | 2024-08-28 | 79 | Manufacturing distruption | 231999 |
5055 | D07AD01 | TEVA-CLOBETASOL | 0.05% | Teva Canada Limited | Resolved | 2024-08-28 | 74 | Manufacturing distruption | 236359 |
5056 | A02BX02 | TEVA-SUCRALFATE | 1G | Teva Canada Limited | Resolved | 2024-08-28 | 74 | Manufacturing distruption | 236362 |
5057 | M03BX08 | TEVA-CYCLOBENZAPRINE | 10MG | Teva Canada Limited | Resolved | 2024-08-28 | 104 | Manufacturing distruption | 236365 |
5058 | J01DB01 | TEVA-CEPHALEXIN 250 | 250MG | Teva Canada Limited | Resolved | 2024-08-28 | 33 | Manufacturing distruption | 236353 |
5059 | R03BA05 | FLOVENT HFA | 125MCG | Glaxosmithkline Inc | Resolved | 2024-08-28 | 16 | Demand increase | 236413 |
5060 | N06AB06 | SERTRALINE | 100MG | Sanis Health Inc | Resolved | 2024-08-28 | 93 | Manufacturing distruption | 233530 |
5062 | C08DB01 | TEVA-DILTIAZEM XC | 240MG | Teva Canada Limited | Resolved | 2024-08-28 | 84 | Manufacturing distruption | 236386 |
5063 | C08DB01 | TEVA-DILTIAZEM XC | 360MG | Teva Canada Limited | Resolved | 2024-08-28 | 74 | Manufacturing distruption | 236389 |
5069 | C09BA04 | TEVA-PERINDOPRIL/INDAPAMIDE | 1.25MG 4MG | Teva Canada Limited | Resolved | 2024-08-28 | 215 | Manufacturing distruption | 236383 |
5036 | G04BD11 | SANDOZ FESOTERODINE FUMARATE | 8MG | Sandoz Canada Incorporated | Resolved | 2024-08-27 | 10 | Shipping delay | 236045 |
5037 | J02AX05 | MICAFUNGIN SODIUM FOR INJECTIO... | 50MG | Juno Pharmaceuticals Corp. | Resolved | 2024-08-27 | 65 | Manufacturing distruption | 235971 |
5038 | R06AA11 | DIMENHYDRINATE INJECTION USP | 50MG | Sandoz Canada Incorporated | Resolved | 2024-08-27 | 3 | Manufacturing distruption | 236038 |
5039 | N02BF01 | APO-GABAPENTIN | 400MG | Apotex Inc | Resolved | 2024-08-27 | 59 | Manufacturing distruption | 236252 |
5040 | G03CA03 | ESTRADOT 25 | 25MCG | Sandoz Canada Incorporated | Resolved | 2024-08-27 | 38 | Manufacturing distruption | 236041 |
5041 | N03AF01 | SANDOZ-CARBAMAZEPINE CR | 400MG | Sandoz Canada Incorporated | Resolved | 2024-08-27 | 66 | Manufacturing distruption | 236035 |
5042 | C09AA04 | APO-PERINDOPRIL | 4MG | Apotex Inc | Resolved | 2024-08-27 | 31 | Manufacturing distruption | 236255 |
5043 | C09AA04 | APO-PERINDOPRIL | 8MG | Apotex Inc | Resolved | 2024-08-27 | 31 | Manufacturing distruption | 236237 |
5044 | N06AB10 | APO-ESCITALOPRAM | 10MG | Apotex Inc | Resolved | 2024-08-27 | 38 | Manufacturing distruption | 236258 |
5045 | N06AB10 | APO-ESCITALOPRAM | 20MG | Apotex Inc | Resolved | 2024-08-27 | 80 | Manufacturing distruption | 236243 |
5046 | A10BB09 | APO-GLICLAZIDE MR | 30MG | Apotex Inc | Resolved | 2024-08-27 | Manufacturing distruption | 236261 | |
5047 | C09DA01 | SANDOZ LOSARTAN HCT DS | 25MG 100MG | Sandoz Canada Incorporated | Resolved | 2024-08-27 | 108 | Manufacturing distruption | 236048 |
5048 | C09CA03 | SANDOZ VALSARTAN | 320MG | Sandoz Canada Incorporated | Resolved | 2024-08-27 | 3 | Manufacturing distruption | 236052 |
5049 | J05AF06 | APO-ABACAVIR | 300MG | Apotex Inc | Resolved | 2024-08-27 | 38 | Manufacturing distruption | 236249 |
5050 | A10BH01 | APO-SITAGLIPTIN MALATE | 25MG | Apotex Inc | Resolved | 2024-08-27 | 38 | Manufacturing distruption | 236246 |
5051 | APO-MELOXICAM | 1.5G | Apotex Inc | Resolved | 2024-08-27 | 206 | Manufacturing distruption | 236240 | |
5012 | N04BA02 | AURO-LEVOCARB | 10MG 100MG | Auro Pharma Inc | Active | 2024-08-26 | Demand increase | 235894 | |
5013 | N04BA02 | AURO-LEVOCARB | 25MG 100MG | Auro Pharma Inc | Active | 2024-08-26 | Demand increase | 235888 | |
5014 | N04BA02 | AURO-LEVOCARB | 25MG 250MG | Auro Pharma Inc | Active | 2024-08-26 | Demand increase | 235891 | |
5015 | M04AA03 | AURO-FEBUXOSTAT | 80MG | Auro Pharma Inc | Active | 2024-08-26 | Demand increase | 235867 | |
5020 | C10AA01 | AURO-SIMVASTATIN | 80MG | Auro Pharma Inc | Active | 2024-08-26 | Demand increase | 235912 | |
5021 | C09DA03 | AURO-VALSARTAN HCT | 12.5MG 80MG | Auro Pharma Inc | Active | 2024-08-26 | Demand increase | 235921 | |
5022 | C09DA03 | AURO-VALSARTAN HCT | 25MG 160MG | Auro Pharma Inc | Active | 2024-08-26 | Demand increase | 235924 | |
5023 | C09DA03 | AURO-VALSARTAN HCT | 12.5MG 320MG | Auro Pharma Inc | Active | 2024-08-26 | Demand increase | 235930 | |
5024 | C09DA03 | AURO-VALSARTAN HCT | 25MG 320MG | Auro Pharma Inc | Active | 2024-08-26 | Demand increase | 235927 | |
5010 | G03DA04 | PROGESTERONE | 100MG | Sanis Health Inc | Resolved | 2024-08-26 | 39 | Manufacturing distruption | 235853 |
5011 | J05AE03 | AURO-RITONAVIR | 100MG | Auro Pharma Inc | Resolved | 2024-08-26 | 81 | Demand increase | 235903 |
5016 | V08CA03 | OMNISCAN | 287MG | Ge Healthcare Canada Inc | Resolved | 2024-08-26 | 35 | Shipping delay | 235933 |
5017 | N03AX11 | AURO-TOPIRAMATE | 100MG | Auro Pharma Inc | Resolved | 2024-08-26 | 165 | Demand increase | 235915 |
5018 | M05BA04 | AURO-ALENDRONATE | 10MG | Auro Pharma Inc | Resolved | 2024-08-26 | 50 | Demand increase | 235870 |
5019 | C10AA01 | AURO-SIMVASTATIN | 5MG | Auro Pharma Inc | Resolved | 2024-08-26 | 35 | Demand increase | 235909 |
5025 | C07AG02 | AURO-CARVEDILOL | 12.5MG | Auro Pharma Inc | Resolved | 2024-08-26 | 65 | Demand increase | 235879 |
5026 | N04BC05 | AURO-PRAMIPEXOLE | 1.5MG | Auro Pharma Inc | Resolved | 2024-08-26 | 35 | Demand increase | 235900 |
5027 | N06AX21 | AURO-DULOXETINE | 30MG | Auro Pharma Inc | Resolved | 2024-08-26 | 186 | Demand increase | 235882 |
5028 | N01BB09 | ROPIVACAINE HYDROCHLORIDE INJE... | 5MG | Fresenius Kabi Canada Ltd | Resolved | 2024-08-26 | 65 | Shipping delay | 235457 |
5029 | N07CA01 | AURO-BETAHISTINE | 24MG | Auro Pharma Inc | Resolved | 2024-08-26 | 35 | Demand increase | 235876 |
5030 | C10AX09 | AURO-EZETIMIBE | 10MG | Auro Pharma Inc | Resolved | 2024-08-26 | 81 | Demand increase | 235885 |
5031 | C09DA08 | AURO-OLMESARTAN HCTZ | 25MG 40MG | Auro Pharma Inc | Resolved | 2024-08-26 | 111 | Demand increase | 235897 |
5032 | G04CA04 | AURO-SILODOSIN | 4MG | Auro Pharma Inc | Resolved | 2024-08-26 | 65 | Demand increase | 235906 |
5033 | C09AA04 | PERINDOPRIL ERBUMINE | 4MG | Sanis Health Inc | Resolved | 2024-08-26 | 53 | Manufacturing distruption | 235850 |
5034 | J01FA10 | AURO-AZITHROMYCIN | 200MG | Auro Pharma Inc | Resolved | 2024-08-26 | 20 | Demand increase | 235873 |
5035 | H04AA01 | BAQSIMI | 3MG | Amphastar Pharmaceuticals, Inc. | Resolved | 2024-08-26 | 28 | Other | 235530 |
5001 | A02BC02 | PANTOPRAZOLE SODIUM FOR INJECT... | 40MG | Jamp Pharma Corporation | Active | 2024-08-23 | 281 | Demand increase | 235856 |
5005 | G04CB01 | JAMP-FINASTERIDE | 5MG | Jamp Pharma Corporation | Active | 2024-08-23 | 281 | Manufacturing distruption | 235810 |
5006 | G04CB01 | JAMP-FINASTERIDE | 5MG | Jamp Pharma Corporation | Active | 2024-08-23 | 281 | Manufacturing distruption | 235814 |
5007 | C09CA06 | CANDESARTAN | 8MG | Sanis Health Inc | Active | 2024-08-23 | Manufacturing distruption | 234192 | |
5009 | N02BF01 | GABAPENTIN | 800MG | Sanis Health Inc | Active | 2024-08-23 | Manufacturing distruption | 232020 | |
5003 | C09BA02 | VASERETIC | 25MG 8MG | Organon Canada Inc. | Avoided | 2024-08-23 | 7 | Shipping delay | 230533 |
5002 | N03AX22 | TARO-PERAMPANEL | 12MG | Taro Pharmaceuticals Inc | Resolved | 2024-08-23 | 35 | Manufacturing distruption | 237248 |
5004 | J01DD04 | CEFTRIAXONE SODIUM FOR INJECTI... | 2G | Sterimax Inc | Resolved | 2024-08-23 | 129 | Shipping delay | 235273 |
5008 | L01CD01 | PACLITAXEL INJECTION USP | 6MG | Accord Healthcare Inc | Resolved | 2024-08-23 | 63 | Manufacturing practices | 225231 |
4996 | B01AF01 | XARELTO | 10MG | Bayer Inc | Avoided | 2024-08-22 | 1 | Demand increase | 229971 |
4997 | C09DA04 | PMS-IRBESARTAN-HCTZ | 25MG 300MG | Pharmascience Inc | Resolved | 2024-08-22 | 38 | Manufacturing distruption | 235745 |
4998 | N05CF02 | PMS-ZOLPIDEM ODT | 10MG | Pharmascience Inc | Resolved | 2024-08-22 | 38 | Manufacturing distruption | 235748 |
4999 | M03AC09 | ROCURONIUM BROMIDE INJECTION | 10MG | Auro Pharma Inc | Resolved | 2024-08-22 | Other | 235718 | |
5000 | N05AE05 | TARO-LURASIDONE | 40MG | Taro Pharmaceuticals Inc | Resolved | 2024-08-22 | 92 | Manufacturing distruption | 242677 |
4993 | D07AC01 | DIPROSONE | 0.05% | Organon Canada Inc. | Resolved | 2024-08-21 | 107 | Demand increase | 235627 |
4994 | N05AX08 | RISPERIDONE | 0.25MG | Sanis Health Inc | Resolved | 2024-08-21 | 44 | Manufacturing distruption | 233527 |
4995 | J01CR05 | PIPERACILLIN AND TAZOBACTAM FO... | 0.375G 3G | Auro Pharma Inc | Resolved | 2024-08-21 | Other | 235624 | |
4985 | N06AB03 | ACH-FLUOXETINE | 20MG | Accord Healthcare Inc | Active | 2024-08-20 | Manufacturing practices | 225244 | |
4987 | N02BF02 | APO-PREGABALIN | 300MG | Apotex Inc | Active | 2024-08-20 | Manufacturing distruption | 216735 | |
4992 | N02CC03 | AURO-ZOLMITRIPTAN | 2.5MG | Auro Pharma Inc | Active | 2024-08-20 | 253 | Demand increase | 235553 |
4974 | C07AB04 | APO-ACEBUTOLOL | 200MG | Apotex Inc | Resolved | 2024-08-20 | 24 | Manufacturing distruption | 235708 |
4975 | C02DC01 | LONITEN 2.5MG | 2.5MG | Pfizer Canada Ulc | Resolved | 2024-08-20 | 206 | Manufacturing distruption | 235548 |
4976 | L01BA01 | METHOTREXATE INJECTION USP | 25MG | Pfizer Canada Ulc | Resolved | 2024-08-20 | Manufacturing distruption | 233173 | |
4977 | G03CA03 | ESTRADOT 50 | 50MCG | Sandoz Canada Incorporated | Resolved | 2024-08-20 | 52 | Manufacturing distruption | 235566 |
4978 | C10AB05 | AA-FENO-SUPER | 160MG | Aa Pharma Inc | Resolved | 2024-08-20 | 10 | Manufacturing distruption | 235656 |
4979 | C09AA05 | APO-RAMIPRIL | 10MG | Apotex Inc | Resolved | 2024-08-20 | 87 | Manufacturing distruption | 235689 |
4980 | N06AX11 | MYLAN-MIRTAZAPINE | 15MG | Mylan Pharmaceuticals Ulc | Resolved | 2024-08-20 | 98 | Manufacturing distruption | 232547 |
4981 | N06AX11 | APO-MIRTAZAPINE | 30MG | Apotex Inc | Resolved | 2024-08-20 | 17 | Manufacturing distruption | 235711 |
4982 | N06DA03 | SANDOZ RIVASTIGMINE | 6MG | Sandoz Canada Incorporated | Resolved | 2024-08-20 | Manufacturing distruption | 235570 | |
4983 | J01MA12 | APO-LEVOFLOXACIN | 750MG | Apotex Inc | Resolved | 2024-08-20 | 87 | Manufacturing distruption | 235695 |
4984 | N02CC03 | SANDOZ ZOLMITRIPTAN | 2.5MG | Sandoz Canada Incorporated | Resolved | 2024-08-20 | 59 | Manufacturing practices | 235574 |
4986 | N02CC04 | APO-RIZATRIPTAN | 10MG | Apotex Inc | Resolved | 2024-08-20 | 101 | Manufacturing distruption | 235698 |
4988 | G03AA09 | MIRVALA 28 | 0.0300MG 0.1500MG | Apotex Inc | Resolved | 2024-08-20 | 66 | Manufacturing distruption | 235701 |
4989 | C10BX03 | APO-AMLODIPINE-ATORVASTATIN | 80MG 10MG | Apotex Inc | Resolved | 2024-08-20 | 24 | Manufacturing distruption | 235705 |
4990 | N06AX21 | APO-DULOXETINE | 60MG | Apotex Inc | Resolved | 2024-08-20 | 80 | Manufacturing distruption | 235692 |
4991 | B01AF03 | LIXIANA | 30MG | Servier Canada Inc | Resolved | 2024-08-20 | 2 | Other | 235557 |
4972 | C09AA03 | PRO-LISINOPRIL - 20 | 20MG | Pro Doc Limitee | Active | 2024-08-19 | Manufacturing distruption | 235484 | |
4971 | N05AB04 | PROCHLORAZINE | 5MG | Aa Pharma Inc | Resolved | 2024-08-19 | 39 | Manufacturing distruption | 235433 |
4973 | J01FA10 | M-AZITHROMYCIN | 250MG | Mantra Pharma Inc | Resolved | 2024-08-19 | 165 | Shipping delay | 245387 |
4962 | C09AA03 | LISINOPRIL | 5MG | Sanis Health Inc | Active | 2024-08-16 | Manufacturing distruption | 232026 | |
4969 | A03AB02 | GLYCOPYRROLATE INJECTION USP | 4MG | Sterimax Inc | Active | 2024-08-16 | 262 | Manufacturing practices | 234808 |
4963 | N01AX03 | KETAMINE INJECTION, BP | 50MG | Sterimax Inc | Resolved | 2024-08-16 | 21 | Shipping delay | 234822 |
4964 | N01AX10 | PROPOFOL INJECTION | 10MG | Baxter Corporation | Resolved | 2024-08-16 | 5 | Shipping delay | 235264 |
4965 | V09GA02 | MYOVIEW 30ML | 1.38MG | Ge Healthcare Canada Inc | Resolved | 2024-08-16 | 14 | Shipping delay | 235488 |
4966 | N01AH03 | SUFENTANIL CITRATE INJECTION U... | 50MCG | Sterimax Inc | Resolved | 2024-08-16 | 210 | Shipping delay | 234813 |
4967 | D07CB01 | VIADERM KC CRM | 100000UNIT 0.25MG 2.5MG 1MG | Taro Pharmaceuticals Inc | Resolved | 2024-08-16 | 98 | Manufacturing distruption | 237272 |
4968 | D07CB01 | VIADERM KC CRM | 100000UNIT 0.25MG 2.5MG 1MG | Taro Pharmaceuticals Inc | Resolved | 2024-08-16 | 211 | Manufacturing distruption | 238060 |
4970 | B01AF01 | TARO-RIVAROXABAN | 20MG | Taro Pharmaceuticals Inc | Resolved | 2024-08-16 | 35 | Manufacturing distruption | 238049 |
4957 | L02BG04 | LETROZOLE | 2.5MG | Sivem Pharmaceuticals Ulc | Active | 2024-08-15 | Manufacturing distruption | 217986 | |
4958 | C10AC02 | COLESTID TABLETS | 1G | Pfizer Canada Ulc | Resolved | 2024-08-15 | 197 | Manufacturing distruption | 233212 |
4959 | R03BA09 | ARNUITY ELLIPTA | 100MCG | Glaxosmithkline Inc | Resolved | 2024-08-15 | 29 | Demand increase | 235373 |
4960 | J01CA01 | AMPICILLIN SODIUM FOR INJECTIO... | 2G | Auro Pharma Inc | Resolved | 2024-08-15 | Other | 235334 | |
4961 | J01DD04 | CEFTRIAXONE INJECTION, USP | 1000MG | Baxter Corporation | Resolved | 2024-08-15 | 8 | Ingredient shortage | 235267 |
4956 | G04BD10 | JAMP DARIFENACIN | 7.5MG | Jamp Pharma Corporation | Active | 2024-08-14 | 229 | Manufacturing distruption | 235221 |
4949 | G03BA03 | TESTOSTERONE ENANTHATE INJECTI... | 200MG | Hikma Canada Limited | Resolved | 2024-08-14 | 9 | Shipping delay | 235077 |
4950 | R03BA05 | FLOVENT DISKUS | 250MCG | Glaxosmithkline Inc | Resolved | 2024-08-14 | 42 | Manufacturing distruption | 235014 |
4951 | L04AC02 | SIMULECT | 20MG | Novartis Pharmaceuticals Canada Inc | Resolved | 2024-08-14 | 20 | Manufacturing distruption | 232638 |
4952 | N02BF02 | PREGABALIN | 50MG | Sanis Health Inc | Resolved | 2024-08-14 | 65 | Manufacturing distruption | 234198 |
4953 | N02BF02 | PREGABALIN | 50MG | Sanis Health Inc | Resolved | 2024-08-14 | 107 | Manufacturing distruption | 234201 |
4954 | G04BD08 | SOLIFENACIN | 5MG | Sanis Health Inc | Resolved | 2024-08-14 | 51 | Manufacturing distruption | 234204 |
4955 | L04AX03 | METHOTREXATE SUBCUTANEOUS | 15MG | Accord Healthcare Inc | Resolved | 2024-08-14 | 56 | Manufacturing distruption | 235408 |
4945 | N07XX02 | APO-RILUZOLE | 50MG | Apotex Inc | Active | 2024-08-13 | 493 | Manufacturing distruption | 229974 |
4948 | N06AB03 | NRA-FLUOXETINE | 10MG | Nora Pharma Inc | Active | 2024-08-13 | 241 | Manufacturing distruption | 248683 |
4939 | N04BA02 | APO-LEVOCARB-TAB 25MG/100MG | 100MG 25MG | Apotex Inc | Resolved | 2024-08-13 | 52 | Manufacturing distruption | 235339 |
4940 | J01AA07 | TETRACYCLINE | 250MG | Aa Pharma Inc | Resolved | 2024-08-13 | 17 | Manufacturing distruption | 235427 |
4941 | N07CA03 | FLUNARIZINE | 5MG | Aa Pharma Inc | Resolved | 2024-08-13 | 38 | Manufacturing distruption | 235430 |
4942 | G03CA03 | CLIMARA 25 | 25MCG | Bayer Inc | Resolved | 2024-08-13 | 31 | Other | 235229 |
4943 | B01AC04 | APO-CLOPIDOGREL | 75MG | Apotex Inc | Resolved | 2024-08-13 | 59 | Manufacturing distruption | 235348 |
4944 | M05BB03 | FOSAVANCE | 2800UNIT 70MG | Organon Canada Inc. | Resolved | 2024-08-13 | 17 | Shipping delay | 235351 |
4946 | C08CA02 | APO-FELODIPINE | 5MG | Apotex Inc | Resolved | 2024-08-13 | 59 | Manufacturing distruption | 235345 |
4947 | C09BA04 | APO-PERINDOPRIL-INDAPAMIDE | 8MG 2.5MG | Apotex Inc | Resolved | 2024-08-13 | 178 | Manufacturing distruption | 235342 |
4929 | S01ED01 | TIMOLOL MALEATE-EX | 0.5% | Sandoz Canada Incorporated | Active | 2024-08-12 | 277 | Manufacturing distruption | 235074 |
4924 | N05AN01 | CARBOLITH | 600MG | Bausch Health, Canada Inc. | Resolved | 2024-08-12 | 45 | Demand increase | 234348 |
4925 | B05XA03 | SODIUM CHLORIDE INJECTION USP | 9MG | Icu Medical Canada Inc | Resolved | 2024-08-12 | 11 | Manufacturing distruption | 235354 |
4926 | B05XA03 | SODIUM CHLORIDE INJECTION USP | 9MG | Icu Medical Canada Inc | Resolved | 2024-08-12 | 98 | Manufacturing distruption | 235358 |
4927 | B05XA03 | SODIUM CHLORIDE INJECTION USP | 9MG | Icu Medical Canada Inc | Resolved | 2024-08-12 | 18 | Manufacturing distruption | 235363 |
4928 | B05XA03 | SODIUM CHLORIDE INJECTION USP | 9MG | Icu Medical Canada Inc | Resolved | 2024-08-12 | 7 | Manufacturing distruption | 235366 |
4930 | N06DA03 | SANDOZ RIVASTIGMINE | 1.5MG | Sandoz Canada Incorporated | Resolved | 2024-08-12 | Manufacturing distruption | 235071 | |
4931 | J01CR05 | PIPERACILLIN AND TAZOBACTAM FO... | 0.5G 4G | Auro Pharma Inc | Resolved | 2024-08-12 | Demand increase | 235089 | |
4932 | C09DA01 | LOSARTAN/HCTZ | 25MG 100MG | Sanis Health Inc | Resolved | 2024-08-12 | 151 | Manufacturing distruption | 235045 |
4933 | C09CA08 | SANDOZ OLMESARTAN | 20MG | Sandoz Canada Incorporated | Resolved | 2024-08-12 | 102 | Demand increase | 235068 |
4934 | J01CA01 | AMPICILLIN SODIUM FOR INJECTIO... | 250MG | Auro Pharma Inc | Resolved | 2024-08-12 | Demand increase | 235098 | |
4935 | J01FA10 | AZITHROMYCIN FOR INJECTION, US... | 500MG | Auro Pharma Inc | Resolved | 2024-08-12 | Demand increase | 235095 | |
4936 | A04AA01 | AURO-ONDANSETRON INJECTION | 2MG | Auro Pharma Inc | Resolved | 2024-08-12 | Demand increase | 235116 | |
4937 | J01DH03 | ERTAPENEM FOR INJECTION | 1G | Auro Pharma Inc | Resolved | 2024-08-12 | Demand increase | 235113 | |
4938 | L01CE02 | IRINOTECAN HYDROCHLORIDE INJEC... | 500MG | Auro Pharma Inc | Resolved | 2024-08-12 | Demand increase | 235109 | |
4918 | L02BG03 | ANASTROZOLE | 1MG | Sivem Pharmaceuticals Ulc | Active | 2024-08-10 | 295 | Manufacturing distruption | 217977 |
4922 | C09AA03 | LISINOPRIL | 10MG | Sivem Pharmaceuticals Ulc | Active | 2024-08-10 | Ingredient shortage | 243471 | |
4923 | C09AA03 | LISINOPRIL | 20MG | Sivem Pharmaceuticals Ulc | Active | 2024-08-10 | Ingredient shortage | 243474 | |
4919 | C10AA05 | TARO-ATORVASTATIN | 10MG | Taro Pharmaceuticals Inc | Resolved | 2024-08-10 | 111 | Manufacturing distruption | 242482 |
4920 | C10AA05 | TARO-ATORVASTATIN | 20MG | Taro Pharmaceuticals Inc | Resolved | 2024-08-10 | 111 | Manufacturing distruption | 242487 |
4921 | C10AA05 | TARO-ATORVASTATIN | 40MG | Taro Pharmaceuticals Inc | Resolved | 2024-08-10 | 111 | Manufacturing distruption | 242492 |
4908 | N02CC03 | BIO-ZOLMITRIPTAN | 2.5MG | Biomed Pharma | Active | 2024-08-09 | Manufacturing practices | 235779 | |
4910 | N05AH04 | QUETIAPINE FUMARATE XR | 50MG | Sanis Health Inc | Active | 2024-08-09 | Manufacturing distruption | 223344 | |
4917 | C09DA08 | OLMESARTAN/HCTZ | 40MG 12.5MG | Sanis Health Inc | Active | 2024-08-09 | Manufacturing distruption | 223383 | |
4915 | J07BD54 | PROQUAD | 3.99Log10 PFU 3.00Log10 TCID50 4.30Log10 TCID50 3.00Log10 TCID50 | Merck Canada Inc | Avoided | 2024-08-09 | 21 | Demand increase | 221447 |
4909 | B05XA03 | 0.9% SODIUM CHLORIDE INJECTION... | 900MG | Baxter Corporation | Resolved | 2024-08-09 | 113 | Manufacturing distruption | 235026 |
4911 | N02BE01 | ACETAMINOPHEN INJECTION | 10MG | Baxter Corporation | Resolved | 2024-08-09 | 35 | Shipping delay | 234740 |
4912 | N02AA01 | MS.IR | 5MG | Purdue Pharma | Resolved | 2024-08-09 | 49 | Demand increase | 234951 |
4913 | D10BA01 | CLARUS | 40MG | Mylan Pharmaceuticals Ulc | Resolved | 2024-08-09 | Demand increase | 232553 | |
4914 | J01CR05 | PIPERACILLIN AND TAZOBACTAM FO... | 0.5G 4.0G | Sterimax Inc | Resolved | 2024-08-09 | Demand increase | 235137 | |
4916 | N01AH01 | FENTANYL INJECTION BP | 100MCG | Sterimax Inc | Resolved | 2024-08-09 | 31 | Shipping delay | 234115 |
4905 | R03BA02 | TEVA-BUDESONIDE | 0.125MG | Teva Canada Limited | Active | 2024-08-08 | 479 | Manufacturing distruption | 234891 |
4904 | L01DB01 | CAELYX | 2MG | Baxter Corporation | Resolved | 2024-08-08 | 23 | Shipping delay | 229782 |
4906 | J05AX18 | PREVYMIS | 20MG | Merck Canada Inc | Resolved | 2024-08-08 | 57 | Demand increase | 233731 |
4907 | J01XA01 | VANCOMYCIN INJECTION USP IN 0.... | 1000MG | Baxter Corporation | Resolved | 2024-08-08 | 11 | Shipping delay | 234758 |
4889 | J01XE01 | TEVA-NITROFURANTOIN | 50MG | Teva Canada Limited | Active | 2024-08-07 | 246 | Manufacturing distruption | 234873 |
4891 | N06AX02 | TEVA-TRYPTOPHAN | 500MG | Teva Canada Limited | Active | 2024-08-07 | Manufacturing distruption | 234876 | |
4887 | N06AX05 | TEVA-TRAZODONE | 100MG | Teva Canada Limited | Resolved | 2024-08-07 | 74 | Manufacturing distruption | 234870 |
4888 | L01BA01 | METHOTREXATE INJECTION USP | 25MG | Pfizer Canada Ulc | Resolved | 2024-08-07 | Manufacturing distruption | 228024 | |
4890 | N06AB06 | APO-SERTRALINE | 50MG | Apotex Inc | Resolved | 2024-08-07 | 30 | Manufacturing distruption | 234992 |
4892 | N02BF01 | TEVA-GABAPENTIN | 400MG | Teva Canada Limited | Resolved | 2024-08-07 | 34 | Manufacturing distruption | 234879 |
4893 | A02BC01 | APO-OMEPRAZOLE | 20MG | Apotex Inc | Resolved | 2024-08-07 | 58 | Manufacturing distruption | 234999 |
4894 | C09AA05 | TEVA-RAMIPRIL | 2.5MG | Teva Canada Limited | Resolved | 2024-08-07 | 85 | Manufacturing distruption | 234882 |
4895 | C09AA07 | BENAZEPRIL | 20MG | Aa Pharma Inc | Resolved | 2024-08-07 | 26 | Manufacturing distruption | 234903 |
4896 | N02AB03 | TEVA-FENTANYL | 75MCG | Teva Canada Limited | Resolved | 2024-08-07 | 105 | Manufacturing distruption | 234885 |
4897 | C09AA07 | BENAZEPRIL | 10MG | Aa Pharma Inc | Resolved | 2024-08-07 | 13 | Manufacturing distruption | 234900 |
4898 | N06AB04 | TEVA-CITALOPRAM | 40MG | Teva Canada Limited | Resolved | 2024-08-07 | 85 | Manufacturing distruption | 234888 |
4899 | N06BA09 | APO-ATOMOXETINE | 40MG | Apotex Inc | Resolved | 2024-08-07 | 65 | Manufacturing distruption | 229167 |
4900 | N07BA03 | APO-VARENICLINE | 1MG | Apotex Inc | Resolved | 2024-08-07 | 16 | Manufacturing distruption | 234996 |
4901 | C09DA01 | LOSARTAN/HCTZ | 12.5MG 50MG | Sanis Health Inc | Resolved | 2024-08-07 | 58 | Manufacturing distruption | 232005 |
4902 | J01FA09 | CLARITHROMYCIN | 500MG | Sanis Health Inc | Resolved | 2024-08-07 | 72 | Manufacturing distruption | 231996 |
4903 | A02BD07 | AA-LANSOPRAZOLE-AMOXICILLIN-CL... | 500MG 500MG 30MG | Aa Pharma Inc | Resolved | 2024-08-07 | 215 | Manufacturing distruption | 234906 |
4880 | L04AX03 | AURO-METHOTREXATE | 2.5MG | Auro Pharma Inc | Active | 2024-08-06 | Demand increase | 234710 | |
4881 | A10BH01 | AURO-SITAGLIPTIN | 25MG | Auro Pharma Inc | Resolved | 2024-08-06 | 177 | Demand increase | 234713 |
4882 | R03AC02 | PMS-SALBUTAMOL | 2MG | Pharmascience Inc | Resolved | 2024-08-06 | 24 | Manufacturing distruption | 234078 |
4883 | R03AC02 | PMS-SALBUTAMOL | 1MG | Pharmascience Inc | Resolved | 2024-08-06 | 55 | Manufacturing distruption | 234075 |
4884 | V09HA02 | CERETEC | 0.5MG | Ge Healthcare Canada Inc | Resolved | 2024-08-06 | 17 | Manufacturing distruption | 232987 |
4885 | N03AX09 | AURO-LAMOTRIGINE | 25MG | Auro Pharma Inc | Resolved | 2024-08-06 | 24 | Demand increase | 234707 |
4886 | V09HA02 | CERETEC | 0.5MG | Ge Healthcare Canada Inc | Resolved | 2024-08-06 | 24 | Manufacturing distruption | 232992 |
4868 | B05XA02 | SODIUM BICARBONATE INJECTION U... | 84MG | Jamp Pharma Corporation | Active | 2024-08-05 | 360 | Demand increase | 234555 |
4879 | A16AB17 | BRINEURA | 150MG | Biomarin International Limited | Avoided | 2024-08-05 | Manufacturing practices | 222042 | |
4869 | S01EB09 | MIOCHOL-E | 20MG | Bausch & Lomb Inc | Resolved | 2024-08-05 | 217 | Manufacturing practices | 234072 |
4870 | N05AH01 | LOXAPAC IM | 50MG | Sandoz Canada Incorporated | Resolved | 2024-08-05 | 4 | Manufacturing distruption | 226623 |
4871 | M01AG01 | MEFENAMIC | 250MG | Aa Pharma Inc | Resolved | 2024-08-05 | 25 | Manufacturing distruption | 234154 |
4872 | A10BA02 | SANDOZ METFORMIN FC | 500MG | Sandoz Canada Incorporated | Resolved | 2024-08-05 | 4 | Manufacturing distruption | 234484 |
4873 | C09DA01 | SANDOZ LOSARTAN HCT | 12.5MG 50MG | Sandoz Canada Incorporated | Resolved | 2024-08-05 | 60 | Manufacturing distruption | 234475 |
4874 | N06DA03 | SANDOZ RIVASTIGMINE | 4.5MG | Sandoz Canada Incorporated | Resolved | 2024-08-05 | Manufacturing distruption | 234493 | |
4875 | N02CC03 | SANDOZ ZOLMITRIPTAN | 2.5MG | Sandoz Canada Incorporated | Resolved | 2024-08-05 | 88 | Manufacturing distruption | 234502 |
4876 | N06AA12 | SINEQUAN | 10MG | Aa Pharma Inc | Resolved | 2024-08-05 | 25 | Manufacturing distruption | 234151 |
4877 | N06BA01 | SANDOZ AMPHETAMINE XR | 10MG | Sandoz Canada Incorporated | Resolved | 2024-08-05 | 25 | Manufacturing distruption | 234467 |
4878 | G04CA04 | SANDOZ SILODOSIN | 8MG | Sandoz Canada Incorporated | Resolved | 2024-08-05 | 11 | Manufacturing distruption | 234496 |
4832 | N03AX18 | LACOSAMIDE | 100MG | Sanis Health Inc | Active | 2024-08-02 | Manufacturing distruption | 232023 | |
4835 | N02BA01 | JAMP-ASA CHEW | 80MG | Jamp Pharma Corporation | Active | 2024-08-02 | 302 | Manufacturing distruption | 234412 |
4836 | N02BA01 | JAMP-ASA CHEW | 80MG | Jamp Pharma Corporation | Active | 2024-08-02 | 302 | Manufacturing distruption | 234415 |
4837 | L04AA06 | JAMP-MYCOPHENOLATE | 500MG | Jamp Pharma Corporation | Active | 2024-08-02 | 271 | Manufacturing distruption | 234454 |
4838 | L04AA06 | JAMP-MYCOPHENOLATE CAPSULES | 250MG | Jamp Pharma Corporation | Active | 2024-08-02 | 271 | Manufacturing distruption | 234444 |
4843 | C09DA07 | JAMP TELMISARTAN-HCT | 12.5MG 80MG | Jamp Pharma Corporation | Active | 2024-08-02 | 332 | Manufacturing distruption | 234521 |
4844 | C09DA07 | JAMP TELMISARTAN-HCT | 12.5MG 80MG | Jamp Pharma Corporation | Active | 2024-08-02 | 332 | Manufacturing distruption | 234524 |
4845 | C09DA07 | JAMP TELMISARTAN-HCT | 25MG 80MG | Jamp Pharma Corporation | Active | 2024-08-02 | 332 | Manufacturing distruption | 234511 |
4846 | C09DA07 | JAMP TELMISARTAN-HCT | 25MG 80MG | Jamp Pharma Corporation | Active | 2024-08-02 | 332 | Manufacturing distruption | 234514 |
4848 | A02BC02 | JAMP PANTOPRAZOLE SODIUM | 20MG | Jamp Pharma Corporation | Active | 2024-08-02 | 347 | Manufacturing distruption | 234462 |
4850 | A02BC02 | JAMP PANTOPRAZOLE SODIUM | 40MG | Jamp Pharma Corporation | Active | 2024-08-02 | 241 | Manufacturing distruption | 234472 |
4852 | B01AC04 | JAMP-CLOPIDOGREL | 75MG | Jamp Pharma Corporation | Active | 2024-08-02 | 317 | Manufacturing distruption | 234418 |
4853 | B01AC04 | JAMP-CLOPIDOGREL | 75MG | Jamp Pharma Corporation | Active | 2024-08-02 | 317 | Manufacturing distruption | 234421 |
4854 | B01AC04 | JAMP-CLOPIDOGREL | 75MG | Jamp Pharma Corporation | Active | 2024-08-02 | 317 | Manufacturing distruption | 234424 |
4833 | N03AX22 | TARO-PERAMPANEL | 8MG | Taro Pharmaceuticals Inc | Resolved | 2024-08-02 | 56 | Manufacturing distruption | 237245 |
4834 | J01CE01 | PENICILLIN G SODIUM FOR INJECT... | 5000000UNIT | Fresenius Kabi Canada Ltd | Resolved | 2024-08-02 | 182 | Manufacturing distruption | 238762 |
4839 | C09CA07 | JAMP TELMISARTAN | 40MG | Jamp Pharma Corporation | Resolved | 2024-08-02 | 101 | Manufacturing distruption | 234498 |
4840 | C09CA07 | JAMP TELMISARTAN | 40MG | Jamp Pharma Corporation | Resolved | 2024-08-02 | 241 | Manufacturing distruption | 234490 |
4841 | C09CA07 | JAMP TELMISARTAN | 80MG | Jamp Pharma Corporation | Resolved | 2024-08-02 | 126 | Manufacturing distruption | 234505 |
4842 | C09CA07 | JAMP TELMISARTAN | 80MG | Jamp Pharma Corporation | Resolved | 2024-08-02 | 101 | Manufacturing distruption | 234508 |
4847 | J01FA09 | TARO-CLARITHROMYCIN | 125MG | Taro Pharmaceuticals Inc | Resolved | 2024-08-02 | 105 | Manufacturing distruption | 237235 |
4849 | A02BC02 | JAMP PANTOPRAZOLE SODIUM | 40MG | Jamp Pharma Corporation | Resolved | 2024-08-02 | 151 | Manufacturing distruption | 234465 |
4851 | A02BC02 | JAMP PANTOPRAZOLE SODIUM | 40MG | Jamp Pharma Corporation | Resolved | 2024-08-02 | 241 | Manufacturing distruption | 234477 |
4855 | N06AB04 | CITALOPRAM | 10MG | Jamp Pharma Corporation | Resolved | 2024-08-02 | Manufacturing distruption | 234535 | |
4856 | N06AB04 | CITALOPRAM | 20MG | Jamp Pharma Corporation | Resolved | 2024-08-02 | Manufacturing distruption | 234538 | |
4857 | N06AB04 | CITALOPRAM | 20MG | Jamp Pharma Corporation | Resolved | 2024-08-02 | Manufacturing distruption | 234542 | |
4858 | N06AB04 | CITALOPRAM | 20MG | Jamp Pharma Corporation | Resolved | 2024-08-02 | Manufacturing distruption | 234546 | |
4859 | N06AB04 | CITALOPRAM | 40MG | Jamp Pharma Corporation | Resolved | 2024-08-02 | 42 | Manufacturing distruption | 234549 |
4860 | N06AB04 | CITALOPRAM | 40MG | Jamp Pharma Corporation | Resolved | 2024-08-02 | Manufacturing distruption | 234552 | |
4861 | C10AB02 | JAMP-BEZAFIBRATE SR | 400MG | Jamp Pharma Corporation | Resolved | 2024-08-02 | Manufacturing distruption | 234527 | |
4862 | C10AB02 | JAMP-BEZAFIBRATE SR | 400MG | Jamp Pharma Corporation | Resolved | 2024-08-02 | Manufacturing distruption | 234532 | |
4863 | J01XE01 | PMS-NITROFURANTOIN BID | 100MG | Pharmascience Inc | Resolved | 2024-08-02 | 221 | Manufacturing distruption | 234611 |
4864 | N03AX14 | JAMP LEVETIRACETAM TABLETS | 250MG | Jamp Pharma Corporation | Resolved | 2024-08-02 | 140 | Manufacturing distruption | 234434 |
4865 | N03AX14 | JAMP LEVETIRACETAM TABLETS | 500MG | Jamp Pharma Corporation | Resolved | 2024-08-02 | 140 | Manufacturing distruption | 234437 |
4866 | N03AX14 | JAMP LEVETIRACETAM TABLETS | 750MG | Jamp Pharma Corporation | Resolved | 2024-08-02 | 140 | Manufacturing distruption | 234440 |
4867 | D10AD53 | TARO-ADAPALENE/BENZOYL PEROXID... | 2.5% 0.3% | Taro Pharmaceuticals Inc | Resolved | 2024-08-02 | 49 | Manufacturing distruption | 237226 |
4819 | A05AA02 | URSODIOL C | 500MG | Sanis Health Inc | Active | 2024-08-01 | Manufacturing distruption | 234207 | |
4825 | N06AB03 | ACH-FLUOXETINE | 20MG | Accord Healthcare Inc | Active | 2024-08-01 | Manufacturing practices | 223389 | |
4827 | L01BA04 | TARO-PEMETREXED | 100MG | Taro Pharmaceuticals Inc | Active | 2024-08-01 | Manufacturing distruption | 237242 | |
4829 | L01BA04 | TARO-PEMETREXED | 1000MG | Taro Pharmaceuticals Inc | Active | 2024-08-01 | Manufacturing distruption | 237239 | |
4822 | N01BB01 | SENSORCAINE | 2.5MG | Aspen Pharmacare Canada Inc. | Avoided | 2024-08-01 | 30 | Manufacturing distruption | 222689 |
4823 | N01BB01 | SENSORCAINE | 5MG | Aspen Pharmacare Canada Inc. | Avoided | 2024-08-01 | 60 | Manufacturing distruption | 227436 |
4824 | N01BB02 | XYLOCAINE 1% | 10MG | Aspen Pharmacare Canada Inc. | Avoided | 2024-08-01 | 60 | Manufacturing distruption | 222681 |
4826 | M03AC11 | CISATRACURIUM OMEGA MULTIDOSE | 2MG | Omega Laboratories Limited | Avoided | 2024-08-01 | Demand increase | 224261 | |
4820 | A10BH01 | TARO-SITAGLIPTIN FUMARATE | 50MG | Taro Pharmaceuticals Inc | Resolved | 2024-08-01 | 169 | Manufacturing distruption | 237257 |
4821 | A10BH01 | TARO-SITAGLIPTIN FUMARATE | 100MG | Taro Pharmaceuticals Inc | Resolved | 2024-08-01 | 197 | Manufacturing distruption | 237260 |
4828 | S01AE07 | PMS-MOXIFLOXACIN | 0.5% | Pharmascience Inc | Resolved | 2024-08-01 | 59 | Manufacturing distruption | 234387 |
4830 | V04CX01 | INDOCYANINE GREEN FOR INJECTIO... | 25MG | Diagnostic Green Limited | Resolved | 2024-08-01 | 211 | Manufacturing distruption | 234081 |
4831 | A07EA06 | UCERIS | 2MG | Bausch Health, Canada Inc. | Resolved | 2024-08-01 | 169 | Other | 234354 |
4817 | C01AA05 | JAMP DIGOXIN | 0.0625MG | Jamp Pharma Corporation | Active | 2024-07-31 | 334 | Manufacturing distruption | 234168 |
4818 | C01AA05 | JAMP DIGOXIN | 0.125MG | Jamp Pharma Corporation | Active | 2024-07-31 | 334 | Manufacturing distruption | 234171 |
4815 | V03AF03 | LEUCOVORIN CALCIUM INJECTION U... | 10MG | Pfizer Canada Ulc | Resolved | 2024-07-31 | Manufacturing distruption | 229061 | |
4816 | C09DA06 | AURO-CANDESARTAN HCT | 12.5MG 32MG | Auro Pharma Inc | Resolved | 2024-07-31 | Demand increase | 90585 | |
4796 | C01CA24 | EPINEPHRINE INJECTION | 1MG | Laboratoire Aguettant | Active | 2024-07-30 | 82 | Demand increase | 234068 |
4797 | N05BA12 | APO-ALPRAZ | 0.5MG | Apotex Inc | Resolved | 2024-07-30 | 59 | Manufacturing distruption | 234286 |
4798 | M01AB05 | APO-DICLO SR | 100MG | Apotex Inc | Resolved | 2024-07-30 | 31 | Manufacturing distruption | 234274 |
4799 | N05BA06 | ATIVAN | 1MG | Pfizer Canada Ulc | Resolved | 2024-07-30 | 14 | Demand increase | 234109 |
4800 | M04AA01 | ZYLOPRIM | 100MG | Aa Pharma Inc | Resolved | 2024-07-30 | Manufacturing distruption | 234330 | |
4801 | M04AA01 | ZYLOPRIM | 100MG | Aa Pharma Inc | Resolved | 2024-07-30 | Manufacturing distruption | 234333 | |
4802 | M04AA01 | ZYLOPRIM | 300MG | Aa Pharma Inc | Resolved | 2024-07-30 | Manufacturing distruption | 234345 | |
4803 | M04AA01 | ZYLOPRIM | 300MG | Aa Pharma Inc | Resolved | 2024-07-30 | Manufacturing distruption | 234351 | |
4804 | M04AA01 | ZYLOPRIM | 200MG | Aa Pharma Inc | Resolved | 2024-07-30 | Manufacturing distruption | 234338 | |
4805 | N02BE01 | APO-ACETAMINOPHEN | 325MG | Apotex Inc | Resolved | 2024-07-30 | 17 | Manufacturing distruption | 234283 |
4806 | N01AB06 | ISOFLURANE USP | 99.9% | Fresenius Kabi Canada Ltd | Resolved | 2024-07-30 | 29 | Other | 234157 |
4807 | N01AB06 | ISOFLURANE USP | 99.9% | Fresenius Kabi Canada Ltd | Resolved | 2024-07-30 | 29 | Other | 234160 |
4808 | C01BD01 | AMIODARONE HYDROCHLORIDE FOR I... | 50MG | Fresenius Kabi Canada Ltd | Resolved | 2024-07-30 | 25 | Manufacturing distruption | 231738 |
4809 | V03AE01 | SOLYSTAT | 1G | Pendopharm Division Of Pharmascience Inc | Resolved | 2024-07-30 | 77 | Ingredient shortage | 234061 |
4810 | R06AA59 | APO-DOXYLAMINE/B6 | 10MG 10MG | Apotex Inc | Resolved | 2024-07-30 | 171 | Manufacturing distruption | 234271 |
4811 | G03CA57 | PREMARIN | 0.625MG | Pfizer Canada Ulc | Resolved | 2024-07-30 | 32 | Manufacturing distruption | 233199 |
4812 | J01FA10 | APO-AZITHROMYCIN Z | 250MG | Apotex Inc | Resolved | 2024-07-30 | 101 | Manufacturing distruption | 234280 |
4813 | N07BA03 | APO-VARENICLINE | 0.5MG | Apotex Inc | Resolved | 2024-07-30 | 24 | Manufacturing distruption | 234277 |
4814 | ISOFLURANE USP | 99.9% | Fresenius Kabi Canada Ltd | Resolved | 2024-07-30 | 29 | Other | 234163 | |
4790 | C01CA24 | ALLERJECT | 0.15MG | Valeo Pharma Inc | Active | 2024-07-29 | Other | 230882 | |
4793 | N02CC03 | NAT-ZOLMITRIPTAN | 2.5MG | Natco Pharma (Canada) Inc | Active | 2024-07-29 | Manufacturing distruption | 233895 | |
4791 | G04BD07 | SANDOZ TOLTERODINE LA | 2MG | Sandoz Canada Incorporated | Resolved | 2024-07-29 | 95 | Shipping delay | 233875 |
4792 | C09DA06 | AURO-CANDESARTAN HCT | 12.5MG 16MG | Auro Pharma Inc | Resolved | 2024-07-29 | Demand increase | 90199 | |
4794 | N03AB02 | PHENYTOIN SODIUM | 100MG | Aa Pharma Inc | Resolved | 2024-07-29 | 11 | Manufacturing distruption | 232778 |
4795 | J02AC04 | SANDOZ POSACONAZOLE | 100MG | Sandoz Canada Incorporated | Resolved | 2024-07-29 | 32 | Manufacturing distruption | 233872 |
4789 | J02AX04 | CASPOFUNGIN FOR INJECTION | 50MG | Fresenius Kabi Canada Ltd | Resolved | 2024-07-27 | 65 | Manufacturing distruption | 233432 |
4783 | N05BA06 | ATIVAN | 2MG | Pfizer Canada Ulc | Active | 2024-07-26 | Manufacturing distruption | 232288 | |
4782 | N05AN01 | CARBOLITH | 300MG | Bausch Health, Canada Inc. | Resolved | 2024-07-26 | 62 | Demand increase | 234336 |
4784 | V03AE01 | KAYEXALATE | 1G | Sanofi-Aventis Canada Inc | Resolved | 2024-07-26 | 20 | Other | 233798 |
4785 | R01AX03 | IPRAVENT | 42MCG | Aa Pharma Inc | Resolved | 2024-07-26 | 42 | Manufacturing distruption | 233340 |
4786 | D10BA01 | CLARUS | 10MG | Mylan Pharmaceuticals Ulc | Resolved | 2024-07-26 | Manufacturing distruption | 232550 | |
4787 | L01BA01 | METHOTREXATE INJECTION BP | 25MG | Accord Healthcare Inc | Resolved | 2024-07-26 | Manufacturing practices | 223395 | |
4788 | B01AC24 | TARO-TICAGRELOR | 90MG | Taro Pharmaceuticals Inc | Resolved | 2024-07-26 | 91 | Manufacturing distruption | 237263 |
4780 | M01AE02 | ANAPROX | 275MG | Atnahs Pharma Uk Limited | Active | 2024-07-25 | 153 | Other | 232627 |
4781 | C09AA02 | VASOTEC | 16MG | Organon Canada Inc. | Resolved | 2024-07-25 | 29 | Shipping delay | 230527 |
4777 | A16AB11 | ELELYSO | 200UNIT | Pfizer Canada Ulc | Active | 2024-07-24 | Manufacturing distruption | 233801 | |
4774 | J01DB01 | CEPHALEXIN | 500MG | Sanis Health Inc | Resolved | 2024-07-24 | 44 | Manufacturing distruption | 233524 |
4775 | A10BB09 | DIAMICRON MR | 30MG | Servier Canada Inc | Resolved | 2024-07-24 | 16 | Demand increase | 233639 |
4776 | H02AB04 | SOLU-MEDROL | 40MG | Pfizer Canada Ulc | Resolved | 2024-07-24 | Manufacturing distruption | 233168 | |
4778 | G03CC07 | DUAVIVE | 20MG 0.45MG | Pfizer Canada Ulc | Resolved | 2024-07-24 | 98 | Manufacturing distruption | 233656 |
4779 | G03CC07 | DUAVIVE | 20MG 0.45MG | Pfizer Canada Ulc | Resolved | 2024-07-24 | 184 | Manufacturing distruption | 235491 |
4772 | L01BA01 | METHOTREXATE INJECTION BP | 25MG | Accord Healthcare Inc | Active | 2024-07-23 | Manufacturing practices | 227100 | |
4763 | B05XA03 | 0.9% SODIUM CHLORIDE INJECTION... | 900MG | Baxter Corporation | Resolved | 2024-07-23 | 146 | Manufacturing distruption | 234265 |
4764 | B05XA03 | 0.9% SODIUM CHLORIDE INJECTION... | 900MG | Baxter Corporation | Resolved | 2024-07-23 | 130 | Manufacturing distruption | 234268 |
4765 | B05BA03 | 5% DEXTROSE INJECTION, USP | 5G | Baxter Corporation | Resolved | 2024-07-23 | 146 | Manufacturing distruption | 234262 |
4766 | M03BX01 | APO-BACLOFEN | 10MG | Apotex Inc | Resolved | 2024-07-23 | 52 | Manufacturing distruption | 233703 |
4767 | C10AA01 | ZOCOR | 40MG | Organon Canada Inc. | Resolved | 2024-07-23 | 45 | Shipping delay | 231667 |
4768 | J01DB05 | APO-CEFADROXIL | 500MG | Apotex Inc | Resolved | 2024-07-23 | 17 | Manufacturing distruption | 233706 |
4769 | C09BA04 | APO-PERINDOPRIL-INDAPAMIDE | 1.25MG 4MG | Apotex Inc | Resolved | 2024-07-23 | 129 | Manufacturing distruption | 233709 |
4770 | M04AA01 | APO-ALLOPURINOL | 100MG | Apotex Inc | Resolved | 2024-07-23 | 73 | Manufacturing distruption | 233697 |
4771 | N07BC51 | PMS-BUPRENORPHINE-NALOXONE | 0.5MG 2MG | Pharmascience Inc | Resolved | 2024-07-23 | 31 | Manufacturing distruption | 233605 |
4773 | A06AX05 | APO-PRUCALOPRIDE | 1MG | Apotex Inc | Resolved | 2024-07-23 | 17 | Manufacturing distruption | 233700 |
4759 | L01XA02 | CARBOPLATIN INJECTION BP | 10MG | Pfizer Canada Ulc | Resolved | 2024-07-22 | 24 | Manufacturing distruption | 229058 |
4760 | G03CA03 | ESTRADOT 50 | 50MCG | Sandoz Canada Incorporated | Resolved | 2024-07-22 | 11 | Manufacturing distruption | 233502 |
4761 | J05AB11 | MYLAN-VALACYCLOVIR | 500MG | Mylan Pharmaceuticals Ulc | Resolved | 2024-07-22 | 14 | Demand increase | 233559 |
4762 | V03AE02 | RENVELA | 0.8G | Sanofi-Aventis Canada Inc | Resolved | 2024-07-22 | 252 | Other | 233720 |
4757 | N01BB51 | SENSORCAINE WITH EPINEPHRINE | 5MCG 2.5MG | Aspen Pharmacare Canada Inc. | Avoided | 2024-07-20 | 43 | Manufacturing distruption | 228282 |
4758 | M04AA01 | ZYLOPRIM | 200MG | Aa Pharma Inc | Resolved | 2024-07-20 | Manufacturing distruption | 234342 | |
4753 | L02AB01 | MEGESTROL | 40MG | Aa Pharma Inc | Active | 2024-07-19 | Manufacturing distruption | 230221 | |
4752 | H01BA02 | BIPAZEN | 4MCG | Kvr Pharmaceuticals Inc. | Resolved | 2024-07-19 | 164 | Manufacturing distruption | 232584 |
4754 | V07AC | SAG-M | 0.525% 0.9% 0.0169% 0.877% | Haemonetics Corporation | Resolved | 2024-07-19 | 44 | Manufacturing distruption | 243503 |
4755 | N05CF02 | PMS-ZOLPIDEM ODT | 5MG | Pharmascience Inc | Resolved | 2024-07-19 | 52 | Manufacturing distruption | 233507 |
4756 | L01BA01 | METHOTREXATE INJECTION BP | 25MG | Accord Healthcare Inc | Resolved | 2024-07-19 | Manufacturing distruption | 233457 | |
4751 | B05XA05 | MAGNESIUM SULFATE INJECTION, U... | 500MG | Fresenius Kabi Canada Ltd | Resolved | 2024-07-18 | 22 | Other | 233435 |
4743 | C10AA01 | ZOCOR | 10MG | Organon Canada Inc. | Resolved | 2024-07-17 | 51 | Shipping delay | 231664 |
4744 | N06AA10 | AVENTYL | 25MG | Aa Pharma Inc | Resolved | 2024-07-17 | 14 | Manufacturing distruption | 233328 |
4745 | S01BC05 | KETOROLAC | 0.5% | Aa Pharma Inc | Resolved | 2024-07-17 | 30 | Manufacturing distruption | 232781 |
4746 | C10AA05 | TEVA-ATORVASTATIN | 40MG | Teva Canada Limited | Resolved | 2024-07-17 | 126 | Manufacturing distruption | 233267 |
4747 | L02BG04 | TEVA-LETROZOLE | 2.5MG | Teva Canada Limited | Resolved | 2024-07-17 | 55 | Manufacturing distruption | 233270 |
4748 | C09CA06 | TEVA-CANDESARTAN | 16MG | Teva Canada Limited | Resolved | 2024-07-17 | 55 | Manufacturing distruption | 233273 |
4749 | N02BF02 | PREGABALIN | 300MG | Sanis Health Inc | Resolved | 2024-07-17 | 30 | Manufacturing distruption | 232054 |
4750 | C01CA03 | NOREPINEPHRINE BITARTRATE IN 5... | 0.032MG | Baxter Corporation | Resolved | 2024-07-17 | 45 | Shipping delay | 233218 |
4734 | N02BF02 | APO-PREGABALIN | 75MG | Apotex Inc | Active | 2024-07-16 | Manufacturing distruption | 216741 | |
4735 | N02BF02 | APO-PREGABALIN | 150MG | Apotex Inc | Active | 2024-07-16 | Manufacturing distruption | 216726 | |
4740 | N05AH04 | APO-QUETIAPINE XR | 400MG | Apotex Inc | Active | 2024-07-16 | Manufacturing distruption | 216696 | |
4728 | N05AN01 | CARBOLITH | 300MG | Bausch Health, Canada Inc. | Resolved | 2024-07-16 | 76 | Demand increase | 234694 |
4729 | P01BA02 | APO-HYDROXYQUINE | 200MG | Apotex Inc | Resolved | 2024-07-16 | 87 | Manufacturing distruption | 233330 |
4730 | N03AX11 | AURO-TOPIRAMATE | 25MG | Auro Pharma Inc | Resolved | 2024-07-16 | 106 | Demand increase | 233076 |
4731 | N03AX11 | AURO-TOPIRAMATE | 200MG | Auro Pharma Inc | Resolved | 2024-07-16 | 122 | Demand increase | 233073 |
4732 | N05AH03 | APO-OLANZAPINE ODT | 20MG | Apotex Inc | Resolved | 2024-07-16 | 66 | Manufacturing distruption | 233349 |
4733 | N06AB05 | AURO-PAROXETINE | 20MG | Auro Pharma Inc | Resolved | 2024-07-16 | 137 | Demand increase | 233070 |
4736 | M04AA01 | APO-ALLOPURINOL | 200MG | Apotex Inc | Resolved | 2024-07-16 | 80 | Manufacturing distruption | 233336 |
4737 | N06AX21 | APO-DULOXETINE | 30MG | Apotex Inc | Resolved | 2024-07-16 | 129 | Manufacturing distruption | 233346 |
4738 | N06AX21 | APO-DULOXETINE | 60MG | Apotex Inc | Resolved | 2024-07-16 | Manufacturing distruption | 233325 | |
4739 | N06AX21 | APO-DULOXETINE | 60MG | Apotex Inc | Resolved | 2024-07-16 | Manufacturing distruption | 233358 | |
4741 | J01DE01 | APO-CEFEPIME | 2G | Apotex Inc | Resolved | 2024-07-16 | 80 | Manufacturing distruption | 233343 |
4742 | V03AC03 | APO-DEFERASIROX (TYPE J) | 360MG | Apotex Inc | Resolved | 2024-07-16 | 45 | Manufacturing distruption | 233321 |
4716 | N01BB54 | EMLA CREAM | 2.5% 2.5% | Aspen Pharmacare Canada Inc. | Avoided | 2024-07-15 | 16 | Shipping delay | 227423 |
4720 | N01BB52 | XYLOCAINE 1% W EPINEPHRINE 1:2... | 5MCG 10MG | Aspen Pharmacare Canada Inc. | Avoided | 2024-07-15 | 16 | Manufacturing distruption | 222673 |
4713 | G04BD11 | SANDOZ FESOTERODINE FUMARATE | 4MG | Sandoz Canada Incorporated | Resolved | 2024-07-15 | 46 | Shipping delay | 232903 |
4714 | C09CA04 | M-IRBESARTAN | 300MG | Mantra Pharma Inc | Resolved | 2024-07-15 | 92 | Shipping delay | 233177 |
4715 | A10BD07 | SANDOZ SITAGLIPTIN-METFORMIN X... | 500MG 50MG | Sandoz Canada Incorporated | Resolved | 2024-07-15 | 32 | Shipping delay | 232912 |
4717 | V03AC01 | DESFERAL 500MG | 500MG | Novartis Pharmaceuticals Canada Inc | Resolved | 2024-07-15 | 62 | Demand increase | 232790 |
4718 | N03AA02 | PHENOBARB | 60MG | Pendopharm Division Of Pharmascience Inc | Resolved | 2024-07-15 | 148 | Ingredient shortage | 232933 |
4719 | G03GA01 | PREGNYL | 10000UNIT | Organon Canada Inc. | Resolved | 2024-07-15 | 114 | Shipping delay | 232871 |
4721 | N03AA02 | PHENOBARB ELIXIR | 5MG | Pendopharm Division Of Pharmascience Inc | Resolved | 2024-07-15 | 154 | Ingredient shortage | 232926 |
4722 | D06AX30 | TRIPLE ANTIBIOTIC OINTMENT | 0.25MG 500UNIT 10000UNIT | Taro Pharmaceuticals Inc | Resolved | 2024-07-15 | 88 | Manufacturing distruption | 237269 |
4723 | J01FA10 | SANDOZ AZITHROMYCIN | 250MG | Sandoz Canada Incorporated | Resolved | 2024-07-15 | 88 | Manufacturing distruption | 232900 |
4724 | J01CR05 | PIPERACILLIN AND TAZOBACTAM FO... | 0.375G 3G | Sandoz Canada Incorporated | Resolved | 2024-07-15 | 18 | Shipping delay | 232909 |
4725 | L04AA06 | SANDOZ MYCOPHENOLATE MOFETIL | 500MG | Sandoz Canada Incorporated | Resolved | 2024-07-15 | 11 | Shipping delay | 232906 |
4726 | V03AE01 | SOLYSTAT | 250MG | Pendopharm Division Of Pharmascience Inc | Resolved | 2024-07-15 | 50 | Ingredient shortage | 232936 |
4727 | B01AF01 | TARO-RIVAROXABAN | 10MG | Taro Pharmaceuticals Inc | Resolved | 2024-07-15 | 67 | Manufacturing distruption | 237251 |
4704 | A05AA02 | URSODIOL C | 250MG | Sanis Health Inc | Active | 2024-07-12 | Manufacturing distruption | 232032 | |
4708 | M05BA04 | ACH-ALENDRONATE | 5MG | Accord Healthcare Inc | Active | 2024-07-12 | Manufacturing practices | 232857 | |
4709 | C09AA02 | ENALAPRILAT INJECTION USP | 1.25MG | Hikma Canada Limited | Active | 2024-07-12 | 280 | Manufacturing distruption | 231317 |
4710 | N02BF02 | ACH-PREGABALIN | 150MG | Accord Healthcare Inc | Active | 2024-07-12 | Manufacturing practices | 232860 | |
4705 | M03CA01 | DANTROLENE SODIUM FOR INJECTIO... | 20MG | Hikma Canada Limited | Resolved | 2024-07-12 | 19 | Shipping delay | 231326 |
4706 | J01XE01 | NITROFURANTOIN | 50MG | Aa Pharma Inc | Resolved | 2024-07-12 | 49 | Manufacturing distruption | 233334 |
4707 | N03AG01 | DEPAKENE | 250MG | Bgp Pharma Ulc | Resolved | 2024-07-12 | 21 | Manufacturing distruption | 232045 |
4711 | J01XE01 | AURO-NITROFURANTOIN BID | 100MG | Auro Pharma Inc | Resolved | 2024-07-12 | 143 | Demand increase | 229854 |
4712 | M05BA07 | AA-RISEDRONATE DR | 35MG | Aa Pharma Inc | Resolved | 2024-07-12 | 17 | Manufacturing distruption | 232775 |
4703 | N05AH01 | XYLAC | 2.5MG | Pendopharm Division Of Pharmascience Inc | Resolved | 2024-07-11 | 78 | Ingredient shortage | 232696 |
4697 | D07CB01 | TEVA-TRIACOMB | 0.25MG 2.5MG 100000UNIT 1MG | Teva Canada Limited | Active | 2024-07-10 | 284 | Manufacturing distruption | 232735 |
4698 | D07AD01 | MYLAN-CLOBETASOL OINTMENT | 0.05% | Mylan Pharmaceuticals Ulc | Avoided | 2024-07-10 | 83 | Manufacturing distruption | 231248 |
4696 | R06AE07 | TEVA-CETIRIZINE | 20MG | Teva Canada Limited | Resolved | 2024-07-10 | 52 | Manufacturing distruption | 232750 |
4699 | A07AA02 | TEVA-NYSTATIN | 100000UNIT | Teva Canada Limited | Resolved | 2024-07-10 | Manufacturing distruption | 232741 | |
4700 | C07AB02 | TEVA-METOPROLOL | 50MG | Teva Canada Limited | Resolved | 2024-07-10 | 31 | Manufacturing distruption | 232738 |
4701 | N06AB04 | TEVA-CITALOPRAM | 20MG | Teva Canada Limited | Resolved | 2024-07-10 | 7 | Manufacturing distruption | 232744 |
4702 | N06AX12 | TEVA-BUPROPION XL | 150MG | Teva Canada Limited | Resolved | 2024-07-10 | 194 | Manufacturing distruption | 232747 |
4683 | R03BA05 | APO-FLUTICASONE HFA | 125MCG | Apotex Inc | Resolved | 2024-07-09 | 38 | Manufacturing distruption | 232835 |
4684 | N05BA06 | APO-LORAZEPAM | 1MG | Apotex Inc | Resolved | 2024-07-09 | 87 | Manufacturing distruption | 232846 |
4685 | C10AA03 | APO-PRAVASTATIN | 10MG | Apotex Inc | Resolved | 2024-07-09 | 31 | Manufacturing distruption | 232826 |
4686 | C10AA03 | PMS-PRAVASTATIN | 10MG | Pharmascience Inc | Resolved | 2024-07-09 | 44 | Manufacturing distruption | 232608 |
4687 | J05AB09 | APO-FAMCICLOVIR | 500MG | Apotex Inc | Resolved | 2024-07-09 | 52 | Manufacturing distruption | 232832 |
4688 | N06BA09 | APO-ATOMOXETINE | 10MG | Apotex Inc | Resolved | 2024-07-09 | 87 | Manufacturing distruption | 232818 |
4689 | N06BA09 | APO-ATOMOXETINE | 25MG | Apotex Inc | Resolved | 2024-07-09 | 87 | Manufacturing distruption | 229164 |
4690 | J01MA12 | APO-LEVOFLOXACIN | 750MG | Apotex Inc | Resolved | 2024-07-09 | 17 | Manufacturing distruption | 232829 |
4691 | A02BC05 | APO-ESOMEPRAZOLE | 20MG | Apotex Inc | Resolved | 2024-07-09 | 38 | Manufacturing distruption | 232815 |
4692 | L02BG04 | APO-LETROZOLE | 2.5MG | Apotex Inc | Resolved | 2024-07-09 | 59 | Manufacturing distruption | 232838 |
4693 | J05AR06 | APO-EFAVIRENZ-EMTRICITABINE-TE... | 300MG 200MG 600MG | Apotex Inc | Resolved | 2024-07-09 | 59 | Manufacturing distruption | 232821 |
4694 | B01AE07 | APO-DABIGATRAN | 150MG | Apotex Inc | Resolved | 2024-07-09 | 10 | Manufacturing distruption | 232842 |
4695 | N01AH01 | FENTANYL CITRATE INJECTION, US... | 50MCG | Fresenius Kabi Canada Ltd | Resolved | 2024-07-09 | 98 | Manufacturing distruption | 232398 |
4676 | C08CA01 | SANDOZ AMLODIPINE | 5MG | Sandoz Canada Incorporated | Resolved | 2024-07-08 | 11 | Manufacturing distruption | 232465 |
4677 | J01CR05 | PIPERACILLIN AND TAZOBACTAM FO... | 0.5G 4G | Sandoz Canada Incorporated | Resolved | 2024-07-08 | 74 | Manufacturing distruption | 232477 |
4678 | N04BA03 | STALEVO | 200MG 37.5MG 150MG | Sandoz Canada Incorporated | Resolved | 2024-07-08 | 18 | Manufacturing distruption | 232480 |
4679 | G04CB01 | SANDOZ FINASTERIDE | 5MG | Sandoz Canada Incorporated | Resolved | 2024-07-08 | Manufacturing distruption | 232483 | |
4680 | C10AA05 | SANDOZ ATORVASTATIN | 80MG | Sandoz Canada Incorporated | Resolved | 2024-07-08 | 25 | Demand increase | 232468 |
4681 | N05AH03 | SANDOZ OLANZAPINE ODT | 10MG | Sandoz Canada Incorporated | Resolved | 2024-07-08 | 4 | Manufacturing distruption | 232474 |
4682 | S01ED51 | SANDOZ DORZOLAMIDE/TIMOLOL | 5MG 20MG | Sandoz Canada Incorporated | Resolved | 2024-07-08 | 137 | Manufacturing practices | 232471 |
4671 | D10AD01 | RETIN-A | 0.05% | Bausch Health, Canada Inc. | Resolved | 2024-07-07 | 39 | Demand increase | 232661 |
4672 | R03BB01 | PMS-IPRATROPIUM | 250MCG | Pharmascience Inc | Resolved | 2024-07-07 | 53 | Manufacturing distruption | 232417 |
4673 | M05BA04 | PMS-ALENDRONATE-FC | 70MG | Pharmascience Inc | Resolved | 2024-07-07 | 124 | Manufacturing distruption | 232411 |
4674 | M05BA07 | PMS-RISEDRONATE | 35MG | Pharmascience Inc | Resolved | 2024-07-07 | 145 | Manufacturing distruption | 232420 |
4675 | N06DA02 | PMS-DONEPEZIL | 5MG | Pharmascience Inc | Resolved | 2024-07-07 | 113 | Manufacturing distruption | 232414 |
4666 | L01CE02 | IRINOTECAN HYDROCHLORIDE INJEC... | 20MG | Accord Healthcare Inc | Active | 2024-07-05 | Manufacturing practices | 223399 | |
4667 | L01CE02 | IRINOTECAN HYDROCHLORIDE INJEC... | 20MG | Accord Healthcare Inc | Active | 2024-07-05 | Manufacturing practices | 223404 | |
4669 | S02CA02 | LOCACORTEN VIOFORM EARDROPS | 1% 0.02% | Paladin Pharma Inc. | Active | 2024-07-05 | 280 | Other | 232490 |
4670 | N05AH04 | ACH-QUETIAPINE | 150MG | Accord Healthcare Inc | Active | 2024-07-05 | Manufacturing practices | 229917 | |
4662 | G03DA04 | PROGESTERONE INJECTION, USP | 50MG | Hikma Canada Limited | Resolved | 2024-07-05 | 16 | Shipping delay | 231323 |
4663 | G02AD02 | PROSTIN E2 TABLETS | 0.5MG | Pfizer Canada Ulc | Resolved | 2024-07-05 | Manufacturing distruption | 232361 | |
4664 | J01EE01 | SULFATRIM DS | 160MG 800MG | Aa Pharma Inc | Resolved | 2024-07-05 | 24 | Manufacturing distruption | 233381 |
4665 | A02BA03 | FAMOTIDINE OMEGA -(WITHOUT PR... | 10MG | Omega Laboratories Limited | Resolved | 2024-07-05 | 60 | Demand increase | 232393 |
4668 | B05CB10 | LACTATED RINGER'S IRRIGATION | 20MG 30MG 600MG 310MG | Icu Medical Canada Inc | Resolved | 2024-07-05 | 56 | Manufacturing distruption | 228393 |
4655 | N03AF01 | MINT-CARBAMAZEPINE | 200MG | Mint Pharmaceuticals Inc | Resolved | 2024-07-04 | 88 | Manufacturing distruption | 235587 |
4656 | N05BA06 | ATIVAN | 1MG | Pfizer Canada Ulc | Resolved | 2024-07-04 | Manufacturing distruption | 232270 | |
4657 | N01BB01 | SENSORCAINE | 5MG | Aspen Pharmacare Canada Inc. | Resolved | 2024-07-04 | 113 | Manufacturing distruption | 228304 |
4658 | N05BA06 | ATIVAN | 0.5MG | Pfizer Canada Ulc | Resolved | 2024-07-04 | Manufacturing distruption | 232281 | |
4659 | N01BB52 | XYLOCAINE 2% W EPINEPHRINE 1:2... | 5MCG 20MG | Aspen Pharmacare Canada Inc. | Resolved | 2024-07-04 | 59 | Manufacturing distruption | 222670 |
4660 | M01AB05 | VOLTAREN | 50MG | Novartis Pharmaceuticals Canada Inc | Resolved | 2024-07-04 | 76 | Manufacturing distruption | 231706 |
4661 | N05CF04 | LUNESTA | 1MG | Sumitomo Pharma Canada, Inc. | Resolved | 2024-07-04 | 27 | Shipping delay | 230162 |
4628 | N03AX18 | LACOSAMIDE | 200MG | Sanis Health Inc | Active | 2024-07-03 | Manufacturing distruption | 232014 | |
4647 | G04BD04 | OXYBUTYNIN | 5MG | Sanis Health Inc | Active | 2024-07-03 | Manufacturing distruption | 231993 | |
4650 | N02CC04 | ACT RIZATRIPTAN | 10MG | Teva Canada Limited | Active | 2024-07-03 | 212 | Manufacturing distruption | 232235 |
4651 | C09CA06 | CANDESARTAN | 8MG | Sanis Health Inc | Active | 2024-07-03 | Manufacturing distruption | 232008 | |
4629 | M01AB05 | APO-DICLO | 50MG | Apotex Inc | Resolved | 2024-07-03 | 23 | Manufacturing distruption | 232306 |
4630 | D07AC01 | TEVA-TOPISONE | 0.05% | Teva Canada Limited | Resolved | 2024-07-03 | 140 | Manufacturing distruption | 232198 |
4631 | M03BX08 | APO-CYCLOBENZAPRINE | 10MG | Apotex Inc | Resolved | 2024-07-03 | 86 | Manufacturing distruption | 232292 |
4632 | M01AB05 | APO-DICLO SR | 75MG | Apotex Inc | Resolved | 2024-07-03 | 65 | Manufacturing distruption | 232303 |
4633 | J02AB02 | TEVA-KETOCONAZOLE | 200MG | Teva Canada Limited | Resolved | 2024-07-03 | 69 | Manufacturing distruption | 232201 |
4634 | J02AB02 | TEVA-KETOCONAZOLE | 200MG | Teva Canada Limited | Resolved | 2024-07-03 | 48 | Manufacturing distruption | 232203 |
4635 | J01MA02 | CIPRO ORAL SUSPENSION | 500MG | Bayer Inc | Resolved | 2024-07-03 | 13 | Other | 229988 |
4636 | N03AG01 | APO-DIVALPROEX | 500MG | Apotex Inc | Resolved | 2024-07-03 | 51 | Manufacturing distruption | 232286 |
4637 | N06AB06 | TEVA-SERTRALINE | 50MG | Teva Canada Limited | Resolved | 2024-07-03 | 38 | Manufacturing distruption | 232206 |
4638 | R03AK06 | ADVAIR 125 | 125MCG 25MCG | Glaxosmithkline Inc | Resolved | 2024-07-03 | 28 | Shipping delay | 232364 |
4639 | N06AB08 | TEVA-FLUVOXAMINE | 100MG | Teva Canada Limited | Resolved | 2024-07-03 | 201 | Manufacturing distruption | 232214 |
4640 | N03AX14 | TEVA-LEVETIRACETAM | 500MG | Teva Canada Limited | Resolved | 2024-07-03 | 38 | Manufacturing distruption | 232217 |
4641 | N07CA01 | TEVA-BETAHISTINE | 8MG | Teva Canada Limited | Resolved | 2024-07-03 | 17 | Manufacturing distruption | 232220 |
4642 | N06AB05 | PAROXETINE | 30MG | Sanis Health Inc | Resolved | 2024-07-03 | 44 | Manufacturing distruption | 232017 |
4643 | A02BC03 | APO-LANSOPRAZOLE | 15MG | Apotex Inc | Resolved | 2024-07-03 | 16 | Manufacturing distruption | 232332 |
4644 | G03AA07 | SEASONALE | 0.03MG 0.15MG | Teva Canada Limited | Resolved | 2024-07-03 | 69 | Manufacturing distruption | 232223 |
4645 | C10AA05 | TEVA-ATORVASTATIN | 20MG | Teva Canada Limited | Resolved | 2024-07-03 | 69 | Manufacturing distruption | 232226 |
4646 | C09CA07 | TEVA-TELMISARTAN | 80MG | Teva Canada Limited | Resolved | 2024-07-03 | 38 | Manufacturing distruption | 232229 |
4648 | C09CA06 | TEVA-CANDESARTAN | 8MG | Teva Canada Limited | Resolved | 2024-07-03 | 201 | Manufacturing distruption | 232232 |
4649 | L02BG03 | APO-ANASTROZOLE | 1MG | Apotex Inc | Resolved | 2024-07-03 | 93 | Manufacturing distruption | 225101 |
4652 | N06AX21 | APO-DULOXETINE | 30MG | Apotex Inc | Resolved | 2024-07-03 | 128 | Manufacturing distruption | 232335 |
4653 | A10BD07 | APO-SITAGLIPTIN MALATE / METFO... | 500MG 50MG | Apotex Inc | Resolved | 2024-07-03 | 37 | Manufacturing distruption | 232328 |
4654 | A10BD07 | APO-SITAGLIPTIN MALATE / METFO... | 850MG 50MG | Apotex Inc | Resolved | 2024-07-03 | 86 | Manufacturing distruption | 232324 |
4614 | N05AN01 | LITHANE | 300MG | Searchlight Pharma Inc | Active | 2024-07-02 | Other | 228275 | |
4611 | C08DB01 | DILTIAZEM HYDROCHLORIDE INJECT... | 5MG | Omega Laboratories Limited | Resolved | 2024-07-02 | 30 | Demand increase | 231763 |
4612 | A10BK01 | SANDOZ DAPAGLIFLOZIN | 10MG | Sandoz Canada Incorporated | Resolved | 2024-07-02 | 38 | Manufacturing distruption | 231744 |
4613 | N01BB02 | XYLOCAINE SPRAY | 10MG | Aspen Pharmacare Canada Inc. | Resolved | 2024-07-02 | 61 | Shipping delay | 229845 |
4615 | D01BA02 | AURO-TERBINAFINE | 250MG | Auro Pharma Inc | Resolved | 2024-07-02 | 218 | Demand increase | 231872 |
4616 | N05CM18 | PRECEDEX | 100MCG | Pfizer Canada Ulc | Resolved | 2024-07-02 | Manufacturing distruption | 231896 | |
4617 | M03BX08 | AURO-CYCLOBENZAPRINE | 10MG | Auro Pharma Inc | Resolved | 2024-07-02 | 29 | Demand increase | 231841 |
4618 | N04BX02 | SANDOZ ENTACAPONE | 200MG | Sandoz Canada Incorporated | Resolved | 2024-07-02 | 13 | Manufacturing practices | 231749 |
4619 | N03AX09 | AURO-LAMOTRIGINE | 25MG | Auro Pharma Inc | Resolved | 2024-07-02 | 29 | Demand increase | 231851 |
4620 | N02BF02 | SANDOZ PREGABALIN | 150MG | Sandoz Canada Incorporated | Resolved | 2024-07-02 | 31 | Demand increase | 231752 |
4621 | C10AA01 | AURO-SIMVASTATIN | 5MG | Auro Pharma Inc | Resolved | 2024-07-02 | 59 | Demand increase | 231867 |
4622 | N06AX11 | AURO-MIRTAZAPINE | 15MG | Auro Pharma Inc | Resolved | 2024-07-02 | 29 | Demand increase | 231856 |
4623 | N06AX11 | AURO-MIRTAZAPINE | 30MG | Auro Pharma Inc | Resolved | 2024-07-02 | 60 | Demand increase | 231859 |
4624 | N06DA04 | AURO-GALANTAMINE ER | 16MG | Auro Pharma Inc | Resolved | 2024-07-02 | 60 | Demand increase | 231844 |
4625 | C09CA08 | AURO-OLMESARTAN | 20MG | Auro Pharma Inc | Resolved | 2024-07-02 | 75 | Demand increase | 231864 |
4626 | N06BA01 | SANDOZ AMPHETAMINE XR | 25MG | Sandoz Canada Incorporated | Resolved | 2024-07-02 | 45 | Manufacturing practices | 231741 |
4627 | C09AA10 | AURO-TRANDOLAPRIL | 2MG | Auro Pharma Inc | Resolved | 2024-07-02 | 166 | Demand increase | 231875 |
4607 | N05AH04 | QUETIAPINE XR | 50MG | Sivem Pharmaceuticals Ulc | Active | 2024-07-01 | Manufacturing distruption | 217989 | |
4608 | N05AH04 | QUETIAPINE XR | 200MG | Sivem Pharmaceuticals Ulc | Active | 2024-07-01 | Manufacturing distruption | 217995 | |
4609 | N05AH04 | QUETIAPINE XR | 300MG | Sivem Pharmaceuticals Ulc | Active | 2024-07-01 | Manufacturing distruption | 217998 | |
4610 | A04AA01 | NAT-ONDANSETRON | 4MG | Natco Pharma (Canada) Inc | Active | 2024-07-01 | Manufacturing distruption | 230407 | |
4601 | N01AX10 | DIPRIVAN 1% | 10MG | Aspen Pharmacare Canada Inc. | Avoided | 2024-07-01 | 62 | Demand increase | 225152 |
4602 | N01AX10 | DIPRIVAN 1% | 10MG | Aspen Pharmacare Canada Inc. | Avoided | 2024-07-01 | 61 | Demand increase | 222695 |
4603 | N01BB51 | SENSORCAINE WITH EPINEPHRINE | 2.5MG 5MCG | Aspen Pharmacare Canada Inc. | Avoided | 2024-07-01 | 30 | Manufacturing distruption | 222678 |
4605 | N01BB01 | SENSORCAINE | 5MG | Aspen Pharmacare Canada Inc. | Avoided | 2024-07-01 | 61 | Manufacturing distruption | 222686 |
4599 | J01CA04 | AMOXICILLIN CAPSULES BP | 500MG | Sanis Health Inc | Resolved | 2024-07-01 | 137 | Manufacturing distruption | 229018 |
4600 | G03BA03 | TESTOSTERONE ENANTHATE INJECTI... | 200MG | Hikma Canada Limited | Resolved | 2024-07-01 | 14 | Shipping delay | 231320 |
4604 | N01BB51 | SENSORCAINE WITH EPINEPHRINE | 5MCG 5MG | Aspen Pharmacare Canada Inc. | Resolved | 2024-07-01 | 30 | Manufacturing distruption | 225252 |
4606 | C09BA08 | INHIBACE PLUS | 12.5MG 5MG | Cheplapharm Arzneimittel Gmbh | Resolved | 2024-07-01 | 111 | Manufacturing distruption | 230712 |
4596 | H01CA01 | LUTREPULSE PWS 0.8MG/VIAL | 0.8MG | Ferring Inc | Active | 2024-06-30 | Other | 220371 | |
4597 | J05AX05 | IMUNOVIR | 500MG | Kora Healthcare | Active | 2024-06-30 | 396 | Other | 221336 |
4598 | N06AX05 | TRAZODONE | 50MG | Sanis Health Inc | Resolved | 2024-06-30 | 19 | Manufacturing distruption | 229009 |
4584 | L04AK02 | ACH-TERIFLUNOMIDE | 14MG | Accord Healthcare Inc | Active | 2024-06-28 | Manufacturing practices | 231612 | |
4585 | A10BH01 | ACH-SITAGLIPTIN | 25MG | Accord Healthcare Inc | Active | 2024-06-28 | Manufacturing practices | 231597 | |
4586 | A10BH01 | ACH-SITAGLIPTIN | 50MG | Accord Healthcare Inc | Active | 2024-06-28 | Manufacturing practices | 231600 | |
4591 | N03AX14 | ACH-LEVETIRACETAM | 500MG | Accord Healthcare Inc | Active | 2024-06-28 | Manufacturing practices | 231603 | |
4594 | C10AA03 | ACH-PRAVASTATIN | 20MG | Accord Healthcare Inc | Active | 2024-06-28 | Manufacturing practices | 231609 | |
4595 | C09DA08 | ACH-OLMESARTAN HCTZ | 40MG 25MG | Accord Healthcare Inc | Active | 2024-06-28 | Manufacturing practices | 231606 | |
4587 | N06AX23 | DESVENLAFAXINE | 100MG | Sanis Health Inc | Resolved | 2024-06-28 | 140 | Manufacturing distruption | 231507 |
4588 | H02AB07 | WINPRED | 1MG | Aa Pharma Inc | Resolved | 2024-06-28 | 40 | Manufacturing distruption | 230218 |
4589 | C03BA11 | MYLAN-INDAPAMIDE | 1.25MG | Mylan Pharmaceuticals Ulc | Resolved | 2024-06-28 | Manufacturing distruption | 230100 | |
4590 | G04CB01 | ACH-FINASTERIDE | 5MG | Accord Healthcare Inc | Resolved | 2024-06-28 | 49 | Shipping delay | 231594 |
4592 | P01BB51 | MYLAN-ATOVAQUONE/PROGUANIL | 100MG 250MG | Mylan Pharmaceuticals Ulc | Resolved | 2024-06-28 | 35 | Ingredient shortage | 228299 |
4593 | G03CA57 | PREMARIN | 1.25MG | Pfizer Canada Ulc | Resolved | 2024-06-28 | Demand increase | 231329 | |
4573 | C09AA03 | LISINOPRIL | 20MG | Sanis Health Inc | Resolved | 2024-06-26 | 278 | Manufacturing distruption | 229015 |
4574 | D07AD01 | TEVA-CLOBETASOL | 0.05% | Teva Canada Limited | Resolved | 2024-06-26 | 55 | Manufacturing distruption | 231421 |
4575 | A09AA02 | CREON MINIMICROSPHERES 10 | 11200UNIT 10000UNIT 730UNIT | Bgp Pharma Ulc | Resolved | 2024-06-26 | 62 | Other | 232561 |
4576 | A10BB09 | TEVA-GLICLAZIDE | 80MG | Teva Canada Limited | Resolved | 2024-06-26 | 76 | Manufacturing distruption | 231424 |
4577 | A10BB09 | DIAMICRON MR | 30MG | Servier Canada Inc | Resolved | 2024-06-26 | 12 | Demand increase | 231500 |
4578 | N06AX11 | MYLAN-MIRTAZAPINE | 45MG | Mylan Pharmaceuticals Ulc | Resolved | 2024-06-26 | 239 | Manufacturing distruption | 230092 |
4579 | N07CA01 | TEVA-BETAHISTINE | 16MG | Teva Canada Limited | Resolved | 2024-06-26 | 24 | Manufacturing distruption | 231427 |
4580 | J01FA10 | AZITHROMYCIN | 250MG | Sanis Health Inc | Resolved | 2024-06-26 | 121 | Manufacturing distruption | 229000 |
4581 | A02BC05 | TEVA-ESOMEPRAZOLE | 40MG | Teva Canada Limited | Resolved | 2024-06-26 | 127 | Manufacturing distruption | 231430 |
4582 | A02BC05 | TEVA-ESOMEPRAZOLE | 40MG | Teva Canada Limited | Resolved | 2024-06-26 | 188 | Manufacturing distruption | 231433 |
4583 | B01AF01 | TEVA-RIVAROXABAN | 20MG | Teva Canada Limited | Resolved | 2024-06-26 | 177 | Manufacturing distruption | 231436 |
4555 | N05AH04 | M-QUETIAPINE FUMARATE XR | 150MG | Mantra Pharma Inc | Active | 2024-06-25 | Shipping delay | 233180 | |
4556 | N05AH04 | M-QUETIAPINE FUMARATE XR | 200MG | Mantra Pharma Inc | Active | 2024-06-25 | Shipping delay | 233183 | |
4557 | N05AH04 | M-QUETIAPINE FUMARATE XR | 300MG | Mantra Pharma Inc | Active | 2024-06-25 | Shipping delay | 233186 | |
4558 | N05AH04 | M-QUETIAPINE FUMARATE XR | 400MG | Mantra Pharma Inc | Active | 2024-06-25 | Shipping delay | 233189 | |
4560 | J07BG01 | IMOVAX RABIES | 2.5UNIT | Sanofi Pasteur Limited | Active | 2024-06-25 | 493 | Other | 231556 |
4562 | A10BG03 | APO-PIOGLITAZONE | 30MG | Apotex Inc | Active | 2024-06-25 | Manufacturing distruption | 231559 | |
4572 | APO-MELOXICAM | 1.5G | Apotex Inc | Active | 2024-06-25 | 451 | Manufacturing distruption | 231487 | |
4564 | B05XA03 | SODIUM CHLORIDE INJECTION USP | 9MG | Pfizer Canada Ulc | Avoided | 2024-06-25 | Manufacturing distruption | 200828 | |
4554 | N05AE05 | SANDOZ LURASIDONE | 80MG | Sandoz Canada Incorporated | Resolved | 2024-06-25 | 17 | Shipping delay | 231206 |
4559 | C02DB02 | APO-HYDRALAZINE | 25MG | Apotex Inc | Resolved | 2024-06-25 | 87 | Manufacturing distruption | 231481 |
4561 | N05BA06 | APO-LORAZEPAM | 0.5MG | Apotex Inc | Resolved | 2024-06-25 | 94 | Manufacturing distruption | 231484 |
4563 | A02BC04 | SANDOZ RABEPRAZOLE | 10MG | Sandoz Canada Incorporated | Resolved | 2024-06-25 | 45 | Manufacturing distruption | 231215 |
4565 | C09DA04 | SANDOZ IRBESARTAN HCT | 12.5MG 150MG | Sandoz Canada Incorporated | Resolved | 2024-06-25 | 24 | Manufacturing distruption | 231202 |
4566 | A10BB09 | APO-GLICLAZIDE MR | 60MG | Apotex Inc | Resolved | 2024-06-25 | 45 | Manufacturing distruption | 231493 |
4567 | M01AH01 | APO-CELECOXIB | 100MG | Apotex Inc | Resolved | 2024-06-25 | 45 | Manufacturing distruption | 231490 |
4568 | S01GX09 | SANDOZ OLOPATADINE 0.2% | 0.2% | Sandoz Canada Incorporated | Resolved | 2024-06-25 | 3 | Shipping delay | 231212 |
4569 | C09CA08 | SANDOZ OLMESARTAN | 20MG | Sandoz Canada Incorporated | Resolved | 2024-06-25 | 17 | Demand increase | 231209 |
4570 | G04CA04 | SANDOZ SILODOSIN | 8MG | Sandoz Canada Incorporated | Resolved | 2024-06-25 | 24 | Manufacturing distruption | 231218 |
4571 | A10BD07 | SANDOZ SITAGLIPTIN-METFORMIN | 500MG 50MG | Sandoz Canada Incorporated | Resolved | 2024-06-25 | 10 | Shipping delay | 231221 |
4551 | N01BB54 | EMLA CREAM | 2.5% 2.5% | Aspen Pharmacare Canada Inc. | Avoided | 2024-06-24 | 6 | Shipping delay | 222665 |
4552 | J01XX10 | BACIJECT | 50000UNIT | Sterimax Inc | Resolved | 2024-06-24 | 36 | Other | 231137 |
4553 | N01BB52 | XYLOCAINE 2% WITH EPINEPHRINE ... | 0.005MG 20MG | Aspen Pharmacare Canada Inc. | Resolved | 2024-06-24 | 6 | Shipping delay | 220855 |
4548 | H03BB02 | TAPAZOLE | 5MG | Paladin Pharma Inc. | Active | 2024-06-21 | Manufacturing distruption | 231107 | |
4549 | N06AB03 | BIO-FLUOXETINE | 20MG | Biomed Pharma | Active | 2024-06-21 | 259 | Manufacturing practices | 245164 |
4550 | C09DA08 | ACH-OLMESARTAN HCTZ | 40MG 12.5MG | Accord Healthcare Inc | Active | 2024-06-21 | Manufacturing practices | 231104 | |
4547 | J07BG01 | RABAVERT | 2.5UNIT | Bavarian Nordic As | Resolved | 2024-06-21 | 55 | Shipping delay | 231161 |
4542 | C01CA24 | ALLERJECT | 0.3MG | Valeo Pharma Inc | Active | 2024-06-20 | Other | 230879 | |
4541 | N02AB03 | TEVA-FENTANYL | 50MCG | Teva Canada Limited | Resolved | 2024-06-20 | 99 | Manufacturing distruption | 230964 |
4543 | N06AX12 | TEVA-BUPROPION XL | 150MG | Teva Canada Limited | Resolved | 2024-06-20 | 235 | Manufacturing distruption | 230961 |
4544 | N06AX12 | TEVA-BUPROPION XL | 300MG | Teva Canada Limited | Resolved | 2024-06-20 | 214 | Manufacturing distruption | 230958 |
4545 | N03AF01 | TEVA-CARBAMAZEPINE | 200MG | Teva Canada Limited | Resolved | 2024-06-20 | 133 | Manufacturing distruption | 230967 |
4546 | V09FX01 | ULTRA-TECHNEKOW V4 | 19CI | Curium Canada Inc | Resolved | 2024-06-20 | 20 | Other | 231229 |
4537 | G03AA05 | SELECT 1/35 (21-DAY) | 0.035MG 1.0MG | Pfizer Canada Ulc | Active | 2024-06-19 | 303 | Manufacturing distruption | 226994 |
4539 | M05BA04 | ALENDRONATE | 70MG | Sanis Health Inc | Active | 2024-06-19 | Manufacturing distruption | 223355 | |
4538 | C09AA02 | VASOTEC | 4MG | Organon Canada Inc. | Resolved | 2024-06-19 | 107 | Shipping delay | 230530 |
4540 | R03BA07 | ASMANEX TWISTHALER | 100MCG | Organon Canada Inc. | Resolved | 2024-06-19 | 28 | Shipping delay | 231114 |
4521 | A10BA02 | PMSC-METFORMIN | 500MG | Pharmascience Inc | Resolved | 2024-06-18 | 133 | Manufacturing distruption | 230876 |
4522 | A10BD15 | APO-DAPAGLIFLOZIN-METFORMIN | 1000MG 5MG | Apotex Inc | Resolved | 2024-06-18 | 45 | Manufacturing distruption | 231020 |
4523 | D07AD01 | MYLAN-CLOBETASOL CREAM | 0.05% | Mylan Pharmaceuticals Ulc | Resolved | 2024-06-18 | 155 | Manufacturing distruption | 230115 |
4524 | G01AA10 | DALACIN VAGINAL CREAM | 20MG | Pfizer Canada Ulc | Resolved | 2024-06-18 | Manufacturing distruption | 231351 | |
4525 | R01AD01 | APO-BECLOMETHASONE NASAL SPRAY | 50MCG | Apotex Inc | Resolved | 2024-06-18 | 52 | Manufacturing distruption | 231010 |
4526 | R03AK06 | ADVAIR 100 DISKUS | 100MCG 50MCG | Glaxosmithkline Inc | Resolved | 2024-06-18 | 31 | Manufacturing distruption | 231082 |
4527 | C07AG01 | APO-LABETALOL | 200MG | Apotex Inc | Resolved | 2024-06-18 | 10 | Manufacturing distruption | 231030 |
4528 | A10BB09 | APO-GLICLAZIDE | 80MG | Apotex Inc | Resolved | 2024-06-18 | 45 | Manufacturing distruption | 231033 |
4529 | N06BA04 | APO-METHYLPHENIDATE | 10MG | Apotex Inc | Resolved | 2024-06-18 | 31 | Manufacturing distruption | 231036 |
4530 | A02BC03 | APO-LANSOPRAZOLE | 30MG | Apotex Inc | Resolved | 2024-06-18 | 10 | Manufacturing distruption | 231024 |
4531 | S01EE01 | APO-LATANOPROST | 50MCG | Apotex Inc | Resolved | 2024-06-18 | 94 | Manufacturing distruption | 231039 |
4532 | J05AB11 | MYLAN-VALACYCLOVIR | 500MG | Mylan Pharmaceuticals Ulc | Resolved | 2024-06-18 | 7 | Demand increase | 230137 |
4533 | L01XA01 | CISPLATIN INJECTION, BP | 1MG | Accord Healthcare Inc | Resolved | 2024-06-18 | 129 | Manufacturing practices | 225228 |
4534 | R06AX13 | LORATADINE | 10MG | Apotex Inc | Resolved | 2024-06-18 | 45 | Manufacturing distruption | 231015 |
4535 | G04CA02 | TAMSULOSIN CR | 0.4MG | Sanis Health Inc | Resolved | 2024-06-18 | 171 | Manufacturing distruption | 230839 |
4536 | C09BA04 | APO-PERINDOPRIL-INDAPAMIDE | 8MG 2.5MG | Apotex Inc | Resolved | 2024-06-18 | 164 | Manufacturing distruption | 231027 |
4511 | S01ED01 | TIMOPTIC | 0.5% | Elvium Life Sciences | Active | 2024-06-17 | 318 | Demand increase | 230791 |
4520 | H01CB02 | SANDOSTATIN | 50MCG | Novartis Pharmaceuticals Canada Inc | Active | 2024-06-17 | Manufacturing distruption | 223074 | |
4512 | N01BB52 | XYLOCAINE 1% W EPINEPHRINE 1:1... | 0.01MG 10MG | Aspen Pharmacare Canada Inc. | Avoided | 2024-06-17 | 13 | Manufacturing distruption | 220858 |
4510 | S01ED01 | SANDOZ TIMOLOL | 0.5% | Sandoz Canada Incorporated | Resolved | 2024-06-17 | 32 | Manufacturing distruption | 230771 |
4513 | S01ED51 | COSOPT PRESERVATIVE-FREE | 5MG 20MG | Elvium Life Sciences | Resolved | 2024-06-17 | 11 | Demand increase | 230800 |
4514 | C09CA01 | SANDOZ LOSARTAN | 50MG | Sandoz Canada Incorporated | Resolved | 2024-06-17 | 81 | Manufacturing distruption | 230751 |
4515 | C09CA01 | SANDOZ LOSARTAN | 50MG | Sandoz Canada Incorporated | Resolved | 2024-06-17 | 81 | Manufacturing distruption | 230755 |
4516 | N06DA03 | SANDOZ RIVASTIGMINE | 1.5MG | Sandoz Canada Incorporated | Resolved | 2024-06-17 | Manufacturing distruption | 230768 | |
4517 | C10AA05 | SANDOZ ATORVASTATIN | 40MG | Sandoz Canada Incorporated | Resolved | 2024-06-17 | 60 | Manufacturing distruption | 230748 |
4518 | A10BB09 | DIAMICRON MR | 60MG | Servier Canada Inc | Resolved | 2024-06-17 | 53 | Other | 230501 |
4519 | L04AX05 | SANDOZ PIRFENIDONE CAPSULES | 267MG | Sandoz Canada Incorporated | Resolved | 2024-06-17 | 130 | Manufacturing distruption | 230763 |
4505 | J01DH02 | TARO-MEROPENEM | 1G | Sun Pharma Canada Inc | Active | 2024-06-14 | Manufacturing distruption | 237299 | |
4506 | L04AA06 | MYCOPHENOLATE MOFETIL FOR INJE... | 500MG | Accord Healthcare Inc | Active | 2024-06-14 | Manufacturing distruption | 207554 | |
4507 | C09BA05 | TARO-RAMIPRIL HCTZ | 25MG 10MG | Sun Pharma Canada Inc | Active | 2024-06-14 | 287 | Manufacturing distruption | 237308 |
4500 | A02BC06 | APO-DEXLANSOPRAZOLE | 30MG | Apotex Inc | Resolved | 2024-06-14 | 182 | Demand increase | 230576 |
4501 | A02BC06 | APO-DEXLANSOPRAZOLE | 60MG | Apotex Inc | Resolved | 2024-06-14 | 182 | Demand increase | 230579 |
4502 | D07AD01 | MYLAN-CLOBETASOL SCALP APPLICA... | 0.05% | Mylan Pharmaceuticals Ulc | Resolved | 2024-06-14 | Manufacturing distruption | 217873 | |
4503 | D07AD01 | MYLAN-CLOBETASOL SCALP APPLICA... | 0.05% | Mylan Pharmaceuticals Ulc | Resolved | 2024-06-14 | Manufacturing distruption | 228369 | |
4504 | V09CA03 | TECHNESCAN MAG3 | 1MG | Curium Canada Inc | Resolved | 2024-06-14 | 17 | Other | 229736 |
4508 | J02AX04 | CASPOFUNGIN FOR INJECTION | 50MG | Juno Pharmaceuticals Corp. | Resolved | 2024-06-14 | 78 | Other | 230495 |
4509 | J02AX04 | CASPOFUNGIN FOR INJECTION | 70MG | Juno Pharmaceuticals Corp. | Resolved | 2024-06-14 | 78 | Other | 230498 |
4495 | A02BC01 | NAT-OMEPRAZOLE DR | 20MG | Natco Pharma (Canada) Inc | Active | 2024-06-13 | 444 | Manufacturing distruption | 230400 |
4496 | N06DA02 | NAT-DONEPEZIL | 5MG | Natco Pharma (Canada) Inc | Active | 2024-06-13 | 444 | Manufacturing distruption | 230392 |
4484 | L04AA32 | AURO-APREMILAST | 30MG | Auro Pharma Inc | Resolved | 2024-06-13 | 78 | Demand increase | 230383 |
4485 | N01AB08 | SEVOFLURANE | 99.97% | Baxter Corporation | Resolved | 2024-06-13 | 19 | Manufacturing distruption | 230374 |
4486 | N06AB04 | AURO-CITALOPRAM | 40MG | Auro Pharma Inc | Resolved | 2024-06-13 | 48 | Demand increase | 230405 |
4487 | N05CF02 | SUBLINOX | 10MG | Bausch Health, Canada Inc. | Resolved | 2024-06-13 | 67 | Shipping delay | 229320 |
4488 | N06AB10 | AURO-ESCITALOPRAM | 10MG | Auro Pharma Inc | Resolved | 2024-06-13 | 48 | Demand increase | 230417 |
4489 | J05AB11 | AURO-VALACYCLOVIR | 1000MG | Auro Pharma Inc | Resolved | 2024-06-13 | 109 | Demand increase | 230446 |
4490 | C10AA01 | AURO-SIMVASTATIN | 40MG | Auro Pharma Inc | Resolved | 2024-06-13 | 170 | Demand increase | 230443 |
4491 | C10AA01 | AURO-SIMVASTATIN | 20MG | Auro Pharma Inc | Resolved | 2024-06-13 | 155 | Demand increase | 230440 |
4492 | M05BA07 | AURO-RISEDRONATE | 35MG | Auro Pharma Inc | Resolved | 2024-06-13 | 124 | Demand increase | 230435 |
4493 | C09CA03 | AURO-VALSARTAN | 40MG | Auro Pharma Inc | Resolved | 2024-06-13 | -135 | Demand increase | 230449 |
4494 | J01MA14 | AURO-MOXIFLOXACIN | 400MG | Auro Pharma Inc | Resolved | 2024-06-13 | 231 | Demand increase | 230424 |
4497 | N07CA01 | AURO-BETAHISTINE | 24MG | Auro Pharma Inc | Resolved | 2024-06-13 | 78 | Demand increase | 230397 |
4498 | B01AF02 | AURO-APIXABAN | 2.5MG | Auro Pharma Inc | Resolved | 2024-06-13 | 109 | Demand increase | 230380 |
4499 | B01AF02 | AURO-APIXABAN | 5MG | Auro Pharma Inc | Resolved | 2024-06-13 | 201 | Demand increase | 230377 |
4479 | N02CC03 | SANDOZ ZOLMITRIPTAN ODT | 2.5MG | Sandoz Canada Incorporated | Active | 2024-06-12 | Manufacturing distruption | 230196 | |
4476 | J05AB11 | APO-VALACYCLOVIR | 500MG | Apotex Inc | Resolved | 2024-06-12 | 282 | Manufacturing distruption | 230350 |
4477 | S01EA05 | SANDOZ BRIMONIDINE | 0.2% | Sandoz Canada Incorporated | Resolved | 2024-06-12 | 16 | Manufacturing distruption | 230185 |
4478 | N04BA03 | STALEVO | 200MG 25MG 100MG | Sandoz Canada Incorporated | Resolved | 2024-06-12 | 30 | Manufacturing distruption | 230192 |
4480 | A10BB09 | SANDOZ GLICLAZIDE MR | 30MG | Sandoz Canada Incorporated | Resolved | 2024-06-12 | Manufacturing distruption | 230199 | |
4481 | J07BC01 | ENGERIX-B | 10MCG | Glaxosmithkline Inc | Resolved | 2024-06-12 | 86 | Shipping delay | 230537 |
4482 | L04AX05 | SANDOZ PIRFENIDONE CAPSULES | 267MG | Sandoz Canada Incorporated | Resolved | 2024-06-12 | 114 | Manufacturing distruption | 230189 |
4483 | N02AA03 | HYDROMORPHONE HYDROCHLORIDE IN... | 2MG | Fresenius Kabi Canada Ltd | Resolved | 2024-06-12 | 37 | Shipping delay | 230033 |
4459 | G03DA04 | PROGESTERONE | 100MG | Sanis Health Inc | Avoided | 2024-06-11 | Manufacturing distruption | 229006 | |
4460 | L02BA01 | APO-TAMOX TAB 20MG | 20MG | Apotex Inc | Resolved | 2024-06-11 | 38 | Manufacturing distruption | 230480 |
4461 | N05CF01 | APO-ZOPICLONE | 7.5MG | Apotex Inc | Resolved | 2024-06-11 | 87 | Manufacturing distruption | 230469 |
4462 | N05CF01 | APO-ZOPICLONE | 7.5MG | Apotex Inc | Resolved | 2024-06-11 | 87 | Manufacturing distruption | 230474 |
4463 | M01AE02 | APO-NAPROXEN | 500MG | Apotex Inc | Resolved | 2024-06-11 | 59 | Manufacturing distruption | 230489 |
4464 | B01AA03 | APO-WARFARIN | 1MG | Apotex Inc | Resolved | 2024-06-11 | 73 | Manufacturing distruption | 230483 |
4465 | A02BC01 | APO-OMEPRAZOLE | 20MG | Apotex Inc | Resolved | 2024-06-11 | 66 | Manufacturing distruption | 230486 |
4466 | N07BB03 | CAMPRAL | 333MG | Mylan Pharmaceuticals Ulc | Resolved | 2024-06-11 | 7 | Manufacturing distruption | 228363 |
4467 | A02BC03 | APO-LANSOPRAZOLE | 30MG | Apotex Inc | Resolved | 2024-06-11 | 17 | Manufacturing distruption | 230463 |
4468 | S01EE04 | TRAVATAN Z | 0.004% | Novartis Pharmaceuticals Canada Inc | Resolved | 2024-06-11 | 38 | Shipping delay | 230095 |
4469 | C10AA07 | APO-ROSUVASTATIN | 40MG | Apotex Inc | Resolved | 2024-06-11 | 31 | Manufacturing distruption | 230492 |
4470 | L02BG03 | APO-ANASTROZOLE | 1MG | Apotex Inc | Resolved | 2024-06-11 | 129 | Manufacturing distruption | 229161 |
4471 | M04AA01 | APO-ALLOPURINOL | 200MG | Apotex Inc | Resolved | 2024-06-11 | 115 | Manufacturing distruption | 230466 |
4472 | H05BX01 | APO-CINACALCET | 60MG | Apotex Inc | Resolved | 2024-06-11 | 122 | Manufacturing distruption | 230460 |
4473 | B01AE07 | APO-DABIGATRAN | 75MG | Apotex Inc | Resolved | 2024-06-11 | 38 | Manufacturing distruption | 230477 |
4474 | B01AE07 | APO-DABIGATRAN | 110MG | Apotex Inc | Resolved | 2024-06-11 | 115 | Manufacturing distruption | 230561 |
4475 | B01AE07 | APO-DABIGATRAN | 150MG | Apotex Inc | Resolved | 2024-06-11 | 130 | Manufacturing distruption | 230558 |
4454 | J01XE01 | TEVA-NITROFURANTOIN | 100MG | Teva Canada Limited | Active | 2024-06-10 | 304 | Manufacturing distruption | 230320 |
4457 | N02AA03 | HYDROMORPHONE HYDROCHLORIDE IN... | 10MG | Pfizer Canada Ulc | Active | 2024-06-10 | Manufacturing distruption | 225629 | |
4456 | N06AX11 | REMERON RD | 15MG | Organon Canada Inc. | Avoided | 2024-06-10 | 4 | Demand increase | 227146 |
4448 | H05BX01 | SENSIPAR | 30MG | Amgen Canada Inc | Resolved | 2024-06-10 | Other | 230090 | |
4449 | H05BX01 | SENSIPAR | 60MG | Amgen Canada Inc | Resolved | 2024-06-10 | Other | 230105 | |
4450 | H05BX01 | SENSIPAR | 90MG | Amgen Canada Inc | Resolved | 2024-06-10 | Other | 230112 | |
4451 | B05BB01 | LACTATED RINGER'S INJECTION | 3.1MG 0.2MG 0.3MG 6MG | Icu Medical Canada Inc | Resolved | 2024-06-10 | 130 | Manufacturing distruption | 228396 |
4452 | S01JA01 | MINIMS FLUORESCEIN SODIUM | 2% | Bausch & Lomb Inc | Resolved | 2024-06-10 | 11 | Shipping delay | 230071 |
4453 | B05CX10 | SORBITOL MANNITOL IRRIGATION | 5.4MG 27MG | Icu Medical Canada Inc | Resolved | 2024-06-10 | 98 | Manufacturing distruption | 228390 |
4455 | N01BB03 | CARBOCAINE 2% | 20MG | Pfizer Canada Ulc | Resolved | 2024-06-10 | Manufacturing distruption | 227352 | |
4458 | N03AF01 | TEVA-CARBAMAZEPINE | 200MG | Teva Canada Limited | Resolved | 2024-06-10 | 153 | Manufacturing distruption | 230316 |
4441 | N02AX02 | TRIDURAL | 100MG | Paladin Pharma Inc. | Active | 2024-06-07 | 298 | Manufacturing distruption | 229156 |
4442 | G04CB01 | ACH-FINASTERIDE | 5MG | Accord Healthcare Inc | Active | 2024-06-07 | Manufacturing practices | 229914 | |
4443 | J01DH02 | TARO-MEROPENEM | 500MG | Sun Pharma Canada Inc | Active | 2024-06-07 | Manufacturing distruption | 237302 | |
4447 | L01EA01 | IMATINIB | 100MG | Sanis Health Inc | Active | 2024-06-07 | Manufacturing distruption | 225711 | |
4444 | N03AF04 | APTIOM | 200MG | Sumitomo Pharma Canada, Inc. | Avoided | 2024-06-07 | 30 | Shipping delay | 227211 |
4439 | B05BA03 | 5% DEXTROSE INJECTION, USP | 5G | Baxter Corporation | Resolved | 2024-06-07 | 176 | Manufacturing distruption | 229848 |
4440 | B05BA03 | 5% DEXTROSE INJECTION, USP | 5G | Baxter Corporation | Resolved | 2024-06-07 | 176 | Manufacturing distruption | 229851 |
4445 | D07CB01 | VIADERM KC CRM | 100000UNIT 0.25MG 2.5MG 1MG | Taro Pharmaceuticals Inc | Resolved | 2024-06-07 | 168 | Manufacturing distruption | 237278 |
4446 | N02AA03 | HYDROMORPHONE HYDROCHLORIDE IN... | 10MG | Fresenius Kabi Canada Ltd | Resolved | 2024-06-07 | 21 | Shipping delay | 230030 |
4422 | N07CA01 | MINT-BETAHISTINE | 8MG | Mint Pharmaceuticals Inc | Active | 2024-06-06 | 389 | Manufacturing practices | 230038 |
4423 | N07CA01 | MINT-BETAHISTINE | 16MG | Mint Pharmaceuticals Inc | Active | 2024-06-06 | 389 | Manufacturing practices | 230041 |
4424 | N07CA01 | MINT-BETAHISTINE | 24MG | Mint Pharmaceuticals Inc | Active | 2024-06-06 | 389 | Manufacturing practices | 230044 |
4426 | J01DC01 | CEFOXITIN FOR INJECTION | 2G | Teva Canada Limited | Active | 2024-06-06 | 328 | Manufacturing distruption | 229942 |
4428 | N05BE01 | TEVA-BUSPIRONE | 10MG | Teva Canada Limited | Active | 2024-06-06 | 147 | Manufacturing distruption | 229945 |
4432 | C09CA04 | IRBESARTAN | 75MG | Sanis Health Inc | Active | 2024-06-06 | Manufacturing distruption | 86036 | |
4435 | L01DB01 | DOXORUBICIN HYDROCHLORIDE INJE... | 2MG | Teva Canada Limited | Active | 2024-06-06 | 420 | Manufacturing distruption | 229963 |
4436 | N02CC05 | TEVA-ALMOTRIPTAN | 12.5MG | Teva Canada Limited | Active | 2024-06-06 | Manufacturing distruption | 229966 | |
4425 | D07AC01 | TEVA-TOPISONE | 0.05% | Teva Canada Limited | Resolved | 2024-06-06 | 136 | Manufacturing distruption | 229939 |
4427 | C03CA01 | TEVA-FUROSEMIDE | 40MG | Teva Canada Limited | Resolved | 2024-06-06 | 0 | Manufacturing distruption | 229936 |
4429 | C10AA03 | TEVA-PRAVASTATIN | 10MG | Teva Canada Limited | Resolved | 2024-06-06 | 136 | Manufacturing distruption | 229948 |
4430 | M01AC06 | TEVA-MELOXICAM | 15MG | Teva Canada Limited | Resolved | 2024-06-06 | 65 | Manufacturing distruption | 229951 |
4431 | C10AA05 | TEVA-ATORVASTATIN | 40MG | Teva Canada Limited | Resolved | 2024-06-06 | 65 | Manufacturing distruption | 229954 |
4433 | L01EB02 | TEVA-ERLOTINIB | 25MG | Teva Canada Limited | Resolved | 2024-06-06 | 55 | Manufacturing distruption | 229957 |
4434 | L01EB02 | TEVA-ERLOTINIB | 100MG | Teva Canada Limited | Resolved | 2024-06-06 | 65 | Manufacturing distruption | 229960 |
4437 | N03AX23 | BRIVLERA | 10MG | Ucb Canada Inc | Resolved | 2024-06-06 | 11 | Demand increase | 229811 |
4438 | A02BC02 | PANTOPRAZOLE FOR INJECTION | 40MG | Auro Pharma Inc | Resolved | 2024-06-06 | Demand increase | 229795 | |
4417 | B05XA03 | SODIUM CHLORIDE INJECTION USP | 9MG | Icu Medical Canada Inc | Resolved | 2024-06-05 | 47 | Manufacturing distruption | 228488 |
4418 | N03AX14 | LEVETIRACETAM | 750MG | Sanis Health Inc | Resolved | 2024-06-05 | 44 | Manufacturing distruption | 229012 |
4419 | B02BD11 | TRETTEN | 2500UNIT | Novo Nordisk Canada Inc | Resolved | 2024-06-05 | 5 | Other | 229680 |
4420 | A10BG02 | ROSIGLITAZONE | 2MG | Aa Pharma Inc | Resolved | 2024-06-05 | 27 | Manufacturing distruption | 229713 |
4421 | C09DA01 | LOSARTAN/HCTZ | 12.5MG 100MG | Sanis Health Inc | Resolved | 2024-06-05 | 121 | Manufacturing distruption | 229003 |
4409 | C01DA14 | APO-ISMN | 60MG | Apotex Inc | Active | 2024-06-04 | 451 | Manufacturing distruption | 229755 |
4406 | N06AB06 | APO-SERTRALINE | 25MG | Apotex Inc | Resolved | 2024-06-04 | 136 | Manufacturing distruption | 229767 |
4407 | N06AB06 | APO-SERTRALINE | 50MG | Apotex Inc | Resolved | 2024-06-04 | Manufacturing distruption | 229773 | |
4408 | P01AB01 | APO-METRONIDAZOLE | 500MG | Apotex Inc | Resolved | 2024-06-04 | 143 | Manufacturing distruption | 229749 |
4410 | A10BA02 | APO-METFORMIN ER | 500MG | Apotex Inc | Resolved | 2024-06-04 | 52 | Manufacturing distruption | 229761 |
4411 | N06DA02 | APO-DONEPEZIL | 5MG | Apotex Inc | Resolved | 2024-06-04 | 136 | Manufacturing distruption | 229779 |
4412 | C07AB02 | APO-METOPROLOL (TYPE L) | 100MG | Apotex Inc | Resolved | 2024-06-04 | 31 | Manufacturing distruption | 229770 |
4413 | N07XX06 | APO-TETRABENAZINE | 25MG | Apotex Inc | Resolved | 2024-06-04 | 108 | Manufacturing distruption | 229764 |
4414 | R06AA59 | APO-DOXYLAMINE/B6 | 10MG 10MG | Apotex Inc | Resolved | 2024-06-04 | 150 | Manufacturing distruption | 229776 |
4415 | N05AX12 | APO-ARIPIPRAZOLE | 15MG | Apotex Inc | Resolved | 2024-06-04 | 115 | Manufacturing distruption | 229758 |
4416 | J05AE10 | APO-DARUNAVIR | 600MG | Apotex Inc | Resolved | 2024-06-04 | 119 | Manufacturing distruption | 229752 |
4393 | A04AA01 | ACCEL-ONDANSETRON ODT | 4MG | Accel Pharma Inc | Active | 2024-06-03 | 301 | Manufacturing distruption | 229588 |
4394 | A04AA01 | ACCEL-ONDANSETRON ODT | 8MG | Accel Pharma Inc | Active | 2024-06-03 | 301 | Manufacturing distruption | 229581 |
4395 | D07AD01 | MYLAN-CLOBETASOL CREAM | 0.05% | Mylan Pharmaceuticals Ulc | Avoided | 2024-06-03 | 29 | Manufacturing distruption | 217870 |
4398 | N03AB02 | DILANTIN-125 SUSPENSION | 125MG | Bgp Pharma Ulc | Avoided | 2024-06-03 | 190 | Manufacturing distruption | 228357 |
4396 | J07BC02 | HAVRIX 1440 | 1440UNIT | Glaxosmithkline Inc | Resolved | 2024-06-03 | 39 | Shipping delay | 229977 |
4397 | B01AB05 | LOVENOX WITH PRESERVATIVE 300M... | 100MG | Sanofi-Aventis Canada Inc | Resolved | 2024-06-03 | 67 | Other | 229574 |
4399 | N03AB02 | DILANTIN-125 SUSPENSION | 125MG | Bgp Pharma Ulc | Resolved | 2024-06-03 | Manufacturing distruption | 246922 | |
4400 | N03AB02 | DILANTIN-125 SUSPENSION | 125MG | Bgp Pharma Ulc | Resolved | 2024-06-03 | 190 | Manufacturing distruption | 230126 |
4401 | G03CA03 | ESTRADOT 75 | 75MCG | Sandoz Canada Incorporated | Resolved | 2024-06-03 | 123 | Manufacturing distruption | 229491 |
4402 | N03AA02 | PHENOBARBITAL SODIUM INJECTION... | 120MG | Sandoz Canada Incorporated | Resolved | 2024-06-03 | 4 | Manufacturing distruption | 229498 |
4403 | C09DA06 | SANDOZ CANDESARTAN PLUS | 12.5MG 16MG | Sandoz Canada Incorporated | Resolved | 2024-06-03 | 67 | Manufacturing distruption | 229487 |
4404 | C09DA06 | AURO-CANDESARTAN HCT | 25MG 32MG | Auro Pharma Inc | Resolved | 2024-06-03 | Demand increase | 85514 | |
4405 | C07AB07 | SANDOZ BISOPROLOL TABLETS | 5MG | Sandoz Canada Incorporated | Resolved | 2024-06-03 | 3 | Shipping delay | 229480 |
4384 | A10BH01 | TARO-SITAGLIPTIN FUMARATE | 25MG | Taro Pharmaceuticals Inc | Active | 2024-06-01 | 293 | Manufacturing distruption | 237254 |
4389 | S01EC01 | ACETAZOLAMIDE FOR INJECTION, U... | 500MG | Sterimax Inc | Active | 2024-06-01 | 944 | Other | 188809 |
4390 | C09DA04 | IRBESARTAN/HCTZ | 25MG 300MG | Sanis Health Inc | Active | 2024-06-01 | Manufacturing distruption | 229801 | |
4391 | C09CA06 | TARO-CANDESARTAN | 4MG | Sun Pharma Canada Inc | Active | 2024-06-01 | 328 | Manufacturing distruption | 237290 |
4392 | A11CC04 | CALCITRIOL INJECTION USP | 1MCG | Sterimax Inc | Active | 2024-06-01 | Manufacturing distruption | 218148 | |
4388 | N01AX10 | PROPOFOL INJECTION | 10MG | Baxter Corporation | Avoided | 2024-06-01 | Manufacturing practices | 210586 | |
4383 | G04CA01 | ALFUZOSIN | 10MG | Sanis Health Inc | Resolved | 2024-06-01 | 160 | Manufacturing distruption | 229797 |
4385 | C03EA01 | AA-AMILZIDE | 5MG 50MG | Aa Pharma Inc | Resolved | 2024-06-01 | 54 | Manufacturing distruption | 228768 |
4386 | C01DA08 | ISDN | 10MG | Aa Pharma Inc | Resolved | 2024-06-01 | 55 | Manufacturing distruption | 228774 |
4387 | J01GB01 | TOBRAMYCIN FOR INJECTION | 1.2G | Fresenius Kabi Canada Ltd | Resolved | 2024-06-01 | 34 | Shipping delay | 229350 |
4382 | N06DA02 | ARICEPT | 5MG | Pfizer Canada Ulc | Resolved | 2024-05-31 | 153 | Manufacturing distruption | 229720 |
4381 | C09DA08 | ACH-OLMESARTAN HCTZ | 12.5MG 20MG | Accord Healthcare Inc | Active | 2024-05-30 | Manufacturing practices | 229347 | |
4380 | G03CC07 | DUAVIVE | 20MG 0.45MG | Pfizer Canada Ulc | Resolved | 2024-05-30 | Manufacturing distruption | 229180 | |
4372 | C10AB04 | TEVA-GEMFIBROZIL | 600MG | Teva Canada Limited | Active | 2024-05-29 | Manufacturing distruption | 229233 | |
4373 | J05AB11 | VALTREX | 500MG | Glaxosmithkline Inc | Resolved | 2024-05-29 | 63 | Demand increase | 229356 |
4374 | L01BC01 | CYTARABINE INJECTION | 100MG | Pfizer Canada Ulc | Resolved | 2024-05-29 | Manufacturing distruption | 229064 | |
4375 | N05BA09 | TEVA-CLOBAZAM | 10MG | Teva Canada Limited | Resolved | 2024-05-29 | 326 | Ingredient shortage | 229230 |
4376 | R01AD09 | NASONEX | 50MCG | Organon Canada Inc. | Resolved | 2024-05-29 | 30 | Demand increase | 228746 |
4377 | J05AB11 | VALTREX | 1000MG | Glaxosmithkline Inc | Resolved | 2024-05-29 | 63 | Demand increase | 229353 |
4378 | J01MA12 | LEVOFLOXACIN IN 5% DEXTROSE IN... | 5MG | Pfizer Canada Ulc | Resolved | 2024-05-29 | Manufacturing distruption | 229094 | |
4379 | N04BX02 | TEVA-ENTACAPONE | 200MG | Teva Canada Limited | Resolved | 2024-05-29 | 124 | Manufacturing distruption | 229227 |
4347 | N03AX18 | LACOSAMIDE | 150MG | Sanis Health Inc | Active | 2024-05-28 | Manufacturing distruption | 228975 | |
4351 | B01AA03 | APO-WARFARIN | 2.5MG | Apotex Inc | Active | 2024-05-28 | Manufacturing distruption | 229419 | |
4358 | C01CA24 | EPINEPHRINE INJECTION USP | 1MG | Pfizer Canada Ulc | Active | 2024-05-28 | 398 | Manufacturing distruption | 228930 |
4367 | N05AH04 | APO-QUETIAPINE XR | 200MG | Apotex Inc | Active | 2024-05-28 | Manufacturing distruption | 216690 | |
4348 | A05AA02 | URSODIOL C | 500MG | Sanis Health Inc | Resolved | 2024-05-28 | 59 | Manufacturing distruption | 228972 |
4349 | C07AB04 | APO-ACEBUTOLOL | 400MG | Apotex Inc | Resolved | 2024-05-28 | 101 | Manufacturing distruption | 229410 |
4350 | V08AB02 | OMNIPAQUE 240 | 518MG | Ge Healthcare Canada Inc | Resolved | 2024-05-28 | 15 | Demand increase | 229037 |
4352 | C10AA03 | APO-PRAVASTATIN | 10MG | Apotex Inc | Resolved | 2024-05-28 | 31 | Manufacturing distruption | 229413 |
4353 | A02BC01 | APO-OMEPRAZOLE | 20MG | Apotex Inc | Resolved | 2024-05-28 | 66 | Manufacturing distruption | 229430 |
4354 | M01AC06 | APO-MELOXICAM | 15MG | Apotex Inc | Resolved | 2024-05-28 | 10 | Manufacturing distruption | 229422 |
4355 | N06AX11 | APO-MIRTAZAPINE | 15MG | Apotex Inc | Resolved | 2024-05-28 | 31 | Manufacturing distruption | 229392 |
4356 | C09AA04 | APO-PERINDOPRIL | 8MG | Apotex Inc | Resolved | 2024-05-28 | 24 | Manufacturing distruption | 229416 |
4357 | C10AA05 | APO-ATORVASTATIN | 40MG | Apotex Inc | Resolved | 2024-05-28 | 17 | Manufacturing distruption | 229401 |
4359 | N02BF01 | GABAPENTIN | 100MG | Sanis Health Inc | Resolved | 2024-05-28 | 143 | Manufacturing distruption | 228997 |
4360 | N06AB06 | SERTRALINE | 100MG | Sanis Health Inc | Resolved | 2024-05-28 | 17 | Manufacturing distruption | 228955 |
4361 | M04AA01 | APO-ALLOPURINOL | 300MG | Apotex Inc | Resolved | 2024-05-28 | 129 | Manufacturing distruption | 229389 |
4362 | C10BX03 | APO-AMLODIPINE-ATORVASTATIN | 40MG 5MG | Apotex Inc | Resolved | 2024-05-28 | 10 | Manufacturing distruption | 229404 |
4363 | N07BA03 | APO-VARENICLINE | 0.5MG | Apotex Inc | Resolved | 2024-05-28 | 38 | Manufacturing distruption | 229427 |
4364 | N06AB10 | ESCITALOPRAM | 10MG | Sanis Health Inc | Resolved | 2024-05-28 | 66 | Manufacturing distruption | 228992 |
4365 | H05BX01 | APO-CINACALCET | 30MG | Apotex Inc | Resolved | 2024-05-28 | 80 | Manufacturing distruption | 229407 |
4366 | G02CB03 | APO-CABERGOLINE | 0.5MG | Apotex Inc | Resolved | 2024-05-28 | 143 | Manufacturing distruption | 215982 |
4368 | S01XA25 | XIIDRA | 5% | Novartis Pharmaceuticals Canada Inc | Resolved | 2024-05-28 | 6 | Other | 228910 |
4369 | N05AX12 | APO-ARIPIPRAZOLE | 15MG | Apotex Inc | Resolved | 2024-05-28 | 38 | Manufacturing distruption | 229395 |
4370 | B01AC24 | APO-TICAGRELOR | 60MG | Apotex Inc | Resolved | 2024-05-28 | 52 | Manufacturing distruption | 229398 |
4371 | A09AA02 | CREON MINIMICROSPHERES 35 | 2240UNIT 35700UNIT 35000UNIT | Bgp Pharma Ulc | Resolved | 2024-05-28 | 57 | Other | 232558 |
4346 | G04BE09 | MYLAN-VARDENAFIL | 20MG | Mylan Pharmaceuticals Ulc | Active | 2024-05-27 | 365 | Ingredient shortage | 228378 |
4341 | D10AX05 | ACZONE | 5% | Bausch Health, Canada Inc. | Resolved | 2024-05-27 | 115 | Other | 229317 |
4342 | C10AA07 | SANDOZ ROSUVASTATIN | 40MG | Sandoz Canada Incorporated | Resolved | 2024-05-27 | 39 | Manufacturing distruption | 228893 |
4343 | J05AB11 | MYLAN-VALACYCLOVIR | 500MG | Mylan Pharmaceuticals Ulc | Resolved | 2024-05-27 | 22 | Demand increase | 228375 |
4344 | J01XX08 | SANDOZ LINEZOLID | 600MG | Sandoz Canada Incorporated | Resolved | 2024-05-27 | 18 | Manufacturing distruption | 228890 |
4345 | C10AX14 | PRALUENT | 150MG | Sanofi-Aventis Canada Inc | Resolved | 2024-05-27 | 9 | Other | 228879 |
4340 | C09CA06 | CANDESARTAN | 8MG | Sanis Health Inc | Resolved | 2024-05-25 | 69 | Manufacturing distruption | 228960 |
4318 | N05AE05 | AURO-LURASIDONE | 20MG | Auro Pharma Inc | Active | 2024-05-24 | 341 | Demand increase | 228826 |
4319 | N05AE05 | AURO-LURASIDONE | 40MG | Auro Pharma Inc | Active | 2024-05-24 | 341 | Demand increase | 228829 |
4320 | N05AE05 | AURO-LURASIDONE | 60MG | Auro Pharma Inc | Active | 2024-05-24 | 341 | Demand increase | 228832 |
4321 | N05AE05 | AURO-LURASIDONE | 80MG | Auro Pharma Inc | Active | 2024-05-24 | 341 | Demand increase | 228835 |
4322 | N05AE05 | AURO-LURASIDONE | 120MG | Auro Pharma Inc | Active | 2024-05-24 | 341 | Demand increase | 228823 |
4323 | L04AF01 | AURO-TOFACITINIB | 5MG | Auro Pharma Inc | Resolved | 2024-05-24 | 129 | Demand increase | 228744 |
4324 | L04AF01 | AURO-TOFACITINIB | 10MG | Auro Pharma Inc | Resolved | 2024-05-24 | 98 | Demand increase | 228749 |
4325 | M01AB55 | ARTHROTEC 75 | 200MCG 75MG | Pfizer Canada Ulc | Resolved | 2024-05-24 | 89 | Demand increase | 227000 |
4326 | V03AF01 | UROMITEXAN | 100MG | Baxter Corporation | Resolved | 2024-05-24 | 17 | Demand increase | 228511 |
4327 | B01AA03 | TARO-WARFARIN | 1MG | Taro Pharmaceuticals Inc | Resolved | 2024-05-24 | 161 | Manufacturing distruption | 237287 |
4328 | L04AX02 | THALOMID | 50MG | Bristol-Myers Squibb Canada | Resolved | 2024-05-24 | 31 | Manufacturing distruption | 228619 |
4329 | M05BA04 | AURO-ALENDRONATE | 10MG | Auro Pharma Inc | Resolved | 2024-05-24 | 40 | Demand increase | 228614 |
4330 | N05AH04 | AURO-QUETIAPINE | 25MG | Auro Pharma Inc | Resolved | 2024-05-24 | 37 | Demand increase | 228759 |
4331 | C10AA01 | AURO-SIMVASTATIN | 80MG | Auro Pharma Inc | Resolved | 2024-05-24 | Demand increase | 228756 | |
4332 | C07AG02 | AURO-CARVEDILOL | 25MG | Auro Pharma Inc | Resolved | 2024-05-24 | 22 | Demand increase | 228732 |
4333 | N06DA04 | AURO-GALANTAMINE ER | 16MG | Auro Pharma Inc | Resolved | 2024-05-24 | 54 | Demand increase | 228738 |
4334 | G04BD08 | AURO-SOLIFENACIN | 5MG | Auro Pharma Inc | Resolved | 2024-05-24 | 190 | Demand increase | 228753 |
4335 | N07CA01 | AURO-BETAHISTINE | 8MG | Auro Pharma Inc | Resolved | 2024-05-24 | 276 | Demand increase | 228644 |
4336 | P01AB01 | AURO-METRONIDAZOLE | 500MG | Auro Pharma Inc | Resolved | 2024-05-24 | 40 | Demand increase | 228741 |
4337 | J01DB01 | AURO-CEPHALEXIN | 500MG | Auro Pharma Inc | Resolved | 2024-05-24 | 205 | Demand increase | 228735 |
4338 | L04AX03 | METHOTREXATE SUBCUTANEOUS | 25MG | Accord Healthcare Inc | Resolved | 2024-05-24 | 66 | Manufacturing distruption | 228605 |
4339 | C01AA05 | JAMP DIGOXIN | 0.0625MG | Jamp Pharma Corporation | Resolved | 2024-05-24 | 21 | Manufacturing distruption | 228715 |
4311 | L04AX05 | PMS-PIRFENIDONE | 267MG | Pharmascience Inc | Active | 2024-05-23 | 559 | Manufacturing distruption | 229695 |
4312 | L04AX05 | PMS-PIRFENIDONE | 267MG | Pharmascience Inc | Active | 2024-05-23 | 564 | Manufacturing distruption | 229699 |
4313 | L04AX05 | PMS-PIRFENIDONE | 801MG | Pharmascience Inc | Active | 2024-05-23 | 550 | Manufacturing distruption | 229702 |
4314 | N04AA01 | TRIHEXYPHENIDYL | 5MG | Aa Pharma Inc | Resolved | 2024-05-23 | 64 | Manufacturing distruption | 228798 |
4315 | N02AA01 | KADIAN | 10MG | Bgp Pharma Ulc | Resolved | 2024-05-23 | 5 | Manufacturing distruption | 228360 |
4316 | A03AX04 | PINAVERIUM | 50MG | Aa Pharma Inc | Resolved | 2024-05-23 | 56 | Manufacturing distruption | 228794 |
4317 | A03AX04 | PINAVERIUM | 100MG | Aa Pharma Inc | Resolved | 2024-05-23 | 53 | Manufacturing distruption | 228789 |
4308 | A09AA02 | COTAZYM | 35000UNIT 40000UNIT 10000UNIT | Organon Canada Inc. | Active | 2024-05-22 | 331 | Manufacturing distruption | 225096 |
4309 | R01AX03 | IPRAVENT | 42MCG | Aa Pharma Inc | Resolved | 2024-05-22 | 37 | Manufacturing distruption | 228771 |
4310 | V09GA06 | ULTRATAG RBC | 20MCI | Curium Canada Inc | Resolved | 2024-05-22 | 26 | Manufacturing distruption | 228585 |
4302 | L02BG03 | RIVA-ANASTROZOLE | 1MG | Laboratoire Riva Inc. | Active | 2024-05-21 | Manufacturing practices | 217917 | |
4287 | C08DA01 | APO-VERAP TAB 80MG | 80MG | Apotex Inc | Resolved | 2024-05-21 | 10 | Manufacturing distruption | 228810 |
4288 | A10BD07 | SANDOZ SITAGLIPTIN-METFORMIN X... | 1000MG 100MG | Sandoz Canada Incorporated | Resolved | 2024-05-21 | 10 | Manufacturing distruption | 228423 |
4289 | L02BA01 | APO-TAMOX TAB 10MG | 10MG | Apotex Inc | Resolved | 2024-05-21 | 59 | Manufacturing distruption | 228777 |
4290 | C02DB02 | APO-HYDRALAZINE | 25MG | Apotex Inc | Resolved | 2024-05-21 | 24 | Manufacturing distruption | 228804 |
4291 | V07AB | STERILE WATER FOR IRRIGATION U... | 100% | Icu Medical Canada Inc | Resolved | 2024-05-21 | 38 | Manufacturing distruption | 228387 |
4292 | N06AB06 | APO-SERTRALINE | 100MG | Apotex Inc | Resolved | 2024-05-21 | 66 | Manufacturing distruption | 228786 |
4293 | C01BD01 | APO-AMIODARONE TABLETS | 200MG | Apotex Inc | Resolved | 2024-05-21 | 31 | Manufacturing distruption | 228816 |
4294 | P01BA02 | APO-HYDROXYQUINE | 200MG | Apotex Inc | Resolved | 2024-05-21 | 24 | Manufacturing distruption | 228780 |
4295 | N01BB02 | XYLOCAINE 2% | 20MG | Aspen Pharmacare Canada Inc. | Resolved | 2024-05-21 | 17 | Shipping delay | 228339 |
4296 | J05AB11 | PRO-VALACYCLOVIR | 500MG | Pro Doc Limitee | Resolved | 2024-05-21 | 63 | Shipping delay | 230788 |
4297 | N06BA09 | APO-ATOMOXETINE | 100MG | Apotex Inc | Resolved | 2024-05-21 | 150 | Manufacturing distruption | 228792 |
4298 | C10AA05 | SANDOZ ATORVASTATIN | 40MG | Sandoz Canada Incorporated | Resolved | 2024-05-21 | 38 | Manufacturing distruption | 228415 |
4299 | C10AA07 | SANDOZ ROSUVASTATIN | 10MG | Sandoz Canada Incorporated | Resolved | 2024-05-21 | 10 | Manufacturing distruption | 228419 |
4300 | G04CA02 | SANDOZ TAMSULOSIN CR | 0.4MG | Sandoz Canada Incorporated | Resolved | 2024-05-21 | 178 | Manufacturing distruption | 228441 |
4301 | G04CA02 | SANDOZ TAMSULOSIN CR | 0.4MG | Sandoz Canada Incorporated | Resolved | 2024-05-21 | 167 | Manufacturing distruption | 228446 |
4303 | B01AC04 | APO-CLOPIDOGREL | 300MG | Apotex Inc | Resolved | 2024-05-21 | 45 | Manufacturing distruption | 228813 |
4304 | G04BD08 | SANDOZ SOLIFENACIN | 5MG | Sandoz Canada Incorporated | Resolved | 2024-05-21 | 24 | Manufacturing distruption | 228426 |
4305 | G04BD07 | SANDOZ TOLTERODINE LA | 4MG | Sandoz Canada Incorporated | Resolved | 2024-05-21 | 45 | Shipping delay | 228430 |
4306 | J01DE01 | APO-CEFEPIME | 2G | Apotex Inc | Resolved | 2024-05-21 | 31 | Manufacturing distruption | 228807 |
4307 | B01AF01 | APO-RIVAROXABAN | 15MG | Apotex Inc | Resolved | 2024-05-21 | 87 | Manufacturing distruption | 228801 |
4285 | M01AB55 | GD-DICLOFENAC/MISOPROSTOL 50 | 200MCG 50MG | Genmed A Division Of Pfizer Canada Ulc | Resolved | 2024-05-20 | 176 | Demand increase | 220932 |
4286 | G04BD08 | SOLIFENACIN | 10MG | Sanis Health Inc | Resolved | 2024-05-20 | 123 | Manufacturing distruption | 228966 |
4280 | L02AB01 | MEGESTROL | 160MG | Aa Pharma Inc | Active | 2024-05-17 | Manufacturing distruption | 228783 | |
4284 | N02BF01 | GABAPENTIN CAPSULES USP | 400MG | Accord Healthcare Inc | Active | 2024-05-17 | Manufacturing practices | 228242 | |
4279 | N05BA06 | ATIVAN | 1MG | Pfizer Canada Ulc | Resolved | 2024-05-17 | Manufacturing distruption | 210722 | |
4281 | B02BC30 | TISSEEL | 40MCMOL 500UNIT 3000KIU 125MG | Baxter Corporation | Resolved | 2024-05-17 | 197 | Manufacturing distruption | 229097 |
4282 | B02BC30 | TISSEEL | 40MCMOL 500UNIT 3000KIU 125MG | Baxter Corporation | Resolved | 2024-05-17 | 197 | Manufacturing distruption | 229100 |
4283 | J05AB11 | AURO-VALACYCLOVIR | 500MG | Auro Pharma Inc | Resolved | 2024-05-17 | 107 | Demand increase | 227536 |
4276 | C03AA03 | HYDROCHLOROTHIAZIDE | 50MG | Sanis Health Inc | Active | 2024-05-16 | Manufacturing distruption | 229804 | |
4277 | G04BD04 | OXYBUTYNIN | 5MG | Sanis Health Inc | Active | 2024-05-16 | Manufacturing distruption | 228963 | |
4278 | N06AX24 | VIIBRYD | 20MG | Abbvie Corporation | Resolved | 2024-05-16 | 18 | Shipping delay | 228152 |
4267 | N01AX10 | DIPRIVAN 1% | 10MG | Aspen Pharmacare Canada Inc. | Avoided | 2024-05-15 | 16 | Demand increase | 222698 |
4275 | L04AC19 | ENSPRYNG | 120MG | Hoffmann-La Roche Limited | Avoided | 2024-05-15 | 44 | Manufacturing practices | 227132 |
4266 | N06AB03 | PROZAC CAPSULES 10MG | 10MG | Eli Lilly Canada Inc | Resolved | 2024-05-15 | Other | 220045 | |
4268 | B05XC | MULTI 12 INJECTION | 1MCG 80MCG 12MCG 2UNIT 3MG 0.8MG 8MG 0.72MG 0.6MG 40UNIT 660UNIT 20MG | Sandoz Canada Incorporated | Resolved | 2024-05-15 | Manufacturing practices | 217399 | |
4269 | J01CE01 | PENICILLIN G SODIUM FOR INJECT... | 10000000UNIT | Fresenius Kabi Canada Ltd | Resolved | 2024-05-15 | 31 | Manufacturing distruption | 226550 |
4270 | M01AE02 | TEVA-NAPROXEN | 500MG | Teva Canada Limited | Resolved | 2024-05-15 | 26 | Manufacturing distruption | 228140 |
4271 | D07XC01 | RATIO-TOPISALIC | 20MG 0.5MG | Teva Canada Limited | Resolved | 2024-05-15 | 87 | Manufacturing distruption | 228146 |
4272 | M01AB55 | GD-DICLOFENAC/MISOPROSTOL 75 | 200MCG 75MG | Genmed A Division Of Pfizer Canada Ulc | Resolved | 2024-05-15 | 37 | Demand increase | 227003 |
4273 | H02AB04 | SOLU-MEDROL | 1G | Pfizer Canada Ulc | Resolved | 2024-05-15 | Manufacturing distruption | 220618 | |
4274 | N06BA04 | ACT METHYLPHENIDATE ER | 54MG | Teva Canada Limited | Resolved | 2024-05-15 | 128 | Manufacturing distruption | 228143 |
4252 | L02BG03 | ANASTROZOLE | 1MG | Sivem Pharmaceuticals Ulc | Active | 2024-05-13 | Manufacturing distruption | 217972 | |
4255 | N05AN01 | LITHANE | 150MG | Searchlight Pharma Inc | Active | 2024-05-13 | Other | 227896 | |
4257 | S01ED01 | TIMOLOL MALEATE-EX | 0.25% | Sandoz Canada Incorporated | Active | 2024-05-13 | 368 | Manufacturing distruption | 227853 |
4264 | G04BE09 | MYLAN-VARDENAFIL | 10MG | Mylan Pharmaceuticals Ulc | Active | 2024-05-13 | 379 | Ingredient shortage | 228366 |
4253 | C01CA04 | DOPAMINE HCL 1.6MG/ML DEXTROSE... | 50MG 1.6MG | Baxter Corporation | Resolved | 2024-05-13 | 50 | Manufacturing distruption | 228098 |
4254 | N05AN01 | LITHANE | 150MG | Searchlight Pharma Inc | Resolved | 2024-05-13 | Other | 227894 | |
4256 | N04AC01 | BENZTROPINE OMEGA | 1MG | Omega Laboratories Limited | Resolved | 2024-05-13 | 39 | Demand increase | 228008 |
4258 | D07AD01 | TARO-CLOBETASOL CREAM USP, 0.0... | 0.05% | Taro Pharmaceuticals Inc | Resolved | 2024-05-13 | 39 | Manufacturing distruption | 230669 |
4259 | N03AB02 | TARO-PHENYTOIN | 125MG | Taro Pharmaceuticals Inc | Resolved | 2024-05-13 | 165 | Manufacturing distruption | 238044 |
4260 | S01ED51 | COSOPT PRESERVATIVE-FREE | 5MG 20MG | Elvium Life Sciences | Resolved | 2024-05-13 | 18 | Shipping delay | 227864 |
4261 | L04AK01 | SANDOZ LEFLUNOMIDE | 10MG | Sandoz Canada Incorporated | Resolved | 2024-05-13 | 4 | Shipping delay | 227847 |
4262 | C08CA01 | SANDOZ AMLODIPINE | 5MG | Sandoz Canada Incorporated | Resolved | 2024-05-13 | 18 | Manufacturing practices | 227841 |
4263 | S01EA05 | SANDOZ BRIMONIDINE | 0.2% | Sandoz Canada Incorporated | Resolved | 2024-05-13 | 18 | Manufacturing distruption | 227844 |
4265 | R03AL12 | ENERZAIR BREEZHALER | 160MCG 50MCG 150MCG | Novartis Pharmaceuticals Canada Inc | Resolved | 2024-05-13 | 10 | Shipping delay | 228307 |
4250 | C09CA06 | CANDESARTAN | 16MG | Sanis Health Inc | Active | 2024-05-11 | Manufacturing distruption | 228989 | |
4251 | N06DA02 | DONEPEZIL | 5MG | Sanis Health Inc | Resolved | 2024-05-11 | 195 | Manufacturing distruption | 228969 |
4248 | S01XA18 | TEVA-CYCLOSPORINE | 0.05% | Teva Canada Limited | Active | 2024-05-10 | Manufacturing distruption | 228149 | |
4249 | C09DA08 | ACH-OLMESARTAN HCTZ | 40MG 25MG | Accord Healthcare Inc | Active | 2024-05-10 | Manufacturing practices | 227794 | |
4245 | V08AB09 | VISIPAQUE 270 | 550MG | Ge Healthcare Canada Inc | Resolved | 2024-05-10 | 11 | Shipping delay | 227151 |
4246 | G03AA05 | BREVICON 0.5/35 TABLETS (28-DA... | .5MG .035MG | Pfizer Canada Ulc | Resolved | 2024-05-10 | 46 | Demand increase | 226997 |
4247 | J05AB11 | MYLAN-VALACYCLOVIR | 1000MG | Mylan Pharmaceuticals Ulc | Resolved | 2024-05-10 | 138 | Demand increase | 228372 |
4238 | C09AA03 | LISINOPRIL | 10MG | Sanis Health Inc | Active | 2024-05-09 | Manufacturing distruption | 228978 | |
4242 | G04BD08 | ACH-SOLIFENACIN SUCCINATE | 5MG | Accord Healthcare Inc | Active | 2024-05-09 | Manufacturing practices | 227797 | |
4239 | N02BF01 | PMS-GABAPENTIN | 400MG | Pharmascience Inc | Resolved | 2024-05-09 | 91 | Manufacturing distruption | 227771 |
4240 | N01BB02 | XYLOCAINE 2% | 20MG | Aspen Pharmacare Canada Inc. | Resolved | 2024-05-09 | 16 | Shipping delay | 227445 |
4241 | C10AC04 | LODALIS | 625MG | Bausch Health, Canada Inc. | Resolved | 2024-05-09 | 85 | Other | 226788 |
4243 | J05AF07 | PMS-TENOFOVIR | 300MG | Pharmascience Inc | Resolved | 2024-05-09 | 143 | Manufacturing distruption | 227785 |
4244 | J01XD01 | PMS-METRONIDAZOLE | 500MG | Pharmascience Inc | Resolved | 2024-05-09 | 169 | Manufacturing distruption | 227776 |
4222 | S01EE01 | TEVA-LATANOPROST | 50MCG | Teva Canada Limited | Active | 2024-05-08 | 357 | Manufacturing distruption | 227477 |
4228 | N02CC04 | ACT RIZATRIPTAN | 10MG | Teva Canada Limited | Active | 2024-05-08 | 268 | Manufacturing distruption | 227492 |
4229 | J01GB01 | TEVA-TOBRAMYCIN | 60MG | Teva Canada Limited | Active | 2024-05-08 | 337 | Manufacturing distruption | 227495 |
4230 | J02AC03 | TEVA-VORICONAZOLE | 50MG | Teva Canada Limited | Active | 2024-05-08 | Manufacturing distruption | 227500 | |
4231 | J02AC03 | TEVA-VORICONAZOLE | 200MG | Teva Canada Limited | Active | 2024-05-08 | Manufacturing distruption | 227503 | |
4234 | N05AH04 | BIO-QUETIAPINE | 25MG | Biomed Pharma | Active | 2024-05-08 | Manufacturing practices | 245161 | |
4235 | L04AH02 | TEVA-EVEROLIMUS | 5MG | Teva Canada Limited | Active | 2024-05-08 | Manufacturing distruption | 227509 | |
4214 | D07AC01 | TEVA-TOPISONE | 0.05% | Teva Canada Limited | Resolved | 2024-05-08 | Manufacturing distruption | 227462 | |
4215 | B05XA03 | SODIUM CHLORIDE INJECTION USP | 9MG | Icu Medical Canada Inc | Resolved | 2024-05-08 | 21 | Manufacturing distruption | 224716 |
4216 | J01DB01 | TEVA-CEPHALEXIN 250 | 250MG | Teva Canada Limited | Resolved | 2024-05-08 | 33 | Manufacturing distruption | 227459 |
4217 | J01AA07 | TETRACYCLINE | 250MG | Aa Pharma Inc | Resolved | 2024-05-08 | 57 | Manufacturing distruption | 227333 |
4218 | N06AB06 | TEVA-SERTRALINE | 50MG | Teva Canada Limited | Resolved | 2024-05-08 | 43 | Manufacturing distruption | 227465 |
4219 | C10AA03 | TEVA-PRAVASTATIN | 10MG | Teva Canada Limited | Resolved | 2024-05-08 | 176 | Manufacturing distruption | 227468 |
4220 | C07AG02 | TEVA-CARVEDILOL | 3.125MG | Teva Canada Limited | Resolved | 2024-05-08 | 115 | Manufacturing distruption | 227471 |
4221 | C07AG02 | TEVA-CARVEDILOL | 6.25MG | Teva Canada Limited | Resolved | 2024-05-08 | 115 | Manufacturing distruption | 227474 |
4223 | L01CE02 | IRINOTECAN HYDROCHLORIDE INJEC... | 20MG | Pfizer Canada Ulc | Resolved | 2024-05-08 | Manufacturing distruption | 227322 | |
4224 | N06AX11 | TEVA-MIRTAZAPINE | 30MG | Teva Canada Limited | Resolved | 2024-05-08 | 145 | Manufacturing distruption | 227480 |
4225 | A10BG03 | ACT PIOGLITAZONE | 30MG | Teva Canada Limited | Resolved | 2024-05-08 | Manufacturing distruption | 227486 | |
4226 | N03AF01 | TEGRETOL CR | 200MG | Novartis Pharmaceuticals Canada Inc | Resolved | 2024-05-08 | 71 | Demand increase | 227205 |
4227 | C10AX09 | TEVA-EZETIMIBE | 10MG | Teva Canada Limited | Resolved | 2024-05-08 | Manufacturing distruption | 227489 | |
4232 | N02AB03 | FENTORA | 800MCG | Teva Canada Limited | Resolved | 2024-05-08 | 125 | Manufacturing distruption | 227506 |
4233 | N01BB01 | BUPIVACAINE INJECTION BP | 2.5MG | Sterimax Inc | Resolved | 2024-05-08 | 176 | Manufacturing distruption | 213678 |
4236 | N01AH01 | FENTANYL INJECTION BP | 250MCG | Sterimax Inc | Resolved | 2024-05-08 | 36 | Shipping delay | 221598 |
4237 | B01AF01 | TEVA-RIVAROXABAN | 20MG | Teva Canada Limited | Resolved | 2024-05-08 | 33 | Manufacturing distruption | 227456 |
4208 | N02BF02 | APO-PREGABALIN | 25MG | Apotex Inc | Active | 2024-05-07 | Manufacturing distruption | 216732 | |
4210 | C09CA08 | APO-OLMESARTAN | 20MG | Apotex Inc | Active | 2024-05-07 | Manufacturing distruption | 216711 | |
4212 | L04AE01 | APO-FINGOLIMOD | 0.5MG | Apotex Inc | Active | 2024-05-07 | Manufacturing distruption | 216744 | |
4199 | N02BE01 | APO-ACETAMINOPHEN EXTRA STRENG... | 500MG | Apotex Inc | Resolved | 2024-05-07 | 52 | Manufacturing distruption | 227722 |
4200 | A06AB56 | SANDOZ SENNA S | 50MG 8.6MG | Sandoz Canada Incorporated | Resolved | 2024-05-07 | Manufacturing distruption | 227201 | |
4201 | J01AA02 | APO-DOXY CAP 100MG | 100MG | Apotex Inc | Resolved | 2024-05-07 | 45 | Manufacturing distruption | 227728 |
4202 | C10AA05 | APO-ATORVASTATIN | 80MG | Apotex Inc | Resolved | 2024-05-07 | 45 | Manufacturing distruption | 227725 |
4203 | B01AB01 | HEPARIN SODIUM INJECTION USP ... | 10000UNIT | Sandoz Canada Incorporated | Resolved | 2024-05-07 | Manufacturing distruption | 227194 | |
4204 | N01BB01 | MARCAINE | 250MG | Pfizer Canada Ulc | Resolved | 2024-05-07 | Manufacturing distruption | 221477 | |
4205 | N03AF01 | TEGRETOL CR | 400MG | Novartis Pharmaceuticals Canada Inc | Resolved | 2024-05-07 | 78 | Demand increase | 227209 |
4206 | J05AB11 | APO-VALACYCLOVIR | 1000MG | Apotex Inc | Resolved | 2024-05-07 | 325 | Manufacturing distruption | 227714 |
4207 | N02AA03 | HYDROMORPHONE HYDROCHLORIDE IN... | 10MG | Pfizer Canada Ulc | Resolved | 2024-05-07 | Manufacturing distruption | 226090 | |
4209 | G04BE08 | TARO-TADALAFIL | 20MG | Sun Pharma Canada Inc | Resolved | 2024-05-07 | 192 | Manufacturing distruption | 242666 |
4211 | A10BB09 | SANDOZ GLICLAZIDE MR | 30MG | Sandoz Canada Incorporated | Resolved | 2024-05-07 | Manufacturing distruption | 227197 | |
4213 | A10BH01 | APO-SITAGLIPTIN MALATE | 25MG | Apotex Inc | Resolved | 2024-05-07 | 24 | Manufacturing distruption | 227717 |
4197 | R03DC03 | ACH-MONTELUKAST | 10MG | Accord Healthcare Inc | Active | 2024-05-03 | Manufacturing practices | 227094 | |
4195 | S01AA17 | PDP-ERYTHROMYCIN | 5MG | Pendopharm Division Of Pharmascience Inc | Resolved | 2024-05-03 | 150 | Ingredient shortage | 227343 |
4196 | B01AF01 | XARELTO | 10MG | Bayer Inc | Resolved | 2024-05-03 | 14 | Shipping delay | 226202 |
4198 | C09DA06 | CANDESARTAN-HCTZ | 12.5MG 16.0MG | Pro Doc Limitee | Resolved | 2024-05-03 | 20 | Shipping delay | 227037 |
4191 | R03AL02 | TEVA-COMBO STERINEBS | 0.5MG 2.5MG | Teva Canada Limited | Active | 2024-05-02 | 333 | Manufacturing distruption | 226939 |
4188 | J01MA14 | MOXIFLOXACIN | 400MG | Sanis Health Inc | Resolved | 2024-05-02 | 274 | Manufacturing distruption | 228981 |
4189 | A06AD11 | RATIO-LACTULOSE | 667MG | Teva Canada Limited | Resolved | 2024-05-02 | 69 | Manufacturing distruption | 226933 |
4190 | C10AA03 | TEVA-PRAVASTATIN | 10MG | Teva Canada Limited | Resolved | 2024-05-02 | 151 | Manufacturing distruption | 226936 |
4192 | N02AB03 | FENTORA | 800MCG | Teva Canada Limited | Resolved | 2024-05-02 | 131 | Manufacturing distruption | 226942 |
4193 | V09GA02 | MYOVIEW 30ML | 1.38MG | Ge Healthcare Canada Inc | Resolved | 2024-05-02 | 15 | Manufacturing distruption | 226858 |
4194 | N06AX21 | TEVA-DULOXETINE | 60MG | Teva Canada Limited | Resolved | 2024-05-02 | 232 | Manufacturing distruption | 226945 |
4179 | N02BA01 | PRO-AAS EC - 80 | 80MG | Pro Doc Limitee | Active | 2024-05-01 | 379 | Other | 227097 |
4183 | N05AH04 | QUETIAPINE XR | 400MG | Sivem Pharmaceuticals Ulc | Active | 2024-05-01 | Manufacturing distruption | 218001 | |
4184 | G03AA07 | LAYLAA 21 | 0.02MG 0.1MG | Lupin Pharma Canada Limited | Active | 2024-05-01 | Manufacturing distruption | 226799 | |
4185 | G03AA07 | LAYLAA 28 | 0.02MG 0.1MG | Lupin Pharma Canada Limited | Active | 2024-05-01 | Manufacturing distruption | 226802 | |
4175 | V07AB | BACTERIOSTATIC WATER FOR INJEC... | 30ML | Pfizer Canada Ulc | Avoided | 2024-05-01 | Manufacturing distruption | 200807 | |
4177 | N01AX10 | PROPOFOL INJECTION | 10MG | Baxter Corporation | Avoided | 2024-05-01 | Manufacturing practices | 210580 | |
4174 | B01AX07 | CABLIVI | 11MG | Sanofi-Aventis Canada Inc | Resolved | 2024-05-01 | Other | 225859 | |
4176 | N01BB01 | SENSORCAINE | 2.5MG | Aspen Pharmacare Canada Inc. | Resolved | 2024-05-01 | 177 | Manufacturing distruption | 225255 |
4178 | J02AC03 | VFEND | 200MG | Pfizer Canada Ulc | Resolved | 2024-05-01 | Manufacturing distruption | 226796 | |
4180 | D01AE14 | TARO-CICLOPIROX | 8% | Taro Pharmaceuticals Inc | Resolved | 2024-05-01 | 58 | Manufacturing distruption | 227628 |
4181 | J01CR05 | PIPERACILLIN AND TAZOBACTAM FO... | 0.375G 3.000G | Sterimax Inc | Resolved | 2024-05-01 | Shipping delay | 227019 | |
4182 | J01CR05 | PIPERACILLIN AND TAZOBACTAM FO... | 0.5G 4.0G | Sterimax Inc | Resolved | 2024-05-01 | 75 | Shipping delay | 227022 |
4186 | J01MA14 | MOXIFLOXACIN INJECTION | 400MG | Fresenius Kabi Canada Ltd | Resolved | 2024-05-01 | 138 | Shipping delay | 224325 |
4187 | N05CM18 | DEXMEDETOMIDINE HYDROCHLORIDE ... | 200MCG | Juno Pharmaceuticals Corp. | Resolved | 2024-05-01 | 90 | Manufacturing distruption | 225929 |
4152 | R03DC03 | NAT-MONTELUKAST | 4MG | Natco Pharma (Canada) Inc | Active | 2024-04-30 | Other | 226579 | |
4153 | R03DC03 | NAT-MONTELUKAST | 5MG | Natco Pharma (Canada) Inc | Active | 2024-04-30 | Other | 226582 | |
4154 | M03BX08 | APO-CYCLOBENZAPRINE | 10MG | Apotex Inc | Resolved | 2024-04-30 | 17 | Manufacturing distruption | 227091 |
4155 | H02AB09 | SOLU-CORTEF | 250MG | Pfizer Canada Ulc | Resolved | 2024-04-30 | Manufacturing distruption | 225355 | |
4156 | A03FA03 | APO-DOMPERIDONE | 10MG | Apotex Inc | Resolved | 2024-04-30 | 17 | Manufacturing distruption | 227076 |
4157 | D01BA02 | APO-TERBINAFINE | 250MG | Apotex Inc | Resolved | 2024-04-30 | 94 | Manufacturing distruption | 227065 |
4158 | N05AN01 | APO-LITHIUM CARBONATE | 300MG | Apotex Inc | Resolved | 2024-04-30 | 234 | Manufacturing distruption | 227079 |
4159 | A02BC02 | APO-PANTOPRAZOLE | 20MG | Apotex Inc | Resolved | 2024-04-30 | 31 | Manufacturing distruption | 227034 |
4160 | C10AA05 | APO-ATORVASTATIN | 80MG | Apotex Inc | Resolved | 2024-04-30 | 24 | Manufacturing distruption | 227088 |
4161 | J05AB11 | APO-VALACYCLOVIR | 500MG | Apotex Inc | Resolved | 2024-04-30 | 262 | Manufacturing distruption | 227031 |
4162 | C10AA05 | SANDOZ ATORVASTATIN | 20MG | Sandoz Canada Incorporated | Resolved | 2024-04-30 | 45 | Manufacturing distruption | 226664 |
4163 | C09CA06 | SANDOZ CANDESARTAN | 16MG | Sandoz Canada Incorporated | Resolved | 2024-04-30 | 10 | Manufacturing distruption | 226667 |
4164 | N06DA03 | APO-RIVASTIGMINE | 3MG | Apotex Inc | Resolved | 2024-04-30 | 17 | Manufacturing distruption | 227085 |
4165 | C10AA07 | SANDOZ ROSUVASTATIN | 5MG | Sandoz Canada Incorporated | Resolved | 2024-04-30 | 10 | Manufacturing distruption | 226673 |
4166 | A02BC05 | APO-ESOMEPRAZOLE | 20MG | Apotex Inc | Resolved | 2024-04-30 | 38 | Manufacturing distruption | 227073 |
4167 | C07AB02 | APO-METOPROLOL (TYPE L) | 100MG | Apotex Inc | Resolved | 2024-04-30 | 66 | Manufacturing distruption | 227068 |
4168 | S01ED51 | APO-BRIMONIDINE-TIMOP | 0.5% 0.2% | Apotex Inc | Resolved | 2024-04-30 | 10 | Manufacturing distruption | 227028 |
4169 | J01MA14 | APO-MOXIFLOXACIN | 400MG | Apotex Inc | Resolved | 2024-04-30 | 290 | Manufacturing distruption | 227025 |
4170 | A10BB09 | SANDOZ GLICLAZIDE MR | 60MG | Sandoz Canada Incorporated | Resolved | 2024-04-30 | Manufacturing distruption | 226677 | |
4171 | N03AX14 | SANDOZ LEVETIRACETAM | 1000MG | Sandoz Canada Incorporated | Resolved | 2024-04-30 | 87 | Manufacturing distruption | 226670 |
4172 | J01DE01 | APO-CEFEPIME | 1G | Apotex Inc | Resolved | 2024-04-30 | 52 | Manufacturing distruption | 227082 |
4173 | A10BH01 | APO-SITAGLIPTIN MALATE | 100MG | Apotex Inc | Resolved | 2024-04-30 | 52 | Manufacturing distruption | 227016 |
4145 | L04AH02 | NAT-EVEROLIMUS | 2.5MG | Natco Pharma (Canada) Inc | Active | 2024-04-29 | 427 | Shipping delay | 226575 |
4149 | N05AH04 | NAT-QUETIAPINE | 150MG | Natco Pharma (Canada) Inc | Active | 2024-04-29 | 489 | Manufacturing distruption | 226594 |
4150 | N06DA02 | NAT-DONEPEZIL | 5MG | Natco Pharma (Canada) Inc | Active | 2024-04-29 | 489 | Manufacturing distruption | 226585 |
4151 | N05AX12 | AURO-ARIPIPRAZOLE | 30MG | Auro Pharma Inc | Active | 2024-04-29 | 351 | Demand increase | 226448 |
4146 | R07AA02 | SURVANTA | 25MG | Abbvie Corporation | Resolved | 2024-04-29 | 15 | Demand increase | 226027 |
4147 | N01BB09 | NAROPIN | 5MG | Aspen Pharmacare Canada Inc. | Resolved | 2024-04-29 | 7 | Shipping delay | 226546 |
4148 | N05AH01 | XYLAC | 10MG | Pendopharm Division Of Pharmascience Inc | Resolved | 2024-04-29 | 162 | Manufacturing distruption | 226445 |
4142 | L04AA06 | ACH-MYCOPHENOLATE | 250MG | Accord Healthcare Inc | Active | 2024-04-26 | Manufacturing practices | 226247 | |
4144 | D06BB10 | TARO-IMIQUIMOD PUMP | 5% | Taro Pharmaceuticals Inc | Active | 2024-04-26 | Manufacturing distruption | 230672 | |
4141 | D10AF01 | TARO-CLINDAMYCIN | 1% | Taro Pharmaceuticals Inc | Resolved | 2024-04-26 | 77 | Manufacturing distruption | 227634 |
4143 | D07AC01 | BETADERM CRM 0.05% | 0.05% | Taro Pharmaceuticals Inc | Resolved | 2024-04-26 | 28 | Manufacturing distruption | 227615 |
4136 | L02BB03 | BICALUTAMIDE | 50MG | Sanis Health Inc | Active | 2024-04-25 | Manufacturing distruption | 223349 | |
4140 | N05CM18 | DEXMEDETOMIDINE HYDROCHLORIDE ... | 100MCG | Accord Healthcare Inc | Active | 2024-04-25 | Manufacturing practices | 247133 | |
4135 | N06AX21 | CYMBALTA | 30MG | Eli Lilly Canada Inc | Resolved | 2024-04-25 | Other | 220039 | |
4137 | N05BA06 | ATIVAN | 2MG | Pfizer Canada Ulc | Resolved | 2024-04-25 | 175 | Manufacturing distruption | 210735 |
4138 | L01BC02 | EFUDEX | 5% | Bausch Health, Canada Inc. | Resolved | 2024-04-25 | Demand increase | 226785 | |
4139 | H01BB02 | OXYTOCIN INJECTION, USP | 10UNIT | Fresenius Kabi Canada Ltd | Resolved | 2024-04-25 | 60 | Manufacturing distruption | 225346 |
4131 | D07AC01 | TEVA-ECTOSONE | 0.1% | Teva Canada Limited | Active | 2024-04-24 | Manufacturing distruption | 226171 | |
4132 | S01EC01 | ACETAZOLAMIDE | 250MG | Aa Pharma Inc | Resolved | 2024-04-24 | 35 | Manufacturing distruption | 226024 |
4133 | N05BE01 | TEVA-BUSPIRONE | 10MG | Teva Canada Limited | Resolved | 2024-04-24 | 320 | Manufacturing distruption | 226174 |
4134 | G04BE08 | TEVA-TADALAFIL | 2.5MG | Teva Canada Limited | Resolved | 2024-04-24 | 129 | Manufacturing distruption | 226177 |
4123 | N02CC03 | SANDOZ ZOLMITRIPTAN ODT | 2.5MG | Sandoz Canada Incorporated | Active | 2024-04-23 | Manufacturing distruption | 225976 | |
4107 | C02AC01 | SANDOZ CLONIDINE | 0.1MG | Sandoz Canada Incorporated | Resolved | 2024-04-23 | 17 | Demand increase | 225959 |
4108 | S01ED01 | SANDOZ TIMOLOL | 0.25% | Sandoz Canada Incorporated | Resolved | 2024-04-23 | 87 | Manufacturing distruption | 225972 |
4109 | J01CA01 | AMPICILLIN FOR INJECTION, USP | 250MG | Fresenius Kabi Canada Ltd | Resolved | 2024-04-23 | 14 | Shipping delay | 226471 |
4110 | V08AB02 | OMNIPAQUE 240 | 518MG | Ge Healthcare Canada Inc | Resolved | 2024-04-23 | 10 | Demand increase | 225946 |
4111 | G04CA03 | APO-TERAZOSIN | 2MG | Apotex Inc | Resolved | 2024-04-23 | 17 | Manufacturing distruption | 226330 |
4112 | C10AA03 | APO-PRAVASTATIN | 10MG | Apotex Inc | Resolved | 2024-04-23 | 66 | Manufacturing distruption | 226336 |
4113 | C01BD01 | SANDOZ AMIODARONE | 200MG | Sandoz Canada Incorporated | Resolved | 2024-04-23 | 66 | Ingredient shortage | 225953 |
4114 | N06AB04 | APO-CITALOPRAM | 20MG | Apotex Inc | Resolved | 2024-04-23 | 164 | Manufacturing distruption | 226312 |
4115 | N06AB04 | APO-CITALOPRAM | 20MG | Apotex Inc | Resolved | 2024-04-23 | Manufacturing distruption | 226324 | |
4116 | N06AB04 | APO-CITALOPRAM | 40MG | Apotex Inc | Resolved | 2024-04-23 | 164 | Manufacturing distruption | 226321 |
4117 | N06AB04 | APO-CITALOPRAM | 40MG | Apotex Inc | Resolved | 2024-04-23 | Manufacturing distruption | 226342 | |
4118 | N06BA04 | APO-METHYLPHENIDATE | 10MG | Apotex Inc | Resolved | 2024-04-23 | 17 | Manufacturing distruption | 226327 |
4119 | L04AK01 | APO-LEFLUNOMIDE | 20MG | Apotex Inc | Resolved | 2024-04-23 | 38 | Manufacturing distruption | 226315 |
4120 | C09AA09 | APO-FOSINOPRIL | 10MG | Apotex Inc | Resolved | 2024-04-23 | 10 | Manufacturing distruption | 226339 |
4121 | N06AX11 | APO-MIRTAZAPINE | 45MG | Apotex Inc | Resolved | 2024-04-23 | 31 | Manufacturing distruption | 226333 |
4122 | J01MA12 | SANDOZ LEVOFLOXACIN | 250MG | Sandoz Canada Incorporated | Resolved | 2024-04-23 | 31 | Manufacturing distruption | 225968 |
4124 | L04AA06 | APO-MYCOPHENOLIC ACID | 360MG | Apotex Inc | Resolved | 2024-04-23 | 59 | Manufacturing distruption | 226309 |
4125 | G04CB02 | APO-DUTASTERIDE | 0.5MG | Apotex Inc | Resolved | 2024-04-23 | 66 | Manufacturing distruption | 226318 |
4126 | J01FF01 | CLINDAMYCIN IV INFUSION | 18MG | Sandoz Canada Incorporated | Resolved | 2024-04-23 | 17 | Manufacturing distruption | 225956 |
4127 | V03AC03 | SANDOZ DEFERASIROX (TYPE J) | 360MG | Sandoz Canada Incorporated | Resolved | 2024-04-23 | 66 | Shipping delay | 225962 |
4128 | L04AH02 | SANDOZ EVEROLIMUS | 5MG | Sandoz Canada Incorporated | Resolved | 2024-04-23 | 10 | Manufacturing practices | 225965 |
4129 | A10BH01 | APO-SITAGLIPTIN MALATE | 100MG | Apotex Inc | Resolved | 2024-04-23 | 59 | Manufacturing distruption | 226345 |
4130 | APO-MELOXICAM | 1.5G | Apotex Inc | Resolved | 2024-04-23 | Manufacturing distruption | 226348 | ||
4099 | G04BE09 | VARDENAFIL | 20MG | Sanis Health Inc | Active | 2024-04-22 | Manufacturing distruption | 225884 | |
4100 | S01FA06 | ODAN-TROPICAMIDE | 1% | Odan Laboratories Ltd | Active | 2024-04-22 | 403 | Manufacturing distruption | 225869 |
4101 | V03AC01 | DEFEROXAMINE MESYLATE FOR INJE... | 500MG | Pfizer Canada Ulc | Resolved | 2024-04-22 | Manufacturing distruption | 223131 | |
4102 | S01ED51 | COSOPT PRESERVATIVE-FREE | 5MG 20MG | Elvium Life Sciences | Resolved | 2024-04-22 | 18 | Shipping delay | 225825 |
4103 | N06AX16 | VENLAFAXINE XR | 37.5MG | Sanis Health Inc | Resolved | 2024-04-22 | 25 | Manufacturing distruption | 225878 |
4104 | C09CA01 | LOSARTAN | 100MG | Sanis Health Inc | Resolved | 2024-04-22 | 151 | Manufacturing distruption | 145888 |
4105 | C09DA06 | CANDESARTAN/HCTZ | 12.5MG 16MG | Sanis Health Inc | Resolved | 2024-04-22 | 123 | Manufacturing distruption | 225881 |
4106 | N04BD03 | ONSTRYV | 100MG | Valeo Pharma Inc | Resolved | 2024-04-22 | 161 | Shipping delay | 226366 |
4098 | V09HX01 | GALLIUM (GA67) CITRATE INJECTI... | 74MBq | Curium Canada Inc | Resolved | 2024-04-21 | 7 | Manufacturing distruption | 225852 |
4096 | C09CA08 | ACH-OLMESARTAN | 40MG | Accord Healthcare Inc | Active | 2024-04-19 | Manufacturing practices | 225694 | |
4091 | L01AA01 | PROCYTOX | 2000MG | Baxter Corporation | Resolved | 2024-04-19 | 17 | Other | 225670 |
4092 | N01AX10 | PROPOFOL INJECTION | 10MG | Baxter Corporation | Resolved | 2024-04-19 | 20 | Other | 225667 |
4093 | N05CC01 | CHLORAL HYDRATE SYRUP ODAN | 500MG | Odan Laboratories Ltd | Resolved | 2024-04-19 | 31 | Manufacturing distruption | 225866 |
4094 | N03AX11 | MYLAN-TOPIRAMATE | 100MG | Mylan Pharmaceuticals Ulc | Resolved | 2024-04-19 | 26 | Manufacturing distruption | 224061 |
4095 | A10BB09 | DIAMICRON MR | 60MG | Servier Canada Inc | Resolved | 2024-04-19 | 7 | Other | 225677 |
4097 | J07BK | SHINGRIX | 50MCG | Glaxosmithkline Inc | Resolved | 2024-04-19 | 104 | Manufacturing distruption | 226055 |
4073 | M02AA15 | PMS-DICLOFENAC | 1.5% | Pharmascience Inc | Active | 2024-04-18 | 622 | Manufacturing distruption | 222375 |
4076 | M01AC06 | AURO-MELOXICAM | 7.5MG | Auro Pharma Inc | Active | 2024-04-18 | Demand increase | 225579 | |
4080 | C09CA03 | AURO-VALSARTAN | 320MG | Auro Pharma Inc | Active | 2024-04-18 | 362 | Demand increase | 225613 |
4086 | N05AX12 | AURO-ARIPIPRAZOLE | 10MG | Auro Pharma Inc | Active | 2024-04-18 | 362 | Demand increase | 225539 |
4087 | J01CR02 | AURO-AMOXICLAV | 125MG 875MG | Auro Pharma Inc | Avoided | 2024-04-18 | 104 | Demand increase | 225533 |
4069 | A10BH01 | AURO-SITAGLIPTIN | 25MG | Auro Pharma Inc | Resolved | 2024-04-18 | Demand increase | 225605 | |
4070 | R03BA05 | FLOVENT HFA | 250MCG | Glaxosmithkline Inc | Resolved | 2024-04-18 | 22 | Manufacturing distruption | 225664 |
4071 | J05AG01 | AURO-NEVIRAPINE | 200MG | Auro Pharma Inc | Resolved | 2024-04-18 | 195 | Demand increase | 225589 |
4072 | N03AX11 | AURO-TOPIRAMATE | 25MG | Auro Pharma Inc | Resolved | 2024-04-18 | 43 | Demand increase | 225610 |
4074 | N06AB05 | AURO-PAROXETINE | 30MG | Auro Pharma Inc | Resolved | 2024-04-18 | 211 | Demand increase | 225592 |
4075 | J01CA04 | AURO-AMOXICILLIN | 250MG | Auro Pharma Inc | Resolved | 2024-04-18 | 13 | Demand increase | 225529 |
4077 | N06DA02 | AURO-DONEPEZIL | 5MG | Auro Pharma Inc | Resolved | 2024-04-18 | 27 | Demand increase | 225562 |
4078 | R03DC03 | AURO-MONTELUKAST | 10MG | Auro Pharma Inc | Resolved | 2024-04-18 | 13 | Demand increase | 225583 |
4079 | C09CA03 | AURO-VALSARTAN | 160MG | Auro Pharma Inc | Resolved | 2024-04-18 | 196 | Demand increase | 225618 |
4081 | G04BE03 | AURO-SILDENAFIL | 25MG | Auro Pharma Inc | Resolved | 2024-04-18 | 43 | Demand increase | 225599 |
4082 | B01AC04 | AURO-CLOPIDOGREL | 75MG | Auro Pharma Inc | Resolved | 2024-04-18 | 150 | Demand increase | 225554 |
4083 | N02BF01 | AURO-GABAPENTIN TABLETS | 600MG | Auro Pharma Inc | Resolved | 2024-04-18 | 104 | Demand increase | 225568 |
4084 | J01DD08 | AURO-CEFIXIME | 400MG | Auro Pharma Inc | Resolved | 2024-04-18 | 104 | Demand increase | 225545 |
4085 | M01AH01 | AURO-CELECOXIB | 100MG | Auro Pharma Inc | Resolved | 2024-04-18 | 104 | Demand increase | 225551 |
4088 | N03AX18 | AURO-LACOSAMIDE | 50MG | Auro Pharma Inc | Resolved | 2024-04-18 | 104 | Demand increase | 225573 |
4089 | G04CA04 | AURO-SILODOSIN | 8MG | Auro Pharma Inc | Resolved | 2024-04-18 | 150 | Demand increase | 225602 |
4090 | L04AX03 | METHOTREXATE SUBCUTANEOUS | 20MG | Accord Healthcare Inc | Resolved | 2024-04-18 | 29 | Shipping delay | 225687 |
4067 | C09AA03 | AURO-LISINOPRIL | 5MG | Auro Pharma Inc | Active | 2024-04-17 | Demand increase | 225503 | |
4059 | D07AC01 | TEVA-TOPISONE | 0.05% | Teva Canada Limited | Resolved | 2024-04-17 | Manufacturing distruption | 225480 | |
4060 | J01AA02 | TEVA-DOXYCYCLINE | 100MG | Teva Canada Limited | Resolved | 2024-04-17 | 64 | Manufacturing distruption | 225483 |
4061 | G03CA03 | CLIMARA 50 | 50MCG | Bayer Inc | Resolved | 2024-04-17 | 64 | Other | 225331 |
4062 | A10AB01 | HUMULIN R | 100UNIT | Eli Lilly Canada Inc | Resolved | 2024-04-17 | 8 | Other | 225163 |
4063 | N02AJ06 | TEVA-LENOLTEC NO. 3 | 300MG 30MG 15MG | Teva Canada Limited | Resolved | 2024-04-17 | 44 | Manufacturing distruption | 225477 |
4064 | A16AX06 | ZAVESCA | 100MG | Janssen Inc | Resolved | 2024-04-17 | 14 | Demand increase | 225362 |
4065 | C09AA02 | ACT ENALAPRIL | 8MG | Teva Canada Limited | Resolved | 2024-04-17 | 115 | Manufacturing distruption | 225486 |
4066 | J05AB11 | TEVA-VALACYCLOVIR | 500MG | Teva Canada Limited | Resolved | 2024-04-17 | 125 | Manufacturing distruption | 225489 |
4068 | N06AX12 | TEVA-BUPROPION XL | 150MG | Teva Canada Limited | Resolved | 2024-04-17 | 33 | Manufacturing distruption | 225492 |
4045 | J01AA02 | APO-DOXYCYCLINE MR | 40MG | Apotex Inc | Resolved | 2024-04-16 | 38 | Manufacturing distruption | 225796 |
4046 | N05AN01 | APO-LITHIUM CARBONATE | 150MG | Apotex Inc | Resolved | 2024-04-16 | 45 | Manufacturing distruption | 225802 |
4047 | B01AA03 | APO-WARFARIN | 1MG | Apotex Inc | Resolved | 2024-04-16 | 31 | Manufacturing distruption | 225782 |
4048 | A10BB09 | APO-GLICLAZIDE | 80MG | Apotex Inc | Resolved | 2024-04-16 | 52 | Manufacturing distruption | 225799 |
4049 | A03AA05 | APO-TRIMEBUTINE | 100MG | Apotex Inc | Resolved | 2024-04-16 | 31 | Manufacturing distruption | 225767 |
4050 | A02BC03 | APO-LANSOPRAZOLE | 30MG | Apotex Inc | Resolved | 2024-04-16 | 17 | Manufacturing distruption | 225761 |
4051 | A10BB09 | APO-GLICLAZIDE MR | 30MG | Apotex Inc | Resolved | 2024-04-16 | 66 | Manufacturing distruption | 225793 |
4052 | A10BA02 | APO-METFORMIN ER | 500MG | Apotex Inc | Resolved | 2024-04-16 | 59 | Manufacturing distruption | 225770 |
4053 | G04CA01 | APO-ALFUZOSIN | 10MG | Apotex Inc | Resolved | 2024-04-16 | 80 | Manufacturing distruption | 225779 |
4054 | N07BA03 | APO-VARENICLINE | 1MG | Apotex Inc | Resolved | 2024-04-16 | 87 | Manufacturing distruption | 225764 |
4055 | G04BE08 | APO-TADALAFIL PAH | 20MG | Apotex Inc | Resolved | 2024-04-16 | 17 | Manufacturing distruption | 225785 |
4056 | G04BE08 | APO-TADALAFIL | 2.5MG | Apotex Inc | Resolved | 2024-04-16 | 52 | Manufacturing distruption | 225773 |
4057 | G04BE08 | APO-TADALAFIL | 10MG | Apotex Inc | Resolved | 2024-04-16 | 24 | Manufacturing distruption | 225790 |
4058 | L01EA02 | APO-DASATINIB | 70MG | Apotex Inc | Resolved | 2024-04-16 | 66 | Manufacturing distruption | 225776 |
4032 | N07CA01 | M-BETAHISTINE | 16MG | Mantra Pharma Inc | Resolved | 2024-04-15 | 30 | Shipping delay | 225585 |
4033 | B05BC01 | MANNITOL INJECTION USP | 25% | Pfizer Canada Ulc | Resolved | 2024-04-15 | Manufacturing distruption | 200816 | |
4034 | A11CC05 | SANDOZ D 10 000 | 10000UNIT | Sandoz Canada Incorporated | Resolved | 2024-04-15 | Manufacturing distruption | 225223 | |
4035 | N03AF01 | SANDOZ-CARBAMAZEPINE CR | 400MG | Sandoz Canada Incorporated | Resolved | 2024-04-15 | 137 | Manufacturing distruption | 225212 |
4036 | D10AD01 | RETIN-A MICRO | 0.04% | Bausch Health, Canada Inc. | Resolved | 2024-04-15 | 13 | Other | 217267 |
4037 | C09AA02 | SANDOZ ENALAPRIL | 2MG | Sandoz Canada Incorporated | Resolved | 2024-04-15 | 242 | Manufacturing distruption | 225215 |
4038 | G04CA01 | SANDOZ ALFUZOSIN | 10MG | Sandoz Canada Incorporated | Resolved | 2024-04-15 | 32 | Shipping delay | 225209 |
4039 | L01DB06 | IDARUBICIN | 1MG | Pfizer Canada Ulc | Resolved | 2024-04-15 | Manufacturing distruption | 219730 | |
4040 | N03AF04 | APTIOM | 400MG | Sumitomo Pharma Canada, Inc. | Resolved | 2024-04-15 | 15 | Shipping delay | 224106 |
4041 | D07CB01 | VIADERM KC CRM | 100000UNIT 0.25MG 2.5MG 1MG | Taro Pharmaceuticals Inc | Resolved | 2024-04-15 | 193 | Manufacturing distruption | 237275 |
4042 | N03AX18 | SANDOZ LACOSAMIDE | 100MG | Sandoz Canada Incorporated | Resolved | 2024-04-15 | 53 | Demand increase | 225218 |
4043 | D01AC20 | TARO-CLOTRIMAZOLE/BETAMETHASON... | 1% 0.05% | Taro Pharmaceuticals Inc | Resolved | 2024-04-15 | 39 | Manufacturing distruption | 227643 |
4044 | N05AE05 | TARO-LURASIDONE | 20MG | Taro Pharmaceuticals Inc | Resolved | 2024-04-15 | 74 | Manufacturing distruption | 227656 |
4031 | V09FX01 | ULTRA-TECHNEKOW V4 | 19CI | Curium Canada Inc | Resolved | 2024-04-14 | 2 | Ingredient shortage | 224803 |
4029 | N05AH04 | QUETIAPINE FUMARATE XR | 150MG | Sanis Health Inc | Active | 2024-04-13 | Manufacturing distruption | 223281 | |
4030 | N01BB01 | BUPIVACAINE INJECTION BP | 2.5MG | Sterimax Inc | Resolved | 2024-04-13 | 125 | Manufacturing distruption | 213681 |
4025 | M05BA04 | ACH-ALENDRONATE | 10MG | Accord Healthcare Inc | Active | 2024-04-12 | Manufacturing practices | 224954 | |
4026 | A02BC01 | OMEPRAZOLE MAGNESIUM DELAYED R... | 20MG | Accord Healthcare Inc | Active | 2024-04-12 | Manufacturing practices | 224957 | |
4027 | N01BB01 | BUPIVACAINE HYDROCHLORIDE INJE... | 7.5MG | Baxter Corporation | Avoided | 2024-04-12 | Manufacturing practices | 210780 | |
4020 | N06AX21 | CYMBALTA | 60MG | Eli Lilly Canada Inc | Resolved | 2024-04-12 | Other | 220042 | |
4021 | M01AB55 | ARTHROTEC 50 | 200MCG 50MG | Pfizer Canada Ulc | Resolved | 2024-04-12 | 125 | Demand increase | 224337 |
4022 | M03BX08 | PMS-CYCLOBENZAPRINE - TAB 10MG | 10MG | Pharmascience Inc | Resolved | 2024-04-12 | 115 | Manufacturing distruption | 225089 |
4023 | N02AJ17 | SANDOZ OXYCODONE/ACETAMINOPHEN | 325MG 5MG | Sandoz Canada Incorporated | Resolved | 2024-04-12 | Manufacturing distruption | 224969 | |
4024 | N02AJ17 | SANDOZ OXYCODONE/ACETAMINOPHEN | 325MG 5MG | Sandoz Canada Incorporated | Resolved | 2024-04-12 | Manufacturing distruption | 224972 | |
4028 | L04AX03 | METHOTREXATE SUBCUTANEOUS | 25MG | Accord Healthcare Inc | Resolved | 2024-04-12 | 108 | Shipping delay | 224951 |
4016 | A10BK01 | PRO-DAPAGLIFLOZIN | 10MG | Pro Doc Limitee | Resolved | 2024-04-11 | 15 | Shipping delay | 224975 |
4017 | N05BA01 | VALIUM | 5MG | Searchlight Pharma Inc | Resolved | 2024-04-11 | 143 | Ingredient shortage | 224936 |
4018 | H02AB04 | DEPO-MEDROL 80 MG/ML | 80MG | Pfizer Canada Ulc | Resolved | 2024-04-11 | Manufacturing distruption | 222049 | |
4019 | C09CA06 | AURO-CANDESARTAN | 8MG | Auro Pharma Inc | Resolved | 2024-04-11 | Demand increase | 81461 | |
4009 | H02AB09 | SOLU-CORTEF | 100MG | Pfizer Canada Ulc | Avoided | 2024-04-10 | Manufacturing distruption | 219588 | |
4010 | J01FA10 | AZITHROMYCIN | 250MG | Sanis Health Inc | Resolved | 2024-04-10 | 23 | Manufacturing distruption | 224788 |
4011 | N05AH03 | OLANZAPINE ODT | 10MG | Sanis Health Inc | Resolved | 2024-04-10 | 68 | Manufacturing distruption | 224800 |
4012 | A02BC04 | RABEPRAZOLE EC | 20MG | Sanis Health Inc | Resolved | 2024-04-10 | 156 | Manufacturing distruption | 224797 |
4013 | N03AX18 | VIMPAT | 10MG | Ucb Canada Inc | Resolved | 2024-04-10 | 7 | Manufacturing practices | 225092 |
4014 | C07AG02 | CARVEDILOL | 12.5MG | Sanis Health Inc | Resolved | 2024-04-10 | 20 | Manufacturing distruption | 224791 |
4015 | N02CC03 | ZOLMITRIPTAN | 2.5MG | Sanis Health Inc | Resolved | 2024-04-10 | 211 | Manufacturing distruption | 224794 |
3987 | N03AX18 | LACOSAMIDE | 50MG | Sanis Health Inc | Active | 2024-04-09 | Manufacturing distruption | 228984 | |
4002 | C09CA06 | CANDESARTAN | 4MG | Sanis Health Inc | Active | 2024-04-09 | Manufacturing distruption | 224727 | |
3988 | L02BA01 | APO-TAMOX TAB 20MG | 20MG | Apotex Inc | Resolved | 2024-04-09 | 45 | Manufacturing distruption | 224990 |
3989 | M03BX01 | APO-BACLOFEN | 10MG | Apotex Inc | Resolved | 2024-04-09 | 45 | Manufacturing distruption | 225011 |
3990 | N01BB02 | LIDOCAINE HYDROCHLORIDE INJECT... | 20MG | Pfizer Canada Ulc | Resolved | 2024-04-09 | Manufacturing distruption | 213834 | |
3991 | G04CA03 | APO-TERAZOSIN | 5MG | Apotex Inc | Resolved | 2024-04-09 | 38 | Manufacturing distruption | 224999 |
3992 | N05BA06 | APO-LORAZEPAM | 0.5MG | Apotex Inc | Resolved | 2024-04-09 | 17 | Manufacturing distruption | 225014 |
3993 | D01BA02 | APO-TERBINAFINE | 250MG | Apotex Inc | Resolved | 2024-04-09 | 115 | Manufacturing distruption | 225005 |
3994 | N02AA01 | STATEX TAB 5MG | 5MG | Paladin Labs Inc. | Resolved | 2024-04-09 | 22 | Shipping delay | 224966 |
3995 | N06BA04 | APO-METHYLPHENIDATE | 10MG | Apotex Inc | Resolved | 2024-04-09 | 31 | Manufacturing distruption | 224980 |
3996 | C07AB07 | APO-BISOPROLOL | 5MG | Apotex Inc | Resolved | 2024-04-09 | 108 | Manufacturing distruption | 225023 |
3997 | N06AX11 | APO-MIRTAZAPINE | 30MG | Apotex Inc | Resolved | 2024-04-09 | 45 | Manufacturing distruption | 225002 |
3998 | N04BC05 | APO-PRAMIPEXOLE | 0.25MG | Apotex Inc | Resolved | 2024-04-09 | 17 | Manufacturing distruption | 224993 |
3999 | A02BC05 | APO-ESOMEPRAZOLE | 20MG | Apotex Inc | Resolved | 2024-04-09 | 10 | Manufacturing distruption | 224984 |
4000 | N05AH03 | APO-OLANZAPINE ODT | 20MG | Apotex Inc | Resolved | 2024-04-09 | 45 | Manufacturing distruption | 225008 |
4001 | L01CD02 | DOCETAXEL INJECTION USP | 10MG | Pfizer Canada Ulc | Resolved | 2024-04-09 | Manufacturing distruption | 223128 | |
4003 | J01DB01 | APO-CEPHALEX | 500MG | Apotex Inc | Resolved | 2024-04-09 | 94 | Manufacturing distruption | 225020 |
4004 | B01AC24 | APO-TICAGRELOR | 90MG | Apotex Inc | Resolved | 2024-04-09 | 129 | Manufacturing distruption | 225026 |
4005 | C08DA01 | APO-VERAP TABLET 120MG | 120MG | Apotex Inc | Resolved | 2024-04-09 | 45 | Manufacturing distruption | 225017 |
4006 | A10BH01 | APO-SITAGLIPTIN MALATE | 25MG | Apotex Inc | Resolved | 2024-04-09 | 52 | Manufacturing distruption | 224977 |
4007 | A10BH01 | APO-SITAGLIPTIN MALATE | 50MG | Apotex Inc | Resolved | 2024-04-09 | 52 | Manufacturing distruption | 224996 |
4008 | APO-MELOXICAM | 1.5G | Apotex Inc | Resolved | 2024-04-09 | Manufacturing distruption | 224987 | ||
3983 | N02AA03 | HYDROMORPHONE HYDROCHLORIDE IN... | 10MG | Pfizer Canada Ulc | Avoided | 2024-04-08 | Manufacturing distruption | 216641 | |
3978 | N07CA01 | M-BETAHISTINE | 8MG | Mantra Pharma Inc | Resolved | 2024-04-08 | 37 | Shipping delay | 225577 |
3979 | D10AD01 | RETIN-A MICRO | 0.1% | Bausch Health, Canada Inc. | Resolved | 2024-04-08 | 18 | Other | 222130 |
3980 | C09AA02 | SANDOZ ENALAPRIL | 16MG | Sandoz Canada Incorporated | Resolved | 2024-04-08 | 186 | Manufacturing distruption | 224636 |
3981 | C09BA03 | SANDOZ LISINOPRIL HCT | 25MG 20MG | Sandoz Canada Incorporated | Resolved | 2024-04-08 | 354 | Ingredient shortage | 224639 |
3982 | V09HX01 | GALLIUM (GA67) CITRATE INJECTI... | 74MBq | Curium Canada Inc | Resolved | 2024-04-08 | 7 | Other | 224695 |
3984 | C10AA03 | SANDOZ PRAVASTATIN TABLETS | 20MG | Sandoz Canada Incorporated | Resolved | 2024-04-08 | Manufacturing practices | 224645 | |
3985 | C10AA03 | SANDOZ PRAVASTATIN TABLETS | 40MG | Sandoz Canada Incorporated | Resolved | 2024-04-08 | Manufacturing practices | 224648 | |
3986 | L04AX05 | SANDOZ PIRFENIDONE TABLETS | 801MG | Sandoz Canada Incorporated | Resolved | 2024-04-08 | 74 | Manufacturing distruption | 224642 |
3977 | J01FA09 | BIAXIN BID | 250MG | Bgp Pharma Ulc | Avoided | 2024-04-07 | 37 | Manufacturing distruption | 220089 |
3971 | D01AC01 | CLOTRIMADERM TOPICAL | 1% | Taro Pharmaceuticals Inc | Resolved | 2024-04-05 | 56 | Manufacturing distruption | 227648 |
3972 | N06AA10 | AVENTYL | 10MG | Aa Pharma Inc | Resolved | 2024-04-05 | Manufacturing distruption | 224511 | |
3973 | C09AA03 | ZESTRIL | 20MG | Searchlight Pharma Inc | Resolved | 2024-04-05 | 163 | Ingredient shortage | 216942 |
3974 | C10AA07 | MAR-ROSUVASTATIN | 40MG | Marcan Pharmaceuticals Inc | Resolved | 2024-04-05 | 147 | Demand increase | 224359 |
3975 | J01XX08 | LINEZOLID INJECTION | 2MG | Fresenius Kabi Canada Ltd | Resolved | 2024-04-05 | 26 | Shipping delay | 222722 |
3976 | A10BB09 | SANDOZ GLICLAZIDE MR | 60MG | Sandoz Canada Incorporated | Resolved | 2024-04-05 | Manufacturing distruption | 224577 | |
3962 | C08DB01 | DILTIAZEM HYDROCHLORIDE INJECT... | 5MG | Omega Laboratories Limited | Resolved | 2024-04-04 | 46 | Demand increase | 224281 |
3963 | N07AB02 | DUVOID | 25MG | Paladin Labs Inc. | Resolved | 2024-04-04 | 27 | Shipping delay | 225247 |
3964 | R03AC02 | PMS-SALBUTAMOL | 2MG | Pharmascience Inc | Resolved | 2024-04-04 | 27 | Manufacturing distruption | 224605 |
3965 | N02CC01 | IMITREX | 5MG | Glaxosmithkline Inc | Resolved | 2024-04-04 | 36 | Manufacturing distruption | 224362 |
3966 | S01FA04 | ODAN-CYCLOPENTOLATE | 1% | Odan Laboratories Ltd | Resolved | 2024-04-04 | 56 | Other | 224572 |
3967 | R01AD09 | NASONEX | 50MCG | Organon Canada Inc. | Resolved | 2024-04-04 | 46 | Demand increase | 224304 |
3968 | V03AB33 | CYANOKIT | 5G | Serb S.a. | Resolved | 2024-04-04 | 26 | Shipping delay | 224331 |
3969 | N06AB10 | M-ESCITALOPRAM | 20MG | Mantra Pharma Inc | Resolved | 2024-04-04 | 57 | Shipping delay | 225521 |
3970 | N06AX21 | M-DULOXETINE | 30MG | Mantra Pharma Inc | Resolved | 2024-04-04 | 57 | Shipping delay | 225510 |
3951 | L02BA01 | TEVA-TAMOXIFEN | 10MG | Teva Canada Limited | Active | 2024-04-03 | Manufacturing distruption | 224454 | |
3957 | N05AH04 | QUETIAPINE TABLETS | 150MG | Accord Healthcare Inc | Active | 2024-04-03 | Manufacturing practices | 224562 | |
3955 | N06AX02 | TRYPTAN | 500MG | Bausch Health, Canada Inc. | Avoided | 2024-04-03 | 54 | Other | 224266 |
3952 | N06AX02 | TRYPTAN | 500MG | Bausch Health, Canada Inc. | Resolved | 2024-04-03 | 58 | Other | 224274 |
3953 | N06AX02 | TRYPTAN | 250MG | Bausch Health, Canada Inc. | Resolved | 2024-04-03 | 58 | Other | 224269 |
3954 | N02BA71 | TEVA-TECNAL | 330MG 40MG 50MG | Teva Canada Limited | Resolved | 2024-04-03 | 78 | Manufacturing distruption | 224448 |
3956 | N06BA09 | TEVA-ATOMOXETINE | 25MG | Teva Canada Limited | Resolved | 2024-04-03 | 27 | Manufacturing distruption | 224451 |
3958 | N04BC09 | NEUPRO | 8MG | Ucb Canada Inc | Resolved | 2024-04-03 | 13 | Manufacturing practices | 224301 |
3959 | N06AB10 | ACH-ESCITALOPRAM | 20MG | Accord Healthcare Inc | Resolved | 2024-04-03 | 51 | Shipping delay | 224568 |
3960 | N06AX12 | TEVA-BUPROPION XL | 300MG | Teva Canada Limited | Resolved | 2024-04-03 | 68 | Manufacturing distruption | 224445 |
3961 | M05BA07 | AA-RISEDRONATE DR | 35MG | Aa Pharma Inc | Resolved | 2024-04-03 | 56 | Manufacturing distruption | 224320 |
3938 | C09AA03 | APO-LISINOPRIL | 20MG | Apotex Inc | Active | 2024-04-02 | Ingredient shortage | 198536 | |
3946 | J05AB11 | SANDOZ VALACYCLOVIR | 500MG | Sandoz Canada Incorporated | Active | 2024-04-02 | 465 | Demand increase | 224186 |
3935 | N05AE05 | SANDOZ LURASIDONE | 40MG | Sandoz Canada Incorporated | Resolved | 2024-04-02 | 31 | Shipping delay | 224161 |
3936 | S01ED01 | TIMOPTIC-XE | 0.5% | Elvium Life Sciences | Resolved | 2024-04-02 | 17 | Demand increase | 224103 |
3937 | M01AB05 | APO-DICLO SR | 75MG | Apotex Inc | Resolved | 2024-04-02 | 10 | Manufacturing distruption | 224580 |
3939 | N06AB08 | APO-FLUVOXAMINE | 100MG | Apotex Inc | Resolved | 2024-04-02 | 45 | Manufacturing distruption | 224592 |
3940 | C07AB02 | APO-METOPROLOL | 50MG | Apotex Inc | Resolved | 2024-04-02 | 31 | Manufacturing distruption | 224595 |
3941 | B01AA03 | APO-WARFARIN | 1MG | Apotex Inc | Resolved | 2024-04-02 | 45 | Manufacturing distruption | 224589 |
3942 | A10BB09 | APO-GLICLAZIDE | 80MG | Apotex Inc | Resolved | 2024-04-02 | 66 | Manufacturing distruption | 224583 |
3943 | N03AF02 | APO-OXCARBAZEPINE | 300MG | Apotex Inc | Resolved | 2024-04-02 | 45 | Manufacturing distruption | 224598 |
3944 | A02BC01 | SANDOZ OMEPRAZOLE | 20MG | Sandoz Canada Incorporated | Resolved | 2024-04-02 | Manufacturing distruption | 224142 | |
3945 | C09AA10 | SANDOZ TRANDOLAPRIL | 2MG | Sandoz Canada Incorporated | Resolved | 2024-04-02 | 73 | Manufacturing distruption | 224183 |
3947 | N04BC09 | NEUPRO | 1MG | Ucb Canada Inc | Resolved | 2024-04-02 | 14 | Manufacturing practices | 224297 |
3948 | N06DA03 | SANDOZ RIVASTIGMINE PATCH 10 | 9.5MG | Sandoz Canada Incorporated | Resolved | 2024-04-02 | 24 | Manufacturing distruption | 224174 |
3949 | C09CA08 | SANDOZ OLMESARTAN | 20MG | Sandoz Canada Incorporated | Resolved | 2024-04-02 | 80 | Demand increase | 224166 |
3950 | C09BB04 | APO-PERINDOPRIL/AMLODIPINE | 10MG 14MG | Apotex Inc | Resolved | 2024-04-02 | 17 | Manufacturing distruption | 224586 |
3922 | B05XA02 | SODIUM BICARBONATE INJECTION U... | 84MG | Pfizer Canada Ulc | Active | 2024-04-01 | Manufacturing distruption | 200825 | |
3932 | C09CA06 | TARO-CANDESARTAN | 32MG | Sun Pharma Canada Inc | Active | 2024-04-01 | 389 | Manufacturing distruption | 237293 |
3919 | V07AB | BACTERIOSTATIC SODIUM CHLORIDE... | 9MG | Pfizer Canada Ulc | Avoided | 2024-04-01 | Manufacturing distruption | 200893 | |
3921 | R07AA02 | SURVANTA | 25MG | Abbvie Corporation | Avoided | 2024-04-01 | 88 | Manufacturing distruption | 206918 |
3930 | B05XA03 | SODIUM CHLORIDE INJECTION USP | 9MG | Pfizer Canada Ulc | Avoided | 2024-04-01 | Manufacturing distruption | 200831 | |
3918 | B05BA03 | DEXTROSE INJECTION | 50% | Omega Laboratories Limited | Resolved | 2024-04-01 | 152 | Other | 223983 |
3920 | N01BB02 | LIDOCAINE HYDROCHLORIDE INJECT... | 10MG | Pfizer Canada Ulc | Resolved | 2024-04-01 | Manufacturing distruption | 200813 | |
3923 | A10AB04 | HUMALOG | 100UNIT | Eli Lilly Canada Inc | Resolved | 2024-04-01 | 11 | Shipping delay | 223890 |
3924 | G04CA03 | APO-TERAZOSIN | 1MG | Apotex Inc | Resolved | 2024-04-01 | 29 | Ingredient shortage | 195250 |
3925 | G04CA03 | APO-TERAZOSIN | 2MG | Apotex Inc | Resolved | 2024-04-01 | 29 | Ingredient shortage | 195253 |
3926 | G04CA03 | APO-TERAZOSIN | 5MG | Apotex Inc | Resolved | 2024-04-01 | 29 | Ingredient shortage | 195256 |
3927 | N03AF01 | TARO-CARBAMAZEPINE CHEWABLE TA... | 100MG | Taro Pharmaceuticals Inc | Resolved | 2024-04-01 | 53 | Manufacturing distruption | 227622 |
3928 | S01EC05 | METHAZOLAMIDE | 50MG | Aa Pharma Inc | Resolved | 2024-04-01 | 217 | Manufacturing distruption | 221860 |
3929 | N05AN01 | LITHMAX | 300MG | Aa Pharma Inc | Resolved | 2024-04-01 | 112 | Manufacturing distruption | 221857 |
3931 | J07BA02 | IXIARO | 6MCG | Valneva Austria Gmbh | Resolved | 2024-04-01 | 59 | Demand increase | 223338 |
3933 | N06DA03 | MYLAN-RIVASTIGMINE PATCH 10 | 9.5MG | Mylan Pharmaceuticals Ulc | Resolved | 2024-04-01 | 9 | Manufacturing distruption | 223273 |
3934 | D07AD01 | TARO-CLOBETASOL SHAMPOO | 0.05% | Taro Pharmaceuticals Inc | Resolved | 2024-04-01 | 39 | Manufacturing distruption | 227640 |
3916 | N06AB10 | AURO-ESCITALOPRAM | 20MG | Auro Pharma Inc | Resolved | 2024-03-31 | 122 | Demand increase | 223606 |
3917 | C01EB10 | ADENOSINE INJECTION | 3MG | Fresenius Kabi Canada Ltd | Resolved | 2024-03-31 | 45 | Demand increase | 222725 |
3910 | N05AH03 | JAMP OLANZAPINE ODT | 5MG | Jamp Pharma Corporation | Active | 2024-03-29 | 458 | Manufacturing distruption | 223965 |
3913 | N02CC07 | JAMP FROVATRIPTAN | 2.5MG | Jamp Pharma Corporation | Active | 2024-03-29 | 428 | Manufacturing distruption | 223980 |
3907 | L01BC06 | CAPECITABINE | 150MG | Jamp Pharma Corporation | Resolved | 2024-03-29 | 17 | Manufacturing distruption | 223925 |
3908 | L01BC06 | CAPECITABINE | 500MG | Jamp Pharma Corporation | Resolved | 2024-03-29 | 17 | Manufacturing distruption | 223962 |
3909 | L03AX16 | PLERIXAFOR INJECTION | 20MG | Jamp Pharma Corporation | Resolved | 2024-03-29 | 124 | Other | 223974 |
3911 | G04BD10 | JAMP DARIFENACIN | 7.5MG | Jamp Pharma Corporation | Resolved | 2024-03-29 | 78 | Manufacturing distruption | 223940 |
3912 | G04BD10 | JAMP DARIFENACIN | 15MG | Jamp Pharma Corporation | Resolved | 2024-03-29 | 78 | Manufacturing distruption | 223959 |
3914 | N03AX14 | JAMP LEVETIRACETAM TABLETS | 250MG | Jamp Pharma Corporation | Resolved | 2024-03-29 | 91 | Demand increase | 223970 |
3915 | J01CR02 | JAMP AMOXI CLAV | 125MG 875MG | Jamp Pharma Corporation | Resolved | 2024-03-29 | 63 | Demand increase | 223977 |
3904 | R01AD09 | MOMETASONE | 50MCG | Sanis Health Inc | Resolved | 2024-03-28 | Demand increase | 224066 | |
3905 | G04BE08 | TEVA-TADALAFIL | 5MG | Teva Canada Limited | Resolved | 2024-03-28 | 33 | Manufacturing distruption | 223859 |
3906 | N06BA04 | ACT METHYLPHENIDATE ER | 18MG | Teva Canada Limited | Resolved | 2024-03-28 | 43 | Manufacturing distruption | 223862 |
3892 | D07AC01 | TEVA-ECTOSONE | 0.05% | Teva Canada Limited | Active | 2024-03-27 | Manufacturing distruption | 223832 | |
3901 | N01BB01 | BUPIVACAINE HYDROCHLORIDE IN D... | 7.5MG | Sterimax Inc | Avoided | 2024-03-27 | Manufacturing distruption | 211218 | |
3890 | J01AA02 | TEVA-DOXYCYCLINE | 100MG | Teva Canada Limited | Resolved | 2024-03-27 | 14 | Manufacturing distruption | 223835 |
3891 | M03BX08 | TEVA-CYCLOBENZAPRINE | 10MG | Teva Canada Limited | Resolved | 2024-03-27 | 34 | Manufacturing distruption | 223838 |
3893 | A10BA02 | TEVA-METFORMIN | 500MG | Teva Canada Limited | Resolved | 2024-03-27 | 126 | Manufacturing distruption | 223841 |
3894 | N05AH03 | TEVA-OLANZAPINE | 5MG | Teva Canada Limited | Resolved | 2024-03-27 | 34 | Manufacturing distruption | 223844 |
3895 | J05AB11 | RIVA-VALACYCLOVIR | 500MG | Laboratoire Riva Inc. | Resolved | 2024-03-27 | 310 | Shipping delay | 223689 |
3896 | C09CA07 | TEVA-TELMISARTAN | 80MG | Teva Canada Limited | Resolved | 2024-03-27 | 136 | Manufacturing distruption | 223847 |
3897 | C10AX09 | TEVA-EZETIMIBE | 10MG | Teva Canada Limited | Resolved | 2024-03-27 | 65 | Manufacturing distruption | 223850 |
3898 | C09CA06 | TEVA-CANDESARTAN | 32MG | Teva Canada Limited | Resolved | 2024-03-27 | 167 | Manufacturing distruption | 223853 |
3899 | N06AX12 | TEVA-BUPROPION XL | 300MG | Teva Canada Limited | Resolved | 2024-03-27 | 75 | Manufacturing distruption | 223856 |
3900 | N05AE04 | AURO-ZIPRASIDONE | 20MG | Auro Pharma Inc | Resolved | 2024-03-27 | 80 | Demand increase | 223668 |
3902 | J05AE10 | AURO-DARUNAVIR | 800MG | Auro Pharma Inc | Resolved | 2024-03-27 | 80 | Demand increase | 223580 |
3903 | J05AR03 | AURO-EMTRICITABINE-TENOFOVIR | 200MG 300MG | Auro Pharma Inc | Resolved | 2024-03-27 | 126 | Demand increase | 223603 |
3888 | S01GX09 | APO-OLOPATADINE | 0.2% | Apotex Inc | Active | 2024-03-26 | Manufacturing distruption | 223564 | |
3876 | G04CA01 | ALFUZOSIN | 10MG | Sanis Health Inc | Resolved | 2024-03-26 | 52 | Demand increase | 223485 |
3877 | A10BB09 | GLICLAZIDE MR | 30MG | Sanis Health Inc | Resolved | 2024-03-26 | 65 | Demand increase | 223456 |
3878 | N05BA12 | APO-ALPRAZ | 0.5MG | Apotex Inc | Resolved | 2024-03-26 | 38 | Manufacturing distruption | 223546 |
3879 | N06AB06 | APO-SERTRALINE | 100MG | Apotex Inc | Resolved | 2024-03-26 | 17 | Manufacturing distruption | 223540 |
3880 | R01AD01 | APO-BECLOMETHASONE NASAL SPRAY | 50MCG | Apotex Inc | Resolved | 2024-03-26 | 10 | Manufacturing distruption | 223552 |
3881 | C10AA03 | APO-PRAVASTATIN | 10MG | Apotex Inc | Resolved | 2024-03-26 | 17 | Manufacturing distruption | 223549 |
3882 | D07AD01 | TARO-CLOBETASOL CREAM USP, 0.0... | 0.05% | Taro Pharmaceuticals Inc | Resolved | 2024-03-26 | 113 | Manufacturing distruption | 227637 |
3883 | C09AA09 | APO-FOSINOPRIL | 20MG | Apotex Inc | Resolved | 2024-03-26 | 31 | Manufacturing distruption | 223558 |
3884 | N05AX08 | APO-RISPERIDONE | 1.0MG | Apotex Inc | Resolved | 2024-03-26 | 38 | Manufacturing distruption | 223543 |
3885 | S01AE06 | APO-GATIFLOXACIN | 0.3% | Apotex Inc | Resolved | 2024-03-26 | 17 | Manufacturing distruption | 223555 |
3886 | N05AH04 | AURO-QUETIAPINE | 100MG | Auro Pharma Inc | Resolved | 2024-03-26 | 99 | Demand increase | 223641 |
3887 | M04AA01 | APO-ALLOPURINOL | 100MG | Apotex Inc | Resolved | 2024-03-26 | 24 | Manufacturing distruption | 223561 |
3889 | J01FA10 | AURO-AZITHROMYCIN | 200MG | Auro Pharma Inc | Resolved | 2024-03-26 | 142 | Demand increase | 223448 |
3860 | C02AC01 | SANDOZ CLONIDINE | 0.1MG | Sandoz Canada Incorporated | Resolved | 2024-03-25 | 4 | Shipping delay | 223188 |
3861 | J05AB11 | VALACYCLOVIR | 1000MG | Sanis Health Inc | Resolved | 2024-03-25 | 242 | Manufacturing distruption | 223251 |
3862 | N06AX23 | DESVENLAFAXINE | 100MG | Sanis Health Inc | Resolved | 2024-03-25 | 26 | Manufacturing distruption | 223265 |
3863 | D10AD01 | RETIN-A | 0.05% | Bausch Health, Canada Inc. | Resolved | 2024-03-25 | 82 | Other | 222127 |
3864 | N06AX05 | PMS TRAZODONE HCL TAB 50MG | 50MG | Pharmascience Inc | Resolved | 2024-03-25 | 16 | Manufacturing distruption | 222387 |
3865 | G03CA03 | ESTRADOT 25 | 25MCG | Sandoz Canada Incorporated | Resolved | 2024-03-25 | 109 | Manufacturing distruption | 223191 |
3866 | J01MA12 | SANDOZ LEVOFLOXACIN | 500MG | Sandoz Canada Incorporated | Resolved | 2024-03-25 | 4 | Manufacturing distruption | 223194 |
3867 | C10AA07 | SANDOZ ROSUVASTATIN | 40MG | Sandoz Canada Incorporated | Resolved | 2024-03-25 | 81 | Manufacturing distruption | 223204 |
3868 | J05AB11 | MYLAN-VALACYCLOVIR | 500MG | Mylan Pharmaceuticals Ulc | Resolved | 2024-03-25 | 50 | Demand increase | 223279 |
3869 | N02BF01 | GABAPENTIN | 400MG | Sanis Health Inc | Resolved | 2024-03-25 | 144 | Manufacturing distruption | 223259 |
3870 | N05AX08 | RISPERIDONE | 0.25MG | Sanis Health Inc | Resolved | 2024-03-25 | 53 | Manufacturing distruption | 223270 |
3871 | J01FA09 | TARO-CLARITHROMYCIN | 250MG | Taro Pharmaceuticals Inc | Resolved | 2024-03-25 | 95 | Manufacturing distruption | 227631 |
3872 | G04BE03 | SILDENAFIL | 100MG | Sanis Health Inc | Resolved | 2024-03-25 | 37 | Manufacturing distruption | 223262 |
3873 | C09CA08 | SANDOZ OLMESARTAN | 20MG | Sandoz Canada Incorporated | Resolved | 2024-03-25 | 53 | Manufacturing distruption | 223197 |
3874 | N06AB10 | M-ESCITALOPRAM | 20MG | Mantra Pharma Inc | Resolved | 2024-03-25 | 67 | Shipping delay | 225524 |
3875 | N05AE05 | TARO-LURASIDONE | 60MG | Taro Pharmaceuticals Inc | Resolved | 2024-03-25 | 200 | Manufacturing distruption | 230675 |
3859 | C09CA07 | TELMISARTAN | 40MG | Sanis Health Inc | Resolved | 2024-03-24 | 131 | Manufacturing distruption | 223276 |
3855 | C09CA06 | ACH-CANDESARTAN | 16MG | Accord Healthcare Inc | Active | 2024-03-22 | Manufacturing practices | 223118 | |
3856 | C10AA05 | ACH-ATORVASTATIN CALCIUM | 10MG | Accord Healthcare Inc | Active | 2024-03-22 | Manufacturing practices | 223109 | |
3857 | L01EA01 | ACH-IMATINIB | 100MG | Accord Healthcare Inc | Active | 2024-03-22 | Manufacturing practices | 223112 | |
3858 | L01EA01 | ACH-IMATINIB | 400MG | Accord Healthcare Inc | Active | 2024-03-22 | Manufacturing practices | 223115 | |
3854 | A02BC06 | DEXILANT | 30MG | Takeda Canada Inc | Resolved | 2024-03-22 | 56 | Shipping delay | 223152 |
3852 | V03AC01 | DESFERAL 500MG | 500MG | Novartis Pharmaceuticals Canada Inc | Resolved | 2024-03-21 | 84 | Demand increase | 222962 |
3853 | A10BB09 | MYLAN-GLICLAZIDE MR | 30MG | Mylan Pharmaceuticals Ulc | Resolved | 2024-03-21 | 146 | Demand increase | 224058 |
3841 | C09XA02 | RASILEZ | 150MG | Noden Pharma Dac | Active | 2024-03-20 | Ingredient shortage | 221270 | |
3842 | A10BH01 | ACH-SITAGLIPTIN | 100MG | Accord Healthcare Inc | Active | 2024-03-20 | Manufacturing practices | 223106 | |
3851 | A09AA02 | CREON MINIMICROSPHERES 35 | 2240UNIT 35700UNIT 35000UNIT | Bgp Pharma Ulc | Avoided | 2024-03-20 | 62 | Other | 222222 |
3843 | D07AC01 | TEVA-TOPISONE | 0.05% | Teva Canada Limited | Resolved | 2024-03-20 | Manufacturing distruption | 222944 | |
3844 | N02AA01 | MS.IR | 10MG | Purdue Pharma | Resolved | 2024-03-20 | 9 | Shipping delay | 222882 |
3845 | N02AJ17 | TEVA-OXYCOCET | 325MG 5MG | Teva Canada Limited | Resolved | 2024-03-20 | 41 | Manufacturing distruption | 222935 |
3846 | N06AB06 | TEVA-SERTRALINE | 100MG | Teva Canada Limited | Resolved | 2024-03-20 | 51 | Manufacturing distruption | 222938 |
3847 | G04BD07 | TEVA-TOLTERODINE | 1MG | Teva Canada Limited | Resolved | 2024-03-20 | Manufacturing distruption | 222947 | |
3848 | A06AD11 | TEVA-LACTULOSE | 667MG | Teva Canada Limited | Resolved | 2024-03-20 | Manufacturing distruption | 222952 | |
3849 | N06DA02 | TEVA-DONEPEZIL | 5MG | Teva Canada Limited | Resolved | 2024-03-20 | 61 | Manufacturing distruption | 222941 |
3850 | G04CA02 | TAMSULOSIN CR | 0.4MG | Sanis Health Inc | Resolved | 2024-03-20 | 93 | Manufacturing distruption | 222839 |
3827 | G04BE09 | VARDENAFIL | 10MG | Sanis Health Inc | Active | 2024-03-19 | Manufacturing distruption | 222747 | |
3828 | N07AA02 | MESTINON | 60MG | Bausch Health, Canada Inc. | Resolved | 2024-03-19 | 17 | Demand increase | 222851 |
3829 | C03CA01 | APO-FUROSEMIDE | 20MG | Apotex Inc | Resolved | 2024-03-19 | 38 | Manufacturing distruption | 223067 |
3830 | N05AH01 | XYLAC | 25MG | Pendopharm Division Of Pharmascience Inc | Resolved | 2024-03-19 | 84 | Manufacturing distruption | 222737 |
3831 | C01BC03 | APO-PROPAFENONE | 150MG | Apotex Inc | Resolved | 2024-03-19 | 38 | Manufacturing distruption | 223049 |
3832 | J01CR02 | APO-AMOXI CLAV | 125MG 250MG | Apotex Inc | Resolved | 2024-03-19 | 24 | Manufacturing distruption | 223052 |
3833 | C10AA03 | APO-PRAVASTATIN | 40MG | Apotex Inc | Resolved | 2024-03-19 | 24 | Manufacturing distruption | 223064 |
3834 | J01CR02 | APO-AMOXI CLAV | 125MG 875MG | Apotex Inc | Resolved | 2024-03-19 | 38 | Manufacturing distruption | 223046 |
3835 | N04BC05 | APO-PRAMIPEXOLE | 1.5MG | Apotex Inc | Resolved | 2024-03-19 | 38 | Manufacturing distruption | 223055 |
3836 | C03AA03 | APO-HYDROCHLOROTHIAZIDE | 12.5MG | Apotex Inc | Resolved | 2024-03-19 | 38 | Manufacturing distruption | 223083 |
3837 | L02BG04 | APO-LETROZOLE | 2.5MG | Apotex Inc | Resolved | 2024-03-19 | 31 | Manufacturing distruption | 223043 |
3838 | R03DC03 | APO-MONTELUKAST | 10MG | Apotex Inc | Resolved | 2024-03-19 | 31 | Manufacturing distruption | 223058 |
3839 | M04AA01 | APO-ALLOPURINOL | 300MG | Apotex Inc | Resolved | 2024-03-19 | 24 | Manufacturing distruption | 223061 |
3840 | N06AB10 | ESCITALOPRAM | 20MG | Sanis Health Inc | Resolved | 2024-03-19 | 101 | Manufacturing distruption | 222742 |
3813 | N06AB03 | PROZAC CAPSULES 20MG | 20MG | Eli Lilly Canada Inc | Resolved | 2024-03-18 | Other | 220048 | |
3814 | J04AB02 | ROFACT | 300MG | Bausch Health, Canada Inc. | Resolved | 2024-03-18 | 30 | Other | 222584 |
3815 | N02CC01 | IMITREX | 6MG | Glaxosmithkline Inc | Resolved | 2024-03-18 | 18 | Demand increase | 222990 |
3816 | M01AB05 | SANDOZ DICLOFENAC RAPIDE | 50MG | Sandoz Canada Incorporated | Resolved | 2024-03-18 | 263 | Manufacturing distruption | 222606 |
3817 | V09IB01 | OCTREOSCAN | 10MCG 111MBq | Curium Canada Inc | Resolved | 2024-03-18 | 13 | Other | 222588 |
3818 | H02AB04 | SOLU-MEDROL | 125MG | Pfizer Canada Ulc | Resolved | 2024-03-18 | Manufacturing distruption | 220621 | |
3819 | L04AA24 | ORENCIA | 125MG | Bristol-Myers Squibb Canada | Resolved | 2024-03-18 | 196 | Manufacturing distruption | 222656 |
3820 | L01BC05 | GEMCITABINE INJECTION | 38MG | Pfizer Canada Ulc | Resolved | 2024-03-18 | Manufacturing distruption | 222052 | |
3821 | L01BC05 | GEMCITABINE INJECTION | 38MG | Pfizer Canada Ulc | Resolved | 2024-03-18 | Manufacturing distruption | 222055 | |
3822 | L01BC05 | GEMCITABINE INJECTION | 38MG | Pfizer Canada Ulc | Resolved | 2024-03-18 | Manufacturing distruption | 222058 | |
3823 | C10AX09 | SANDOZ EZETIMIBE | 10MG | Sandoz Canada Incorporated | Resolved | 2024-03-18 | 39 | Manufacturing practices | 222611 |
3824 | S01GX09 | SANDOZ OLOPATADINE 0.2% | 0.2% | Sandoz Canada Incorporated | Resolved | 2024-03-18 | 46 | Manufacturing distruption | 222614 |
3825 | J02AC04 | POSANOL | 100MG | Merck Canada Inc | Resolved | 2024-03-18 | 84 | Demand increase | 222593 |
3826 | G04CA04 | SANDOZ SILODOSIN | 4MG | Sandoz Canada Incorporated | Resolved | 2024-03-18 | 11 | Shipping delay | 222617 |
3812 | M05BA04 | AURO-ALENDRONATE | 70MG | Auro Pharma Inc | Resolved | 2024-03-17 | 136 | Demand increase | 223434 |
3811 | L01BA04 | ALIMTA | 100MG | Eli Lilly Canada Inc | Resolved | 2024-03-16 | 48 | Other | 226352 |
3803 | D11AH02 | ELIDEL | 1% | Bausch Health, Canada Inc. | Avoided | 2024-03-15 | 14 | Other | 217264 |
3802 | C01BD01 | PMS-AMIODARONE | 200MG | Pharmascience Inc | Resolved | 2024-03-15 | 46 | Manufacturing distruption | 222366 |
3804 | N02CC01 | PMS-SUMATRIPTAN | 50MG | Pharmascience Inc | Resolved | 2024-03-15 | 116 | Manufacturing distruption | 222384 |
3805 | J05AB11 | PMS-VALACYCLOVIR | 500MG | Pharmascience Inc | Resolved | 2024-03-15 | 166 | Manufacturing distruption | 222390 |
3806 | M01AB05 | PMS-DICLOFENAC | 50MG | Pharmascience Inc | Resolved | 2024-03-15 | 166 | Manufacturing distruption | 222372 |
3807 | J05AB11 | PMS-VALACYCLOVIR | 1000MG | Pharmascience Inc | Resolved | 2024-03-15 | 256 | Manufacturing distruption | 222393 |
3808 | C09CA06 | PMS-CANDESARTAN | 32MG | Pharmascience Inc | Resolved | 2024-03-15 | 87 | Manufacturing distruption | 222369 |
3809 | M01AB55 | PMS-DICLOFENAC-MISOPROSTOL | 200MCG 75MG | Pharmascience Inc | Resolved | 2024-03-15 | 301 | Manufacturing distruption | 222378 |
3810 | J01XE01 | PMS-NITROFURANTOIN BID | 100MG | Pharmascience Inc | Resolved | 2024-03-15 | 184 | Manufacturing distruption | 222381 |
3797 | C03CA02 | BURINEX | 1MG | Karo Pharma Ab | Active | 2024-03-14 | 78 | Ingredient shortage | 226761 |
3798 | L01BA03 | TOMUDEX | 2MG | Pfizer Canada Ulc | Resolved | 2024-03-14 | Manufacturing distruption | 222272 | |
3799 | G03BA03 | ANDROGEL | 1% | Bgp Pharma Ulc | Resolved | 2024-03-14 | 13 | Manufacturing distruption | 219747 |
3800 | N07BC02 | METADOL | 1MG | Paladin Labs Inc. | Resolved | 2024-03-14 | 11 | Shipping delay | 222730 |
3801 | B01AF02 | MAR-APIXABAN | 5MG | Marcan Pharmaceuticals Inc | Resolved | 2024-03-14 | 108 | Demand increase | 222212 |
3794 | D07AC13 | ELOCOM | 0.1% | Organon Canada Inc. | Resolved | 2024-03-13 | 47 | Shipping delay | 222064 |
3795 | C01BD07 | MULTAQ | 400MG | Sanofi-Aventis Canada Inc | Resolved | 2024-03-13 | 41 | Other | 222061 |
3796 | J01AA02 | APPRILON | 40MG | Galderma Canada Inc | Resolved | 2024-03-13 | 9 | Manufacturing practices | 222034 |
3781 | C08DB01 | DILTIAZEM HYDROCHLORIDE INJECT... | 5MG | Omega Laboratories Limited | Resolved | 2024-03-12 | 38 | Manufacturing distruption | 221999 |
3782 | M03BX01 | APO-BACLOFEN | 20MG | Apotex Inc | Resolved | 2024-03-12 | 73 | Manufacturing distruption | 222455 |
3783 | N06AA04 | ANAFRANIL | 25MG | Apotex Inc | Resolved | 2024-03-12 | 10 | Manufacturing distruption | 222473 |
3784 | H02AB07 | APO PREDNISONE TAB 5MG | 5MG | Apotex Inc | Resolved | 2024-03-12 | 10 | Manufacturing distruption | 222467 |
3785 | M01AE02 | APO-NAPROXEN | 500MG | Apotex Inc | Resolved | 2024-03-12 | 122 | Manufacturing distruption | 222478 |
3786 | M01AE01 | APO-IBUPROFEN | 400MG | Apotex Inc | Resolved | 2024-03-12 | 24 | Manufacturing distruption | 222470 |
3787 | N06AB06 | APO-SERTRALINE | 25MG | Apotex Inc | Resolved | 2024-03-12 | 52 | Manufacturing distruption | 222481 |
3788 | N02CC01 | APO-SUMATRIPTAN | 50MG | Apotex Inc | Resolved | 2024-03-12 | 38 | Manufacturing distruption | 222464 |
3789 | J01AA02 | APO-DOXY CAP 100MG | 100MG | Apotex Inc | Resolved | 2024-03-12 | 24 | Manufacturing distruption | 222414 |
3790 | N06AB06 | SERTRALINE | 100MG | Sanis Health Inc | Resolved | 2024-03-12 | 45 | Manufacturing distruption | 223214 |
3791 | M04AA01 | APO-ALLOPURINOL | 300MG | Apotex Inc | Resolved | 2024-03-12 | 31 | Manufacturing distruption | 222458 |
3792 | A02BC01 | HEARTBURN CONTROL | 20MG | Apotex Inc | Resolved | 2024-03-12 | 38 | Manufacturing distruption | 222461 |
3793 | A09AA02 | CREON MINIMICROSPHERES 35 | 2240UNIT 35700UNIT 35000UNIT | Bgp Pharma Ulc | Resolved | 2024-03-12 | 72 | Other | 224680 |
3767 | V08AB02 | OMNIPAQUE 240 | 518MG | Ge Healthcare Canada Inc | Resolved | 2024-03-11 | 22 | Demand increase | 221863 |
3768 | N03AF01 | SANDOZ-CARBAMAZEPINE CR | 200MG | Sandoz Canada Incorporated | Resolved | 2024-03-11 | 151 | Manufacturing distruption | 221829 |
3769 | N03AA02 | PHENOBARBITAL SODIUM INJECTION... | 120MG | Sandoz Canada Incorporated | Resolved | 2024-03-11 | 46 | Manufacturing distruption | 221838 |
3770 | C10AA05 | SANDOZ ATORVASTATIN | 20MG | Sandoz Canada Incorporated | Resolved | 2024-03-11 | 18 | Shipping delay | 221825 |
3771 | N03AF01 | TARO-CARBAMAZEPINE | 100MG | Taro Pharmaceuticals Inc | Resolved | 2024-03-11 | 109 | Manufacturing distruption | 227625 |
3772 | S01AE07 | SANDOZ MOXIFLOXACIN | 0.5% | Sandoz Canada Incorporated | Resolved | 2024-03-11 | 4 | Shipping delay | 221835 |
3773 | N06DA03 | SANDOZ RIVASTIGMINE PATCH 5 | 4.6MG | Sandoz Canada Incorporated | Resolved | 2024-03-11 | 32 | Manufacturing distruption | 221841 |
3774 | G04CB02 | DUTASTERIDE | 0.5MG | Sanis Health Inc | Resolved | 2024-03-11 | 94 | Manufacturing distruption | 221877 |
3775 | J02AA01 | FUNGIZONE | 50MG | Cheplapharm Arzneimittel Gmbh | Resolved | 2024-03-11 | 173 | Manufacturing distruption | 221737 |
3776 | A16AX06 | SANDOZ MIGLUSTAT | 100MG | Sandoz Canada Incorporated | Resolved | 2024-03-11 | 46 | Manufacturing distruption | 221832 |
3777 | N06AB10 | M-ESCITALOPRAM | 10MG | Mantra Pharma Inc | Resolved | 2024-03-11 | 81 | Shipping delay | 225515 |
3778 | N06AB10 | M-ESCITALOPRAM | 10MG | Mantra Pharma Inc | Resolved | 2024-03-11 | 81 | Shipping delay | 225518 |
3779 | C09CA08 | OLMESARTAN | 20MG | Sanis Health Inc | Resolved | 2024-03-11 | 88 | Manufacturing distruption | 221869 |
3780 | C09CA08 | OLMESARTAN | 40MG | Sanis Health Inc | Resolved | 2024-03-11 | 102 | Manufacturing distruption | 221872 |
3758 | C09DA04 | TEVA-IRBESARTAN HCTZ | 300MG 25MG | Teva Canada Limited | Active | 2024-03-10 | Manufacturing distruption | 224898 | |
3763 | H05BX01 | TEVA-CINACALCET | 30MG | Teva Canada Limited | Active | 2024-03-10 | Manufacturing distruption | 224907 | |
3764 | H05BX01 | TEVA-CINACALCET | 60MG | Teva Canada Limited | Active | 2024-03-10 | Manufacturing distruption | 224910 | |
3765 | H05BX01 | TEVA-CINACALCET | 90MG | Teva Canada Limited | Active | 2024-03-10 | Manufacturing distruption | 224913 | |
3750 | N02AJ17 | TEVA-OXYCOCET | 325MG 5MG | Teva Canada Limited | Resolved | 2024-03-10 | 92 | Manufacturing distruption | 224883 |
3751 | N02AA79 | TEVA-TECNAL C 1/2 | 30MG 330MG 40MG 50MG | Teva Canada Limited | Resolved | 2024-03-10 | 92 | Manufacturing distruption | 222560 |
3752 | C09AA09 | TEVA-FOSINOPRIL | 20MG | Teva Canada Limited | Resolved | 2024-03-10 | 21 | Manufacturing distruption | 222563 |
3753 | D07AC13 | TEVA-MOMETASONE | 0.1% | Teva Canada Limited | Resolved | 2024-03-10 | 235 | Manufacturing distruption | 224886 |
3754 | N03AX11 | TEVA-TOPIRAMATE | 25MG | Teva Canada Limited | Resolved | 2024-03-10 | 71 | Manufacturing distruption | 224889 |
3755 | A10BA02 | TEVA-METFORMIN | 500MG | Teva Canada Limited | Resolved | 2024-03-10 | 143 | Manufacturing distruption | 224892 |
3756 | N05AH04 | ACT QUETIAPINE | 25MG | Teva Canada Limited | Resolved | 2024-03-10 | 41 | Manufacturing distruption | 222566 |
3757 | C09DA04 | TEVA-IRBESARTAN HCTZ | 300MG 12.5MG | Teva Canada Limited | Resolved | 2024-03-10 | Manufacturing distruption | 224895 | |
3759 | C10AX09 | TEVA-EZETIMIBE | 10MG | Teva Canada Limited | Resolved | 2024-03-10 | 82 | Manufacturing distruption | 222569 |
3760 | C09DA07 | TEVA-TELMISARTAN HCTZ | 25.0MG 80.0MG | Teva Canada Limited | Resolved | 2024-03-10 | 275 | Manufacturing distruption | 224901 |
3761 | N05AH04 | TEVA-QUETIAPINE XR | 400MG | Teva Canada Limited | Resolved | 2024-03-10 | 92 | Manufacturing distruption | 222572 |
3762 | N06BA01 | TEVA-AMPHETAMINE XR | 20MG | Teva Canada Limited | Resolved | 2024-03-10 | 92 | Manufacturing distruption | 224904 |
3766 | N03AX18 | TEVA-LACOSAMIDE | 50MG | Teva Canada Limited | Resolved | 2024-03-10 | 82 | Manufacturing distruption | 222575 |
3746 | N02AX02 | TRIDURAL | 300MG | Paladin Labs Inc. | Active | 2024-03-08 | 389 | Shipping delay | 221612 |
3749 | B05XA02 | SODIUM BICARBONATE INJECTION, ... | 42MG | Fresenius Kabi Canada Ltd | Active | 2024-03-08 | Manufacturing distruption | 186632 | |
3741 | J04AB02 | ROFACT | 300MG | Bausch Health, Canada Inc. | Avoided | 2024-03-08 | 20 | Other | 220173 |
3742 | N01BB02 | XYLOCAINE 1% | 10MG | Aspen Pharmacare Canada Inc. | Resolved | 2024-03-08 | 38 | Shipping delay | 221714 |
3743 | J07BD52 | PRIORIX | 0.5ML 1000CCID50 1000CCID50 10000CCID50 | Glaxosmithkline Inc | Resolved | 2024-03-08 | Demand increase | 221711 | |
3744 | V03AF01 | UROMITEXAN | 100MG | Baxter Corporation | Resolved | 2024-03-08 | 14 | Demand increase | 221775 |
3745 | V03AF01 | UROMITEXAN | 100MG | Baxter Corporation | Resolved | 2024-03-08 | 24 | Demand increase | 221778 |
3747 | A10BG03 | ACT PIOGLITAZONE | 15MG | Teva Canada Limited | Resolved | 2024-03-08 | 312 | Manufacturing distruption | 227483 |
3748 | J01CR05 | PIPERACILLIN AND TAZOBACTAM FO... | 0.375G 3.000G | Sterimax Inc | Resolved | 2024-03-08 | 38 | Shipping delay | 221595 |
3737 | C09AA04 | COVERSYL | 2MG | Servier Canada Inc | Resolved | 2024-03-07 | 15 | Manufacturing practices | 221850 |
3738 | V08AB09 | VISIPAQUE 320 | 652MG | Ge Healthcare Canada Inc | Resolved | 2024-03-07 | 8 | Shipping delay | 221590 |
3739 | J07BK01 | VARIVAX III | 1350UNIT | Merck Canada Inc | Resolved | 2024-03-07 | 22 | Demand increase | 221683 |
3740 | V07AB | STERILE DILUENT FOR MERCK SHAR... | 100% | Merck Canada Inc | Resolved | 2024-03-07 | 22 | Demand increase | 221688 |
3730 | A02BC02 | TEVA-PANTOPRAZOLE | 20MG | Teva Canada Limited | Active | 2024-03-06 | Manufacturing distruption | 221567 | |
3731 | J01MA12 | ACT LEVOFLOXACIN | 750MG | Teva Canada Limited | Active | 2024-03-06 | Manufacturing distruption | 221531 | |
3724 | G04BE09 | VARDENAFIL | 10MG | Sanis Health Inc | Avoided | 2024-03-06 | 55 | Manufacturing distruption | 218999 |
3725 | A02BX02 | TEVA-SUCRALFATE | 1G | Teva Canada Limited | Resolved | 2024-03-06 | 86 | Manufacturing distruption | 221540 |
3726 | J07BD52 | M-M-R II | 1000UNIT 5000UNIT 1000UNIT | Merck Canada Inc | Resolved | 2024-03-06 | 72 | Demand increase | 221457 |
3727 | V03AF03 | LEUCOVORIN CALCIUM INJECTION U... | 10MG | Pfizer Canada Ulc | Resolved | 2024-03-06 | Manufacturing distruption | 220361 | |
3728 | C02CA04 | TEVA-DOXAZOSIN | 4MG | Teva Canada Limited | Resolved | 2024-03-06 | 55 | Manufacturing distruption | 221543 |
3729 | A10BA02 | TEVA-METFORMIN | 850MG | Teva Canada Limited | Resolved | 2024-03-06 | 147 | Manufacturing distruption | 221549 |
3732 | A02BC05 | TEVA-ESOMEPRAZOLE | 20MG | Teva Canada Limited | Resolved | 2024-03-06 | 106 | Manufacturing distruption | 221552 |
3733 | J02AC04 | POSANOL | 100MG | Merck Canada Inc | Resolved | 2024-03-06 | 9 | Demand increase | 221418 |
3734 | C08DB01 | TEVA-DILTIAZEM XC | 360MG | Teva Canada Limited | Resolved | 2024-03-06 | 65 | Manufacturing distruption | 221546 |
3735 | N07BC51 | TEVA-BUPRENORPHINE/NALOXONE | 2MG 0.5MG | Teva Canada Limited | Resolved | 2024-03-06 | 116 | Manufacturing distruption | 221534 |
3736 | N07BC51 | TEVA-BUPRENORPHINE/NALOXONE | 2MG 8MG | Teva Canada Limited | Resolved | 2024-03-06 | 116 | Manufacturing distruption | 221537 |
3705 | A10BK01 | SANDOZ DAPAGLIFLOZIN | 10MG | Sandoz Canada Incorporated | Resolved | 2024-03-05 | 66 | Manufacturing distruption | 221380 |
3706 | A10BK01 | APO-DAPAGLIFLOZIN | 10MG | Apotex Inc | Resolved | 2024-03-05 | 52 | Manufacturing distruption | 221678 |
3707 | D10AD01 | RETIN-A | 0.025% | Bausch Health, Canada Inc. | Resolved | 2024-03-05 | 28 | Other | 220170 |
3708 | N01BB51 | SENSORCAINE WITH EPINEPHRINE | 5MCG 5MG | Aspen Pharmacare Canada Inc. | Resolved | 2024-03-05 | 57 | Manufacturing distruption | 219442 |
3709 | M03BX01 | APO-BACLOFEN | 10MG | Apotex Inc | Resolved | 2024-03-05 | 80 | Manufacturing distruption | 221696 |
3710 | C03EA01 | APO TRIAZIDE | 25MG 50MG | Apotex Inc | Resolved | 2024-03-05 | 38 | Manufacturing distruption | 221702 |
3711 | N02CC01 | APO-SUMATRIPTAN | 100MG | Apotex Inc | Resolved | 2024-03-05 | 45 | Manufacturing distruption | 221732 |
3712 | N06BA04 | APO-METHYLPHENIDATE | 5MG | Apotex Inc | Resolved | 2024-03-05 | 66 | Manufacturing distruption | 221723 |
3713 | J01FA09 | APO-CLARITHROMYCIN | 250MG | Apotex Inc | Resolved | 2024-03-05 | 52 | Manufacturing distruption | 221720 |
3714 | N06DA03 | APO-RIVASTIGMINE | 1.5MG | Apotex Inc | Resolved | 2024-03-05 | 66 | Manufacturing distruption | 221729 |
3715 | N02AX06 | NUCYNTA IR | 50MG | Endo Ventures Ltd. | Resolved | 2024-03-05 | 25 | Shipping delay | 222495 |
3716 | N02BF02 | SANDOZ PREGABALIN | 25MG | Sandoz Canada Incorporated | Resolved | 2024-03-05 | 17 | Demand increase | 221383 |
3717 | G03AA12 | MYA | 0.02MG 3.00MG | Apotex Inc | Resolved | 2024-03-05 | 10 | Manufacturing distruption | 221690 |
3718 | G04BE08 | APO-TADALAFIL | 5MG | Apotex Inc | Resolved | 2024-03-05 | 66 | Manufacturing distruption | 221705 |
3719 | S01EE03 | VISTITAN | 0.03% | Sandoz Canada Incorporated | Resolved | 2024-03-05 | 115 | Ingredient shortage | 221377 |
3720 | C07AB03 | APO-ATENOL TAB 100MG | 100MG | Apotex Inc | Resolved | 2024-03-05 | 45 | Manufacturing distruption | 221726 |
3721 | N06BA04 | APO-METHYLPHENIDATE ER | 27MG | Apotex Inc | Resolved | 2024-03-05 | 10 | Manufacturing distruption | 221717 |
3722 | N05AX12 | APO-ARIPIPRAZOLE | 2MG | Apotex Inc | Resolved | 2024-03-05 | 10 | Manufacturing distruption | 221708 |
3723 | B02BX05 | APO-ELTROMBOPAG | 50MG | Apotex Inc | Resolved | 2024-03-05 | 38 | Manufacturing distruption | 221699 |
3693 | C02DB02 | HYDRALAZINE HYDROCHLORIDE INJE... | 20MG | Auro Pharma Inc | Resolved | 2024-03-04 | Demand increase | 221285 | |
3694 | L01BA04 | PEMETREXED DISODIUM FOR INJECT... | 500MG | Auro Pharma Inc | Resolved | 2024-03-04 | Demand increase | 221294 | |
3695 | D05AX52 | TARO-CALCIPOTRIOL / BETAMETHAS... | 0.5MG 50MCG | Taro Pharmaceuticals Inc | Resolved | 2024-03-04 | 21 | Manufacturing distruption | 222075 |
3696 | J01FA09 | BIAXIN BID | 500MG | Bgp Pharma Ulc | Resolved | 2024-03-04 | 11 | Ingredient shortage | 220833 |
3697 | D07AD01 | TARO-CLOBETASOL OINTMENT USP, ... | 0.05% | Taro Pharmaceuticals Inc | Resolved | 2024-03-04 | 11 | Manufacturing distruption | 222078 |
3698 | V03AC01 | DEFEROXAMINE MESYLATE FOR INJE... | 2G | Pfizer Canada Ulc | Resolved | 2024-03-04 | Manufacturing distruption | 212030 | |
3699 | J07AL01 | PNEUMOVAX 23 | 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG | Merck Canada Inc | Resolved | 2024-03-04 | 27 | Demand increase | 219866 |
3700 | N01BB02 | LIDOCAINE INJECTION BP | 1% | Auro Pharma Inc | Resolved | 2024-03-04 | Demand increase | 221291 | |
3701 | N01BB02 | LIDOCAINE INJECTION BP | 2% | Auro Pharma Inc | Resolved | 2024-03-04 | 121 | Demand increase | 221288 |
3702 | N05CM18 | DEXMEDETOMIDINE HYDROCHLORIDE ... | 100MCG | Auro Pharma Inc | Resolved | 2024-03-04 | 57 | Demand increase | 221282 |
3703 | B02AA02 | TRANEXAMIC ACID INJECTION | 100MG | Auro Pharma Inc | Resolved | 2024-03-04 | 88 | Demand increase | 221297 |
3704 | J05AB01 | ACYCLOVIR SODIUM INJECTION | 50MG | Auro Pharma Inc | Resolved | 2024-03-04 | Demand increase | 221279 | |
3692 | V09IB01 | OCTREOSCAN | 10MCG 111MBq | Curium Canada Inc | Resolved | 2024-03-03 | 7 | Other | 221581 |
3690 | N05AX08 | TARO-RISPERIDONE | 0.25MG | Sun Pharma Canada Inc | Active | 2024-03-01 | Manufacturing distruption | 237311 | |
3689 | B05XA30 | TPN ELECTROLYTES | 16.05MG 121MG 25.4MG 74.55MG 16.55MG | Pfizer Canada Ulc | Avoided | 2024-03-01 | Manufacturing distruption | 200837 | |
3685 | N01AX03 | KETALAR | 10MG | Searchlight Pharma Inc | Resolved | 2024-03-01 | 20 | Shipping delay | 215627 |
3686 | N06BA02 | DEXEDRINE SPANSULE SRC 10MG | 10MG | Paladin Labs Inc. | Resolved | 2024-03-01 | 26 | Shipping delay | 222987 |
3687 | B05XA03 | SODIUM CHLORIDE INJECTION, USP | 234MG | Fresenius Kabi Canada Ltd | Resolved | 2024-03-01 | 60 | Other | 221460 |
3688 | A07EB01 | NALCROM | 100MG | Sanofi-Aventis Canada Inc | Resolved | 2024-03-01 | 244 | Other | 220296 |
3691 | N02AX06 | NUCYNTA EXTENDED-RELEASE | 250MG | Endo Ventures Ltd. | Resolved | 2024-03-01 | 21 | Shipping delay | 222492 |
3684 | A08AA62 | CONTRAVE | 90MG 8MG | Bausch Health, Canada Inc. | Avoided | 2024-02-29 | 8 | Shipping delay | 218165 |
3683 | C09AA08 | MYLAN-CILAZAPRIL | 5.0MG | Mylan Pharmaceuticals Ulc | Resolved | 2024-02-29 | 22 | Other | 221438 |
3676 | B05XA08 | SODIUM ACETATE INJECTION USP | 328MG | Omega Laboratories Limited | Active | 2024-02-28 | 398 | Other | 252444 |
3673 | A03FA03 | TEVA-DOMPERIDONE | 10MG | Teva Canada Limited | Resolved | 2024-02-28 | 82 | Manufacturing distruption | 220980 |
3674 | D07AC01 | TEVA-TOPISONE | 0.05% | Teva Canada Limited | Resolved | 2024-02-28 | 140 | Manufacturing distruption | 220992 |
3675 | D07AC01 | TEVA-TOPILENE | 0.05% | Teva Canada Limited | Resolved | 2024-02-28 | 140 | Manufacturing distruption | 220989 |
3677 | R03AC02 | VENTOLIN RESPIRATOR SOLUTION | 5MG | Glaxosmithkline Inc | Resolved | 2024-02-28 | 191 | Manufacturing distruption | 221012 |
3678 | L02AE01 | SUPREFACT | 1MG | Cheplapharm Arzneimittel Gmbh | Resolved | 2024-02-28 | 123 | Manufacturing distruption | 220741 |
3679 | J01DB01 | TEVA-CEPHALEXIN 250 | 250MG | Teva Canada Limited | Resolved | 2024-02-28 | 82 | Manufacturing distruption | 220977 |
3680 | D07AC13 | TEVA-MOMETASONE | 0.1% | Teva Canada Limited | Resolved | 2024-02-28 | 296 | Manufacturing distruption | 220986 |
3681 | C10AA04 | TEVA-FLUVASTATIN | 40MG | Teva Canada Limited | Resolved | 2024-02-28 | 195 | Manufacturing distruption | 220983 |
3682 | C09AA04 | PERINDOPRIL ERBUMINE | 2MG | Sanis Health Inc | Resolved | 2024-02-28 | 17 | Manufacturing distruption | 220840 |
3671 | L01AA09 | BENDAMUSTINE HYDROCHLORIDE FOR... | 100MG | Accord Healthcare Inc | Active | 2024-02-27 | Manufacturing practices | 220886 | |
3659 | M01AE01 | APO-IBUPROFEN | 200MG | Apotex Inc | Resolved | 2024-02-27 | 31 | Manufacturing distruption | 221087 |
3660 | M01AB15 | APO-KETOROLAC | 10MG | Apotex Inc | Resolved | 2024-02-27 | 59 | Manufacturing distruption | 221084 |
3661 | M01AB15 | APO-KETOROLAC | 10MG | Apotex Inc | Resolved | 2024-02-27 | 59 | Manufacturing distruption | 221102 |
3662 | A10BB09 | APO-GLICLAZIDE | 80MG | Apotex Inc | Resolved | 2024-02-27 | 17 | Manufacturing distruption | 221093 |
3663 | N05AX08 | APO-RISPERIDONE | 2.0MG | Apotex Inc | Resolved | 2024-02-27 | 59 | Manufacturing distruption | 221090 |
3664 | C09CA01 | JAMP-LOSARTAN | 50MG | Jamp Pharma Corporation | Resolved | 2024-02-27 | 388 | Manufacturing distruption | 221985 |
3665 | N06BA12 | VYVANSE | 10MG | Takeda Canada Inc | Resolved | 2024-02-27 | 33 | Shipping delay | 220802 |
3666 | A11CC05 | JAMP-VITAMIN D | 50000UNIT | Jamp Pharma Corporation | Resolved | 2024-02-27 | 139 | Demand increase | 221988 |
3667 | N06BA04 | APO-METHYLPHENIDATE ER | 36MG | Apotex Inc | Resolved | 2024-02-27 | 24 | Manufacturing distruption | 221096 |
3668 | N05AX12 | APO-ARIPIPRAZOLE | 2MG | Apotex Inc | Resolved | 2024-02-27 | 17 | Manufacturing distruption | 221099 |
3669 | L04AE01 | JAMP FINGOLIMOD | 0.5MG | Jamp Pharma Corporation | Resolved | 2024-02-27 | 33 | Manufacturing distruption | 221979 |
3670 | P01BA02 | JAMP HYDROXYCHLOROQUINE SULFAT... | 200MG | Jamp Pharma Corporation | Resolved | 2024-02-27 | 52 | Manufacturing distruption | 221982 |
3672 | C01AA05 | JAMP DIGOXIN | 0.125MG | Jamp Pharma Corporation | Resolved | 2024-02-27 | 33 | Demand increase | 221976 |
3639 | N03AB02 | DILANTIN | 30MG | Bgp Pharma Ulc | Resolved | 2024-02-26 | 15 | Manufacturing distruption | 219753 |
3640 | J01XD01 | METRONIDAZOLE INJECTION, USP | 5MG | Baxter Corporation | Resolved | 2024-02-26 | 18 | Manufacturing distruption | 220718 |
3641 | G03GA01 | CHORIONIC GONADOTROPIN FOR INJ... | 10000UNIT | Fresenius Kabi Canada Ltd | Resolved | 2024-02-26 | 28 | Manufacturing distruption | 220032 |
3642 | N07BC02 | METADOL | 25MG | Paladin Labs Inc. | Resolved | 2024-02-26 | 28 | Shipping delay | 220799 |
3643 | A02BC02 | PANTOPRAZOLE SODIUM FOR INJECT... | 40MG | Sandoz Canada Incorporated | Resolved | 2024-02-26 | 403 | Manufacturing distruption | 220548 |
3644 | C09CA06 | SANDOZ CANDESARTAN | 16MG | Sandoz Canada Incorporated | Resolved | 2024-02-26 | 32 | Manufacturing distruption | 220544 |
3645 | M05BA07 | SANDOZ RISEDRONATE | 35MG | Sandoz Canada Incorporated | Resolved | 2024-02-26 | 11 | Demand increase | 220555 |
3646 | N01BB54 | 4% CITANEST FORTE DENTAL WITH ... | 0.005MG 40MG | Dentsply Canada Limited | Resolved | 2024-02-26 | 64 | Shipping delay | 220614 |
3647 | N06AX05 | TRAZODONE | 150MG | Sanis Health Inc | Resolved | 2024-02-26 | 60 | Manufacturing distruption | 220686 |
3648 | N02BF01 | GABAPENTIN | 300MG | Sanis Health Inc | Resolved | 2024-02-26 | 116 | Demand increase | 220627 |
3649 | N06AB06 | SERTRALINE | 50MG | Sanis Health Inc | Resolved | 2024-02-26 | 115 | Manufacturing distruption | 220643 |
3650 | N06AB06 | SERTRALINE | 100MG | Sanis Health Inc | Resolved | 2024-02-26 | 67 | Manufacturing distruption | 220633 |
3651 | C09CA06 | CANDESARTAN | 16MG | Sanis Health Inc | Resolved | 2024-02-26 | 67 | Manufacturing distruption | 220656 |
3652 | C09DA06 | CANDESARTAN/HCTZ | 12.5MG 16MG | Sanis Health Inc | Resolved | 2024-02-26 | 11 | Manufacturing distruption | 220663 |
3653 | A02BC05 | ESOMEPRAZOLE | 40MG | Sanis Health Inc | Resolved | 2024-02-26 | 102 | Manufacturing distruption | 220681 |
3654 | J07AL01 | PNEUMOVAX 23 | 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG | Merck Canada Inc | Resolved | 2024-02-26 | 34 | Demand increase | 219869 |
3655 | N02CC04 | RIZATRIPTAN ODT | 5MG | Sanis Health Inc | Resolved | 2024-02-26 | 44 | Manufacturing distruption | 220668 |
3656 | J05AB11 | VALACYCLOVIR | 500MG | Sanis Health Inc | Resolved | 2024-02-26 | 256 | Manufacturing distruption | 220653 |
3657 | G04BD08 | SOLIFENACIN | 10MG | Sanis Health Inc | Resolved | 2024-02-26 | 11 | Manufacturing distruption | 220673 |
3658 | A10BD07 | SANDOZ SITAGLIPTIN-METFORMIN | 500MG 50MG | Sandoz Canada Incorporated | Resolved | 2024-02-26 | 4 | Shipping delay | 220558 |
3635 | N03AX22 | TARO-PERAMPANEL | 4MG | Taro Pharmaceuticals Inc | Resolved | 2024-02-23 | 21 | Manufacturing distruption | 222090 |
3636 | G04BD07 | DETROL | 1MG | Bgp Pharma Ulc | Resolved | 2024-02-23 | Manufacturing distruption | 219750 | |
3637 | C10AX09 | EZETROL | 10MG | Organon Canada Inc. | Resolved | 2024-02-23 | 7 | Shipping delay | 220624 |
3638 | G03BA03 | TARO-TESTOSTERONE GEL | 1% | Taro Pharmaceuticals Inc | Resolved | 2024-02-23 | 28 | Manufacturing distruption | 222104 |
3632 | D01AC01 | CLOTRIMADERM TOPICAL | 1% | Taro Pharmaceuticals Inc | Resolved | 2024-02-22 | 30 | Manufacturing distruption | 222081 |
3633 | J07BC02 | VAQTA | 50UNIT | Merck Canada Inc | Resolved | 2024-02-22 | 39 | Demand increase | 220279 |
3634 | N05AH01 | XYLAC | 2.5MG | Pendopharm Division Of Pharmascience Inc | Resolved | 2024-02-22 | 85 | Manufacturing distruption | 220293 |
3623 | H02AB04 | MEDROL 4 MG | 4MG | Pfizer Canada Ulc | Resolved | 2024-02-21 | Manufacturing distruption | 213920 | |
3624 | B01AC09 | FLOLAN | 1.5MG | Glaxosmithkline Inc | Resolved | 2024-02-21 | 100 | Manufacturing distruption | 220338 |
3625 | J07BC02 | HAVRIX 720 JUNIOR | 720UNIT | Glaxosmithkline Inc | Resolved | 2024-02-21 | 86 | Demand increase | 220335 |
3626 | H01AC01 | GENOTROPIN | 0.2MG | Pfizer Canada Ulc | Resolved | 2024-02-21 | Demand increase | 220131 | |
3627 | H01AC01 | GENOTROPIN | 0.4MG | Pfizer Canada Ulc | Resolved | 2024-02-21 | 303 | Demand increase | 220134 |
3628 | H01AC01 | GENOTROPIN | 1MG | Pfizer Canada Ulc | Resolved | 2024-02-21 | 303 | Demand increase | 220137 |
3629 | H01AC01 | GENOTROPIN | 1.4MG | Pfizer Canada Ulc | Resolved | 2024-02-21 | 303 | Demand increase | 220140 |
3630 | H01AC01 | GENOTROPIN | 2MG | Pfizer Canada Ulc | Resolved | 2024-02-21 | 303 | Demand increase | 220144 |
3631 | H04AA01 | BAQSIMI | 3MG | Eli Lilly Canada Inc | Resolved | 2024-02-21 | 7 | Shipping delay | 220276 |
3598 | R03AC02 | TEVA-SALBUTAMOL STERINEBS P.F. | 2MG | Teva Canada Limited | Active | 2024-02-20 | 497 | Manufacturing distruption | 220261 |
3622 | N05AH04 | APO-QUETIAPINE FUMARATE | 300MG | Apotex Inc | Active | 2024-02-20 | Manufacturing distruption | 216708 | |
3599 | N06AB03 | APO-FLUOXETINE | 20MG | Apotex Inc | Resolved | 2024-02-20 | Manufacturing distruption | 220453 | |
3600 | N06AB03 | APO-FLUOXETINE | 20MG | Apotex Inc | Resolved | 2024-02-20 | Manufacturing distruption | 220650 | |
3601 | N06AB03 | APO-FLUOXETINE | 10MG | Apotex Inc | Resolved | 2024-02-20 | Manufacturing distruption | 220450 | |
3602 | N05CM05 | SCOPOLAMINE HYDROBROMIDE INJEC... | 0.6MG | Omega Laboratories Limited | Resolved | 2024-02-20 | Demand increase | 218675 | |
3603 | G03CA03 | ESTRADOT 75 | 75MCG | Sandoz Canada Incorporated | Resolved | 2024-02-20 | 3 | Manufacturing distruption | 219977 |
3604 | A06AA02 | SANDOZ DOCUSATE SODIUM | 100MG | Sandoz Canada Incorporated | Resolved | 2024-02-20 | Manufacturing distruption | 219987 | |
3605 | A06AB56 | SANDOZ SENNA S | 50MG 8.6MG | Sandoz Canada Incorporated | Resolved | 2024-02-20 | Manufacturing distruption | 219991 | |
3606 | N06AX02 | APO-TRYPTOPHAN | 1G | Apotex Inc | Resolved | 2024-02-20 | 45 | Manufacturing distruption | 220468 |
3607 | A10BA02 | TEVA-METFORMIN | 850MG | Teva Canada Limited | Resolved | 2024-02-20 | 70 | Manufacturing distruption | 220264 |
3608 | A02BC04 | SANDOZ RABEPRAZOLE | 10MG | Sandoz Canada Incorporated | Resolved | 2024-02-20 | 101 | Manufacturing distruption | 219980 |
3609 | C10AA05 | SANDOZ ATORVASTATIN | 10MG | Sandoz Canada Incorporated | Resolved | 2024-02-20 | 17 | Demand increase | 219970 |
3610 | N02CC04 | SANDOZ RIZATRIPTAN ODT | 10MG | Sandoz Canada Incorporated | Resolved | 2024-02-20 | 31 | Manufacturing distruption | 219984 |
3611 | N06DA02 | APO-DONEPEZIL | 10MG | Apotex Inc | Resolved | 2024-02-20 | 87 | Manufacturing distruption | 220441 |
3612 | C09CA06 | TEVA-CANDESARTAN | 16MG | Teva Canada Limited | Resolved | 2024-02-20 | 384 | Manufacturing distruption | 220267 |
3613 | R03DC03 | APO-MONTELUKAST | 10MG | Apotex Inc | Resolved | 2024-02-20 | 45 | Manufacturing distruption | 220456 |
3614 | N02AX06 | NUCYNTA IR | 100MG | Endo Ventures Ltd. | Resolved | 2024-02-20 | 36 | Shipping delay | 222501 |
3615 | N02CC05 | MYLAN-ALMOTRIPTAN | 6.25MG | Mylan Pharmaceuticals Ulc | Resolved | 2024-02-20 | 35 | Ingredient shortage | 213129 |
3616 | R06AA59 | APO-DOXYLAMINE/B6 | 10MG 10MG | Apotex Inc | Resolved | 2024-02-20 | 31 | Manufacturing distruption | 220459 |
3617 | C09CA06 | SANDOZ CANDESARTAN | 32MG | Sandoz Canada Incorporated | Resolved | 2024-02-20 | 38 | Manufacturing distruption | 219974 |
3618 | H05BX01 | APO-CINACALCET | 30MG | Apotex Inc | Resolved | 2024-02-20 | 38 | Manufacturing distruption | 220447 |
3619 | N06AX23 | APO-DESVENLAFAXINE EXTENDED-RE... | 100MG | Apotex Inc | Resolved | 2024-02-20 | 38 | Manufacturing distruption | 220465 |
3620 | J01DE01 | APO-CEFEPIME | 2G | Apotex Inc | Resolved | 2024-02-20 | 10 | Manufacturing distruption | 220444 |
3621 | L02BX03 | APO-ABIRATERONE FILM COATED TA... | 250MG | Apotex Inc | Resolved | 2024-02-20 | 17 | Manufacturing distruption | 220471 |
3596 | N03AX14 | M-LEVETIRACETAM | 500MG | Mantra Pharma Inc | Active | 2024-02-19 | Shipping delay | 225527 | |
3597 | N03AX14 | M-LEVETIRACETAM | 750MG | Mantra Pharma Inc | Active | 2024-02-19 | Shipping delay | 225536 | |
3595 | B05CB01 | SODIUM CHLORIDE IRRIGATION USP | 9MG | Icu Medical Canada Inc | Resolved | 2024-02-18 | 57 | Manufacturing distruption | 217425 |
3594 | C09DA08 | ACH-OLMESARTAN HCTZ | 20MG 12.5MG | Accord Healthcare Inc | Active | 2024-02-16 | Manufacturing practices | 219792 | |
3593 | N02AX06 | NUCYNTA IR | 75MG | Endo Ventures Ltd. | Resolved | 2024-02-16 | 40 | Shipping delay | 222498 |
3591 | V08AB02 | OMNIPAQUE 350 | 755MG | Ge Healthcare Canada Inc | Avoided | 2024-02-15 | 5 | Demand increase | 217731 |
3588 | N07AB02 | DUVOID | 10MG | Paladin Labs Inc. | Resolved | 2024-02-15 | 41 | Shipping delay | 220923 |
3589 | N06AA01 | DESIPRAMINE | 25MG | Aa Pharma Inc | Resolved | 2024-02-15 | 54 | Manufacturing distruption | 219719 |
3590 | H02AB09 | SOLU-CORTEF | 250MG | Pfizer Canada Ulc | Resolved | 2024-02-15 | Manufacturing distruption | 219585 | |
3592 | L01CE02 | IRINOTECAN HYDROCHLORIDE INJEC... | 20MG | Pfizer Canada Ulc | Resolved | 2024-02-15 | Manufacturing distruption | 219700 | |
3585 | N05AX08 | TARO-RISPERIDONE | 0.5MG | Sun Pharma Canada Inc | Active | 2024-02-14 | Manufacturing distruption | 242649 | |
3582 | P01CX01 | PENTAMIDINE ISETIONATE FOR INJ... | 300MG | Pfizer Canada Ulc | Resolved | 2024-02-14 | Manufacturing distruption | 212039 | |
3583 | J01XE01 | TEVA-NITROFURANTOIN | 100MG | Teva Canada Limited | Resolved | 2024-02-14 | 107 | Manufacturing distruption | 219677 |
3584 | M05BA03 | PAMIDRONATE DISODIUM FOR INJEC... | 9MG | Pfizer Canada Ulc | Resolved | 2024-02-14 | Manufacturing distruption | 202767 | |
3586 | J05AB11 | TEVA-VALACYCLOVIR | 500MG | Teva Canada Limited | Resolved | 2024-02-14 | 56 | Manufacturing distruption | 219674 |
3587 | B01AF01 | TEVA-RIVAROXABAN | 15MG | Teva Canada Limited | Resolved | 2024-02-14 | 107 | Manufacturing distruption | 219671 |
3576 | G04CB01 | APO-FINASTERIDE | 5MG | Apotex Inc | Active | 2024-02-13 | Manufacturing distruption | 216684 | |
3569 | S01AE01 | OCUFLOX | 0.3% | Abbvie Corporation | Resolved | 2024-02-13 | 101 | Demand increase | 217532 |
3570 | V07AB | SODIUM CHLORIDE BACTERIOSTATIC... | 9MG | Omega Laboratories Limited | Resolved | 2024-02-13 | 45 | Manufacturing distruption | 216108 |
3571 | V08AB02 | OMNIPAQUE 300 | 647MG | Ge Healthcare Canada Inc | Resolved | 2024-02-13 | 7 | Demand increase | 217411 |
3572 | N05CM05 | SCOPOLAMINE HYDROBROMIDE INJEC... | 0.4MG | Omega Laboratories Limited | Resolved | 2024-02-13 | Demand increase | 218664 | |
3573 | A02BC01 | APO-OMEPRAZOLE | 20MG | Apotex Inc | Resolved | 2024-02-13 | 52 | Manufacturing distruption | 219840 |
3574 | C09AA04 | APO-PERINDOPRIL | 4MG | Apotex Inc | Resolved | 2024-02-13 | 31 | Manufacturing distruption | 219837 |
3575 | V03AE02 | RENVELA | 800MG | Sanofi-Aventis Canada Inc | Resolved | 2024-02-13 | 94 | Other | 219863 |
3577 | C10BX03 | APO-AMLODIPINE-ATORVASTATIN | 80MG 10MG | Apotex Inc | Resolved | 2024-02-13 | 115 | Manufacturing distruption | 219843 |
3578 | J02AC04 | POSANOL | 100MG | Merck Canada Inc | Resolved | 2024-02-13 | 21 | Demand increase | 219437 |
3579 | A06AX05 | APO-PRUCALOPRIDE | 1MG | Apotex Inc | Resolved | 2024-02-13 | 52 | Manufacturing distruption | 219834 |
3580 | L01CE02 | IRINOTECAN HYDROCHLORIDE INJEC... | 100MG | Auro Pharma Inc | Resolved | 2024-02-13 | Demand increase | 219467 | |
3581 | L01CE02 | IRINOTECAN HYDROCHLORIDE INJEC... | 500MG | Auro Pharma Inc | Resolved | 2024-02-13 | Demand increase | 219470 | |
3567 | J01DB01 | AURO-CEPHALEXIN | 125MG | Auro Pharma Inc | Active | 2024-02-12 | Demand increase | 219262 | |
3549 | C02AC01 | SANDOZ CLONIDINE | 0.1MG | Sandoz Canada Incorporated | Resolved | 2024-02-12 | 18 | Shipping delay | 219217 |
3550 | N05AE05 | SANDOZ LURASIDONE | 80MG | Sandoz Canada Incorporated | Resolved | 2024-02-12 | 25 | Shipping delay | 219228 |
3551 | N03AX22 | TARO-PERAMPANEL | 12MG | Taro Pharmaceuticals Inc | Resolved | 2024-02-12 | 32 | Manufacturing distruption | 222093 |
3552 | N06DA04 | MYLAN-GALANTAMINE ER | 16MG | Mylan Pharmaceuticals Ulc | Resolved | 2024-02-12 | 36 | Manufacturing distruption | 198994 |
3553 | N01AH01 | FENTANYL CITRATE INJECTION SDZ | 50MCG | Sandoz Canada Incorporated | Resolved | 2024-02-12 | 25 | Manufacturing distruption | 219224 |
3554 | N06AB06 | AURO-SERTRALINE | 25MG | Auro Pharma Inc | Resolved | 2024-02-12 | 65 | Demand increase | 219324 |
3555 | C09AA03 | AURO-LISINOPRIL | 10MG | Auro Pharma Inc | Resolved | 2024-02-12 | Demand increase | 219291 | |
3556 | R03DC03 | AURO-MONTELUKAST | 10MG | Auro Pharma Inc | Resolved | 2024-02-12 | 17 | Demand increase | 219302 |
3557 | A10BX02 | AURO-REPAGLINIDE | 0.5MG | Auro Pharma Inc | Resolved | 2024-02-12 | Demand increase | 219353 | |
3558 | A10BX02 | AURO-REPAGLINIDE | 1MG | Auro Pharma Inc | Resolved | 2024-02-12 | 46 | Demand increase | 219319 |
3559 | N06AX21 | AURO-DULOXETINE | 30MG | Auro Pharma Inc | Resolved | 2024-02-12 | 170 | Demand increase | 219267 |
3560 | N06AX21 | AURO-DULOXETINE | 60MG | Auro Pharma Inc | Resolved | 2024-02-12 | 124 | Demand increase | 219270 |
3561 | N06AX21 | SANDOZ DULOXETINE | 30MG | Sandoz Canada Incorporated | Resolved | 2024-02-12 | 46 | Manufacturing distruption | 219220 |
3562 | N06DA04 | GALANTAMINE ER | 8MG | Sanis Health Inc | Resolved | 2024-02-12 | 53 | Manufacturing distruption | 219378 |
3563 | N06AX16 | AURO-VENLAFAXINE XR | 150MG | Auro Pharma Inc | Resolved | 2024-02-12 | 52 | Demand increase | 219346 |
3564 | C09AA10 | AURO-TRANDOLAPRIL | 2MG | Auro Pharma Inc | Resolved | 2024-02-12 | Demand increase | 219339 | |
3565 | J01CR02 | SANDOZ AMOXI-CLAV TABLET | 125MG 875MG | Sandoz Canada Incorporated | Resolved | 2024-02-12 | 32 | Shipping delay | 219213 |
3566 | C09AA04 | M-PERINDOPRIL ERBUMINE | 8MG | Mantra Pharma Inc | Resolved | 2024-02-12 | 78 | Shipping delay | 225542 |
3568 | N05BE01 | AURO-BUSPIRONE | 10MG | Auro Pharma Inc | Resolved | 2024-02-12 | Demand increase | 219235 | |
3548 | A02BA01 | CIMETIDINE | 300MG | Aa Pharma Inc | Resolved | 2024-02-09 | 73 | Manufacturing distruption | 216222 |
3544 | A11DA01 | VITAMIN B1 | 100MG | Sandoz Canada Incorporated | Resolved | 2024-02-08 | 116 | Demand increase | 219763 |
3545 | A09AA02 | CREON MINIMICROSPHERES 25 | 1600UNIT 25500UNIT 25000UNIT | Bgp Pharma Ulc | Resolved | 2024-02-08 | 47 | Other | 221427 |
3546 | V01AA07 | HYMENOPTERA VENOM PRODUCT-WHIT... | 550MCG | Jubilant Hollisterstier Llc | Resolved | 2024-02-08 | 266 | Ingredient shortage | 219006 |
3547 | R03BA05 | FLOVENT HFA | 250MCG | Glaxosmithkline Inc | Resolved | 2024-02-08 | 15 | Shipping delay | 219434 |
3525 | L02BA01 | TEVA-TAMOXIFEN | 20MG | Teva Canada Limited | Active | 2024-02-07 | Other | 219038 | |
3541 | C10AX09 | TEVA-EZETIMIBE | 10MG | Teva Canada Limited | Active | 2024-02-07 | Manufacturing distruption | 218980 | |
3543 | L01AX03 | TEVA-TEMOZOLOMIDE | 5MG | Teva Canada Limited | Active | 2024-02-07 | Manufacturing distruption | 218986 | |
3526 | D07AC01 | TEVA-TOPILENE | 0.05% | Teva Canada Limited | Resolved | 2024-02-07 | 161 | Manufacturing distruption | 218949 |
3527 | C03CA01 | TEVA-FUROSEMIDE | 40MG | Teva Canada Limited | Resolved | 2024-02-07 | 369 | Manufacturing distruption | 218940 |
3528 | A07AA02 | TEVA-NYSTATIN | 100000UNIT | Teva Canada Limited | Resolved | 2024-02-07 | 154 | Manufacturing distruption | 218952 |
3529 | A07AA02 | TEVA-NYSTATIN | 100000UNIT | Teva Canada Limited | Resolved | 2024-02-07 | 407 | Manufacturing distruption | 218955 |
3530 | J01DB01 | TEVA-CEPHALEXIN | 500MG | Teva Canada Limited | Resolved | 2024-02-07 | 53 | Manufacturing distruption | 218943 |
3531 | N02AJ06 | TEVA-EMTEC-30 | 30MG 300MG | Teva Canada Limited | Resolved | 2024-02-07 | 42 | Manufacturing distruption | 218946 |
3532 | J01FF01 | TEVA-CLINDAMYCIN | 300MG | Teva Canada Limited | Resolved | 2024-02-07 | 73 | Manufacturing distruption | 218960 |
3533 | C10AB05 | AA-FENO-SUPER | 160MG | Aa Pharma Inc | Resolved | 2024-02-07 | 56 | Manufacturing distruption | 219018 |
3534 | G03CA03 | CLIMARA 25 | 25MCG | Bayer Inc | Resolved | 2024-02-07 | 134 | Other | 216236 |
3535 | N07BC02 | METADOL | 5MG | Paladin Labs Inc. | Resolved | 2024-02-07 | 47 | Shipping delay | 219424 |
3536 | S01EE01 | TEVA-LATANOPROST | 50MCG | Teva Canada Limited | Resolved | 2024-02-07 | 195 | Manufacturing distruption | 218963 |
3537 | L02BB03 | TEVA-BICALUTAMIDE | 50MG | Teva Canada Limited | Resolved | 2024-02-07 | 42 | Manufacturing distruption | 218966 |
3538 | G04BE03 | TEVA-SILDENAFIL | 25MG | Teva Canada Limited | Resolved | 2024-02-07 | 53 | Manufacturing distruption | 218971 |
3539 | N05AH04 | ACT QUETIAPINE | 100MG | Teva Canada Limited | Resolved | 2024-02-07 | 63 | Manufacturing distruption | 218974 |
3540 | N04BC04 | TEVA-ROPINIROLE | 0.25MG | Teva Canada Limited | Resolved | 2024-02-07 | 256 | Manufacturing distruption | 218977 |
3542 | N05AH04 | TEVA-QUETIAPINE XR | 400MG | Teva Canada Limited | Resolved | 2024-02-07 | 42 | Manufacturing distruption | 218983 |
3504 | H01CB02 | SANDOSTATIN | 100MCG | Novartis Pharmaceuticals Canada Inc | Active | 2024-02-06 | Manufacturing distruption | 218624 | |
3505 | J01XD01 | METRONIDAZOLE INJECTION, USP | 5MG | Baxter Corporation | Resolved | 2024-02-06 | 8 | Manufacturing distruption | 218656 |
3506 | M01AB05 | APO-DICLO SR | 100MG | Apotex Inc | Resolved | 2024-02-06 | 73 | Manufacturing distruption | 219177 |
3507 | N05BA06 | ATIVAN | 0.5MG | Pfizer Canada Ulc | Resolved | 2024-02-06 | 143 | Manufacturing distruption | 210709 |
3508 | N06AX05 | APO-TRAZODONE TABLETS 100MG | 100MG | Apotex Inc | Resolved | 2024-02-06 | 24 | Manufacturing distruption | 219122 |
3509 | M01AE02 | APO-NAPROXEN | 500MG | Apotex Inc | Resolved | 2024-02-06 | 80 | Manufacturing distruption | 219171 |
3510 | A02BC01 | APO-OMEPRAZOLE | 20MG | Apotex Inc | Resolved | 2024-02-06 | 87 | Manufacturing distruption | 219180 |
3511 | M01AE02 | APO-NAPROXEN EC TABLETS | 250MG | Apotex Inc | Resolved | 2024-02-06 | 52 | Ingredient shortage | 219165 |
3512 | A02BA03 | FAMOTIDINE OMEGA -(WITHOUT PR... | 10MG | Omega Laboratories Limited | Resolved | 2024-02-06 | 31 | Manufacturing distruption | 218659 |
3513 | C09AA09 | APO-FOSINOPRIL | 10MG | Apotex Inc | Resolved | 2024-02-06 | 10 | Manufacturing distruption | 219168 |
3514 | C01CA17 | APO-MIDODRINE | 2.5MG | Apotex Inc | Resolved | 2024-02-06 | 115 | Manufacturing distruption | 219162 |
3515 | N03AF02 | APO-OXCARBAZEPINE | 150MG | Apotex Inc | Resolved | 2024-02-06 | 101 | Manufacturing distruption | 219159 |
3516 | J01MA12 | APO-LEVOFLOXACIN | 250MG | Apotex Inc | Resolved | 2024-02-06 | 389 | Manufacturing distruption | 219156 |
3517 | N06AB10 | APO-ESCITALOPRAM | 20MG | Apotex Inc | Resolved | 2024-02-06 | 31 | Manufacturing distruption | 219144 |
3518 | A04AA02 | GRANISETRON HYDROCHLORIDE INJE... | 1MG | Omega Laboratories Limited | Resolved | 2024-02-06 | 38 | Demand increase | 217902 |
3519 | C10AC04 | LODALIS | 625MG | Bausch Health, Canada Inc. | Resolved | 2024-02-06 | 50 | Shipping delay | 217261 |
3520 | N06AX21 | APO-DULOXETINE | 30MG | Apotex Inc | Resolved | 2024-02-06 | 38 | Manufacturing distruption | 219174 |
3521 | C01EB17 | LANCORA | 5MG | Servier Canada Inc | Resolved | 2024-02-06 | 15 | Other | 218522 |
3522 | B01AE07 | APO-DABIGATRAN | 110MG | Apotex Inc | Resolved | 2024-02-06 | 24 | Manufacturing distruption | 219152 |
3523 | B01AE07 | APO-DABIGATRAN | 150MG | Apotex Inc | Resolved | 2024-02-06 | 17 | Manufacturing distruption | 219149 |
3524 | V03AC03 | APO-DEFERASIROX (TYPE J) | 360MG | Apotex Inc | Resolved | 2024-02-06 | 45 | Manufacturing distruption | 219141 |
3478 | D07AB08 | PDP-DESONIDE | 0.05% | Pendopharm Division Of Pharmascience Inc | Active | 2024-02-05 | 451 | Manufacturing distruption | 220290 |
3479 | N01BB51 | MARCAINE E | 0.182MG 100MG | Pfizer Canada Ulc | Active | 2024-02-05 | 427 | Manufacturing distruption | 213236 |
3493 | N06AB03 | JAMP-FLUOXETINE | 10MG | Jamp Pharma Corporation | Active | 2024-02-05 | 511 | Manufacturing distruption | 218706 |
3495 | J01MA14 | JAMP-MOXIFLOXACIN | 400MG | Jamp Pharma Corporation | Active | 2024-02-05 | 695 | Manufacturing distruption | 218879 |
3502 | L01EA01 | JAMP IMATINIB | 100MG | Jamp Pharma Corporation | Active | 2024-02-05 | 695 | Manufacturing distruption | 218839 |
3503 | L01EA01 | JAMP IMATINIB | 400MG | Jamp Pharma Corporation | Active | 2024-02-05 | 695 | Manufacturing distruption | 218844 |
3483 | L01AX03 | TEMODAL | 140MG | Merck Canada Inc | Avoided | 2024-02-05 | 7 | Shipping delay | 212123 |
3473 | R03DC03 | JAMP MONTELUKAST CHEWABLE TABL... | 4MG | Jamp Pharma Corporation | Resolved | 2024-02-05 | 39 | Manufacturing distruption | 218697 |
3474 | D10AD53 | SANDOZ ADAPALENE / BENZOYL PER... | 2.5% 0.3% | Sandoz Canada Incorporated | Resolved | 2024-02-05 | 32 | Shipping delay | 218447 |
3475 | A02BC05 | ESOMEPRAZOLE | 20MG | Jamp Pharma Corporation | Resolved | 2024-02-05 | 208 | Manufacturing distruption | 218836 |
3476 | C02KX02 | SANDOZ AMBRISENTAN TABLETS | 10MG | Sandoz Canada Incorporated | Resolved | 2024-02-05 | 74 | Manufacturing distruption | 218454 |
3477 | N05CD02 | MOGADON | 5MG | Aa Pharma Inc | Resolved | 2024-02-05 | 73 | Manufacturing distruption | 216225 |
3480 | A10BA02 | SANDOZ METFORMIN FC | 500MG | Sandoz Canada Incorporated | Resolved | 2024-02-05 | 25 | Manufacturing distruption | 218474 |
3481 | C10AX09 | EZETROL | 10MG | Organon Canada Inc. | Resolved | 2024-02-05 | 18 | Shipping delay | 218689 |
3482 | C09BA03 | SANDOZ LISINOPRIL HCT | 25MG 20MG | Sandoz Canada Incorporated | Resolved | 2024-02-05 | 417 | Ingredient shortage | 218465 |
3484 | N05AH04 | JAMP-QUETIAPINE | 100MG | Jamp Pharma Corporation | Resolved | 2024-02-05 | 331 | Other | 218725 |
3485 | G04CA02 | JAMP TAMSULOSIN | 0.4MG | Jamp Pharma Corporation | Resolved | 2024-02-05 | 91 | Demand increase | 218723 |
3486 | C09CA03 | SANDOZ VALSARTAN | 80MG | Sandoz Canada Incorporated | Resolved | 2024-02-05 | 18 | Shipping delay | 218477 |
3487 | L04AA06 | JAMP-MYCOPHENOLATE | 500MG | Jamp Pharma Corporation | Resolved | 2024-02-05 | 39 | Manufacturing distruption | 218720 |
3488 | L04AA06 | JAMP-MYCOPHENOLATE CAPSULES | 250MG | Jamp Pharma Corporation | Resolved | 2024-02-05 | 39 | Manufacturing distruption | 218727 |
3489 | C09CA06 | JAMP-CANDESARTAN | 8MG | Jamp Pharma Corporation | Resolved | 2024-02-05 | 70 | Demand increase | 218717 |
3490 | C09CA06 | JAMP-CANDESARTAN | 16MG | Jamp Pharma Corporation | Resolved | 2024-02-05 | 116 | Demand increase | 218712 |
3491 | C09CA06 | JAMP-CANDESARTAN | 32MG | Jamp Pharma Corporation | Resolved | 2024-02-05 | 146 | Demand increase | 218709 |
3492 | C09CA01 | JAMP-LOSARTAN | 25MG | Jamp Pharma Corporation | Resolved | 2024-02-05 | 305 | Manufacturing distruption | 218703 |
3494 | G04CA02 | TAMSULOSIN CR | 0.4MG | Sivem Pharmaceuticals Ulc | Resolved | 2024-02-05 | 148 | Manufacturing distruption | 218433 |
3496 | C09DA06 | JAMP CANDESARTAN-HCT | 12.5MG 16MG | Jamp Pharma Corporation | Resolved | 2024-02-05 | 161 | Demand increase | 218700 |
3497 | C09AA02 | JAMP ENALAPRIL | 2.5MG | Jamp Pharma Corporation | Resolved | 2024-02-05 | 39 | Manufacturing distruption | 218874 |
3498 | C09AA02 | JAMP ENALAPRIL | 5MG | Jamp Pharma Corporation | Resolved | 2024-02-05 | 39 | Manufacturing distruption | 218861 |
3499 | C09AA02 | JAMP ENALAPRIL | 10MG | Jamp Pharma Corporation | Resolved | 2024-02-05 | 39 | Manufacturing distruption | 218852 |
3500 | C09AA02 | JAMP ENALAPRIL | 20MG | Jamp Pharma Corporation | Resolved | 2024-02-05 | 39 | Manufacturing distruption | 218847 |
3501 | B01AF01 | TARO-RIVAROXABAN | 20MG | Taro Pharmaceuticals Inc | Resolved | 2024-02-05 | 46 | Manufacturing distruption | 222101 |
3470 | L01BA01 | METHOTREXATE INJECTION BP | 25MG | Accord Healthcare Inc | Active | 2024-02-02 | Shipping delay | 218309 | |
3461 | A06AA02 | SOFLAX CAPSULES 100MG | 100MG | Pharmascience Inc | Resolved | 2024-02-02 | 55 | Manufacturing distruption | 218770 |
3462 | A06AA02 | SOFLAX CAPSULES 100MG | 100MG | Pharmascience Inc | Resolved | 2024-02-02 | 74 | Manufacturing distruption | 218773 |
3463 | B05XA05 | MAGNESIUM SULFATE INJECTION, U... | 500MG | Fresenius Kabi Canada Ltd | Resolved | 2024-02-02 | 88 | Manufacturing distruption | 217935 |
3464 | C09DA04 | PMS-IRBESARTAN-HCTZ | 25MG 300MG | Pharmascience Inc | Resolved | 2024-02-02 | 131 | Manufacturing distruption | 218776 |
3465 | G04BE08 | PMS-TADALAFIL | 5MG | Pharmascience Inc | Resolved | 2024-02-02 | 74 | Manufacturing distruption | 218779 |
3466 | G04BE08 | PMS-TADALAFIL | 10MG | Pharmascience Inc | Resolved | 2024-02-02 | 46 | Manufacturing distruption | 218782 |
3467 | C10AA07 | ACH-ROSUVASTATIN | 5MG | Accord Healthcare Inc | Resolved | 2024-02-02 | 231 | Manufacturing distruption | 218314 |
3468 | N06DA02 | NAT-DONEPEZIL | 5MG | Natco Pharma (Canada) Inc | Resolved | 2024-02-02 | Other | 218262 | |
3469 | N06AB10 | NAT-ESCITALOPRAM | 20MG | Natco Pharma (Canada) Inc | Resolved | 2024-02-02 | Shipping delay | 218258 | |
3471 | B01AF02 | ACH-APIXABAN | 2.5MG | Accord Healthcare Inc | Resolved | 2024-02-02 | 42 | Manufacturing distruption | 218339 |
3472 | N02CD02 | EMGALITY | 120MG | Eli Lilly Canada Inc | Resolved | 2024-02-02 | 35 | Demand increase | 218192 |
3460 | L02BB03 | ACH-BICALUTAMIDE | 50MG | Accord Healthcare Inc | Active | 2024-02-01 | Manufacturing practices | 251375 | |
3452 | R07AA02 | SURVANTA | 25MG | Abbvie Corporation | Avoided | 2024-02-01 | 148 | Manufacturing distruption | 206915 |
3451 | C02AC01 | MAR-CLONIDINE | 0.025MG | Marcan Pharmaceuticals Inc | Resolved | 2024-02-01 | 59 | Demand increase | 216012 |
3453 | V08AB09 | VISIPAQUE 320 | 652MG | Ge Healthcare Canada Inc | Resolved | 2024-02-01 | 12 | Demand increase | 217414 |
3454 | V08AB09 | VISIPAQUE 320 | 652MG | Ge Healthcare Canada Inc | Resolved | 2024-02-01 | 20 | Demand increase | 217420 |
3455 | H01AC01 | SAIZEN | 5MG | Emd Serono, A Division Of Emd Inc., Canada | Resolved | 2024-02-01 | 29 | Shipping delay | 217970 |
3456 | B01AA03 | TARO-WARFARIN | 6MG | Taro Pharmaceuticals Inc | Resolved | 2024-02-01 | 56 | Manufacturing distruption | 222113 |
3457 | M01AB15 | KETOROLAC TROMETHAMINE INJECTI... | 30MG | Fresenius Kabi Canada Ltd | Resolved | 2024-02-01 | 19 | Manufacturing distruption | 217938 |
3458 | C10AB05 | AA-FENO-SUPER | 100MG | Aa Pharma Inc | Resolved | 2024-02-01 | 62 | Manufacturing distruption | 217948 |
3459 | B01AF01 | XARELTO | 10MG | Bayer Inc | Resolved | 2024-02-01 | 14 | Demand increase | 215603 |
3441 | B05AA55 | LMD 10% IN DEXTROSE 5% | 5% 10% | Pfizer Canada Ulc | Active | 2024-01-31 | 455 | Manufacturing distruption | 213206 |
3443 | C09CA06 | TARO-CANDESARTAN | 16MG | Sun Pharma Canada Inc | Active | 2024-01-31 | 450 | Manufacturing distruption | 240421 |
3449 | N01AX07 | TOMVI | 2MG | Sterimax Inc | Avoided | 2024-01-31 | 0 | Shipping delay | 211209 |
3440 | N06BA02 | DEXEDRINE SPANSULE SRC 15MG | 15MG | Paladin Labs Inc. | Resolved | 2024-01-31 | 54 | Shipping delay | 220374 |
3442 | A02BC02 | SANDOZ PANTOPRAZOLE | 20MG | Sandoz Canada Incorporated | Resolved | 2024-01-31 | 37 | Manufacturing practices | 218020 |
3444 | R01AD09 | SANDOZ MOMETASONE | 50MCG | Sandoz Canada Incorporated | Resolved | 2024-01-31 | 45 | Manufacturing distruption | 218015 |
3445 | N03AX14 | SANDOZ LEVETIRACETAM | 1000MG | Sandoz Canada Incorporated | Resolved | 2024-01-31 | 16 | Manufacturing distruption | 218012 |
3446 | J05AX18 | PREVYMIS | 20MG | Merck Canada Inc | Resolved | 2024-01-31 | 65 | Demand increase | 210157 |
3447 | J01XX01 | IVOZFO | 4G | Verity Pharmaceuticals Inc. | Resolved | 2024-01-31 | 120 | Other | 210486 |
3448 | J02AC04 | SANDOZ POSACONAZOLE | 100MG | Sandoz Canada Incorporated | Resolved | 2024-01-31 | 79 | Manufacturing distruption | 218024 |
3450 | C01CA06 | PHENYLEPHRINE HYDROCHLORIDE IN... | 10MG | Sterimax Inc | Resolved | 2024-01-31 | 58 | Shipping delay | 218216 |
3434 | L01BC05 | GEMCITABINE INJECTION | 38MG | Pfizer Canada Ulc | Avoided | 2024-01-30 | Manufacturing distruption | 215539 | |
3417 | J01AA02 | APO-DOXYCYCLINE MR | 40MG | Apotex Inc | Resolved | 2024-01-30 | 45 | Manufacturing distruption | 218403 |
3418 | C08DA01 | APO-VERAP TAB 80MG | 80MG | Apotex Inc | Resolved | 2024-01-30 | 80 | Manufacturing distruption | 218394 |
3419 | C02KX02 | SANDOZ AMBRISENTAN TABLETS | 5MG | Sandoz Canada Incorporated | Resolved | 2024-01-30 | 80 | Manufacturing practices | 217887 |
3420 | V08AB02 | OMNIPAQUE 300 | 647MG | Ge Healthcare Canada Inc | Resolved | 2024-01-30 | 22 | Demand increase | 217417 |
3421 | M01AE02 | TEVA-NAPROXEN | 500MG | Teva Canada Limited | Resolved | 2024-01-30 | 91 | Manufacturing distruption | 218123 |
3422 | M01AE02 | TEVA-NAPROXEN | 500MG | Teva Canada Limited | Resolved | 2024-01-30 | 101 | Manufacturing distruption | 218126 |
3423 | C10AA03 | APO-PRAVASTATIN | 10MG | Apotex Inc | Resolved | 2024-01-30 | 73 | Manufacturing distruption | 218400 |
3424 | C10AA03 | APO-PRAVASTATIN | 40MG | Apotex Inc | Resolved | 2024-01-30 | 73 | Manufacturing distruption | 218397 |
3425 | C09AA05 | APO-RAMIPRIL | 1.25MG | Apotex Inc | Resolved | 2024-01-30 | 31 | Manufacturing distruption | 218388 |
3426 | N07CA01 | TEVA-BETAHISTINE | 24MG | Teva Canada Limited | Resolved | 2024-01-30 | 101 | Manufacturing distruption | 218129 |
3427 | N02AB03 | TEVA-FENTANYL | 25MCG | Teva Canada Limited | Resolved | 2024-01-30 | 122 | Manufacturing distruption | 218132 |
3428 | N02AB03 | TEVA-FENTANYL | 25MCG | Teva Canada Limited | Resolved | 2024-01-30 | 0 | Manufacturing distruption | 218134 |
3429 | N02AB03 | TEVA-FENTANYL | 50MCG | Teva Canada Limited | Resolved | 2024-01-30 | 122 | Manufacturing distruption | 218137 |
3430 | N03AX14 | APO-LEVETIRACETAM | 750MG | Apotex Inc | Resolved | 2024-01-30 | 45 | Manufacturing distruption | 218370 |
3431 | C09AA04 | APO-PERINDOPRIL | 4MG | Apotex Inc | Resolved | 2024-01-30 | 45 | Manufacturing distruption | 218385 |
3432 | C10AA05 | APO-ATORVASTATIN | 40MG | Apotex Inc | Resolved | 2024-01-30 | 52 | Manufacturing distruption | 218373 |
3433 | N06BA04 | APO-METHYLPHENIDATE ER | 54MG | Apotex Inc | Resolved | 2024-01-30 | 24 | Manufacturing distruption | 218376 |
3435 | G03AA12 | ZAMINE 21 | 0.03MG 3MG | Apotex Inc | Resolved | 2024-01-30 | 66 | Manufacturing distruption | 218391 |
3436 | N06BA02 | ACT DEXTROAMPHETAMINE SR | 10MG | Teva Canada Limited | Resolved | 2024-01-30 | 91 | Manufacturing distruption | 218145 |
3437 | H05BX01 | APO-CINACALCET | 60MG | Apotex Inc | Resolved | 2024-01-30 | 59 | Manufacturing distruption | 218382 |
3438 | A10BB09 | SANDOZ GLICLAZIDE MR | 60MG | Sandoz Canada Incorporated | Resolved | 2024-01-30 | Manufacturing distruption | 217890 | |
3439 | APO-MELOXICAM | 1.5G | Apotex Inc | Resolved | 2024-01-30 | Manufacturing distruption | 218379 | ||
3383 | A10BH01 | AURO-SITAGLIPTIN | 50MG | Auro Pharma Inc | Resolved | 2024-01-29 | Demand increase | 217667 | |
3384 | V08AB05 | ULTRAVIST 300 | 62% | Bayer Inc | Resolved | 2024-01-29 | 221 | Manufacturing distruption | 224122 |
3385 | V08AB05 | ULTRAVIST 300 | 62% | Bayer Inc | Resolved | 2024-01-29 | Manufacturing distruption | 224127 | |
3386 | V08AB05 | ULTRAVIST 300 | 62% | Bayer Inc | Resolved | 2024-01-29 | 149 | Manufacturing distruption | 215772 |
3387 | V08AB05 | ULTRAVIST 370 | 77% | Bayer Inc | Resolved | 2024-01-29 | 95 | Manufacturing distruption | 218759 |
3388 | V08AB05 | ULTRAVIST 370 | 77% | Bayer Inc | Resolved | 2024-01-29 | 214 | Manufacturing distruption | 215779 |
3389 | V08AB05 | ULTRAVIST 370 | 77% | Bayer Inc | Resolved | 2024-01-29 | 88 | Manufacturing distruption | 215787 |
3390 | V08AB05 | ULTRAVIST 370 | 77% | Bayer Inc | Resolved | 2024-01-29 | 64 | Manufacturing distruption | 215790 |
3391 | L01AA01 | PROCYTOX | 2000MG | Baxter Corporation | Resolved | 2024-01-29 | 46 | Manufacturing distruption | 217583 |
3392 | J01DC10 | AURO-CEFPROZIL | 500MG | Auro Pharma Inc | Resolved | 2024-01-29 | 123 | Demand increase | 217630 |
3393 | J01CA04 | AMOXICILLIN | 250MG | Sanis Health Inc | Resolved | 2024-01-29 | 84 | Manufacturing distruption | 217816 |
3394 | N02BF01 | GABAPENTIN | 100MG | Sanis Health Inc | Resolved | 2024-01-29 | 47 | Manufacturing distruption | 217766 |
3395 | N03AX14 | LEVETIRACETAM | 250MG | Sanis Health Inc | Resolved | 2024-01-29 | 46 | Manufacturing distruption | 217793 |
3396 | N06AB06 | SERTRALINE | 50MG | Sanis Health Inc | Resolved | 2024-01-29 | 121 | Manufacturing distruption | 217783 |
3397 | C07AG02 | CARVEDILOL | 6.25MG | Sanis Health Inc | Resolved | 2024-01-29 | 11 | Manufacturing distruption | 217832 |
3398 | C09DA04 | IRBESARTAN/HCTZ | 25MG 300MG | Sanis Health Inc | Resolved | 2024-01-29 | 49 | Manufacturing distruption | 217829 |
3399 | N03AX14 | AURO-LEVETIRACETAM | 250MG | Auro Pharma Inc | Resolved | 2024-01-29 | 46 | Demand increase | 217649 |
3400 | N03AX09 | AURO-LAMOTRIGINE | 150MG | Auro Pharma Inc | Resolved | 2024-01-29 | 60 | Demand increase | 217646 |
3401 | J01MA02 | AURO-CIPROFLOXACIN | 500MG | Auro Pharma Inc | Resolved | 2024-01-29 | 60 | Demand increase | 217633 |
3402 | C09CA06 | CANDESARTAN | 8MG | Sanis Health Inc | Resolved | 2024-01-29 | 88 | Manufacturing distruption | 217790 |
3403 | N05AH04 | AURO-QUETIAPINE | 200MG | Auro Pharma Inc | Resolved | 2024-01-29 | 230 | Demand increase | 217661 |
3404 | C09CA03 | AURO-VALSARTAN | 40MG | Auro Pharma Inc | Resolved | 2024-01-29 | 30 | Demand increase | 217675 |
3405 | C09CA03 | AURO-VALSARTAN | 80MG | Auro Pharma Inc | Resolved | 2024-01-29 | 276 | Demand increase | 217678 |
3406 | N04BC05 | AURO-PRAMIPEXOLE | 1MG | Auro Pharma Inc | Resolved | 2024-01-29 | 46 | Demand increase | 217658 |
3407 | A02BC05 | ESOMEPRAZOLE | 40MG | Sanis Health Inc | Resolved | 2024-01-29 | 4 | Manufacturing distruption | 217837 |
3408 | A10BA02 | AURO-METFORMIN | 500MG | Auro Pharma Inc | Resolved | 2024-01-29 | 79 | Demand increase | 217652 |
3409 | C10AA07 | AURO-ROSUVASTATIN | 5MG | Auro Pharma Inc | Resolved | 2024-01-29 | 245 | Demand increase | 217664 |
3410 | L04AA06 | MYCOPHENOLATE MOFETIL | 500MG | Sanis Health Inc | Resolved | 2024-01-29 | 11 | Manufacturing distruption | 217798 |
3411 | G04BD08 | SOLIFENACIN | 5MG | Sanis Health Inc | Resolved | 2024-01-29 | 179 | Manufacturing distruption | 217809 |
3412 | J05AF07 | AURO-TENOFOVIR | 300MG | Auro Pharma Inc | Resolved | 2024-01-29 | 291 | Demand increase | 217670 |
3413 | G04CB02 | AURO-DUTASTERIDE | 0.5MG | Auro Pharma Inc | Resolved | 2024-01-29 | 138 | Demand increase | 217636 |
3414 | P01AB01 | AURO-METRONIDAZOLE | 500MG | Auro Pharma Inc | Resolved | 2024-01-29 | 107 | Demand increase | 217655 |
3415 | N03AX18 | AURO-LACOSAMIDE | 50MG | Auro Pharma Inc | Resolved | 2024-01-29 | 17 | Demand increase | 217643 |
3416 | N03AX18 | AURO-LACOSAMIDE | 150MG | Auro Pharma Inc | Resolved | 2024-01-29 | 184 | Demand increase | 217639 |
3382 | V09IB01 | OCTREOSCAN | 10MCG 111MBq | Curium Canada Inc | Resolved | 2024-01-28 | Ingredient shortage | 216132 | |
3377 | L02BG04 | ACH-LETROZOLE | 2.5MG | Accord Healthcare Inc | Active | 2024-01-26 | Manufacturing practices | 217355 | |
3379 | C09CA06 | ACH-CANDESARTAN | 32MG | Accord Healthcare Inc | Active | 2024-01-26 | Demand increase | 217363 | |
3371 | D06BX01 | NORITATE | 1% | Bausch Health, Canada Inc. | Resolved | 2024-01-26 | 50 | Other | 213952 |
3372 | L01BC02 | EFUDEX | 5% | Bausch Health, Canada Inc. | Resolved | 2024-01-26 | 110 | Other | 213446 |
3373 | D07AC03 | TOPICORT | 0.05% | Bausch Health, Canada Inc. | Resolved | 2024-01-26 | 28 | Other | 211244 |
3374 | V08AB02 | OMNIPAQUE 240 | 518MG | Ge Healthcare Canada Inc | Resolved | 2024-01-26 | 23 | Other | 217288 |
3375 | B05XA01 | POTASSIUM CHLORIDE INJECTION | 20mEq | Baxter Corporation | Resolved | 2024-01-26 | 19 | Manufacturing distruption | 218224 |
3376 | N06BA04 | APO-METHYLPHENIDATE ER | 54MG | Apotex Inc | Resolved | 2024-01-26 | 28 | Manufacturing distruption | 217300 |
3378 | D10AF51 | BIACNA TOPICAL GEL | 0.025% 1.2% | Bausch Health, Canada Inc. | Resolved | 2024-01-26 | 7 | Other | 213471 |
3380 | C10AA07 | ACH-ROSUVASTATIN | 10MG | Accord Healthcare Inc | Resolved | 2024-01-26 | 221 | Manufacturing distruption | 217358 |
3381 | C10AA05 | ACH-ATORVASTATIN CALCIUM | 10MG | Accord Healthcare Inc | Resolved | 2024-01-26 | 47 | Demand increase | 217342 |
3370 | L01BB04 | CLADRIBINE INJECTION | 1MG | Generic Medical Partners Inc | Active | 2024-01-25 | 32 | Demand increase | 220112 |
3366 | A10BB09 | APO-GLICLAZIDE | 80MG | Apotex Inc | Resolved | 2024-01-25 | 50 | Manufacturing distruption | 217487 |
3367 | R03DX05 | XOLAIR | 150MG | Novartis Pharmaceuticals Canada Inc | Resolved | 2024-01-25 | 66 | Shipping delay | 211221 |
3368 | N03AX22 | FYCOMPA | 4.0MG | Eisai Limited | Resolved | 2024-01-25 | 11 | Demand increase | 216471 |
3369 | L01BB04 | CLADRIBINE INJECTION | 1MG | Generic Medical Partners Inc | Resolved | 2024-01-25 | 21 | Demand increase | 217270 |
3353 | S01GX05 | ALOMIDE | 0.1% | Novartis Pharmaceuticals Canada Inc | Resolved | 2024-01-24 | 82 | Demand increase | 217088 |
3354 | J07BC02 | VAQTA | 50UNIT | Merck Canada Inc | Resolved | 2024-01-24 | 68 | Demand increase | 217125 |
3355 | L04AA06 | CELLCEPT | 500MG | Hoffmann-La Roche Limited | Resolved | 2024-01-24 | 47 | Shipping delay | 217099 |
3356 | N02AB03 | TEVA-FENTANYL | 100MCG | Teva Canada Limited | Resolved | 2024-01-24 | 107 | Manufacturing distruption | 217223 |
3357 | A02BC01 | TEVA-OMEPRAZOLE | 10MG | Teva Canada Limited | Resolved | 2024-01-24 | 56 | Manufacturing distruption | 217229 |
3358 | A02BC01 | TEVA-OMEPRAZOLE | 10MG | Teva Canada Limited | Resolved | 2024-01-24 | 148 | Manufacturing distruption | 217231 |
3359 | A02BC01 | TEVA-OMEPRAZOLE | 20MG | Teva Canada Limited | Resolved | 2024-01-24 | 56 | Manufacturing distruption | 217226 |
3360 | N01BB02 | XYLOCAINE 2% | 20MG | Aspen Pharmacare Canada Inc. | Resolved | 2024-01-24 | 33 | Manufacturing distruption | 218682 |
3361 | J05AG04 | INTELENCE | 100MG | Janssen Inc | Resolved | 2024-01-24 | 21 | Demand increase | 217120 |
3362 | L02BG04 | PMS-LETROZOLE | 2.5MG | Pharmascience Inc | Resolved | 2024-01-24 | 34 | Manufacturing distruption | 217128 |
3363 | C09CA04 | TEVA-IRBESARTAN | 75MG | Teva Canada Limited | Resolved | 2024-01-24 | Manufacturing distruption | 217234 | |
3364 | C09CA06 | TEVA-CANDESARTAN | 32MG | Teva Canada Limited | Resolved | 2024-01-24 | 27 | Manufacturing distruption | 217237 |
3365 | M01AE52 | MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 500MG | Mylan Pharmaceuticals Ulc | Resolved | 2024-01-24 | 8 | Manufacturing distruption | 217867 |
3334 | N05BE01 | APO-BUSPIRONE | 10MG | Apotex Inc | Active | 2024-01-23 | Manufacturing distruption | 217484 | |
3335 | B05XC | MULTI 1000 | 1.2MG 10MG 1MG 4.5MG 1UNIT 100UNIT 1000UNIT 100MG 2.6MG | Sandoz Canada Incorporated | Resolved | 2024-01-23 | 66 | Manufacturing practices | 216971 |
3336 | G03FA01 | ESTALIS 140/50 MCG | 140MCG 50MCG | Sandoz Canada Incorporated | Resolved | 2024-01-23 | 24 | Manufacturing practices | 217041 |
3337 | G03CA03 | ESTRADOT 37.5 | 37.5MCG | Sandoz Canada Incorporated | Resolved | 2024-01-23 | 101 | Manufacturing distruption | 217044 |
3338 | R03BA05 | FLOVENT HFA | 125MCG | Glaxosmithkline Inc | Resolved | 2024-01-23 | 45 | Demand increase | 217406 |
3339 | J01CR02 | APO-AMOXI CLAV | 125MG 875MG | Apotex Inc | Resolved | 2024-01-23 | 52 | Manufacturing distruption | 217490 |
3340 | N06AX02 | APO-TRYPTOPHAN | 500MG | Apotex Inc | Resolved | 2024-01-23 | 73 | Manufacturing distruption | 217469 |
3341 | J01MA02 | SANDOZ CIPROFLOXACIN | 750MG | Sandoz Canada Incorporated | Resolved | 2024-01-23 | 10 | Manufacturing distruption | 217033 |
3342 | C01CA17 | APO-MIDODRINE | 5MG | Apotex Inc | Resolved | 2024-01-23 | 122 | Manufacturing distruption | 217472 |
3343 | C10AA05 | APO-ATORVASTATIN | 80MG | Apotex Inc | Resolved | 2024-01-23 | 24 | Manufacturing distruption | 217478 |
3344 | B01AB01 | HEPARIN SODIUM INJECTION USP ... | 1000UNIT | Sandoz Canada Incorporated | Resolved | 2024-01-23 | 31 | Manufacturing distruption | 217049 |
3345 | N05AH03 | OLANZAPINE | 10MG | Pro Doc Limitee | Resolved | 2024-01-23 | 29 | Shipping delay | 218231 |
3346 | C05BB04 | TROMBOJECT 1% | 10MG | Omega Laboratories Limited | Resolved | 2024-01-23 | 75 | Manufacturing distruption | 216046 |
3347 | N02CC04 | SANDOZ RIZATRIPTAN ODT | 5MG | Sandoz Canada Incorporated | Resolved | 2024-01-23 | 60 | Manufacturing distruption | 217053 |
3348 | G04BD08 | SANDOZ SOLIFENACIN | 5MG | Sandoz Canada Incorporated | Resolved | 2024-01-23 | 17 | Manufacturing distruption | 217056 |
3349 | A10BB09 | APO-GLICLAZIDE MR | 60MG | Apotex Inc | Resolved | 2024-01-23 | 192 | Manufacturing distruption | 217481 |
3350 | J01FF01 | CLINDAMYCIN IV INFUSION | 18MG | Sandoz Canada Incorporated | Resolved | 2024-01-23 | 73 | Shipping delay | 217037 |
3351 | G03AA12 | ZAMINE 28 | 0.03MG 3MG | Apotex Inc | Resolved | 2024-01-23 | 45 | Manufacturing distruption | 217475 |
3352 | J01CR02 | SANDOZ AMOXI-CLAV TABLET | 125MG 875MG | Sandoz Canada Incorporated | Resolved | 2024-01-23 | 17 | Manufacturing distruption | 217029 |
3330 | B05XA01 | POTASSIUM CHLORIDE FOR INJECTI... | 20mEq | Omega Laboratories Limited | Resolved | 2024-01-22 | 130 | Manufacturing distruption | 216968 |
3331 | J07BC02 | AVAXIM | 160UNIT | Sanofi Pasteur Limited | Resolved | 2024-01-22 | 172 | Demand increase | 216069 |
3332 | A10AB05 | NOVORAPID | 100UNIT | Novo Nordisk Canada Inc | Resolved | 2024-01-22 | 18 | Manufacturing distruption | 216886 |
3333 | N06AX11 | MYLAN-MIRTAZAPINE | 30MG | Mylan Pharmaceuticals Ulc | Resolved | 2024-01-22 | 101 | Manufacturing distruption | 216953 |
3329 | N02AX02 | TRIDURAL | 200MG | Paladin Labs Inc. | Active | 2024-01-20 | 437 | Shipping delay | 221609 |
3304 | N05AH04 | QUETIAPINE XR | 50MG | Jamp Pharma Corporation | Active | 2024-01-19 | 712 | Manufacturing distruption | 216847 |
3305 | N05AH04 | QUETIAPINE XR | 150MG | Jamp Pharma Corporation | Active | 2024-01-19 | 712 | Manufacturing distruption | 216835 |
3306 | N05AH04 | QUETIAPINE XR | 200MG | Jamp Pharma Corporation | Active | 2024-01-19 | 712 | Manufacturing distruption | 216838 |
3307 | N05AH04 | QUETIAPINE XR | 300MG | Jamp Pharma Corporation | Active | 2024-01-19 | 712 | Manufacturing distruption | 216841 |
3308 | N05AH04 | QUETIAPINE XR | 400MG | Jamp Pharma Corporation | Active | 2024-01-19 | 712 | Manufacturing distruption | 216844 |
3310 | M05BA04 | ACH-ALENDRONATE | 70MG | Accord Healthcare Inc | Active | 2024-01-19 | Manufacturing practices | 216767 | |
3312 | N05AH04 | QUETIAPINE TABLETS | 25MG | Accord Healthcare Inc | Active | 2024-01-19 | Manufacturing practices | 216811 | |
3317 | C09CA07 | ACH-TELMISARTAN | 40MG | Accord Healthcare Inc | Active | 2024-01-19 | Manufacturing practices | 216814 | |
3319 | N02BF01 | GABAPENTIN CAPSULES USP | 100MG | Accord Healthcare Inc | Active | 2024-01-19 | Manufacturing practices | 216785 | |
3320 | A02BC01 | JAMP-OMEPRAZOLE DR | 20MG | Jamp Pharma Corporation | Active | 2024-01-19 | 712 | Manufacturing distruption | 216850 |
3321 | A02BC01 | JAMP-OMEPRAZOLE DR | 20MG | Jamp Pharma Corporation | Active | 2024-01-19 | 712 | Manufacturing distruption | 216853 |
3322 | A02BC01 | JAMP-OMEPRAZOLE DR | 20MG | Jamp Pharma Corporation | Active | 2024-01-19 | 712 | Manufacturing distruption | 216856 |
3323 | C10AX09 | ACH-EZETIMIBE | 10MG | Accord Healthcare Inc | Active | 2024-01-19 | Manufacturing practices | 216782 | |
3325 | C09CA08 | ACH-OLMESARTAN | 40MG | Accord Healthcare Inc | Active | 2024-01-19 | Manufacturing practices | 216791 | |
3311 | G03AA12 | YAZ PLUS | 0.451MG 0.451MG 0.02MG 3.00MG | Bayer Inc | Avoided | 2024-01-19 | 7 | Other | 215319 |
3309 | C09CA06 | ACH-CANDESARTAN | 8MG | Accord Healthcare Inc | Resolved | 2024-01-19 | 56 | Manufacturing distruption | 216779 |
3313 | N05AH04 | QUETIAPINE TABLETS | 100MG | Accord Healthcare Inc | Resolved | 2024-01-19 | 49 | Manufacturing distruption | 216802 |
3314 | N05AH04 | QUETIAPINE TABLETS | 150MG | Accord Healthcare Inc | Resolved | 2024-01-19 | 54 | Manufacturing distruption | 216805 |
3315 | N05AH04 | QUETIAPINE TABLETS | 200MG | Accord Healthcare Inc | Resolved | 2024-01-19 | 53 | Manufacturing distruption | 216808 |
3316 | N03AX14 | ACH-LEVETIRACETAM | 500MG | Accord Healthcare Inc | Resolved | 2024-01-19 | 46 | Manufacturing practices | 216788 |
3318 | A02BC01 | OMEPRAZOLE MAGNESIUM DELAYED R... | 20MG | Accord Healthcare Inc | Resolved | 2024-01-19 | 49 | Manufacturing distruption | 216794 |
3324 | N02BF02 | ACH-PREGABALIN | 75MG | Accord Healthcare Inc | Resolved | 2024-01-19 | 47 | Manufacturing distruption | 216797 |
3326 | C10AA05 | ACH-ATORVASTATIN CALCIUM | 20MG | Accord Healthcare Inc | Resolved | 2024-01-19 | 49 | Manufacturing distruption | 216770 |
3327 | C10AA05 | ACH-ATORVASTATIN CALCIUM | 40MG | Accord Healthcare Inc | Resolved | 2024-01-19 | 49 | Manufacturing distruption | 216773 |
3328 | C10AA05 | ACH-ATORVASTATIN CALCIUM | 80MG | Accord Healthcare Inc | Resolved | 2024-01-19 | 46 | Manufacturing distruption | 216776 |
3280 | N05AH04 | MINT-QUETIAPINE XR | 50MG | Mint Pharmaceuticals Inc | Active | 2024-01-18 | 468 | Manufacturing distruption | 217384 |
3281 | N05AH04 | MINT-QUETIAPINE XR | 400MG | Mint Pharmaceuticals Inc | Active | 2024-01-18 | 468 | Manufacturing distruption | 217396 |
3282 | N05AH04 | MINT-QUETIAPINE XR | 150MG | Mint Pharmaceuticals Inc | Active | 2024-01-18 | 468 | Manufacturing distruption | 217387 |
3286 | M05BA07 | TEVA-RISEDRONATE | 30MG | Teva Canada Limited | Active | 2024-01-18 | Manufacturing distruption | 216497 | |
3294 | M05BA04 | MINT-ALENDRONATE | 70.0MG | Mint Pharmaceuticals Inc | Active | 2024-01-18 | 468 | Manufacturing distruption | 217366 |
3295 | L02BG04 | RIVA-LETROZOLE | 2.5MG | Laboratoire Riva Inc. | Active | 2024-01-18 | 400 | Manufacturing practices | 216506 |
3303 | L02BG04 | MINT-LETROZOLE | 2.5MG | Mint Pharmaceuticals Inc | Active | 2024-01-18 | 468 | Manufacturing distruption | 217372 |
3283 | N05AH04 | MINT-QUETIAPINE XR | 200MG | Mint Pharmaceuticals Inc | Resolved | 2024-01-18 | 103 | Manufacturing distruption | 217390 |
3284 | N05AH04 | MINT-QUETIAPINE XR | 300MG | Mint Pharmaceuticals Inc | Resolved | 2024-01-18 | 103 | Manufacturing distruption | 217393 |
3285 | L01DC01 | BLEOMYCIN FOR INJECTION USP | 15UNIT | Pfizer Canada Ulc | Resolved | 2024-01-18 | Manufacturing distruption | 212050 | |
3287 | N03AX11 | MINT-TOPIRAMATE | 25MG | Mint Pharmaceuticals Inc | Resolved | 2024-01-18 | 103 | Manufacturing distruption | 217681 |
3288 | N03AX11 | MINT-TOPIRAMATE | 100MG | Mint Pharmaceuticals Inc | Resolved | 2024-01-18 | 256 | Manufacturing distruption | 217684 |
3289 | N03AX11 | MINT-TOPIRAMATE | 200MG | Mint Pharmaceuticals Inc | Resolved | 2024-01-18 | 256 | Manufacturing distruption | 217687 |
3290 | C10AA03 | MINT-PRAVASTATIN | 10MG | Mint Pharmaceuticals Inc | Resolved | 2024-01-18 | 103 | Shipping delay | 217375 |
3291 | C10AA03 | MINT-PRAVASTATIN | 20MG | Mint Pharmaceuticals Inc | Resolved | 2024-01-18 | 256 | Shipping delay | 217378 |
3292 | C10AA03 | MINT-PRAVASTATIN | 40MG | Mint Pharmaceuticals Inc | Resolved | 2024-01-18 | 103 | Shipping delay | 217381 |
3293 | L02BG03 | MINT-ANASTROZOLE | 1MG | Mint Pharmaceuticals Inc | Resolved | 2024-01-18 | 103 | Manufacturing distruption | 217369 |
3296 | N03AX22 | FYCOMPA | 8.0MG | Eisai Limited | Resolved | 2024-01-18 | 18 | Demand increase | 216474 |
3297 | C08DB01 | TEVA-DILTIAZEM XC | 300MG | Teva Canada Limited | Resolved | 2024-01-18 | 113 | Manufacturing distruption | 216466 |
3298 | J01DB01 | LUPIN-CEPHALEXIN | 125MG | Lupin Pharma Canada Limited | Resolved | 2024-01-18 | 74 | Demand increase | 216518 |
3299 | J01DB01 | LUPIN-CEPHALEXIN | 250MG | Lupin Pharma Canada Limited | Resolved | 2024-01-18 | 13 | Demand increase | 206745 |
3300 | C10AA05 | MINT-ATORVASTATIN | 10MG | Mint Pharmaceuticals Inc | Resolved | 2024-01-18 | 103 | Manufacturing distruption | 217690 |
3301 | C10AA05 | MINT-ATORVASTATIN | 20MG | Mint Pharmaceuticals Inc | Resolved | 2024-01-18 | 103 | Manufacturing distruption | 217693 |
3302 | C10AA05 | MINT-ATORVASTATIN | 40MG | Mint Pharmaceuticals Inc | Resolved | 2024-01-18 | 103 | Manufacturing distruption | 217696 |
3271 | A10BB01 | TEVA-GLYBURIDE | 2.5MG | Teva Canada Limited | Resolved | 2024-01-17 | 34 | Manufacturing distruption | 216460 |
3272 | N02AJ17 | TEVA-OXYCOCET | 325MG 5MG | Teva Canada Limited | Resolved | 2024-01-17 | 74 | Manufacturing distruption | 216457 |
3273 | D07XC01 | RATIO-TOPISALIC | 20MG 0.5MG | Teva Canada Limited | Resolved | 2024-01-17 | 135 | Manufacturing distruption | 216463 |
3274 | L04AK01 | SANDOZ LEFLUNOMIDE | 10MG | Sandoz Canada Incorporated | Resolved | 2024-01-17 | 16 | Shipping delay | 216205 |
3275 | A10BG03 | ACT PIOGLITAZONE | 45MG | Teva Canada Limited | Resolved | 2024-01-17 | Manufacturing distruption | 216454 | |
3276 | V09XX | TECHNETIUM TC 99M TSC | 2MG | Ge Healthcare Canada Inc | Resolved | 2024-01-17 | 136 | Manufacturing practices | 216303 |
3277 | G04CA02 | SANDOZ TAMSULOSIN CR | 0.4MG | Sandoz Canada Incorporated | Resolved | 2024-01-17 | 86 | Manufacturing distruption | 216208 |
3278 | L01AX03 | ACH-TEMOZOLOMIDE | 250MG | Accord Healthcare Inc | Resolved | 2024-01-17 | 247 | Manufacturing distruption | 216270 |
3279 | N06BA02 | ACT DEXTROAMPHETAMINE SR | 15MG | Teva Canada Limited | Resolved | 2024-01-17 | 104 | Manufacturing distruption | 217240 |
3249 | L04AX07 | SANDOZ DIMETHYL FUMARATE DELAY... | 120MG | Sandoz Canada Incorporated | Resolved | 2024-01-16 | Manufacturing distruption | 216171 | |
3250 | A10BK01 | SANDOZ DAPAGLIFLOZIN | 10MG | Sandoz Canada Incorporated | Resolved | 2024-01-16 | 17 | Shipping delay | 216168 |
3251 | S01BC11 | APO-BROMFENAC | 0.07% | Apotex Inc | Resolved | 2024-01-16 | 66 | Manufacturing distruption | 216678 |
3252 | C02DB02 | APO-HYDRALAZINE | 25MG | Apotex Inc | Resolved | 2024-01-16 | 80 | Manufacturing distruption | 216650 |
3253 | N01BB01 | SENSORCAINE | 5MG | Aspen Pharmacare Canada Inc. | Resolved | 2024-01-16 | 41 | Shipping delay | 216097 |
3254 | N01BB01 | SENSORCAINE | 5MG | Aspen Pharmacare Canada Inc. | Resolved | 2024-01-16 | 43 | Manufacturing distruption | 209399 |
3255 | N02BE01 | APO-ACETAMINOPHEN CAPLETS | 325MG | Apotex Inc | Resolved | 2024-01-16 | 38 | Manufacturing distruption | 216656 |
3256 | N01BB52 | XYLOCAINE 1% W EPINEPHRINE 1:1... | 0.01MG 10MG | Aspen Pharmacare Canada Inc. | Resolved | 2024-01-16 | 35 | Manufacturing distruption | 217529 |
3257 | G03FA01 | ESTALIS 250/50 MCG | 250MCG 50MCG | Sandoz Canada Incorporated | Resolved | 2024-01-16 | 94 | Manufacturing distruption | 216175 |
3258 | G03CA03 | ESTRADOT 50 | 50MCG | Sandoz Canada Incorporated | Resolved | 2024-01-16 | 52 | Manufacturing distruption | 216178 |
3259 | M05BA03 | PAMIDRONATE DISODIUM OMEGA 9 M... | 9.0MG | Omega Laboratories Limited | Resolved | 2024-01-16 | 31 | Manufacturing distruption | 215446 |
3260 | L04AK01 | APO-LEFLUNOMIDE | 10MG | Apotex Inc | Resolved | 2024-01-16 | 24 | Manufacturing distruption | 216659 |
3261 | N01BB02 | XYLOCAINE 2% | 20MG | Aspen Pharmacare Canada Inc. | Resolved | 2024-01-16 | 43 | Manufacturing distruption | 209393 |
3262 | R01AD09 | APO-MOMETASONE | 50MCG | Apotex Inc | Resolved | 2024-01-16 | 136 | Manufacturing distruption | 216669 |
3263 | N06AX21 | APO-DULOXETINE | 30MG | Apotex Inc | Resolved | 2024-01-16 | 66 | Manufacturing distruption | 216653 |
3264 | N06BA01 | APO-AMPHETAMINE XR | 5MG | Apotex Inc | Resolved | 2024-01-16 | 45 | Manufacturing distruption | 216681 |
3265 | C08CA02 | APO-FELODIPINE | 2.5MG | Apotex Inc | Resolved | 2024-01-16 | 24 | Manufacturing distruption | 216662 |
3266 | J01DE01 | APO-CEFEPIME | 1G | Apotex Inc | Resolved | 2024-01-16 | 24 | Manufacturing distruption | 216672 |
3267 | B01AC24 | APO-TICAGRELOR | 90MG | Apotex Inc | Resolved | 2024-01-16 | 80 | Manufacturing distruption | 216675 |
3268 | B01AC24 | TARO-TICAGRELOR | 60MG | Taro Pharmaceuticals Inc | Resolved | 2024-01-16 | 59 | Manufacturing distruption | 222107 |
3269 | C10AC04 | APO-COLESEVELAM | 625MG | Apotex Inc | Resolved | 2024-01-16 | 164 | Manufacturing distruption | 216646 |
3270 | S02CA06 | SANDOZ CIPROFLOXACIN / DEXAMET... | 0.1% 0.3% | Sandoz Canada Incorporated | Resolved | 2024-01-16 | 17 | Manufacturing distruption | 216164 |
3247 | N01BB09 | NAROPIN | 5MG | Aspen Pharmacare Canada Inc. | Resolved | 2024-01-15 | 36 | Manufacturing distruption | 209405 |
3248 | B02AA02 | TRANEXAMIC ACID INJECTION | 100MG | Auro Pharma Inc | Resolved | 2024-01-15 | 106 | Demand increase | 216024 |
3246 | V09HX01 | GALLIUM (GA67) CITRATE INJECTI... | 74MBq | Curium Canada Inc | Resolved | 2024-01-14 | 7 | Manufacturing distruption | 215600 |
3231 | C07AB02 | JAMP-METOPROLOL-L | 50MG | Jamp Pharma Corporation | Active | 2024-01-12 | 489 | Manufacturing distruption | 215886 |
3232 | C07AB02 | JAMP-METOPROLOL-L | 50MG | Jamp Pharma Corporation | Active | 2024-01-12 | 489 | Manufacturing distruption | 215889 |
3233 | C07AB02 | JAMP-METOPROLOL-L | 100MG | Jamp Pharma Corporation | Active | 2024-01-12 | 455 | Manufacturing distruption | 215880 |
3234 | C07AB02 | JAMP-METOPROLOL-L | 100MG | Jamp Pharma Corporation | Active | 2024-01-12 | 455 | Manufacturing distruption | 215883 |
3241 | N06DA02 | DONEPEZIL | 5MG | Laboratoire Riva Inc. | Active | 2024-01-12 | Manufacturing practices | 216058 | |
3244 | H05BX01 | JAMP CINACALCET TABLETS | 30MG | Jamp Pharma Corporation | Active | 2024-01-12 | 719 | Manufacturing distruption | 215865 |
3224 | M05BA04 | RIVA-ALENDRONATE | 70MG | Laboratoire Riva Inc. | Resolved | 2024-01-12 | Manufacturing practices | 215855 | |
3225 | N03AX14 | LEVETIRACETAM | 500MG | Sanis Health Inc | Resolved | 2024-01-12 | 91 | Manufacturing distruption | 216276 |
3226 | N06AB06 | SERTRALINE | 25MG | Sanis Health Inc | Resolved | 2024-01-12 | 126 | Manufacturing distruption | 216264 |
3227 | N06AB06 | SERTRALINE | 50MG | Sanis Health Inc | Resolved | 2024-01-12 | 164 | Manufacturing distruption | 216267 |
3228 | N06AB06 | SERTRALINE | 100MG | Sanis Health Inc | Resolved | 2024-01-12 | 140 | Manufacturing distruption | 216254 |
3229 | N06AB06 | SERTRALINE | 100MG | Sanis Health Inc | Resolved | 2024-01-12 | 28 | Manufacturing distruption | 216259 |
3230 | A02BC04 | RABEPRAZOLE EC | 20MG | Sanis Health Inc | Resolved | 2024-01-12 | 238 | Manufacturing distruption | 216283 |
3235 | C09CA06 | CANDESARTAN | 16MG | Sanis Health Inc | Resolved | 2024-01-12 | 231 | Manufacturing distruption | 216273 |
3236 | L02BG03 | RIVA-ANASTROZOLE | 1MG | Laboratoire Riva Inc. | Resolved | 2024-01-12 | Manufacturing practices | 215859 | |
3237 | L02BG04 | RIVA-LETROZOLE | 2.5MG | Laboratoire Riva Inc. | Resolved | 2024-01-12 | Manufacturing practices | 215862 | |
3238 | G04CA02 | TAMSULOSIN CR | 0.4MG | Sanis Health Inc | Resolved | 2024-01-12 | 99 | Manufacturing distruption | 216290 |
3239 | G04CB01 | RIVA-FINASTERIDE | 5MG | Laboratoire Riva Inc. | Resolved | 2024-01-12 | Manufacturing practices | 216064 | |
3240 | D07CB01 | VIADERM KC ONT | 100000UNIT 0.25MG 2.5MG 1MG | Taro Pharmaceuticals Inc | Resolved | 2024-01-12 | 245 | Manufacturing distruption | 237284 |
3242 | N06DA02 | DONEPEZIL | 10MG | Laboratoire Riva Inc. | Resolved | 2024-01-12 | Manufacturing practices | 216061 | |
3243 | C09AA04 | PERINDOPRIL ERBUMINE | 8MG | Sanis Health Inc | Resolved | 2024-01-12 | 31 | Manufacturing distruption | 216247 |
3245 | B01AF01 | XARELTO | 51.7MG | Bayer Inc | Resolved | 2024-01-12 | 28 | Demand increase | 215608 |
3223 | D01AE14 | STIEPROX SHAMPOO | 1.5% | Glaxosmithkline Inc | Resolved | 2024-01-11 | Manufacturing distruption | 216182 | |
3196 | R03AC02 | TEVA-SALBUTAMOL STERINEBS P.F. | 1MG | Teva Canada Limited | Active | 2024-01-10 | 538 | Manufacturing distruption | 215707 |
3211 | L01AX03 | TEVA-TEMOZOLOMIDE | 140MG | Teva Canada Limited | Active | 2024-01-10 | Manufacturing distruption | 215734 | |
3220 | L04AH02 | TEVA-EVEROLIMUS | 2.5MG | Teva Canada Limited | Active | 2024-01-10 | Manufacturing distruption | 215754 | |
3206 | A11HA02 | PYRIDOXINE HYDROCHLORIDE INJEC... | 100MG | Mylan Pharmaceuticals Ulc | Avoided | 2024-01-10 | Manufacturing distruption | 213767 | |
3193 | G01AF01 | FLAGYL | 10% | Sanofi-Aventis Canada Inc | Resolved | 2024-01-10 | 163 | Other | 215793 |
3194 | G01AA51 | FLAGYSTATIN | 100000UNIT 500MG | Sanofi-Aventis Canada Inc | Resolved | 2024-01-10 | 30 | Other | 215796 |
3195 | D07AD01 | TEVA-CLOBETASOL | 0.05% | Teva Canada Limited | Resolved | 2024-01-10 | Manufacturing distruption | 215704 | |
3197 | N05BA01 | DIAZEPAM | 5MG | Aa Pharma Inc | Resolved | 2024-01-10 | 13 | Manufacturing distruption | 215477 |
3198 | N07BB04 | REVIA | 50MG | Teva Canada Limited | Resolved | 2024-01-10 | 31 | Manufacturing distruption | 215710 |
3199 | L01BA01 | METHOTREXATE INJECTION USP | 25MG | Pfizer Canada Ulc | Resolved | 2024-01-10 | Manufacturing distruption | 215532 | |
3200 | N06AX02 | TEVA-TRYPTOPHAN | 1G | Teva Canada Limited | Resolved | 2024-01-10 | 60 | Manufacturing distruption | 215713 |
3201 | N06AB06 | TEVA-SERTRALINE | 100MG | Teva Canada Limited | Resolved | 2024-01-10 | 60 | Manufacturing distruption | 215716 |
3202 | C07AB02 | TEVA-METOPROLOL | 100MG | Teva Canada Limited | Resolved | 2024-01-10 | 101 | Manufacturing distruption | 215701 |
3203 | C10AA05 | LIPITOR | 80MG | Bgp Pharma Ulc | Resolved | 2024-01-10 | 49 | Manufacturing distruption | 215527 |
3204 | M01AE02 | TEVA-NAPROXEN EC | 375MG | Teva Canada Limited | Resolved | 2024-01-10 | 60 | Manufacturing distruption | 215719 |
3205 | J07BC01 | RECOMBIVAX HB | 10MCG | Merck Canada Inc | Resolved | 2024-01-10 | 79 | Demand increase | 215470 |
3207 | C10AA01 | TEVA-SIMVASTATIN | 40MG | Teva Canada Limited | Resolved | 2024-01-10 | 182 | Manufacturing distruption | 215722 |
3208 | N05AH04 | ACT QUETIAPINE | 200MG | Teva Canada Limited | Resolved | 2024-01-10 | 70 | Manufacturing distruption | 215725 |
3209 | C09CA07 | TEVA-TELMISARTAN | 80MG | Teva Canada Limited | Resolved | 2024-01-10 | 111 | Manufacturing distruption | 215728 |
3210 | C10AA07 | TEVA-ROSUVASTATIN | 10MG | Teva Canada Limited | Resolved | 2024-01-10 | 31 | Manufacturing distruption | 215731 |
3212 | L01BC05 | GEMCITABINE INJECTION | 38MG | Pfizer Canada Ulc | Resolved | 2024-01-10 | Manufacturing distruption | 215535 | |
3213 | J01FA09 | ACT CLARITHROMYCIN XL | 500MG | Teva Canada Limited | Resolved | 2024-01-10 | 131 | Manufacturing distruption | 215737 |
3214 | J07AH09 | BEXSERO | 25MCG 50MCG 50MCG 50MCG | Glaxosmithkline Inc | Resolved | 2024-01-10 | 37 | Shipping delay | 215839 |
3215 | M02AA15 | TARO-DICLOFENAC | 1.5% | Taro Pharmaceuticals Inc | Resolved | 2024-01-10 | 149 | Manufacturing distruption | 227653 |
3216 | C08DB01 | TEVA-DILTIAZEM XC | 240MG | Teva Canada Limited | Resolved | 2024-01-10 | 121 | Manufacturing distruption | 215740 |
3217 | N06AX12 | TEVA-BUPROPION XL | 150MG | Teva Canada Limited | Resolved | 2024-01-10 | 41 | Manufacturing distruption | 215743 |
3218 | N06AX12 | TEVA-BUPROPION XL | 300MG | Teva Canada Limited | Resolved | 2024-01-10 | 41 | Manufacturing distruption | 215746 |
3219 | N06AX21 | TEVA-DULOXETINE | 30MG | Teva Canada Limited | Resolved | 2024-01-10 | 315 | Manufacturing distruption | 215751 |
3221 | C09BA04 | TEVA-PERINDOPRIL/INDAPAMIDE | 2.5MG 8MG | Teva Canada Limited | Resolved | 2024-01-10 | 41 | Manufacturing distruption | 215757 |
3222 | R01AD09 | TEVA-MOMETASONE | 50MCG | Teva Canada Limited | Resolved | 2024-01-10 | 203 | Manufacturing distruption | 215760 |
3181 | C07AG02 | APO-CARVEDILOL | 25MG | Apotex Inc | Active | 2024-01-09 | Manufacturing distruption | 215952 | |
3182 | C07AA07 | APO-SOTALOL | 160MG | Apotex Inc | Resolved | 2024-01-09 | Manufacturing distruption | 215976 | |
3183 | H02AB07 | WINPRED | 1MG | Aa Pharma Inc | Resolved | 2024-01-09 | 24 | Manufacturing distruption | 215480 |
3184 | M01AE01 | APO-IBUPROFEN TAB 600MG | 600MG | Apotex Inc | Resolved | 2024-01-09 | 87 | Manufacturing distruption | 215967 |
3185 | S01LA01 | VISUDYNE | 15MG | Cheplapharm Arzneimittel Gmbh | Resolved | 2024-01-09 | 51 | Shipping delay | 214845 |
3186 | N02AA01 | STATEX TAB 10MG | 10MG | Paladin Labs Inc. | Resolved | 2024-01-09 | 76 | Shipping delay | 216127 |
3187 | G04CA01 | APO-ALFUZOSIN | 10MG | Apotex Inc | Resolved | 2024-01-09 | 73 | Manufacturing distruption | 215973 |
3188 | C10AA07 | APO-ROSUVASTATIN | 10MG | Apotex Inc | Resolved | 2024-01-09 | 31 | Manufacturing distruption | 215979 |
3189 | B01AC04 | APO-CLOPIDOGREL | 300MG | Apotex Inc | Resolved | 2024-01-09 | 73 | Manufacturing distruption | 215970 |
3190 | N03AX22 | FYCOMPA | 12.0MG | Eisai Limited | Resolved | 2024-01-09 | 27 | Demand increase | 215437 |
3191 | N06BA01 | APO-AMPHETAMINE XR | 25MG | Apotex Inc | Resolved | 2024-01-09 | 52 | Manufacturing distruption | 215964 |
3192 | G03DB08 | JAMP DIENOGEST | 2MG | Jamp Pharma Corporation | Resolved | 2024-01-09 | 17 | Demand increase | 215416 |
3166 | N05AN01 | CARBOLITH | 300MG | Bausch Health, Canada Inc. | Avoided | 2024-01-08 | 14 | Other | 212587 |
3179 | L01CD02 | DOCETAXEL INJECTION | 10MG | Sandoz Canada Incorporated | Avoided | 2024-01-08 | 32 | Demand increase | 215330 |
3167 | N02AA03 | HYDROMORPHONE HYDROCHLORIDE IN... | 2MG | Sandoz Canada Incorporated | Resolved | 2024-01-08 | 25 | Manufacturing distruption | 215339 |
3168 | S01FB01 | MINIMS PHENYLEPHRINE HYDROCHLO... | 10% | Bausch & Lomb Inc | Resolved | 2024-01-08 | 17 | Manufacturing practices | 215365 |
3169 | S01FB01 | MINIMS PHENYLEPHRINE HYDROCHLO... | 2.5% | Bausch & Lomb Inc | Resolved | 2024-01-08 | 17 | Manufacturing practices | 215362 |
3170 | B05XC | MULTI-12/K1 PEDIATRIC | 1MCG 140MCG 20MCG 0.2MG 7UNIT 5MG 17MG 1MG 1.4MG 1.2MG 400UNIT 2300UNIT 80MG | Sandoz Canada Incorporated | Resolved | 2024-01-08 | 18 | Manufacturing distruption | 215358 |
3171 | M01AB05 | SANDOZ-DICLOFENAC | 50MG | Sandoz Canada Incorporated | Resolved | 2024-01-08 | 102 | Manufacturing distruption | 215326 |
3172 | A02BC01 | SANDOZ OMEPRAZOLE | 20MG | Sandoz Canada Incorporated | Resolved | 2024-01-08 | Manufacturing distruption | 215347 | |
3173 | C09AA02 | SANDOZ ENALAPRIL | 8MG | Sandoz Canada Incorporated | Resolved | 2024-01-08 | 277 | Manufacturing distruption | 215335 |
3174 | N03AA02 | PHENOBARBITAL SODIUM INJECTION... | 30MG | Sandoz Canada Incorporated | Resolved | 2024-01-08 | 74 | Demand increase | 215343 |
3175 | A11CC05 | JAMP-VITAMIN D | 10000UNIT | Jamp Pharma Corporation | Resolved | 2024-01-08 | 327 | Manufacturing distruption | 215310 |
3176 | A11CC05 | JAMP-VITAMIN D | 10000UNIT | Jamp Pharma Corporation | Resolved | 2024-01-08 | 327 | Manufacturing distruption | 215313 |
3177 | A11CC05 | JAMP-VITAMIN D | 10000UNIT | Jamp Pharma Corporation | Resolved | 2024-01-08 | 327 | Manufacturing distruption | 215316 |
3178 | A10BB09 | MINT-GLICLAZIDE MR | 30MG | Mint Pharmaceuticals Inc | Resolved | 2024-01-08 | 174 | Manufacturing distruption | 222750 |
3180 | A04AA01 | ONDANSETRON INJECTION USP | 2MG | Sterimax Inc | Resolved | 2024-01-08 | Manufacturing distruption | 211215 | |
3164 | P01BA02 | NRA-HYDROXYCHLOROQUINE | 200MG | Nora Pharma Inc | Active | 2024-01-06 | Manufacturing distruption | 248695 | |
3165 | N02BF01 | GABAPENTIN | 600MG | Sivem Pharmaceuticals Ulc | Resolved | 2024-01-06 | 338 | Manufacturing distruption | 243954 |
3159 | C01CA06 | PHENYLEPHRINE HYDROCHLORIDE IN... | 10MG | Omega Laboratories Limited | Avoided | 2024-01-05 | 35 | Demand increase | 213104 |
3157 | A03AX04 | DICETEL | 50MG | Bgp Pharma Ulc | Resolved | 2024-01-05 | 39 | Manufacturing distruption | 215518 |
3158 | V04CC03 | KINEVAC | 5MCG | Bracco Imaging Canada | Resolved | 2024-01-05 | 328 | Other | 197753 |
3160 | J05AB14 | VALCYTE | 450MG | Cheplapharm Arzneimittel Gmbh | Resolved | 2024-01-05 | 31 | Shipping delay | 214848 |
3161 | C10AA07 | ACH-ROSUVASTATIN | 40MG | Accord Healthcare Inc | Resolved | 2024-01-05 | 255 | Manufacturing distruption | 215056 |
3162 | A10BJ06 | RYBELSUS | 3MG | Novo Nordisk Canada Inc | Resolved | 2024-01-05 | 4 | Shipping delay | 214716 |
3163 | A10BJ06 | RYBELSUS | 14MG | Novo Nordisk Canada Inc | Resolved | 2024-01-05 | 4 | Shipping delay | 214721 |
3156 | A10BJ05 | TRULICITY | 1.5MG | Eli Lilly Canada Inc | Active | 2024-01-04 | 543 | Demand increase | 211404 |
3152 | G03AA05 | BREVICON 1/35 TABLETS (28-DAY ... | 0.035MG 1MG | Pfizer Canada Ulc | Resolved | 2024-01-04 | 82 | Demand increase | 213856 |
3153 | J01FA09 | BIAXIN | 250MG | Bgp Pharma Ulc | Resolved | 2024-01-04 | 131 | Manufacturing distruption | 215507 |
3154 | C09AA05 | APO-RAMIPRIL | 2.5MG | Apotex Inc | Resolved | 2024-01-04 | 78 | Manufacturing distruption | 215221 |
3155 | H02AB04 | SOLU-MEDROL | 500MG | Pfizer Canada Ulc | Resolved | 2024-01-04 | Manufacturing distruption | 212079 | |
3144 | G03BA03 | DELATESTRYL | 200MG | Bausch Health, Canada Inc. | Resolved | 2024-01-03 | 23 | Other | 216889 |
3145 | G03CA03 | ESTRADOT 25 | 25MCG | Sandoz Canada Incorporated | Resolved | 2024-01-03 | 51 | Manufacturing distruption | 214774 |
3146 | A10BA02 | SANDOZ METFORMIN FC | 500MG | Sandoz Canada Incorporated | Resolved | 2024-01-03 | 37 | Manufacturing distruption | 214781 |
3147 | H01CB02 | OCTREOTIDE ACETATE OMEGA | 50MCG | Omega Laboratories Limited | Resolved | 2024-01-03 | 12 | Demand increase | 213107 |
3148 | H01CB02 | OCTREOTIDE ACETATE OMEGA | 100MCG | Omega Laboratories Limited | Resolved | 2024-01-03 | 37 | Demand increase | 213871 |
3149 | A10AE04 | LANTUS | 100UNIT | Sanofi-Aventis Canada Inc | Resolved | 2024-01-03 | 51 | Other | 213961 |
3150 | C10AA05 | SANDOZ ATORVASTATIN | 10MG | Sandoz Canada Incorporated | Resolved | 2024-01-03 | 72 | Manufacturing distruption | 214771 |
3151 | C09DA04 | SANDOZ IRBESARTAN HCT | 12.5MG 150MG | Sandoz Canada Incorporated | Resolved | 2024-01-03 | 65 | Manufacturing distruption | 214777 |
3130 | M05BA04 | NRA-ALENDRONATE | 70MG | Nora Pharma Inc | Active | 2024-01-02 | Manufacturing distruption | 248692 | |
3142 | C10AX09 | APO-EZETIMIBE | 10MG | Apotex Inc | Active | 2024-01-02 | Manufacturing distruption | 215247 | |
3129 | J01AA02 | APO-DOXYCYCLINE MR | 40MG | Apotex Inc | Resolved | 2024-01-02 | 17 | Manufacturing distruption | 215207 |
3131 | N06AX05 | APO-TRAZODONE D TABLETS 150MG | 150MG | Apotex Inc | Resolved | 2024-01-02 | 59 | Manufacturing distruption | 215224 |
3132 | H02AB07 | APO PREDNISONE TAB 50MG | 50MG | Apotex Inc | Resolved | 2024-01-02 | 17 | Manufacturing distruption | 215230 |
3133 | D07AD01 | TARO-CLOBETASOL TOPICAL SOLUTI... | 0.05% | Taro Pharmaceuticals Inc | Resolved | 2024-01-02 | 10 | Manufacturing distruption | 215085 |
3134 | C07AB02 | APO-METOPROLOL | 25MG | Apotex Inc | Resolved | 2024-01-02 | 80 | Manufacturing distruption | 215233 |
3135 | C01BC04 | APO-FLECAINIDE | 50MG | Apotex Inc | Resolved | 2024-01-02 | 45 | Manufacturing distruption | 215218 |
3136 | L01BC05 | GEMCITABINE INJECTION | 38MG | Pfizer Canada Ulc | Resolved | 2024-01-02 | Manufacturing distruption | 213209 | |
3137 | N07XX06 | APO-TETRABENAZINE | 25MG | Apotex Inc | Resolved | 2024-01-02 | 31 | Manufacturing distruption | 215212 |
3138 | S01ED01 | APO-TIMOP | 0.5% | Apotex Inc | Resolved | 2024-01-02 | 185 | Manufacturing distruption | 215215 |
3139 | G04BE08 | APO-TADALAFIL | 2.5MG | Apotex Inc | Resolved | 2024-01-02 | 73 | Manufacturing distruption | 215227 |
3140 | G04BE08 | APO-TADALAFIL | 5MG | Apotex Inc | Resolved | 2024-01-02 | 29 | Manufacturing distruption | 215242 |
3141 | G04BE08 | APO-TADALAFIL | 10MG | Apotex Inc | Resolved | 2024-01-02 | 73 | Manufacturing distruption | 215239 |
3143 | G03AB09 | TRI-CIRA 21 | 0.035MG 0.25MG 0.035MG 0.215MG 0.035MG 0.18MG | Apotex Inc | Resolved | 2024-01-02 | 38 | Manufacturing distruption | 215236 |
3124 | J02AC01 | NRA-FLUCONAZOLE-150 | 150MG | Nora Pharma Inc | Active | 2024-01-01 | Manufacturing distruption | 253395 | |
3126 | N05AH04 | NRA-QUETIAPINE XR | 50MG | Nora Pharma Inc | Active | 2024-01-01 | Manufacturing distruption | 250806 | |
3127 | N05AH04 | NRA-QUETIAPINE XR | 150MG | Nora Pharma Inc | Active | 2024-01-01 | Manufacturing distruption | 250809 | |
3128 | N05AH04 | NRA-QUETIAPINE XR | 200MG | Nora Pharma Inc | Active | 2024-01-01 | Manufacturing distruption | 250812 | |
3120 | N01BB52 | XYLOCAINE 1% W EPINEPHRINE 1:1... | 0.01MG 10MG | Aspen Pharmacare Canada Inc. | Avoided | 2024-01-01 | 30 | Manufacturing distruption | 209382 |
3125 | N06AX21 | NRA-DULOXETINE | 60MG | Nora Pharma Inc | Avoided | 2024-01-01 | Other | 199235 | |
3119 | C09BA03 | ZESTORETIC | 12.5MG 20MG | Searchlight Pharma Inc | Resolved | 2024-01-01 | 21 | Ingredient shortage | 211672 |
3121 | L01BB04 | CLADRIBINE INJECTION | 1MG | Fresenius Kabi Canada Ltd | Resolved | 2024-01-01 | 104 | Manufacturing distruption | 212507 |
3122 | A03BA01 | ATROPINE INJECTION BP | 0.4MG | Hikma Canada Limited | Resolved | 2024-01-01 | 91 | Demand increase | 210686 |
3123 | A03BA01 | ATROPINE INJECTION BP | 0.6MG | Hikma Canada Limited | Resolved | 2024-01-01 | 91 | Demand increase | 210691 |
3108 | N02BF01 | GABAPENTIN CAPSULES USP | 300MG | Accord Healthcare Inc | Active | 2023-12-29 | Manufacturing distruption | 214528 | |
3099 | L04AX03 | AURO-METHOTREXATE | 2.5MG | Auro Pharma Inc | Resolved | 2023-12-29 | Demand increase | 214555 | |
3100 | A10BH01 | AURO-SITAGLIPTIN | 100MG | Auro Pharma Inc | Resolved | 2023-12-29 | 62 | Demand increase | 214583 |
3101 | N06AX11 | AURO-MIRTAZAPINE OD | 15MG | Auro Pharma Inc | Resolved | 2023-12-29 | 77 | Demand increase | 214561 |
3102 | D01BA02 | AURO-TERBINAFINE | 250MG | Auro Pharma Inc | Resolved | 2023-12-29 | 90 | Demand increase | 214586 |
3103 | N06AB06 | AURO-SERTRALINE | 50MG | Auro Pharma Inc | Resolved | 2023-12-29 | 124 | Demand increase | 214575 |
3104 | N06AB06 | AURO-SERTRALINE | 100MG | Auro Pharma Inc | Resolved | 2023-12-29 | 110 | Demand increase | 214572 |
3105 | N06AX11 | AURO-MIRTAZAPINE | 30MG | Auro Pharma Inc | Resolved | 2023-12-29 | 77 | Demand increase | 214558 |
3106 | G04BE03 | AURO-SILDENAFIL | 25MG | Auro Pharma Inc | Resolved | 2023-12-29 | 61 | Demand increase | 214580 |
3107 | B01AC04 | AURO-CLOPIDOGREL | 75MG | Auro Pharma Inc | Resolved | 2023-12-29 | 48 | Demand increase | 214543 |
3109 | C08CA01 | ACH-AMLODIPINE | 2.5MG | Accord Healthcare Inc | Resolved | 2023-12-29 | 224 | Manufacturing distruption | 214531 |
3110 | N04BC05 | AURO-PRAMIPEXOLE | 0.25MG | Auro Pharma Inc | Resolved | 2023-12-29 | 77 | Demand increase | 214564 |
3111 | N06DA04 | AURO-GALANTAMINE ER | 16MG | Auro Pharma Inc | Resolved | 2023-12-29 | 124 | Demand increase | 214549 |
3112 | N02BF01 | AURO-GABAPENTIN TABLETS | 600MG | Auro Pharma Inc | Resolved | 2023-12-29 | 98 | Demand increase | 214546 |
3113 | A10BA02 | AURO-METFORMIN | 850MG | Auro Pharma Inc | Resolved | 2023-12-29 | 124 | Demand increase | 214552 |
3114 | C10AA07 | ACH-ROSUVASTATIN | 10MG | Accord Healthcare Inc | Resolved | 2023-12-29 | 248 | Manufacturing distruption | 214534 |
3115 | C10AA07 | AURO-ROSUVASTATIN | 20MG | Auro Pharma Inc | Resolved | 2023-12-29 | 91 | Demand increase | 214569 |
3116 | M01AH01 | AURO-CELECOXIB | 100MG | Auro Pharma Inc | Resolved | 2023-12-29 | 98 | Demand increase | 214537 |
3117 | C09DA08 | ACH-OLMESARTAN HCTZ | 40MG 25MG | Accord Healthcare Inc | Resolved | 2023-12-29 | 77 | Manufacturing distruption | 214525 |
3118 | J01DB01 | AURO-CEPHALEXIN | 250MG | Auro Pharma Inc | Resolved | 2023-12-29 | 123 | Shipping delay | 214540 |
3096 | N05AX12 | AURO-ARIPIPRAZOLE | 15MG | Auro Pharma Inc | Active | 2023-12-28 | 474 | Demand increase | 214401 |
3097 | N05AX12 | AURO-ARIPIPRAZOLE | 20MG | Auro Pharma Inc | Active | 2023-12-28 | 474 | Demand increase | 214404 |
3094 | C08CA01 | AURO-AMLODIPINE | 5MG | Auro Pharma Inc | Resolved | 2023-12-28 | 94 | Demand increase | 214398 |
3095 | N05AX12 | AURO-ARIPIPRAZOLE | 5MG | Auro Pharma Inc | Resolved | 2023-12-28 | 216 | Demand increase | 214407 |
3098 | J01FA10 | AURO-AZITHROMYCIN | 200MG | Auro Pharma Inc | Resolved | 2023-12-28 | 49 | Demand increase | 214410 |
3091 | N03AX11 | ACH-TOPIRAMATE | 25MG | Accord Healthcare Inc | Active | 2023-12-27 | Manufacturing distruption | 214522 | |
3092 | N06AX21 | MAR-DULOXETINE | 30MG | Marcan Pharmaceuticals Inc | Resolved | 2023-12-27 | 79 | Demand increase | 214358 |
3093 | M01AE52 | MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 375MG | Mylan Pharmaceuticals Ulc | Resolved | 2023-12-27 | 17 | Manufacturing distruption | 213764 |
3090 | C09BA03 | ZESTORETIC | 25MG 20MG | Searchlight Pharma Inc | Active | 2023-12-25 | 584 | Manufacturing distruption | 211675 |
3072 | H02AB09 | SOLU-CORTEF | 500MG | Pfizer Canada Ulc | Resolved | 2023-12-22 | Manufacturing distruption | 210575 | |
3073 | R03BB01 | PMS-IPRATROPIUM | 21MCG | Pharmascience Inc | Resolved | 2023-12-22 | 175 | Manufacturing distruption | 214337 |
3074 | V03AF01 | UROMITEXAN | 100MG | Baxter Corporation | Resolved | 2023-12-22 | 63 | Demand increase | 214355 |
3075 | N06AB05 | PMS-PAROXETINE | 20MG | Pharmascience Inc | Resolved | 2023-12-22 | 49 | Manufacturing distruption | 214349 |
3076 | N01BB02 | XYLOCAINE 2% | 20MG | Aspen Pharmacare Canada Inc. | Resolved | 2023-12-22 | 40 | Manufacturing distruption | 209396 |
3077 | C09CA01 | PMS-LOSARTAN | 25MG | Pharmascience Inc | Resolved | 2023-12-22 | 164 | Manufacturing distruption | 214340 |
3078 | N03AX11 | PMS-TOPIRAMATE | 50MG | Pharmascience Inc | Resolved | 2023-12-22 | 130 | Manufacturing distruption | 214352 |
3079 | A02BC04 | RABEPRAZOLE EC | 10MG | Sanis Health Inc | Resolved | 2023-12-22 | 287 | Manufacturing distruption | 214284 |
3080 | N06BA09 | PMS-ATOMOXETINE | 10MG | Pharmascience Inc | Resolved | 2023-12-22 | 120 | Manufacturing distruption | 214319 |
3081 | N06BA09 | PMS-ATOMOXETINE | 40MG | Pharmascience Inc | Resolved | 2023-12-22 | 95 | Manufacturing distruption | 214322 |
3082 | N06BA09 | PMS-ATOMOXETINE | 60MG | Pharmascience Inc | Resolved | 2023-12-22 | 101 | Manufacturing distruption | 214325 |
3083 | N06BA09 | PMS-ATOMOXETINE | 60MG | Pharmascience Inc | Resolved | 2023-12-22 | 104 | Manufacturing distruption | 214328 |
3084 | N06DX01 | PMS-MEMANTINE | 5.0MG | Pharmascience Inc | Resolved | 2023-12-22 | 132 | Manufacturing distruption | 214343 |
3085 | N07AA01 | NEOSTIGMINE OMEGA | 2.5MG | Omega Laboratories Limited | Resolved | 2023-12-22 | Manufacturing distruption | 210095 | |
3086 | J01XE01 | PMS-NITROFURANTOIN BID | 100MG | Pharmascience Inc | Resolved | 2023-12-22 | 60 | Manufacturing distruption | 214346 |
3087 | N06AB03 | PMS-FLUOXETINE | 40MG | Pharmascience Inc | Resolved | 2023-12-22 | 54 | Manufacturing distruption | 214331 |
3088 | N06AB03 | PMS-FLUOXETINE | 60MG | Pharmascience Inc | Resolved | 2023-12-22 | 61 | Manufacturing distruption | 214334 |
3089 | N02CD02 | EMGALITY | 120MG | Eli Lilly Canada Inc | Resolved | 2023-12-22 | 48 | Other | 210906 |
3069 | N02CC01 | IMITREX DF - TAB 50MG | 50MG | Glaxosmithkline Inc | Active | 2023-12-21 | Manufacturing distruption | 214042 | |
3071 | J07AE01 | DUKORAL | 31250000000CELLS 31250000000CELLS 31250000000CELLS 1MG 31250000000CELLS | Valneva Sweden Ab | Avoided | 2023-12-21 | -345 | Shipping delay | 179026 |
3070 | C02AB02 | METHYLDOPA | 500MG | Aa Pharma Inc | Resolved | 2023-12-21 | 35 | Manufacturing distruption | 213999 |
3065 | C07AB02 | JAMP-METOPROLOL-L | 25MG | Jamp Pharma Corporation | Active | 2023-12-20 | 478 | Manufacturing distruption | 213955 |
3066 | C07AB02 | JAMP-METOPROLOL-L | 25MG | Jamp Pharma Corporation | Active | 2023-12-20 | 478 | Manufacturing distruption | 213958 |
3062 | N01BB54 | EMLA CREAM | 2.5% 2.5% | Aspen Pharmacare Canada Inc. | Resolved | 2023-12-20 | 26 | Manufacturing distruption | 209402 |
3063 | N07BC02 | METADOL | 1MG | Paladin Labs Inc. | Resolved | 2023-12-20 | 71 | Shipping delay | 214969 |
3064 | A10AE04 | LANTUS | 100UNIT | Sanofi-Aventis Canada Inc | Resolved | 2023-12-20 | 65 | Other | 213964 |
3067 | V03AE01 | SOLYSTAT | 1G | Pendopharm Division Of Pharmascience Inc | Resolved | 2023-12-20 | 103 | Manufacturing distruption | 213439 |
3068 | A10BJ02 | SAXENDA | 6MG | Novo Nordisk Canada Inc | Resolved | 2023-12-20 | 16 | Demand increase | 213933 |
3028 | L04AX07 | SANDOZ DIMETHYL FUMARATE DELAY... | 240MG | Sandoz Canada Incorporated | Resolved | 2023-12-19 | Manufacturing distruption | 213804 | |
3029 | M01AB05 | APO-DICLO | 50MG | Apotex Inc | Resolved | 2023-12-19 | 66 | Manufacturing distruption | 214238 |
3030 | A10BK01 | SANDOZ DAPAGLIFLOZIN | 5MG | Sandoz Canada Incorporated | Resolved | 2023-12-19 | 3 | Manufacturing distruption | 213801 |
3031 | C02AC02 | APO-GUANFACINE XR | 2MG | Apotex Inc | Resolved | 2023-12-19 | 24 | Manufacturing distruption | 214232 |
3032 | C02AC02 | APO-GUANFACINE XR | 3MG | Apotex Inc | Resolved | 2023-12-19 | 31 | Manufacturing distruption | 214220 |
3033 | D10AD01 | RETIN-A | 0.05% | Bausch Health, Canada Inc. | Resolved | 2023-12-19 | 43 | Other | 211258 |
3034 | A03AD01 | PAPAVERINE HYDROCHLORIDE INJEC... | 65MG | Sandoz Canada Incorporated | Resolved | 2023-12-19 | Manufacturing distruption | 213882 | |
3035 | N05AD01 | HALOPERIDOL LA | 100MG | Sandoz Canada Incorporated | Resolved | 2023-12-19 | 24 | Manufacturing distruption | 213813 |
3036 | A11DA01 | THIAMIJECT INJECTION - LIQ IM... | 100MG | Omega Laboratories Limited | Resolved | 2023-12-19 | 196 | Manufacturing distruption | 213098 |
3037 | H02AB02 | DEXAMETHASONE-OMEGA | 10MG | Omega Laboratories Limited | Resolved | 2023-12-19 | 24 | Manufacturing distruption | 211728 |
3038 | N05CF01 | APO-ZOPICLONE | 7.5MG | Apotex Inc | Resolved | 2023-12-19 | 66 | Manufacturing distruption | 214229 |
3039 | R03DA05 | AMINOPHYLLINE INJ 25MG/ML | 25MG | Omega Laboratories Limited | Resolved | 2023-12-19 | 209 | Manufacturing distruption | 213095 |
3040 | S01ED01 | TIMOLOL MALEATE-EX | 0.5% | Sandoz Canada Incorporated | Resolved | 2023-12-19 | 143 | Manufacturing distruption | 213825 |
3041 | N03AX09 | MYLAN-LAMOTRIGINE | 150MG | Mylan Pharmaceuticals Ulc | Resolved | 2023-12-19 | 9 | Manufacturing distruption | 213761 |
3042 | N05AX08 | APO-RISPERIDONE | 2.0MG | Apotex Inc | Resolved | 2023-12-19 | 136 | Manufacturing distruption | 214247 |
3043 | N06AX11 | APO-MIRTAZAPINE | 30MG | Apotex Inc | Resolved | 2023-12-19 | 59 | Manufacturing distruption | 214244 |
3044 | A02BC03 | APO-LANSOPRAZOLE | 30MG | Apotex Inc | Resolved | 2023-12-19 | 45 | Manufacturing distruption | 214215 |
3045 | A02BC02 | PANTOPRAZOLE SODIUM FOR INJECT... | 40MG | Sandoz Canada Incorporated | Resolved | 2023-12-19 | 52 | Manufacturing distruption | 213817 |
3046 | A04AA02 | GRANISETRON HYDROCHLORIDE INJE... | 1MG | Omega Laboratories Limited | Resolved | 2023-12-19 | Demand increase | 213110 | |
3047 | C10AA05 | SANDOZ ATORVASTATIN | 20MG | Sandoz Canada Incorporated | Resolved | 2023-12-19 | 3 | Manufacturing distruption | 213794 |
3048 | C10AA05 | SANDOZ ATORVASTATIN | 80MG | Sandoz Canada Incorporated | Resolved | 2023-12-19 | 45 | Manufacturing distruption | 213798 |
3049 | N05AH03 | APO-OLANZAPINE ODT | 10MG | Apotex Inc | Resolved | 2023-12-19 | 17 | Manufacturing distruption | 214223 |
3050 | B05XA17 | POTASSIUM ACETATE INJECTION US... | 39.2% | Omega Laboratories Limited | Resolved | 2023-12-19 | 146 | Demand increase | 213117 |
3051 | L02BG03 | TARO-ANASTROZOLE | 1MG | Taro Pharmaceuticals Inc | Resolved | 2023-12-19 | 31 | Manufacturing distruption | 215067 |
3052 | C09AA02 | ENALAPRILAT INJECTION USP | 1.25MG | Hikma Canada Limited | Resolved | 2023-12-19 | 153 | Shipping delay | 213843 |
3053 | C10AX09 | SANDOZ EZETIMIBE | 10MG | Sandoz Canada Incorporated | Resolved | 2023-12-19 | 3 | Manufacturing distruption | 213810 |
3054 | N05CF02 | APO-ZOLPIDEM ODT | 10MG | Apotex Inc | Resolved | 2023-12-19 | 66 | Manufacturing distruption | 214235 |
3055 | N02BF02 | ACH-PREGABALIN | 50MG | Accord Healthcare Inc | Resolved | 2023-12-19 | 22 | Demand increase | 214071 |
3056 | N06BA04 | APO-METHYLPHENIDATE ER | 36MG | Apotex Inc | Resolved | 2023-12-19 | 38 | Manufacturing distruption | 214241 |
3057 | A02BC05 | SANDOZ ESOMEPRAZOLE | 40MG | Sandoz Canada Incorporated | Resolved | 2023-12-19 | 3 | Manufacturing practices | 213807 |
3058 | N05AX12 | APO-ARIPIPRAZOLE | 15MG | Apotex Inc | Resolved | 2023-12-19 | 73 | Manufacturing distruption | 214226 |
3059 | B01AC24 | APO-TICAGRELOR | 90MG | Apotex Inc | Resolved | 2023-12-19 | 115 | Manufacturing distruption | 214250 |
3060 | B01AF02 | MAR-APIXABAN | 5MG | Marcan Pharmaceuticals Inc | Resolved | 2023-12-19 | 71 | Demand increase | 213726 |
3061 | A10BD07 | SANDOZ SITAGLIPTIN-METFORMIN | 500MG 50MG | Sandoz Canada Incorporated | Resolved | 2023-12-19 | 45 | Manufacturing distruption | 213821 |
3019 | A10BD16 | INVOKAMET | 500MG 150MG | Janssen Inc | Avoided | 2023-12-18 | 0 | Ingredient shortage | 199845 |
3026 | A10BD16 | INVOKAMET | 1000MG 150MG | Janssen Inc | Avoided | 2023-12-18 | 19 | Ingredient shortage | 199839 |
3020 | L04AA06 | MAR-MYCOPHENOLIC ACID | 180MG | Marcan Pharmaceuticals Inc | Resolved | 2023-12-18 | 72 | Demand increase | 213723 |
3021 | D10AD01 | RETIN-A | 0.025% | Bausch Health, Canada Inc. | Resolved | 2023-12-18 | 31 | Other | 211261 |
3022 | A11CC03 | ONE-ALPHA | 2MCG | Cheplapharm Arzneimittel Gmbh | Resolved | 2023-12-18 | 305 | Manufacturing distruption | 213256 |
3023 | C09AA04 | COVERSYL | 8MG | Servier Canada Inc | Resolved | 2023-12-18 | 21 | Shipping delay | 213729 |
3024 | N06DA04 | MYLAN-GALANTAMINE ER | 8MG | Mylan Pharmaceuticals Ulc | Resolved | 2023-12-18 | 92 | Manufacturing distruption | 209416 |
3025 | J01MA02 | MAR-CIPROFLOXACIN | 500MG | Marcan Pharmaceuticals Inc | Resolved | 2023-12-18 | 134 | Demand increase | 213720 |
3027 | B01AF01 | TARO-RIVAROXABAN | 20MG | Taro Pharmaceuticals Inc | Resolved | 2023-12-18 | 95 | Manufacturing distruption | 222098 |
3017 | N02BF02 | LYRICA | 25MG | Bgp Pharma Ulc | Resolved | 2023-12-16 | 66 | Manufacturing distruption | 212590 |
3018 | N07BB03 | CAMPRAL | 333MG | Mylan Pharmaceuticals Ulc | Resolved | 2023-12-16 | 18 | Other | 213971 |
3013 | N05AH04 | ACH-QUETIAPINE FUMARATE XR | 50MG | Accord Healthcare Inc | Active | 2023-12-15 | Manufacturing distruption | 213623 | |
3015 | N07AA02 | RIVA-PYRIDOSTIGMINE | 60MG | Laboratoire Riva Inc. | Active | 2023-12-15 | 455 | Shipping delay | 212593 |
3008 | N03AD01 | ZARONTIN | 250MG | Searchlight Pharma Inc | Avoided | 2023-12-15 | 48 | Shipping delay | 210026 |
3014 | A10BD16 | INVOKAMET | 1000MG 50MG | Janssen Inc | Avoided | 2023-12-15 | 22 | Ingredient shortage | 199842 |
3001 | L04AA06 | MYCOPHENOLATE MOFETIL FOR INJE... | 500MG | Sterimax Inc | Resolved | 2023-12-15 | 48 | Manufacturing distruption | 207582 |
3002 | A10BX16 | MOUNJARO | 12.5MG | Eli Lilly Canada Inc | Resolved | 2023-12-15 | 353 | Other | 210461 |
3003 | C08DA01 | ISOPTIN SR | 120MG | Bgp Pharma Ulc | Resolved | 2023-12-15 | 161 | Demand increase | 213750 |
3004 | M03CA01 | DANTRIUM CAPSULES | 25MG | Endo Par Innovation Company, Llc | Resolved | 2023-12-15 | 47 | Shipping delay | 215589 |
3005 | J06BA02 | GAMMAGARD S/D | 5G | Takeda Canada Inc | Resolved | 2023-12-15 | 137 | Other | 207306 |
3006 | J05AB01 | ACYCLOVIR SODIUM INJECTION | 50MG | Fresenius Kabi Canada Ltd | Resolved | 2023-12-15 | 77 | Manufacturing distruption | 215434 |
3007 | A01AB03 | PERICHLOR | 0.12% | Pendopharm Division Of Pharmascience Inc | Resolved | 2023-12-15 | 87 | Manufacturing distruption | 213436 |
3009 | B01AF01 | XARELTO | 10MG | Bayer Inc | Resolved | 2023-12-15 | 21 | Shipping delay | 212621 |
3010 | N02AX06 | NUCYNTA EXTENDED-RELEASE | 50MG | Endo Ventures Ltd. | Resolved | 2023-12-15 | 98 | Shipping delay | 214713 |
3011 | R06AA11 | DIMENHYDRINATE INJECTION USP | 50MG | Hikma Canada Limited | Resolved | 2023-12-15 | 213 | Manufacturing distruption | 210671 |
3012 | A09AA02 | CREON MINIMICROSPHERES MICRO | 320UNIT 5100UNIT 5000UNIT | Bgp Pharma Ulc | Resolved | 2023-12-15 | 81 | Demand increase | 213745 |
3016 | N07AA02 | JAMP PYRIDOSTIGMINE BROMIDE | 60MG | Jamp Pharma Corporation | Resolved | 2023-12-15 | 137 | Demand increase | 213590 |
3000 | S01AA13 | FUCITHALMIC | 1% | Amdipharm Limited | Resolved | 2023-12-14 | 108 | Other | 213398 |
2996 | G04BE08 | MYLAN-TADALAFIL | 20MG | Mylan Pharmaceuticals Ulc | Avoided | 2023-12-13 | 16 | Manufacturing distruption | 204802 |
2984 | H03BA02 | PROPYLTHIOURACIL TABLETS | 50MG | Phebra Canada Inc | Resolved | 2023-12-13 | 56 | Shipping delay | 213216 |
2985 | A02BX02 | TEVA-SUCRALFATE | 1G | Teva Canada Limited | Resolved | 2023-12-13 | 180 | Manufacturing distruption | 213368 |
2986 | B05XA08 | SODIUM ACETATE INJECTION USP | 328MG | Omega Laboratories Limited | Resolved | 2023-12-13 | 30 | Demand increase | 213101 |
2987 | H02AB01 | CELESTONE SOLUSPAN | 3MG 3MG | Organon Canada Inc. | Resolved | 2023-12-13 | 51 | Demand increase | 213243 |
2988 | N03AB05 | CEREBYX | 75MG | Searchlight Pharma Inc | Resolved | 2023-12-13 | 49 | Demand increase | 213247 |
2989 | H02AB07 | TEVA-PREDNISONE | 5MG | Teva Canada Limited | Resolved | 2023-12-13 | 69 | Manufacturing distruption | 213365 |
2990 | C07AB02 | TEVA-METOPROLOL | 100MG | Teva Canada Limited | Resolved | 2023-12-13 | 129 | Manufacturing distruption | 219684 |
2991 | A02BC01 | LOSEC MUPS | 20MG | Cheplapharm Arzneimittel Gmbh | Resolved | 2023-12-13 | 170 | Manufacturing distruption | 213267 |
2992 | C10AA05 | TEVA-ATORVASTATIN | 80MG | Teva Canada Limited | Resolved | 2023-12-13 | 49 | Manufacturing distruption | 213371 |
2993 | N06DX01 | ACT MEMANTINE | 10MG | Teva Canada Limited | Resolved | 2023-12-13 | 98 | Manufacturing distruption | 213374 |
2994 | L04AG04 | BENLYSTA | 120MG | Glaxosmithkline Inc | Resolved | 2023-12-13 | 58 | Manufacturing distruption | 213253 |
2995 | N02CC05 | MYLAN-ALMOTRIPTAN | 12.5MG | Mylan Pharmaceuticals Ulc | Resolved | 2023-12-13 | 104 | Ingredient shortage | 208613 |
2997 | D01AA01 | NYADERM | 100000UNIT | Taro Pharmaceuticals Inc | Resolved | 2023-12-13 | 345 | Manufacturing distruption | 230682 |
2998 | A03AX04 | PINAVERIUM | 50MG | Aa Pharma Inc | Resolved | 2023-12-13 | 56 | Manufacturing distruption | 213140 |
2999 | M05BA07 | AA-RISEDRONATE DR | 35MG | Aa Pharma Inc | Resolved | 2023-12-13 | 69 | Manufacturing distruption | 213143 |
2967 | C09AA03 | APO-LISINOPRIL | 10MG | Apotex Inc | Active | 2023-12-12 | Manufacturing distruption | 213581 | |
2970 | V07AB | SODIUM CHLORIDE BACTERIOSTATIC... | 9MG | Omega Laboratories Limited | Avoided | 2023-12-12 | 3 | Demand increase | 205150 |
2968 | C02AC02 | APO-GUANFACINE XR | 4MG | Apotex Inc | Resolved | 2023-12-12 | 38 | Manufacturing distruption | 213559 |
2969 | C09AA02 | APO-ENALAPRIL | 20MG | Apotex Inc | Resolved | 2023-12-12 | 10 | Manufacturing distruption | 213562 |
2971 | N05CF01 | APO-ZOPICLONE | 5MG | Apotex Inc | Resolved | 2023-12-12 | 73 | Manufacturing distruption | 213565 |
2972 | L01CE02 | IRINOTECAN HYDROCHLORIDE INJEC... | 20MG | Pfizer Canada Ulc | Resolved | 2023-12-12 | Manufacturing distruption | 212033 | |
2973 | C09AA04 | APO-PERINDOPRIL | 8MG | Apotex Inc | Resolved | 2023-12-12 | 17 | Manufacturing distruption | 213550 |
2974 | C10AA05 | APO-ATORVASTATIN | 20MG | Apotex Inc | Resolved | 2023-12-12 | 115 | Manufacturing distruption | 213556 |
2975 | N05AH03 | APO-OLANZAPINE ODT | 15MG | Apotex Inc | Resolved | 2023-12-12 | 17 | Manufacturing distruption | 213576 |
2976 | N05AH03 | APO-OLANZAPINE ODT | 20MG | Apotex Inc | Resolved | 2023-12-12 | 17 | Manufacturing distruption | 213553 |
2977 | M05BA04 | ACH-ALENDRONATE | 70MG | Accord Healthcare Inc | Resolved | 2023-12-12 | 9 | Shipping delay | 213617 |
2978 | M04AA01 | APO-ALLOPURINOL | 200MG | Apotex Inc | Resolved | 2023-12-12 | 45 | Manufacturing distruption | 213584 |
2979 | M03AC11 | CISATRACURIUM OMEGA MULTIDOSE | 2MG | Omega Laboratories Limited | Resolved | 2023-12-12 | 155 | Demand increase | 213113 |
2980 | G03AA12 | MYA | 0.02MG 3.00MG | Apotex Inc | Resolved | 2023-12-12 | 10 | Manufacturing distruption | 213568 |
2981 | J01FA10 | APO-AZITHROMYCIN Z | 250MG | Apotex Inc | Resolved | 2023-12-12 | 24 | Manufacturing distruption | 213573 |
2982 | G04BD10 | APO-DARIFENACIN | 7.5MG | Apotex Inc | Resolved | 2023-12-12 | 311 | Manufacturing distruption | 213547 |
2983 | G02CB03 | APO-CABERGOLINE | 0.5MG | Apotex Inc | Resolved | 2023-12-12 | 10 | Manufacturing distruption | 213587 |
2956 | N07AB02 | DUVOID | 50MG | Paladin Labs Inc. | Active | 2023-12-11 | Manufacturing distruption | 217075 | |
2966 | A10BB09 | TARO-GLICLAZIDE MR | 30MG | Sun Pharma Canada Inc | Active | 2023-12-11 | 473 | Manufacturing distruption | 215021 |
2957 | S01FA06 | MINIMS TROPICAMIDE | 1% | Bausch & Lomb Inc | Resolved | 2023-12-11 | 35 | Shipping delay | 212483 |
2958 | N02CC01 | IMITREX | 6MG | Glaxosmithkline Inc | Resolved | 2023-12-11 | 32 | Shipping delay | 213449 |
2959 | R05CB01 | ACETYLCYSTEINE SOLUTION | 200MG | Sandoz Canada Incorporated | Resolved | 2023-12-11 | 11 | Manufacturing distruption | 212999 |
2960 | A02BC04 | PARIET, ENTERIC-COATED TABLET ... | 10MG | Janssen Inc | Resolved | 2023-12-11 | 30 | Demand increase | 212758 |
2961 | A02BC04 | PARIET, ENTERIC-COATED TABLET ... | 20MG | Janssen Inc | Resolved | 2023-12-11 | 30 | Demand increase | 212763 |
2962 | C09AA02 | SANDOZ ENALAPRIL | 4MG | Sandoz Canada Incorporated | Resolved | 2023-12-11 | 67 | Manufacturing distruption | 213008 |
2963 | C10AA05 | SANDOZ ATORVASTATIN | 40MG | Sandoz Canada Incorporated | Resolved | 2023-12-11 | 11 | Manufacturing distruption | 213002 |
2964 | C10AA05 | SANDOZ ATORVASTATIN | 40MG | Sandoz Canada Incorporated | Resolved | 2023-12-11 | 60 | Manufacturing distruption | 213005 |
2965 | C10AX09 | SANDOZ EZETIMIBE | 10MG | Sandoz Canada Incorporated | Resolved | 2023-12-11 | 326 | Ingredient shortage | 213011 |
2955 | C10AX09 | AURO-EZETIMIBE | 10MG | Auro Pharma Inc | Resolved | 2023-12-09 | 235 | Demand increase | 135358 |
2948 | N06AA09 | ELAVIL | 10MG | Aa Pharma Inc | Active | 2023-12-08 | Manufacturing distruption | 212824 | |
2949 | D07AC03 | TOPICORT | 0.25% | Bausch Health, Canada Inc. | Resolved | 2023-12-08 | 37 | Other | 211247 |
2950 | N07BC02 | METADOL | 10MG | Paladin Labs Inc. | Resolved | 2023-12-08 | 108 | Shipping delay | 214966 |
2951 | A02BC01 | OMEPRAZOLE MAGNESIUM DELAYED R... | 20MG | Accord Healthcare Inc | Resolved | 2023-12-08 | 11 | Shipping delay | 212845 |
2952 | B01AF02 | ACH-APIXABAN | 5MG | Accord Healthcare Inc | Resolved | 2023-12-08 | 97 | Manufacturing distruption | 212848 |
2953 | A09AA02 | CREON MINIMICROSPHERES 35 | 2240UNIT 35700UNIT 35000UNIT | Bgp Pharma Ulc | Resolved | 2023-12-08 | 42 | Demand increase | 213742 |
2954 | N06AA04 | TARO-CLOMIPRAMINE | 25MG | Taro Pharmaceuticals Inc | Resolved | 2023-12-08 | 63 | Manufacturing distruption | 215088 |
2943 | J05AP01 | VIRAZOLE | 6G | Bausch Health, Canada Inc. | Resolved | 2023-12-07 | 47 | Demand increase | 213468 |
2944 | N05AN01 | LITHMAX | 300MG | Aa Pharma Inc | Resolved | 2023-12-07 | 46 | Manufacturing distruption | 212786 |
2945 | N06AX24 | VIIBRYD | 10MG | Abbvie Corporation | Resolved | 2023-12-07 | 43 | Shipping delay | 212766 |
2946 | N06AX24 | VIIBRYD | 20MG | Abbvie Corporation | Resolved | 2023-12-07 | 43 | Shipping delay | 212769 |
2947 | R03BA09 | ARNUITY ELLIPTA | 100MCG | Glaxosmithkline Inc | Resolved | 2023-12-07 | 55 | Manufacturing distruption | 212815 |
2929 | J01XD01 | METRONIDAZOLE INJECTION, USP | 5MG | Baxter Corporation | Resolved | 2023-12-06 | 5 | Demand increase | 212704 |
2930 | J01XD01 | METRONIDAZOLE INJECTION, USP | 5MG | Baxter Corporation | Resolved | 2023-12-06 | 58 | Demand increase | 212707 |
2931 | R05FA02 | TEVA-COTRIDIN EXPECTORANT | 10MG 100MG 30MG 2MG | Teva Canada Limited | Resolved | 2023-12-06 | 95 | Manufacturing distruption | 212714 |
2932 | B05CX10 | SORBITOL MANNITOL IRRIGATION | 5.4MG 27MG | Icu Medical Canada Inc | Resolved | 2023-12-06 | 14 | Manufacturing distruption | 209770 |
2933 | J01DB01 | TEVA-CEPHALEXIN | 500MG | Teva Canada Limited | Resolved | 2023-12-06 | 136 | Manufacturing distruption | 219687 |
2934 | C09DA01 | HYZAAR DS | 25MG 100MG | Organon Canada Inc. | Resolved | 2023-12-06 | 16 | Shipping delay | 212618 |
2935 | D07XC01 | RATIO-TOPISALIC | 20MG 0.5MG | Teva Canada Limited | Resolved | 2023-12-06 | 35 | Manufacturing distruption | 212717 |
2936 | J01MA02 | PRO-CIPROFLOXACIN | 500MG | Pro Doc Limitee | Resolved | 2023-12-06 | 71 | Shipping delay | 212576 |
2937 | B01AC04 | TEVA-CLOPIDOGREL | 300MG | Teva Canada Limited | Resolved | 2023-12-06 | 197 | Manufacturing distruption | 212720 |
2938 | M01AC06 | AURO-MELOXICAM | 15MG | Auro Pharma Inc | Resolved | 2023-12-06 | 345 | Demand increase | 211603 |
2939 | G04BE08 | TEVA-TADALAFIL | 20MG | Teva Canada Limited | Resolved | 2023-12-06 | 105 | Manufacturing distruption | 212725 |
2940 | J02AX04 | CASPOFUNGIN FOR INJECTION | 50MG | Juno Pharmaceuticals Corp. | Resolved | 2023-12-06 | 56 | Demand increase | 212548 |
2941 | J02AX04 | CASPOFUNGIN FOR INJECTION | 70MG | Juno Pharmaceuticals Corp. | Resolved | 2023-12-06 | 56 | Demand increase | 212553 |
2942 | S01XA18 | TEVA-CYCLOSPORINE | 0.05% | Teva Canada Limited | Resolved | 2023-12-06 | 105 | Manufacturing distruption | 212730 |
2906 | N05AH04 | APO-QUETIAPINE XR | 150MG | Apotex Inc | Active | 2023-12-05 | Manufacturing distruption | 212969 | |
2920 | L04AA06 | APO-MYCOPHENOLATE | 250MG | Apotex Inc | Active | 2023-12-05 | Manufacturing distruption | 212958 | |
2921 | L04AA06 | APO-MYCOPHENOLATE | 500MG | Apotex Inc | Active | 2023-12-05 | Manufacturing distruption | 212965 | |
2925 | C10AX09 | APO-EZETIMIBE | 10MG | Apotex Inc | Active | 2023-12-05 | Manufacturing distruption | 212961 | |
2907 | N01BB01 | BUPIVACAINE HYDROCHLORIDE IN D... | 7.5MG | Omega Laboratories Limited | Resolved | 2023-12-05 | Demand increase | 211742 | |
2908 | C02AC02 | APO-GUANFACINE XR | 2MG | Apotex Inc | Resolved | 2023-12-05 | 38 | Manufacturing distruption | 212949 |
2909 | G03DA04 | PROMETRIUM | 100MG | Organon Canada Inc. | Resolved | 2023-12-05 | 71 | Other | 205419 |
2910 | C07AA07 | APO-SOTALOL | 160MG | Apotex Inc | Resolved | 2023-12-05 | 45 | Manufacturing distruption | 212952 |
2911 | C02CA04 | APO-DOXAZOSIN | 4MG | Apotex Inc | Resolved | 2023-12-05 | 108 | Manufacturing distruption | 212946 |
2912 | A02BA03 | FAMOTIDINE OMEGA -(WITHOUT PR... | 10MG | Omega Laboratories Limited | Resolved | 2023-12-05 | 52 | Manufacturing distruption | 210891 |
2913 | H01CB02 | OCTREOTIDE ACETATE OMEGA | 200MCG | Omega Laboratories Limited | Resolved | 2023-12-05 | 300 | Manufacturing distruption | 211733 |
2914 | J01FA09 | APO-CLARITHROMYCIN | 250MG | Apotex Inc | Resolved | 2023-12-05 | 10 | Manufacturing distruption | 212928 |
2915 | N03AX14 | APO-LEVETIRACETAM | 500MG | Apotex Inc | Resolved | 2023-12-05 | 10 | Manufacturing distruption | 212931 |
2916 | N06AX11 | APO-MIRTAZAPINE | 45MG | Apotex Inc | Resolved | 2023-12-05 | 10 | Manufacturing distruption | 212922 |
2917 | J05AB09 | APO-FAMCICLOVIR | 500MG | Apotex Inc | Resolved | 2023-12-05 | 73 | Manufacturing distruption | 212955 |
2918 | J01MA12 | APO-LEVOFLOXACIN | 750MG | Apotex Inc | Resolved | 2023-12-05 | 101 | Manufacturing distruption | 212569 |
2919 | L02BG03 | ACH-ANASTROZOLE | 1MG | Accord Healthcare Inc | Resolved | 2023-12-05 | 41 | Demand increase | 213620 |
2922 | G04CB02 | APO-DUTASTERIDE | 0.5MG | Apotex Inc | Resolved | 2023-12-05 | 17 | Manufacturing distruption | 212937 |
2923 | C10BX03 | APO-AMLODIPINE-ATORVASTATIN | 80MG 10MG | Apotex Inc | Resolved | 2023-12-05 | 45 | Manufacturing distruption | 212940 |
2924 | N02AX02 | APO-TRAMADOL | 50MG | Apotex Inc | Resolved | 2023-12-05 | 66 | Manufacturing distruption | 212925 |
2926 | C07AA12 | APO-NADOLOL | 80MG | Apotex Inc | Resolved | 2023-12-05 | 52 | Manufacturing distruption | 212919 |
2927 | N05CF02 | APO-ZOLPIDEM ODT | 5MG | Apotex Inc | Resolved | 2023-12-05 | 80 | Manufacturing distruption | 212934 |
2928 | N06AX21 | APO-DULOXETINE | 60MG | Apotex Inc | Resolved | 2023-12-05 | 31 | Manufacturing distruption | 212943 |
2900 | C09AA02 | VASOTEC | 16MG | Organon Canada Inc. | Avoided | 2023-12-04 | 39 | Shipping delay | 206439 |
2893 | A10BX16 | MOUNJARO | 10MG | Eli Lilly Canada Inc | Resolved | 2023-12-04 | 274 | Other | 210458 |
2894 | A10BX16 | MOUNJARO | 15MG | Eli Lilly Canada Inc | Resolved | 2023-12-04 | 364 | Other | 210464 |
2895 | S01FA01 | MINIMS ATROPINE SULPHATE | 1% | Bausch & Lomb Inc | Resolved | 2023-12-04 | 58 | Ingredient shortage | 212478 |
2896 | M01CC01 | CUPRIMINE | 250MG | Bausch Health, Canada Inc. | Resolved | 2023-12-04 | 7 | Other | 206596 |
2897 | R06AA11 | DIMENHYDRINATE INJECTION USP | 10MG | Sandoz Canada Incorporated | Resolved | 2023-12-04 | 18 | Manufacturing distruption | 212442 |
2898 | B05XC | MULTI 1000 | 1.2MG 10MG 1MG 4.5MG 1UNIT 100UNIT 1000UNIT 100MG 2.6MG | Sandoz Canada Incorporated | Resolved | 2023-12-04 | 116 | Manufacturing practices | 212448 |
2899 | A02BC04 | SANDOZ RABEPRAZOLE | 20MG | Sandoz Canada Incorporated | Resolved | 2023-12-04 | 18 | Manufacturing distruption | 212457 |
2901 | N05AH03 | SANDOZ OLANZAPINE ODT | 15MG | Sandoz Canada Incorporated | Resolved | 2023-12-04 | 39 | Ingredient shortage | 212451 |
2902 | C09DA04 | SANDOZ IRBESARTAN HCT | 12.5MG 300MG | Sandoz Canada Incorporated | Resolved | 2023-12-04 | 46 | Manufacturing distruption | 212445 |
2903 | D07CB01 | VIADERM KC CRM | 100000UNIT 0.25MG 2.5MG 1MG | Taro Pharmaceuticals Inc | Resolved | 2023-12-04 | 326 | Manufacturing distruption | 237281 |
2904 | A04AA01 | ONDANSETRON ODT | 4MG | Sandoz Canada Incorporated | Resolved | 2023-12-04 | 53 | Manufacturing distruption | 212454 |
2905 | S02CA06 | SANDOZ CIPROFLOXACIN / DEXAMET... | 0.1% 0.3% | Sandoz Canada Incorporated | Resolved | 2023-12-04 | 11 | Demand increase | 212439 |
2892 | N06BA07 | AURO-MODAFINIL | 100MG | Auro Pharma Inc | Resolved | 2023-12-03 | 287 | Demand increase | 208757 |
2891 | L01DB06 | IDARUBICIN | 1MG | Pfizer Canada Ulc | Resolved | 2023-12-02 | Manufacturing distruption | 205354 | |
2879 | L01XG01 | TARO-BORTEZOMIB | 2.5MG | Taro Pharmaceuticals Inc | Active | 2023-12-01 | Manufacturing distruption | 237229 | |
2886 | L04AD02 | ACH-TACROLIMUS | 0.5MG | Accord Healthcare Inc | Active | 2023-12-01 | Manufacturing distruption | 213250 | |
2887 | C09CA08 | ACH-OLMESARTAN | 20MG | Accord Healthcare Inc | Active | 2023-12-01 | Demand increase | 212213 | |
2881 | M03BX01 | BACLOFEN | 10MG | Sanis Health Inc | Avoided | 2023-12-01 | Manufacturing distruption | 212107 | |
2882 | N01BB02 | XYLOCAINE 1% | 10MG | Aspen Pharmacare Canada Inc. | Avoided | 2023-12-01 | 31 | Shipping delay | 188990 |
2878 | L01XG01 | TARO-BORTEZOMIB | 2.5MG | Taro Pharmaceuticals Inc | Resolved | 2023-12-01 | 210 | Other | 215073 |
2880 | B02AA02 | CYKLOKAPRON 100 MG/ML | 100MG | Pfizer Canada Ulc | Resolved | 2023-12-01 | Manufacturing distruption | 212036 | |
2883 | N05AH04 | QUETIAPINE TABLETS | 25MG | Accord Healthcare Inc | Resolved | 2023-12-01 | 19 | Demand increase | 212202 |
2884 | A02BC03 | TARO-LANSOPRAZOLE | 15MG | Sun Pharma Canada Inc | Resolved | 2023-12-01 | 42 | Manufacturing distruption | 215033 |
2885 | C09CA07 | ACH-TELMISARTAN | 80MG | Accord Healthcare Inc | Resolved | 2023-12-01 | 33 | Shipping delay | 212184 |
2888 | C10AA05 | ACH-ATORVASTATIN CALCIUM | 20MG | Accord Healthcare Inc | Resolved | 2023-12-01 | 49 | Demand increase | 212210 |
2889 | C10AA05 | ACH-ATORVASTATIN CALCIUM | 40MG | Accord Healthcare Inc | Resolved | 2023-12-01 | 7 | Shipping delay | 212187 |
2890 | C10AA05 | ACH-ATORVASTATIN CALCIUM | 40MG | Accord Healthcare Inc | Resolved | 2023-12-01 | 35 | Shipping delay | 212199 |
2875 | A10BJ05 | TRULICITY | 0.75MG | Eli Lilly Canada Inc | Active | 2023-11-30 | 578 | Demand increase | 211401 |
2871 | C03CC01 | ETHACRYNATE SODIUM FOR INJECTI... | 50MG | Sterimax Inc | Resolved | 2023-11-30 | Ingredient shortage | 218436 | |
2872 | D07AC01 | DIPROSONE | 0.05% | Organon Canada Inc. | Resolved | 2023-11-30 | 15 | Shipping delay | 210021 |
2873 | G03GA01 | PREGNYL | 10000UNIT | Organon Canada Inc. | Resolved | 2023-11-30 | 148 | Shipping delay | 211906 |
2874 | G04CA01 | AURO-ALFUZOSIN | 10MG | Auro Pharma Inc | Resolved | 2023-11-30 | 244 | Demand increase | 211587 |
2876 | N06BA04 | APO-METHYLPHENIDATE ER | 27MG | Apotex Inc | Resolved | 2023-11-30 | 91 | Manufacturing distruption | 212371 |
2877 | C09BB04 | APO-PERINDOPRIL/AMLODIPINE | 2.5MG 3.5MG | Apotex Inc | Resolved | 2023-11-30 | 29 | Manufacturing distruption | 212386 |
2857 | N06AA09 | ELAVIL | 10MG | Aa Pharma Inc | Active | 2023-11-29 | Manufacturing distruption | 211837 | |
2858 | A07AA02 | TEVA-NYSTATIN | 100000UNIT | Teva Canada Limited | Resolved | 2023-11-29 | 42 | Manufacturing distruption | 211976 |
2859 | M01AE02 | TEVA-NAPROXEN | 250MG | Teva Canada Limited | Resolved | 2023-11-29 | 21 | Manufacturing distruption | 211970 |
2860 | N06AX11 | TEVA-MIRTAZAPINE | 30MG | Teva Canada Limited | Resolved | 2023-11-29 | 52 | Manufacturing distruption | 211979 |
2861 | C10AA05 | TEVA-ATORVASTATIN | 10MG | Teva Canada Limited | Resolved | 2023-11-29 | 52 | Manufacturing distruption | 211982 |
2862 | C10AA05 | TEVA-ATORVASTATIN | 40MG | Teva Canada Limited | Resolved | 2023-11-29 | 21 | Manufacturing distruption | 211988 |
2863 | C10AA05 | TEVA-ATORVASTATIN | 40MG | Teva Canada Limited | Resolved | 2023-11-29 | 42 | Manufacturing distruption | 211992 |
2864 | N06DX01 | ACT MEMANTINE | 10MG | Teva Canada Limited | Resolved | 2023-11-29 | 21 | Manufacturing distruption | 211998 |
2865 | N06DX01 | ACT MEMANTINE | 10MG | Teva Canada Limited | Resolved | 2023-11-29 | 63 | Manufacturing distruption | 212001 |
2866 | C09CA06 | TEVA-CANDESARTAN | 8MG | Teva Canada Limited | Resolved | 2023-11-29 | 52 | Manufacturing distruption | 211985 |
2867 | C10AA01 | SIMVASTATIN | 20MG | Sivem Pharmaceuticals Ulc | Resolved | 2023-11-29 | 86 | Shipping delay | 211160 |
2868 | D07AC01 | BETADERM CRM 0.05% | 0.05% | Taro Pharmaceuticals Inc | Resolved | 2023-11-29 | 51 | Manufacturing distruption | 215070 |
2869 | D01AA01 | NYADERM | 100000UNIT | Taro Pharmaceuticals Inc | Resolved | 2023-11-29 | 359 | Manufacturing distruption | 230685 |
2870 | N03AF01 | TEVA-CARBAMAZEPINE | 200MG | Teva Canada Limited | Resolved | 2023-11-29 | 83 | Manufacturing distruption | 211973 |
2842 | J01AA02 | APO-DOXYCYCLINE MR | 40MG | Apotex Inc | Resolved | 2023-11-28 | 24 | Manufacturing distruption | 212374 |
2843 | S01BC11 | APO-BROMFENAC | 0.07% | Apotex Inc | Resolved | 2023-11-28 | 38 | Manufacturing distruption | 212389 |
2844 | M01AB05 | APO-DICLO SR | 100MG | Apotex Inc | Resolved | 2023-11-28 | 38 | Manufacturing distruption | 212392 |
2845 | H02AB02 | DEXAMETHASONE-OMEGA | 4MG | Omega Laboratories Limited | Resolved | 2023-11-28 | Manufacturing distruption | 209449 | |
2846 | C01DA02 | TRINIPATCH 0.4 | 0.4MG | Paladin Labs Inc. | Resolved | 2023-11-28 | 94 | Other | 211678 |
2847 | D01BA02 | APO-TERBINAFINE | 250MG | Apotex Inc | Resolved | 2023-11-28 | 52 | Manufacturing distruption | 212377 |
2848 | C07AG01 | APO-LABETALOL | 100MG | Apotex Inc | Resolved | 2023-11-28 | 59 | Manufacturing distruption | 212359 |
2849 | D10AF51 | BENZACLIN | 5% 1% | Bausch Health, Canada Inc. | Resolved | 2023-11-28 | 55 | Demand increase | 207376 |
2850 | N02CC01 | APO-SUMATRIPTAN | 50MG | Apotex Inc | Resolved | 2023-11-28 | 17 | Manufacturing distruption | 212380 |
2851 | A10BA02 | APO-METFORMIN ER | 500MG | Apotex Inc | Resolved | 2023-11-28 | 66 | Manufacturing distruption | 212362 |
2852 | D10AF51 | BIACNA TOPICAL GEL | 0.025% 1.2% | Bausch Health, Canada Inc. | Resolved | 2023-11-28 | 17 | Other | 211253 |
2853 | N02AA03 | APO-HYDROMORPHONE | 2MG | Apotex Inc | Resolved | 2023-11-28 | 52 | Manufacturing distruption | 212383 |
2854 | R06AA59 | APO-DOXYLAMINE/B6 | 10MG 10MG | Apotex Inc | Resolved | 2023-11-28 | 80 | Manufacturing distruption | 212365 |
2855 | G04BD10 | APO-DARIFENACIN | 15MG | Apotex Inc | Resolved | 2023-11-28 | 234 | Manufacturing distruption | 212368 |
2856 | A01AB03 | PERICHLOR WITHOUT ALCOHOL | 0.12% | Pendopharm Division Of Pharmascience Inc | Resolved | 2023-11-28 | 421 | Manufacturing distruption | 211878 |
2822 | A02BC04 | JAMP RABEPRAZOLE | 10MG | Jamp Pharma Corporation | Active | 2023-11-27 | 704 | Manufacturing distruption | 211804 |
2826 | A07AA02 | JAMP-NYSTATIN ORAL SUSPENSION ... | 100000UNIT | Jamp Pharma Corporation | Active | 2023-11-27 | 551 | Demand increase | 211795 |
2830 | D05BB02 | TARO-ACITRETIN | 25MG | Taro Pharmaceuticals Inc | Active | 2023-11-27 | Manufacturing distruption | 215064 | |
2841 | G04CB02 | JAMP DUTASTERIDE | 0.5MG | Jamp Pharma Corporation | Active | 2023-11-27 | 490 | Manufacturing distruption | 211786 |
2813 | C02AC01 | JAMP CLONIDINE | 0.025MG | Jamp Pharma Corporation | Resolved | 2023-11-27 | 80 | Demand increase | 211783 |
2814 | J02AC04 | JAMP POSACONAZOLE | 40MG | Jamp Pharma Corporation | Resolved | 2023-11-27 | 161 | Manufacturing distruption | 211801 |
2815 | H02AB01 | CELESTONE SOLUSPAN | 3MG 3MG | Organon Canada Inc. | Resolved | 2023-11-27 | 158 | Shipping delay | 211633 |
2816 | R03AC12 | SEREVENT DISKUS (50MCG/DOSE) | 50MCG | Glaxosmithkline Inc | Resolved | 2023-11-27 | 18 | Manufacturing distruption | 212066 |
2817 | J05AG01 | AURO-NEVIRAPINE | 200MG | Auro Pharma Inc | Resolved | 2023-11-27 | 125 | Demand increase | 211613 |
2818 | L04AA06 | JAMP-MYCOPHENOLATE | 500MG | Jamp Pharma Corporation | Resolved | 2023-11-27 | 18 | Manufacturing distruption | 211792 |
2819 | C09DA07 | JAMP TELMISARTAN-HCT | 12.5MG 80MG | Jamp Pharma Corporation | Resolved | 2023-11-27 | 140 | Manufacturing distruption | 211813 |
2820 | C09DA07 | JAMP TELMISARTAN-HCT | 12.5MG 80MG | Jamp Pharma Corporation | Resolved | 2023-11-27 | 186 | Manufacturing distruption | 211816 |
2821 | C09DA07 | JAMP TELMISARTAN-HCT | 25MG 80MG | Jamp Pharma Corporation | Resolved | 2023-11-27 | 140 | Manufacturing distruption | 211810 |
2823 | N05AH03 | JAMP OLANZAPINE FC | 20MG | Jamp Pharma Corporation | Resolved | 2023-11-27 | 170 | Manufacturing distruption | 211798 |
2824 | A10BX02 | AURO-REPAGLINIDE | 1MG | Auro Pharma Inc | Resolved | 2023-11-27 | 22 | Demand increase | 211622 |
2825 | J01DD08 | AURO-CEFIXIME | 400MG | Auro Pharma Inc | Resolved | 2023-11-27 | 123 | Demand increase | 211590 |
2827 | A11CC05 | JAMP-VITAMIN D | 50000UNIT | Jamp Pharma Corporation | Resolved | 2023-11-27 | 65 | Manufacturing distruption | 211819 |
2828 | N07CA01 | AURO-BETAHISTINE | 16MG | Auro Pharma Inc | Resolved | 2023-11-27 | 308 | Demand increase | 211580 |
2829 | S01EE01 | JAMP LATANOPROST | 50MCG | Jamp Pharma Corporation | Resolved | 2023-11-27 | 49 | Manufacturing distruption | 211789 |
2831 | J01DD08 | AURO-CEFIXIME | 100MG | Auro Pharma Inc | Resolved | 2023-11-27 | 278 | Demand increase | 211593 |
2832 | C02KX | JAMP-SILDENAFIL R | 20MG | Jamp Pharma Corporation | Resolved | 2023-11-27 | 65 | Demand increase | 211807 |
2833 | C09DA06 | JAMP CANDESARTAN-HCT | 16MG 12.5MG | Jamp Pharma Corporation | Resolved | 2023-11-27 | 231 | Other | 211765 |
2834 | C09DA06 | JAMP CANDESARTAN-HCT | 12.5MG 32MG | Jamp Pharma Corporation | Resolved | 2023-11-27 | 247 | Manufacturing distruption | 211768 |
2835 | C09DA06 | JAMP CANDESARTAN-HCT | 12.5MG 32MG | Jamp Pharma Corporation | Resolved | 2023-11-27 | 247 | Manufacturing distruption | 211771 |
2836 | C09DA06 | JAMP CANDESARTAN-HCT | 25MG 32MG | Jamp Pharma Corporation | Resolved | 2023-11-27 | 247 | Manufacturing distruption | 211774 |
2837 | C09DA06 | JAMP CANDESARTAN-HCT | 25MG 32MG | Jamp Pharma Corporation | Resolved | 2023-11-27 | 247 | Manufacturing distruption | 211777 |
2838 | N03AX18 | SANDOZ LACOSAMIDE | 50MG | Sandoz Canada Incorporated | Resolved | 2023-11-27 | 60 | Manufacturing distruption | 211547 |
2839 | N03AX18 | AURO-LACOSAMIDE | 200MG | Auro Pharma Inc | Resolved | 2023-11-27 | 94 | Demand increase | 211598 |
2840 | C10AC01 | JAMP-CHOLESTYRAMINE | 4G | Jamp Pharma Corporation | Resolved | 2023-11-27 | 308 | Manufacturing distruption | 211780 |
2812 | G04CA02 | TAMSULOSIN CR | 0.4MG | Sanis Health Inc | Resolved | 2023-11-25 | 259 | Manufacturing distruption | 211102 |
2810 | V09BA03 | KIT FOR THE PREPARATION OF TEC... | 12MG | Isologic Innovative Radiopharmaceuticals Ltd. | Active | 2023-11-24 | 403 | Manufacturing distruption | 212529 |
2811 | C01DA14 | PMS-ISMN | 60MG | Pharmascience Inc | Active | 2023-11-24 | 698 | Manufacturing distruption | 211901 |
2809 | G04CA02 | FLOMAX CR | 0.4MG | Boehringer Ingelheim (Canada) Ltd Ltee | Resolved | 2023-11-24 | 73 | Demand increase | 210443 |
2805 | A10BX16 | MOUNJARO | 5MG | Eli Lilly Canada Inc | Resolved | 2023-11-23 | 207 | Other | 210452 |
2806 | L01AX03 | TEMODAL | 20MG | Merck Canada Inc | Resolved | 2023-11-23 | 67 | Demand increase | 209360 |
2807 | G04CA52 | JALYN | 0.4MG 0.5MG | Glaxosmithkline Inc | Resolved | 2023-11-23 | 251 | Demand increase | 211335 |
2808 | C09CA07 | ACH-TELMISARTAN | 80MG | Accord Healthcare Inc | Resolved | 2023-11-23 | 41 | Shipping delay | 211391 |
2796 | J01DB01 | TEVA-CEPHALEXIN 125 | 125MG | Teva Canada Limited | Resolved | 2023-11-22 | 130 | Manufacturing distruption | 211316 |
2797 | M01AE02 | TEVA-NAPROXEN | 500MG | Teva Canada Limited | Resolved | 2023-11-22 | 39 | Manufacturing distruption | 211319 |
2798 | C10AA05 | SANDOZ ATORVASTATIN | 10MG | Sandoz Canada Incorporated | Resolved | 2023-11-22 | 93 | Manufacturing distruption | 211127 |
2799 | C09CA06 | SANDOZ CANDESARTAN | 16MG | Sandoz Canada Incorporated | Resolved | 2023-11-22 | 65 | Manufacturing distruption | 211122 |
2800 | C10AA07 | TEVA-ROSUVASTATIN | 20MG | Teva Canada Limited | Resolved | 2023-11-22 | 39 | Manufacturing distruption | 211322 |
2801 | C10AX09 | ACH-EZETIMIBE | 10MG | Accord Healthcare Inc | Resolved | 2023-11-22 | 20 | Demand increase | 211396 |
2802 | D10AF51 | TARO-CLINDAMYCIN/BENZOYL PEROX... | 1% 5% | Taro Pharmaceuticals Inc | Resolved | 2023-11-22 | 51 | Manufacturing distruption | 215079 |
2803 | L04AX03 | METHOTREXATE SUBCUTANEOUS | 20MG | Accord Healthcare Inc | Resolved | 2023-11-22 | 58 | Manufacturing distruption | 211388 |
2804 | N01AH01 | FENTANYL INJECTION BP | 250MCG | Sterimax Inc | Resolved | 2023-11-22 | 37 | Shipping delay | 211212 |
2785 | M03BX01 | APO-BACLOFEN | 10MG | Apotex Inc | Resolved | 2023-11-21 | 31 | Manufacturing distruption | 211499 |
2786 | D07AC03 | TOPICORT | 0.05% | Bausch Health, Canada Inc. | Resolved | 2023-11-21 | 9 | Other | 211250 |
2787 | L01AX03 | TEMODAL | 5MG | Merck Canada Inc | Resolved | 2023-11-21 | 69 | Shipping delay | 209354 |
2788 | C09BA08 | APO-CILAZAPRIL/HCTZ | 12.5MG 5MG | Apotex Inc | Resolved | 2023-11-21 | 10 | Manufacturing distruption | 211496 |
2789 | C09AA04 | APO-PERINDOPRIL | 2MG | Apotex Inc | Resolved | 2023-11-21 | 24 | Manufacturing distruption | 211502 |
2790 | C10AA05 | APO-ATORVASTATIN | 80MG | Apotex Inc | Resolved | 2023-11-21 | 17 | Manufacturing distruption | 211493 |
2791 | G03AA12 | ZAMINE 28 | 0.03MG 3MG | Apotex Inc | Resolved | 2023-11-21 | 45 | Manufacturing distruption | 211487 |
2792 | G04BE08 | APO-TADALAFIL PAH | 20MG | Apotex Inc | Resolved | 2023-11-21 | 31 | Manufacturing distruption | 211478 |
2793 | N06AX21 | APO-DULOXETINE | 30MG | Apotex Inc | Resolved | 2023-11-21 | 45 | Manufacturing distruption | 211481 |
2794 | C08CA02 | APO-FELODIPINE | 10MG | Apotex Inc | Resolved | 2023-11-21 | 80 | Manufacturing distruption | 211484 |
2795 | C09BB04 | APO-PERINDOPRIL/AMLODIPINE | 5MG 7MG | Apotex Inc | Resolved | 2023-11-21 | 38 | Manufacturing distruption | 211490 |
2784 | B01AF01 | XARELTO | 51.7MG | Bayer Inc | Avoided | 2023-11-20 | 4 | Ingredient shortage | 196859 |
2770 | A10BK01 | SANDOZ DAPAGLIFLOZIN | 10MG | Sandoz Canada Incorporated | Resolved | 2023-11-20 | 53 | Manufacturing distruption | 210838 |
2771 | M04AC01 | SANDOZ COLCHICINE | 0.6MG | Sandoz Canada Incorporated | Resolved | 2023-11-20 | Manufacturing distruption | 210855 | |
2772 | D02AC | STERILE LIGHT MINERAL OIL 100% | 100% | Omega Laboratories Limited | Resolved | 2023-11-20 | Manufacturing distruption | 210098 | |
2773 | V03AB14 | PROTAMINE SULFATE INJECTION US... | 10MG | Sandoz Canada Incorporated | Resolved | 2023-11-20 | 74 | Manufacturing distruption | 210852 |
2774 | R03DA05 | AMINOPHYLLINE INJ 25MG/ML | 25MG | Omega Laboratories Limited | Resolved | 2023-11-20 | Demand increase | 210886 | |
2775 | N01AX03 | KETAMINE HYDROCHLORIDE INJECTI... | 10MG | Sandoz Canada Incorporated | Resolved | 2023-11-20 | 32 | Manufacturing practices | 179532 |
2776 | N01AX03 | KETAMINE HYDROCHLORIDE INJECTI... | 50MG | Sandoz Canada Incorporated | Resolved | 2023-11-20 | 28 | Manufacturing practices | 204614 |
2777 | A10BA02 | SANDOZ METFORMIN FC | 850MG | Sandoz Canada Incorporated | Resolved | 2023-11-20 | 11 | Manufacturing distruption | 210849 |
2778 | D11AX10 | SANDOZ FINASTERIDE A | 1MG | Sandoz Canada Incorporated | Resolved | 2023-11-20 | 60 | Demand increase | 210844 |
2779 | B02AA02 | TRANEXAMIC ACID INJECTION | 100MG | Omega Laboratories Limited | Resolved | 2023-11-20 | Manufacturing distruption | 209473 | |
2780 | C09DA06 | SANDOZ CANDESARTAN PLUS | 25MG 32MG | Sandoz Canada Incorporated | Resolved | 2023-11-20 | 60 | Manufacturing distruption | 210835 |
2781 | N06BA01 | SANDOZ AMPHETAMINE XR | 25MG | Sandoz Canada Incorporated | Resolved | 2023-11-20 | 32 | Demand increase | 210832 |
2782 | J01CR02 | SANDOZ AMOXI-CLAV TABLET | 125MG 875MG | Sandoz Canada Incorporated | Resolved | 2023-11-20 | 25 | Manufacturing distruption | 210829 |
2783 | J01XX09 | DAPTOMYCIN FOR INJECTION | 500MG | Sandoz Canada Incorporated | Resolved | 2023-11-20 | 4 | Manufacturing distruption | 210841 |
2769 | N06AX21 | DULOXETINE | 60MG | Sivem Pharmaceuticals Ulc | Resolved | 2023-11-19 | Manufacturing distruption | 211141 | |
2768 | G04CA02 | TAMSULOSIN CR | 0.4MG | Sivem Pharmaceuticals Ulc | Active | 2023-11-18 | Shipping delay | 211157 | |
2767 | A03BA01 | ATROPINE SULFATE INJECTION USP | 1MG | Pfizer Canada Ulc | Resolved | 2023-11-18 | Manufacturing distruption | 213831 | |
2759 | V03AB15 | NALOXONE HYDROCHLORIDE INJECTI... | 0.4MG | Hikma Canada Limited | Active | 2023-11-17 | Other | 210664 | |
2750 | N06AX21 | DULOXETINE | 60MG | Sanis Health Inc | Resolved | 2023-11-17 | 66 | Manufacturing distruption | 211052 |
2751 | N03AX18 | LACOSAMIDE | 150MG | Sanis Health Inc | Resolved | 2023-11-17 | 66 | Manufacturing distruption | 211034 |
2752 | A09AA02 | COTAZYM | 35000UNIT 40000UNIT 10000UNIT | Organon Canada Inc. | Resolved | 2023-11-17 | 14 | Shipping delay | 210882 |
2753 | N06DA03 | EXELON PATCH 10 | 9.5MG | Knight Therapeutics Inc. | Resolved | 2023-11-17 | Shipping delay | 210801 | |
2754 | N06AX05 | TRAZODONE | 150MG | Sanis Health Inc | Resolved | 2023-11-17 | 35 | Manufacturing distruption | 211117 |
2755 | N02BF01 | GABAPENTIN | 300MG | Sanis Health Inc | Resolved | 2023-11-17 | 112 | Manufacturing distruption | 211055 |
2756 | N06AB06 | SERTRALINE | 50MG | Sanis Health Inc | Resolved | 2023-11-17 | Manufacturing distruption | 211074 | |
2757 | N06AB06 | SERTRALINE | 100MG | Sanis Health Inc | Resolved | 2023-11-17 | 13 | Manufacturing distruption | 211071 |
2758 | N04BC05 | PRAMIPEXOLE | 0.25MG | Sanis Health Inc | Resolved | 2023-11-17 | 35 | Manufacturing distruption | 211037 |
2760 | C03CA01 | FUROSEMIDE INJECTION USP | 20MG | Hikma Canada Limited | Resolved | 2023-11-17 | 105 | Shipping delay | 210680 |
2761 | C09CA06 | CANDESARTAN | 4MG | Sanis Health Inc | Resolved | 2023-11-17 | 24 | Manufacturing distruption | 211086 |
2762 | C09DA06 | CANDESARTAN/HCTZ | 12.5MG 16MG | Sanis Health Inc | Resolved | 2023-11-17 | 41 | Manufacturing distruption | 211081 |
2763 | N02BF02 | PREGABALIN | 75MG | Sanis Health Inc | Resolved | 2023-11-17 | 27 | Manufacturing distruption | 211068 |
2764 | N02BF02 | PREGABALIN | 300MG | Sanis Health Inc | Resolved | 2023-11-17 | 93 | Manufacturing distruption | 211065 |
2765 | L04AA06 | MYCOPHENOLATE MOFETIL | 500MG | Sanis Health Inc | Resolved | 2023-11-17 | 26 | Ingredient shortage | 211089 |
2766 | C09AA04 | PERINDOPRIL ERBUMINE | 8MG | Sanis Health Inc | Resolved | 2023-11-17 | 13 | Manufacturing distruption | 211058 |
2746 | N01BB01 | MARCAINE | 250MG | Pfizer Canada Ulc | Avoided | 2023-11-16 | Manufacturing distruption | 206248 | |
2743 | A10BX16 | MOUNJARO | 2.5MG | Eli Lilly Canada Inc | Resolved | 2023-11-16 | 214 | Other | 210449 |
2744 | L01BA03 | TOMUDEX | 2MG | Pfizer Canada Ulc | Resolved | 2023-11-16 | Manufacturing distruption | 210280 | |
2745 | N01AX10 | PROPOFOL INJECTION | 10MG | Baxter Corporation | Resolved | 2023-11-16 | Manufacturing practices | 210583 | |
2747 | H02AB04 | SOLU-MEDROL | 1G | Pfizer Canada Ulc | Resolved | 2023-11-16 | Manufacturing distruption | 201990 | |
2748 | M01AE52 | MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 500MG | Mylan Pharmaceuticals Ulc | Resolved | 2023-11-16 | 41 | Manufacturing distruption | 205932 |
2749 | C10AX14 | PRALUENT | 150MG | Sanofi-Aventis Canada Inc | Resolved | 2023-11-16 | 36 | Other | 209520 |
2735 | C09AA04 | AURO-PERINDOPRIL | 2MG | Auro Pharma Inc | Active | 2023-11-15 | Demand increase | 204530 | |
2724 | C03CA01 | LASIX ORAL SOLUTION | 10MG | Sanofi-Aventis Canada Inc | Resolved | 2023-11-15 | 15 | Other | 210570 |
2725 | M01AG01 | MEFENAMIC | 250MG | Aa Pharma Inc | Resolved | 2023-11-15 | 75 | Manufacturing distruption | 210273 |
2726 | N06AX16 | EFFEXOR XR | 37.5MG | Bgp Pharma Ulc | Resolved | 2023-11-15 | Other | 213124 | |
2727 | S01BC05 | KETOROLAC | 0.5% | Aa Pharma Inc | Resolved | 2023-11-15 | 79 | Manufacturing distruption | 210268 |
2728 | N05AH03 | TEVA-OLANZAPINE | 10MG | Teva Canada Limited | Resolved | 2023-11-15 | 25 | Manufacturing distruption | 210434 |
2729 | C10AA05 | TEVA-ATORVASTATIN | 20MG | Teva Canada Limited | Resolved | 2023-11-15 | 25 | Manufacturing distruption | 210428 |
2730 | C10AA07 | TEVA-ROSUVASTATIN | 20MG | Teva Canada Limited | Resolved | 2023-11-15 | 46 | Manufacturing distruption | 210437 |
2731 | N05AH04 | AURO-QUETIAPINE | 100MG | Auro Pharma Inc | Resolved | 2023-11-15 | 76 | Demand increase | 210226 |
2732 | J05AB14 | TEVA-VALGANCICLOVIR | 450MG | Teva Canada Limited | Resolved | 2023-11-15 | 137 | Manufacturing distruption | 210440 |
2733 | N05AE04 | AURO-ZIPRASIDONE | 20MG | Auro Pharma Inc | Resolved | 2023-11-15 | 92 | Demand increase | 210229 |
2734 | N05AE04 | AURO-ZIPRASIDONE | 40MG | Auro Pharma Inc | Resolved | 2023-11-15 | 213 | Demand increase | 210257 |
2736 | C09AA04 | AURO-PERINDOPRIL | 4MG | Auro Pharma Inc | Resolved | 2023-11-15 | 369 | Demand increase | 210221 |
2737 | C01BC04 | AURO-FLECAINIDE | 100MG | Auro Pharma Inc | Resolved | 2023-11-15 | 231 | Demand increase | 210218 |
2738 | C01EB17 | LANCORA | 5MG | Servier Canada Inc | Resolved | 2023-11-15 | 9 | Shipping delay | 210469 |
2739 | N05AX12 | AURO-ARIPIPRAZOLE | 2MG | Auro Pharma Inc | Resolved | 2023-11-15 | 259 | Demand increase | 210208 |
2740 | S01XA18 | TEVA-CYCLOSPORINE | 0.05% | Teva Canada Limited | Resolved | 2023-11-15 | 97 | Manufacturing distruption | 210431 |
2741 | A10BJ06 | OZEMPIC | 1.34MG | Novo Nordisk Canada Inc | Resolved | 2023-11-15 | 92 | Demand increase | 208495 |
2742 | C09DA08 | AURO-OLMESARTAN HCTZ | 12.5MG 20MG | Auro Pharma Inc | Resolved | 2023-11-15 | 396 | Demand increase | 106080 |
2708 | M03BX01 | APO-BACLOFEN | 20MG | Apotex Inc | Resolved | 2023-11-14 | 38 | Manufacturing distruption | 210677 |
2709 | C07AB04 | APO-ACEBUTOLOL | 200MG | Apotex Inc | Resolved | 2023-11-14 | 31 | Manufacturing distruption | 210707 |
2710 | M01AE01 | APO-IBUPROFEN TAB 600MG | 600MG | Apotex Inc | Resolved | 2023-11-14 | 16 | Manufacturing distruption | 210733 |
2711 | N06AB06 | APO-SERTRALINE | 100MG | Apotex Inc | Resolved | 2023-11-14 | 66 | Manufacturing distruption | 210683 |
2712 | B01AA03 | APO-WARFARIN | 1MG | Apotex Inc | Resolved | 2023-11-14 | 38 | Manufacturing distruption | 210698 |
2713 | C01CA17 | APO-MIDODRINE | 2.5MG | Apotex Inc | Resolved | 2023-11-14 | 38 | Manufacturing distruption | 210701 |
2714 | N03AX14 | APO-LEVETIRACETAM | 750MG | Apotex Inc | Resolved | 2023-11-14 | 31 | Manufacturing distruption | 210656 |
2715 | N06AX11 | APO-MIRTAZAPINE | 30MG | Apotex Inc | Resolved | 2023-11-14 | 24 | Manufacturing distruption | 210662 |
2716 | N04BC05 | APO-PRAMIPEXOLE | 1.5MG | Apotex Inc | Resolved | 2023-11-14 | 24 | Manufacturing distruption | 210659 |
2717 | C10AA05 | APO-ATORVASTATIN | 80MG | Apotex Inc | Resolved | 2023-11-14 | 38 | Manufacturing distruption | 210695 |
2718 | J05AB11 | APO-VALACYCLOVIR | 500MG | Apotex Inc | Resolved | 2023-11-14 | 87 | Manufacturing distruption | 210725 |
2719 | N04BD02 | APO-RASAGILINE | 1MG | Apotex Inc | Resolved | 2023-11-14 | 31 | Manufacturing distruption | 210743 |
2720 | G03AA12 | ZAMINE 21 | 0.03MG 3MG | Apotex Inc | Resolved | 2023-11-14 | 52 | Manufacturing distruption | 210668 |
2721 | C07AA12 | APO-NADOLOL | 40MG | Apotex Inc | Resolved | 2023-11-14 | 73 | Manufacturing distruption | 210715 |
2722 | C08CA02 | APO-FELODIPINE | 5MG | Apotex Inc | Resolved | 2023-11-14 | 80 | Manufacturing distruption | 210689 |
2723 | C10AC04 | APO-COLESEVELAM | 625MG | Apotex Inc | Resolved | 2023-11-14 | 38 | Manufacturing distruption | 210674 |
2698 | D06BX01 | NORITATE | 1% | Bausch Health, Canada Inc. | Avoided | 2023-11-13 | 14 | Other | 206593 |
2696 | A10BX16 | MOUNJARO | 7.5MG | Eli Lilly Canada Inc | Resolved | 2023-11-13 | 295 | Other | 210455 |
2697 | A03AB02 | GLYCOPYRROLATE INJECTION USP | 0.2MG | Sandoz Canada Incorporated | Resolved | 2023-11-13 | 25 | Manufacturing distruption | 210061 |
2699 | B05XA01 | POTASSIUM CHLORIDE FOR INJECTI... | 20mEq | Omega Laboratories Limited | Resolved | 2023-11-13 | 215 | Manufacturing distruption | 209438 |
2700 | A11DA01 | THIAMIJECT INJECTION - LIQ IM... | 100MG | Omega Laboratories Limited | Resolved | 2023-11-13 | 11 | Demand increase | 210082 |
2701 | N01BB51 | MARCAINE E | 0.182MG 50MG | Pfizer Canada Ulc | Resolved | 2023-11-13 | Manufacturing distruption | 207832 | |
2702 | N02AA01 | KADIAN | 10MG | Bgp Pharma Ulc | Resolved | 2023-11-13 | 29 | Manufacturing distruption | 207195 |
2703 | M03BC01 | SANDOZ ORPHENADRINE | 100MG | Sandoz Canada Incorporated | Resolved | 2023-11-13 | 32 | Manufacturing distruption | 210064 |
2704 | G03CA03 | ESTRADOT 75 | 75MCG | Sandoz Canada Incorporated | Resolved | 2023-11-13 | 39 | Manufacturing distruption | 210056 |
2705 | N02AA05 | SUPEUDOL | 20MG | Sandoz Canada Incorporated | Resolved | 2023-11-13 | 4 | Manufacturing distruption | 210069 |
2706 | L01CD01 | PACLITAXEL INJECTION USP | 6MG | Sandoz Canada Incorporated | Resolved | 2023-11-13 | 11 | Manufacturing distruption | 210067 |
2707 | C10AX14 | PRALUENT | 75MG | Sanofi-Aventis Canada Inc | Resolved | 2023-11-13 | 39 | Other | 209523 |
2689 | N05AB02 | FLUPHENAZINE | 5MG | Aa Pharma Inc | Resolved | 2023-11-10 | 82 | Manufacturing distruption | 208867 |
2690 | N04BA02 | AA-LEVOCARB CR | 50MG 200MG | Aa Pharma Inc | Resolved | 2023-11-10 | 70 | Manufacturing distruption | 208870 |
2691 | R06AA59 | PMS-DOXYLAMINE-PYRIDOXINE | 10MG 10MG | Pharmascience Inc | Resolved | 2023-11-10 | 11 | Manufacturing distruption | 210340 |
2692 | M01AB55 | PMS-DICLOFENAC-MISOPROSTOL | 200MCG 50MG | Pharmascience Inc | Resolved | 2023-11-10 | 272 | Manufacturing distruption | 210336 |
2693 | N02BF01 | GABAPENTIN CAPSULES USP | 100MG | Accord Healthcare Inc | Resolved | 2023-11-10 | 35 | Manufacturing distruption | 209759 |
2694 | G04BD08 | ACH-SOLIFENACIN SUCCINATE | 10MG | Accord Healthcare Inc | Resolved | 2023-11-10 | 61 | Demand increase | 209762 |
2695 | N02BF02 | ACH-PREGABALIN | 150MG | Accord Healthcare Inc | Resolved | 2023-11-10 | 42 | Shipping delay | 209753 |
2688 | B03BB01 | FOLIC ACID | 5MG | Aa Pharma Inc | Resolved | 2023-11-09 | 57 | Manufacturing distruption | 209690 |
2683 | A02BC02 | TEVA-PANTOPRAZOLE | 40MG | Teva Canada Limited | Active | 2023-11-08 | Manufacturing distruption | 209666 | |
2684 | N01BB01 | MARCAINE | 250MG | Pfizer Canada Ulc | Avoided | 2023-11-08 | Manufacturing distruption | 206848 | |
2678 | S01EB09 | MIOCHOL-E | 20MG | Bausch & Lomb Inc | Resolved | 2023-11-08 | 236 | Manufacturing practices | 212474 |
2679 | A11CC04 | ROCALTROL | 0.5MCG | Searchlight Pharma Inc | Resolved | 2023-11-08 | 44 | Shipping delay | 209549 |
2680 | A11CC04 | ROCALTROL | 0.25MCG | Searchlight Pharma Inc | Resolved | 2023-11-08 | 30 | Shipping delay | 209554 |
2681 | M01AE02 | TEVA-NAPROXEN | 375MG | Teva Canada Limited | Resolved | 2023-11-08 | 42 | Manufacturing distruption | 209661 |
2682 | S01AE06 | ZYMAR | 0.3% | Abbvie Corporation | Resolved | 2023-11-08 | 28 | Manufacturing distruption | 210159 |
2685 | N06BA09 | TEVA-ATOMOXETINE | 10MG | Teva Canada Limited | Resolved | 2023-11-08 | 32 | Manufacturing distruption | 209669 |
2686 | G04CA02 | APO-TAMSULOSIN CR | 0.4MG | Apotex Inc | Resolved | 2023-11-08 | 380 | Ingredient shortage | 209286 |
2687 | A10BD07 | JANUMET XR | 1000MG 50MG | Merck Canada Inc | Resolved | 2023-11-08 | 2 | Demand increase | 209562 |
2660 | N06AB06 | APO-SERTRALINE | 25MG | Apotex Inc | Resolved | 2023-11-07 | 73 | Manufacturing distruption | 209945 |
2661 | C07AG01 | APO-LABETALOL | 200MG | Apotex Inc | Resolved | 2023-11-07 | 59 | Manufacturing distruption | 209964 |
2662 | R03BA05 | FLOVENT HFA | 250MCG | Glaxosmithkline Inc | Resolved | 2023-11-07 | 29 | Manufacturing distruption | 209694 |
2663 | C09AA04 | COVERSYL | 8MG | Servier Canada Inc | Resolved | 2023-11-07 | 23 | Shipping delay | 209503 |
2664 | C10AA01 | APO-SIMVASTATIN | 10MG | Apotex Inc | Resolved | 2023-11-07 | 17 | Manufacturing distruption | 209939 |
2665 | D11AH02 | ELIDEL | 1% | Bausch Health, Canada Inc. | Resolved | 2023-11-07 | 28 | Other | 207373 |
2666 | N07BC02 | METADOL | 1MG | Paladin Labs Inc. | Resolved | 2023-11-07 | 69 | Shipping delay | 210150 |
2667 | N07BC02 | METADOL | 10MG | Paladin Labs Inc. | Resolved | 2023-11-07 | 114 | Other | 209512 |
2668 | N03AX11 | APO-TOPIRAMATE | 200MG | Apotex Inc | Resolved | 2023-11-07 | 59 | Manufacturing distruption | 209948 |
2669 | N05AX08 | APO-RISPERIDONE | 0.50MG | Apotex Inc | Resolved | 2023-11-07 | 178 | Manufacturing distruption | 209957 |
2670 | C03AA03 | APO-HYDROCHLOROTHIAZIDE | 12.5MG | Apotex Inc | Resolved | 2023-11-07 | 10 | Manufacturing distruption | 209942 |
2671 | A02BC05 | APO-ESOMEPRAZOLE | 40MG | Apotex Inc | Resolved | 2023-11-07 | 38 | Manufacturing distruption | 209951 |
2672 | J05AB11 | APO-VALACYCLOVIR | 1000MG | Apotex Inc | Resolved | 2023-11-07 | 87 | Manufacturing distruption | 209961 |
2673 | R03DC03 | APO-MONTELUKAST | 10MG | Apotex Inc | Resolved | 2023-11-07 | 23 | Manufacturing distruption | 209954 |
2674 | L01DB06 | IDARUBICIN | 1MG | Pfizer Canada Ulc | Resolved | 2023-11-07 | Manufacturing distruption | 201980 | |
2675 | C09BB04 | APO-PERINDOPRIL/AMLODIPINE | 10MG 14MG | Apotex Inc | Resolved | 2023-11-07 | 94 | Manufacturing distruption | 209936 |
2676 | A03AX04 | PINAVERIUM | 100MG | Aa Pharma Inc | Resolved | 2023-11-07 | 52 | Manufacturing distruption | 208859 |
2677 | A06AX05 | APO-PRUCALOPRIDE | 2MG | Apotex Inc | Resolved | 2023-11-07 | 24 | Manufacturing distruption | 209922 |
2631 | J04AK02 | ETIBI | 400MG | Bausch Health, Canada Inc. | Avoided | 2023-11-06 | 4 | Other | 207367 |
2630 | C01DA02 | NITROJECT | 50MG | Omega Laboratories Limited | Resolved | 2023-11-06 | Manufacturing distruption | 209460 | |
2632 | C08DA01 | VERAPAMIL HYDROCHLORIDE INJECT... | 2.5MG | Sandoz Canada Incorporated | Resolved | 2023-11-06 | 46 | Manufacturing distruption | 209230 |
2633 | J07BC02 | HAVRIX - SUS IM 1440 ELISA UNI... | 1440UNIT | Glaxosmithkline Inc | Resolved | 2023-11-06 | 112 | Shipping delay | 209700 |
2634 | N05CF01 | APO-ZOPICLONE | 7.5MG | Apotex Inc | Resolved | 2023-11-06 | 18 | Manufacturing distruption | 209933 |
2635 | V03AB17 | METHYLENE BLUE INJECTION USP | 10MG | Omega Laboratories Limited | Resolved | 2023-11-06 | Manufacturing distruption | 207139 | |
2636 | S01AA12 | SANDOZ TOBRAMYCIN | 0.3% | Sandoz Canada Incorporated | Resolved | 2023-11-06 | 11 | Demand increase | 209227 |
2637 | R03BA05 | FLOVENT HFA | 125MCG | Glaxosmithkline Inc | Resolved | 2023-11-06 | 39 | Manufacturing distruption | 209697 |
2638 | H01CB02 | OCTREOTIDE ACETATE OMEGA | 100MCG | Omega Laboratories Limited | Resolved | 2023-11-06 | 14 | Demand increase | 208725 |
2639 | L04AK01 | SANDOZ LEFLUNOMIDE | 10MG | Sandoz Canada Incorporated | Resolved | 2023-11-06 | 4 | Shipping delay | 209221 |
2640 | A02BC04 | SANDOZ RABEPRAZOLE | 20MG | Sandoz Canada Incorporated | Resolved | 2023-11-06 | 228 | Manufacturing distruption | 209224 |
2641 | C09DA04 | SANDOZ IRBESARTAN HCT | 12.5MG 150MG | Sandoz Canada Incorporated | Resolved | 2023-11-06 | 32 | Manufacturing distruption | 209216 |
2642 | N05AH03 | OLANZAPINE ODT | 5MG | Sivem Pharmaceuticals Ulc | Resolved | 2023-11-06 | 84 | Shipping delay | 211151 |
2643 | R03DC03 | ACH-MONTELUKAST | 10MG | Accord Healthcare Inc | Resolved | 2023-11-06 | 14 | Shipping delay | 209750 |
2644 | B02AA02 | TRANEXAMIC ACID INJECTION | 100MG | Omega Laboratories Limited | Resolved | 2023-11-06 | Manufacturing distruption | 205775 | |
2645 | V03AB06 | SODIUM THIOSULFATE INJECTION U... | 250MG | Hope Pharmaceuticals Ltd | Resolved | 2023-11-06 | 55 | Shipping delay | 209480 |
2646 | J01DB01 | APO-CEPHALEX | 500MG | Apotex Inc | Resolved | 2023-11-06 | 74 | Manufacturing distruption | 209930 |
2647 | C10AA07 | ACH-ROSUVASTATIN | 40MG | Accord Healthcare Inc | Resolved | 2023-11-06 | 310 | Manufacturing distruption | 209765 |
2648 | N02BF02 | ACH-PREGABALIN | 300MG | Accord Healthcare Inc | Resolved | 2023-11-06 | 17 | Shipping delay | 209756 |
2649 | N05AX12 | APO-ARIPIPRAZOLE | 2MG | Apotex Inc | Resolved | 2023-11-06 | Manufacturing distruption | 209901 | |
2650 | N05AX12 | APO-ARIPIPRAZOLE | 2MG | Apotex Inc | Resolved | 2023-11-06 | Manufacturing distruption | 209904 | |
2651 | N05AX12 | APO-ARIPIPRAZOLE | 5MG | Apotex Inc | Resolved | 2023-11-06 | 74 | Manufacturing distruption | 209919 |
2652 | N05AX12 | APO-ARIPIPRAZOLE | 10MG | Apotex Inc | Resolved | 2023-11-06 | 74 | Manufacturing distruption | 209907 |
2653 | N05AX12 | APO-ARIPIPRAZOLE | 15MG | Apotex Inc | Resolved | 2023-11-06 | Manufacturing distruption | 209889 | |
2654 | N05AX12 | APO-ARIPIPRAZOLE | 15MG | Apotex Inc | Resolved | 2023-11-06 | Manufacturing distruption | 209895 | |
2655 | N05AX12 | APO-ARIPIPRAZOLE | 20MG | Apotex Inc | Resolved | 2023-11-06 | Manufacturing distruption | 209898 | |
2656 | N05AX12 | APO-ARIPIPRAZOLE | 20MG | Apotex Inc | Resolved | 2023-11-06 | Manufacturing distruption | 209916 | |
2657 | N05AX12 | APO-ARIPIPRAZOLE | 30MG | Apotex Inc | Resolved | 2023-11-06 | Demand increase | 209892 | |
2658 | N05AX12 | APO-ARIPIPRAZOLE | 30MG | Apotex Inc | Resolved | 2023-11-06 | Manufacturing distruption | 209913 | |
2659 | APO-MELOXICAM | 1.5G | Apotex Inc | Resolved | 2023-11-06 | 32 | Ingredient shortage | 209926 | |
2624 | C09XA02 | RASILEZ | 150MG | Noden Pharma Dac | Resolved | 2023-11-03 | 45 | Ingredient shortage | 210808 |
2625 | G04BD08 | VESICARE | 5MG | Astellas Pharma Canada Inc | Resolved | 2023-11-03 | 7 | Demand increase | 208998 |
2626 | G04BD08 | VESICARE | 10MG | Astellas Pharma Canada Inc | Resolved | 2023-11-03 | 7 | Demand increase | 208279 |
2627 | M01AB55 | GD-DICLOFENAC/MISOPROSTOL 75 | 200MCG 75MG | Genmed A Division Of Pfizer Canada Ulc | Resolved | 2023-11-03 | 89 | Demand increase | 208030 |
2628 | N06BA04 | APO-METHYLPHENIDATE ER | 18MG | Apotex Inc | Resolved | 2023-11-03 | 168 | Manufacturing distruption | 209298 |
2629 | N05AX12 | APO-ARIPIPRAZOLE | 5MG | Apotex Inc | Resolved | 2023-11-03 | 77 | Manufacturing distruption | 209910 |
2622 | N07BB03 | CAMPRAL | 333MG | Mylan Pharmaceuticals Ulc | Resolved | 2023-11-02 | 20 | Manufacturing distruption | 206781 |
2623 | G04BD08 | ACH-SOLIFENACIN SUCCINATE | 10MG | Accord Healthcare Inc | Resolved | 2023-11-02 | 69 | Demand increase | 208981 |
2577 | N01AH01 | FENTANYL CITRATE INJECTION USP | 50MCG | Hikma Canada Limited | Active | 2023-11-01 | Manufacturing distruption | 205826 | |
2584 | N01BB02 | XYLOCAINE JELLY 2% | 20MG | Aspen Pharmacare Canada Inc. | Avoided | 2023-11-01 | 60 | Manufacturing distruption | 186439 |
2609 | N02BF02 | TARO-PREGABALIN | 150MG | Sun Pharma Canada Inc | Avoided | 2023-11-01 | 16 | Manufacturing distruption | 208108 |
2578 | C02AC02 | APO-GUANFACINE XR | 1MG | Apotex Inc | Resolved | 2023-11-01 | 72 | Manufacturing distruption | 209339 |
2579 | A10BK01 | APO-DAPAGLIFLOZIN | 10MG | Apotex Inc | Resolved | 2023-11-01 | 65 | Manufacturing distruption | 209333 |
2580 | D07AC01 | TEVA-TOPISONE | 0.05% | Teva Canada Limited | Resolved | 2023-11-01 | 49 | Manufacturing distruption | 209119 |
2581 | D07AC01 | TEVA-TOPISONE | 0.05% | Teva Canada Limited | Resolved | 2023-11-01 | 70 | Manufacturing distruption | 209116 |
2582 | N06AX05 | TEVA-TRAZODONE | 100MG | Teva Canada Limited | Resolved | 2023-11-01 | 119 | Manufacturing distruption | 209139 |
2583 | N06AX05 | TEVA-TRAZODONE | 100MG | Teva Canada Limited | Resolved | 2023-11-01 | 49 | Manufacturing distruption | 209142 |
2585 | N05AB04 | PROCHLORAZINE | 5MG | Aa Pharma Inc | Resolved | 2023-11-01 | 49 | Manufacturing distruption | 208873 |
2586 | R05DA04 | CODEINE CONTIN 50MG CONTROLLED... | 50MG | Purdue Pharma | Resolved | 2023-11-01 | 65 | Demand increase | 208850 |
2587 | J01DB01 | TEVA-CEPHALEXIN | 250MG | Teva Canada Limited | Resolved | 2023-11-01 | 232 | Manufacturing distruption | 209136 |
2588 | C03EA01 | APO TRIAZIDE | 25MG 50MG | Apotex Inc | Resolved | 2023-11-01 | 9 | Manufacturing distruption | 209357 |
2589 | J02AX04 | CANCIDAS | 50MG | Merck Canada Inc | Resolved | 2023-11-01 | 44 | Shipping delay | 208711 |
2590 | C01CE02 | MILRINONE LACTATE INJECTION, U... | 1MG | Fresenius Kabi Canada Ltd | Resolved | 2023-11-01 | 173 | Manufacturing distruption | 208900 |
2591 | N06BA04 | APO-METHYLPHENIDATE | 10MG | Apotex Inc | Resolved | 2023-11-01 | 30 | Manufacturing distruption | 209351 |
2592 | N06AB08 | ACT FLUVOXAMINE | 100MG | Teva Canada Limited | Resolved | 2023-11-01 | 191 | Manufacturing distruption | 209108 |
2593 | C01CA17 | APO-MIDODRINE | 5MG | Apotex Inc | Resolved | 2023-11-01 | 51 | Manufacturing distruption | 209375 |
2594 | N03AX11 | APO-TOPIRAMATE | 100MG | Apotex Inc | Resolved | 2023-11-01 | 65 | Manufacturing distruption | 209345 |
2595 | N05AH03 | APO-OLANZAPINE | 2.5MG | Apotex Inc | Resolved | 2023-11-01 | 128 | Manufacturing distruption | 209363 |
2596 | A02BC03 | APO-LANSOPRAZOLE | 30MG | Apotex Inc | Resolved | 2023-11-01 | 23 | Manufacturing distruption | 209348 |
2597 | C10AA04 | TEVA-FLUVASTATIN | 20MG | Teva Canada Limited | Resolved | 2023-11-01 | 181 | Manufacturing distruption | 209111 |
2598 | N01BB02 | XYLOCAINE 1% | 10MG | Aspen Pharmacare Canada Inc. | Resolved | 2023-11-01 | 91 | Manufacturing distruption | 206661 |
2599 | G04CA01 | APO-ALFUZOSIN | 10MG | Apotex Inc | Resolved | 2023-11-01 | 51 | Manufacturing distruption | 209372 |
2600 | L02BB03 | ACH-BICALUTAMIDE | 50MG | Accord Healthcare Inc | Resolved | 2023-11-01 | 42 | Demand increase | 212190 |
2601 | C09DA04 | TEVA-IRBESARTAN HCTZ | 300MG 25MG | Teva Canada Limited | Resolved | 2023-11-01 | 130 | Manufacturing distruption | 209122 |
2602 | C09AA02 | TARO-ENALAPRIL | 2MG | Sun Pharma Canada Inc | Resolved | 2023-11-01 | 149 | Manufacturing distruption | 209173 |
2603 | C10AX09 | TEVA-EZETIMIBE | 10MG | Teva Canada Limited | Resolved | 2023-11-01 | 232 | Manufacturing distruption | 209125 |
2604 | C10AX09 | TEVA-EZETIMIBE | 10MG | Teva Canada Limited | Resolved | 2023-11-01 | 70 | Manufacturing distruption | 209130 |
2605 | C10AX09 | TEVA-EZETIMIBE | 10MG | Teva Canada Limited | Resolved | 2023-11-01 | 140 | Manufacturing distruption | 209133 |
2606 | G04CA02 | TEVA-TAMSULOSIN CR | 0.4MG | Teva Canada Limited | Resolved | 2023-11-01 | 375 | Manufacturing distruption | 209148 |
2607 | R03DC03 | ACH-MONTELUKAST | 10MG | Accord Healthcare Inc | Resolved | 2023-11-01 | 19 | Shipping delay | 208987 |
2608 | N06DA02 | TARO-DONEPEZIL | 10MG | Sun Pharma Canada Inc | Resolved | 2023-11-01 | 9 | Manufacturing distruption | 209170 |
2610 | M04AA01 | APO-ALLOPURINOL | 200MG | Apotex Inc | Resolved | 2023-11-01 | 86 | Manufacturing distruption | 209369 |
2611 | C10AA01 | AURO-SIMVASTATIN | 10MG | Auro Pharma Inc | Resolved | 2023-11-01 | 182 | Demand increase | 208787 |
2612 | R06AA59 | APO-DOXYLAMINE/B6 | 10MG 10MG | Apotex Inc | Resolved | 2023-11-01 | 107 | Manufacturing distruption | 209342 |
2613 | N07BA03 | APO-VARENICLINE | 1MG | Apotex Inc | Resolved | 2023-11-01 | 30 | Manufacturing distruption | 209366 |
2614 | N01BB02 | LIDOCAINE HYDROCHLORIDE INJECT... | 10MG | Hikma Canada Limited | Resolved | 2023-11-01 | 128 | Shipping delay | 207616 |
2615 | N01BB02 | LIDOCAINE HYDROCHLORIDE INJECT... | 10MG | Hikma Canada Limited | Resolved | 2023-11-01 | 151 | Shipping delay | 207619 |
2616 | N06AX12 | TEVA-BUPROPION XL | 300MG | Teva Canada Limited | Resolved | 2023-11-01 | 49 | Manufacturing distruption | 209672 |
2617 | N06AX21 | APO-DULOXETINE | 60MG | Apotex Inc | Resolved | 2023-11-01 | 65 | Manufacturing distruption | 209336 |
2618 | N02BF02 | ACH-PREGABALIN | 50MG | Accord Healthcare Inc | Resolved | 2023-11-01 | 23 | Shipping delay | 208984 |
2619 | R03BA02 | TEVA-BUDESONIDE | 0.125MG | Teva Canada Limited | Resolved | 2023-11-01 | 120 | Manufacturing distruption | 209145 |
2620 | A03AX04 | PINAVERIUM | 50MG | Aa Pharma Inc | Resolved | 2023-11-01 | 28 | Manufacturing distruption | 208864 |
2621 | H01BB03 | CARBETOCIN INJECTION | 100MCG | Juno Pharmaceuticals Corp. | Resolved | 2023-11-01 | 212 | Demand increase | 206942 |
2574 | C09AA10 | AURO-TRANDOLAPRIL | 2MG | Auro Pharma Inc | Avoided | 2023-10-31 | 30 | Demand increase | 208797 |
2573 | H02AB09 | AURO-HYDROCORTISONE | 10MG | Auro Pharma Inc | Resolved | 2023-10-31 | 89 | Demand increase | 208748 |
2575 | N03AX18 | AURO-LACOSAMIDE | 50MG | Auro Pharma Inc | Resolved | 2023-10-31 | 73 | Demand increase | 208754 |
2576 | N03AX18 | AURO-LACOSAMIDE | 100MG | Auro Pharma Inc | Resolved | 2023-10-31 | 107 | Demand increase | 208751 |
2562 | A10BB12 | SANDOZ GLIMEPIRIDE | 1MG | Sandoz Canada Incorporated | Resolved | 2023-10-30 | 25 | Ingredient shortage | 208534 |
2563 | A10BB12 | SANDOZ GLIMEPIRIDE | 2MG | Sandoz Canada Incorporated | Resolved | 2023-10-30 | 25 | Ingredient shortage | 208541 |
2564 | J01DD04 | CEFTRIAXONE SODIUM FOR INJECTI... | 250MG | Sandoz Canada Incorporated | Resolved | 2023-10-30 | 74 | Demand increase | 208527 |
2565 | A02BC02 | PANTOPRAZOLE SODIUM FOR INJECT... | 40MG | Sandoz Canada Incorporated | Resolved | 2023-10-30 | 25 | Manufacturing distruption | 208546 |
2566 | N06AX11 | PRO-MIRTAZAPINE | 30MG | Pro Doc Limitee | Resolved | 2023-10-30 | 137 | Shipping delay | 208835 |
2567 | C09CA07 | SANDOZ TELMISARTAN | 40MG | Sandoz Canada Incorporated | Resolved | 2023-10-30 | 4 | Demand increase | 208559 |
2568 | N02BF02 | SANDOZ PREGABALIN | 50MG | Sandoz Canada Incorporated | Resolved | 2023-10-30 | 11 | Manufacturing practices | 208549 |
2569 | N02BF02 | SANDOZ PREGABALIN | 50MG | Sandoz Canada Incorporated | Resolved | 2023-10-30 | 11 | Manufacturing practices | 208556 |
2570 | B02AA02 | TRANEXAMIC ACID INJECTION | 100MG | Omega Laboratories Limited | Resolved | 2023-10-30 | Manufacturing distruption | 205772 | |
2571 | N02AX06 | NUCYNTA EXTENDED-RELEASE | 150MG | Endo Ventures Ltd. | Resolved | 2023-10-30 | 144 | Shipping delay | 208783 |
2572 | N06AX21 | APO-DULOXETINE | 60MG | Apotex Inc | Resolved | 2023-10-30 | 67 | Manufacturing distruption | 210639 |
2559 | A10BG03 | ACH-PIOGLITAZONE | 15MG | Accord Healthcare Inc | Active | 2023-10-27 | Manufacturing distruption | 208456 | |
2551 | H01CA02 | SYNAREL | 200MCG | Pfizer Canada Ulc | Resolved | 2023-10-27 | 81 | Manufacturing distruption | 197652 |
2552 | N05AX08 | PMS-RISPERIDONE | 1MG | Pharmascience Inc | Resolved | 2023-10-27 | 136 | Manufacturing distruption | 208577 |
2553 | C09CA01 | PMS-LOSARTAN | 50MG | Pharmascience Inc | Resolved | 2023-10-27 | 53 | Manufacturing distruption | 208567 |
2554 | C09CA01 | PMS-LOSARTAN | 100MG | Pharmascience Inc | Resolved | 2023-10-27 | 82 | Manufacturing distruption | 208572 |
2555 | J01DC10 | TARO-CEFPROZIL | 125MG | Sun Pharma Canada Inc | Resolved | 2023-10-27 | 56 | Manufacturing distruption | 208964 |
2556 | C08CA05 | MYLAN-NIFEDIPINE EXTENDED RELE... | 30MG | Mylan Pharmaceuticals Ulc | Resolved | 2023-10-27 | 17 | Manufacturing distruption | 209413 |
2557 | J05AB11 | MYLAN-VALACYCLOVIR | 1000MG | Mylan Pharmaceuticals Ulc | Resolved | 2023-10-27 | Manufacturing distruption | 207184 | |
2558 | N05AH04 | QUETIAPINE TABLETS | 200MG | Accord Healthcare Inc | Resolved | 2023-10-27 | 27 | Demand increase | 208453 |
2560 | M03AB01 | SUCCINYLCHOLINE CHLORIDE INJEC... | 20MG | Dr Reddy's Laboratories Ltd | Resolved | 2023-10-27 | 34 | Other | 207797 |
2561 | R03BA05 | PMS-FLUTICASONE HFA | 50MCG | Pharmascience Inc | Resolved | 2023-10-27 | 687 | Manufacturing distruption | 208562 |
2546 | G01AF01 | FLAGYL | 10% | Sanofi-Aventis Canada Inc | Resolved | 2023-10-26 | 22 | Other | 208580 |
2547 | V03AE01 | RESONIUM CALCIUM | 999MG | Sanofi-Aventis Canada Inc | Resolved | 2023-10-26 | 120 | Demand increase | 208624 |
2548 | R03AC02 | VENTOLIN HFA | 100MCG | Glaxosmithkline Inc | Resolved | 2023-10-26 | 98 | Manufacturing distruption | 208287 |
2549 | J02AX04 | CANCIDAS | 70MG | Merck Canada Inc | Resolved | 2023-10-26 | 36 | Demand increase | 207815 |
2550 | R03BA05 | FLOVENT HFA | 250MCG | Glaxosmithkline Inc | Resolved | 2023-10-26 | 50 | Manufacturing distruption | 208284 |
2543 | R06AA02 | UNISOM SLEEPGELS EXTRA STRENGT... | 50MG | Paladin Labs Inc. | Active | 2023-10-25 | Shipping delay | 208033 | |
2544 | N04BA02 | AA-LEVOCARB CR | 25MG 100MG | Aa Pharma Inc | Resolved | 2023-10-25 | 86 | Manufacturing distruption | 208027 |
2545 | C09CA06 | TARO-CANDESARTAN | 16MG | Sun Pharma Canada Inc | Resolved | 2023-10-25 | 30 | Shipping delay | 208958 |
2524 | L02AE01 | SUPREFACT DEPOT 3 MONTHS | 9.45MG | Cheplapharm Arzneimittel Gmbh | Active | 2023-10-24 | Manufacturing distruption | 232667 | |
2541 | C09CA08 | NRA-OLMESARTAN | 40MG | Nora Pharma Inc | Active | 2023-10-24 | Manufacturing distruption | 248764 | |
2523 | L02AE01 | SUPREFACT DEPOT 3 MONTHS | 9.45MG | Cheplapharm Arzneimittel Gmbh | Resolved | 2023-10-24 | Manufacturing distruption | 207981 | |
2525 | R03BA05 | APO-FLUTICASONE HFA | 125MCG | Apotex Inc | Resolved | 2023-10-24 | 10 | Manufacturing distruption | 208406 |
2526 | A10BK01 | APO-DAPAGLIFLOZIN | 10MG | Apotex Inc | Resolved | 2023-10-24 | 66 | Manufacturing distruption | 208370 |
2527 | N06AX05 | APO-TRAZODONE TABLETS 100MG | 100MG | Apotex Inc | Resolved | 2023-10-24 | 73 | Manufacturing distruption | 208376 |
2528 | L01BC02 | EFUDEX | 5% | Bausch Health, Canada Inc. | Resolved | 2023-10-24 | 10 | Other | 207370 |
2529 | H02AB07 | APO PREDNISONE TAB 5MG | 5MG | Apotex Inc | Resolved | 2023-10-24 | 87 | Manufacturing distruption | 208420 |
2530 | L01AX03 | TEMODAL | 250MG | Merck Canada Inc | Resolved | 2023-10-24 | 118 | Shipping delay | 202904 |
2531 | G04BE03 | APO-SILDENAFIL | 50MG | Apotex Inc | Resolved | 2023-10-24 | 44 | Manufacturing distruption | 208414 |
2532 | H01AC01 | SAIZEN | 8MG | Emd Serono, A Division Of Emd Inc., Canada | Resolved | 2023-10-24 | 34 | Shipping delay | 207741 |
2533 | N02AA03 | APO-HYDROMORPHONE | 1MG | Apotex Inc | Resolved | 2023-10-24 | 73 | Manufacturing distruption | 208397 |
2534 | R03DC03 | APO-MONTELUKAST | 10MG | Apotex Inc | Resolved | 2023-10-24 | 37 | Manufacturing distruption | 208388 |
2535 | N02AA05 | APO-OXYCODONE CR | 15MG | Apotex Inc | Resolved | 2023-10-24 | 10 | Manufacturing distruption | 208382 |
2536 | G04BE08 | APO-TADALAFIL | 5MG | Apotex Inc | Resolved | 2023-10-24 | 37 | Manufacturing distruption | 208373 |
2537 | G04BE08 | APO-TADALAFIL | 10MG | Apotex Inc | Resolved | 2023-10-24 | 37 | Manufacturing distruption | 208403 |
2538 | J01XX08 | APO-LINEZOLID | 600MG | Apotex Inc | Resolved | 2023-10-24 | 10 | Manufacturing distruption | 208379 |
2539 | N06BA04 | APO-METHYLPHENIDATE ER | 27MG | Apotex Inc | Resolved | 2023-10-24 | 37 | Manufacturing distruption | 208400 |
2540 | C09BA04 | APO-PERINDOPRIL-INDAPAMIDE | 8MG 2.5MG | Apotex Inc | Resolved | 2023-10-24 | 108 | Manufacturing distruption | 208411 |
2542 | L04AK02 | APO-TERIFLUNOMIDE | 14MG | Apotex Inc | Resolved | 2023-10-24 | 87 | Manufacturing distruption | 208385 |
2497 | N05AN01 | PMS-LITHIUM CARBONATE - CAP 30... | 300MG | Pharmascience Inc | Active | 2023-10-23 | Manufacturing distruption | 207103 | |
2522 | J01XX09 | DAPTOMYCIN FOR INJECTION | 500MG | Accord Healthcare Inc | Active | 2023-10-23 | Manufacturing distruption | 207820 | |
2491 | J05AB11 | VALACYCLOVIR | 1000MG | Sanis Health Inc | Resolved | 2023-10-23 | 35 | Manufacturing distruption | 207872 |
2492 | J01CR05 | PIPERACILLIN AND TAZOBACTAM FO... | 4.5G 36G | Sandoz Canada Incorporated | Resolved | 2023-10-23 | 25 | Manufacturing distruption | 207770 |
2493 | H02AB09 | AURO-HYDROCORTISONE | 20MG | Auro Pharma Inc | Resolved | 2023-10-23 | 177 | Demand increase | 207399 |
2494 | J07AG01 | ACT-HIB | 30MCG 10MCG | Sanofi Pasteur Limited | Resolved | 2023-10-23 | 33 | Other | 207261 |
2495 | N01BB01 | SENSORCAINE | 2.5MG | Aspen Pharmacare Canada Inc. | Resolved | 2023-10-23 | 175 | Manufacturing distruption | 203911 |
2496 | N05AN01 | PMS-LITHIUM CARBONATE - CAP 15... | 150MG | Pharmascience Inc | Resolved | 2023-10-23 | 164 | Manufacturing distruption | 207100 |
2498 | G03FA01 | ESTALIS 250/50 MCG | 250MCG 50MCG | Sandoz Canada Incorporated | Resolved | 2023-10-23 | 18 | Manufacturing distruption | 207761 |
2499 | L04AA06 | SANDOZ MYCOPHENOLATE MOFETIL | 500MG | Sandoz Canada Incorporated | Resolved | 2023-10-23 | 11 | Manufacturing distruption | 207767 |
2500 | A02BC04 | SANDOZ RABEPRAZOLE | 20MG | Sandoz Canada Incorporated | Resolved | 2023-10-23 | 46 | Manufacturing distruption | 207773 |
2501 | C09CA04 | SANDOZ IRBESARTAN | 150MG | Sandoz Canada Incorporated | Resolved | 2023-10-23 | 11 | Manufacturing practices | 207764 |
2502 | N03AX11 | AURO-TOPIRAMATE | 25MG | Auro Pharma Inc | Resolved | 2023-10-23 | 99 | Demand increase | 207426 |
2503 | N03AX11 | AURO-TOPIRAMATE | 200MG | Auro Pharma Inc | Resolved | 2023-10-23 | 205 | Demand increase | 207419 |
2504 | N06AX05 | TRAZODONE | 50MG | Sanis Health Inc | Resolved | 2023-10-23 | 23 | Manufacturing distruption | 207906 |
2505 | N02BF01 | GABAPENTIN | 100MG | Sanis Health Inc | Resolved | 2023-10-23 | Manufacturing distruption | 207859 | |
2506 | C09CA04 | IRBESARTAN | 300MG | Sanis Health Inc | Resolved | 2023-10-23 | 144 | Manufacturing distruption | 207903 |
2507 | A03AB02 | GLYCOPYRROLATE INJECTION | 0.2MG | Omega Laboratories Limited | Resolved | 2023-10-23 | 11 | Demand increase | 207147 |
2508 | N02BF02 | PREGABALIN | 25MG | Sanis Health Inc | Resolved | 2023-10-23 | 155 | Manufacturing distruption | 207865 |
2509 | N02BF02 | PREGABALIN | 150MG | Sanis Health Inc | Resolved | 2023-10-23 | 35 | Manufacturing distruption | 207862 |
2510 | S01BA | DUREZOL | 0.05% | Novartis Pharmaceuticals Canada Inc | Resolved | 2023-10-23 | 137 | Shipping delay | 207835 |
2511 | L04AD02 | SANDOZ TACROLIMUS | 0.5MG | Sandoz Canada Incorporated | Resolved | 2023-10-23 | 11 | Manufacturing distruption | 207776 |
2512 | C09CA06 | CANDESARTAN | 32MG | Sanis Health Inc | Resolved | 2023-10-23 | 143 | Manufacturing distruption | 207878 |
2513 | N06AX21 | APO-DULOXETINE | 30MG | Apotex Inc | Resolved | 2023-10-23 | 74 | Manufacturing distruption | 208417 |
2514 | C10AA07 | AURO-ROSUVASTATIN | 5MG | Auro Pharma Inc | Resolved | 2023-10-23 | 66 | Demand increase | 207405 |
2515 | N06DA04 | GALANTAMINE ER | 16MG | Sanis Health Inc | Resolved | 2023-10-23 | 165 | Manufacturing distruption | 207850 |
2516 | J05AB11 | VALACYCLOVIR | 500MG | Sanis Health Inc | Resolved | 2023-10-23 | 35 | Manufacturing distruption | 207875 |
2517 | N05AX12 | AURO-ARIPIPRAZOLE | 2MG | Auro Pharma Inc | Resolved | 2023-10-23 | 128 | Demand increase | 207384 |
2518 | J05AF07 | AURO-TENOFOVIR | 300MG | Auro Pharma Inc | Resolved | 2023-10-23 | 23 | Demand increase | 207412 |
2519 | J01DB01 | AURO-CEPHALEXIN | 500MG | Auro Pharma Inc | Resolved | 2023-10-23 | 128 | Demand increase | 207389 |
2520 | G04CA04 | AURO-SILODOSIN | 4MG | Auro Pharma Inc | Resolved | 2023-10-23 | 191 | Demand increase | 207409 |
2521 | C09CA08 | OLMESARTAN | 40MG | Sanis Health Inc | Resolved | 2023-10-23 | 109 | Manufacturing distruption | 207885 |
2482 | D07AC13 | ELOCOM | 0.1% | Organon Canada Inc. | Resolved | 2023-10-20 | 192 | Shipping delay | 205536 |
2483 | S01FB01 | MINIMS PHENYLEPHRINE HYDROCHLO... | 10% | Bausch & Lomb Inc | Resolved | 2023-10-20 | 42 | Other | 206354 |
2484 | S01FB01 | MINIMS PHENYLEPHRINE HYDROCHLO... | 2.5% | Bausch & Lomb Inc | Resolved | 2023-10-20 | 42 | Other | 206343 |
2485 | D07AC03 | TOPICORT | 0.05% | Bausch Health, Canada Inc. | Resolved | 2023-10-20 | 0 | Other | 202719 |
2486 | C09AA02 | TARO-ENALAPRIL | 8MG | Sun Pharma Canada Inc | Resolved | 2023-10-20 | 21 | Manufacturing distruption | 209176 |
2487 | N05AH04 | QUETIAPINE TABLETS | 100MG | Accord Healthcare Inc | Resolved | 2023-10-20 | 34 | Demand increase | 207613 |
2488 | N02BF01 | GABAPENTIN CAPSULES USP | 100MG | Accord Healthcare Inc | Resolved | 2023-10-20 | 12 | Shipping delay | 207607 |
2489 | N02BF01 | GABAPENTIN CAPSULES USP | 300MG | Accord Healthcare Inc | Resolved | 2023-10-20 | 7 | Shipping delay | 207610 |
2490 | L04AX03 | METHOTREXATE SUBCUTANEOUS | 20MG | Accord Healthcare Inc | Resolved | 2023-10-20 | 6 | Shipping delay | 207602 |
2481 | C09CA08 | NRA-OLMESARTAN | 20MG | Nora Pharma Inc | Active | 2023-10-19 | Manufacturing distruption | 248761 | |
2478 | G03GA01 | PREGNYL | 10000UNIT | Organon Canada Inc. | Resolved | 2023-10-19 | 36 | Shipping delay | 207456 |
2479 | L01CE02 | IRINOTECAN HYDROCHLORIDE INJEC... | 20MG | Pfizer Canada Ulc | Resolved | 2023-10-19 | Manufacturing distruption | 204240 | |
2480 | N03AX14 | AURO-LEVETIRACETAM | 500MG | Auro Pharma Inc | Resolved | 2023-10-19 | 88 | Demand increase | 207402 |
2476 | L01AX03 | TEVA-TEMOZOLOMIDE | 20MG | Teva Canada Limited | Active | 2023-10-18 | Manufacturing distruption | 207542 | |
2471 | N07CA01 | TEVA-BETAHISTINE | 24MG | Teva Canada Limited | Resolved | 2023-10-18 | 23 | Manufacturing distruption | 208257 |
2472 | L04AG06 | MABCAMPATH | 30MG | Sanofi Genzyme, A Division Of Sanofi-Aventis Canada Inc | Resolved | 2023-10-18 | 68 | Manufacturing distruption | 207255 |
2473 | C09CA07 | TEVA-TELMISARTAN | 40MG | Teva Canada Limited | Resolved | 2023-10-18 | 205 | Manufacturing distruption | 207530 |
2474 | C09AA02 | VASOTEC | 4MG | Organon Canada Inc. | Resolved | 2023-10-18 | 44 | Shipping delay | 206442 |
2475 | J01DC10 | TARO-CEFPROZIL | 125MG | Sun Pharma Canada Inc | Resolved | 2023-10-18 | 37 | Manufacturing distruption | 208961 |
2477 | C01EB17 | LANCORA | 5MG | Servier Canada Inc | Resolved | 2023-10-18 | 23 | Shipping delay | 207976 |
2469 | N03AF01 | TEGRETOL SUSPENSION | 100MG | Novartis Pharmaceuticals Canada Inc | Resolved | 2023-10-17 | 132 | Manufacturing distruption | 216049 |
2470 | N01BB09 | NAROPIN | 10MG | Aspen Pharmacare Canada Inc. | Resolved | 2023-10-17 | 59 | Shipping delay | 203931 |
2431 | V03AE01 | JAMP CALCIUM POLYSTYRENE SULFO... | 999MG | Jamp Pharma Corporation | Active | 2023-10-16 | Manufacturing distruption | 207347 | |
2433 | G04BD08 | M-SOLIFENACIN SUCCINATE | 5MG | Mantra Pharma Inc | Active | 2023-10-16 | Shipping delay | 225565 | |
2434 | G04BD08 | M-SOLIFENACIN SUCCINATE | 10MG | Mantra Pharma Inc | Active | 2023-10-16 | Shipping delay | 225571 | |
2449 | N05AX08 | JAMP-RISPERIDONE | 1MG | Jamp Pharma Corporation | Active | 2023-10-16 | 807 | Other | 207292 |
2450 | J05AG03 | JAMP-EFAVIRENZ | 600MG | Jamp Pharma Corporation | Active | 2023-10-16 | 807 | Manufacturing distruption | 207333 |
2453 | S01AE07 | JAMP-MOXIFLOXACIN | 0.5% | Jamp Pharma Corporation | Active | 2023-10-16 | 807 | Manufacturing distruption | 207295 |
2430 | N06AA09 | APO-AMITRIPTYLINE | 10MG | Apotex Inc | Resolved | 2023-10-16 | Manufacturing distruption | 207698 | |
2432 | R06AE07 | CETIRIZINE EXTRA STRENGTH | 10MG | Jamp Pharma Corporation | Resolved | 2023-10-16 | 76 | Manufacturing distruption | 207328 |
2435 | N01BB51 | SENSORCAINE WITH EPINEPHRINE | 2.5MG 5MCG | Aspen Pharmacare Canada Inc. | Resolved | 2023-10-16 | 135 | Manufacturing distruption | 203898 |
2436 | N01BB51 | SENSORCAINE WITH EPINEPHRINE | 5MCG 5MG | Aspen Pharmacare Canada Inc. | Resolved | 2023-10-16 | 76 | Manufacturing distruption | 206658 |
2437 | C07AB04 | APO-ACEBUTOLOL | 100MG | Apotex Inc | Resolved | 2023-10-16 | 60 | Manufacturing distruption | 207725 |
2438 | N06AA04 | ANAFRANIL | 50MG | Apotex Inc | Resolved | 2023-10-16 | 67 | Manufacturing distruption | 207713 |
2439 | N06AB08 | APO-FLUVOXAMINE | 100MG | Apotex Inc | Resolved | 2023-10-16 | 102 | Manufacturing distruption | 207710 |
2440 | G03FA01 | ESTALIS 140/50 MCG | 140MCG 50MCG | Sandoz Canada Incorporated | Resolved | 2023-10-16 | 25 | Manufacturing distruption | 207082 |
2441 | N05CM05 | SCOPOLAMINE HYDROBROMIDE INJEC... | 0.6MG | Omega Laboratories Limited | Resolved | 2023-10-16 | Demand increase | 207142 | |
2442 | C07AB02 | APO-METOPROLOL | 25MG | Apotex Inc | Resolved | 2023-10-16 | 45 | Manufacturing distruption | 207728 |
2443 | N03AF01 | SANDOZ-CARBAMAZEPINE CR | 400MG | Sandoz Canada Incorporated | Resolved | 2023-10-16 | 53 | Manufacturing distruption | 207076 |
2444 | J01FA09 | APO-CLARITHROMYCIN | 500MG | Apotex Inc | Resolved | 2023-10-16 | 60 | Manufacturing distruption | 207722 |
2445 | A02BC03 | APO-LANSOPRAZOLE | 15MG | Apotex Inc | Resolved | 2023-10-16 | 25 | Manufacturing distruption | 207716 |
2446 | J01XA01 | VANCOMYCIN HYDROCHLORIDE FOR I... | 1G | Sandoz Canada Incorporated | Resolved | 2023-10-16 | 214 | Manufacturing distruption | 207085 |
2447 | G04CB02 | APO-DUTASTERIDE | 0.5MG | Apotex Inc | Resolved | 2023-10-16 | 33 | Manufacturing distruption | 207719 |
2448 | N06AX21 | SANDOZ DULOXETINE | 30MG | Sandoz Canada Incorporated | Resolved | 2023-10-16 | 144 | Manufacturing practices | 207079 |
2451 | C09BB04 | APO-PERINDOPRIL/AMLODIPINE | 5MG 7MG | Apotex Inc | Resolved | 2023-10-16 | 60 | Manufacturing distruption | 207707 |
2452 | C09BB04 | APO-PERINDOPRIL/AMLODIPINE | 10MG 14MG | Apotex Inc | Resolved | 2023-10-16 | 60 | Manufacturing distruption | 207704 |
2454 | A05AA02 | JAMP-URSODIOL | 250MG | Jamp Pharma Corporation | Resolved | 2023-10-16 | 396 | Manufacturing distruption | 207298 |
2455 | A05AA02 | JAMP-URSODIOL | 250MG | Jamp Pharma Corporation | Resolved | 2023-10-16 | 258 | Manufacturing distruption | 207301 |
2456 | J07BC01 | ENGERIX-B | 20MCG | Glaxosmithkline Inc | Resolved | 2023-10-16 | 36 | Shipping delay | 207381 |
2457 | N05CM18 | DEXMEDETOMIDINE HYDROCHLORIDE ... | 200MCG | Juno Pharmaceuticals Corp. | Resolved | 2023-10-16 | 15 | Shipping delay | 206945 |
2458 | N05CM18 | DEXMEDETOMIDINE HYDROCHLORIDE ... | 400MCG | Juno Pharmaceuticals Corp. | Resolved | 2023-10-16 | 15 | Shipping delay | 206948 |
2459 | L02BX03 | APO-ABIRATERONE FILM COATED TA... | 250MG | Apotex Inc | Resolved | 2023-10-16 | 32 | Manufacturing distruption | 207692 |
2460 | L02BX03 | APO-ABIRATERONE FILM COATED TA... | 500MG | Apotex Inc | Resolved | 2023-10-16 | 32 | Manufacturing distruption | 207701 |
2461 | N02CC06 | JAMP ELETRIPTAN | 20MG | Jamp Pharma Corporation | Resolved | 2023-10-16 | 442 | Manufacturing distruption | 207338 |
2462 | N02CC06 | JAMP ELETRIPTAN | 40MG | Jamp Pharma Corporation | Resolved | 2023-10-16 | 442 | Manufacturing distruption | 207344 |
2463 | L01EB01 | JAMP GEFITINIB | 250MG | Jamp Pharma Corporation | Resolved | 2023-10-16 | 91 | Manufacturing distruption | 207314 |
2464 | J05AR01 | JAMP LAMIVUDINE / ZIDOVUDINE | 150MG 300MG | Jamp Pharma Corporation | Resolved | 2023-10-16 | 350 | Manufacturing distruption | 207304 |
2465 | L04AX04 | APO-LENALIDOMIDE | 20MG | Apotex Inc | Resolved | 2023-10-16 | 46 | Manufacturing distruption | 207695 |
2466 | A10BD07 | APO-SITAGLIPTIN MALATE / METFO... | 500MG 50MG | Apotex Inc | Resolved | 2023-10-16 | 18 | Manufacturing distruption | 207683 |
2467 | A10BD07 | APO-SITAGLIPTIN MALATE / METFO... | 850MG 50MG | Apotex Inc | Resolved | 2023-10-16 | 74 | Manufacturing distruption | 207686 |
2468 | A10BD07 | APO-SITAGLIPTIN MALATE / METFO... | 850MG 50MG | Apotex Inc | Resolved | 2023-10-16 | 74 | Manufacturing distruption | 207689 |
2429 | M03AB01 | SUCCINYLCHOLINE CHLORIDE INJEC... | 20MG | Hikma Canada Limited | Resolved | 2023-10-15 | 79 | Demand increase | 205822 |
2427 | N06AB08 | LUVOX | 50MG | Bgp Pharma Ulc | Resolved | 2023-10-13 | 88 | Manufacturing distruption | 203103 |
2428 | A11GA01 | VITAMIN C | 500MG | Mylan Pharmaceuticals Ulc | Resolved | 2023-10-13 | Demand increase | 207192 | |
2423 | G03CA03 | CLIMARA 50 | 50MCG | Bayer Inc | Resolved | 2023-10-12 | 62 | Other | 203740 |
2424 | N06AA06 | TRIMIPRAMINE | 50MG | Aa Pharma Inc | Resolved | 2023-10-12 | 55 | Manufacturing distruption | 206939 |
2425 | C10AX09 | ACH-EZETIMIBE | 10MG | Accord Healthcare Inc | Resolved | 2023-10-12 | 13 | Demand increase | 207014 |
2426 | V09FX01 | ULTRA-TECHNEKOW V4 | 19CI | Curium Canada Inc | Resolved | 2023-10-12 | 0 | Ingredient shortage | 206722 |
2409 | J01MA02 | CIPROFLOXACIN | 250MG | Sanis Health Inc | Active | 2023-10-11 | Manufacturing distruption | 211197 | |
2418 | J02AC03 | TEVA-VORICONAZOLE | 50MG | Teva Canada Limited | Active | 2023-10-11 | Manufacturing distruption | 207545 | |
2419 | R03DC03 | MAR-MONTELUKAST | 10MG | Marcan Pharmaceuticals Inc | Active | 2023-10-11 | 386 | Manufacturing distruption | 206808 |
2410 | B05BA03 | 5% DEXTROSE INJECTION, USP | 5G | Baxter Corporation | Resolved | 2023-10-11 | 12 | Manufacturing distruption | 206816 |
2411 | M01AE02 | TEVA-NAPROXEN SODIUM DS | 550MG | Teva Canada Limited | Resolved | 2023-10-11 | 40 | Manufacturing distruption | 207509 |
2412 | A03BB01 | BUSCOPAN | 20MG | Sanofi Consumer Health Inc | Resolved | 2023-10-11 | 163 | Shipping delay | 206788 |
2413 | R03BB01 | TEVA-IPRATROPIUM STERINEBS | 250MCG | Teva Canada Limited | Resolved | 2023-10-11 | 243 | Manufacturing distruption | 207512 |
2414 | J01DB01 | TEVA-CEPHALEXIN 250 | 250MG | Teva Canada Limited | Resolved | 2023-10-11 | 132 | Manufacturing distruption | 207500 |
2415 | N05AH03 | TEVA-OLANZAPINE | 15MG | Teva Canada Limited | Resolved | 2023-10-11 | 60 | Manufacturing distruption | 207527 |
2416 | N07CA01 | TEVA-BETAHISTINE | 8MG | Teva Canada Limited | Resolved | 2023-10-11 | 40 | Manufacturing distruption | 208254 |
2417 | N04BC05 | ACT PRAMIPEXOLE | 0.5MG | Teva Canada Limited | Resolved | 2023-10-11 | 112 | Manufacturing distruption | 208260 |
2420 | N06DA02 | AURO-DONEPEZIL | 5MG | Auro Pharma Inc | Resolved | 2023-10-11 | Demand increase | 207394 | |
2421 | M03AC11 | CISATRACURIUM OMEGA MULTIDOSE | 2MG | Omega Laboratories Limited | Resolved | 2023-10-11 | 65 | Manufacturing distruption | 202569 |
2422 | G04BE08 | TEVA-TADALAFIL | 20MG | Teva Canada Limited | Resolved | 2023-10-11 | 233 | Manufacturing distruption | 207551 |
2400 | C10AA01 | TEVA-SIMVASTATIN | 40MG | Teva Canada Limited | Resolved | 2023-10-10 | 281 | Manufacturing distruption | 207518 |
2401 | B01AB01 | HEPARIN SODIUM INJECTION USP ... | 10000UNIT | Sandoz Canada Incorporated | Resolved | 2023-10-10 | Manufacturing distruption | 206707 | |
2402 | C09CA06 | SANDOZ CANDESARTAN | 16MG | Sandoz Canada Incorporated | Resolved | 2023-10-10 | 122 | Manufacturing distruption | 206689 |
2403 | C10AA07 | SANDOZ ROSUVASTATIN | 5MG | Sandoz Canada Incorporated | Resolved | 2023-10-10 | 45 | Manufacturing distruption | 206697 |
2404 | C10AA07 | SANDOZ ROSUVASTATIN | 40MG | Sandoz Canada Incorporated | Resolved | 2023-10-10 | 129 | Manufacturing distruption | 206693 |
2405 | G04CA02 | SANDOZ TAMSULOSIN CR | 0.4MG | Sandoz Canada Incorporated | Resolved | 2023-10-10 | 24 | Manufacturing distruption | 206701 |
2406 | N05CD08 | MIDAZOLAM INJECTION USP | 1MG | Pfizer Canada Ulc | Resolved | 2023-10-10 | Manufacturing distruption | 200822 | |
2407 | C09DA07 | SANDOZ TELMISARTAN HCT | 12.5MG 80MG | Sandoz Canada Incorporated | Resolved | 2023-10-10 | 3 | Shipping delay | 206704 |
2408 | N06BA01 | SANDOZ AMPHETAMINE XR | 20MG | Sandoz Canada Incorporated | Resolved | 2023-10-10 | 17 | Demand increase | 206684 |
2395 | C01BB01 | LIDOCAINE HYDROCHLORIDE INJECT... | 100MG | Laboratoire Aguettant | Resolved | 2023-10-06 | 10 | Shipping delay | 205384 |
2396 | G03AA05 | BREVICON 0.5/35 TABLETS (21-DA... | 0.5MG 0.035MG | Pfizer Canada Ulc | Resolved | 2023-10-06 | 21 | Demand increase | 206521 |
2397 | G03AA05 | BREVICON 0.5/35 TABLETS (28-DA... | .5MG .035MG | Pfizer Canada Ulc | Resolved | 2023-10-06 | 21 | Demand increase | 206524 |
2398 | C07AB12 | BYSTOLIC | 2.5MG | Abbvie Corporation | Resolved | 2023-10-06 | 56 | Demand increase | 206797 |
2399 | N01AH01 | FENTANYL CITRATE INJECTION, US... | 50MCG | Fresenius Kabi Canada Ltd | Resolved | 2023-10-06 | 40 | Shipping delay | 205907 |
2393 | D01AE14 | STIEPROX SHAMPOO | 1.5% | Glaxosmithkline Inc | Resolved | 2023-10-05 | 33 | Manufacturing distruption | 206484 |
2394 | C08DA01 | MYLAN-VERAPAMIL SR | 120MG | Mylan Pharmaceuticals Ulc | Resolved | 2023-10-05 | 131 | Manufacturing distruption | 200642 |
2387 | N06AX11 | TEVA-MIRTAZAPINE | 30MG | Teva Canada Limited | Active | 2023-10-04 | Manufacturing distruption | 206407 | |
2388 | G04BD07 | TEVA-TOLTERODINE | 1MG | Teva Canada Limited | Active | 2023-10-04 | Manufacturing distruption | 206410 | |
2389 | G04BD07 | TEVA-TOLTERODINE | 2MG | Teva Canada Limited | Active | 2023-10-04 | Manufacturing distruption | 206413 | |
2392 | C09CA06 | TARO-CANDESARTAN | 8MG | Sun Pharma Canada Inc | Active | 2023-10-04 | 569 | Manufacturing distruption | 208955 |
2382 | C01BB02 | TEVA-MEXILETINE | 200MG | Teva Canada Limited | Resolved | 2023-10-04 | 27 | Manufacturing distruption | 206895 |
2383 | C01DA02 | RHO-NITRO PUMPSPRAY | 0.4MG | Sandoz Canada Incorporated | Resolved | 2023-10-04 | Demand increase | 206051 | |
2384 | G03BA03 | ANDROGEL | 1% | Bgp Pharma Ulc | Resolved | 2023-10-04 | 20 | Manufacturing distruption | 204107 |
2385 | C10AA03 | TEVA-PRAVASTATIN | 40MG | Teva Canada Limited | Resolved | 2023-10-04 | 98 | Manufacturing distruption | 206395 |
2386 | N03AX11 | TEVA-TOPIRAMATE | 200MG | Teva Canada Limited | Resolved | 2023-10-04 | 118 | Manufacturing distruption | 206398 |
2390 | L04AA06 | TEVA-MYCOPHENOLATE | 500MG | Teva Canada Limited | Resolved | 2023-10-04 | 148 | Manufacturing distruption | 207536 |
2391 | N06AX11 | MIRTAZAPINE | 30MG | Sanis Health Inc | Resolved | 2023-10-04 | 114 | Manufacturing distruption | 197632 |
2369 | J01AA02 | APO-DOXYCYCLINE MR | 40MG | Apotex Inc | Resolved | 2023-10-03 | 31 | Manufacturing distruption | 206573 |
2370 | C02AC02 | APO-GUANFACINE XR | 1MG | Apotex Inc | Resolved | 2023-10-03 | 101 | Manufacturing distruption | 206579 |
2371 | A12BA02 | UROCIT-K | 540MG | Mission Pharmacal Company | Resolved | 2023-10-03 | 149 | Shipping delay | 206032 |
2372 | S01ED51 | COSOPT | 5MG 20MG | Elvium Life Sciences | Resolved | 2023-10-03 | 24 | Shipping delay | 205939 |
2373 | C10AA01 | APO-SIMVASTATIN | 40MG | Apotex Inc | Resolved | 2023-10-03 | 59 | Manufacturing distruption | 206576 |
2374 | C09AA09 | APO-FOSINOPRIL | 20MG | Apotex Inc | Resolved | 2023-10-03 | 136 | Manufacturing distruption | 206582 |
2375 | A10BB09 | APO-GLICLAZIDE MR | 30MG | Apotex Inc | Resolved | 2023-10-03 | 136 | Manufacturing distruption | 206563 |
2376 | N06BA09 | APO-ATOMOXETINE | 40MG | Apotex Inc | Resolved | 2023-10-03 | 73 | Manufacturing distruption | 206566 |
2377 | A12BA02 | UROCIT-K | 1080MG | Mission Pharmacal Company | Resolved | 2023-10-03 | 149 | Shipping delay | 206035 |
2378 | H02AB04 | SOLU-MEDROL | 125MG | Pfizer Canada Ulc | Resolved | 2023-10-03 | Manufacturing distruption | 201998 | |
2379 | N06AX21 | APO-DULOXETINE | 30MG | Apotex Inc | Resolved | 2023-10-03 | 94 | Manufacturing distruption | 206560 |
2380 | B01AC24 | APO-TICAGRELOR | 90MG | Apotex Inc | Resolved | 2023-10-03 | 66 | Manufacturing distruption | 206569 |
2381 | A06AX05 | APO-PRUCALOPRIDE | 1MG | Apotex Inc | Resolved | 2023-10-03 | 59 | Manufacturing distruption | 206557 |
2353 | N02CX01 | SANDOMIGRAN DS | 1MG | Paladin Labs Inc. | Active | 2023-10-02 | 557 | Other | 205711 |
2354 | J01FF01 | CLINDAMYCIN INJECTION USP | 150MG | Sandoz Canada Incorporated | Resolved | 2023-10-02 | 123 | Manufacturing practices | 205789 |
2355 | R03DA05 | AMINOPHYLLINE INJ 25MG/ML | 25MG | Omega Laboratories Limited | Resolved | 2023-10-02 | Manufacturing distruption | 205759 | |
2356 | D07AD01 | TARO-CLOBETASOL CREAM USP, 0.0... | 0.05% | Taro Pharmaceuticals Inc | Resolved | 2023-10-02 | 109 | Manufacturing distruption | 215082 |
2357 | G03CA03 | ESTRADOT 25 | 25MCG | Sandoz Canada Incorporated | Resolved | 2023-10-02 | 39 | Manufacturing distruption | 205793 |
2358 | R01AX03 | IPRAVENT | 42MCG | Aa Pharma Inc | Resolved | 2023-10-02 | 28 | Ingredient shortage | 206273 |
2359 | N01AX03 | KETAMINE HYDROCHLORIDE INJECTI... | 10MG | Sandoz Canada Incorporated | Resolved | 2023-10-02 | 81 | Manufacturing distruption | 187807 |
2360 | J01MA02 | SANDOZ CIPROFLOXACIN | 500MG | Sandoz Canada Incorporated | Resolved | 2023-10-02 | 67 | Manufacturing practices | 205785 |
2361 | A02BC01 | SANDOZ OMEPRAZOLE | 10MG | Sandoz Canada Incorporated | Resolved | 2023-10-02 | Manufacturing distruption | 205814 | |
2362 | N05AH03 | SANDOZ OLANZAPINE | 10.0MG | Sandoz Canada Incorporated | Resolved | 2023-10-02 | 137 | Manufacturing practices | 205802 |
2363 | C09CA04 | SANDOZ IRBESARTAN | 75MG | Sandoz Canada Incorporated | Resolved | 2023-10-02 | 123 | Manufacturing distruption | 205797 |
2364 | C08CA01 | SANDOZ AMLODIPINE | 2.5MG | Sandoz Canada Incorporated | Resolved | 2023-10-02 | 4 | Manufacturing practices | 205778 |
2365 | N02BF02 | SANDOZ PREGABALIN | 75MG | Sandoz Canada Incorporated | Resolved | 2023-10-02 | 18 | Manufacturing distruption | 205808 |
2366 | N06BA01 | SANDOZ AMPHETAMINE XR | 10MG | Sandoz Canada Incorporated | Resolved | 2023-10-02 | 32 | Demand increase | 205782 |
2367 | J02AC04 | SANDOZ POSACONAZOLE | 100MG | Sandoz Canada Incorporated | Resolved | 2023-10-02 | 18 | Shipping delay | 205805 |
2368 | A10BD07 | SANDOZ SITAGLIPTIN-METFORMIN | 500MG 50MG | Sandoz Canada Incorporated | Resolved | 2023-10-02 | Shipping delay | 205811 | |
2342 | N04BC07 | MOVAPO | 10MG | Paladin Labs Inc. | Active | 2023-10-01 | Manufacturing distruption | 207114 | |
2346 | J01XD01 | METRONIDAZOLE INJECTION USP | 5MG | Pfizer Canada Ulc | Active | 2023-10-01 | Manufacturing distruption | 202725 | |
2343 | N01BB52 | XYLOCAINE 2% W EPINEPHRINE 1:2... | 5MCG 20MG | Aspen Pharmacare Canada Inc. | Avoided | 2023-10-01 | 30 | Shipping delay | 188729 |
2344 | N01BB52 | XYLOCAINE 2% W EPINEPHRINE 1:2... | 5MCG 20MG | Aspen Pharmacare Canada Inc. | Avoided | 2023-10-01 | 82 | Manufacturing distruption | 200026 |
2345 | N01BB52 | XYLOCAINE 1% W EPINEPHRINE 1:2... | 5MCG 10MG | Aspen Pharmacare Canada Inc. | Avoided | 2023-10-01 | 60 | Manufacturing distruption | 188735 |
2347 | N01BB02 | XYLOCAINE 1% | 10MG | Aspen Pharmacare Canada Inc. | Avoided | 2023-10-01 | 30 | Shipping delay | 183697 |
2351 | N06AX21 | NRA-DULOXETINE | 30MG | Nora Pharma Inc | Avoided | 2023-10-01 | Other | 199232 | |
2348 | C05BB04 | TROMBOJECT 3% | 30MG | Omega Laboratories Limited | Resolved | 2023-10-01 | Manufacturing distruption | 206243 | |
2349 | G04BD08 | AURO-SOLIFENACIN | 5MG | Auro Pharma Inc | Resolved | 2023-10-01 | 199 | Demand increase | 204540 |
2350 | G04BD08 | AURO-SOLIFENACIN | 10MG | Auro Pharma Inc | Resolved | 2023-10-01 | 197 | Demand increase | 135417 |
2352 | N02AA03 | HYDROMORPHONE HYDROCHLORIDE IN... | 10MG | Fresenius Kabi Canada Ltd | Resolved | 2023-10-01 | Manufacturing distruption | 201627 | |
2339 | A10BA02 | TEVA-METFORMIN | 500MG | Teva Canada Limited | Resolved | 2023-09-30 | 71 | Manufacturing distruption | 207521 |
2340 | N06AB05 | AURO-PAROXETINE | 30MG | Auro Pharma Inc | Resolved | 2023-09-30 | 61 | Demand increase | 203283 |
2341 | C09CA07 | AURO-TELMISARTAN | 40MG | Auro Pharma Inc | Resolved | 2023-09-30 | 61 | Demand increase | 99162 |
2334 | C01DA14 | PMS-ISMN | 60MG | Pharmascience Inc | Active | 2023-09-29 | 758 | Manufacturing distruption | 214316 |
2328 | N06AX16 | VENLAFAXINE XR | 150MG | Jamp Pharma Corporation | Resolved | 2023-09-29 | 326 | Manufacturing distruption | 205261 |
2329 | D10BA01 | ABSORICA LD | 8MG | Sun Pharmaceutical Industries Limited | Resolved | 2023-09-29 | Shipping delay | 206725 | |
2330 | D10BA01 | ABSORICA LD | 16MG | Sun Pharmaceutical Industries Limited | Resolved | 2023-09-29 | Shipping delay | 206731 | |
2331 | D10BA01 | ABSORICA LD | 24MG | Sun Pharmaceutical Industries Limited | Resolved | 2023-09-29 | Shipping delay | 206728 | |
2332 | D10BA01 | ABSORICA LD | 32MG | Sun Pharmaceutical Industries Limited | Resolved | 2023-09-29 | Shipping delay | 206734 | |
2333 | C01AA05 | PMS-DIGOXIN | 0.05MG | Pharmascience Inc | Resolved | 2023-09-29 | 18 | Manufacturing distruption | 205607 |
2335 | C09DA04 | PMS-IRBESARTAN-HCTZ | 25MG 300MG | Pharmascience Inc | Resolved | 2023-09-29 | 82 | Manufacturing distruption | 205611 |
2336 | M01AB15 | KETOROLAC TROMETHAMINE INJECTI... | 30MG | Pfizer Canada Ulc | Resolved | 2023-09-29 | Manufacturing distruption | 200810 | |
2337 | N05CF02 | PMS-ZOLPIDEM ODT | 5MG | Pharmascience Inc | Resolved | 2023-09-29 | 57 | Manufacturing distruption | 205614 |
2338 | N05CF02 | PMS-ZOLPIDEM ODT | 10MG | Pharmascience Inc | Resolved | 2023-09-29 | 42 | Manufacturing distruption | 205617 |
2324 | A09AA02 | CREON MINIMICROSPHERES 25 | 1600UNIT 25500UNIT 25000UNIT | Bgp Pharma Ulc | Resolved | 2023-09-28 | 54 | Manufacturing distruption | 205876 |
2325 | J05AB14 | VALCYTE | 450MG | Cheplapharm Arzneimittel Gmbh | Resolved | 2023-09-28 | 63 | Manufacturing distruption | 205325 |
2326 | J01AA02 | APPRILON | 40MG | Galderma Canada Inc | Resolved | 2023-09-28 | 22 | Shipping delay | 204639 |
2327 | P02CF01 | STROMECTOL | 3MG | Merck Canada Inc | Resolved | 2023-09-28 | 22 | Demand increase | 204142 |
2316 | J01CA01 | TEVA-AMPICILLIN | 500MG | Teva Canada Limited | Resolved | 2023-09-27 | 44 | Manufacturing distruption | 207494 |
2317 | S01BC03 | VOLTAREN OPHTHA | 0.1% | Novartis Pharmaceuticals Canada Inc | Resolved | 2023-09-27 | 135 | Shipping delay | 205330 |
2318 | C02DC01 | LONITEN 10MG | 10MG | Pfizer Canada Ulc | Resolved | 2023-09-27 | 50 | Manufacturing distruption | 174131 |
2319 | C02DC01 | LONITEN 2.5MG | 2.5MG | Pfizer Canada Ulc | Resolved | 2023-09-27 | 50 | Manufacturing distruption | 174141 |
2320 | M01AE02 | TEVA-NAPROXEN EC | 500MG | Teva Canada Limited | Resolved | 2023-09-27 | 74 | Manufacturing distruption | 206392 |
2321 | C03EA01 | TEVA-SPIRONOLACTONE/HCTZ | 50MG 50MG | Teva Canada Limited | Resolved | 2023-09-27 | 44 | Manufacturing distruption | 208251 |
2322 | N05BB01 | HYDROXYZINE | 10MG | Aa Pharma Inc | Resolved | 2023-09-27 | 54 | Manufacturing distruption | 205344 |
2323 | C07AB02 | TEVA-METOPROLOL | 100MG | Teva Canada Limited | Resolved | 2023-09-27 | 64 | Manufacturing distruption | 206377 |
2301 | N03AB02 | DILANTIN | 30MG | Bgp Pharma Ulc | Resolved | 2023-09-26 | Manufacturing distruption | 203106 | |
2302 | G03BA03 | DELATESTRYL | 200MG | Bausch Health, Canada Inc. | Resolved | 2023-09-26 | 28 | Shipping delay | 205404 |
2303 | N02AA01 | KADIAN | 50MG | Bgp Pharma Ulc | Resolved | 2023-09-26 | 28 | Manufacturing distruption | 205233 |
2304 | D10AF52 | BENZAMYCIN | 5% 3% | Bausch Health, Canada Inc. | Resolved | 2023-09-26 | 79 | Demand increase | 204911 |
2305 | N02BE01 | APO-ACETAMINOPHEN CAPLETS EXTR... | 500MG | Apotex Inc | Resolved | 2023-09-26 | 31 | Manufacturing distruption | 205492 |
2306 | M01AE02 | APO-NAPROXEN | 500MG | Apotex Inc | Resolved | 2023-09-26 | 52 | Manufacturing distruption | 205489 |
2307 | M01AE02 | APO-NAPROXEN | 500MG | Apotex Inc | Resolved | 2023-09-26 | 52 | Manufacturing distruption | 205498 |
2308 | B01AC04 | PLAVIX | 75MG | Sanofi-Aventis Canada Inc | Resolved | 2023-09-26 | 108 | Other | 205398 |
2309 | J01CR02 | APO-AMOXI CLAV | 125MG 250MG | Apotex Inc | Resolved | 2023-09-26 | 17 | Manufacturing distruption | 205483 |
2310 | S01AE06 | APO-GATIFLOXACIN | 0.3% | Apotex Inc | Resolved | 2023-09-26 | 59 | Manufacturing distruption | 205486 |
2311 | N06DA03 | APO-RIVASTIGMINE | 3MG | Apotex Inc | Resolved | 2023-09-26 | 115 | Manufacturing distruption | 205501 |
2312 | G04CA02 | APO-TAMSULOSIN CR | 0.4MG | Apotex Inc | Resolved | 2023-09-26 | 437 | Manufacturing distruption | 205480 |
2313 | R03DC03 | APO-MONTELUKAST | 4MG | Apotex Inc | Resolved | 2023-09-26 | 24 | Manufacturing distruption | 205495 |
2314 | G04BE08 | MYLAN-TADALAFIL | 20MG | Mylan Pharmaceuticals Ulc | Resolved | 2023-09-26 | 77 | Manufacturing distruption | 207187 |
2315 | G04BD08 | SOLIFENACIN | 5MG | Sanis Health Inc | Resolved | 2023-09-26 | 62 | Manufacturing distruption | 205212 |
2293 | M01AB01 | ODAN-INDOMETHACIN | 100MG | Odan Laboratories Ltd | Active | 2023-09-25 | 644 | Manufacturing distruption | 205248 |
2290 | H02AB02 | DEXAMETHASONE SOD PHOSPH INJ 1... | 10MG | Sandoz Canada Incorporated | Resolved | 2023-09-25 | 32 | Manufacturing distruption | 205147 |
2291 | C01DA02 | NITROSTAT | 0.3MG | Bgp Pharma Ulc | Resolved | 2023-09-25 | 36 | Demand increase | 201387 |
2292 | A03AX04 | DICETEL | 100MG | Bgp Pharma Ulc | Resolved | 2023-09-25 | 190 | Manufacturing distruption | 198997 |
2294 | B02AA02 | TRANEXAMIC ACID INJECTION BP | 100MG | Sandoz Canada Incorporated | Resolved | 2023-09-25 | 32 | Manufacturing distruption | 205159 |
2295 | D10AF51 | BENZACLIN | 5% 1% | Bausch Health, Canada Inc. | Resolved | 2023-09-25 | 9 | Demand increase | 205401 |
2296 | R01AD12 | AVAMYS | 27.5MCG | Glaxosmithkline Inc | Resolved | 2023-09-25 | 74 | Manufacturing distruption | 205521 |
2297 | J01MA12 | SANDOZ LEVOFLOXACIN | 750MG | Sandoz Canada Incorporated | Resolved | 2023-09-25 | 305 | Manufacturing distruption | 205153 |
2298 | A04AA02 | GRANISETRON HYDROCHLORIDE INJE... | 1MG | Omega Laboratories Limited | Resolved | 2023-09-25 | Demand increase | 204668 | |
2299 | G04CA02 | SANDOZ TAMSULOSIN CR | 0.4MG | Sandoz Canada Incorporated | Resolved | 2023-09-25 | 109 | Manufacturing distruption | 205156 |
2300 | B05XA17 | POTASSIUM ACETATE INJECTION US... | 39.2% | Omega Laboratories Limited | Resolved | 2023-09-25 | Manufacturing distruption | 204135 | |
2288 | N02AX06 | NUCYNTA EXTENDED-RELEASE | 200MG | Endo Ventures Ltd. | Active | 2023-09-22 | 297 | Shipping delay | 205952 |
2287 | N06AX11 | MYLAN-MIRTAZAPINE | 30MG | Mylan Pharmaceuticals Ulc | Avoided | 2023-09-22 | Demand increase | 200648 | |
2283 | D01AC01 | CLOTRIMADERM TOPICAL | 1% | Taro Pharmaceuticals Inc | Resolved | 2023-09-22 | 56 | Manufacturing distruption | 205192 |
2284 | B05BC01 | MANNITOL INJECTION USP | 20% | Icu Medical Canada Inc | Resolved | 2023-09-22 | 28 | Manufacturing distruption | 200395 |
2285 | J01XE01 | NITROFURANTOIN | 100MG | Aa Pharma Inc | Resolved | 2023-09-22 | 81 | Manufacturing distruption | 205034 |
2286 | N01BB52 | XYLOCAINE 1% W EPINEPHRINE 1:1... | 0.01MG 10MG | Aspen Pharmacare Canada Inc. | Resolved | 2023-09-22 | 69 | Manufacturing distruption | 197712 |
2289 | B01AF01 | XARELTO | 103.4MG | Bayer Inc | Resolved | 2023-09-22 | 56 | Ingredient shortage | 196862 |
2279 | M01AE02 | NAPROSYN | 500MG | Atnahs Pharma Uk Limited | Active | 2023-09-21 | 451 | Other | 204887 |
2280 | D07AC15 | PROPADERM | 0.025% | Bausch Health, Canada Inc. | Avoided | 2023-09-21 | 7 | Shipping delay | 201534 |
2281 | J02AX04 | CANCIDAS | 50MG | Merck Canada Inc | Resolved | 2023-09-21 | 57 | Demand increase | 203308 |
2282 | N05AB04 | ODAN-PROCHLORPERAZINE | 10MG | Odan Laboratories Ltd | Resolved | 2023-09-21 | 448 | Manufacturing distruption | 210201 |
2274 | N01BB01 | BUPIVACAINE HYDROCHLORIDE IN D... | 7.5MG | Omega Laboratories Limited | Resolved | 2023-09-20 | 58 | Demand increase | 204665 |
2275 | A03BB01 | BUSCOPAN | 10MG | Sanofi Consumer Health Inc | Resolved | 2023-09-20 | 65 | Demand increase | 204870 |
2276 | G03AA05 | BREVICON 1/35 TABLETS (28-DAY ... | 0.035MG 1MG | Pfizer Canada Ulc | Resolved | 2023-09-20 | 37 | Manufacturing distruption | 204196 |
2277 | L01XA02 | CARBOPLATIN INJECTION BP | 10MG | Pfizer Canada Ulc | Resolved | 2023-09-20 | Manufacturing distruption | 204867 | |
2278 | N02CC01 | MYLAN-SUMATRIPTAN | 25MG | Mylan Pharmaceuticals Ulc | Resolved | 2023-09-20 | 13 | Manufacturing distruption | 204095 |
2255 | C02DB02 | APO-HYDRALAZINE | 25MG | Apotex Inc | Resolved | 2023-09-19 | 45 | Manufacturing distruption | 204999 |
2256 | N06AB05 | APO-PAROXETINE | 10MG | Apotex Inc | Resolved | 2023-09-19 | 17 | Manufacturing distruption | 205006 |
2257 | N06AB05 | APO-PAROXETINE | 30MG | Apotex Inc | Resolved | 2023-09-19 | 17 | Manufacturing distruption | 205018 |
2258 | L04AD01 | SANDOZ CYCLOSPORINE | 100MG | Sandoz Canada Incorporated | Resolved | 2023-09-19 | 45 | Manufacturing practices | 204722 |
2259 | G03CA03 | ESTRADOT 37.5 | 37.5MCG | Sandoz Canada Incorporated | Resolved | 2023-09-19 | 52 | Manufacturing distruption | 204735 |
2260 | J01CR02 | APO-AMOXI CLAV | 125MG 875MG | Apotex Inc | Resolved | 2023-09-19 | 80 | Manufacturing distruption | 204990 |
2261 | L04AK01 | APO-LEFLUNOMIDE | 10MG | Apotex Inc | Resolved | 2023-09-19 | 52 | Manufacturing distruption | 205009 |
2262 | N05AX08 | APO-RISPERIDONE | 2.0MG | Apotex Inc | Resolved | 2023-09-19 | 87 | Manufacturing distruption | 205002 |
2263 | S01ED51 | APO-DORZO-TIMOP | 5MG 20MG | Apotex Inc | Resolved | 2023-09-19 | 72 | Manufacturing distruption | 205015 |
2264 | N05AH03 | SANDOZ OLANZAPINE ODT | 15MG | Sandoz Canada Incorporated | Resolved | 2023-09-19 | 24 | Ingredient shortage | 204741 |
2265 | C09DA04 | SANDOZ IRBESARTAN HCT | 25MG 300MG | Sandoz Canada Incorporated | Resolved | 2023-09-19 | 115 | Manufacturing distruption | 204738 |
2266 | N04BX02 | SANDOZ ENTACAPONE | 200MG | Sandoz Canada Incorporated | Resolved | 2023-09-19 | 87 | Shipping delay | 204731 |
2267 | N02BF02 | SANDOZ PREGABALIN | 75MG | Sandoz Canada Incorporated | Resolved | 2023-09-19 | 24 | Manufacturing distruption | 204744 |
2268 | G04BD08 | SANDOZ SOLIFENACIN | 5MG | Sandoz Canada Incorporated | Resolved | 2023-09-19 | 24 | Manufacturing distruption | 204748 |
2269 | G03AA12 | MYA | 0.02MG 3.00MG | Apotex Inc | Resolved | 2023-09-19 | 24 | Manufacturing distruption | 204996 |
2270 | G03AD01 | BACKUP PLAN ONESTEP | 1.5MG | Apotex Inc | Resolved | 2023-09-19 | 38 | Manufacturing distruption | 205012 |
2271 | N06BA01 | APO-AMPHETAMINE XR | 10MG | Apotex Inc | Resolved | 2023-09-19 | 66 | Manufacturing distruption | 204987 |
2272 | V03AC03 | SANDOZ DEFERASIROX | 250MG | Sandoz Canada Incorporated | Resolved | 2023-09-19 | 52 | Demand increase | 204727 |
2273 | APO-MELOXICAM | 1.5G | Apotex Inc | Resolved | 2023-09-19 | 87 | Manufacturing distruption | 204993 | |
2244 | L02BB02 | ANANDRON | 50MG | Cheplapharm Arzneimittel Gmbh | Active | 2023-09-18 | Manufacturing distruption | 232663 | |
2254 | C10AC01 | CHOLESTYRAMINE-ODAN | 4G | Odan Laboratories Ltd | Active | 2023-09-18 | Demand increase | 204546 | |
2248 | B05BB02 | 5% DEXTROSE AND 0.45% SODIUM C... | 4.5MG 50MG | Icu Medical Canada Inc | Avoided | 2023-09-18 | 42 | Manufacturing distruption | 200398 |
2243 | L02BB02 | ANANDRON | 50MG | Cheplapharm Arzneimittel Gmbh | Resolved | 2023-09-18 | Manufacturing distruption | 204346 | |
2245 | J01DD08 | SUPRAX | 400MG | Odan Laboratories Ltd | Resolved | 2023-09-18 | 73 | Demand increase | 204671 |
2246 | C01DA02 | NITROSTAT | 0.6MG | Bgp Pharma Ulc | Resolved | 2023-09-18 | Demand increase | 201390 | |
2247 | M03BX01 | MYLAN-BACLOFEN | 20MG | Mylan Pharmaceuticals Ulc | Resolved | 2023-09-18 | 43 | Manufacturing distruption | 201960 |
2249 | D07AD01 | MYLAN-CLOBETASOL SCALP APPLICA... | 0.05% | Mylan Pharmaceuticals Ulc | Resolved | 2023-09-18 | 46 | Manufacturing distruption | 203708 |
2250 | S01FA04 | ODAN-CYCLOPENTOLATE | 1% | Odan Laboratories Ltd | Resolved | 2023-09-18 | 21 | Demand increase | 204543 |
2251 | N01AX03 | KETAMINE HYDROCHLORIDE INJECTI... | 50MG | Sandoz Canada Incorporated | Resolved | 2023-09-18 | 95 | Manufacturing practices | 204611 |
2252 | A02BA03 | FAMOTIDINE OMEGA -(WITH PRES... | 10MG | Omega Laboratories Limited | Resolved | 2023-09-18 | 218 | Manufacturing distruption | 202613 |
2253 | N06DA04 | PAT-GALANTAMINE ER | 16MG | Janssen Inc | Resolved | 2023-09-18 | 25 | Demand increase | 204227 |
2242 | J01MA12 | LEVOFLOXACIN IN 5% DEXTROSE IN... | 5MG | Pfizer Canada Ulc | Resolved | 2023-09-16 | Ingredient shortage | 193609 | |
2231 | C10AC01 | OLESTYR | 4G | Pharmascience Inc | Active | 2023-09-15 | 1143 | Manufacturing distruption | 204499 |
2235 | C09AA03 | AURO-LISINOPRIL | 20MG | Auro Pharma Inc | Active | 2023-09-15 | Demand increase | 204527 | |
2237 | D05BB02 | TARO-ACITRETIN | 10MG | Taro Pharmaceuticals Inc | Active | 2023-09-15 | Manufacturing distruption | 215061 | |
2238 | N06AB10 | PMS-ESCITALOPRAM | 20MG | Pharmascience Inc | Active | 2023-09-15 | 714 | Manufacturing distruption | 204505 |
2239 | N06AB10 | PMS-ESCITALOPRAM | 20MG | Pharmascience Inc | Active | 2023-09-15 | 714 | Manufacturing distruption | 204508 |
2230 | N01BB54 | EMLA CREAM | 2.5% 2.5% | Aspen Pharmacare Canada Inc. | Resolved | 2023-09-15 | 20 | Shipping delay | 203737 |
2232 | N06AB03 | PMS-FLUOXETINE - CAP 10MG | 10MG | Pharmascience Inc | Resolved | 2023-09-15 | 62 | Manufacturing distruption | 204502 |
2233 | J01DC02 | AURO-CEFUROXIME | 250MG | Auro Pharma Inc | Resolved | 2023-09-15 | 119 | Demand increase | 204518 |
2234 | J01DC10 | AURO-CEFPROZIL | 500MG | Auro Pharma Inc | Resolved | 2023-09-15 | 29 | Demand increase | 204515 |
2236 | C10AA07 | AURO-ROSUVASTATIN | 40MG | Auro Pharma Inc | Resolved | 2023-09-15 | Demand increase | 204536 | |
2240 | J05AR06 | AURO-EFAVIRENZ-EMTRICITABINE-T... | 300MG 200MG 600MG | Auro Pharma Inc | Resolved | 2023-09-15 | 47 | Demand increase | 204524 |
2241 | G03DA04 | AURO-PROGESTERONE | 100MG | Auro Pharma Inc | Resolved | 2023-09-15 | Demand increase | 204533 | |
2228 | C01EA01 | PROSTIN VR STERILE SOLUTION | 500MCG | Pfizer Canada Ulc | Resolved | 2023-09-14 | Manufacturing distruption | 204343 | |
2229 | L01CD01 | PACLITAXEL INJECTION USP | 6MG | Accord Healthcare Inc | Resolved | 2023-09-14 | 53 | Manufacturing distruption | 207557 |
2222 | A07EA06 | BUDESONIDE | 3MG | Tillotts Pharma Gmbh | Active | 2023-09-13 | Manufacturing distruption | 204928 | |
2223 | A09AA02 | COTAZYM | 35000UNIT 40000UNIT 10000UNIT | Organon Canada Inc. | Resolved | 2023-09-13 | 47 | Shipping delay | 203960 |
2224 | J02AC01 | MYLAN-FLUCONAZOLE | 100MG | Mylan Pharmaceuticals Ulc | Resolved | 2023-09-13 | 23 | Manufacturing distruption | 204098 |
2225 | C09BA04 | COVERSYL PLUS HD | 2.5MG 8MG | Servier Canada Inc | Resolved | 2023-09-13 | 30 | Other | 205207 |
2226 | C09BB04 | VIACORAM | 7MG 5MG | Servier Canada Inc | Resolved | 2023-09-13 | 69 | Shipping delay | 204772 |
2227 | N06BA04 | FOQUEST | 55MG | Elvium Life Sciences | Resolved | 2023-09-13 | 9 | Shipping delay | 204210 |
2213 | J01DB01 | TEVA-CEPHALEXIN 125 | 125MG | Teva Canada Limited | Resolved | 2023-09-12 | 180 | Manufacturing distruption | 217220 |
2214 | N06AB06 | APO-SERTRALINE | 25MG | Apotex Inc | Resolved | 2023-09-12 | 24 | Manufacturing distruption | 204420 |
2215 | D01BA02 | APO-TERBINAFINE | 250MG | Apotex Inc | Resolved | 2023-09-12 | 52 | Manufacturing distruption | 204417 |
2216 | G03DA02 | APO-MEDROXY TABLETS | 5MG | Apotex Inc | Resolved | 2023-09-12 | 79 | Manufacturing distruption | 204414 |
2217 | C01BD01 | APO-AMIODARONE TABLETS | 200MG | Apotex Inc | Resolved | 2023-09-12 | 17 | Manufacturing distruption | 204408 |
2218 | N03AX14 | APO-LEVETIRACETAM | 750MG | Apotex Inc | Resolved | 2023-09-12 | 45 | Manufacturing distruption | 204405 |
2219 | N06BA09 | APO-ATOMOXETINE | 40MG | Apotex Inc | Resolved | 2023-09-12 | 87 | Manufacturing distruption | 204411 |
2220 | C09BB04 | APO-PERINDOPRIL/AMLODIPINE | 10MG 14MG | Apotex Inc | Resolved | 2023-09-12 | 31 | Manufacturing distruption | 204424 |
2221 | L04AX04 | TARO-LENALIDOMIDE | 2.5MG | Taro Pharmaceuticals Inc | Resolved | 2023-09-12 | 185 | Manufacturing distruption | 222084 |
2206 | V01AA20 | ALLERGENIC EXTRACT NON POLLENS | 100000UNIT | Alk-Abello Inc | Active | 2023-09-11 | 842 | Shipping delay | 204072 |
2204 | D07AD01 | MYLAN-CLOBETASOL CREAM | 0.05% | Mylan Pharmaceuticals Ulc | Resolved | 2023-09-11 | 92 | Manufacturing distruption | 203693 |
2205 | A03AB02 | GLYCOPYRROLATE INJECTION USP | 0.2MG | Sandoz Canada Incorporated | Resolved | 2023-09-11 | 25 | Manufacturing distruption | 204118 |
2207 | D07AB09 | ARISTOCORT R | 0.1% | Bausch Health, Canada Inc. | Resolved | 2023-09-11 | 9 | Other | 202716 |
2208 | R05CB01 | ACETYLCYSTEINE SOLUTION | 200MG | Sandoz Canada Incorporated | Resolved | 2023-09-11 | 46 | Ingredient shortage | 204114 |
2209 | A10BA02 | SANDOZ METFORMIN FC | 500MG | Sandoz Canada Incorporated | Resolved | 2023-09-11 | 11 | Shipping delay | 204121 |
2210 | L01XD03 | METVIX | 168MG | Galderma Canada Inc | Resolved | 2023-09-11 | 75 | Manufacturing distruption | 203874 |
2211 | N05AH03 | OLANZAPINE ODT | 20MG | Sivem Pharmaceuticals Ulc | Resolved | 2023-09-11 | 157 | Shipping delay | 211154 |
2212 | N06AX24 | VIIBRYD | 20MG | Abbvie Corporation | Resolved | 2023-09-11 | 18 | Shipping delay | 204062 |
2197 | J01XE01 | TEVA-NITROFURANTOIN | 50MG | Teva Canada Limited | Resolved | 2023-09-09 | 92 | Manufacturing distruption | 207515 |
2198 | C10AA01 | TEVA-SIMVASTATIN | 10MG | Teva Canada Limited | Resolved | 2023-09-09 | 305 | Manufacturing distruption | 206401 |
2199 | N06AB08 | ACT FLUVOXAMINE | 100MG | Teva Canada Limited | Resolved | 2023-09-09 | 82 | Manufacturing distruption | 206404 |
2200 | C09AA02 | SANDOZ ENALAPRIL | 2MG | Sandoz Canada Incorporated | Resolved | 2023-09-09 | 69 | Manufacturing distruption | 203659 |
2201 | R06AA59 | PMS-DOXYLAMINE-PYRIDOXINE | 10MG 10MG | Pharmascience Inc | Resolved | 2023-09-09 | 12 | Manufacturing distruption | 203920 |
2202 | N06AX21 | TEVA-DULOXETINE | 30MG | Teva Canada Limited | Resolved | 2023-09-09 | 173 | Manufacturing distruption | 206431 |
2203 | J01DB01 | LUPIN-CEPHALEXIN | 250MG | Lupin Pharma Canada Limited | Resolved | 2023-09-09 | 31 | Demand increase | 204786 |
2192 | A02BC04 | JAMP RABEPRAZOLE | 20MG | Jamp Pharma Corporation | Active | 2023-09-08 | 784 | Manufacturing distruption | 204044 |
2193 | A02BC04 | JAMP RABEPRAZOLE | 20MG | Jamp Pharma Corporation | Active | 2023-09-08 | 784 | Manufacturing distruption | 204047 |
2187 | N06AB03 | PMS-FLUOXETINE - CAP 20MG | 20MG | Pharmascience Inc | Resolved | 2023-09-08 | 69 | Manufacturing distruption | 203914 |
2188 | N06AX05 | PMS-TRAZODONE | 75MG | Pharmascience Inc | Resolved | 2023-09-08 | 76 | Manufacturing distruption | 203917 |
2189 | L01AA06 | IFEX | 1G | Baxter Corporation | Resolved | 2023-09-08 | 31 | Shipping delay | 203950 |
2190 | L02AE02 | ELIGARD | 7.5MG | Tolmar International Ltd. | Resolved | 2023-09-08 | Shipping delay | 204001 | |
2191 | V03AF01 | UROMITEXAN | 100MG | Baxter Corporation | Resolved | 2023-09-08 | 14 | Demand increase | 203947 |
2194 | A06AX04 | CONSTELLA | 290MCG | Abbvie Corporation | Resolved | 2023-09-08 | 21 | Shipping delay | 203963 |
2195 | N06BA04 | FOQUEST | 85MG | Elvium Life Sciences | Resolved | 2023-09-08 | 14 | Shipping delay | 203858 |
2196 | A05AA02 | JAMP-URSODIOL | 500MG | Jamp Pharma Corporation | Resolved | 2023-09-08 | 296 | Manufacturing distruption | 204041 |
2183 | G04BD08 | ACH-SOLIFENACIN SUCCINATE | 5MG | Accord Healthcare Inc | Resolved | 2023-09-07 | 125 | Demand increase | 203972 |
2184 | G04BD08 | ACH-SOLIFENACIN SUCCINATE | 10MG | Accord Healthcare Inc | Resolved | 2023-09-07 | 43 | Demand increase | 203969 |
2185 | C10AA05 | ACH-ATORVASTATIN CALCIUM | 20MG | Accord Healthcare Inc | Resolved | 2023-09-07 | 14 | Shipping delay | 203975 |
2186 | C10AA05 | ACH-ATORVASTATIN CALCIUM | 40MG | Accord Healthcare Inc | Resolved | 2023-09-07 | 48 | Shipping delay | 203978 |
2180 | D07AC13 | ELOCOM | 0.1% | Organon Canada Inc. | Resolved | 2023-09-06 | 39 | Shipping delay | 196133 |
2181 | D10AF51 | CLINDOXYL GEL | 1% 5% | Glaxosmithkline Inc | Resolved | 2023-09-06 | 191 | Demand increase | 203953 |
2182 | M05BA04 | TEVA-ALENDRONATE | 70MG | Teva Canada Limited | Resolved | 2023-09-06 | 95 | Manufacturing distruption | 207524 |
2157 | N03AG01 | APO-VALPROIC ACID ORAL SOLUTIO... | 250MG | Apotex Inc | Active | 2023-09-05 | Manufacturing distruption | 194593 | |
2153 | A10BK01 | SANDOZ DAPAGLIFLOZIN | 10MG | Sandoz Canada Incorporated | Resolved | 2023-09-05 | 45 | Demand increase | 203653 |
2154 | H01AC01 | NORDITROPIN FLEXPRO | 15MG | Novo Nordisk Canada Inc | Resolved | 2023-09-05 | 45 | Shipping delay | 203363 |
2155 | N01BB52 | XYLOCAINE 2% W EPINEPHRINE 1:2... | 5MCG 20MG | Aspen Pharmacare Canada Inc. | Resolved | 2023-09-05 | 176 | Manufacturing distruption | 203734 |
2156 | M01AE02 | APO-NAPROXEN | 375MG | Apotex Inc | Resolved | 2023-09-05 | 38 | Manufacturing distruption | 203849 |
2158 | D01BA02 | APO-TERBINAFINE | 250MG | Apotex Inc | Resolved | 2023-09-05 | 59 | Manufacturing distruption | 203843 |
2159 | J01GB06 | AMIKACIN SULFATE INJECTION USP | 250MG | Sandoz Canada Incorporated | Resolved | 2023-09-05 | 24 | Manufacturing distruption | 203649 |
2160 | G03DA02 | APO-MEDROXY TABLETS | 2.5MG | Apotex Inc | Resolved | 2023-09-05 | 86 | Manufacturing distruption | 203822 |
2161 | C03BA11 | APO-INDAPAMIDE 1.25 MG TABLETS | 1.25MG | Apotex Inc | Resolved | 2023-09-05 | 86 | Manufacturing distruption | 203846 |
2162 | R03AC02 | APO-SALBUTAMOL HFA | 100MCG | Apotex Inc | Resolved | 2023-09-05 | 269 | Manufacturing distruption | 198539 |
2163 | C10AA01 | APO-SIMVASTATIN | 40MG | Apotex Inc | Resolved | 2023-09-05 | 227 | Manufacturing distruption | 203834 |
2164 | J01MA02 | PMS-CIPROFLOXACIN | 250MG | Pharmascience Inc | Resolved | 2023-09-05 | Manufacturing distruption | 193024 | |
2165 | M05BA04 | APO-ALENDRONATE | 70MG | Apotex Inc | Resolved | 2023-09-05 | 52 | Manufacturing distruption | 203837 |
2166 | N06BA04 | APO-METHYLPHENIDATE | 10MG | Apotex Inc | Resolved | 2023-09-05 | 52 | Manufacturing distruption | 203812 |
2167 | J01FA09 | APO-CLARITHROMYCIN | 250MG | Apotex Inc | Resolved | 2023-09-05 | 10 | Manufacturing distruption | 203828 |
2168 | N03AX14 | APO-LEVETIRACETAM | 500MG | Apotex Inc | Resolved | 2023-09-05 | 52 | Manufacturing distruption | 203840 |
2169 | N01BB20 | ORAQIX | 2.5% 2.5% | Dentsply Canada Limited | Resolved | 2023-09-05 | 71 | Shipping delay | 203938 |
2170 | A06AB52 | BI-PEGLYTE | 0.76G 1.46G 1.69G 5.74G 59.55G 5MG | Pendopharm Division Of Pharmascience Inc | Resolved | 2023-09-05 | 253 | Manufacturing distruption | 203635 |
2171 | N02AA03 | APO-HYDROMORPHONE | 4MG | Apotex Inc | Resolved | 2023-09-05 | 59 | Manufacturing distruption | 203852 |
2172 | R03DC03 | APO-MONTELUKAST | 5MG | Apotex Inc | Resolved | 2023-09-05 | 45 | Manufacturing distruption | 203825 |
2173 | J01XA01 | VANCOMYCIN HYDROCHLORIDE FOR I... | 500MG | Sandoz Canada Incorporated | Resolved | 2023-09-05 | 213 | Manufacturing distruption | 203663 |
2174 | G03AA12 | ZAMINE 28 | 0.03MG 3MG | Apotex Inc | Resolved | 2023-09-05 | 24 | Manufacturing distruption | 203831 |
2175 | H05BX01 | APO-CINACALCET | 60MG | Apotex Inc | Resolved | 2023-09-05 | 45 | Manufacturing distruption | 203809 |
2176 | N06BA04 | APO-METHYLPHENIDATE ER | 18MG | Apotex Inc | Resolved | 2023-09-05 | 52 | Manufacturing distruption | 203804 |
2177 | N06BA04 | APO-METHYLPHENIDATE ER | 27MG | Apotex Inc | Resolved | 2023-09-05 | 48 | Manufacturing distruption | 203855 |
2178 | V03AC03 | APO-DEFERASIROX | 250MG | Apotex Inc | Resolved | 2023-09-05 | 17 | Manufacturing distruption | 203819 |
2179 | N05AX12 | APO-ARIPIPRAZOLE | 10MG | Apotex Inc | Resolved | 2023-09-05 | 136 | Manufacturing distruption | 203816 |
2151 | C09BA03 | ZESTORETIC | 10MG 12.5MG | Searchlight Pharma Inc | Resolved | 2023-09-04 | 0 | Ingredient shortage | 204548 |
2152 | C09CA04 | IRBESARTAN | 75MG | Sivem Pharmaceuticals Ulc | Resolved | 2023-09-04 | 179 | Shipping delay | 211146 |
2150 | C09BA03 | ZESTORETIC | 10MG 12.5MG | Searchlight Pharma Inc | Active | 2023-09-02 | 637 | Manufacturing distruption | 202917 |
2139 | H02AB08 | TRISPAN | 20MG | Medexus Inc | Active | 2023-09-01 | Other | 197812 | |
2142 | N01BB52 | XYLOCAINE 2% WITH EPINEPHRINE ... | 0.005MG 20MG | Aspen Pharmacare Canada Inc. | Avoided | 2023-09-01 | 60 | Manufacturing distruption | 188723 |
2140 | L04AC18 | SKYRIZI | 90MG | Abbvie Corporation | Resolved | 2023-09-01 | Other | 188265 | |
2141 | G03DA02 | PROVERA 10MG TABLETS | 10MG | Pfizer Canada Ulc | Resolved | 2023-09-01 | 60 | Demand increase | 203392 |
2143 | L01DB01 | DOXORUBICIN | 2MG | Pfizer Canada Ulc | Resolved | 2023-09-01 | Manufacturing distruption | 200032 | |
2144 | C01CA24 | EPINEPHRINE INJECTION USP | 1MG | Hikma Canada Limited | Resolved | 2023-09-01 | 206 | Manufacturing distruption | 200978 |
2145 | C10AA05 | ACH-ATORVASTATIN CALCIUM | 80MG | Accord Healthcare Inc | Resolved | 2023-09-01 | 54 | Shipping delay | 203456 |
2146 | L01XA03 | OXALIPLATIN INJECTION, USP | 5MG | Dr Reddy's Laboratories Ltd | Resolved | 2023-09-01 | 90 | Other | 203427 |
2147 | B03BA01 | CYANOCOBALAMIN INJECTION USP | 1000MCG | Hikma Canada Limited | Resolved | 2023-09-01 | 90 | Manufacturing distruption | 200983 |
2148 | L04AX03 | METHOTREXATE SUBCUTANEOUS | 20MG | Accord Healthcare Inc | Resolved | 2023-09-01 | 21 | Shipping delay | 203459 |
2149 | N05AE05 | TARO-LURASIDONE | 120MG | Taro Pharmaceuticals Inc | Resolved | 2023-09-01 | 294 | Manufacturing distruption | 230679 |
2136 | N05AB06 | TRIFLUOPERAZINE | 20MG | Aa Pharma Inc | Active | 2023-08-31 | Manufacturing distruption | 200930 | |
2137 | C09XA02 | RASILEZ | 300MG | Noden Pharma Dac | Active | 2023-08-31 | Ingredient shortage | 196602 | |
2138 | L01DB01 | DOXORUBICIN HYDROCHLORIDE FOR ... | 50MG | Pfizer Canada Ulc | Resolved | 2023-08-31 | Manufacturing distruption | 199246 | |
2127 | N05AB06 | TRIFLUOPERAZINE | 10MG | Aa Pharma Inc | Active | 2023-08-30 | Manufacturing distruption | 190062 | |
2128 | S01XA24 | OXERVATE | 0.002% | Dompé Farmaceutici S.p.a. | Resolved | 2023-08-30 | Other | 201866 | |
2129 | N03AB02 | DILANTIN INFATABS | 50MG | Bgp Pharma Ulc | Resolved | 2023-08-30 | 34 | Manufacturing distruption | 204814 |
2130 | R03AK06 | ADVAIR 100 DISKUS | 100MCG 50MCG | Glaxosmithkline Inc | Resolved | 2023-08-30 | 42 | Manufacturing distruption | 203384 |
2131 | G03CA03 | CLIMARA 25 | 25MCG | Bayer Inc | Resolved | 2023-08-30 | 105 | Other | 203402 |
2132 | G03CA03 | CLIMARA 75 | 75MCG | Bayer Inc | Resolved | 2023-08-30 | 105 | Other | 203406 |
2133 | N02AA79 | FIORINAL-C 1/4 | 15MG 50MG 40MG 330MG | Aralez Pharmaceuticals Canada Inc | Resolved | 2023-08-30 | 37 | Manufacturing distruption | 203315 |
2134 | C08DB01 | TEVA-DILTIAZEM XC | 180MG | Teva Canada Limited | Resolved | 2023-08-30 | 102 | Manufacturing distruption | 206904 |
2135 | N06BA12 | VYVANSE | 10MG | Takeda Canada Inc | Resolved | 2023-08-30 | 21 | Demand increase | 203355 |
2107 | A10BK01 | APO-DAPAGLIFLOZIN | 10MG | Apotex Inc | Resolved | 2023-08-29 | 122 | Manufacturing distruption | 203563 |
2108 | N02AA03 | HYDROMORPHONE HYDROCHLORIDE IN... | 2MG | Sandoz Canada Incorporated | Resolved | 2023-08-29 | 0 | Manufacturing distruption | 203181 |
2109 | J05AB01 | APO-ACYCLOVIR | 400MG | Apotex Inc | Resolved | 2023-08-29 | Manufacturing distruption | 203566 | |
2110 | G04CA03 | APO-TERAZOSIN | 10MG | Apotex Inc | Resolved | 2023-08-29 | 262 | Ingredient shortage | 195259 |
2111 | N03AX09 | APO-LAMOTRIGINE | 100MG | Apotex Inc | Resolved | 2023-08-29 | 31 | Manufacturing distruption | 203545 |
2112 | C07AG02 | APO-CARVEDILOL | 12.5MG | Apotex Inc | Resolved | 2023-08-29 | 80 | Manufacturing distruption | 203554 |
2113 | C01BC04 | APO-FLECAINIDE | 50MG | Apotex Inc | Resolved | 2023-08-29 | 10 | Manufacturing distruption | 203539 |
2114 | G03DA02 | APO-MEDROXY | 10MG | Apotex Inc | Resolved | 2023-08-29 | 113 | Manufacturing distruption | 203557 |
2115 | N02CC02 | SANDOZ NARATRIPTAN | 2.5MG | Sandoz Canada Incorporated | Resolved | 2023-08-29 | 10 | Manufacturing distruption | 203189 |
2116 | N02AA03 | APO-HYDROMORPHONE | 2MG | Apotex Inc | Resolved | 2023-08-29 | 45 | Manufacturing distruption | 203548 |
2117 | N06AB06 | AURO-SERTRALINE | 25MG | Auro Pharma Inc | Resolved | 2023-08-29 | 78 | Demand increase | 203280 |
2118 | N06AB06 | AURO-SERTRALINE | 50MG | Auro Pharma Inc | Resolved | 2023-08-29 | 108 | Demand increase | 203277 |
2119 | N02BF02 | APO-PREGABALIN | 25MG | Apotex Inc | Resolved | 2023-08-29 | 66 | Manufacturing distruption | 203560 |
2120 | N02BF02 | PREGABALIN | 50MG | Sanis Health Inc | Resolved | 2023-08-29 | 72 | Manufacturing distruption | 203109 |
2121 | A16AX06 | SANDOZ MIGLUSTAT | 100MG | Sandoz Canada Incorporated | Resolved | 2023-08-29 | 3 | Manufacturing practices | 203185 |
2122 | N05AX12 | APO-ARIPIPRAZOLE | 15MG | Apotex Inc | Resolved | 2023-08-29 | 24 | Manufacturing distruption | 203551 |
2123 | J01CR02 | AURO-AMOXICLAV | 125MG 875MG | Auro Pharma Inc | Resolved | 2023-08-29 | 78 | Demand increase | 203286 |
2124 | L01CD04 | CABAZITAXEL FOR INJECTION | 45MG | Sandoz Canada Incorporated | Resolved | 2023-08-29 | 80 | Manufacturing practices | 203175 |
2125 | A10BD07 | SANDOZ SITAGLIPTIN-METFORMIN | 500MG 50MG | Sandoz Canada Incorporated | Resolved | 2023-08-29 | 31 | Manufacturing distruption | 203193 |
2126 | APO-MELOXICAM | 1.5G | Apotex Inc | Resolved | 2023-08-29 | 164 | Manufacturing distruption | 203542 | |
2102 | N06BC01 | CAFFEINE CITRATE ORAL SOLUTION... | 20MG | Omega Laboratories Limited | Resolved | 2023-08-28 | Demand increase | 203082 | |
2103 | S03CA01 | SOFRACORT | 0.05MG 0.5MG 5MG | Sanofi-Aventis Canada Inc | Resolved | 2023-08-28 | Other | 202983 | |
2104 | L01XX05 | MYLAN-HYDROXYUREA | 500MG | Mylan Pharmaceuticals Ulc | Resolved | 2023-08-28 | 64 | Manufacturing distruption | 201965 |
2105 | D10AF51 | BENZACLIN | 5% 1% | Bausch Health, Canada Inc. | Resolved | 2023-08-28 | 31 | Demand increase | 203270 |
2106 | J01GB06 | AMIKACIN SULFATE INJECTION | 250MG | Omega Laboratories Limited | Resolved | 2023-08-28 | 184 | Manufacturing distruption | 201872 |
2101 | J01MA02 | PMS-CIPROFLOXACIN | 750MG | Pharmascience Inc | Resolved | 2023-08-26 | Manufacturing distruption | 193021 | |
2094 | G03AA12 | YAZ | 0.02MG 3MG | Bayer Inc | Avoided | 2023-08-25 | 3 | Shipping delay | 202308 |
2089 | N02BF01 | JAMP-GABAPENTIN TABLETS | 600MG | Jamp Pharma Corporation | Resolved | 2023-08-25 | 859 | Other | 202961 |
2090 | N02BF01 | JAMP-GABAPENTIN TABLETS | 800MG | Jamp Pharma Corporation | Resolved | 2023-08-25 | 859 | Other | 202964 |
2091 | G03DA04 | PROGESTERONE | 100MG | Sanis Health Inc | Resolved | 2023-08-25 | Manufacturing distruption | 203121 | |
2092 | L01XA02 | CARBOPLATIN INJECTION BP | 10MG | Pfizer Canada Ulc | Resolved | 2023-08-25 | Manufacturing distruption | 201480 | |
2093 | M03BX01 | BACLOFEN | 20MG | Sanis Health Inc | Resolved | 2023-08-25 | Manufacturing distruption | 203125 | |
2095 | N06AX05 | TRAZODONE | 150MG | Sanis Health Inc | Resolved | 2023-08-25 | Manufacturing distruption | 203118 | |
2096 | N02BF01 | GABAPENTIN | 300MG | Sanis Health Inc | Resolved | 2023-08-25 | 56 | Manufacturing distruption | 203128 |
2097 | A10BA02 | METFORMIN | 500MG | Sanis Health Inc | Resolved | 2023-08-25 | Manufacturing distruption | 203144 | |
2098 | N02BF02 | PREGABALIN | 75MG | Sanis Health Inc | Resolved | 2023-08-25 | 66 | Manufacturing distruption | 203135 |
2099 | N03AX14 | JAMP LEVETIRACETAM TABLETS | 500MG | Jamp Pharma Corporation | Resolved | 2023-08-25 | 371 | Demand increase | 202967 |
2100 | N03AX14 | JAMP LEVETIRACETAM TABLETS | 750MG | Jamp Pharma Corporation | Resolved | 2023-08-25 | 203 | Demand increase | 202970 |
2087 | S01GX09 | JAMP-OLOPATADINE | 0.1% | Jamp Pharma Corporation | Active | 2023-08-24 | 860 | Other | 202886 |
2085 | S01EA05 | BRIMONIDINE P | 0.15% | Aa Pharma Inc | Resolved | 2023-08-24 | 50 | Manufacturing distruption | 202748 |
2086 | M01AE52 | MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 500MG | Mylan Pharmaceuticals Ulc | Resolved | 2023-08-24 | 36 | Ingredient shortage | 203214 |
2088 | B01AF03 | LIXIANA | 15MG | Servier Canada Inc | Resolved | 2023-08-24 | 27 | Other | 202915 |
2081 | B03BB01 | FOLIC ACID | 5MG | Aa Pharma Inc | Resolved | 2023-08-23 | 77 | Manufacturing distruption | 202758 |
2082 | J06BA02 | GAMMAGARD S/D | 5G | Takeda Canada Inc | Resolved | 2023-08-23 | 38 | Shipping delay | 202833 |
2083 | P01BC02 | MEFLOQUINE | 250MG | Aa Pharma Inc | Resolved | 2023-08-23 | 21 | Manufacturing distruption | 202753 |
2084 | B01AC07 | DIPYRIDAMOLE INJECTION, USP | 5MG | Fresenius Kabi Canada Ltd | Resolved | 2023-08-23 | 312 | Manufacturing distruption | 193649 |
2073 | N06AX21 | DULOXETINE | 30MG | Sanis Health Inc | Resolved | 2023-08-22 | 153 | Manufacturing distruption | 202687 |
2074 | N06AX05 | APO-TRAZODONE TABLETS 100MG | 100MG | Apotex Inc | Resolved | 2023-08-22 | 52 | Manufacturing distruption | 202821 |
2075 | G04CA01 | APO-ALFUZOSIN | 10MG | Apotex Inc | Resolved | 2023-08-22 | 10 | Manufacturing distruption | 202830 |
2076 | C10AA07 | APO-ROSUVASTATIN | 40MG | Apotex Inc | Resolved | 2023-08-22 | 17 | Manufacturing distruption | 202827 |
2077 | G04CA02 | APO-TAMSULOSIN CR | 0.4MG | Apotex Inc | Resolved | 2023-08-22 | 80 | Manufacturing distruption | 202824 |
2078 | N02BF02 | PREGABALIN | 150MG | Sanis Health Inc | Resolved | 2023-08-22 | 14 | Manufacturing distruption | 202695 |
2079 | N07XX06 | APO-TETRABENAZINE | 25MG | Apotex Inc | Resolved | 2023-08-22 | 45 | Manufacturing distruption | 202818 |
2080 | R01AD58 | DYMISTA | 137MCG 50MCG | Bgp Pharma Ulc | Resolved | 2023-08-22 | Manufacturing distruption | 201912 | |
2070 | G04BD08 | PMS-SOLIFENACIN | 5MG | Pharmascience Inc | Active | 2023-08-21 | 610 | Manufacturing distruption | 202582 |
2071 | G04BD08 | PMS-SOLIFENACIN | 10MG | Pharmascience Inc | Active | 2023-08-21 | 608 | Manufacturing distruption | 202585 |
2067 | N02AA05 | PMS-OXYCODONE CR | 40MG | Pharmascience Inc | Avoided | 2023-08-21 | 120 | Manufacturing distruption | 198022 |
2061 | A10BK01 | SANDOZ DAPAGLIFLOZIN | 10MG | Sandoz Canada Incorporated | Resolved | 2023-08-21 | 88 | Demand increase | 202538 |
2062 | B05BA03 | DEXTROSE INJECTION USP | 500MG | Icu Medical Canada Inc | Resolved | 2023-08-21 | Manufacturing distruption | 203389 | |
2063 | D07CB05 | LOCACORTEN VIOFORM | 0.02% 3% | Paladin Labs Inc. | Resolved | 2023-08-21 | 277 | Ingredient shortage | 203880 |
2064 | A04AA01 | ONDANSETRON INJECTION USP ... | 2MG | Sandoz Canada Incorporated | Resolved | 2023-08-21 | 123 | Ingredient shortage | 202547 |
2065 | C08CA01 | SANDOZ AMLODIPINE | 10MG | Sandoz Canada Incorporated | Resolved | 2023-08-21 | 4 | Manufacturing distruption | 202533 |
2066 | N05AE04 | ZELDOX | 60MG | Upjohn Canada Ulc | Resolved | 2023-08-21 | 50 | Manufacturing distruption | 201950 |
2068 | N05AH03 | SANDOZ OLANZAPINE ODT | 5MG | Sandoz Canada Incorporated | Resolved | 2023-08-21 | 53 | Ingredient shortage | 202544 |
2069 | C10AX09 | SANDOZ EZETIMIBE | 10MG | Sandoz Canada Incorporated | Resolved | 2023-08-21 | 67 | Manufacturing distruption | 202541 |
2072 | A10BJ06 | OZEMPIC | 1MG | Novo Nordisk Canada Inc | Resolved | 2023-08-21 | 223 | Demand increase | 202216 |
2060 | N01BB02 | XYLOCAINE 2% | 20MG | Aspen Pharmacare Canada Inc. | Avoided | 2023-08-20 | 0 | Manufacturing distruption | 197732 |
2057 | N05BA09 | TEVA-CLOBAZAM | 10MG | Teva Canada Limited | Resolved | 2023-08-18 | 33 | Manufacturing distruption | 202490 |
2058 | C09BB04 | VIACORAM | 10MG 14MG | Servier Canada Inc | Resolved | 2023-08-18 | 138 | Shipping delay | 201791 |
2059 | L01CE02 | ONIVYDE | 4.3MG | Servier Canada Inc | Resolved | 2023-08-18 | Other | 202912 | |
2056 | L01AX03 | TEVA-TEMOZOLOMIDE | 100MG | Teva Canada Limited | Active | 2023-08-17 | Manufacturing distruption | 202295 | |
2046 | A09AA02 | CREON MINIMICROSPHERES 25 | 1600UNIT 25500UNIT 25000UNIT | Bgp Pharma Ulc | Resolved | 2023-08-17 | 39 | Other | 201970 |
2047 | A02BX02 | TEVA-SUCRALFATE | 1G | Teva Canada Limited | Resolved | 2023-08-17 | 24 | Manufacturing distruption | 202228 |
2048 | A07AA02 | TEVA-NYSTATIN | 100000UNIT | Teva Canada Limited | Resolved | 2023-08-17 | 125 | Manufacturing distruption | 202239 |
2049 | C03EA01 | TEVA-TRIAMTERENE/HCTZ | 25MG 50MG | Teva Canada Limited | Resolved | 2023-08-17 | 54 | Manufacturing distruption | 202200 |
2050 | J01XE01 | TEVA-NITROFURANTOIN | 50MG | Teva Canada Limited | Resolved | 2023-08-17 | 3 | Manufacturing distruption | 202246 |
2051 | C02CA04 | TEVA-DOXAZOSIN | 4MG | Teva Canada Limited | Resolved | 2023-08-17 | 24 | Manufacturing distruption | 202249 |
2052 | N07BC02 | METADOL | 25MG | Paladin Labs Inc. | Resolved | 2023-08-17 | 54 | Other | 204173 |
2053 | C10AA01 | TEVA-SIMVASTATIN | 5MG | Teva Canada Limited | Resolved | 2023-08-17 | 390 | Manufacturing distruption | 202252 |
2054 | N02AB03 | TEVA-FENTANYL | 50MCG | Teva Canada Limited | Resolved | 2023-08-17 | 34 | Manufacturing distruption | 202265 |
2055 | C09BA03 | TEVA-LISINOPRIL/HCTZ (TYPE Z) | 25MG 20MG | Teva Canada Limited | Resolved | 2023-08-17 | 13 | Manufacturing distruption | 202278 |
2039 | J02AX05 | MICAFUNGIN SODIUM FOR INJECTIO... | 50MG | Juno Pharmaceuticals Corp. | Resolved | 2023-08-16 | 16 | Other | 202027 |
2040 | J02AX05 | MICAFUNGIN SODIUM FOR INJECTIO... | 100MG | Juno Pharmaceuticals Corp. | Resolved | 2023-08-16 | 16 | Other | 202032 |
2041 | N01BB52 | XYLOCAINE 1% W EPINEPHRINE 1:2... | 5MCG 10MG | Aspen Pharmacare Canada Inc. | Resolved | 2023-08-16 | 138 | Manufacturing distruption | 200029 |
2042 | H02AB04 | DEPO-MEDROL 80 MG/ML | 80MG | Pfizer Canada Ulc | Resolved | 2023-08-16 | Manufacturing distruption | 201955 | |
2043 | N06AB10 | MYLAN-ESCITALOPRAM | 10MG | Mylan Pharmaceuticals Ulc | Resolved | 2023-08-16 | 6 | Manufacturing distruption | 196698 |
2044 | A02BC02 | MYLAN-PANTOPRAZOLE T | 40MG | Mylan Pharmaceuticals Ulc | Resolved | 2023-08-16 | 13 | Demand increase | 198991 |
2045 | N06BA04 | FOQUEST | 70MG | Elvium Life Sciences | Resolved | 2023-08-16 | 9 | Shipping delay | 201903 |
2027 | N05BA02 | CHLORDIAZEPOXIDE | 5MG | Aa Pharma Inc | Active | 2023-08-15 | Manufacturing distruption | 202741 | |
2028 | N05BA02 | CHLORDIAZEPOXIDE | 10MG | Aa Pharma Inc | Active | 2023-08-15 | Manufacturing distruption | 202738 | |
2031 | V01AA20 | ALLERGENIC EXTRACT NON POLLENS | 100000UNIT | Alk-Abello Inc | Active | 2023-08-15 | 869 | Shipping delay | 201856 |
2029 | R01AD59 | RYALTRIS | 25MCG 665MCG | Glenmark Specialty Sa | Resolved | 2023-08-15 | 104 | Manufacturing distruption | 201860 |
2030 | G03BA03 | DEPO-TESTOSTERONE INJ 100MG/ML | 100MG | Pfizer Canada Ulc | Resolved | 2023-08-15 | Manufacturing distruption | 199303 | |
2032 | N05BA02 | CHLORDIAZEPOXIDE | 25MG | Aa Pharma Inc | Resolved | 2023-08-15 | Ingredient shortage | 202731 | |
2033 | A02BC01 | APO-OMEPRAZOLE | 20MG | Apotex Inc | Resolved | 2023-08-15 | 31 | Manufacturing distruption | 202409 |
2034 | L01XX05 | APO-HYDROXYUREA | 500MG | Apotex Inc | Resolved | 2023-08-15 | 38 | Manufacturing distruption | 202406 |
2035 | N05AH03 | APO-OLANZAPINE | 2.5MG | Apotex Inc | Resolved | 2023-08-15 | 45 | Manufacturing distruption | 202403 |
2036 | N06DA04 | PAT-GALANTAMINE ER | 8MG | Janssen Inc | Resolved | 2023-08-15 | 59 | Demand increase | 202024 |
2037 | J01MA14 | APO-MOXIFLOXACIN | 400MG | Apotex Inc | Resolved | 2023-08-15 | Manufacturing distruption | 202397 | |
2038 | C08DA01 | APO-VERAP TABLET 120MG | 120MG | Apotex Inc | Resolved | 2023-08-15 | 45 | Manufacturing distruption | 202400 |
2011 | B05XA07 | CALCIJECT INJ 100MG/ML | 100MG | Omega Laboratories Limited | Resolved | 2023-08-14 | 116 | Demand increase | 201624 |
2012 | N01BB01 | SENSORCAINE | 2.5MG | Aspen Pharmacare Canada Inc. | Resolved | 2023-08-14 | 170 | Manufacturing distruption | 181243 |
2013 | B05XA01 | POTASSIUM CHLORIDE FOR INJECTI... | 20mEq | Omega Laboratories Limited | Resolved | 2023-08-14 | 154 | Manufacturing distruption | 201621 |
2014 | D07AD01 | TARO-CLOBETASOL CREAM USP, 0.0... | 0.05% | Taro Pharmaceuticals Inc | Resolved | 2023-08-14 | 46 | Manufacturing distruption | 202450 |
2015 | S01EA05 | ALPHAGAN P | 0.15% | Abbvie Corporation | Resolved | 2023-08-14 | 130 | Manufacturing distruption | 201801 |
2016 | S01EA05 | ALPHAGAN P | 0.15% | Abbvie Corporation | Resolved | 2023-08-14 | 109 | Manufacturing distruption | 201805 |
2017 | M01AB05 | SANDOZ-DICLOFENAC SR | 100MG | Sandoz Canada Incorporated | Resolved | 2023-08-14 | Manufacturing distruption | 201774 | |
2018 | C08CA01 | SANDOZ AMLODIPINE | 5MG | Sandoz Canada Incorporated | Resolved | 2023-08-14 | 25 | Demand increase | 201722 |
2019 | C08CA01 | SANDOZ AMLODIPINE | 5MG | Sandoz Canada Incorporated | Resolved | 2023-08-14 | 11 | Demand increase | 201725 |
2020 | C09BA03 | SANDOZ LISINOPRIL HCT | 12.5MG 20MG | Sandoz Canada Incorporated | Resolved | 2023-08-14 | 221 | Manufacturing practices | 201730 |
2021 | C09BA03 | SANDOZ LISINOPRIL HCT | 12.5MG 20MG | Sandoz Canada Incorporated | Resolved | 2023-08-14 | 200 | Manufacturing practices | 201735 |
2022 | N02CC03 | SANDOZ ZOLMITRIPTAN ODT | 2.5MG | Sandoz Canada Incorporated | Resolved | 2023-08-14 | 25 | Manufacturing distruption | 201769 |
2023 | C09CA07 | TELMISARTAN | 40MG | Sivem Pharmaceuticals Ulc | Resolved | 2023-08-14 | 245 | Shipping delay | 211180 |
2024 | C09DA07 | SANDOZ TELMISARTAN HCT | 25MG 80MG | Sandoz Canada Incorporated | Resolved | 2023-08-14 | 32 | Shipping delay | 201762 |
2025 | G04BD08 | SANDOZ SOLIFENACIN | 10MG | Sandoz Canada Incorporated | Resolved | 2023-08-14 | 67 | Manufacturing distruption | 201755 |
2026 | C09BA04 | SANDOZ PERINDOPRIL ERBUMINE/ I... | 0.625MG 2MG | Sandoz Canada Incorporated | Resolved | 2023-08-14 | 18 | Manufacturing distruption | 201744 |
2009 | D07CB05 | LOCACORTEN VIOFORM | 0.02% 3% | Paladin Pharma Inc. | Active | 2023-08-12 | Manufacturing distruption | 233533 | |
2008 | C05AA01 | ANUSOL-HC OINTMENT | 0.5% 0.5% | Church & Dwight Canada Corp | Resolved | 2023-08-12 | 31 | Demand increase | 202909 |
2010 | L01XA03 | OXALIPLATIN INJECTION, USP | 5MG | Dr Reddy's Laboratories Ltd | Resolved | 2023-08-12 | 415 | Shipping delay | 235198 |
2004 | N06AB03 | ACH-FLUOXETINE | 10MG | Accord Healthcare Inc | Resolved | 2023-08-11 | 29 | Shipping delay | 201604 |
2005 | C10AA05 | ACH-ATORVASTATIN CALCIUM | 20MG | Accord Healthcare Inc | Resolved | 2023-08-11 | 21 | Shipping delay | 201598 |
2006 | C10AA05 | ACH-ATORVASTATIN CALCIUM | 20MG | Accord Healthcare Inc | Resolved | 2023-08-11 | 6 | Shipping delay | 201601 |
2007 | N05CM18 | DEXMEDETOMIDINE HYDROCHLORIDE ... | 200MCG | Juno Pharmaceuticals Corp. | Resolved | 2023-08-11 | 81 | Manufacturing distruption | 201593 |
1974 | G03CA03 | ESTRING | 2MG | Pfizer Canada Ulc | Active | 2023-08-10 | Manufacturing distruption | 201581 | |
2000 | N06AX12 | TARO-BUPROPION XL | 150MG | Sun Pharma Canada Inc | Active | 2023-08-10 | 596 | Manufacturing distruption | 202122 |
2001 | N06AX12 | TARO-BUPROPION XL | 150MG | Sun Pharma Canada Inc | Active | 2023-08-10 | 596 | Manufacturing distruption | 202125 |
2002 | N06AX12 | TARO-BUPROPION XL | 300MG | Sun Pharma Canada Inc | Active | 2023-08-10 | 596 | Manufacturing distruption | 202116 |
2003 | N06AX12 | TARO-BUPROPION XL | 300MG | Sun Pharma Canada Inc | Active | 2023-08-10 | 596 | Manufacturing distruption | 202119 |
1972 | G04CA04 | PMS-SILODOSIN | 8MG | Pharmascience Inc | Resolved | 2023-08-10 | 18 | Manufacturing distruption | 201556 |
1973 | N06AX05 | PMS TRAZODONE HCL TAB 100MG | 100MG | Pharmascience Inc | Resolved | 2023-08-10 | 75 | Manufacturing distruption | 201559 |
1975 | B05XA08 | SODIUM ACETATE-OMEGA | 328MG | Omega Laboratories Limited | Resolved | 2023-08-10 | 120 | Demand increase | 201216 |
1976 | C10BX03 | CADUET | 20MG 5MG | Upjohn Canada Ulc | Resolved | 2023-08-10 | 41 | Manufacturing distruption | 201947 |
1977 | C09DA01 | HYZAAR | 12.5MG 100MG | Organon Canada Inc. | Resolved | 2023-08-10 | 43 | Shipping delay | 201570 |
1978 | C10AA05 | TARO-ATORVASTATIN | 10MG | Sun Pharma Canada Inc | Resolved | 2023-08-10 | 442 | Manufacturing distruption | 202095 |
1979 | C10AA05 | TARO-ATORVASTATIN | 10MG | Sun Pharma Canada Inc | Resolved | 2023-08-10 | 477 | Manufacturing distruption | 202098 |
1980 | C10AA05 | TARO-ATORVASTATIN | 20MG | Sun Pharma Canada Inc | Resolved | 2023-08-10 | 442 | Manufacturing distruption | 202101 |
1981 | C10AA05 | TARO-ATORVASTATIN | 20MG | Sun Pharma Canada Inc | Resolved | 2023-08-10 | 477 | Manufacturing distruption | 202104 |
1982 | C10AA05 | TARO-ATORVASTATIN | 40MG | Sun Pharma Canada Inc | Resolved | 2023-08-10 | 442 | Manufacturing distruption | 202107 |
1983 | C10AA05 | TARO-ATORVASTATIN | 40MG | Sun Pharma Canada Inc | Resolved | 2023-08-10 | 477 | Manufacturing distruption | 202110 |
1984 | C10AA05 | TARO-ATORVASTATIN | 80MG | Sun Pharma Canada Inc | Resolved | 2023-08-10 | 526 | Manufacturing distruption | 202113 |
1985 | C09CA04 | PMS-IRBESARTAN | 75MG | Pharmascience Inc | Resolved | 2023-08-10 | 14 | Manufacturing distruption | 201548 |
1986 | C09AA06 | PMS-QUINAPRIL | 20MG | Pharmascience Inc | Resolved | 2023-08-10 | 608 | Manufacturing distruption | 201551 |
1987 | C10AA07 | TARO-ROSUVASTATIN | 5MG | Sun Pharma Canada Inc | Resolved | 2023-08-10 | 92 | Manufacturing distruption | 202875 |
1988 | C10AA07 | TARO-ROSUVASTATIN | 5MG | Sun Pharma Canada Inc | Resolved | 2023-08-10 | 92 | Manufacturing distruption | 202878 |
1989 | C10AA07 | TARO-ROSUVASTATIN | 10MG | Sun Pharma Canada Inc | Resolved | 2023-08-10 | 92 | Manufacturing distruption | 202881 |
1990 | C10AA07 | TARO-ROSUVASTATIN | 10MG | Sun Pharma Canada Inc | Resolved | 2023-08-10 | 92 | Manufacturing distruption | 202884 |
1991 | C10AA07 | TARO-ROSUVASTATIN | 20MG | Sun Pharma Canada Inc | Resolved | 2023-08-10 | 92 | Manufacturing distruption | 202889 |
1992 | C10AA07 | TARO-ROSUVASTATIN | 20MG | Sun Pharma Canada Inc | Resolved | 2023-08-10 | 109 | Manufacturing distruption | 202893 |
1993 | C10AA07 | TARO-ROSUVASTATIN | 40MG | Sun Pharma Canada Inc | Resolved | 2023-08-10 | 176 | Manufacturing distruption | 202896 |
1994 | C10AA07 | TARO-ROSUVASTATIN | 40MG | Sun Pharma Canada Inc | Resolved | 2023-08-10 | 176 | Manufacturing distruption | 202899 |
1995 | C09CA06 | PMS-CANDESARTAN | 32MG | Pharmascience Inc | Resolved | 2023-08-10 | 76 | Manufacturing distruption | 201545 |
1996 | N02BF02 | TARO-PREGABALIN | 50MG | Sun Pharma Canada Inc | Resolved | 2023-08-10 | 323 | Manufacturing distruption | 202869 |
1997 | N02BF02 | TARO-PREGABALIN | 75MG | Sun Pharma Canada Inc | Resolved | 2023-08-10 | 99 | Manufacturing distruption | 202872 |
1998 | G04BD08 | TARO-SOLIFENACIN | 5MG | Sun Pharma Canada Inc | Resolved | 2023-08-10 | 442 | Manufacturing distruption | 202932 |
1999 | G04BD08 | TARO-SOLIFENACIN | 10MG | Sun Pharma Canada Inc | Resolved | 2023-08-10 | 568 | Manufacturing distruption | 202935 |
1970 | L01AX03 | TEVA-TEMOZOLOMIDE | 250MG | Teva Canada Limited | Active | 2023-08-09 | Manufacturing distruption | 206901 | |
1966 | N02AJ17 | TEVA-OXYCOCET | 325MG 5MG | Teva Canada Limited | Resolved | 2023-08-09 | 164 | Manufacturing distruption | 206371 |
1967 | N06AX02 | TEVA-TRYPTOPHAN | 500MG | Teva Canada Limited | Resolved | 2023-08-09 | 214 | Manufacturing distruption | 206383 |
1968 | G03GA05 | GONAL-F | 5.5MCG | Emd Serono, A Division Of Emd Inc., Canada | Resolved | 2023-08-09 | 40 | Manufacturing distruption | 201539 |
1969 | C09CA07 | TEVA-TELMISARTAN | 80MG | Teva Canada Limited | Resolved | 2023-08-09 | 275 | Manufacturing distruption | 206898 |
1971 | N06BA04 | FOQUEST | 35MG | Elvium Life Sciences | Resolved | 2023-08-09 | 9 | Shipping delay | 201413 |
1951 | C08DA01 | APO-VERAP TAB 80MG | 80MG | Apotex Inc | Resolved | 2023-08-08 | 52 | Manufacturing distruption | 201713 |
1952 | M01AB05 | APO-DICLO | 50MG | Apotex Inc | Resolved | 2023-08-08 | 59 | Manufacturing distruption | 201704 |
1953 | N03AX09 | APO-LAMOTRIGINE | 150MG | Apotex Inc | Resolved | 2023-08-08 | 59 | Manufacturing distruption | 201693 |
1954 | M01AE02 | APO-NAPROXEN EC TABLETS | 250MG | Apotex Inc | Resolved | 2023-08-08 | 108 | Manufacturing distruption | 201699 |
1955 | N06BA07 | APO-MODAFINIL | 100MG | Apotex Inc | Resolved | 2023-08-08 | 80 | Manufacturing distruption | 201707 |
1956 | C10AA07 | APO-ROSUVASTATIN | 20MG | Apotex Inc | Resolved | 2023-08-08 | 24 | Manufacturing distruption | 201710 |
1957 | B01AC04 | APO-CLOPIDOGREL | 300MG | Apotex Inc | Resolved | 2023-08-08 | 101 | Manufacturing distruption | 201716 |
1958 | H01AC01 | GENOTROPIN | 5.3MG | Pfizer Canada Ulc | Resolved | 2023-08-08 | 568 | Demand increase | 201496 |
1959 | H01AC01 | GENOTROPIN | 12MG | Pfizer Canada Ulc | Resolved | 2023-08-08 | 500 | Demand increase | 201499 |
1960 | H01AC01 | GENOTROPIN | 0.6MG | Pfizer Canada Ulc | Resolved | 2023-08-08 | 591 | Demand increase | 201502 |
1961 | H01AC01 | GENOTROPIN | 0.8MG | Pfizer Canada Ulc | Resolved | 2023-08-08 | Demand increase | 201505 | |
1962 | H01AC01 | GENOTROPIN | 1.2MG | Pfizer Canada Ulc | Resolved | 2023-08-08 | 500 | Demand increase | 201508 |
1963 | H01AC01 | GENOTROPIN | 1.6MG | Pfizer Canada Ulc | Resolved | 2023-08-08 | 591 | Demand increase | 201511 |
1964 | H01AC01 | GENOTROPIN | 1.8MG | Pfizer Canada Ulc | Resolved | 2023-08-08 | 500 | Demand increase | 201514 |
1965 | G04CB02 | APO-DUTASTERIDE | 0.5MG | Apotex Inc | Resolved | 2023-08-08 | 17 | Manufacturing distruption | 201696 |
1937 | B05BA03 | DEXTROSE INJECTION | 50% | Omega Laboratories Limited | Resolved | 2023-08-07 | 268 | Demand increase | 201190 |
1938 | N02AA03 | HYDROMORPHONE HP 10 | 10MG | Sandoz Canada Incorporated | Resolved | 2023-08-07 | 18 | Manufacturing distruption | 201259 |
1939 | C01BA02 | PROCAINAMIDE HYDROCHLORIDE INJ... | 100MG | Sandoz Canada Incorporated | Resolved | 2023-08-07 | 81 | Demand increase | 201280 |
1940 | A10BA02 | SANDOZ METFORMIN FC | 500MG | Sandoz Canada Incorporated | Resolved | 2023-08-07 | 4 | Manufacturing distruption | 201267 |
1941 | A10BB12 | SANDOZ GLIMEPIRIDE | 4MG | Sandoz Canada Incorporated | Resolved | 2023-08-07 | 102 | Ingredient shortage | 201250 |
1942 | A02BC02 | PANTOPRAZOLE SODIUM FOR INJECT... | 40MG | Sandoz Canada Incorporated | Resolved | 2023-08-07 | 53 | Manufacturing distruption | 201273 |
1943 | N05AH03 | SANDOZ OLANZAPINE | 2.5MG | Sandoz Canada Incorporated | Resolved | 2023-08-07 | 193 | Ingredient shortage | 201270 |
1944 | M05BA07 | SANDOZ RISEDRONATE | 35MG | Sandoz Canada Incorporated | Resolved | 2023-08-07 | 25 | Manufacturing distruption | 201283 |
1945 | C09DA04 | SANDOZ IRBESARTAN HCT | 12.5MG 300MG | Sandoz Canada Incorporated | Resolved | 2023-08-07 | 4 | Shipping delay | 201264 |
1946 | C10AA07 | SANDOZ ROSUVASTATIN | 5MG | Sandoz Canada Incorporated | Resolved | 2023-08-07 | 11 | Manufacturing distruption | 201286 |
1947 | C10BX03 | MYLAN-AMLODIPINE/ATORVASTATIN | 80MG 10MG | Mylan Pharmaceuticals Ulc | Resolved | 2023-08-07 | Manufacturing distruption | 217876 | |
1948 | N02BF02 | SANDOZ PREGABALIN | 150MG | Sandoz Canada Incorporated | Resolved | 2023-08-07 | 39 | Demand increase | 201277 |
1949 | G04BE09 | MYLAN-VARDENAFIL | 5MG | Mylan Pharmaceuticals Ulc | Resolved | 2023-08-07 | 29 | Manufacturing distruption | 196692 |
1950 | G04CA04 | SANDOZ SILODOSIN | 8MG | Sandoz Canada Incorporated | Resolved | 2023-08-07 | 4 | Manufacturing distruption | 201289 |
1936 | V08AA04 | CYSTO-CONRAY II | 172MG | Liebel-Flarsheim Company Llc | Active | 2023-08-05 | Manufacturing distruption | 198134 | |
1933 | R03BA01 | QVAR | 50MCG | Bausch Health, Canada Inc. | Resolved | 2023-08-04 | 65 | Demand increase | 186121 |
1934 | C02KX | TEVA-SILDENAFIL R | 20MG | Teva Canada Limited | Resolved | 2023-08-04 | Manufacturing distruption | 201207 | |
1935 | N01BB52 | XYLOCAINE 2% WITH EPINEPHRINE ... | 0.005MG 20MG | Aspen Pharmacare Canada Inc. | Resolved | 2023-08-04 | 150 | Manufacturing distruption | 183684 |
1920 | B05XA07 | CALCIUM CHLORIDE INJECTION USP | 100MG | Pfizer Canada Ulc | Active | 2023-08-03 | Manufacturing distruption | 200787 | |
1914 | B05XA07 | CALCIJECT INJ 100MG/ML | 100MG | Omega Laboratories Limited | Resolved | 2023-08-03 | 89 | Demand increase | 200770 |
1915 | B05XA09 | SODIUM PHOSPHATES INJECTION US... | 268MG 276MG | Sandoz Canada Incorporated | Resolved | 2023-08-03 | 92 | Other | 200953 |
1916 | R05DA09 | KOFFEX DM | 15MG | Teva Canada Limited | Resolved | 2023-08-03 | 180 | Manufacturing distruption | 200882 |
1917 | B05XA02 | SODIUM BICARBONATE INJECTION U... | 84MG | Pfizer Canada Ulc | Resolved | 2023-08-03 | Manufacturing distruption | 200801 | |
1918 | B05XA02 | SODIUM BICARBONATE INJECTION U... | 84MG | Pfizer Canada Ulc | Resolved | 2023-08-03 | Manufacturing distruption | 200804 | |
1919 | B05XA01 | POTASSIUM CHLORIDE FOR INJECTI... | 149MG | Pfizer Canada Ulc | Resolved | 2023-08-03 | Manufacturing distruption | 200798 | |
1921 | N07AA01 | NEOSTIGMINE OMEGA | 0.5MG | Omega Laboratories Limited | Resolved | 2023-08-03 | 238 | Manufacturing distruption | 200777 |
1922 | J01DB01 | TEVA-CEPHALEXIN 250 | 250MG | Teva Canada Limited | Resolved | 2023-08-03 | 271 | Manufacturing distruption | 200864 |
1923 | N02AJ17 | TEVA-OXYCOCET | 325MG 5MG | Teva Canada Limited | Resolved | 2023-08-03 | 17 | Manufacturing distruption | 200873 |
1924 | N02BF01 | TEVA-GABAPENTIN | 100MG | Teva Canada Limited | Resolved | 2023-08-03 | 27 | Manufacturing distruption | 200910 |
1925 | A02BA03 | FAMOTIDINE OMEGA -(WITHOUT PR... | 10MG | Omega Laboratories Limited | Resolved | 2023-08-03 | 15 | Demand increase | 200767 |
1926 | H01CB02 | OCTREOTIDE ACETATE OMEGA | 200MCG | Omega Laboratories Limited | Resolved | 2023-08-03 | 99 | Demand increase | 200780 |
1927 | C01BB01 | LIDOCAINE HYDROCHLORIDE INJECT... | 20MG | Pfizer Canada Ulc | Resolved | 2023-08-03 | Manufacturing distruption | 200795 | |
1928 | N03AF01 | TARO-CARBAMAZEPINE | 100MG | Taro Pharmaceuticals Inc | Resolved | 2023-08-03 | 169 | Manufacturing distruption | 215076 |
1929 | N05CD08 | MIDAZOLAM INJECTION USP | 5MG | Pfizer Canada Ulc | Resolved | 2023-08-03 | Manufacturing distruption | 200819 | |
1930 | N05AH04 | QUETIAPINE TABLETS | 300MG | Accord Healthcare Inc | Resolved | 2023-08-03 | 147 | Demand increase | 201097 |
1931 | A10BD07 | JANUMET XR | 1000MG 50MG | Merck Canada Inc | Resolved | 2023-08-03 | 85 | Demand increase | 197795 |
1932 | B05BA03 | DEXTROSE INJECTION USP | 500MG | Pfizer Canada Ulc | Resolved | 2023-08-03 | Manufacturing distruption | 200792 | |
1912 | C02AC01 | TEVA-CLONIDINE | 0.025MG | Teva Canada Limited | Active | 2023-08-02 | Manufacturing distruption | 206416 | |
1910 | C09BA03 | ZESTORETIC | 12.5MG 20MG | Searchlight Pharma Inc | Resolved | 2023-08-02 | 0 | Manufacturing practices | 200688 |
1911 | N01BB51 | MARCAINE E | 0.182MG 50MG | Pfizer Canada Ulc | Resolved | 2023-08-02 | Manufacturing distruption | 200041 | |
1913 | D10AF51 | CLINDOXYL ADV GEL | 1% 3% | Glaxosmithkline Inc | Resolved | 2023-08-02 | 226 | Demand increase | 200926 |
1896 | B05XA08 | SODIUM ACETATE INJECTION, USP | 328MG | Fresenius Kabi Canada Ltd | Active | 2023-08-01 | Manufacturing distruption | 193516 | |
1895 | V03AB14 | PROTAMINE SULFATE INJECTION, U... | 10MG | Fresenius Kabi Canada Ltd | Resolved | 2023-08-01 | 75 | Other | 200334 |
1897 | G04BD04 | PMS-OXYBUTYNIN | 5MG | Pharmascience Inc | Resolved | 2023-08-01 | 62 | Manufacturing distruption | 197987 |
1898 | C03BA11 | APO-INDAPAMIDE 2.5MG TABLETS | 2.5MG | Apotex Inc | Resolved | 2023-08-01 | 17 | Manufacturing distruption | 201168 |
1899 | L01CA01 | VINBLASTINE SULFATE INJECTION | 1MG | Pfizer Canada Ulc | Resolved | 2023-08-01 | Manufacturing distruption | 199446 | |
1900 | J07BG01 | IMOVAX RABIES RABIES VACCINE I... | 2.5UNIT | Sanofi Pasteur Limited | Resolved | 2023-08-01 | 29 | Demand increase | 200704 |
1901 | M01AE02 | APO-NAPROXEN | 500MG | Apotex Inc | Resolved | 2023-08-01 | 17 | Manufacturing distruption | 201171 |
1902 | G04BD10 | ENABLEX | 7.5MG | Searchlight Pharma Inc | Resolved | 2023-08-01 | 349 | Ingredient shortage | 194461 |
1903 | G04BD10 | ENABLEX | 15MG | Searchlight Pharma Inc | Resolved | 2023-08-01 | 411 | Ingredient shortage | 194549 |
1904 | N01BB02 | XYLOCAINE 2% | 20MG | Aspen Pharmacare Canada Inc. | Resolved | 2023-08-01 | 30 | Shipping delay | 181246 |
1905 | C02DD01 | NIPRIDE | 25MG | Pfizer Canada Ulc | Resolved | 2023-08-01 | Manufacturing distruption | 200680 | |
1906 | S01ED51 | APO-TRAVOPROST-TIMOP PQ | 0.5% 0.004% | Apotex Inc | Resolved | 2023-08-01 | 10 | Manufacturing distruption | 201162 |
1907 | G04BE08 | APO-TADALAFIL | 5MG | Apotex Inc | Resolved | 2023-08-01 | 38 | Manufacturing distruption | 201165 |
1908 | J02AX04 | CASPOFUNGIN FOR INJECTION | 50MG | Fresenius Kabi Canada Ltd | Resolved | 2023-08-01 | 212 | Manufacturing distruption | 201029 |
1909 | M03AB01 | SUCCINYLCHOLINE CHLORIDE INJEC... | 20MG | Dr Reddy's Laboratories Ltd | Resolved | 2023-08-01 | Ingredient shortage | 196970 | |
1878 | C07AB03 | ATENOLOL | 25MG | Pro Doc Limitee | Avoided | 2023-07-31 | 1 | Shipping delay | 188757 |
1869 | L01XK02 | ZEJULA | 100MG | Glaxosmithkline Inc | Resolved | 2023-07-31 | Other | 200374 | |
1870 | N03AX18 | LACOSAMIDE | 100MG | Sanis Health Inc | Resolved | 2023-07-31 | 91 | Manufacturing distruption | 200437 |
1871 | N02CC04 | RIZATRIPTAN | 10MG | Sanis Health Inc | Resolved | 2023-07-31 | Manufacturing distruption | 200440 | |
1872 | R01AD09 | MOMETASONE | 50MCG | Sanis Health Inc | Resolved | 2023-07-31 | Manufacturing distruption | 200446 | |
1873 | J01FF01 | CLINDAMYCIN INJECTION USP | 150MG | Sandoz Canada Incorporated | Resolved | 2023-07-31 | 18 | Manufacturing distruption | 200512 |
1874 | J01FF01 | CLINDAMYCIN INJECTION USP | 150MG | Sandoz Canada Incorporated | Resolved | 2023-07-31 | 11 | Manufacturing distruption | 200525 |
1875 | A10BA02 | SANDOZ METFORMIN FC | 500MG | Sandoz Canada Incorporated | Resolved | 2023-07-31 | 4 | Manufacturing distruption | 200539 |
1876 | M03BX01 | BACLOFEN | 10MG | Sanis Health Inc | Resolved | 2023-07-31 | Manufacturing distruption | 200471 | |
1877 | C01DA14 | PMS-ISMN | 60MG | Pharmascience Inc | Resolved | 2023-07-31 | 173 | Manufacturing distruption | 198000 |
1879 | C09DA04 | SANDOZ IRBESARTAN HCT | 25MG 300MG | Sandoz Canada Incorporated | Resolved | 2023-07-31 | 165 | Manufacturing distruption | 200534 |
1880 | N06AX05 | TRAZODONE | 50MG | Sanis Health Inc | Resolved | 2023-07-31 | 34 | Manufacturing distruption | 200429 |
1881 | C03CA01 | FUROSEMIDE | 20MG | Sanis Health Inc | Resolved | 2023-07-31 | 80 | Manufacturing distruption | 200426 |
1882 | N06AX16 | VENLAFAXINE XR | 37.5MG | Sanis Health Inc | Resolved | 2023-07-31 | Manufacturing distruption | 200434 | |
1883 | J01MA02 | AURO-CIPROFLOXACIN | 250MG | Auro Pharma Inc | Resolved | 2023-07-31 | 168 | Demand increase | 199590 |
1884 | J01FF01 | CLINDAMYCIN IV INFUSION | 12MG | Sandoz Canada Incorporated | Resolved | 2023-07-31 | 179 | Manufacturing distruption | 200495 |
1885 | G04BD08 | ACH-SOLIFENACIN SUCCINATE | 5MG | Accord Healthcare Inc | Resolved | 2023-07-31 | 25 | Demand increase | 201094 |
1886 | N06DA04 | GALANTAMINE ER | 8MG | Sanis Health Inc | Resolved | 2023-07-31 | 175 | Manufacturing distruption | 200443 |
1887 | G04CB02 | DUTASTERIDE | 0.5MG | Sanis Health Inc | Resolved | 2023-07-31 | 123 | Manufacturing distruption | 200468 |
1888 | G04BE08 | TADALAFIL | 5MG | Sanis Health Inc | Resolved | 2023-07-31 | 135 | Manufacturing distruption | 200477 |
1889 | G04BE08 | TADALAFIL | 20MG | Sanis Health Inc | Resolved | 2023-07-31 | 133 | Manufacturing distruption | 200474 |
1890 | G04BD08 | SOLIFENACIN | 10MG | Sanis Health Inc | Resolved | 2023-07-31 | 207 | Manufacturing distruption | 200459 |
1891 | N06BA09 | ATOMOXETINE | 100MG | Sanis Health Inc | Resolved | 2023-07-31 | Manufacturing distruption | 200453 | |
1892 | C09CA08 | OLMESARTAN | 20MG | Sanis Health Inc | Resolved | 2023-07-31 | 151 | Manufacturing distruption | 200465 |
1893 | C09CA08 | OLMESARTAN | 40MG | Sanis Health Inc | Resolved | 2023-07-31 | Manufacturing distruption | 200456 | |
1894 | N01AH01 | FENTANYL CITRATE INJECTION, US... | 50MCG | Fresenius Kabi Canada Ltd | Resolved | 2023-07-31 | 31 | Manufacturing distruption | 201035 |
1868 | C08CA05 | NIFEDIPINE | 5MG | Aa Pharma Inc | Avoided | 2023-07-28 | 10 | Manufacturing distruption | 198729 |
1865 | N05BA01 | DIASTAT | 5MG | Bausch Health, Canada Inc. | Resolved | 2023-07-28 | 175 | Other | 201529 |
1866 | G03GA08 | OVIDREL | 250MCG | Emd Serono, A Division Of Emd Inc., Canada | Resolved | 2023-07-28 | 11 | Shipping delay | 200401 |
1867 | R01AD12 | AVAMYS | 27.5MCG | Glaxosmithkline Inc | Resolved | 2023-07-28 | 34 | Manufacturing distruption | 200368 |
1864 | J02AC03 | TEVA-VORICONAZOLE | 200MG | Teva Canada Limited | Active | 2023-07-27 | Manufacturing distruption | 200307 | |
1853 | A02BX02 | TEVA-SUCRALFATE | 1G | Teva Canada Limited | Resolved | 2023-07-27 | 3 | Manufacturing distruption | 200210 |
1854 | N06AX05 | TEVA-TRAZODONE | 150MG | Teva Canada Limited | Resolved | 2023-07-27 | 136 | Manufacturing distruption | 200226 |
1855 | N06AX05 | TEVA-TRAZODONE | 100MG | Teva Canada Limited | Resolved | 2023-07-27 | 106 | Manufacturing distruption | 200223 |
1856 | A07AA02 | TEVA-NYSTATIN | 100000UNIT | Teva Canada Limited | Resolved | 2023-07-27 | 24 | Manufacturing distruption | 200231 |
1857 | N03AG04 | SABRIL | 500MG | Lundbeck Pharmaceuticals Llc | Resolved | 2023-07-27 | 293 | Manufacturing distruption | 189885 |
1858 | N01BB09 | NAROPIN | 10MG | Aspen Pharmacare Canada Inc. | Resolved | 2023-07-27 | 157 | Shipping delay | 200389 |
1859 | R05DA04 | CODEINE CONTIN 50MG CONTROLLED... | 50MG | Purdue Pharma | Resolved | 2023-07-27 | 50 | Shipping delay | 200267 |
1860 | M01AE02 | TEVA-NAPROXEN | 500MG | Teva Canada Limited | Resolved | 2023-07-27 | 14 | Manufacturing distruption | 200203 |
1861 | N02BF01 | TEVA-GABAPENTIN | 300MG | Teva Canada Limited | Resolved | 2023-07-27 | 75 | Manufacturing distruption | 200240 |
1862 | L04AK01 | TEVA-LEFLUNOMIDE | 20MG | Teva Canada Limited | Resolved | 2023-07-27 | 85 | Manufacturing distruption | 200249 |
1863 | C10AA07 | TEVA-ROSUVASTATIN | 10MG | Teva Canada Limited | Resolved | 2023-07-27 | 188 | Manufacturing distruption | 200290 |
1850 | C09CA01 | COZAAR | 50MG | Organon Canada Inc. | Resolved | 2023-07-26 | 2 | Shipping delay | 200377 |
1851 | C09CA08 | OLMETEC | 20MG | Organon Canada Inc. | Resolved | 2023-07-26 | 9 | Shipping delay | 200392 |
1852 | N01BB02 | XYLOCAINE 0.5% | 5MG | Aspen Pharmacare Canada Inc. | Resolved | 2023-07-26 | 209 | Manufacturing distruption | 174081 |
1841 | J01AA02 | APO-DOXYCYCLINE MR | 40MG | Apotex Inc | Resolved | 2023-07-25 | 17 | Manufacturing distruption | 200194 |
1842 | C08DB01 | APO-DILTIAZ CD | 120MG | Apotex Inc | Resolved | 2023-07-25 | 31 | Ingredient shortage | 200197 |
1843 | R03AC12 | SEREVENT DISKUS (50MCG/DOSE) | 50MCG | Glaxosmithkline Inc | Resolved | 2023-07-25 | 37 | Manufacturing distruption | 200371 |
1844 | G04BE03 | APO-SILDENAFIL | 50MG | Apotex Inc | Resolved | 2023-07-25 | 17 | Manufacturing distruption | 200188 |
1845 | C01CA17 | APO-MIDODRINE | 5MG | Apotex Inc | Resolved | 2023-07-25 | 73 | Manufacturing distruption | 200200 |
1846 | N05AH03 | APO-OLANZAPINE | 7.5MG | Apotex Inc | Resolved | 2023-07-25 | 66 | Manufacturing distruption | 200180 |
1847 | J05AB11 | APO-VALACYCLOVIR | 1000MG | Apotex Inc | Resolved | 2023-07-25 | 37 | Manufacturing distruption | 200191 |
1848 | G04CA02 | APO-TAMSULOSIN CR | 0.4MG | Apotex Inc | Resolved | 2023-07-25 | 486 | Manufacturing distruption | 200177 |
1849 | L02BX03 | APO-ABIRATERONE FILM COATED TA... | 500MG | Apotex Inc | Resolved | 2023-07-25 | 17 | Manufacturing distruption | 200185 |
1819 | N06AB06 | AURO-SERTRALINE | 25MG | Auro Pharma Inc | Avoided | 2023-07-24 | 38 | Demand increase | 199853 |
1820 | N06AB06 | AURO-SERTRALINE | 50MG | Auro Pharma Inc | Avoided | 2023-07-24 | 38 | Demand increase | 199857 |
1822 | C08CA01 | AURO-AMLODIPINE | 10MG | Auro Pharma Inc | Avoided | 2023-07-24 | 38 | Demand increase | 199919 |
1839 | J01CR02 | AURO-AMOXICLAV | 125MG 875MG | Auro Pharma Inc | Avoided | 2023-07-24 | 38 | Demand increase | 199925 |
1810 | A10BH01 | AURO-SITAGLIPTIN | 25MG | Auro Pharma Inc | Resolved | 2023-07-24 | 69 | Demand increase | 199888 |
1811 | A10BH01 | AURO-SITAGLIPTIN | 50MG | Auro Pharma Inc | Resolved | 2023-07-24 | 38 | Demand increase | 199883 |
1812 | A10BH01 | AURO-SITAGLIPTIN | 100MG | Auro Pharma Inc | Resolved | 2023-07-24 | 68 | Demand increase | 199880 |
1813 | C10AB05 | LIPIDIL EZ | 48MG | Bgp Pharma Ulc | Resolved | 2023-07-24 | Manufacturing distruption | 196707 | |
1814 | A10BA02 | APO-METFORMIN ER | 500MG | Apotex Inc | Resolved | 2023-07-24 | 88 | Manufacturing distruption | 201719 |
1815 | D01BA02 | AURO-TERBINAFINE | 250MG | Auro Pharma Inc | Resolved | 2023-07-24 | 129 | Demand increase | 199933 |
1816 | N05AH03 | SANDOZ OLANZAPINE ODT | 20MG | Sandoz Canada Incorporated | Resolved | 2023-07-24 | 53 | Ingredient shortage | 199817 |
1817 | C09DA06 | SANDOZ CANDESARTAN PLUS | 12.5MG 16MG | Sandoz Canada Incorporated | Resolved | 2023-07-24 | 368 | Demand increase | 199810 |
1818 | G04CA02 | SANDOZ TAMSULOSIN CR | 0.4MG | Sandoz Canada Incorporated | Resolved | 2023-07-24 | 4 | Manufacturing distruption | 199832 |
1821 | N06AB06 | AURO-SERTRALINE | 100MG | Auro Pharma Inc | Resolved | 2023-07-24 | 98 | Demand increase | 199850 |
1823 | J05AB11 | AURO-VALACYCLOVIR | 500MG | Auro Pharma Inc | Resolved | 2023-07-24 | 268 | Demand increase | 199910 |
1824 | J05AB11 | AURO-VALACYCLOVIR | 1000MG | Auro Pharma Inc | Resolved | 2023-07-24 | 373 | Demand increase | 199907 |
1825 | C10AA01 | AURO-SIMVASTATIN | 40MG | Auro Pharma Inc | Resolved | 2023-07-24 | 282 | Demand increase | 199874 |
1826 | C10AA01 | AURO-SIMVASTATIN | 10MG | Auro Pharma Inc | Resolved | 2023-07-24 | 69 | Demand increase | 199866 |
1827 | C10AA01 | AURO-SIMVASTATIN | 20MG | Auro Pharma Inc | Resolved | 2023-07-24 | 282 | Demand increase | 199871 |
1828 | C10AA01 | AURO-SIMVASTATIN | 80MG | Auro Pharma Inc | Resolved | 2023-07-24 | 235 | Other | 199877 |
1829 | J05AB14 | AURO-VALGANCICLOVIR | 450MG | Auro Pharma Inc | Resolved | 2023-07-24 | 237 | Demand increase | 199913 |
1830 | G04BE08 | AURO-TADALAFIL | 5MG | Auro Pharma Inc | Resolved | 2023-07-24 | 359 | Demand increase | 199894 |
1831 | G04BE08 | AURO-TADALAFIL | 10MG | Auro Pharma Inc | Resolved | 2023-07-24 | 13 | Demand increase | 199891 |
1832 | N06AX21 | MINT-DULOXETINE | 30MG | Mint Pharmaceuticals Inc | Resolved | 2023-07-24 | 165 | Manufacturing distruption | 199939 |
1833 | N06AX28 | FETZIMA | 120MG | Abbvie Corporation | Resolved | 2023-07-24 | 22 | Manufacturing distruption | 199542 |
1834 | N05AE04 | AURO-ZIPRASIDONE | 20MG | Auro Pharma Inc | Resolved | 2023-07-24 | 7 | Demand increase | 199916 |
1835 | C09CA07 | AURO-TELMISARTAN | 40MG | Auro Pharma Inc | Resolved | 2023-07-24 | 129 | Demand increase | 199899 |
1836 | C09CA07 | AURO-TELMISARTAN | 80MG | Auro Pharma Inc | Resolved | 2023-07-24 | 235 | Demand increase | 199904 |
1837 | N06BA01 | SANDOZ AMPHETAMINE XR | 20MG | Sandoz Canada Incorporated | Resolved | 2023-07-24 | 11 | Demand increase | 199806 |
1838 | J01CR02 | AURO-AMOXICLAV | 125MG 250MG | Auro Pharma Inc | Resolved | 2023-07-24 | Demand increase | 199922 | |
1840 | N02CC06 | AURO-ELETRIPTAN | 20MG | Auro Pharma Inc | Resolved | 2023-07-24 | 144 | Demand increase | 199928 |
1774 | N06AB05 | AURO-PAROXETINE | 30MG | Auro Pharma Inc | Avoided | 2023-07-21 | 41 | Demand increase | 199676 |
1797 | J01FF01 | AURO-CLINDAMYCIN | 300MG | Auro Pharma Inc | Avoided | 2023-07-21 | 41 | Demand increase | 199596 |
1767 | A04AA01 | AURO-ONDANSETRON ODT | 4MG | Auro Pharma Inc | Resolved | 2023-07-21 | 375 | Demand increase | 199673 |
1768 | B05XA01 | POTASSIUM CHLORIDE FOR INJECTI... | 20mEq | Omega Laboratories Limited | Resolved | 2023-07-21 | Demand increase | 199742 | |
1769 | R06AA02 | DIPHENIST 50MG/ML | 50MG | Omega Laboratories Limited | Resolved | 2023-07-21 | 41 | Demand increase | 199745 |
1770 | N07AA01 | NEOSTIGMINE OMEGA | 1MG | Omega Laboratories Limited | Resolved | 2023-07-21 | 224 | Manufacturing distruption | 199750 |
1771 | J01DC10 | AURO-CEFPROZIL | 500MG | Auro Pharma Inc | Resolved | 2023-07-21 | 41 | Demand increase | 199576 |
1772 | C09CA06 | ACH-CANDESARTAN | 32MG | Accord Healthcare Inc | Resolved | 2023-07-21 | 103 | Demand increase | 199644 |
1773 | N03AX09 | AURO-LAMOTRIGINE | 25MG | Auro Pharma Inc | Resolved | 2023-07-21 | 40 | Demand increase | 199653 |
1775 | N06AB03 | AURO-FLUOXETINE | 10MG | Auro Pharma Inc | Resolved | 2023-07-21 | 162 | Demand increase | 199614 |
1776 | N06AB03 | AURO-FLUOXETINE | 20MG | Auro Pharma Inc | Resolved | 2023-07-21 | 162 | Demand increase | 199617 |
1777 | C09AA05 | AURO-RAMIPRIL | 2.5MG | Auro Pharma Inc | Resolved | 2023-07-21 | 147 | Demand increase | 199693 |
1778 | C09AA05 | AURO-RAMIPRIL | 10MG | Auro Pharma Inc | Resolved | 2023-07-21 | 147 | Demand increase | 199690 |
1779 | N05AH04 | AURO-QUETIAPINE | 200MG | Auro Pharma Inc | Resolved | 2023-07-21 | 222 | Demand increase | 199685 |
1780 | N05AH04 | TEVA-QUETIAPINE XR | 50MG | Teva Canada Limited | Resolved | 2023-07-21 | 30 | Manufacturing distruption | 199554 |
1781 | N03AX14 | ACH-LEVETIRACETAM | 500MG | Accord Healthcare Inc | Resolved | 2023-07-21 | 48 | Demand increase | 199638 |
1782 | N06DA02 | AURO-DONEPEZIL | 5MG | Auro Pharma Inc | Resolved | 2023-07-21 | 72 | Demand increase | 199602 |
1783 | N06DA02 | AURO-DONEPEZIL | 10MG | Auro Pharma Inc | Resolved | 2023-07-21 | 40 | Demand increase | 199599 |
1784 | R03DC03 | AURO-MONTELUKAST | 10MG | Auro Pharma Inc | Resolved | 2023-07-21 | 71 | Demand increase | 199656 |
1785 | R03DC03 | AURO-MONTELUKAST | 10MG | Auro Pharma Inc | Resolved | 2023-07-21 | 71 | Demand increase | 199659 |
1786 | C07AG02 | AURO-CARVEDILOL | 3.125MG | Auro Pharma Inc | Resolved | 2023-07-21 | 56 | Demand increase | 199573 |
1787 | C07AG02 | AURO-CARVEDILOL | 12.5MG | Auro Pharma Inc | Resolved | 2023-07-21 | 56 | Demand increase | 199570 |
1788 | A10BX02 | AURO-REPAGLINIDE | 1MG | Auro Pharma Inc | Resolved | 2023-07-21 | 71 | Demand increase | 199696 |
1789 | N06DA04 | AURO-GALANTAMINE ER | 8MG | Auro Pharma Inc | Resolved | 2023-07-21 | 40 | Demand increase | 199647 |
1790 | N06DA04 | AURO-GALANTAMINE ER | 8MG | Auro Pharma Inc | Resolved | 2023-07-21 | 513 | Demand increase | 199650 |
1791 | N06DA04 | AURO-GALANTAMINE ER | 16MG | Auro Pharma Inc | Resolved | 2023-07-21 | 103 | Demand increase | 199636 |
1792 | N02BF01 | AURO-GABAPENTIN TABLETS | 800MG | Auro Pharma Inc | Resolved | 2023-07-21 | 41 | Demand increase | 199630 |
1793 | C08DB01 | TEVA-DILTIAZEM XC | 300MG | Teva Canada Limited | Resolved | 2023-07-21 | 173 | Manufacturing distruption | 199717 |
1794 | J01MA14 | AURO-MOXIFLOXACIN | 400MG | Auro Pharma Inc | Resolved | 2023-07-21 | 25 | Demand increase | 199662 |
1795 | B01AE06 | BIVALIRUDIN FOR INJECTION | 250MG | Fresenius Kabi Canada Ltd | Resolved | 2023-07-21 | 132 | Manufacturing distruption | 201032 |
1796 | N06AX21 | AURO-DULOXETINE | 60MG | Auro Pharma Inc | Resolved | 2023-07-21 | 193 | Demand increase | 199605 |
1798 | C09CA08 | AURO-OLMESARTAN | 20MG | Auro Pharma Inc | Resolved | 2023-07-21 | 315 | Demand increase | 199665 |
1799 | N07CA01 | AURO-BETAHISTINE | 8MG | Auro Pharma Inc | Resolved | 2023-07-21 | 41 | Demand increase | 199567 |
1800 | C10AA05 | ACH-ATORVASTATIN CALCIUM | 10MG | Accord Healthcare Inc | Resolved | 2023-07-21 | 14 | Shipping delay | 199633 |
1801 | C09AA04 | AURO-PERINDOPRIL | 8MG | Auro Pharma Inc | Resolved | 2023-07-21 | 498 | Demand increase | 199682 |
1802 | N05AX12 | AURO-ARIPIPRAZOLE | 2MG | Auro Pharma Inc | Resolved | 2023-07-21 | 25 | Demand increase | 199562 |
1803 | G04CB02 | AURO-DUTASTERIDE | 0.5MG | Auro Pharma Inc | Resolved | 2023-07-21 | 160 | Demand increase | 199608 |
1804 | G04CB02 | AURO-DUTASTERIDE | 0.5MG | Auro Pharma Inc | Resolved | 2023-07-21 | 193 | Demand increase | 199611 |
1805 | N06BA04 | FOQUEST | 85MG | Elvium Life Sciences | Resolved | 2023-07-21 | 35 | Shipping delay | 199441 |
1806 | J01DB01 | AURO-CEPHALEXIN | 250MG | Auro Pharma Inc | Resolved | 2023-07-21 | 132 | Demand increase | 199582 |
1807 | J01CR02 | AURO-AMOXICLAV | 125MG 500MG | Auro Pharma Inc | Resolved | 2023-07-21 | 238 | Demand increase | 199557 |
1808 | C09DA08 | AURO-OLMESARTAN HCTZ | 12.5MG 40MG | Auro Pharma Inc | Resolved | 2023-07-21 | 284 | Demand increase | 199670 |
1809 | J01DB01 | AURO-CEPHALEXIN | 250MG | Auro Pharma Inc | Resolved | 2023-07-21 | 41 | Demand increase | 199587 |
1759 | N05AH03 | TEVA-OLANZAPINE | 10MG | Teva Canada Limited | Avoided | 2023-07-20 | 31 | Manufacturing distruption | 199365 |
1749 | J07AG01 | ACT-HIB | 30MCG 10MCG | Sanofi Pasteur Limited | Resolved | 2023-07-20 | 22 | Other | 199936 |
1750 | D07AD01 | TEVA-CLOBETASOL | 0.05% | Teva Canada Limited | Resolved | 2023-07-20 | 41 | Manufacturing distruption | 199313 |
1751 | J01FF01 | DALACIN C PHOSPHATE | 150MG | Pfizer Canada Ulc | Resolved | 2023-07-20 | Manufacturing distruption | 197701 | |
1752 | M01AE11 | TEVA-TIAPROFENIC ACID | 200MG | Teva Canada Limited | Resolved | 2023-07-20 | 82 | Manufacturing distruption | 199360 |
1753 | C03CA01 | TEVA-FUROSEMIDE | 20MG | Teva Canada Limited | Resolved | 2023-07-20 | 31 | Manufacturing distruption | 199284 |
1754 | B05XA08 | SODIUM ACETATE-OMEGA | 328MG | Omega Laboratories Limited | Resolved | 2023-07-20 | Demand increase | 198687 | |
1755 | M01AE02 | TEVA-NAPROXEN | 500MG | Teva Canada Limited | Resolved | 2023-07-20 | 10 | Manufacturing distruption | 199306 |
1756 | B01AA03 | TARO-WARFARIN | 2.5MG | Taro Pharmaceuticals Inc | Resolved | 2023-07-20 | 127 | Manufacturing distruption | 205186 |
1757 | B01AA03 | TARO-WARFARIN | 2.5MG | Taro Pharmaceuticals Inc | Resolved | 2023-07-20 | 252 | Manufacturing distruption | 222110 |
1758 | N03AX11 | TEVA-TOPIRAMATE | 100MG | Teva Canada Limited | Resolved | 2023-07-20 | 62 | Manufacturing distruption | 199345 |
1760 | N01BB02 | XYLOCAINE 1% | 10MG | Aspen Pharmacare Canada Inc. | Resolved | 2023-07-20 | 133 | Manufacturing distruption | 181249 |
1761 | N02CC02 | TEVA-NARATRIPTAN | 1MG | Teva Canada Limited | Resolved | 2023-07-20 | 41 | Manufacturing distruption | 199387 |
1762 | N05AH04 | ACT QUETIAPINE | 100MG | Teva Canada Limited | Resolved | 2023-07-20 | 82 | Manufacturing distruption | 199390 |
1763 | C09CA07 | TEVA-TELMISARTAN | 40MG | Teva Canada Limited | Resolved | 2023-07-20 | 275 | Manufacturing distruption | 199393 |
1764 | C10AA07 | TEVA-ROSUVASTATIN | 10MG | Teva Canada Limited | Resolved | 2023-07-20 | 195 | Manufacturing distruption | 199398 |
1765 | J01XE01 | PMS-NITROFURANTOIN BID | 100MG | Pharmascience Inc | Resolved | 2023-07-20 | 57 | Manufacturing distruption | 198483 |
1766 | G01AF02 | CLOTRIMADERM VAGINAL 6 | 1% | Taro Pharmaceuticals Inc | Resolved | 2023-07-20 | 120 | Manufacturing distruption | 204793 |
1744 | L01XX05 | HYDREA | 500MG | Cheplapharm Arzneimittel Gmbh | Resolved | 2023-07-19 | 65 | Manufacturing distruption | 198947 |
1745 | G04BE03 | TEVA-SILDENAFIL | 50MG | Teva Canada Limited | Resolved | 2023-07-19 | 144 | Manufacturing distruption | 206419 |
1746 | C09AA02 | TARO-ENALAPRIL | 16MG | Sun Pharma Canada Inc | Resolved | 2023-07-19 | 114 | Manufacturing distruption | 202131 |
1747 | N04BX02 | TEVA-ENTACAPONE | 200MG | Teva Canada Limited | Resolved | 2023-07-19 | 32 | Manufacturing distruption | 199190 |
1748 | C08DB01 | TEVA-DILTIAZEM XC | 240MG | Teva Canada Limited | Resolved | 2023-07-19 | 144 | Manufacturing distruption | 199199 |
1712 | J01DB01 | CEPHALEXIN | 500MG | Sanis Health Inc | Resolved | 2023-07-18 | 148 | Manufacturing distruption | 198745 |
1713 | C10AB04 | TEVA-GEMFIBROZIL | 600MG | Teva Canada Limited | Resolved | 2023-07-18 | 33 | Manufacturing distruption | 198960 |
1714 | N06AX05 | APO-TRAZODONE TABLETS 50MG | 50MG | Apotex Inc | Resolved | 2023-07-18 | 80 | Manufacturing distruption | 199521 |
1715 | A07DA03 | TEVA-LOPERAMIDE | 2MG | Teva Canada Limited | Resolved | 2023-07-18 | 12 | Manufacturing distruption | 198957 |
1716 | N06AX05 | TEVA-TRAZODONE | 100MG | Teva Canada Limited | Resolved | 2023-07-18 | 115 | Manufacturing distruption | 199015 |
1717 | J01XE01 | TEVA-NITROFURANTOIN | 100MG | Teva Canada Limited | Resolved | 2023-07-18 | 43 | Manufacturing distruption | 199026 |
1718 | N03AG01 | APO-DIVALPROEX | 125MG | Apotex Inc | Resolved | 2023-07-18 | 45 | Manufacturing distruption | 199530 |
1719 | N03AG01 | APO-DIVALPROEX | 250MG | Apotex Inc | Resolved | 2023-07-18 | 101 | Manufacturing distruption | 199533 |
1720 | N02BF01 | TEVA-GABAPENTIN | 600MG | Teva Canada Limited | Resolved | 2023-07-18 | 33 | Manufacturing distruption | 199053 |
1721 | N06AB08 | ACT FLUVOXAMINE | 50MG | Teva Canada Limited | Resolved | 2023-07-18 | 246 | Manufacturing distruption | 199092 |
1722 | D07AC13 | TARO-MOMETASONE LOTION | 0.1% | Taro Pharmaceuticals Inc | Resolved | 2023-07-18 | 59 | Manufacturing distruption | 202465 |
1723 | A04AA01 | APO-ONDANSETRON | 4MG | Apotex Inc | Resolved | 2023-07-18 | 234 | Manufacturing distruption | 199536 |
1724 | C09BA03 | TEVA-LISINOPRIL/HCTZ (TYPE Z) | 12.5MG 10MG | Teva Canada Limited | Resolved | 2023-07-18 | 43 | Manufacturing distruption | 199103 |
1725 | C10AA05 | TARO-ATORVASTATIN | 80MG | Sun Pharma Canada Inc | Resolved | 2023-07-18 | 549 | Manufacturing distruption | 199111 |
1726 | N05AH04 | ACT QUETIAPINE | 100MG | Teva Canada Limited | Resolved | 2023-07-18 | 84 | Manufacturing distruption | 199106 |
1727 | N06BA09 | APO-ATOMOXETINE | 80MG | Apotex Inc | Resolved | 2023-07-18 | 38 | Manufacturing distruption | 199524 |
1728 | N06DA03 | APO-RIVASTIGMINE | 1.5MG | Apotex Inc | Resolved | 2023-07-18 | 185 | Manufacturing distruption | 199518 |
1729 | J01CA04 | AMOXICILLIN | 250MG | Sanis Health Inc | Resolved | 2023-07-18 | 108 | Manufacturing distruption | 198944 |
1730 | J01CA04 | AMOXICILLIN | 250MG | Sanis Health Inc | Resolved | 2023-07-18 | 45 | Manufacturing distruption | 198913 |
1731 | N03AX14 | LEVETIRACETAM | 500MG | Sanis Health Inc | Resolved | 2023-07-18 | Manufacturing distruption | 198904 | |
1732 | N03AX14 | LEVETIRACETAM | 750MG | Sanis Health Inc | Resolved | 2023-07-18 | 38 | Manufacturing distruption | 198907 |
1733 | N06AB06 | SERTRALINE | 50MG | Sanis Health Inc | Resolved | 2023-07-18 | 85 | Manufacturing distruption | 198926 |
1734 | A02BC04 | RABEPRAZOLE EC | 20MG | Sanis Health Inc | Resolved | 2023-07-18 | Manufacturing distruption | 198918 | |
1735 | A02BC03 | LANSOPRAZOLE | 30MG | Sanis Health Inc | Resolved | 2023-07-18 | Manufacturing distruption | 198933 | |
1736 | N05AH03 | APO-OLANZAPINE ODT | 20MG | Apotex Inc | Resolved | 2023-07-18 | 108 | Ingredient shortage | 199515 |
1737 | D07AC13 | TARO-MOMETASONE CREAM | 0.1% | Taro Pharmaceuticals Inc | Resolved | 2023-07-18 | 59 | Manufacturing distruption | 202473 |
1738 | C09CA06 | CANDESARTAN | 4MG | Sanis Health Inc | Resolved | 2023-07-18 | 105 | Manufacturing distruption | 198936 |
1739 | N02CC03 | ZOLMITRIPTAN ODT | 2.5MG | Sanis Health Inc | Resolved | 2023-07-18 | 101 | Manufacturing distruption | 198939 |
1740 | C09BA05 | TARO-RAMIPRIL HCTZ | 12.5MG 5MG | Sun Pharma Canada Inc | Resolved | 2023-07-18 | 213 | Manufacturing distruption | 199137 |
1741 | C08CA02 | APO-FELODIPINE | 5MG | Apotex Inc | Resolved | 2023-07-18 | 17 | Manufacturing distruption | 199527 |
1742 | N06BA09 | ATOMOXETINE | 10MG | Sanis Health Inc | Resolved | 2023-07-18 | 45 | Manufacturing distruption | 198910 |
1743 | N06BA09 | ATOMOXETINE | 60MG | Sanis Health Inc | Resolved | 2023-07-18 | 45 | Manufacturing distruption | 198921 |
1708 | J01MA02 | PMS-CIPROFLOXACIN XL | 500MG | Pharmascience Inc | Active | 2023-07-17 | 1057 | Manufacturing distruption | 194525 |
1693 | A10BA02 | GLUCOPHAGE | 500MG | Sanofi-Aventis Canada Inc | Resolved | 2023-07-17 | 45 | Other | 199227 |
1694 | P01BA03 | PRIMAQUINE | 26.3MG | Sanofi-Aventis Canada Inc | Resolved | 2023-07-17 | 11 | Other | 199221 |
1695 | C07AB03 | ATENOLOL | 50MG | Sivem Pharmaceuticals Ulc | Resolved | 2023-07-17 | Other | 211134 | |
1696 | S01AA12 | SANDOZ TOBRAMYCIN | 0.3% | Sandoz Canada Incorporated | Resolved | 2023-07-17 | 4 | Demand increase | 198853 |
1697 | L04AK01 | ARAVA | 10MG | Sanofi-Aventis Canada Inc | Resolved | 2023-07-17 | 133 | Demand increase | 199224 |
1698 | A03AA05 | TRIMEBUTINE | 100MG | Aa Pharma Inc | Resolved | 2023-07-17 | 1117 | Manufacturing distruption | 198716 |
1699 | C08CA01 | SANDOZ AMLODIPINE | 5MG | Sandoz Canada Incorporated | Resolved | 2023-07-17 | 4 | Shipping delay | 198805 |
1700 | S01EA05 | BRIMONIDINE P | 0.15% | Aa Pharma Inc | Resolved | 2023-07-17 | 88 | Manufacturing distruption | 198719 |
1701 | A02BC04 | SANDOZ RABEPRAZOLE | 10MG | Sandoz Canada Incorporated | Resolved | 2023-07-17 | 25 | Manufacturing distruption | 198817 |
1702 | N06AB06 | SERTRALINE | 25MG | Sanis Health Inc | Resolved | 2023-07-17 | 46 | Manufacturing distruption | 198792 |
1703 | N05AH03 | OLANZAPINE | 15MG | Sanis Health Inc | Resolved | 2023-07-17 | 46 | Manufacturing distruption | 198789 |
1704 | C10AA01 | SIMVASTATIN | 40MG | Sivem Pharmaceuticals Ulc | Resolved | 2023-07-17 | 221 | Shipping delay | 211168 |
1705 | C09CA06 | CANDESARTAN | 16MG | Sanis Health Inc | Resolved | 2023-07-17 | 46 | Manufacturing distruption | 198795 |
1706 | C09DA07 | SANDOZ TELMISARTAN HCT | 12.5MG 80MG | Sandoz Canada Incorporated | Resolved | 2023-07-17 | 18 | Demand increase | 198849 |
1707 | G04BE03 | SILDENAFIL | 100MG | Sanis Health Inc | Resolved | 2023-07-17 | Manufacturing distruption | 198785 | |
1709 | G04CA04 | SANDOZ SILODOSIN | 4MG | Sandoz Canada Incorporated | Resolved | 2023-07-17 | 25 | Demand increase | 198824 |
1710 | A10BD07 | SANDOZ SITAGLIPTIN-METFORMIN | 850MG 50MG | Sandoz Canada Incorporated | Resolved | 2023-07-17 | 18 | Ingredient shortage | 198833 |
1711 | A10BD07 | SANDOZ SITAGLIPTIN-METFORMIN | 1000MG 50MG | Sandoz Canada Incorporated | Resolved | 2023-07-17 | 39 | Ingredient shortage | 198838 |
1690 | D03BA02 | SANTYL | 250UNIT | Smith & Nephew Inc | Active | 2023-07-15 | 808 | Manufacturing distruption | 193768 |
1692 | N01BB52 | XYLOCAINE 1% W EPINEPHRINE 1:1... | 0.01MG 10MG | Aspen Pharmacare Canada Inc. | Avoided | 2023-07-15 | 77 | Manufacturing distruption | 183689 |
1691 | C07AB03 | TENORMIN | 50MG | Searchlight Pharma Inc | Resolved | 2023-07-15 | 228 | Manufacturing practices | 201887 |
1687 | J01DB01 | CEPHALEXIN | 250MG | Sanis Health Inc | Resolved | 2023-07-14 | 239 | Manufacturing distruption | 198742 |
1688 | J01XE01 | NITROFURANTOIN | 50MG | Aa Pharma Inc | Resolved | 2023-07-14 | 54 | Manufacturing distruption | 198722 |
1689 | D02AC | STERILE LIGHT MINERAL OIL 100% | 100% | Omega Laboratories Limited | Resolved | 2023-07-14 | 112 | Manufacturing distruption | 198678 |
1679 | J01CF02 | TEVA-CLOXACILLIN | 500MG | Teva Canada Limited | Resolved | 2023-07-13 | 38 | Manufacturing distruption | 198587 |
1680 | N02AJ17 | TEVA-OXYCOCET | 325MG 5MG | Teva Canada Limited | Resolved | 2023-07-13 | 38 | Manufacturing distruption | 198602 |
1681 | R03BA07 | ASMANEX TWISTHALER | 400MCG | Organon Canada Inc. | Resolved | 2023-07-13 | 7 | Shipping delay | 198802 |
1682 | B01AB05 | LOVENOX | 60MG | Sanofi-Aventis Canada Inc | Resolved | 2023-07-13 | 15 | Other | 198185 |
1683 | B02BD04 | RIXUBIS | 1000UNIT | Takeda Canada Inc | Resolved | 2023-07-13 | 49 | Other | 198631 |
1684 | B02BD04 | RIXUBIS | 2000UNIT | Takeda Canada Inc | Resolved | 2023-07-13 | 49 | Other | 198627 |
1685 | B02BD04 | RIXUBIS | 3000UNIT | Takeda Canada Inc | Resolved | 2023-07-13 | 49 | Other | 198634 |
1686 | C10AB05 | TARO-FENOFIBRATE E | 145MG | Sun Pharma Canada Inc | Resolved | 2023-07-13 | 568 | Manufacturing distruption | 237296 |
1671 | N01BB52 | LIDOCAINE HYDROCHLORIDE AND EP... | 0.01MG 20MG | Pfizer Canada Ulc | Resolved | 2023-07-12 | Manufacturing distruption | 198413 | |
1672 | M03AB01 | QUELICIN | 20MG | Pfizer Canada Ulc | Resolved | 2023-07-12 | Manufacturing distruption | 198410 | |
1673 | G03BA03 | ANDROGEL | 1% | Bgp Pharma Ulc | Resolved | 2023-07-12 | 34 | Demand increase | 196710 |
1674 | N06AX23 | PRISTIQ | 100MG | Pfizer Canada Ulc | Resolved | 2023-07-12 | 106 | Manufacturing distruption | 195945 |
1675 | L01FX04 | YERVOY | 5MG | Bristol-Myers Squibb Canada | Resolved | 2023-07-12 | Manufacturing distruption | 198397 | |
1676 | L01AX03 | ACH-TEMOZOLOMIDE | 20MG | Accord Healthcare Inc | Resolved | 2023-07-12 | 261 | Shipping delay | 198405 |
1677 | N06AX21 | TEVA-DULOXETINE | 60MG | Teva Canada Limited | Resolved | 2023-07-12 | 151 | Manufacturing distruption | 198391 |
1678 | L04AE01 | TEVA-FINGOLIMOD | 0.5MG | Teva Canada Limited | Resolved | 2023-07-12 | Manufacturing distruption | 198394 | |
1656 | S01BC03 | APO-DICLOFENAC OPHTHALMIC | 0.1% | Apotex Inc | Active | 2023-07-11 | Manufacturing distruption | 198514 | |
1658 | R03BB01 | TEVA-IPRATROPIUM STERINEBS | 250MCG | Teva Canada Limited | Active | 2023-07-11 | Manufacturing distruption | 198292 | |
1657 | N06AX05 | TEVA-TRAZODONE | 50MG | Teva Canada Limited | Resolved | 2023-07-11 | 193 | Manufacturing distruption | 198283 |
1659 | N03AG01 | APO-DIVALPROEX | 500MG | Apotex Inc | Resolved | 2023-07-11 | 73 | Manufacturing distruption | 198500 |
1660 | C07AG01 | APO-LABETALOL | 200MG | Apotex Inc | Resolved | 2023-07-11 | 17 | Manufacturing distruption | 198511 |
1661 | D10AF51 | BENZACLIN | 5% 1% | Bausch Health, Canada Inc. | Resolved | 2023-07-11 | 22 | Demand increase | 193931 |
1662 | C10AA01 | TEVA-SIMVASTATIN | 5MG | Teva Canada Limited | Resolved | 2023-07-11 | 427 | Manufacturing distruption | 198303 |
1663 | C10AA01 | TEVA-SIMVASTATIN | 20MG | Teva Canada Limited | Resolved | 2023-07-11 | 345 | Manufacturing distruption | 198306 |
1664 | C10AA01 | TEVA-SIMVASTATIN | 20MG | Teva Canada Limited | Resolved | 2023-07-11 | 365 | Manufacturing distruption | 198309 |
1665 | M01AC06 | TEVA-MELOXICAM | 7.5MG | Teva Canada Limited | Resolved | 2023-07-11 | 71 | Manufacturing distruption | 198312 |
1666 | N05AH03 | TEVA-OLANZAPINE | 5MG | Teva Canada Limited | Resolved | 2023-07-11 | 19 | Manufacturing distruption | 198319 |
1667 | N05AH03 | APO-OLANZAPINE | 10MG | Apotex Inc | Resolved | 2023-07-11 | 66 | Manufacturing distruption | 198518 |
1668 | A02BC03 | APO-LANSOPRAZOLE | 30MG | Apotex Inc | Resolved | 2023-07-11 | 122 | Manufacturing distruption | 198525 |
1669 | C09BA04 | APO-PERINDOPRIL-INDAPAMIDE | 1.25MG 4MG | Apotex Inc | Resolved | 2023-07-11 | 164 | Manufacturing distruption | 198505 |
1670 | N02CC07 | APO-FROVATRIPTAN | 2.5MG | Apotex Inc | Resolved | 2023-07-11 | 10 | Manufacturing distruption | 198508 |
1646 | C09AA06 | PMS-QUINAPRIL | 5MG | Pharmascience Inc | Active | 2023-07-10 | 875 | Manufacturing distruption | 198075 |
1654 | N06BA04 | FOQUEST | 85MG | Elvium Life Sciences | Avoided | 2023-07-10 | 4 | Shipping delay | 196767 |
1635 | H02AB02 | DEXAMETHASONE SOD PHOSPH INJ 1... | 10MG | Sandoz Canada Incorporated | Resolved | 2023-07-10 | 46 | Demand increase | 197961 |
1636 | N01BB02 | XYLOCAINE SPRAY | 10MG | Aspen Pharmacare Canada Inc. | Resolved | 2023-07-10 | 174 | Manufacturing distruption | 197729 |
1637 | C08DA01 | VERAPAMIL HYDROCHLORIDE INJECT... | 2.5MG | Sandoz Canada Incorporated | Resolved | 2023-07-10 | 18 | Manufacturing distruption | 198005 |
1638 | C09DA01 | HYZAAR | 12.5MG 50MG | Organon Canada Inc. | Resolved | 2023-07-10 | 60 | Shipping delay | 198083 |
1639 | C09DA01 | HYZAAR DS | 25MG 100MG | Organon Canada Inc. | Resolved | 2023-07-10 | 60 | Shipping delay | 198086 |
1640 | C01BD01 | AMIODARONE HYDROCHLORIDE FOR I... | 50MG | Sandoz Canada Incorporated | Resolved | 2023-07-10 | 4 | Manufacturing distruption | 197956 |
1641 | G03CA03 | ESTRADOT 25 | 25MCG | Sandoz Canada Incorporated | Resolved | 2023-07-10 | 46 | Shipping delay | 197971 |
1642 | M01AB05 | PMS-DICLOFENAC | 25MG | Pharmascience Inc | Resolved | 2023-07-10 | 144 | Manufacturing distruption | 198008 |
1643 | B01AB01 | HEPARIN SODIUM INJECTION USP ... | 1000UNIT | Sandoz Canada Incorporated | Resolved | 2023-07-10 | 46 | Demand increase | 197978 |
1644 | N05AH03 | PMS-OLANZAPINE | 15MG | Pharmascience Inc | Resolved | 2023-07-10 | 99 | Manufacturing distruption | 198015 |
1645 | G04CA02 | SANDOZ TAMSULOSIN CR | 0.4MG | Sandoz Canada Incorporated | Resolved | 2023-07-10 | 18 | Demand increase | 197996 |
1647 | C09AA06 | PMS-QUINAPRIL | 10MG | Pharmascience Inc | Resolved | 2023-07-10 | 639 | Manufacturing distruption | 198078 |
1648 | M01AB55 | GD-DICLOFENAC/MISOPROSTOL 75 | 200MCG 75MG | Genmed A Division Of Pfizer Canada Ulc | Resolved | 2023-07-10 | 50 | Demand increase | 198120 |
1649 | J05AB11 | PMS-VALACYCLOVIR | 1000MG | Pharmascience Inc | Resolved | 2023-07-10 | 179 | Manufacturing distruption | 198027 |
1650 | N02BF02 | SANDOZ PREGABALIN | 50MG | Sandoz Canada Incorporated | Resolved | 2023-07-10 | 25 | Manufacturing distruption | 197984 |
1651 | N02BF02 | SANDOZ PREGABALIN | 50MG | Sandoz Canada Incorporated | Resolved | 2023-07-10 | 25 | Manufacturing distruption | 197990 |
1652 | M02AA15 | TARO-DICLOFENAC | 1.5% | Taro Pharmaceuticals Inc | Resolved | 2023-07-10 | 109 | Manufacturing distruption | 202456 |
1653 | C01BC03 | MYLAN-PROPAFENONE | 150MG | Mylan Pharmaceuticals Ulc | Resolved | 2023-07-10 | 1 | Other | 196695 |
1655 | D06BB10 | TARO-IMIQUIMOD PUMP | 5% | Taro Pharmaceuticals Inc | Resolved | 2023-07-10 | 137 | Manufacturing distruption | 202459 |
1634 | C09CA08 | ACH-OLMESARTAN | 20MG | Accord Healthcare Inc | Avoided | 2023-07-08 | Demand increase | 164326 | |
1624 | H01AC01 | NORDITROPIN NORDIFLEX | 15MG | Novo Nordisk Canada Inc | Resolved | 2023-07-07 | Other | 194906 | |
1625 | A09AA02 | COTAZYM | 35000UNIT 40000UNIT 10000UNIT | Organon Canada Inc. | Resolved | 2023-07-07 | 63 | Shipping delay | 197801 |
1626 | R03DC03 | SINGULAIR | 4MG | Organon Canada Inc. | Resolved | 2023-07-07 | 91 | Shipping delay | 196127 |
1627 | S01BC05 | KETOROLAC | 0.5% | Aa Pharma Inc | Resolved | 2023-07-07 | 88 | Manufacturing distruption | 198735 |
1628 | M05BA04 | ACH-ALENDRONATE | 5MG | Accord Healthcare Inc | Resolved | 2023-07-07 | 19 | Shipping delay | 197911 |
1629 | C10AA07 | TARO-ROSUVASTATIN | 20MG | Sun Pharma Canada Inc | Resolved | 2023-07-07 | 126 | Manufacturing distruption | 208126 |
1630 | C09BB04 | VIACORAM | 10MG 14MG | Servier Canada Inc | Resolved | 2023-07-07 | Shipping delay | 198226 | |
1631 | C10AA05 | ACH-ATORVASTATIN CALCIUM | 80MG | Accord Healthcare Inc | Resolved | 2023-07-07 | 41 | Shipping delay | 197908 |
1632 | L04AX03 | METHOTREXATE SUBCUTANEOUS | 20MG | Accord Healthcare Inc | Resolved | 2023-07-07 | 14 | Manufacturing distruption | 197905 |
1633 | N02AA01 | MORPHINE SULFATE INJECTION EPI... | 0.5MG | Sterimax Inc | Resolved | 2023-07-07 | 24 | Demand increase | 197750 |
1613 | B05BA03 | 5% DEXTROSE INJECTION, USP | 5G | Baxter Corporation | Resolved | 2023-07-06 | 22 | Manufacturing distruption | 197756 |
1614 | B05XA03 | SODIUM CHLORIDE 3% INJ | 3G | Baxter Corporation | Resolved | 2023-07-06 | 39 | Manufacturing distruption | 197763 |
1615 | N02BF01 | NEURONTIN | 100MG | Bgp Pharma Ulc | Resolved | 2023-07-06 | 13 | Manufacturing distruption | 196704 |
1616 | J01GB03 | GENTAMICIN(E) | 1.6MG | Baxter Corporation | Resolved | 2023-07-06 | 22 | Manufacturing distruption | 197760 |
1617 | H02AB09 | SOLU-CORTEF | 250MG | Pfizer Canada Ulc | Resolved | 2023-07-06 | Manufacturing distruption | 197768 | |
1618 | H02AB09 | SOLU-CORTEF | 500MG | Pfizer Canada Ulc | Resolved | 2023-07-06 | Manufacturing distruption | 197771 | |
1619 | H02AB09 | SOLU-CORTEF | 1G | Pfizer Canada Ulc | Resolved | 2023-07-06 | Manufacturing distruption | 197774 | |
1620 | G03DA02 | PROVERA 5MG TABLETS | 5MG | Pfizer Canada Ulc | Resolved | 2023-07-06 | Demand increase | 197202 | |
1621 | J01DB01 | TEVA-CEPHALEXIN 250 | 250MG | Teva Canada Limited | Resolved | 2023-07-06 | 35 | Manufacturing distruption | 197743 |
1622 | N06BA04 | BIPHENTIN | 20MG | Elvium Life Sciences | Resolved | 2023-07-06 | 8 | Shipping delay | 197815 |
1623 | L01CE02 | ONIVYDE | 4.3MG | Servier Canada Inc | Resolved | 2023-07-06 | Other | 191665 | |
1607 | B05XA02 | SODIUM BICARBONATE INJECTION U... | 42MG | Pfizer Canada Ulc | Active | 2023-07-05 | Manufacturing distruption | 197649 | |
1599 | G03AA05 | BREVICON 1/35 TABLETS (21-DAY ... | 0.035MG 1MG | Pfizer Canada Ulc | Resolved | 2023-07-05 | 114 | Manufacturing distruption | 195942 |
1600 | N02AJ17 | TEVA-OXYCOCET | 325MG 5MG | Teva Canada Limited | Resolved | 2023-07-05 | 25 | Manufacturing distruption | 197507 |
1601 | C09AA09 | TEVA-FOSINOPRIL | 20MG | Teva Canada Limited | Resolved | 2023-07-05 | 25 | Manufacturing distruption | 197539 |
1602 | A02BC03 | APO-LANSOPRAZOLE | 30MG | Apotex Inc | Resolved | 2023-07-05 | 72 | Manufacturing distruption | 197879 |
1603 | N05AE04 | ZELDOX | 20MG | Upjohn Canada Ulc | Resolved | 2023-07-05 | 41 | Manufacturing distruption | 193011 |
1604 | C09CA04 | TEVA-IRBESARTAN | 150MG | Teva Canada Limited | Resolved | 2023-07-05 | 118 | Manufacturing distruption | 206422 |
1605 | C09BA04 | COVERSYL PLUS HD | 2.5MG 8MG | Servier Canada Inc | Resolved | 2023-07-05 | 49 | Shipping delay | 198211 |
1606 | N02AJ13 | APO-TRAMADOL/ACET | 37.5MG 325MG | Apotex Inc | Resolved | 2023-07-05 | 65 | Manufacturing distruption | 197884 |
1608 | L04AK01 | LEFLUNOMIDE | 10MG | Sanis Health Inc | Resolved | 2023-07-05 | Manufacturing distruption | 197620 | |
1609 | L04AK01 | LEFLUNOMIDE | 20MG | Sanis Health Inc | Resolved | 2023-07-05 | 121 | Manufacturing distruption | 197624 |
1610 | G04CB02 | TEVA-DUTASTERIDE | 0.5MG | Teva Canada Limited | Resolved | 2023-07-05 | 290 | Manufacturing distruption | 207548 |
1611 | C10BX03 | APO-AMLODIPINE-ATORVASTATIN | 80MG 5MG | Apotex Inc | Resolved | 2023-07-05 | 58 | Manufacturing distruption | 197872 |
1612 | J01DB01 | APO-CEPHALEX | 250MG | Apotex Inc | Resolved | 2023-07-05 | 198 | Manufacturing distruption | 197876 |
1581 | A06AA02 | RATIO-DOCUSATE SODIUM | 20MG | Teva Canada Limited | Resolved | 2023-07-04 | 159 | Manufacturing distruption | 197195 |
1582 | M03BX01 | APO-BACLOFEN | 10MG | Apotex Inc | Resolved | 2023-07-04 | 115 | Manufacturing distruption | 198470 |
1583 | J01DB01 | TEVA-CEPHALEXIN 125 | 125MG | Teva Canada Limited | Resolved | 2023-07-04 | 68 | Manufacturing distruption | 197282 |
1584 | A11CC01 | SANDOZ D-FORTE | 50000UNIT | Sandoz Canada Incorporated | Resolved | 2023-07-04 | Manufacturing distruption | 197064 | |
1585 | R01AD01 | APO-BECLOMETHASONE NASAL SPRAY | 50MCG | Apotex Inc | Resolved | 2023-07-04 | 108 | Manufacturing distruption | 198473 |
1586 | N06AB06 | TEVA-SERTRALINE | 25MG | Teva Canada Limited | Resolved | 2023-07-04 | 57 | Manufacturing distruption | 197218 |
1587 | M01AE02 | TEVA-NAPROXEN EC | 500MG | Teva Canada Limited | Resolved | 2023-07-04 | 0 | Manufacturing distruption | 197052 |
1588 | J01GB03 | GENTAMICIN INJECTION USP | 10MG | Sandoz Canada Incorporated | Resolved | 2023-07-04 | 10 | Manufacturing distruption | 197061 |
1589 | N05AX08 | APO-RISPERIDONE | 0.25MG | Apotex Inc | Resolved | 2023-07-04 | 45 | Manufacturing distruption | 198480 |
1590 | N05AX08 | APO-RISPERIDONE | 0.50MG | Apotex Inc | Resolved | 2023-07-04 | 38 | Manufacturing distruption | 198486 |
1591 | N05AX08 | APO-RISPERIDONE | 1.0MG | Apotex Inc | Resolved | 2023-07-04 | 38 | Manufacturing distruption | 198489 |
1592 | C09BA03 | TEVA-LISINOPRIL/HCTZ (TYPE Z) | 25MG 20MG | Teva Canada Limited | Resolved | 2023-07-04 | 47 | Manufacturing distruption | 197104 |
1593 | N02AA01 | TEVA-MORPHINE SR | 30MG | Teva Canada Limited | Resolved | 2023-07-04 | 26 | Manufacturing distruption | 197169 |
1594 | J01DB04 | CEFAZOLIN FOR INJECTION USP | 500MG | Sandoz Canada Incorporated | Resolved | 2023-07-04 | 199 | Demand increase | 197055 |
1595 | A04AD11 | CESAMET | 0.25MG | Bausch Health, Canada Inc. | Resolved | 2023-07-04 | 3 | Other | 193088 |
1596 | L04AA06 | TEVA-MYCOPHENOLATE | 500MG | Teva Canada Limited | Resolved | 2023-07-04 | 57 | Manufacturing distruption | 197172 |
1597 | N06BA09 | SANDOZ ATOMOXETINE | 18MG | Sandoz Canada Incorporated | Resolved | 2023-07-04 | 31 | Manufacturing distruption | 197039 |
1598 | J05AF06 | APO-ABACAVIR | 300MG | Apotex Inc | Resolved | 2023-07-04 | 38 | Manufacturing distruption | 198465 |
1579 | S01KX02 | VISIONBLUE | 0.06% | Dutch Ophthalmic Research Center International Bv | Resolved | 2023-07-03 | 35 | Other | 199253 |
1580 | A03AB02 | GLYCOPYRROLATE INJECTION USP | 0.2MG | Sterimax Inc | Resolved | 2023-07-03 | 88 | Manufacturing distruption | 200632 |
1573 | D08AC52 | CHLORAPREP ONE-STEP | 70% 2% | Carefusion Canada Ulc | Resolved | 2023-07-01 | Demand increase | 196649 | |
1574 | N01BB01 | SENSORCAINE | 2.5MG | Aspen Pharmacare Canada Inc. | Resolved | 2023-07-01 | 152 | Manufacturing distruption | 198622 |
1575 | M01AB15 | KETOROLAC TROMETHAMINE INJECTI... | 30MG | Fresenius Kabi Canada Ltd | Resolved | 2023-07-01 | 29 | Manufacturing distruption | 194929 |
1576 | C01BD01 | AMIODARONE HYDROCHLORIDE FOR I... | 50MG | Fresenius Kabi Canada Ltd | Resolved | 2023-07-01 | 58 | Manufacturing distruption | 194926 |
1577 | N06AB10 | TARO-ESCITALOPRAM | 10MG | Sun Pharma Canada Inc | Resolved | 2023-07-01 | 118 | Manufacturing distruption | 202134 |
1578 | D08AC52 | CHLORAPREP | 70% 2% | Becton Dickinson Canada Inc. | Resolved | 2023-07-01 | Demand increase | 196092 | |
1570 | V03AF01 | MESNA FOR INJECTION | 100MG | Fresenius Kabi Canada Ltd | Active | 2023-06-30 | Manufacturing distruption | 201038 | |
1569 | G01AF01 | FLAGYL | 10% | Sanofi-Aventis Canada Inc | Resolved | 2023-06-30 | 31 | Other | 196995 |
1571 | G04CA01 | XATRAL | 10MG | Sanofi-Aventis Canada Inc | Resolved | 2023-06-30 | 31 | Other | 196992 |
1572 | B01AC04 | TARO-CLOPIDOGREL | 75MG | Sun Pharma Canada Inc | Resolved | 2023-06-30 | 315 | Manufacturing distruption | 209167 |
1563 | V07AB | SODIUM CHLORIDE BACTERIOSTATIC... | 9MG | Omega Laboratories Limited | Resolved | 2023-06-29 | 22 | Demand increase | 194679 |
1564 | A11DA01 | THIAMIJECT INJECTION - LIQ IM... | 100MG | Omega Laboratories Limited | Resolved | 2023-06-29 | Demand increase | 196179 | |
1565 | S01EC05 | METHAZOLAMIDE | 50MG | Aa Pharma Inc | Resolved | 2023-06-29 | 1159 | Manufacturing distruption | 196840 |
1566 | N05BB01 | HYDROXYZINE | 50MG | Aa Pharma Inc | Resolved | 2023-06-29 | 43 | Manufacturing distruption | 196837 |
1567 | B02AA02 | TRANEXAMIC ACID INJECTION | 100MG | Omega Laboratories Limited | Resolved | 2023-06-29 | 63 | Demand increase | 196188 |
1568 | B02AA02 | TRANEXAMIC ACID INJECTION | 100MG | Omega Laboratories Limited | Resolved | 2023-06-29 | 63 | Demand increase | 194673 |
1554 | D10AF51 | CLINDOXYL GEL | 1% 5% | Glaxosmithkline Inc | Resolved | 2023-06-28 | 93 | Demand increase | 196974 |
1555 | N06BA04 | BIPHENTIN | 10MG | Elvium Life Sciences | Resolved | 2023-06-28 | 13 | Shipping delay | 196775 |
1556 | G04CA02 | SANDOZ TAMSULOSIN | 0.4MG | Sandoz Canada Incorporated | Resolved | 2023-06-28 | 296 | Manufacturing distruption | 196790 |
1557 | C09CA06 | SANDOZ CANDESARTAN | 4MG | Sandoz Canada Incorporated | Resolved | 2023-06-28 | 72 | Demand increase | 196784 |
1558 | D11AX10 | SANDOZ FINASTERIDE A | 1MG | Sandoz Canada Incorporated | Resolved | 2023-06-28 | 16 | Manufacturing distruption | 196760 |
1559 | C09CA07 | SANDOZ TELMISARTAN | 80MG | Sandoz Canada Incorporated | Resolved | 2023-06-28 | 2 | Manufacturing practices | 196793 |
1560 | C09CA07 | TELMISARTAN | 40MG | Sivem Pharmaceuticals Ulc | Resolved | 2023-06-28 | 292 | Shipping delay | 211177 |
1561 | B02BD04 | ALPROLIX | 3000UNIT | Sanofi-Aventis Canada Inc | Resolved | 2023-06-28 | 12 | Demand increase | 196825 |
1562 | L04AH02 | SANDOZ EVEROLIMUS | 2.5MG | Sandoz Canada Incorporated | Resolved | 2023-06-28 | 51 | Manufacturing distruption | 196787 |
1546 | G03CA03 | ESTRING | 2MG | Pfizer Canada Ulc | Resolved | 2023-06-27 | 24 | Manufacturing distruption | 196657 |
1547 | B05BA03 | DEXTROSE INJECTION USP | 200MG | Icu Medical Canada Inc | Resolved | 2023-06-27 | Manufacturing distruption | 203374 | |
1548 | R05CB01 | ACETYLCYSTEINE SOLUTION | 200MG | Sandoz Canada Incorporated | Resolved | 2023-06-27 | 10 | Manufacturing distruption | 196632 |
1549 | N05AH03 | SANDOZ OLANZAPINE | 15.0MG | Sandoz Canada Incorporated | Resolved | 2023-06-27 | 241 | Manufacturing distruption | 196636 |
1550 | N06AX23 | PRISTIQ | 50MG | Pfizer Canada Ulc | Resolved | 2023-06-27 | 121 | Manufacturing distruption | 195948 |
1551 | C09CA04 | IRBESARTAN | 150MG | Sanis Health Inc | Resolved | 2023-06-27 | 135 | Manufacturing distruption | 196716 |
1552 | N06BA01 | SANDOZ AMPHETAMINE XR | 10MG | Sandoz Canada Incorporated | Resolved | 2023-06-27 | 38 | Other | 196662 |
1553 | C07AB03 | ATENOLOL | 50MG | Sanis Health Inc | Resolved | 2023-06-27 | Manufacturing distruption | 196720 | |
1539 | V07AB | STERILE WATER FOR IRRIGATION U... | 100% | Icu Medical Canada Inc | Active | 2023-06-26 | Manufacturing distruption | 172843 | |
1542 | N03AX09 | PMS-LAMOTRIGINE | 25MG | Pharmascience Inc | Active | 2023-06-26 | Manufacturing distruption | 196468 | |
1543 | N03AX09 | PMS-LAMOTRIGINE | 150MG | Pharmascience Inc | Active | 2023-06-26 | Manufacturing distruption | 196484 | |
1535 | S01ED51 | LATANOPROST AND TIMOLOL OPHTHA... | 5MG 50MCG | Hikma Canada Limited | Resolved | 2023-06-26 | Demand increase | 193838 | |
1536 | N05BA01 | DIASTAT | 10MG | Bausch Health, Canada Inc. | Resolved | 2023-06-26 | 207 | Other | 193094 |
1537 | A09AA02 | CREON MINIMICROSPHERES 25 | 1600UNIT 25500UNIT 25000UNIT | Bgp Pharma Ulc | Resolved | 2023-06-26 | 19 | Other | 196713 |
1538 | C10AC01 | OLESTYR | 4G | Pharmascience Inc | Resolved | 2023-06-26 | 605 | Manufacturing distruption | 196455 |
1540 | R03BB01 | PMS-IPRATROPIUM | 21MCG | Pharmascience Inc | Resolved | 2023-06-26 | 134 | Manufacturing distruption | 196481 |
1541 | N06AB06 | PMS-SERTRALINE | 100MG | Pharmascience Inc | Resolved | 2023-06-26 | 21 | Manufacturing distruption | 196459 |
1544 | M05BB03 | FOSAVANCE | 5600UNIT 70MG | Organon Canada Inc. | Resolved | 2023-06-26 | 81 | Demand increase | 196834 |
1545 | N02CC04 | PMS-RIZATRIPTAN RDT | 10MG | Pharmascience Inc | Resolved | 2023-06-26 | 81 | Manufacturing distruption | 196465 |
1531 | M03BX01 | APO-BACLOFEN | 20MG | Apotex Inc | Resolved | 2023-06-25 | 40 | Manufacturing distruption | 196943 |
1532 | N05AH03 | APO-OLANZAPINE ODT | 5MG | Apotex Inc | Resolved | 2023-06-25 | 131 | Manufacturing distruption | 196949 |
1533 | R03DC03 | APO-MONTELUKAST | 10MG | Apotex Inc | Resolved | 2023-06-25 | 40 | Manufacturing distruption | 196952 |
1534 | R01AD09 | APO-MOMETASONE | 50MCG | Apotex Inc | Resolved | 2023-06-25 | 19 | Manufacturing distruption | 196946 |
1529 | C09DA08 | ACH-OLMESARTAN HCTZ | 40MG 25MG | Accord Healthcare Inc | Avoided | 2023-06-23 | 14 | Shipping delay | 196333 |
1514 | R05DA09 | KOFFEX DM | 15MG | Teva Canada Limited | Resolved | 2023-06-23 | 201 | Manufacturing distruption | 196380 |
1515 | H02AB07 | TEVA-PREDNISONE | 50MG | Teva Canada Limited | Resolved | 2023-06-23 | 37 | Manufacturing distruption | 196448 |
1516 | J01DB05 | TEVA-CEFADROXIL | 500MG | Teva Canada Limited | Resolved | 2023-06-23 | 222 | Manufacturing distruption | 196406 |
1517 | N02BF01 | TEVA-GABAPENTIN | 300MG | Teva Canada Limited | Resolved | 2023-06-23 | 7 | Manufacturing distruption | 196427 |
1518 | N03AX09 | MYLAN-LAMOTRIGINE | 25MG | Mylan Pharmaceuticals Ulc | Resolved | 2023-06-23 | 12 | Manufacturing distruption | 196047 |
1519 | N03AX14 | TEVA-LEVETIRACETAM | 750MG | Teva Canada Limited | Resolved | 2023-06-23 | 58 | Manufacturing distruption | 194106 |
1520 | R01AD12 | AVAMYS | 27.5MCG | Glaxosmithkline Inc | Resolved | 2023-06-23 | 40 | Demand increase | 196772 |
1521 | N05AH04 | ACT QUETIAPINE | 25MG | Teva Canada Limited | Resolved | 2023-06-23 | 27 | Manufacturing distruption | 196367 |
1522 | N04BC04 | TEVA-ROPINIROLE | 0.25MG | Teva Canada Limited | Resolved | 2023-06-23 | 58 | Manufacturing distruption | 196471 |
1523 | C09DA07 | TEVA-TELMISARTAN HCTZ | 12.5MG 80MG | Teva Canada Limited | Resolved | 2023-06-23 | 180 | Manufacturing distruption | 196362 |
1524 | N06BA12 | VYVANSE | 20MG | Takeda Canada Inc | Resolved | 2023-06-23 | 119 | Shipping delay | 196238 |
1525 | C10AA07 | TEVA-ROSUVASTATIN | 20MG | Teva Canada Limited | Resolved | 2023-06-23 | 48 | Manufacturing distruption | 196476 |
1526 | N03AX14 | ACH-LEVETIRACETAM | 750MG | Accord Healthcare Inc | Resolved | 2023-06-23 | 82 | Manufacturing distruption | 196330 |
1527 | D07XC01 | TEVA-BETAMETHASONE/ CALCIPOTRI... | 50MCG 0.5MG | Teva Canada Limited | Resolved | 2023-06-23 | 17 | Manufacturing distruption | 196403 |
1528 | N02BF02 | ACH-PREGABALIN | 25MG | Accord Healthcare Inc | Resolved | 2023-06-23 | 131 | Manufacturing distruption | 196327 |
1530 | C08CA01 | PDP-AMLODIPINE | 1MG | Pendopharm Division Of Pharmascience Inc | Resolved | 2023-06-23 | 63 | Shipping delay | 196318 |
1510 | J05AB01 | ZOVIRAX | 200MG | Glaxosmithkline Inc | Resolved | 2023-06-22 | Ingredient shortage | 196208 | |
1511 | G02BB01 | NUVARING | 2.6MG 11.4MG | Organon Canada Inc. | Resolved | 2023-06-22 | 11 | Shipping delay | 196653 |
1512 | C10AA07 | ROSUVASTATIN | 10MG | Sanis Health Inc | Resolved | 2023-06-22 | 71 | Manufacturing distruption | 196102 |
1513 | C10AA07 | ROSUVASTATIN | 20MG | Sanis Health Inc | Resolved | 2023-06-22 | Manufacturing distruption | 196099 | |
1506 | J07BK01 | VARIVAX III | 1350UNIT | Merck Canada Inc | Resolved | 2023-06-21 | 23 | Shipping delay | 195572 |
1507 | J01MA02 | AURO-CIPROFLOXACIN | 500MG | Auro Pharma Inc | Resolved | 2023-06-21 | 147 | Demand increase | 199593 |
1508 | M01AH01 | AURO-CELECOXIB | 100MG | Auro Pharma Inc | Resolved | 2023-06-21 | 71 | Demand increase | 199579 |
1509 | C09AA04 | AURO-PERINDOPRIL | 2MG | Auro Pharma Inc | Resolved | 2023-06-21 | 80 | Demand increase | 199679 |
1474 | N02BE01 | ACÉTAMINOPHÈNE COMPRIMÉ TABLET... | 500MG | Laboratoire Riva Inc. | Active | 2023-06-20 | Manufacturing distruption | 195992 | |
1475 | N06AX16 | APO-VENLAFAXINE XR | 37.5MG | Apotex Inc | Active | 2023-06-20 | Manufacturing distruption | 196306 | |
1476 | L01BC06 | CAPECITABINE | 150MG | Jamp Pharma Corporation | Resolved | 2023-06-20 | Manufacturing distruption | 196200 | |
1477 | L01BC06 | CAPECITABINE | 150MG | Jamp Pharma Corporation | Resolved | 2023-06-20 | Manufacturing distruption | 196203 | |
1478 | L01BC06 | CAPECITABINE | 500MG | Jamp Pharma Corporation | Resolved | 2023-06-20 | Manufacturing distruption | 196206 | |
1479 | L01BC06 | CAPECITABINE | 500MG | Jamp Pharma Corporation | Resolved | 2023-06-20 | Manufacturing distruption | 196216 | |
1480 | J01DB01 | JAMP CEPHALEXIN SUSPENSION | 125MG | Jamp Pharma Corporation | Resolved | 2023-06-20 | 240 | Manufacturing distruption | 196738 |
1481 | J01DB01 | JAMP CEPHALEXIN SUSPENSION | 250MG | Jamp Pharma Corporation | Resolved | 2023-06-20 | 240 | Manufacturing distruption | 196741 |
1482 | J01DB01 | JAMP CEPHALEXIN SUSPENSION | 250MG | Jamp Pharma Corporation | Resolved | 2023-06-20 | 240 | Manufacturing distruption | 196744 |
1483 | N03AB02 | PHENYTOIN SODIUM INJECTION USP | 50MG | Omega Laboratories Limited | Resolved | 2023-06-20 | 133 | Manufacturing distruption | 194661 |
1484 | C09BA03 | ZESTORETIC | 12.5MG 10MG | Searchlight Pharma Inc | Resolved | 2023-06-20 | 22 | Shipping delay | 195535 |
1485 | H02AB09 | SOLU-CORTEF | 250MG | Pfizer Canada Ulc | Resolved | 2023-06-20 | Manufacturing distruption | 196007 | |
1486 | J05AP01 | VIRAZOLE | 6G | Bausch Health, Canada Inc. | Resolved | 2023-06-20 | 133 | Demand increase | 193926 |
1487 | N03AG01 | APO-DIVALPROEX | 500MG | Apotex Inc | Resolved | 2023-06-20 | 17 | Manufacturing distruption | 196292 |
1488 | C10AA01 | APO-SIMVASTATIN | 40MG | Apotex Inc | Resolved | 2023-06-20 | 31 | Manufacturing distruption | 196309 |
1489 | G03DA02 | PROVERA 10MG TABLETS | 10MG | Pfizer Canada Ulc | Resolved | 2023-06-20 | 37 | Demand increase | 195655 |
1490 | G03DA02 | APO-MEDROXY | 100MG | Apotex Inc | Resolved | 2023-06-20 | 122 | Ingredient shortage | 189671 |
1491 | N06BA04 | BIPHENTIN | 30MG | Elvium Life Sciences | Resolved | 2023-06-20 | 24 | Shipping delay | 195936 |
1492 | C09AA05 | TARO-RAMIPRIL | 5MG | Sun Pharma Canada Inc | Resolved | 2023-06-20 | 101 | Manufacturing distruption | 199134 |
1493 | J07CA02 | BOOSTRIX-POLIO | 32D 8D 40D 2.5MCG 8MCG 8MCG 5.0LF 2.5LF | Glaxosmithkline Inc | Resolved | 2023-06-20 | 120 | Shipping delay | 196056 |
1494 | N02AA05 | APO-OXYCODONE CR | 80.0MG | Apotex Inc | Resolved | 2023-06-20 | 59 | Manufacturing distruption | 196312 |
1495 | R03DC03 | APO-MONTELUKAST | 10MG | Apotex Inc | Resolved | 2023-06-20 | 45 | Manufacturing distruption | 196315 |
1496 | N02CC04 | APO-RIZATRIPTAN | 5MG | Apotex Inc | Resolved | 2023-06-20 | 17 | Manufacturing distruption | 196303 |
1497 | M01AH01 | JAMP-CELECOXIB | 100MG | Jamp Pharma Corporation | Resolved | 2023-06-20 | 102 | Manufacturing distruption | 196726 |
1498 | M01AH01 | JAMP-CELECOXIB | 100MG | Jamp Pharma Corporation | Resolved | 2023-06-20 | 102 | Manufacturing distruption | 196729 |
1499 | M01AH01 | JAMP-CELECOXIB | 200MG | Jamp Pharma Corporation | Resolved | 2023-06-20 | 148 | Manufacturing distruption | 196732 |
1500 | M01AH01 | JAMP-CELECOXIB | 200MG | Jamp Pharma Corporation | Resolved | 2023-06-20 | 148 | Manufacturing distruption | 196735 |
1501 | C08CA02 | APO-FELODIPINE | 10MG | Apotex Inc | Resolved | 2023-06-20 | 45 | Manufacturing distruption | 196300 |
1502 | N06BA04 | APO-METHYLPHENIDATE ER | 18MG | Apotex Inc | Resolved | 2023-06-20 | 66 | Demand increase | 196297 |
1503 | N06BA04 | FOQUEST | 35MG | Elvium Life Sciences | Resolved | 2023-06-20 | 17 | Shipping delay | 195939 |
1504 | L01EA01 | JAMP IMATINIB | 100MG | Jamp Pharma Corporation | Resolved | 2023-06-20 | Manufacturing distruption | 196219 | |
1505 | L01EA01 | JAMP IMATINIB | 400MG | Jamp Pharma Corporation | Resolved | 2023-06-20 | Manufacturing distruption | 196224 | |
1413 | A02BC03 | TEVA-LANSOPRAZOLE | 30MG | Teva Canada Limited | Active | 2023-06-19 | Manufacturing distruption | 195879 | |
1414 | A02BC03 | TEVA-LANSOPRAZOLE | 30MG | Teva Canada Limited | Active | 2023-06-19 | Manufacturing distruption | 195649 | |
1464 | G03DA04 | TEVA-PROGESTERONE | 100MG | Teva Canada Limited | Active | 2023-06-19 | 742 | Manufacturing distruption | 195627 |
1469 | R03BA02 | TEVA-BUDESONIDE | 0.5MG | Teva Canada Limited | Active | 2023-06-19 | 651 | Manufacturing distruption | 195478 |
1460 | N06BA01 | TEVA-AMPHETAMINE XR | 5MG | Teva Canada Limited | Avoided | 2023-06-19 | 31 | Manufacturing distruption | 195891 |
1353 | L02BG06 | TEVA-EXEMESTANE | 25MG | Teva Canada Limited | Resolved | 2023-06-19 | 31 | Manufacturing distruption | 195569 |
1354 | C07AA03 | TEVA-PINDOLOL | 15MG | Teva Canada Limited | Resolved | 2023-06-19 | 21 | Manufacturing distruption | 195533 |
1355 | R05DA09 | KOFFEX DM (SUCROSE FREE) | 15MG | Teva Canada Limited | Resolved | 2023-06-19 | 41 | Manufacturing distruption | 195640 |
1356 | R05DA09 | BALMINIL DM (3MG/ML SUCROSE F... | 15MG | Teva Canada Limited | Resolved | 2023-06-19 | 254 | Manufacturing distruption | 195560 |
1357 | D07CB01 | TEVA-TRIACOMB | 0.25MG 2.5MG 100000UNIT 1MG | Teva Canada Limited | Resolved | 2023-06-19 | 41 | Manufacturing distruption | 195812 |
1358 | D07AD01 | TEVA-CLOBETASOL | 0.05% | Teva Canada Limited | Resolved | 2023-06-19 | 123 | Manufacturing distruption | 195867 |
1359 | D07AC01 | TEVA-TOPILENE | 0.05% | Teva Canada Limited | Resolved | 2023-06-19 | 41 | Manufacturing distruption | 195579 |
1360 | J01CA04 | NOVAMOXIN | 250MG | Teva Canada Limited | Resolved | 2023-06-19 | 62 | Manufacturing distruption | 195545 |
1361 | C02AC01 | TEVA-CLONIDINE | 0.2MG | Teva Canada Limited | Resolved | 2023-06-19 | 42 | Manufacturing distruption | 195888 |
1362 | L01CB01 | ETOPOSIDE INJECTION | 20MG | Teva Canada Limited | Resolved | 2023-06-19 | 41 | Manufacturing distruption | 195789 |
1363 | J01CA04 | NOVAMOXIN | 250MG | Teva Canada Limited | Resolved | 2023-06-19 | 184 | Manufacturing distruption | 195754 |
1364 | N06AX05 | TEVA-TRAZODONE | 100MG | Teva Canada Limited | Resolved | 2023-06-19 | 11 | Manufacturing distruption | 195624 |
1365 | N06AX05 | TEVA-TRAZODONE | 100MG | Teva Canada Limited | Resolved | 2023-06-19 | 11 | Manufacturing distruption | 195637 |
1366 | D07AC01 | TEVA-ECTOSONE | 0.1% | Teva Canada Limited | Resolved | 2023-06-19 | 265 | Manufacturing distruption | 195634 |
1367 | J01DB04 | CEFAZOLIN FOR INJECTION | 1G | Teva Canada Limited | Resolved | 2023-06-19 | 73 | Manufacturing distruption | 195853 |
1368 | C07AB03 | TEVA-ATENOLOL | 50MG | Teva Canada Limited | Resolved | 2023-06-19 | 62 | Manufacturing distruption | 195882 |
1369 | C07AB03 | TEVA-ATENOLOL | 50MG | Teva Canada Limited | Resolved | 2023-06-19 | 62 | Manufacturing distruption | 195772 |
1370 | C07AB03 | TEVA-ATENOLOL | 100MG | Teva Canada Limited | Resolved | 2023-06-19 | 72 | Manufacturing distruption | 195751 |
1371 | C03CA01 | TEVA-FUROSEMIDE | 20MG | Teva Canada Limited | Resolved | 2023-06-19 | 21 | Manufacturing distruption | 195459 |
1372 | J01CA04 | NOVAMOXIN | 500MG | Teva Canada Limited | Resolved | 2023-06-19 | 11 | Manufacturing distruption | 195410 |
1373 | J01CA04 | NOVAMOXIN | 500MG | Teva Canada Limited | Resolved | 2023-06-19 | 11 | Manufacturing distruption | 195818 |
1374 | R05FA02 | CALMYLIN PSE WITH CODEINE | 100MG 30MG 3.3MG | Teva Canada Limited | Resolved | 2023-06-19 | 11 | Manufacturing distruption | 195521 |
1375 | A07AA02 | TEVA-NYSTATIN | 100000UNIT | Teva Canada Limited | Resolved | 2023-06-19 | 31 | Manufacturing distruption | 195501 |
1376 | J01CF02 | TEVA-CLOXACILLIN | 125MG | Teva Canada Limited | Resolved | 2023-06-19 | 93 | Manufacturing distruption | 195518 |
1377 | J01DB01 | TEVA-CEPHALEXIN | 250MG | Teva Canada Limited | Resolved | 2023-06-19 | 31 | Manufacturing distruption | 195894 |
1378 | J01DB01 | TEVA-CEPHALEXIN | 500MG | Teva Canada Limited | Resolved | 2023-06-19 | 41 | Manufacturing distruption | 195885 |
1379 | N03AA02 | PHENOBARB | 60MG | Pendopharm Division Of Pharmascience Inc | Resolved | 2023-06-19 | 35 | Demand increase | 195462 |
1380 | N02BE01 | PEDIATRIX | 160MG | Teva Canada Limited | Resolved | 2023-06-19 | 1 | Manufacturing distruption | 195643 |
1381 | C07AA05 | TEVA-PROPRANOLOL | 40MG | Teva Canada Limited | Resolved | 2023-06-19 | 21 | Manufacturing distruption | 195612 |
1382 | C07AA05 | TEVA-PROPRANOLOL | 40MG | Teva Canada Limited | Resolved | 2023-06-19 | 21 | Manufacturing distruption | 195821 |
1383 | C07AA05 | TEVA-PROPRANOLOL | 80MG | Teva Canada Limited | Resolved | 2023-06-19 | 21 | Manufacturing distruption | 195498 |
1384 | C07AA05 | TEVA-PROPRANOLOL | 80MG | Teva Canada Limited | Resolved | 2023-06-19 | 21 | Manufacturing distruption | 195760 |
1385 | R03BB01 | TEVA-IPRATROPIUM STERINEBS | 250MCG | Teva Canada Limited | Resolved | 2023-06-19 | 21 | Manufacturing distruption | 195618 |
1386 | L01BA01 | METHOTREXATE INJECTION USP | 25MG | Pfizer Canada Ulc | Resolved | 2023-06-19 | Manufacturing distruption | 188454 | |
1387 | R05FA02 | CALMYLIN | 125MG 12.5MG 3.33MG | Teva Canada Limited | Resolved | 2023-06-19 | 83 | Manufacturing distruption | 195769 |
1388 | R05FA02 | CALMYLIN | 125MG 12.5MG 3.33MG | Teva Canada Limited | Resolved | 2023-06-19 | 41 | Manufacturing distruption | 195792 |
1389 | R05FA02 | CALMYLIN | 125MG 12.5MG 3.33MG | Teva Canada Limited | Resolved | 2023-06-19 | 103 | Manufacturing distruption | 195836 |
1390 | D07AC01 | TEVA-ECTOSONE | 0.05% | Teva Canada Limited | Resolved | 2023-06-19 | 103 | Manufacturing distruption | 195600 |
1391 | D07AC01 | TEVA-ECTOSONE | 0.1% | Teva Canada Limited | Resolved | 2023-06-19 | 31 | Manufacturing distruption | 195795 |
1392 | C01BB02 | TEVA-MEXILETINE | 100MG | Teva Canada Limited | Resolved | 2023-06-19 | 134 | Manufacturing distruption | 195542 |
1393 | J01DB01 | TEVA-CEPHALEXIN 250 | 250MG | Teva Canada Limited | Resolved | 2023-06-19 | 21 | Manufacturing distruption | 195554 |
1394 | N02AJ17 | TEVA-OXYCOCET | 325MG 5MG | Teva Canada Limited | Resolved | 2023-06-19 | 62 | Manufacturing distruption | 195839 |
1395 | N02BA71 | TEVA-TECNAL | 330MG 40MG 50MG | Teva Canada Limited | Resolved | 2023-06-19 | 42 | Manufacturing distruption | 195850 |
1396 | L04AX01 | TEVA-AZATHIOPRINE | 50MG | Teva Canada Limited | Resolved | 2023-06-19 | 21 | Manufacturing distruption | 195606 |
1397 | N05CD08 | MIDAZOLAM INJECTION | 5MG | Sandoz Canada Incorporated | Resolved | 2023-06-19 | 32 | Manufacturing distruption | 195420 |
1398 | N06AB06 | TEVA-SERTRALINE | 100MG | Teva Canada Limited | Resolved | 2023-06-19 | 31 | Manufacturing distruption | 195449 |
1399 | G03CA03 | ESTRADOT 50 | 50MCG | Sandoz Canada Incorporated | Resolved | 2023-06-19 | 137 | Manufacturing distruption | 195413 |
1400 | M01AC01 | TEVA-PIROXICAM | 20MG | Teva Canada Limited | Resolved | 2023-06-19 | 93 | Manufacturing distruption | 195903 |
1401 | S01BA04 | TEVA-PREDNISOLONE | 1% | Teva Canada Limited | Resolved | 2023-06-19 | 1 | Manufacturing distruption | 195861 |
1402 | J01MA02 | ACT CIPROFLOXACIN | 250MG | Teva Canada Limited | Resolved | 2023-06-19 | 103 | Manufacturing distruption | 195585 |
1403 | D07AC13 | TEVA-MOMETASONE | 0.1% | Teva Canada Limited | Resolved | 2023-06-19 | 41 | Manufacturing distruption | 195472 |
1404 | C07AA05 | TEVA-PROPRANOLOL | 20MG | Teva Canada Limited | Resolved | 2023-06-19 | 21 | Manufacturing distruption | 195809 |
1405 | D01BA02 | ACT TERBINAFINE | 250MG | Teva Canada Limited | Resolved | 2023-06-19 | 52 | Manufacturing distruption | 195629 |
1406 | N06AX11 | TEVA-MIRTAZAPINE | 30MG | Teva Canada Limited | Resolved | 2023-06-19 | 62 | Manufacturing distruption | 195509 |
1407 | L04AK01 | TEVA-LEFLUNOMIDE | 20MG | Teva Canada Limited | Resolved | 2023-06-19 | 72 | Manufacturing distruption | 195864 |
1408 | N03AX14 | TEVA-LEVETIRACETAM | 500MG | Teva Canada Limited | Resolved | 2023-06-19 | 52 | Manufacturing distruption | 195591 |
1409 | N03AX14 | TEVA-LEVETIRACETAM | 750MG | Teva Canada Limited | Resolved | 2023-06-19 | 93 | Manufacturing distruption | 195484 |
1410 | N05AH03 | TEVA-OLANZAPINE | 15MG | Teva Canada Limited | Resolved | 2023-06-19 | 1 | Manufacturing distruption | 195830 |
1411 | N05AX08 | SANDOZ RISPERIDONE | 3MG | Sandoz Canada Incorporated | Resolved | 2023-06-19 | 46 | Manufacturing distruption | 195422 |
1412 | N07CA01 | TEVA-BETAHISTINE | 24MG | Teva Canada Limited | Resolved | 2023-06-19 | 1 | Manufacturing distruption | 195512 |
1415 | J02AC01 | ACT FLUCONAZOLE | 50MG | Teva Canada Limited | Resolved | 2023-06-19 | 21 | Manufacturing distruption | 195530 |
1416 | J02AC01 | ACT FLUCONAZOLE | 100MG | Teva Canada Limited | Resolved | 2023-06-19 | 21 | Manufacturing distruption | 195551 |
1417 | C09AA02 | ACT ENALAPRIL | 2MG | Teva Canada Limited | Resolved | 2023-06-19 | 11 | Manufacturing distruption | 195469 |
1418 | C09AA02 | ACT ENALAPRIL | 8MG | Teva Canada Limited | Resolved | 2023-06-19 | 11 | Manufacturing distruption | 195475 |
1419 | C09AA02 | ACT ENALAPRIL | 16MG | Teva Canada Limited | Resolved | 2023-06-19 | 11 | Manufacturing distruption | 195646 |
1420 | J01DD04 | CEFTRIAXONE SODIUM FOR INJECTI... | 250MG | Sandoz Canada Incorporated | Resolved | 2023-06-19 | 46 | Demand increase | 195408 |
1421 | B01AC04 | TEVA-CLOPIDOGREL | 75MG | Teva Canada Limited | Resolved | 2023-06-19 | 123 | Manufacturing distruption | 195803 |
1422 | B01AC04 | TEVA-CLOPIDOGREL | 75MG | Teva Canada Limited | Resolved | 2023-06-19 | 113 | Manufacturing distruption | 195566 |
1423 | B01AC04 | TEVA-CLOPIDOGREL | 75MG | Teva Canada Limited | Resolved | 2023-06-19 | 123 | Manufacturing distruption | 195824 |
1424 | N04BC05 | ACT PRAMIPEXOLE | 0.25MG | Teva Canada Limited | Resolved | 2023-06-19 | 41 | Manufacturing distruption | 195582 |
1425 | N04BC05 | ACT PRAMIPEXOLE | 1.5MG | Teva Canada Limited | Resolved | 2023-06-19 | 42 | Manufacturing distruption | 195466 |
1426 | C10AA04 | TEVA-FLUVASTATIN | 40MG | Teva Canada Limited | Resolved | 2023-06-19 | 21 | Manufacturing distruption | 195429 |
1427 | C09BA03 | TEVA-LISINOPRIL/HCTZ (TYPE Z) | 12.5MG 20MG | Teva Canada Limited | Resolved | 2023-06-19 | 21 | Manufacturing distruption | 195597 |
1428 | N02CC02 | TEVA-NARATRIPTAN | 2.5MG | Teva Canada Limited | Resolved | 2023-06-19 | 42 | Manufacturing distruption | 195487 |
1429 | J01MA12 | LEVOFLOXACIN IN 5% DEXTROSE IN... | 5MG | Pfizer Canada Ulc | Resolved | 2023-06-19 | Ingredient shortage | 189581 | |
1430 | C09CA04 | TEVA-IRBESARTAN | 75MG | Teva Canada Limited | Resolved | 2023-06-19 | 31 | Manufacturing distruption | 195588 |
1431 | C09CA04 | TEVA-IRBESARTAN | 300MG | Teva Canada Limited | Resolved | 2023-06-19 | 123 | Manufacturing distruption | 195609 |
1432 | C09CA07 | TEVA-TELMISARTAN | 80MG | Teva Canada Limited | Resolved | 2023-06-19 | 31 | Manufacturing distruption | 195603 |
1433 | C09CA07 | TEVA-TELMISARTAN | 80MG | Teva Canada Limited | Resolved | 2023-06-19 | 31 | Manufacturing distruption | 195873 |
1434 | L01DB03 | EPIRUBICIN FOR INJECTION | 2MG | Teva Canada Limited | Resolved | 2023-06-19 | 174 | Manufacturing distruption | 195784 |
1435 | C09DA07 | TEVA-TELMISARTAN HCTZ | 12.5MG 80MG | Teva Canada Limited | Resolved | 2023-06-19 | 72 | Manufacturing distruption | 195897 |
1436 | C09DA07 | TEVA-TELMISARTAN HCTZ | 12.5MG 80MG | Teva Canada Limited | Resolved | 2023-06-19 | 72 | Manufacturing distruption | 195757 |
1437 | C09DA07 | TEVA-TELMISARTAN HCTZ | 12.5MG 80MG | Teva Canada Limited | Resolved | 2023-06-19 | 184 | Manufacturing distruption | 195539 |
1438 | A06AD11 | TEVA-LACTULOSE | 667MG | Teva Canada Limited | Resolved | 2023-06-19 | 103 | Manufacturing distruption | 195766 |
1439 | L02BG04 | TEVA-LETROZOLE | 2.5MG | Teva Canada Limited | Resolved | 2023-06-19 | 72 | Manufacturing distruption | 195833 |
1440 | C10AA07 | TEVA-ROSUVASTATIN | 20MG | Teva Canada Limited | Resolved | 2023-06-19 | 123 | Manufacturing distruption | 195443 |
1441 | C10AA07 | TEVA-ROSUVASTATIN | 40MG | Teva Canada Limited | Resolved | 2023-06-19 | 62 | Manufacturing distruption | 195621 |
1442 | G03XC01 | ACT RALOXIFENE | 60MG | Teva Canada Limited | Resolved | 2023-06-19 | 31 | Manufacturing distruption | 195781 |
1443 | L04AA06 | TEVA-MYCOPHENOLATE | 250MG | Teva Canada Limited | Resolved | 2023-06-19 | 31 | Manufacturing distruption | 195870 |
1444 | C09CA06 | TEVA-CANDESARTAN | 32MG | Teva Canada Limited | Resolved | 2023-06-19 | 41 | Manufacturing distruption | 195557 |
1445 | G04CA02 | TEVA-TAMSULOSIN CR | 0.4MG | Teva Canada Limited | Resolved | 2023-06-19 | 194 | Manufacturing distruption | 195827 |
1446 | J01MA14 | TEVA-MOXIFLOXACIN | 400MG | Teva Canada Limited | Resolved | 2023-06-19 | 103 | Manufacturing distruption | 195847 |
1447 | C09CA07 | SANDOZ TELMISARTAN | 80MG | Sandoz Canada Incorporated | Resolved | 2023-06-19 | 11 | Manufacturing practices | 195416 |
1448 | J05AG03 | TEVA-EFAVIRENZ | 600MG | Teva Canada Limited | Resolved | 2023-06-19 | 11 | Manufacturing distruption | 195858 |
1449 | G04BD08 | TEVA-SOLIFENACIN | 5MG | Teva Canada Limited | Resolved | 2023-06-19 | 357 | Manufacturing distruption | 195652 |
1450 | G04BD08 | TEVA-SOLIFENACIN | 5MG | Teva Canada Limited | Resolved | 2023-06-19 | 103 | Manufacturing distruption | 195506 |
1451 | G04BD08 | TEVA-SOLIFENACIN | 10MG | Teva Canada Limited | Resolved | 2023-06-19 | 357 | Manufacturing distruption | 195456 |
1452 | G04BD08 | TEVA-SOLIFENACIN | 10MG | Teva Canada Limited | Resolved | 2023-06-19 | 357 | Manufacturing distruption | 195481 |
1453 | N02AB03 | FENTORA | 600MCG | Teva Canada Limited | Resolved | 2023-06-19 | 41 | Manufacturing distruption | 195548 |
1454 | G04CB02 | TEVA-DUTASTERIDE | 0.5MG | Teva Canada Limited | Resolved | 2023-06-19 | 41 | Manufacturing distruption | 195775 |
1455 | L01DB01 | DOXORUBICIN HYDROCHLORIDE INJE... | 2MG | Teva Canada Limited | Resolved | 2023-06-19 | 144 | Manufacturing distruption | 195806 |
1456 | G04BD07 | TEVA-TOLTERODINE LA | 4MG | Teva Canada Limited | Resolved | 2023-06-19 | 11 | Manufacturing distruption | 195844 |
1457 | G04BD07 | TEVA-TOLTERODINE LA | 4MG | Teva Canada Limited | Resolved | 2023-06-19 | 11 | Manufacturing distruption | 195515 |
1458 | J05AR02 | TEVA-ABACAVIR/LAMIVUDINE | 300MG 600MG | Teva Canada Limited | Resolved | 2023-06-19 | 72 | Manufacturing distruption | 195900 |
1459 | C08DB01 | TEVA-DILTIAZEM XC | 360MG | Teva Canada Limited | Resolved | 2023-06-19 | 41 | Manufacturing distruption | 195763 |
1461 | N06BA01 | TEVA-AMPHETAMINE XR | 10MG | Teva Canada Limited | Resolved | 2023-06-19 | 31 | Manufacturing distruption | 195876 |
1462 | N06BA01 | TEVA-AMPHETAMINE XR | 20MG | Teva Canada Limited | Resolved | 2023-06-19 | 11 | Manufacturing distruption | 195594 |
1463 | N06BA01 | TEVA-AMPHETAMINE XR | 25MG | Teva Canada Limited | Resolved | 2023-06-19 | 31 | Manufacturing distruption | 195778 |
1465 | A02BC02 | TEVA-PANTOPRAZOLE MAGNESIUM | 40MG | Teva Canada Limited | Resolved | 2023-06-19 | 62 | Manufacturing distruption | 195800 |
1466 | C09BA05 | TARO-RAMIPRIL HCTZ | 25MG 10MG | Sun Pharma Canada Inc | Resolved | 2023-06-19 | 242 | Manufacturing distruption | 199140 |
1467 | S01XA18 | TEVA-CYCLOSPORINE | 0.05% | Teva Canada Limited | Resolved | 2023-06-19 | 72 | Manufacturing distruption | 195563 |
1468 | R03BA02 | TEVA-BUDESONIDE | 0.125MG | Teva Canada Limited | Resolved | 2023-06-19 | 31 | Manufacturing distruption | 195815 |
1470 | B05BA03 | DEXTROSE INJECTION USP | 500MG | Pfizer Canada Ulc | Resolved | 2023-06-19 | Manufacturing distruption | 192972 | |
1471 | N03AX18 | TEVA-LACOSAMIDE | 150MG | Teva Canada Limited | Resolved | 2023-06-19 | 21 | Manufacturing distruption | 195446 |
1472 | J02AC04 | SANDOZ POSACONAZOLE | 100MG | Sandoz Canada Incorporated | Resolved | 2023-06-19 | 18 | Manufacturing distruption | 195434 |
1473 | C07AB02 | TEVA-METOPROLOL | 50MG | Teva Canada Limited | Resolved | 2023-06-19 | 52 | Manufacturing distruption | 195615 |
1352 | N02CC01 | APO-SUMATRIPTAN | 50MG | Apotex Inc | Resolved | 2023-06-18 | 89 | Manufacturing distruption | 199539 |
1346 | G03DA04 | TEVA-PROGESTERONE | 100MG | Teva Canada Limited | Active | 2023-06-16 | 745 | Manufacturing distruption | 195153 |
1292 | H02AB10 | CORTISONE ACETATE | 25MG | Bausch Health, Canada Inc. | Avoided | 2023-06-16 | 3 | Other | 193091 |
1283 | G04BE08 | ACH-TADALAFIL | 5MG | Accord Healthcare Inc | Resolved | 2023-06-16 | Manufacturing practices | 195313 | |
1284 | G04BE08 | ACH-TADALAFIL | 10MG | Accord Healthcare Inc | Resolved | 2023-06-16 | Manufacturing practices | 195316 | |
1285 | G04BE08 | ACH-TADALAFIL | 20MG | Accord Healthcare Inc | Resolved | 2023-06-16 | Manufacturing practices | 195319 | |
1286 | R02AA20 | NEO-LARYNGOBIS | 135MG | Teva Canada Limited | Resolved | 2023-06-16 | 106 | Manufacturing distruption | 195198 |
1287 | R05DA09 | KOFFEX DM | 15MG | Teva Canada Limited | Resolved | 2023-06-16 | 44 | Manufacturing distruption | 195231 |
1288 | D07CB01 | TEVA-TRIACOMB | 0.25MG 2.5MG 100000UNIT 1MG | Teva Canada Limited | Resolved | 2023-06-16 | 44 | Manufacturing distruption | 195192 |
1289 | A02BX02 | TEVA-SUCRALFATE | 1G | Teva Canada Limited | Resolved | 2023-06-16 | 34 | Manufacturing distruption | 195039 |
1290 | A02BX02 | TEVA-SUCRALFATE | 1G | Teva Canada Limited | Resolved | 2023-06-16 | 86 | Manufacturing distruption | 195055 |
1291 | J01CA04 | NOVAMOXIN | 250MG | Teva Canada Limited | Resolved | 2023-06-16 | 137 | Manufacturing distruption | 195109 |
1293 | R05FA02 | CALMYLIN ACE | 10MG 7.5MG 100MG | Teva Canada Limited | Resolved | 2023-06-16 | 136 | Manufacturing distruption | 195061 |
1294 | D06AX30 | POLYDERM OINTMENT USP | 10000UNIT 500UNIT | Taro Pharmaceuticals Inc | Resolved | 2023-06-16 | 161 | Manufacturing distruption | 202483 |
1295 | J01CA04 | NOVAMOXIN | 250MG | Teva Canada Limited | Resolved | 2023-06-16 | 86 | Manufacturing distruption | 195112 |
1296 | J01CA04 | NOVAMOXIN | 250MG | Teva Canada Limited | Resolved | 2023-06-16 | 86 | Manufacturing distruption | 195207 |
1297 | R05FA02 | CALMYLIN PSE WITH CODEINE | 100MG 30MG 3.3MG | Teva Canada Limited | Resolved | 2023-06-16 | 14 | Manufacturing distruption | 195042 |
1298 | N02BE01 | PEDIATRIX | 160MG | Teva Canada Limited | Resolved | 2023-06-16 | 14 | Manufacturing distruption | 195106 |
1299 | C07AA05 | TEVA-PROPRANOLOL | 10MG | Teva Canada Limited | Resolved | 2023-06-16 | 24 | Manufacturing distruption | 195213 |
1300 | C07AA05 | TEVA-PROPRANOLOL | 10MG | Teva Canada Limited | Resolved | 2023-06-16 | 44 | Manufacturing distruption | 195234 |
1301 | C07AB04 | TEVA-ACEBUTOLOL | 100MG | Teva Canada Limited | Resolved | 2023-06-16 | 44 | Manufacturing distruption | 195237 |
1302 | C07AB04 | TEVA-ACEBUTOLOL | 400MG | Teva Canada Limited | Resolved | 2023-06-16 | 44 | Manufacturing distruption | 195142 |
1303 | J01DB01 | TEVA-CEPHALEXIN 125 | 125MG | Teva Canada Limited | Resolved | 2023-06-16 | 65 | Manufacturing distruption | 195228 |
1304 | C03DA01 | TEVA-SPIRONOLACTONE | 100MG | Teva Canada Limited | Resolved | 2023-06-16 | 96 | Manufacturing distruption | 195225 |
1305 | N02AJ17 | TEVA-OXYCOCET | 325MG 5MG | Teva Canada Limited | Resolved | 2023-06-16 | 4 | Manufacturing distruption | 195222 |
1306 | D07AC01 | TEVA-ECTOSONE | 0.05% | Teva Canada Limited | Resolved | 2023-06-16 | 157 | Manufacturing distruption | 195189 |
1307 | D07XC01 | RATIO-TOPISALIC | 20MG 0.5MG | Teva Canada Limited | Resolved | 2023-06-16 | 34 | Manufacturing distruption | 195136 |
1308 | N05CF01 | TEVA-ZOPICLONE | 5MG | Teva Canada Limited | Resolved | 2023-06-16 | 229 | Manufacturing distruption | 195195 |
1309 | C09AA05 | TEVA-RAMIPRIL | 2.5MG | Teva Canada Limited | Resolved | 2023-06-16 | 4 | Manufacturing distruption | 195201 |
1310 | C07AA05 | TEVA-PROPRANOLOL | 20MG | Teva Canada Limited | Resolved | 2023-06-16 | 14 | Manufacturing distruption | 195240 |
1311 | C10AA01 | TEVA-SIMVASTATIN | 40MG | Teva Canada Limited | Resolved | 2023-06-16 | 14 | Manufacturing distruption | 195243 |
1312 | N05AH03 | TEVA-OLANZAPINE | 2.5MG | Teva Canada Limited | Resolved | 2023-06-16 | 34 | Manufacturing distruption | 195216 |
1313 | A02BC03 | TEVA-LANSOPRAZOLE | 15MG | Teva Canada Limited | Resolved | 2023-06-16 | 14 | Manufacturing distruption | 195036 |
1314 | A02BC01 | TEVA-OMEPRAZOLE | 20MG | Teva Canada Limited | Resolved | 2023-06-16 | 44 | Manufacturing distruption | 195177 |
1315 | N04BC05 | ACT PRAMIPEXOLE | 1MG | Teva Canada Limited | Resolved | 2023-06-16 | 44 | Manufacturing distruption | 195127 |
1316 | C09BA03 | TEVA-LISINOPRIL/HCTZ (TYPE Z) | 12.5MG 20MG | Teva Canada Limited | Resolved | 2023-06-16 | 55 | Manufacturing distruption | 195033 |
1317 | C09BA03 | TEVA-LISINOPRIL/HCTZ (TYPE Z) | 25MG 20MG | Teva Canada Limited | Resolved | 2023-06-16 | 44 | Manufacturing distruption | 195124 |
1318 | C09BA03 | TEVA-LISINOPRIL/HCTZ (TYPE Z) | 25MG 20MG | Teva Canada Limited | Resolved | 2023-06-16 | 4 | Manufacturing distruption | 195204 |
1319 | N02AA01 | TEVA-MORPHINE SR | 15MG | Teva Canada Limited | Resolved | 2023-06-16 | 14 | Manufacturing distruption | 195210 |
1320 | N06AB10 | TEVA-ESCITALOPRAM | 10MG | Teva Canada Limited | Resolved | 2023-06-16 | 4 | Manufacturing distruption | 195133 |
1321 | N06DX01 | ACT MEMANTINE | 10MG | Teva Canada Limited | Resolved | 2023-06-16 | 24 | Manufacturing distruption | 195180 |
1322 | C10AA07 | TEVA-ROSUVASTATIN | 40MG | Teva Canada Limited | Resolved | 2023-06-16 | 86 | Manufacturing distruption | 195103 |
1323 | C09CA06 | TEVA-CANDESARTAN | 16MG | Teva Canada Limited | Resolved | 2023-06-16 | 44 | Manufacturing distruption | 195115 |
1324 | G04CA02 | TEVA-TAMSULOSIN CR | 0.4MG | Teva Canada Limited | Resolved | 2023-06-16 | 126 | Manufacturing distruption | 195078 |
1325 | N05AH04 | TEVA-QUETIAPINE XR | 150MG | Teva Canada Limited | Resolved | 2023-06-16 | 24 | Manufacturing distruption | 195118 |
1326 | L01XA01 | CISPLATIN INJECTION | 1.0MG | Teva Canada Limited | Resolved | 2023-06-16 | 55 | Manufacturing distruption | 195121 |
1327 | G04CB02 | TEVA-DUTASTERIDE | 0.5MG | Teva Canada Limited | Resolved | 2023-06-16 | 24 | Manufacturing distruption | 195164 |
1328 | L01DB01 | DOXORUBICIN HYDROCHLORIDE INJE... | 2MG | Teva Canada Limited | Resolved | 2023-06-16 | 187 | Manufacturing distruption | 195219 |
1329 | J05AR02 | TEVA-ABACAVIR/LAMIVUDINE | 300MG 600MG | Teva Canada Limited | Resolved | 2023-06-16 | 65 | Manufacturing distruption | 195072 |
1330 | C09DA07 | ACH-TELMISARTAN HCTZ | 12.5MG 80MG | Accord Healthcare Inc | Resolved | 2023-06-16 | Manufacturing practices | 195322 | |
1331 | C09DA07 | ACH-TELMISARTAN HCTZ | 25MG 80MG | Accord Healthcare Inc | Resolved | 2023-06-16 | Manufacturing practices | 195325 | |
1332 | C08CA01 | ACH-AMLODIPINE | 2.5MG | Accord Healthcare Inc | Resolved | 2023-06-16 | Manufacturing practices | 195262 | |
1333 | C08CA01 | ACH-AMLODIPINE | 5MG | Accord Healthcare Inc | Resolved | 2023-06-16 | Manufacturing practices | 195273 | |
1334 | C08CA01 | ACH-AMLODIPINE | 10MG | Accord Healthcare Inc | Resolved | 2023-06-16 | Manufacturing practices | 195276 | |
1335 | A02BC05 | TEVA-ESOMEPRAZOLE | 40MG | Teva Canada Limited | Resolved | 2023-06-16 | 299 | Manufacturing distruption | 195052 |
1336 | N06AB10 | ACH-ESCITALOPRAM | 10MG | Accord Healthcare Inc | Resolved | 2023-06-16 | Manufacturing practices | 195279 | |
1337 | N06AB10 | ACH-ESCITALOPRAM | 10MG | Accord Healthcare Inc | Resolved | 2023-06-16 | Manufacturing practices | 195282 | |
1338 | N06AB10 | ACH-ESCITALOPRAM | 20MG | Accord Healthcare Inc | Resolved | 2023-06-16 | Manufacturing practices | 195285 | |
1339 | C10AA07 | ACH-ROSUVASTATIN | 5MG | Accord Healthcare Inc | Resolved | 2023-06-16 | Manufacturing practices | 195298 | |
1340 | C10AA07 | ACH-ROSUVASTATIN | 10MG | Accord Healthcare Inc | Resolved | 2023-06-16 | Manufacturing practices | 195304 | |
1341 | C10AA07 | ACH-ROSUVASTATIN | 20MG | Accord Healthcare Inc | Resolved | 2023-06-16 | Manufacturing practices | 195307 | |
1342 | C10AA07 | ACH-ROSUVASTATIN | 40MG | Accord Healthcare Inc | Resolved | 2023-06-16 | Manufacturing practices | 195301 | |
1343 | C10AA07 | ACH-ROSUVASTATIN | 40MG | Accord Healthcare Inc | Resolved | 2023-06-16 | Manufacturing practices | 195310 | |
1344 | N06BA01 | TEVA-AMPHETAMINE XR | 15MG | Teva Canada Limited | Resolved | 2023-06-16 | 14 | Manufacturing distruption | 195130 |
1345 | N06BA01 | TEVA-AMPHETAMINE XR | 30MG | Teva Canada Limited | Resolved | 2023-06-16 | 34 | Manufacturing distruption | 195139 |
1347 | B01AF02 | ACH-APIXABAN | 5MG | Accord Healthcare Inc | Resolved | 2023-06-16 | 7 | Shipping delay | 195183 |
1348 | L01EA01 | ACH-IMATINIB | 100MG | Accord Healthcare Inc | Resolved | 2023-06-16 | Manufacturing practices | 195288 | |
1349 | L01EA01 | ACH-IMATINIB | 400MG | Accord Healthcare Inc | Resolved | 2023-06-16 | Manufacturing practices | 195292 | |
1350 | L04AX03 | METHOTREXATE SUBCUTANEOUS | 25MG | Accord Healthcare Inc | Resolved | 2023-06-16 | 28 | Manufacturing distruption | 195186 |
1351 | L01BA01 | ACH-METHOTREXATE | 2.5MG | Accord Healthcare Inc | Resolved | 2023-06-16 | Manufacturing practices | 195295 | |
1280 | N01BB52 | XYLOCAINE 2% W EPINEPHRINE 1:2... | 5MCG 20MG | Aspen Pharmacare Canada Inc. | Avoided | 2023-06-15 | 15 | Shipping delay | 188726 |
1279 | C10AA01 | ZOCOR | 20MG | Organon Canada Inc. | Resolved | 2023-06-15 | 36 | Manufacturing practices | 194985 |
1281 | J06BB09 | CYTOGAM | 2500MG | Ki Biopharma Llc | Resolved | 2023-06-15 | 214 | Other | 185788 |
1282 | M01AE52 | MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 375MG | Mylan Pharmaceuticals Ulc | Resolved | 2023-06-15 | 75 | Manufacturing distruption | 193442 |
1274 | N05AN01 | PMS-LITHIUM CARBONATE - CAP 15... | 150MG | Pharmascience Inc | Resolved | 2023-06-14 | 47 | Manufacturing distruption | 194542 |
1275 | N05BB01 | ATARAX | 10MG | Searchlight Pharma Inc | Resolved | 2023-06-14 | 37 | Demand increase | 194896 |
1276 | S01BC05 | KETOROLAC | 0.5% | Aa Pharma Inc | Resolved | 2023-06-14 | 111 | Manufacturing distruption | 194899 |
1277 | J07BK | SHINGRIX | 50MCG | Glaxosmithkline Inc | Resolved | 2023-06-14 | 30 | Other | 193889 |
1278 | N07BC51 | SUBOXONE | 1MG 4MG | Indivior Uk Limited | Resolved | 2023-06-14 | 16 | Demand increase | 194776 |
1261 | G04BD04 | APO-OXYBUTYNIN | 5MG | Apotex Inc | Resolved | 2023-06-13 | 31 | Manufacturing distruption | 195086 |
1262 | M01CC01 | CUPRIMINE | 250MG | Bausch Health, Canada Inc. | Resolved | 2023-06-13 | 26 | Other | 192293 |
1263 | M01AE02 | APO-NAPROXEN | 500MG | Apotex Inc | Resolved | 2023-06-13 | 73 | Manufacturing distruption | 195063 |
1264 | C07AB02 | APO-METOPROLOL | 50MG | Apotex Inc | Resolved | 2023-06-13 | 38 | Manufacturing distruption | 195094 |
1265 | N03AG01 | APO-DIVALPROEX | 250MG | Apotex Inc | Resolved | 2023-06-13 | 24 | Manufacturing distruption | 195097 |
1266 | C07AG01 | APO-LABETALOL | 100MG | Apotex Inc | Resolved | 2023-06-13 | 45 | Manufacturing distruption | 195069 |
1267 | G03DA02 | APO-MEDROXY TABLETS | 2.5MG | Apotex Inc | Resolved | 2023-06-13 | 80 | Ingredient shortage | 189662 |
1268 | N03AX09 | APO-LAMOTRIGINE | 100MG | Apotex Inc | Resolved | 2023-06-13 | 17 | Manufacturing distruption | 195100 |
1269 | N03AX09 | APO-LAMOTRIGINE | 150MG | Apotex Inc | Resolved | 2023-06-13 | 17 | Manufacturing distruption | 195075 |
1270 | C10AA01 | APO-SIMVASTATIN | 80MG | Apotex Inc | Resolved | 2023-06-13 | 17 | Manufacturing distruption | 195058 |
1271 | G03AA12 | ZAMINE 21 | 0.03MG 3MG | Apotex Inc | Resolved | 2023-06-13 | 45 | Manufacturing distruption | 195081 |
1272 | C08CA02 | APO-FELODIPINE | 2.5MG | Apotex Inc | Resolved | 2023-06-13 | 52 | Manufacturing distruption | 195091 |
1273 | B01AC24 | APO-TICAGRELOR | 90MG | Apotex Inc | Resolved | 2023-06-13 | 73 | Manufacturing distruption | 195049 |
1241 | H03BA02 | PROPYLTHIOURACIL TABLETS | 50MG | Phebra Canada Inc | Resolved | 2023-06-12 | 35 | Shipping delay | 194988 |
1242 | C01CA06 | PHENYLEPHRINE HYDROCHLORIDE IN... | 10MG | Sandoz Canada Incorporated | Resolved | 2023-06-12 | 11 | Manufacturing practices | 194769 |
1243 | M03CA01 | DANTRIUM INTRAVENOUS | 20MG | Endo Par Innovation Company, Llc | Resolved | 2023-06-12 | 39 | Shipping delay | 194917 |
1244 | N06AB06 | ZOLOFT | 25MG | Upjohn Canada Ulc | Resolved | 2023-06-12 | 43 | Manufacturing distruption | 193014 |
1245 | D06BB10 | ALDARA P | 5% | Bausch Health, Canada Inc. | Resolved | 2023-06-12 | 32 | Demand increase | 194954 |
1246 | C09AA08 | MYLAN-CILAZAPRIL | 5.0MG | Mylan Pharmaceuticals Ulc | Resolved | 2023-06-12 | Manufacturing distruption | 193448 | |
1247 | C08CA01 | SANDOZ AMLODIPINE | 5MG | Sandoz Canada Incorporated | Resolved | 2023-06-12 | 32 | Manufacturing distruption | 194746 |
1248 | J01MA12 | SANDOZ LEVOFLOXACIN | 500MG | Sandoz Canada Incorporated | Resolved | 2023-06-12 | 11 | Manufacturing distruption | 194766 |
1249 | B01AF01 | XARELTO | 10MG | Bayer Inc | Resolved | 2023-06-12 | 7 | Shipping delay | 194785 |
1250 | C09CA06 | SANDOZ CANDESARTAN | 16MG | Sandoz Canada Incorporated | Resolved | 2023-06-12 | 81 | Manufacturing distruption | 194760 |
1251 | C09DA06 | SANDOZ CANDESARTAN PLUS | 12.5MG 16MG | Sandoz Canada Incorporated | Resolved | 2023-06-12 | 67 | Manufacturing distruption | 194754 |
1252 | J01FA10 | SANDOZ AZITHROMYCIN | 100MG | Sandoz Canada Incorporated | Resolved | 2023-06-12 | 39 | Demand increase | 194749 |
1253 | D11AX10 | SANDOZ FINASTERIDE A | 1MG | Sandoz Canada Incorporated | Resolved | 2023-06-12 | 32 | Manufacturing distruption | 194763 |
1254 | L04AA06 | ACH-MYCOPHENOLATE | 500MG | Accord Healthcare Inc | Resolved | 2023-06-12 | 143 | Demand increase | 194727 |
1255 | N02BF02 | SANDOZ PREGABALIN | 150MG | Sandoz Canada Incorporated | Resolved | 2023-06-12 | 32 | Manufacturing distruption | 194773 |
1256 | N03AX14 | ACH-LEVETIRACETAM | 250MG | Accord Healthcare Inc | Resolved | 2023-06-12 | 95 | Demand increase | 194724 |
1257 | N02AX06 | NUCYNTA EXTENDED-RELEASE | 100MG | Endo Ventures Ltd. | Resolved | 2023-06-12 | 284 | Shipping delay | 194857 |
1258 | C09DA06 | SANDOZ CANDESARTAN PLUS | 25MG 32MG | Sandoz Canada Incorporated | Resolved | 2023-06-12 | 214 | Manufacturing distruption | 194757 |
1259 | C10AA07 | ACH-ROSUVASTATIN | 10MG | Accord Healthcare Inc | Resolved | 2023-06-12 | Manufacturing practices | 194730 | |
1260 | C10AA07 | ACH-ROSUVASTATIN | 20MG | Accord Healthcare Inc | Resolved | 2023-06-12 | 466 | Manufacturing practices | 194733 |
1239 | N06AX05 | TEVA-TRAZODONE | 50MG | Teva Canada Limited | Resolved | 2023-06-11 | 223 | Manufacturing distruption | 198280 |
1240 | V09FX01 | ULTRA-TECHNEKOW V4 | 19CI | Curium Canada Inc | Resolved | 2023-06-11 | 3 | Ingredient shortage | 188852 |
1237 | V03AB37 | PRAXBIND | 50MG | Boehringer Ingelheim (Canada) Ltd Ltee | Resolved | 2023-06-10 | 374 | Demand increase | 230064 |
1238 | J01FF01 | CLINDAMYCIN INJECTION IN 5% DE... | 600MG | Baxter Corporation | Resolved | 2023-06-10 | 143 | Ingredient shortage | 183714 |
1223 | D01AE14 | STIEPROX SHAMPOO | 1.5% | Glaxosmithkline Inc | Resolved | 2023-06-09 | 28 | Shipping delay | 193892 |
1224 | N01BB01 | BUPIVACAINE HYDROCHLORIDE IN D... | 7.5MG | Omega Laboratories Limited | Resolved | 2023-06-09 | Demand increase | 194676 | |
1225 | B05XA07 | CALCIJECT INJ 100MG/ML | 100MG | Omega Laboratories Limited | Resolved | 2023-06-09 | Demand increase | 190165 | |
1226 | N05AN01 | PMS-LITHIUM CARBONATE - CAP 30... | 300MG | Pharmascience Inc | Resolved | 2023-06-09 | 52 | Manufacturing distruption | 194510 |
1227 | H02AB02 | DEXAMETHASONE-OMEGA | 4MG | Omega Laboratories Limited | Resolved | 2023-06-09 | Demand increase | 194664 | |
1228 | A02BA03 | FAMOTIDINE OMEGA -(WITHOUT PR... | 10MG | Omega Laboratories Limited | Resolved | 2023-06-09 | Demand increase | 192878 | |
1229 | G04BE08 | PMS-TADALAFIL | 2.5MG | Pharmascience Inc | Resolved | 2023-06-09 | 45 | Manufacturing distruption | 194515 |
1230 | C02KX | PMS-SILDENAFIL R | 20MG | Pharmascience Inc | Resolved | 2023-06-09 | 119 | Manufacturing distruption | 194518 |
1231 | S01AE07 | PMS-MOXIFLOXACIN | 0.5% | Pharmascience Inc | Resolved | 2023-06-09 | 35 | Manufacturing distruption | 194530 |
1232 | C09CA08 | PMS-OLMESARTAN | 40MG | Pharmascience Inc | Resolved | 2023-06-09 | 113 | Manufacturing distruption | 194533 |
1233 | N06AB03 | PMS-FLUOXETINE | 40MG | Pharmascience Inc | Resolved | 2023-06-09 | 174 | Manufacturing distruption | 194536 |
1234 | N06AB03 | PMS-FLUOXETINE | 60MG | Pharmascience Inc | Resolved | 2023-06-09 | 174 | Manufacturing distruption | 194539 |
1235 | L04AX03 | METHOTREXATE SUBCUTANEOUS | 20MG | Accord Healthcare Inc | Resolved | 2023-06-09 | 14 | Shipping delay | 194721 |
1236 | L04AX03 | METHOTREXATE SUBCUTANEOUS | 22.5MG | Accord Healthcare Inc | Resolved | 2023-06-09 | 20 | Shipping delay | 194718 |
1214 | J01MA14 | TEVA-MOXIFLOXACIN | 400MG | Teva Canada Limited | Active | 2023-06-08 | Manufacturing distruption | 194157 | |
1182 | H01AC01 | NORDITROPIN NORDIFLEX | 5MG | Novo Nordisk Canada Inc | Resolved | 2023-06-08 | 83 | Other | 178319 |
1183 | L02BG06 | TEVA-EXEMESTANE | 25MG | Teva Canada Limited | Resolved | 2023-06-08 | 73 | Manufacturing distruption | 194175 |
1184 | D07AD01 | TEVA-CLOBETASOL | 0.05% | Teva Canada Limited | Resolved | 2023-06-08 | 94 | Manufacturing distruption | 194080 |
1185 | D07AC01 | TEVA-TOPILENE | 0.05% | Teva Canada Limited | Resolved | 2023-06-08 | 52 | Manufacturing distruption | 194088 |
1186 | J01CF02 | TEVA-CLOXACILLIN | 125MG | Teva Canada Limited | Resolved | 2023-06-08 | 63 | Manufacturing distruption | 194054 |
1187 | C07AA05 | TEVA-PROPRANOLOL | 80MG | Teva Canada Limited | Resolved | 2023-06-08 | 32 | Manufacturing distruption | 194057 |
1188 | C07AA05 | TEVA-PROPRANOLOL | 80MG | Teva Canada Limited | Resolved | 2023-06-08 | 42 | Manufacturing distruption | 194061 |
1189 | D07AC01 | TEVA-ECTOSONE | 0.05% | Teva Canada Limited | Resolved | 2023-06-08 | 185 | Manufacturing distruption | 194068 |
1190 | C01BB02 | TEVA-MEXILETINE | 100MG | Teva Canada Limited | Resolved | 2023-06-08 | 83 | Manufacturing distruption | 194091 |
1191 | C03DA01 | TEVA-SPIRONOLACTONE | 100MG | Teva Canada Limited | Resolved | 2023-06-08 | 22 | Manufacturing distruption | 194071 |
1192 | M01AE02 | TEVA-NAPROXEN EC | 500MG | Teva Canada Limited | Resolved | 2023-06-08 | 63 | Manufacturing distruption | 194094 |
1193 | D07AC01 | TEVA-ECTOSONE | 0.05% | Teva Canada Limited | Resolved | 2023-06-08 | 347 | Manufacturing distruption | 194074 |
1194 | D07AD01 | TARO-CLOBETASOL CREAM USP, 0.0... | 0.05% | Taro Pharmaceuticals Inc | Resolved | 2023-06-08 | 113 | Manufacturing distruption | 202453 |
1195 | C09AA05 | TEVA-RAMIPRIL | 2.5MG | Teva Canada Limited | Resolved | 2023-06-08 | 22 | Manufacturing distruption | 194097 |
1196 | N02CC06 | RELPAX | 40MG | Upjohn Canada Ulc | Resolved | 2023-06-08 | Manufacturing distruption | 194835 | |
1197 | N06AX11 | TEVA-MIRTAZAPINE | 30MG | Teva Canada Limited | Resolved | 2023-06-08 | 73 | Manufacturing distruption | 194100 |
1198 | N03AX14 | TEVA-LEVETIRACETAM | 500MG | Teva Canada Limited | Resolved | 2023-06-08 | 83 | Manufacturing distruption | 194103 |
1199 | N05AH03 | TEVA-OLANZAPINE | 2.5MG | Teva Canada Limited | Resolved | 2023-06-08 | 42 | Manufacturing distruption | 194109 |
1200 | C09AA02 | ACT ENALAPRIL | 8MG | Teva Canada Limited | Resolved | 2023-06-08 | 52 | Manufacturing distruption | 194113 |
1201 | A02BC01 | TEVA-OMEPRAZOLE | 20MG | Teva Canada Limited | Resolved | 2023-06-08 | 63 | Manufacturing distruption | 194116 |
1202 | C09BA03 | TEVA-LISINOPRIL/HCTZ (TYPE Z) | 12.5MG 20MG | Teva Canada Limited | Resolved | 2023-06-08 | 52 | Manufacturing distruption | 194119 |
1203 | C09BA03 | TEVA-LISINOPRIL/HCTZ (TYPE Z) | 25MG 20MG | Teva Canada Limited | Resolved | 2023-06-08 | 52 | Manufacturing distruption | 194122 |
1204 | N02AA01 | TEVA-MORPHINE SR | 15MG | Teva Canada Limited | Resolved | 2023-06-08 | 22 | Manufacturing distruption | 194125 |
1205 | G03HB01 | TEVA-CYPROTERONE / ETHINYL EST... | 0.035MG 2MG | Teva Canada Limited | Resolved | 2023-06-08 | 12 | Manufacturing distruption | 194128 |
1206 | N02CC02 | TEVA-NARATRIPTAN | 2.5MG | Teva Canada Limited | Resolved | 2023-06-08 | 83 | Manufacturing distruption | 194131 |
1207 | C09CA04 | TEVA-IRBESARTAN | 75MG | Teva Canada Limited | Resolved | 2023-06-08 | 155 | Manufacturing distruption | 194135 |
1208 | C09CA04 | TEVA-IRBESARTAN | 300MG | Teva Canada Limited | Resolved | 2023-06-08 | 317 | Manufacturing distruption | 194138 |
1209 | N06AB10 | TEVA-ESCITALOPRAM | 10MG | Teva Canada Limited | Resolved | 2023-06-08 | 32 | Manufacturing distruption | 194141 |
1210 | L01DB03 | EPIRUBICIN FOR INJECTION | 2MG | Teva Canada Limited | Resolved | 2023-06-08 | 104 | Manufacturing distruption | 194144 |
1211 | C10AA07 | TEVA-ROSUVASTATIN | 20MG | Teva Canada Limited | Resolved | 2023-06-08 | 63 | Manufacturing distruption | 194148 |
1212 | C10AA07 | TEVA-ROSUVASTATIN | 40MG | Teva Canada Limited | Resolved | 2023-06-08 | 104 | Manufacturing distruption | 194151 |
1213 | C09CA06 | TEVA-CANDESARTAN | 32MG | Teva Canada Limited | Resolved | 2023-06-08 | 134 | Manufacturing distruption | 194154 |
1215 | J01GB01 | TEVA-TOBRAMYCIN | 60MG | Teva Canada Limited | Resolved | 2023-06-08 | 52 | Manufacturing distruption | 194160 |
1216 | N05AH04 | TEVA-QUETIAPINE XR | 150MG | Teva Canada Limited | Resolved | 2023-06-08 | 32 | Manufacturing distruption | 194163 |
1217 | G04BD08 | TEVA-SOLIFENACIN | 10MG | Teva Canada Limited | Resolved | 2023-06-08 | 114 | Manufacturing distruption | 194167 |
1218 | N02AB03 | FENTORA | 600MCG | Teva Canada Limited | Resolved | 2023-06-08 | 83 | Manufacturing distruption | 194172 |
1219 | J05AR02 | TEVA-ABACAVIR/LAMIVUDINE | 300MG 600MG | Teva Canada Limited | Resolved | 2023-06-08 | 73 | Manufacturing distruption | 194180 |
1220 | C08DB01 | TEVA-DILTIAZEM XC | 360MG | Teva Canada Limited | Resolved | 2023-06-08 | 195 | Manufacturing distruption | 194191 |
1221 | C03CA01 | TEVA-FUROSEMIDE | 80MG | Teva Canada Limited | Resolved | 2023-06-08 | 12 | Manufacturing distruption | 194077 |
1222 | N03AX18 | TEVA-LACOSAMIDE | 150MG | Teva Canada Limited | Resolved | 2023-06-08 | 205 | Manufacturing distruption | 194194 |
1180 | C10AB05 | LIPIDIL EZ | 48MG | Bgp Pharma Ulc | Avoided | 2023-06-07 | 48 | Manufacturing distruption | 189897 |
1181 | S01XA18 | RESTASIS MULTIDOSE | 0.05% | Abbvie Corporation | Resolved | 2023-06-07 | 51 | Shipping delay | 194083 |
1167 | N06AX16 | APO-VENLAFAXINE XR | 75MG | Apotex Inc | Active | 2023-06-06 | Manufacturing distruption | 194581 | |
1168 | H02AA02 | FLORINEF | 0.1MG | Paladin Labs Inc. | Resolved | 2023-06-06 | 22 | Shipping delay | 193859 |
1169 | B01AC04 | PLAVIX | 75MG | Sanofi-Aventis Canada Inc | Resolved | 2023-06-06 | 108 | Other | 193873 |
1170 | C10AA05 | LIPITOR | 80MG | Upjohn Canada Ulc | Resolved | 2023-06-06 | 77 | Manufacturing distruption | 191722 |
1171 | C07AG02 | APO-CARVEDILOL | 12.5MG | Apotex Inc | Resolved | 2023-06-06 | 52 | Manufacturing distruption | 194584 |
1172 | C10BX03 | CADUET | 80MG 10MG | Upjohn Canada Ulc | Resolved | 2023-06-06 | Manufacturing distruption | 187510 | |
1173 | R01AD12 | AVAMYS | 27.5MCG | Glaxosmithkline Inc | Resolved | 2023-06-06 | 17 | Demand increase | 193896 |
1174 | A02BC05 | APO-ESOMEPRAZOLE | 20MG | Apotex Inc | Resolved | 2023-06-06 | 52 | Manufacturing distruption | 194568 |
1175 | N02AA03 | APO-HYDROMORPHONE | 8MG | Apotex Inc | Resolved | 2023-06-06 | 136 | Manufacturing distruption | 194587 |
1176 | A10BB09 | APO-GLICLAZIDE MR | 60MG | Apotex Inc | Resolved | 2023-06-06 | 115 | Manufacturing distruption | 194571 |
1177 | L02BX03 | APO-ABIRATERONE FILM COATED TA... | 250MG | Apotex Inc | Resolved | 2023-06-06 | 38 | Manufacturing distruption | 194577 |
1178 | L02BX03 | APO-ABIRATERONE FILM COATED TA... | 500MG | Apotex Inc | Resolved | 2023-06-06 | 38 | Manufacturing distruption | 194574 |
1179 | APO-MELOXICAM | 1.5G | Apotex Inc | Resolved | 2023-06-06 | 38 | Manufacturing distruption | 194564 | |
1147 | N02AA03 | HYDROMORPHONE HP FORTE INJECTI... | 1000MG | Sandoz Canada Incorporated | Active | 2023-06-05 | Manufacturing distruption | 193713 | |
1165 | C10AA03 | M-PRAVASTATIN | 40MG | Mantra Pharma Inc | Active | 2023-06-05 | 756 | Shipping delay | 225556 |
1148 | G03AA05 | BREVICON 1/35 TABLETS (28-DAY ... | 0.035MG 1MG | Pfizer Canada Ulc | Resolved | 2023-06-05 | 46 | Manufacturing distruption | 193321 |
1149 | C03BA11 | MYLAN-INDAPAMIDE | 1.25MG | Mylan Pharmaceuticals Ulc | Resolved | 2023-06-05 | 158 | Manufacturing distruption | 196701 |
1150 | D10AF51 | CLINDOXYL GEL | 1% 5% | Glaxosmithkline Inc | Resolved | 2023-06-05 | 40 | Demand increase | 193899 |
1151 | G03CA03 | ESTRADOT 100 | 100MCG | Sandoz Canada Incorporated | Resolved | 2023-06-05 | 74 | Manufacturing distruption | 193719 |
1152 | N01AX03 | KETAMINE HYDROCHLORIDE INJECTI... | 10MG | Sandoz Canada Incorporated | Resolved | 2023-06-05 | 32 | Manufacturing practices | 193726 |
1153 | S01BC05 | ACULAR LS | 0.4% | Abbvie Corporation | Resolved | 2023-06-05 | 32 | Demand increase | 193833 |
1154 | C09AA02 | SANDOZ ENALAPRIL | 16MG | Sandoz Canada Incorporated | Resolved | 2023-06-05 | 60 | Manufacturing distruption | 193715 |
1155 | C09CA04 | SANDOZ IRBESARTAN | 300MG | Sandoz Canada Incorporated | Resolved | 2023-06-05 | 53 | Demand increase | 193723 |
1156 | R03DC03 | SANDOZ MONTELUKAST | 5MG | Sandoz Canada Incorporated | Resolved | 2023-06-05 | 4 | Manufacturing practices | 193742 |
1157 | C10AA01 | SIMVASTATIN | 40MG | Sivem Pharmaceuticals Ulc | Resolved | 2023-06-05 | 263 | Shipping delay | 211164 |
1158 | C09DA07 | SANDOZ TELMISARTAN HCT | 12.5MG 80MG | Sandoz Canada Incorporated | Resolved | 2023-06-05 | 46 | Manufacturing distruption | 193737 |
1159 | P01BB51 | MYLAN-ATOVAQUONE/PROGUANIL | 100MG 250MG | Mylan Pharmaceuticals Ulc | Resolved | 2023-06-05 | 73 | Manufacturing distruption | 189338 |
1160 | C09DA06 | SANDOZ CANDESARTAN PLUS | 12.5MG 32MG | Sandoz Canada Incorporated | Resolved | 2023-06-05 | 263 | Manufacturing distruption | 193703 |
1161 | M01AE52 | MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 500MG | Mylan Pharmaceuticals Ulc | Resolved | 2023-06-05 | 78 | Manufacturing distruption | 191357 |
1162 | R01AD09 | SANDOZ MOMETASONE | 50MCG | Sandoz Canada Incorporated | Resolved | 2023-06-05 | 11 | Shipping delay | 193735 |
1163 | N03AX14 | SANDOZ LEVETIRACETAM | 500MG | Sandoz Canada Incorporated | Resolved | 2023-06-05 | 18 | Manufacturing distruption | 193731 |
1164 | V03AC03 | SANDOZ DEFERASIROX | 500MG | Sandoz Canada Incorporated | Resolved | 2023-06-05 | 144 | Shipping delay | 193710 |
1166 | J01CR02 | SANDOZ AMOXI-CLAV TABLET | 125MG 500MG | Sandoz Canada Incorporated | Resolved | 2023-06-05 | 4 | Shipping delay | 193693 |
1141 | J04AB02 | ROFACT | 150MG | Bausch Health, Canada Inc. | Avoided | 2023-06-02 | 3 | Other | 191061 |
1140 | B05XA07 | CALCIJECT INJ 100MG/ML | 100MG | Omega Laboratories Limited | Resolved | 2023-06-02 | Demand increase | 192434 | |
1142 | L01CA02 | VINCRISTINE SULFATE INJECTION ... | 1MG | Pfizer Canada Ulc | Resolved | 2023-06-02 | Manufacturing distruption | 189937 | |
1143 | N06AG02 | MOCLOBEMIDE | 100MG | Aa Pharma Inc | Resolved | 2023-06-02 | 90 | Manufacturing distruption | 192275 |
1144 | A04AA02 | GRANISETRON HYDROCHLORIDE INJE... | 1MG | Omega Laboratories Limited | Resolved | 2023-06-02 | Demand increase | 192881 | |
1145 | B05XA17 | POTASSIUM ACETATE INJECTION US... | 39.2% | Omega Laboratories Limited | Resolved | 2023-06-02 | Demand increase | 192443 | |
1146 | G04BE03 | ACCEL-SILDENAFIL | 25MG | Accel Pharma Inc | Resolved | 2023-06-02 | 21 | Shipping delay | 193986 |
1136 | R05FA02 | ROBITUSSIN AC | 10MG 100MG 7.5MG | Glaxosmithkline Consumer Healthcare Ulc | Active | 2023-06-01 | Other | 199216 | |
1137 | L01BA04 | PEMETREXED FOR INJECTION | 25MG | Accord Healthcare Inc | Resolved | 2023-06-01 | 50 | Manufacturing distruption | 198402 |
1138 | N01BB09 | NAROPIN | 5MG | Aspen Pharmacare Canada Inc. | Resolved | 2023-06-01 | 29 | Shipping delay | 188744 |
1139 | C05BB04 | TROMBOJECT 1% | 10MG | Omega Laboratories Limited | Resolved | 2023-06-01 | Manufacturing distruption | 206237 | |
1132 | G03DA04 | ENDOMETRIN | 100MG | Ferring Inc | Active | 2023-05-31 | 731 | Other | 193425 |
1129 | J01GB01 | TOBI | 300MG | Bgp Pharma Ulc | Resolved | 2023-05-31 | 489 | Demand increase | 192953 |
1130 | L01XX05 | MYLAN-HYDROXYUREA | 500MG | Mylan Pharmaceuticals Ulc | Resolved | 2023-05-31 | 51 | Manufacturing distruption | 196061 |
1131 | L01XD03 | METVIX | 168MG | Galderma Canada Inc | Resolved | 2023-05-31 | 45 | Manufacturing distruption | 193468 |
1133 | N06DA03 | MYLAN-RIVASTIGMINE PATCH 10 | 9.5MG | Mylan Pharmaceuticals Ulc | Resolved | 2023-05-31 | 30 | Demand increase | 193436 |
1134 | G03GA10 | REKOVELLE | 36MCG | Ferring Inc | Resolved | 2023-05-31 | 65 | Other | 193434 |
1135 | G03GA10 | REKOVELLE | 72MCG | Ferring Inc | Resolved | 2023-05-31 | 49 | Other | 193445 |
1113 | M03BX01 | APO-BACLOFEN | 10MG | Apotex Inc | Resolved | 2023-05-30 | 66 | Manufacturing distruption | 193620 |
1114 | B05BA03 | DEXTROSE INJECTION USP | 50MG | Icu Medical Canada Inc | Resolved | 2023-05-30 | 55 | Manufacturing distruption | 193864 |
1115 | R01AD01 | APO-BECLOMETHASONE NASAL SPRAY | 50MCG | Apotex Inc | Resolved | 2023-05-30 | 24 | Manufacturing distruption | 193611 |
1116 | H02AB02 | DEXAMETHASONE SODIUM PHOSPHATE... | 4MG | Sandoz Canada Incorporated | Resolved | 2023-05-30 | 38 | Manufacturing distruption | 193383 |
1117 | N05AX08 | SANDOZ RISPERIDONE | 2MG | Sandoz Canada Incorporated | Resolved | 2023-05-30 | 17 | Manufacturing distruption | 193391 |
1118 | N02AA05 | APO-OXYCODONE CR | 40MG | Apotex Inc | Resolved | 2023-05-30 | 73 | Manufacturing distruption | 193614 |
1119 | N06BA09 | APO-ATOMOXETINE | 40MG | Apotex Inc | Resolved | 2023-05-30 | 38 | Manufacturing distruption | 193600 |
1120 | N02CC02 | SANDOZ NARATRIPTAN | 2.5MG | Sandoz Canada Incorporated | Resolved | 2023-05-30 | 20 | Manufacturing practices | 193387 |
1121 | G04BD08 | SANDOZ SOLIFENACIN | 5MG | Sandoz Canada Incorporated | Resolved | 2023-05-30 | 143 | Manufacturing distruption | 193395 |
1122 | J02AC03 | SANDOZ VORICONAZOLE | 200MG | Sandoz Canada Incorporated | Resolved | 2023-05-30 | 17 | Ingredient shortage | 193399 |
1123 | B01AC04 | CLOPIDOGREL | 75MG | Sanis Health Inc | Resolved | 2023-05-30 | Manufacturing distruption | 187295 | |
1124 | N07XX06 | APO-TETRABENAZINE | 25MG | Apotex Inc | Resolved | 2023-05-30 | 31 | Manufacturing distruption | 193603 |
1125 | C09CA06 | SANDOZ CANDESARTAN | 32MG | Sandoz Canada Incorporated | Resolved | 2023-05-30 | 3 | Manufacturing distruption | 193358 |
1126 | H05BX01 | APO-CINACALCET | 60MG | Apotex Inc | Resolved | 2023-05-30 | 17 | Manufacturing distruption | 193606 |
1127 | C09BB04 | APO-PERINDOPRIL/AMLODIPINE | 10MG 14MG | Apotex Inc | Resolved | 2023-05-30 | 38 | Manufacturing distruption | 193617 |
1128 | J01XX09 | DAPTOMYCIN FOR INJECTION | 500MG | Sandoz Canada Incorporated | Resolved | 2023-05-30 | 24 | Manufacturing distruption | 193379 |
1105 | N06AX11 | PMS-MIRTAZAPINE | 30MG | Pharmascience Inc | Active | 2023-05-29 | Manufacturing distruption | 193294 | |
1103 | L01EX03 | PMS-PAZOPANIB | 200MG | Pharmascience Inc | Resolved | 2023-05-29 | 139 | Manufacturing distruption | 193291 |
1104 | N03AB02 | DILANTIN INFATABS | 50MG | Upjohn Canada Ulc | Resolved | 2023-05-29 | Demand increase | 193001 | |
1106 | S01AA17 | ERYTHROMYCIN OPHTHALMIC OINTME... | 5MG | Steri-Med Pharma Inc. | Resolved | 2023-05-29 | 49 | Demand increase | 194978 |
1107 | N06DA04 | MYLAN-GALANTAMINE ER | 8MG | Mylan Pharmaceuticals Ulc | Resolved | 2023-05-29 | 60 | Manufacturing distruption | 191317 |
1108 | D10AF51 | BIACNA TOPICAL GEL | 0.025% 1.2% | Bausch Health, Canada Inc. | Resolved | 2023-05-29 | 10 | Shipping delay | 187755 |
1109 | A06AA02 | TARO-DOCUSATE | 100MG | Taro Pharmaceuticals Inc | Resolved | 2023-05-29 | 179 | Shipping delay | 194655 |
1110 | J01DB01 | LUPIN-CEPHALEXIN | 125MG | Lupin Pharma Canada Limited | Resolved | 2023-05-29 | Demand increase | 193299 | |
1111 | J01DB01 | LUPIN-CEPHALEXIN | 250MG | Lupin Pharma Canada Limited | Resolved | 2023-05-29 | Demand increase | 193303 | |
1112 | J01GB01 | TOBRAMYCIN INJECTION USP | 40MG | Sterimax Inc | Resolved | 2023-05-29 | 18 | Shipping delay | 193492 |
1102 | M03BX01 | BACLOFEN INJECTION | 0.05MG | Hikma Canada Limited | Active | 2023-05-26 | Shipping delay | 193244 | |
1095 | C08DB01 | DILTIAZEM HYDROCHLORIDE INJECT... | 5MG | Omega Laboratories Limited | Resolved | 2023-05-26 | Manufacturing distruption | 189684 | |
1096 | B05BA03 | DEXTROSE INJECTION | 50% | Omega Laboratories Limited | Resolved | 2023-05-26 | 60 | Demand increase | 192884 |
1097 | S01BC03 | VOLTAREN OPHTHA | 0.1% | Novartis Pharmaceuticals Canada Inc | Resolved | 2023-05-26 | 122 | Manufacturing distruption | 192835 |
1098 | B05XA01 | POTASSIUM CHLORIDE FOR INJECTI... | 20mEq | Omega Laboratories Limited | Resolved | 2023-05-26 | Demand increase | 193268 | |
1099 | A11DA01 | THIAMIJECT INJECTION - LIQ IM... | 100MG | Omega Laboratories Limited | Resolved | 2023-05-26 | Demand increase | 192873 | |
1100 | G03BA03 | ANDROGEL | 12.5MG | Bgp Pharma Ulc | Resolved | 2023-05-26 | 11 | Manufacturing distruption | 192956 |
1101 | M03AB01 | SUCCINYLCHOLINE CHLORIDE INJEC... | 20MG | Hikma Canada Limited | Resolved | 2023-05-26 | 250 | Demand increase | 193247 |
1087 | N02AA03 | PMS-HYDROMORPHONE TAB 1MG | 1MG | Pharmascience Inc | Resolved | 2023-05-25 | 6 | Manufacturing distruption | 193079 |
1088 | A02BX02 | SULCRATE | 1G | Aptalis Pharma Canada Ulc | Resolved | 2023-05-25 | 97 | Demand increase | 193626 |
1089 | A09AA02 | COTAZYM ECS 8 | 45000UNIT 42000UNIT 10800UNIT | Organon Canada Inc. | Resolved | 2023-05-25 | 29 | Shipping delay | 192697 |
1090 | V03AF07 | FASTURTEC | 1.5MG | Sanofi-Aventis Canada Inc | Resolved | 2023-05-25 | 127 | Other | 193234 |
1091 | N03AB02 | TARO-PHENYTOIN | 125MG | Taro Pharmaceuticals Inc | Resolved | 2023-05-25 | 134 | Manufacturing distruption | 202476 |
1092 | N06AX11 | MYLAN-MIRTAZAPINE | 45MG | Mylan Pharmaceuticals Ulc | Resolved | 2023-05-25 | 47 | Other | 186407 |
1093 | A06AA02 | TARO-DOCUSATE | 100MG | Taro Pharmaceuticals Inc | Resolved | 2023-05-25 | 183 | Shipping delay | 194658 |
1094 | G03GA10 | REKOVELLE | 12MCG | Ferring Inc | Resolved | 2023-05-25 | 92 | Other | 193120 |
1081 | B05XA08 | SODIUM ACETATE-OMEGA | 328MG | Omega Laboratories Limited | Resolved | 2023-05-24 | 40 | Demand increase | 192437 |
1082 | V03AC01 | DEFEROXAMINE MESYLATE FOR INJE... | 500MG | Pfizer Canada Ulc | Resolved | 2023-05-24 | Manufacturing distruption | 188236 | |
1083 | N01BB51 | MARCAINE E | 0.182MG 100MG | Pfizer Canada Ulc | Resolved | 2023-05-24 | Manufacturing distruption | 192966 | |
1084 | N01BB03 | CARBOCAINE 1% | 10MG | Pfizer Canada Ulc | Resolved | 2023-05-24 | Manufacturing distruption | 192969 | |
1085 | L01CE02 | IRINOTECAN HYDROCHLORIDE INJEC... | 20MG | Pfizer Canada Ulc | Resolved | 2023-05-24 | Manufacturing distruption | 187760 | |
1086 | C09DA06 | TEVA-CANDESARTAN/HCTZ | 12.5MG 32MG | Teva Canada Limited | Resolved | 2023-05-24 | 312 | Manufacturing distruption | 206425 |
1069 | L02BA01 | APO-TAMOX TAB 10MG | 10MG | Apotex Inc | Resolved | 2023-05-23 | 10 | Manufacturing distruption | 193209 |
1070 | A09AA02 | CREON MINIMICROSPHERES 25 | 1600UNIT 25500UNIT 25000UNIT | Bgp Pharma Ulc | Resolved | 2023-05-23 | 21 | Other | 192959 |
1071 | M01AE02 | APO-NAPRO-NA DS | 550MG | Apotex Inc | Resolved | 2023-05-23 | 66 | Manufacturing distruption | 193215 |
1072 | N06AX05 | APO-TRAZODONE TABLETS 100MG | 100MG | Apotex Inc | Resolved | 2023-05-23 | 66 | Manufacturing distruption | 193221 |
1073 | D01BA02 | APO-TERBINAFINE | 250MG | Apotex Inc | Resolved | 2023-05-23 | 31 | Manufacturing distruption | 193212 |
1074 | A11GA01 | VITAMIN C | 500MG | Mylan Pharmaceuticals Ulc | Resolved | 2023-05-23 | Demand increase | 189880 | |
1075 | N02AA05 | APO-OXYCODONE CR | 10MG | Apotex Inc | Resolved | 2023-05-23 | 80 | Manufacturing distruption | 193224 |
1076 | G03AA12 | MYA | 0.02MG 3.00MG | Apotex Inc | Resolved | 2023-05-23 | 17 | Manufacturing distruption | 193206 |
1077 | N07BA03 | APO-VARENICLINE | 0.5MG | Apotex Inc | Resolved | 2023-05-23 | 10 | Manufacturing distruption | 193227 |
1078 | C07AB03 | APO-ATENOL TAB 50MG | 50MG | Apotex Inc | Resolved | 2023-05-23 | 52 | Manufacturing distruption | 193203 |
1079 | N06AX23 | APO-DESVENLAFAXINE EXTENDED-RE... | 100MG | Apotex Inc | Resolved | 2023-05-23 | 66 | Manufacturing distruption | 193218 |
1080 | APO-MELOXICAM | 1.5G | Apotex Inc | Resolved | 2023-05-23 | 52 | Manufacturing distruption | 193230 | |
1063 | L04AA06 | SANDOZ MYCOPHENOLATE MOFETIL | 500MG | Sandoz Canada Incorporated | Resolved | 2023-05-22 | 25 | Ingredient shortage | 193049 |
1064 | J01FA10 | SANDOZ AZITHROMYCIN | 200MG | Sandoz Canada Incorporated | Resolved | 2023-05-22 | 53 | Demand increase | 193041 |
1065 | N02BF02 | SANDOZ PREGABALIN | 25MG | Sandoz Canada Incorporated | Resolved | 2023-05-22 | 18 | Manufacturing distruption | 193053 |
1066 | G04BD08 | SANDOZ SOLIFENACIN | 10MG | Sandoz Canada Incorporated | Resolved | 2023-05-22 | 88 | Manufacturing distruption | 193060 |
1067 | R01AD09 | SANDOZ MOMETASONE | 50MCG | Sandoz Canada Incorporated | Resolved | 2023-05-22 | 11 | Shipping delay | 193045 |
1068 | A10BD07 | SANDOZ SITAGLIPTIN-METFORMIN | 500MG 50MG | Sandoz Canada Incorporated | Resolved | 2023-05-22 | 46 | Manufacturing distruption | 193057 |
1058 | C07AB09 | BREVIBLOC PREMIXED INJECTION | 10MG | Baxter Corporation | Resolved | 2023-05-19 | 40 | Demand increase | 192906 |
1059 | M05BA04 | ACH-ALENDRONATE | 5MG | Accord Healthcare Inc | Resolved | 2023-05-19 | 52 | Manufacturing distruption | 192856 |
1060 | L04AA06 | ACH-MYCOPHENOLATE | 250MG | Accord Healthcare Inc | Resolved | 2023-05-19 | 7 | Shipping delay | 192862 |
1061 | A10BJ02 | SAXENDA | 6MG | Novo Nordisk Canada Inc | Resolved | 2023-05-19 | 6 | Shipping delay | 192381 |
1062 | N02BF02 | ACH-PREGABALIN | 300MG | Accord Healthcare Inc | Resolved | 2023-05-19 | 188 | Manufacturing distruption | 192859 |
1055 | A09AA02 | COTAZYM | 35000UNIT 40000UNIT 10000UNIT | Organon Canada Inc. | Resolved | 2023-05-18 | 29 | Shipping delay | 192694 |
1056 | R05DA04 | CODEINE CONTIN 50MG CONTROLLED... | 50MG | Purdue Pharma | Resolved | 2023-05-18 | 29 | Shipping delay | 192720 |
1057 | C09BB04 | VIACORAM | 2.5MG 3.5MG | Servier Canada Inc | Resolved | 2023-05-18 | 8 | Shipping delay | 192838 |
1054 | N02BF02 | NAT-PREGABALIN | 225MG | Natco Pharma (Canada) Inc | Active | 2023-05-17 | 1095 | Other | 192650 |
1051 | B05BB02 | DEXTROSE 5% AND 0.9% SOD CHLOR... | 900MG 5G | Baxter Corporation | Resolved | 2023-05-17 | 19 | Manufacturing distruption | 192661 |
1052 | A03FA03 | TEVA-DOMPERIDONE | 10MG | Teva Canada Limited | Resolved | 2023-05-17 | 197 | Manufacturing distruption | 207506 |
1053 | N02CC06 | RELPAX | 20MG | Upjohn Canada Ulc | Resolved | 2023-05-17 | Demand increase | 193008 | |
1039 | N06AX05 | APO-TRAZODONE D TABLETS 150MG | 150MG | Apotex Inc | Resolved | 2023-05-16 | 143 | Manufacturing distruption | 192809 |
1040 | C07AB02 | APO-METOPROLOL | 100MG | Apotex Inc | Resolved | 2023-05-16 | 66 | Manufacturing distruption | 192791 |
1041 | N06BA04 | APO-METHYLPHENIDATE | 10MG | Apotex Inc | Resolved | 2023-05-16 | 52 | Manufacturing distruption | 192785 |
1042 | N05AX08 | APO-RISPERIDONE | 2.0MG | Apotex Inc | Resolved | 2023-05-16 | 87 | Manufacturing distruption | 192803 |
1043 | N05AX08 | APO-RISPERIDONE | 2.0MG | Apotex Inc | Resolved | 2023-05-16 | 87 | Manufacturing distruption | 192821 |
1044 | A02BC03 | APO-LANSOPRAZOLE | 30MG | Apotex Inc | Resolved | 2023-05-16 | 31 | Manufacturing distruption | 192796 |
1045 | C10AA07 | APO-ROSUVASTATIN | 40MG | Apotex Inc | Resolved | 2023-05-16 | 38 | Manufacturing distruption | 192812 |
1046 | N05AH03 | APO-OLANZAPINE ODT | 10MG | Apotex Inc | Resolved | 2023-05-16 | 17 | Manufacturing distruption | 192788 |
1047 | G04CA02 | APO-TAMSULOSIN CR | 0.4MG | Apotex Inc | Resolved | 2023-05-16 | 73 | Manufacturing distruption | 192800 |
1048 | G04CA02 | APO-TAMSULOSIN CR | 0.4MG | Apotex Inc | Resolved | 2023-05-16 | 45 | Manufacturing distruption | 192818 |
1049 | J05AF10 | APO-ENTECAVIR | 0.5MG | Apotex Inc | Resolved | 2023-05-16 | 38 | Manufacturing distruption | 192815 |
1050 | G04CB02 | APO-DUTASTERIDE | 0.5MG | Apotex Inc | Resolved | 2023-05-16 | 80 | Manufacturing distruption | 192806 |
1035 | C01BD01 | AMIODARONE HYDROCHLORIDE FOR I... | 50MG | Jamp Pharma Corporation | Avoided | 2023-05-15 | 31 | Other | 183741 |
1022 | B01AC30 | TARO-DIPYRIDAMOLE/ ASA | 25MG 200MG | Taro Pharmaceuticals Inc | Resolved | 2023-05-15 | Other | 208040 | |
1023 | V03AC01 | DESFERAL 500MG | 500MG | Novartis Pharmaceuticals Canada Inc | Resolved | 2023-05-15 | 126 | Demand increase | 191074 |
1024 | J07BL01 | YF-VAX | 109648PFU | Sanofi Pasteur Limited | Resolved | 2023-05-15 | 30 | Other | 192079 |
1025 | D07AB09 | ARISTOCORT R | 0.1% | Bausch Health, Canada Inc. | Resolved | 2023-05-15 | 87 | Shipping delay | 192296 |
1026 | B05XA03 | SODIUM CHLORIDE INJECTION USP | 9MG | Icu Medical Canada Inc | Resolved | 2023-05-15 | 21 | Manufacturing distruption | 180332 |
1027 | G03CA03 | ESTRADOT 75 | 75MCG | Sandoz Canada Incorporated | Resolved | 2023-05-15 | 95 | Manufacturing distruption | 192563 |
1028 | C09CA06 | SANDOZ CANDESARTAN | 4MG | Sandoz Canada Incorporated | Resolved | 2023-05-15 | 32 | Manufacturing distruption | 192559 |
1029 | G04CA02 | SANDOZ TAMSULOSIN CR | 0.4MG | Sandoz Canada Incorporated | Resolved | 2023-05-15 | 11 | Shipping delay | 192570 |
1030 | N02CC03 | SANDOZ ZOLMITRIPTAN | 2.5MG | Sandoz Canada Incorporated | Resolved | 2023-05-15 | 74 | Manufacturing distruption | 192573 |
1031 | C09DA07 | TELMISARTAN HCTZ | 12.5MG 80MG | Sivem Pharmaceuticals Ulc | Resolved | 2023-05-15 | 263 | Other | 211171 |
1032 | C09DA07 | TELMISARTAN HCTZ | 12.5MG 80MG | Sivem Pharmaceuticals Ulc | Resolved | 2023-05-15 | 263 | Other | 211174 |
1033 | C07AB12 | BYSTOLIC | 5MG | Abbvie Corporation | Resolved | 2023-05-15 | 207 | Shipping delay | 192664 |
1034 | B02BD04 | ALPROLIX | 3000UNIT | Sanofi-Aventis Canada Inc | Resolved | 2023-05-15 | 36 | Other | 192507 |
1036 | C10AA07 | ACH-ROSUVASTATIN | 5MG | Accord Healthcare Inc | Resolved | 2023-05-15 | Manufacturing practices | 192853 | |
1037 | N06AX24 | VIIBRYD | 10MG | Abbvie Corporation | Resolved | 2023-05-15 | 25 | Shipping delay | 192501 |
1038 | D07AA02 | SANDOZ HYDROCORTISONE | 2.5% | Sandoz Canada Incorporated | Resolved | 2023-05-15 | 11 | Manufacturing practices | 192566 |
1016 | A04AA02 | GRANISETRON HYDROCHLORIDE INJE... | 1MG | Omega Laboratories Limited | Resolved | 2023-05-12 | Demand increase | 192440 | |
1017 | N05AX08 | TARO-RISPERIDONE | 0.5MG | Sun Pharma Canada Inc | Resolved | 2023-05-12 | 126 | Manufacturing distruption | 199146 |
1018 | B05XA03 | SODIUM CHLORIDE INJECTION USP | 9MG | Pfizer Canada Ulc | Resolved | 2023-05-12 | Manufacturing distruption | 192388 | |
1019 | C08CA05 | NIFEDIPINE | 10MG | Aa Pharma Inc | Resolved | 2023-05-12 | 87 | Manufacturing distruption | 192073 |
1020 | R03DC03 | MONTELUKAST | 4MG | Pro Doc Limitee | Resolved | 2023-05-12 | 147 | Manufacturing distruption | 192418 |
1021 | C10AX14 | PRALUENT | 150MG | Sanofi-Aventis Canada Inc | Resolved | 2023-05-12 | 25 | Other | 192669 |
1012 | J01FF01 | DALACIN C PHOSPHATE | 150MG | Pfizer Canada Ulc | Resolved | 2023-05-11 | Manufacturing distruption | 192273 | |
1013 | N02AA05 | OXYNEO | 80MG | Purdue Pharma | Resolved | 2023-05-11 | 15 | Shipping delay | 192391 |
1014 | N02AA05 | OXYNEO | 20MG | Purdue Pharma | Resolved | 2023-05-11 | 8 | Shipping delay | 192385 |
1015 | N05BA06 | LORAZEPAM SUBLINGUAL | 0.5MG | Aa Pharma Inc | Resolved | 2023-05-11 | 60 | Manufacturing distruption | 192270 |
994 | L01AX03 | TEMODAL | 20MG | Merck Canada Inc | Resolved | 2023-05-10 | 30 | Shipping delay | 192163 |
995 | L01DB03 | EPIRUBICIN FOR INJECTION | 2MG | Teva Canada Limited | Resolved | 2023-05-10 | 235 | Manufacturing distruption | 207533 |
996 | C10AA03 | JAMP-PRAVASTATIN | 20MG | Jamp Pharma Corporation | Resolved | 2023-05-10 | 143 | Other | 192211 |
997 | C10AA03 | JAMP-PRAVASTATIN | 20MG | Jamp Pharma Corporation | Resolved | 2023-05-10 | 143 | Other | 192214 |
998 | V03AB24 | DIGIFAB | 40MG | Btg International Inc | Resolved | 2023-05-10 | 247 | Demand increase | 192243 |
999 | L04AA06 | TEVA-MYCOPHENOLATE | 250MG | Teva Canada Limited | Resolved | 2023-05-10 | 346 | Manufacturing distruption | 207539 |
1000 | L04AA06 | JAMP-MYCOPHENOLATE | 500MG | Jamp Pharma Corporation | Resolved | 2023-05-10 | 82 | Manufacturing distruption | 192217 |
1001 | N05AH04 | JAMP QUETIAPINE FUMARATE | 25MG | Jamp Pharma Corporation | Resolved | 2023-05-10 | 72 | Other | 192195 |
1002 | N02CC04 | TEVA-RIZATRIPTAN ODT | 10MG | Teva Canada Limited | Resolved | 2023-05-10 | 184 | Manufacturing distruption | 206428 |
1003 | H01AC01 | GENOTROPIN | 1.6MG | Pfizer Canada Ulc | Resolved | 2023-05-10 | 42 | Demand increase | 191669 |
1004 | N05AH03 | JAMP OLANZAPINE ODT | 10MG | Jamp Pharma Corporation | Resolved | 2023-05-10 | 82 | Manufacturing distruption | 192220 |
1005 | N05AH03 | JAMP OLANZAPINE ODT | 20MG | Jamp Pharma Corporation | Resolved | 2023-05-10 | 82 | Manufacturing distruption | 192233 |
1006 | C10AX09 | JAMP-EZETIMIBE | 10MG | Jamp Pharma Corporation | Resolved | 2023-05-10 | 100 | Other | 192236 |
1007 | A04AA01 | JAMP ONDANSETRON | 4MG | Jamp Pharma Corporation | Resolved | 2023-05-10 | 128 | Other | 192192 |
1008 | N06AX23 | JAMP DESVENLAFAXINE | 50MG | Jamp Pharma Corporation | Resolved | 2023-05-10 | 417 | Manufacturing distruption | 192205 |
1009 | N06AX23 | JAMP DESVENLAFAXINE | 100MG | Jamp Pharma Corporation | Resolved | 2023-05-10 | 417 | Other | 192208 |
1010 | G04BD07 | JAMP TOLTERODINE | 2MG | Jamp Pharma Corporation | Resolved | 2023-05-10 | 143 | Manufacturing distruption | 192202 |
1011 | C07AB03 | ATENOLOL | 50MG | Pro Doc Limitee | Resolved | 2023-05-10 | 52 | Shipping delay | 188760 |
990 | N06AX16 | APO-VENLAFAXINE XR | 37.5MG | Apotex Inc | Active | 2023-05-09 | Manufacturing distruption | 192361 | |
991 | C03BA11 | APO-INDAPAMIDE 1.25 MG TABLETS | 1.25MG | Apotex Inc | Resolved | 2023-05-09 | 17 | Manufacturing distruption | 192370 |
992 | L04AK01 | APO-LEFLUNOMIDE | 20MG | Apotex Inc | Resolved | 2023-05-09 | 24 | Manufacturing distruption | 192367 |
993 | N07BA03 | APO-VARENICLINE | 1MG | Apotex Inc | Resolved | 2023-05-09 | 24 | Manufacturing distruption | 192364 |
975 | H02AB02 | DEXAMETHASONE SOD PHOSPH INJ 1... | 10MG | Sandoz Canada Incorporated | Resolved | 2023-05-08 | 60 | Demand increase | 191996 |
976 | N06AB06 | ZOLOFT | 50MG | Upjohn Canada Ulc | Resolved | 2023-05-08 | 78 | Manufacturing distruption | 191728 |
977 | N02BE51 | MERSYNDOL WITH CODEINE | 325MG 5MG 8MG | Sanofi-Aventis Canada Inc | Resolved | 2023-05-08 | 60 | Other | 191773 |
978 | C10AC02 | COLESTID TABLETS | 1G | Pfizer Canada Ulc | Resolved | 2023-05-08 | 247 | Manufacturing distruption | 191596 |
979 | N05AB04 | PROCHLORAZINE | 5MG | Aa Pharma Inc | Resolved | 2023-05-08 | 11 | Manufacturing distruption | 192076 |
980 | V03AB14 | PROTAMINE SULFATE INJECTION US... | 10MG | Sandoz Canada Incorporated | Resolved | 2023-05-08 | 116 | Manufacturing distruption | 192011 |
981 | N05CD08 | MIDAZOLAM INJECTION | 1MG | Sandoz Canada Incorporated | Resolved | 2023-05-08 | 25 | Manufacturing distruption | 192003 |
982 | N05CD08 | MIDAZOLAM INJECTION | 5MG | Sandoz Canada Incorporated | Resolved | 2023-05-08 | Manufacturing distruption | 192022 | |
983 | N05AE04 | ZELDOX | 80MG | Upjohn Canada Ulc | Resolved | 2023-05-08 | Manufacturing distruption | 191725 | |
984 | A02BC04 | SANDOZ RABEPRAZOLE | 20MG | Sandoz Canada Incorporated | Resolved | 2023-05-08 | 18 | Manufacturing distruption | 192014 |
985 | G04CA02 | SANDOZ TAMSULOSIN CR | 0.4MG | Sandoz Canada Incorporated | Resolved | 2023-05-08 | 39 | Manufacturing distruption | 192018 |
986 | S01ED51 | SANDOZ DORZOLAMIDE/TIMOLOL | 5MG 20MG | Sandoz Canada Incorporated | Resolved | 2023-05-08 | 11 | Manufacturing distruption | 191999 |
987 | N02BF02 | SANDOZ PREGABALIN | 50MG | Sandoz Canada Incorporated | Resolved | 2023-05-08 | 11 | Manufacturing distruption | 192007 |
988 | N06BA01 | SANDOZ AMPHETAMINE XR | 25MG | Sandoz Canada Incorporated | Resolved | 2023-05-08 | 11 | Manufacturing distruption | 191993 |
989 | A02BD07 | AA-LANSOPRAZOLE-AMOXICILLIN-CL... | 500MG 500MG 30MG | Aa Pharma Inc | Resolved | 2023-05-08 | 164 | Manufacturing distruption | 192068 |
974 | N02BF01 | GABAPENTIN TABLETS USP | 600MG | Accord Healthcare Inc | Active | 2023-05-05 | Manufacturing distruption | 191750 | |
970 | C07AB03 | TENORMIN | 50MG | Searchlight Pharma Inc | Resolved | 2023-05-05 | Manufacturing practices | 192723 | |
971 | C07AB03 | TENORMIN | 100MG | Searchlight Pharma Inc | Resolved | 2023-05-05 | 299 | Manufacturing practices | 192726 |
972 | C09CA06 | ACH-CANDESARTAN | 32MG | Accord Healthcare Inc | Resolved | 2023-05-05 | 42 | Demand increase | 191757 |
973 | N05AH04 | QUETIAPINE TABLETS | 25MG | Accord Healthcare Inc | Resolved | 2023-05-05 | 45 | Shipping delay | 191760 |
965 | C01DA02 | NITROSTAT | 0.3MG | Bgp Pharma Ulc | Resolved | 2023-05-04 | Demand increase | 191285 | |
966 | G03BA03 | DELATESTRYL | 200MG | Bausch Health, Canada Inc. | Resolved | 2023-05-04 | 34 | Demand increase | 191622 |
967 | C03BA08 | ZAROXOLYN | 2.5MG | Sanofi-Aventis Canada Inc | Resolved | 2023-05-04 | 27 | Other | 191769 |
968 | A09AA02 | VIOKACE | 113400UNIT 112500UNIT 20880UNIT | Nestle Enterprises S.a. | Resolved | 2023-05-04 | Ingredient shortage | 191469 | |
969 | N02BF02 | TARO-PREGABALIN | 50MG | Sun Pharma Canada Inc | Resolved | 2023-05-04 | 421 | Manufacturing distruption | 199131 |
963 | C01CA24 | EMERADE | 0.3MG | Bausch Health, Canada Inc. | Active | 2023-05-03 | Other | 192281 | |
964 | C01CA24 | EMERADE | 0.5MG | Bausch Health, Canada Inc. | Active | 2023-05-03 | Other | 192284 | |
962 | H01AB01 | THYROGEN | 0.9MG | Sanofi Genzyme, A Division Of Sanofi-Aventis Canada Inc | Resolved | 2023-05-03 | Other | 191764 | |
948 | J01AA02 | APO-DOXYCYCLINE MR | 40MG | Apotex Inc | Resolved | 2023-05-02 | 38 | Manufacturing distruption | 191895 |
949 | N03AG01 | APO-DIVALPROEX | 500MG | Apotex Inc | Resolved | 2023-05-02 | 17 | Manufacturing distruption | 191889 |
950 | C01BC03 | APO-PROPAFENONE | 300MG | Apotex Inc | Resolved | 2023-05-02 | 66 | Manufacturing distruption | 191871 |
951 | N07CA01 | SERC | 16MG | Bgp Pharma Ulc | Resolved | 2023-05-02 | 7 | Other | 191298 |
952 | J05AB14 | VALCYTE | 450MG | Cheplapharm Arzneimittel Gmbh | Resolved | 2023-05-02 | 90 | Manufacturing distruption | 191490 |
953 | N05AH03 | APO-OLANZAPINE | 7.5MG | Apotex Inc | Resolved | 2023-05-02 | 31 | Manufacturing distruption | 191874 |
954 | A02BC03 | APO-LANSOPRAZOLE | 30MG | Apotex Inc | Resolved | 2023-05-02 | 31 | Manufacturing distruption | 191877 |
955 | J05AB14 | VALCYTE | 50MG | Cheplapharm Arzneimittel Gmbh | Resolved | 2023-05-02 | 212 | Manufacturing distruption | 191497 |
956 | N02AJ17 | APO-OXYCODONE/ACET | 325MG 5MG | Apotex Inc | Resolved | 2023-05-02 | 94 | Manufacturing distruption | 191883 |
957 | N06BA04 | APO-METHYLPHENIDATE ER | 18MG | Apotex Inc | Resolved | 2023-05-02 | 52 | Manufacturing distruption | 191880 |
958 | M05BB03 | APO-ALENDRONATE/VITAMIN D3 | 5600UNIT 70MG | Apotex Inc | Resolved | 2023-05-02 | 52 | Manufacturing distruption | 191892 |
959 | N06AX23 | APO-DESVENLAFAXINE EXTENDED-RE... | 100MG | Apotex Inc | Resolved | 2023-05-02 | 10 | Manufacturing distruption | 191898 |
960 | M03BX01 | BACLOFEN INTRATHECAL | 0.05MG | Avir Pharma Inc. | Resolved | 2023-05-02 | Shipping delay | 191464 | |
961 | M03BX01 | BACLOFEN INTRATHECAL | 2MG | Avir Pharma Inc. | Resolved | 2023-05-02 | Shipping delay | 191450 | |
934 | N05AE05 | SANDOZ LURASIDONE | 20MG | Sandoz Canada Incorporated | Resolved | 2023-05-01 | 11 | Demand increase | 191379 |
935 | B03BB01 | FOLIC ACID | 5MG | Aa Pharma Inc | Resolved | 2023-05-01 | 86 | Manufacturing distruption | 191239 |
936 | R06AA02 | DIPHENHYDRAMINE HYDROCHLORIDE ... | 50MG | Sandoz Canada Incorporated | Resolved | 2023-05-01 | 144 | Manufacturing distruption | 191388 |
937 | N01BB52 | XYLOCAINE 1% W EPINEPHRINE 1:2... | 5MCG 10MG | Aspen Pharmacare Canada Inc. | Resolved | 2023-05-01 | 91 | Manufacturing distruption | 188732 |
938 | G03FA01 | ESTALIS 140/50 MCG | 140MCG 50MCG | Sandoz Canada Incorporated | Resolved | 2023-05-01 | 18 | Manufacturing distruption | 191385 |
939 | N06BA04 | BIPHENTIN | 10MG | Elvium Life Sciences | Resolved | 2023-05-01 | 37 | Shipping delay | 191409 |
940 | C08CA01 | SANDOZ AMLODIPINE | 10MG | Sandoz Canada Incorporated | Resolved | 2023-05-01 | 25 | Manufacturing distruption | 191369 |
941 | J01DB04 | CEFAZOLIN FOR INJECTION USP | 10G | Sandoz Canada Incorporated | Resolved | 2023-05-01 | 60 | Manufacturing distruption | 191391 |
942 | C09DA01 | SANDOZ LOSARTAN HCT | 12.5MG 50MG | Sandoz Canada Incorporated | Resolved | 2023-05-01 | 11 | Manufacturing distruption | 191382 |
943 | C09CA04 | PMS-IRBESARTAN | 75MG | Pharmascience Inc | Resolved | 2023-05-01 | 42 | Manufacturing distruption | 150725 |
944 | J01XA01 | VANCOMYCIN HYDROCHLORIDE FOR I... | 1G | Sandoz Canada Incorporated | Resolved | 2023-05-01 | 18 | Manufacturing distruption | 191332 |
945 | C09CA06 | SANDOZ CANDESARTAN | 32MG | Sandoz Canada Incorporated | Resolved | 2023-05-01 | 18 | Manufacturing distruption | 191376 |
946 | S01BC03 | DICLOFENAC | 0.1% | Pharma Stulln Inc. | Resolved | 2023-05-01 | 121 | Shipping delay | 192637 |
947 | D10AD53 | SANDOZ ADAPALENE / BENZOYL PER... | 2.5% 0.1% | Sandoz Canada Incorporated | Resolved | 2023-05-01 | 18 | Demand increase | 191366 |
933 | L02AB01 | MEGESTROL | 40MG | Aa Pharma Inc | Resolved | 2023-04-30 | 111 | Manufacturing distruption | 188323 |
923 | H02AB02 | DEXAMETHASONE-OMEGA | 4MG | Omega Laboratories Limited | Resolved | 2023-04-28 | 28 | Demand increase | 190160 |
924 | H02AB02 | DEXAMETHASONE-OMEGA | 10MG | Omega Laboratories Limited | Resolved | 2023-04-28 | 168 | Manufacturing distruption | 190168 |
925 | S01ED51 | COSOPT PRESERVATIVE-FREE | 5MG 20MG | Elvium Life Sciences | Resolved | 2023-04-28 | 28 | Shipping delay | 191137 |
926 | N06BA04 | BIPHENTIN | 40MG | Elvium Life Sciences | Resolved | 2023-04-28 | 63 | Shipping delay | 191144 |
927 | N06BA04 | BIPHENTIN | 60MG | Elvium Life Sciences | Resolved | 2023-04-28 | 7 | Shipping delay | 191148 |
928 | N02AA05 | OXYNEO | 40MG | Purdue Pharma | Resolved | 2023-04-28 | 21 | Shipping delay | 191123 |
929 | N06BA04 | FOQUEST | 25MG | Elvium Life Sciences | Resolved | 2023-04-28 | 7 | Shipping delay | 191152 |
930 | N06BA04 | FOQUEST | 55MG | Elvium Life Sciences | Resolved | 2023-04-28 | 7 | Shipping delay | 191155 |
931 | L01EX12 | VITRAKVI | 100MG | Bayer Inc | Resolved | 2023-04-28 | 7 | Shipping delay | 191158 |
932 | L04AX03 | METHOTREXATE SUBCUTANEOUS | 20MG | Accord Healthcare Inc | Resolved | 2023-04-28 | 21 | Manufacturing distruption | 191746 |
881 | C07AA03 | TEVA-PINDOLOL | 15MG | Teva Canada Limited | Resolved | 2023-04-27 | 74 | Manufacturing distruption | 190737 |
882 | D07AC13 | ELOCOM | 0.1% | Organon Canada Inc. | Resolved | 2023-04-27 | 43 | Shipping delay | 190247 |
883 | N05AA01 | TEVA-CHLORPROMAZINE | 25.0MG | Teva Canada Limited | Resolved | 2023-04-27 | 54 | Manufacturing distruption | 190761 |
884 | D07AC01 | TEVA-ECTOSONE | 0.1% | Teva Canada Limited | Resolved | 2023-04-27 | 84 | Other | 190689 |
885 | J01DB04 | CEFAZOLIN FOR INJECTION | 1G | Teva Canada Limited | Resolved | 2023-04-27 | 115 | Manufacturing distruption | 190779 |
886 | C07AB03 | TEVA-ATENOLOL | 100MG | Teva Canada Limited | Resolved | 2023-04-27 | 146 | Manufacturing distruption | 190773 |
887 | C07AB04 | TEVA-ACEBUTOLOL | 100MG | Teva Canada Limited | Resolved | 2023-04-27 | 176 | Manufacturing distruption | 190764 |
888 | C07AB04 | TEVA-ACEBUTOLOL | 400MG | Teva Canada Limited | Resolved | 2023-04-27 | 187 | Manufacturing distruption | 190743 |
889 | N07BB04 | REVIA | 50MG | Teva Canada Limited | Resolved | 2023-04-27 | 33 | Manufacturing distruption | 190707 |
890 | R03BB01 | TEVA-IPRATROPIUM STERINEBS | 250MCG | Teva Canada Limited | Resolved | 2023-04-27 | 64 | Manufacturing distruption | 190674 |
891 | J01DB05 | TEVA-CEFADROXIL | 500MG | Teva Canada Limited | Resolved | 2023-04-27 | 33 | Manufacturing distruption | 190716 |
892 | L04AX01 | TEVA-AZATHIOPRINE | 50MG | Teva Canada Limited | Resolved | 2023-04-27 | 84 | Manufacturing distruption | 190782 |
893 | N06AB06 | TEVA-SERTRALINE | 100MG | Teva Canada Limited | Resolved | 2023-04-27 | 84 | Manufacturing distruption | 190746 |
894 | R05DA04 | TEVA-CODEINE | 15MG | Teva Canada Limited | Resolved | 2023-04-27 | 33 | Manufacturing distruption | 190701 |
895 | M01AE02 | TEVA-NAPROXEN EC | 250MG | Teva Canada Limited | Resolved | 2023-04-27 | 44 | Manufacturing distruption | 190740 |
896 | C09AA05 | TEVA-RAMIPRIL | 5MG | Teva Canada Limited | Resolved | 2023-04-27 | 115 | Manufacturing distruption | 190686 |
897 | M05BA03 | PAMIDRONATE DISODIUM OMEGA 9 M... | 9.0MG | Omega Laboratories Limited | Resolved | 2023-04-27 | 22 | Demand increase | 189681 |
898 | L04AK01 | TEVA-LEFLUNOMIDE | 20MG | Teva Canada Limited | Resolved | 2023-04-27 | 176 | Manufacturing distruption | 190710 |
899 | N05AH03 | TEVA-OLANZAPINE | 15MG | Teva Canada Limited | Resolved | 2023-04-27 | 44 | Manufacturing distruption | 190695 |
900 | C09AA03 | TEVA-LISINOPRIL (TYPE Z) | 10MG | Teva Canada Limited | Resolved | 2023-04-27 | 23 | Manufacturing distruption | 190692 |
901 | C09AA02 | ACT ENALAPRIL | 2MG | Teva Canada Limited | Resolved | 2023-04-27 | 74 | Manufacturing distruption | 190776 |
902 | B01AC04 | TEVA-CLOPIDOGREL | 75MG | Teva Canada Limited | Resolved | 2023-04-27 | 84 | Manufacturing distruption | 190752 |
903 | N04BC05 | ACT PRAMIPEXOLE | 0.25MG | Teva Canada Limited | Resolved | 2023-04-27 | 279 | Manufacturing distruption | 190719 |
904 | N04BC05 | ACT PRAMIPEXOLE | 1MG | Teva Canada Limited | Resolved | 2023-04-27 | 279 | Manufacturing distruption | 190722 |
905 | N04BC05 | ACT PRAMIPEXOLE | 1.5MG | Teva Canada Limited | Resolved | 2023-04-27 | 279 | Manufacturing distruption | 190725 |
906 | C09CA07 | TEVA-TELMISARTAN | 80MG | Teva Canada Limited | Resolved | 2023-04-27 | 74 | Manufacturing distruption | 190749 |
907 | N06DX01 | ACT MEMANTINE | 10MG | Teva Canada Limited | Resolved | 2023-04-27 | 187 | Manufacturing distruption | 190680 |
908 | C09DA07 | TEVA-TELMISARTAN HCTZ | 12.5MG 80MG | Teva Canada Limited | Resolved | 2023-04-27 | 237 | Manufacturing distruption | 190677 |
909 | G03XC01 | ACT RALOXIFENE | 60MG | Teva Canada Limited | Resolved | 2023-04-27 | 115 | Manufacturing distruption | 190734 |
910 | G04CA02 | TEVA-TAMSULOSIN CR | 0.4MG | Teva Canada Limited | Resolved | 2023-04-27 | 522 | Manufacturing distruption | 190785 |
911 | J05AG03 | TEVA-EFAVIRENZ | 600MG | Teva Canada Limited | Resolved | 2023-04-27 | 74 | Manufacturing distruption | 190767 |
912 | L01XA01 | CISPLATIN INJECTION | 1.0MG | Teva Canada Limited | Resolved | 2023-04-27 | 125 | Manufacturing distruption | 190671 |
913 | N02AB03 | FENTORA | 400MCG | Teva Canada Limited | Resolved | 2023-04-27 | 64 | Manufacturing distruption | 190698 |
914 | G04BD07 | TEVA-TOLTERODINE LA | 4MG | Teva Canada Limited | Resolved | 2023-04-27 | 54 | Manufacturing distruption | 190713 |
915 | J05AB14 | TEVA-VALGANCICLOVIR | 450MG | Teva Canada Limited | Resolved | 2023-04-27 | 64 | Manufacturing distruption | 190683 |
916 | N06BA01 | TEVA-AMPHETAMINE XR | 15MG | Teva Canada Limited | Resolved | 2023-04-27 | 105 | Manufacturing distruption | 190755 |
917 | N06BA01 | TEVA-AMPHETAMINE XR | 20MG | Teva Canada Limited | Resolved | 2023-04-27 | 94 | Manufacturing distruption | 190758 |
918 | N06AX12 | TEVA-BUPROPION XL | 300MG | Teva Canada Limited | Resolved | 2023-04-27 | 33 | Manufacturing distruption | 190728 |
919 | G03DA04 | TEVA-PROGESTERONE | 100MG | Teva Canada Limited | Resolved | 2023-04-27 | 94 | Manufacturing distruption | 190704 |
920 | A02BC02 | TEVA-PANTOPRAZOLE MAGNESIUM | 40MG | Teva Canada Limited | Resolved | 2023-04-27 | 237 | Manufacturing distruption | 190770 |
921 | N06BA02 | ACT DEXTROAMPHETAMINE SR | 10MG | Teva Canada Limited | Resolved | 2023-04-27 | 33 | Manufacturing distruption | 190731 |
922 | J01FF01 | CLINDAMYCIN INJECTION IN 5% DE... | 900MG | Baxter Corporation | Resolved | 2023-04-27 | 187 | Ingredient shortage | 183717 |
877 | M05BB03 | FOSAVANCE | 5600UNIT 70MG | Organon Canada Inc. | Resolved | 2023-04-26 | 58 | Demand increase | 190331 |
878 | C10AA07 | APO-ROSUVASTATIN | 40MG | Apotex Inc | Resolved | 2023-04-26 | 9 | Manufacturing distruption | 190865 |
879 | B05BA03 | DEXTROSE INJECTION USP | 500MG | Pfizer Canada Ulc | Resolved | 2023-04-26 | Manufacturing distruption | 190311 | |
880 | A09AA02 | COTAZYM ECS 20 | 100000UNIT 100000UNIT 25000UNIT | Organon Canada Inc. | Resolved | 2023-04-26 | 16 | Shipping delay | 191163 |
873 | N01BB01 | SENSORCAINE | 2.5MG | Aspen Pharmacare Canada Inc. | Resolved | 2023-04-25 | 97 | Shipping delay | 190276 |
874 | N03AG01 | APO-DIVALPROEX | 250MG | Apotex Inc | Resolved | 2023-04-25 | 10 | Manufacturing distruption | 190846 |
875 | L01EX12 | VITRAKVI | 25MG | Bayer Inc | Resolved | 2023-04-25 | 52 | Demand increase | 189904 |
876 | B01AF01 | XARELTO | 51.7MG | Bayer Inc | Resolved | 2023-04-25 | 45 | Shipping delay | 188217 |
862 | V07AB | STERILE WATER FOR IRRIGATION U... | 100% | Icu Medical Canada Inc | Active | 2023-04-24 | Manufacturing distruption | 172840 | |
869 | C09BA04 | COVERSYL PLUS HD | 2.5MG 8MG | Servier Canada Inc | Avoided | 2023-04-24 | 16 | Shipping delay | 189916 |
863 | C05AA01 | ANUSOL-HC OINTMENT | 0.5% 0.5% | Church & Dwight Canada Corp | Resolved | 2023-04-24 | 84 | Manufacturing distruption | 191394 |
864 | N06AB03 | APO-FLUOXETINE | 20MG | Apotex Inc | Resolved | 2023-04-24 | 18 | Manufacturing distruption | 190850 |
865 | B05BA01 | PRIMENE 10% | 318MG 300MG 400MG 400MG 600MG 800MG 840MG 1G 45MG 60MG 200MG 240MG 189MG 370MG 380MG 420MG 670MG 760MG 1.1G 1G | Baxter Corporation | Resolved | 2023-04-24 | 113 | Ingredient shortage | 190244 |
866 | C01BC03 | APO-PROPAFENONE | 150MG | Apotex Inc | Resolved | 2023-04-24 | 74 | Manufacturing distruption | 190856 |
867 | G03DA02 | APO-MEDROXY TABLETS | 5MG | Apotex Inc | Resolved | 2023-04-24 | 116 | Ingredient shortage | 189665 |
868 | M01AE02 | APO-NAPROXEN EC | 500MG | Apotex Inc | Resolved | 2023-04-24 | 60 | Manufacturing distruption | 190859 |
870 | N05AH03 | APO-OLANZAPINE ODT | 5MG | Apotex Inc | Resolved | 2023-04-24 | 39 | Manufacturing distruption | 190862 |
871 | G03AA07 | OVIMA 21 | 30MCG 150MCG | Apotex Inc | Resolved | 2023-04-24 | 18 | Manufacturing distruption | 190868 |
872 | S01ED51 | APO-TRAVOPROST-TIMOP PQ | 0.5% 0.004% | Apotex Inc | Resolved | 2023-04-24 | 88 | Manufacturing distruption | 190871 |
860 | N02BA51 | ANACIN | 32MG 325MG | Paladin Labs Inc. | Active | 2023-04-23 | Manufacturing distruption | 198613 | |
861 | N06AX23 | APO-DESVENLAFAXINE EXTENDED-RE... | 50MG | Apotex Inc | Resolved | 2023-04-23 | 68 | Manufacturing distruption | 190874 |
858 | D06BB53 | XERESE | 1% 5% | Bausch Health, Canada Inc. | Avoided | 2023-04-21 | 53 | Ingredient shortage | 183894 |
848 | N05AE05 | SANDOZ LURASIDONE | 60MG | Sandoz Canada Incorporated | Resolved | 2023-04-21 | 28 | Demand increase | 190151 |
849 | C01DA02 | NITROSTAT | 0.6MG | Bgp Pharma Ulc | Resolved | 2023-04-21 | Demand increase | 189875 | |
850 | N02AA03 | HYDROMORPHONE HYDROCHLORIDE IN... | 2MG | Sandoz Canada Incorporated | Resolved | 2023-04-21 | 21 | Manufacturing distruption | 190148 |
851 | N03AB05 | CEREBYX | 75MG | Searchlight Pharma Inc | Resolved | 2023-04-21 | 224 | Manufacturing distruption | 189469 |
852 | C01CA07 | DOBUTAMINE INJECTION USP | 12.5MG | Sandoz Canada Incorporated | Resolved | 2023-04-21 | 77 | Manufacturing distruption | 190144 |
853 | H01CB02 | OCTREOTIDE ACETATE OMEGA | 200MCG | Omega Laboratories Limited | Resolved | 2023-04-21 | 7 | Demand increase | 190174 |
854 | C08CA01 | SANDOZ AMLODIPINE | 5MG | Sandoz Canada Incorporated | Resolved | 2023-04-21 | 7 | Manufacturing distruption | 190130 |
855 | C08CA01 | SANDOZ AMLODIPINE | 10MG | Sandoz Canada Incorporated | Resolved | 2023-04-21 | 28 | Manufacturing distruption | 190126 |
856 | J01FA10 | SANDOZ AZITHROMYCIN | 200MG | Sandoz Canada Incorporated | Resolved | 2023-04-21 | 84 | Manufacturing distruption | 190134 |
857 | J01FA10 | SANDOZ AZITHROMYCIN | 200MG | Sandoz Canada Incorporated | Resolved | 2023-04-21 | 91 | Manufacturing distruption | 190138 |
859 | N06DA03 | SANDOZ RIVASTIGMINE PATCH 10 | 9.5MG | Sandoz Canada Incorporated | Resolved | 2023-04-21 | 49 | Ingredient shortage | 190154 |
844 | N05AB06 | TRIFLUOPERAZINE | 5MG | Aa Pharma Inc | Active | 2023-04-20 | Manufacturing distruption | 228173 | |
845 | B05XC | MULTI 12 INJECTION | 1MCG 80MCG 12MCG 2UNIT 3MG 0.8MG 8MG 0.72MG 0.6MG 40UNIT 660UNIT 20MG | Sandoz Canada Incorporated | Resolved | 2023-04-20 | 57 | Manufacturing distruption | 189909 |
846 | B05XC | MULTI 12 INJECTION | 1MCG 80MCG 12MCG 2UNIT 3MG 0.8MG 8MG 0.72MG 0.6MG 40UNIT 660UNIT 20MG | Sandoz Canada Incorporated | Resolved | 2023-04-20 | 29 | Manufacturing distruption | 189913 |
847 | N02CC01 | IMITREX | 6MG | Glaxosmithkline Inc | Resolved | 2023-04-20 | 34 | Demand increase | 189933 |
841 | J05AB01 | MYLAN-ACYCLOVIR | 800MG | Mylan Pharmaceuticals Ulc | Avoided | 2023-04-19 | 6 | Manufacturing distruption | 187554 |
838 | M01AE02 | NAPROSYN | 375MG | Atnahs Pharma Uk Limited | Resolved | 2023-04-19 | Ingredient shortage | 189849 | |
839 | L01EX22 | RETEVMO | 80MG | Loxo Oncology Inc | Resolved | 2023-04-19 | 34 | Shipping delay | 189931 |
840 | M01AE02 | ANAPROX | 275MG | Atnahs Pharma Uk Limited | Resolved | 2023-04-19 | Ingredient shortage | 189852 | |
842 | N02AJ06 | TEVA-LENOLTEC NO. 4 | 60MG 300MG | Teva Canada Limited | Resolved | 2023-04-19 | 266 | Manufacturing distruption | 206374 |
843 | H05BX01 | MYLAN-CINACALCET | 30MG | Mylan Pharmaceuticals Ulc | Resolved | 2023-04-19 | 16 | Manufacturing distruption | 189342 |
827 | N06AX16 | APO-VENLAFAXINE XR | 75MG | Apotex Inc | Active | 2023-04-18 | Manufacturing distruption | 189999 | |
828 | G03CA03 | CLIMARA 50 | 50MCG | Bayer Inc | Resolved | 2023-04-18 | 115 | Other | 188064 |
829 | J01DB05 | APO-CEFADROXIL | 500MG | Apotex Inc | Resolved | 2023-04-18 | 332 | Manufacturing distruption | 190008 |
830 | N01BB01 | MARCAINE | 150MG | Pfizer Canada Ulc | Resolved | 2023-04-18 | Manufacturing distruption | 189856 | |
831 | A10BB09 | APO-GLICLAZIDE | 80MG | Apotex Inc | Resolved | 2023-04-18 | 73 | Manufacturing distruption | 189988 |
832 | M01AE02 | APO-NAPROXEN EC TABLETS | 250MG | Apotex Inc | Resolved | 2023-04-18 | 66 | Manufacturing distruption | 189991 |
833 | B01AC04 | APO-CLOPIDOGREL | 75MG | Apotex Inc | Resolved | 2023-04-18 | 17 | Manufacturing distruption | 189994 |
834 | C09AA04 | APO-PERINDOPRIL | 2MG | Apotex Inc | Resolved | 2023-04-18 | 21 | Manufacturing distruption | 190005 |
835 | J01FA10 | APO-AZITHROMYCIN Z | 250MG | Apotex Inc | Resolved | 2023-04-18 | 73 | Manufacturing distruption | 190002 |
836 | N07BA03 | APO-VARENICLINE | 1MG | Apotex Inc | Resolved | 2023-04-18 | 10 | Manufacturing distruption | 190014 |
837 | C10AC04 | APO-COLESEVELAM | 625MG | Apotex Inc | Resolved | 2023-04-18 | 101 | Manufacturing distruption | 190011 |
818 | V07AB | STERILE WATER FOR IRRIGATION U... | 100% | Icu Medical Canada Inc | Active | 2023-04-17 | Manufacturing distruption | 172852 | |
817 | S01BA04 | SANDOZ PREDNISOLONE | 1% | Sandoz Canada Incorporated | Resolved | 2023-04-17 | 32 | Demand increase | 189798 |
819 | N06AX11 | SANDOZ MIRTAZAPINE | 30MG | Sandoz Canada Incorporated | Resolved | 2023-04-17 | 18 | Shipping delay | 189795 |
820 | P01BB51 | MALARONE PEDIATRIC | 25.0MG 62.5MG | Glaxosmithkline Inc | Resolved | 2023-04-17 | Manufacturing distruption | 190045 | |
821 | A10BB12 | SANDOZ GLIMEPIRIDE | 1MG | Sandoz Canada Incorporated | Resolved | 2023-04-17 | 18 | Ingredient shortage | 189792 |
822 | C08CA01 | SANDOZ AMLODIPINE | 5MG | Sandoz Canada Incorporated | Resolved | 2023-04-17 | 18 | Manufacturing distruption | 189788 |
823 | G04CA02 | SANDOZ TAMSULOSIN CR | 0.4MG | Sandoz Canada Incorporated | Resolved | 2023-04-17 | 18 | Manufacturing distruption | 189801 |
824 | J02AC03 | SANDOZ VORICONAZOLE | 50MG | Sandoz Canada Incorporated | Resolved | 2023-04-17 | 60 | Manufacturing distruption | 189804 |
825 | M03AB01 | SUCCINYLCHOLINE CHLORIDE INJEC... | 20MG | Hikma Canada Limited | Resolved | 2023-04-17 | 133 | Shipping delay | 189738 |
826 | N07BC51 | SUBOXONE | 2MG 8MG | Indivior Uk Limited | Resolved | 2023-04-17 | 44 | Demand increase | 189554 |
816 | M01AE09 | FLURBIPROFEN | 100MG | Aa Pharma Inc | Resolved | 2023-04-15 | 37 | Manufacturing distruption | 188320 |
806 | N01BB01 | BUPIVACAINE HYDROCHLORIDE IN D... | 7.5MG | Omega Laboratories Limited | Resolved | 2023-04-14 | 42 | Demand increase | 189687 |
807 | B05XA07 | CALCIJECT INJ 100MG/ML | 100MG | Omega Laboratories Limited | Resolved | 2023-04-14 | 21 | Demand increase | 189676 |
808 | B05XA01 | POTASSIUM CHLORIDE FOR INJECTI... | 20mEq | Omega Laboratories Limited | Resolved | 2023-04-14 | 56 | Demand increase | 188476 |
809 | L02BB03 | PMS-BICALUTAMIDE | 50MG | Pharmascience Inc | Resolved | 2023-04-14 | 48 | Manufacturing distruption | 189584 |
810 | L02BB03 | PMS-BICALUTAMIDE | 50MG | Pharmascience Inc | Resolved | 2023-04-14 | 59 | Manufacturing distruption | 189587 |
811 | N07BB03 | CAMPRAL | 333MG | Mylan Pharmaceuticals Ulc | Resolved | 2023-04-14 | 14 | Manufacturing distruption | 189345 |
812 | R03DC03 | PMS-MONTELUKAST | 4MG | Pharmascience Inc | Resolved | 2023-04-14 | Manufacturing distruption | 189590 | |
813 | M02AA15 | PMS-DICLOFENAC | 1.5% | Pharmascience Inc | Resolved | 2023-04-14 | 97 | Manufacturing distruption | 189595 |
814 | C09CA06 | PMS-CANDESARTAN | 4MG | Pharmascience Inc | Resolved | 2023-04-14 | 125 | Manufacturing distruption | 189598 |
815 | V07AB | STERILE WATER FOR IRRIGATION, ... | 100% | Baxter Corporation | Resolved | 2023-04-14 | 553 | Demand increase | 189568 |
803 | H02AB09 | SOLU-CORTEF | 100MG | Pfizer Canada Ulc | Resolved | 2023-04-13 | Manufacturing distruption | 189497 | |
804 | B01AB05 | LOVENOX HP | 120MG | Sanofi-Aventis Canada Inc | Resolved | 2023-04-13 | 40 | Other | 185718 |
805 | L04AE01 | GILENYA | 0.25MG | Novartis Pharmaceuticals Canada Inc | Resolved | 2023-04-13 | 36 | Shipping delay | 191077 |
790 | R06AE07 | JAMP-CETIRIZINE | 10MG | Jamp Pharma Corporation | Active | 2023-04-12 | 263 | Other | 189459 |
800 | A07AA02 | JAMP-NYSTATIN ORAL SUSPENSION ... | 100000UNIT | Jamp Pharma Corporation | Active | 2023-04-12 | 780 | Manufacturing distruption | 189373 |
791 | N06AX16 | VENLAFAXINE XR | 150MG | Jamp Pharma Corporation | Resolved | 2023-04-12 | 496 | Other | 189379 |
792 | B05BA03 | 5% DEXTROSE INJECTION, USP | 5G | Baxter Corporation | Resolved | 2023-04-12 | 16 | Manufacturing distruption | 189362 |
793 | B01AB01 | HEPARIN LEO INJ 1000UNIT/ML | 1000UNIT | Leo Pharma Inc | Resolved | 2023-04-12 | 23 | Demand increase | 189324 |
794 | V07AB | STERILE WATER FOR INJECTION US... | 100% | Pfizer Canada Ulc | Resolved | 2023-04-12 | Manufacturing distruption | 185338 | |
795 | H02AB04 | SOLU-MEDROL | 40MG | Pfizer Canada Ulc | Resolved | 2023-04-12 | Manufacturing distruption | 189321 | |
796 | H02AB04 | SOLU-MEDROL | 125MG | Pfizer Canada Ulc | Resolved | 2023-04-12 | Manufacturing distruption | 189318 | |
797 | H02AB04 | SOLU-MEDROL | 500MG | Pfizer Canada Ulc | Resolved | 2023-04-12 | Manufacturing distruption | 187129 | |
798 | A10BA02 | JAMP METFORMIN | 850MG | Jamp Pharma Corporation | Resolved | 2023-04-12 | 59 | Demand increase | 189466 |
799 | N06AB03 | JAMP-FLUOXETINE | 20MG | Jamp Pharma Corporation | Resolved | 2023-04-12 | 48 | Other | 189365 |
801 | L04AC14 | KEVZARA | 150MG | Sanofi-Aventis Canada Inc | Resolved | 2023-04-12 | 110 | Demand increase | 189382 |
802 | J05AH02 | JAMP OSELTAMIVIR | 75MG | Jamp Pharma Corporation | Resolved | 2023-04-12 | 171 | Other | 189376 |
781 | C01BD01 | AMIODARONE HYDROCHLORIDE FOR I... | 50MG | Jamp Pharma Corporation | Active | 2023-04-11 | 995 | Manufacturing distruption | 189237 |
766 | N06AB06 | ZOLOFT | 50MG | Upjohn Canada Ulc | Resolved | 2023-04-11 | 105 | Manufacturing distruption | 191713 |
767 | C07AA07 | APO-SOTALOL | 80MG | Apotex Inc | Resolved | 2023-04-11 | 80 | Manufacturing distruption | 189635 |
768 | N04BA02 | APO-LEVOCARB-TAB 25MG/100MG | 100MG 25MG | Apotex Inc | Resolved | 2023-04-11 | 24 | Manufacturing distruption | 189632 |
769 | H02AB02 | DEXAMETHASONE-OMEGA | 10MG | Omega Laboratories Limited | Resolved | 2023-04-11 | 38 | Demand increase | 188481 |
770 | M01AB01 | SANDOZ INDOMETHACIN | 50MG | Sandoz Canada Incorporated | Resolved | 2023-04-11 | Manufacturing distruption | 189232 | |
771 | M01AE01 | APO-IBUPROFEN TAB 600MG | 600MG | Apotex Inc | Resolved | 2023-04-11 | 10 | Manufacturing distruption | 189638 |
772 | M05BA08 | ACLASTA | 5MG | Sandoz Canada Incorporated | Resolved | 2023-04-11 | 31 | Manufacturing distruption | 189213 |
773 | N03AX14 | APO-LEVETIRACETAM | 250MG | Apotex Inc | Resolved | 2023-04-11 | 73 | Manufacturing distruption | 189641 |
774 | N06AX11 | APO-MIRTAZAPINE | 30MG | Apotex Inc | Resolved | 2023-04-11 | 115 | Manufacturing distruption | 189644 |
775 | C09CA06 | SANDOZ CANDESARTAN | 16MG | Sandoz Canada Incorporated | Resolved | 2023-04-11 | 10 | Manufacturing distruption | 189217 |
776 | C09CA06 | SANDOZ CANDESARTAN | 16MG | Sandoz Canada Incorporated | Resolved | 2023-04-11 | 24 | Manufacturing distruption | 189220 |
777 | C09CA04 | SANDOZ IRBESARTAN | 300MG | Sandoz Canada Incorporated | Resolved | 2023-04-11 | 38 | Manufacturing distruption | 189223 |
778 | N02AA05 | OXYNEO | 10MG | Purdue Pharma | Resolved | 2023-04-11 | 30 | Shipping delay | 189168 |
779 | N02BF02 | SANDOZ PREGABALIN | 50MG | Sandoz Canada Incorporated | Resolved | 2023-04-11 | 31 | Manufacturing distruption | 189226 |
780 | N06AB03 | JAMP-FLUOXETINE | 10MG | Jamp Pharma Corporation | Resolved | 2023-04-11 | 49 | Other | 189268 |
782 | S01EE03 | VISTITAN | 0.03% | Sandoz Canada Incorporated | Resolved | 2023-04-11 | 17 | Manufacturing distruption | 189229 |
783 | J01DB01 | APO-CEPHALEX | 500MG | Apotex Inc | Resolved | 2023-04-11 | 192 | Manufacturing distruption | 189656 |
784 | J05AR03 | APO-EMTRICITABINE-TENOFOVIR | 200MG 300MG | Apotex Inc | Resolved | 2023-04-11 | 38 | Manufacturing distruption | 189650 |
785 | S01ED51 | JAMP DORZOLAMIDE-TIMOLOL | 5MG 20MG | Jamp Pharma Corporation | Resolved | 2023-04-11 | 94 | Other | 189263 |
786 | A10BA02 | APO-METFORMIN ER | 1000MG | Apotex Inc | Resolved | 2023-04-11 | 297 | Manufacturing distruption | 189647 |
787 | J05AR06 | APO-EFAVIRENZ-EMTRICITABINE-TE... | 300MG 200MG 600MG | Apotex Inc | Resolved | 2023-04-11 | 87 | Manufacturing distruption | 189653 |
788 | B01AE07 | APO-DABIGATRAN | 150MG | Apotex Inc | Resolved | 2023-04-11 | 59 | Manufacturing distruption | 189659 |
789 | M02AA15 | JAMP DICLOFENAC TOPICAL SOLUTI... | 1.5% | Jamp Pharma Corporation | Resolved | 2023-04-11 | 136 | Other | 189256 |
764 | N02AX02 | TARO-TRAMADOL ER | 300MG | Taro Pharmaceuticals Inc | Active | 2023-04-10 | Manufacturing distruption | 237266 | |
763 | H04AA01 | GLUCAGEN HYPOKIT | 1MG | Novo Nordisk Canada Inc | Resolved | 2023-04-10 | 325 | Other | 189007 |
765 | G04BE09 | MYLAN-VARDENAFIL | 20MG | Mylan Pharmaceuticals Ulc | Resolved | 2023-04-10 | 37 | Other | 187546 |
759 | N01BB51 | SENSORCAINE WITH EPINEPHRINE | 2.5MG 5MCG | Aspen Pharmacare Canada Inc. | Resolved | 2023-04-06 | 18 | Shipping delay | 188985 |
760 | B05XA08 | SODIUM ACETATE-OMEGA | 328MG | Omega Laboratories Limited | Resolved | 2023-04-06 | 29 | Demand increase | 189017 |
761 | D02AC | STERILE LIGHT MINERAL OIL 100% | 100% | Omega Laboratories Limited | Resolved | 2023-04-06 | 78 | Manufacturing distruption | 188484 |
762 | A02BA03 | FAMOTIDINE OMEGA -(WITHOUT PR... | 10MG | Omega Laboratories Limited | Resolved | 2023-04-06 | 36 | Demand increase | 189010 |
755 | J01FA09 | BIAXIN | 125MG | Bgp Pharma Ulc | Avoided | 2023-04-05 | 69 | Demand increase | 181319 |
756 | H05BX01 | MYLAN-CINACALCET | 90MG | Mylan Pharmaceuticals Ulc | Resolved | 2023-04-05 | 33 | Manufacturing distruption | 183768 |
757 | N06BA04 | FOQUEST | 45MG | Elvium Life Sciences | Resolved | 2023-04-05 | 9 | Shipping delay | 188874 |
758 | N06BA04 | FOQUEST | 85MG | Elvium Life Sciences | Resolved | 2023-04-05 | 16 | Shipping delay | 188877 |
734 | C02CA01 | APO-PRAZO TAB 2MG | 2MG | Apotex Inc | Resolved | 2023-04-04 | Manufacturing distruption | 188943 | |
735 | A03FA01 | METOCLOPRAMIDE HYDROCHLORIDE I... | 5MG | Sandoz Canada Incorporated | Resolved | 2023-04-04 | 17 | Manufacturing distruption | 188657 |
736 | N05CF01 | APO-ZOPICLONE | 7.5MG | Apotex Inc | Resolved | 2023-04-04 | 52 | Manufacturing distruption | 188946 |
737 | V08AB02 | OMNIPAQUE 240 | 518MG | Ge Healthcare Canada Inc | Resolved | 2023-04-04 | 9 | Shipping delay | 188698 |
738 | N06AB08 | APO-FLUVOXAMINE | 50MG | Apotex Inc | Resolved | 2023-04-04 | 115 | Manufacturing distruption | 188940 |
739 | G03CA03 | SANDOZ ESTRADIOL DERM 100 | 100MCG | Sandoz Canada Incorporated | Resolved | 2023-04-04 | 10 | Manufacturing distruption | 188651 |
740 | N06AX02 | APO-TRYPTOPHAN | 500MG | Apotex Inc | Resolved | 2023-04-04 | 38 | Manufacturing distruption | 188949 |
741 | A10BB12 | SANDOZ GLIMEPIRIDE | 2MG | Sandoz Canada Incorporated | Resolved | 2023-04-04 | 31 | Manufacturing distruption | 188654 |
742 | M05BA04 | SANDOZ ALENDRONATE | 70MG | Sandoz Canada Incorporated | Resolved | 2023-04-04 | 66 | Manufacturing distruption | 188633 |
743 | J01DD04 | CEFTRIAXONE SODIUM FOR INJECTI... | 250MG | Sandoz Canada Incorporated | Resolved | 2023-04-04 | 17 | Shipping delay | 188648 |
744 | C10AA05 | APO-ATORVASTATIN | 80MG | Apotex Inc | Resolved | 2023-04-04 | 24 | Manufacturing distruption | 188976 |
745 | J01DB04 | CEFAZOLIN FOR INJECTION USP | 1G | Sandoz Canada Incorporated | Resolved | 2023-04-04 | 87 | Manufacturing practices | 188643 |
746 | C09CA06 | SANDOZ CANDESARTAN | 4MG | Sandoz Canada Incorporated | Resolved | 2023-04-04 | 31 | Manufacturing distruption | 188640 |
747 | G04CA02 | SANDOZ TAMSULOSIN CR | 0.4MG | Sandoz Canada Incorporated | Resolved | 2023-04-04 | 31 | Manufacturing distruption | 188668 |
748 | N05AH03 | APO-OLANZAPINE ODT | 20MG | Apotex Inc | Resolved | 2023-04-04 | 59 | Manufacturing distruption | 188968 |
749 | G04CA02 | APO-TAMSULOSIN CR | 0.4MG | Apotex Inc | Resolved | 2023-04-04 | 17 | Manufacturing distruption | 188973 |
750 | S01BC10 | ILEVRO | 0.3% | Novartis Pharmaceuticals Canada Inc | Resolved | 2023-04-04 | 42 | Manufacturing distruption | 189506 |
751 | A16AX06 | SANDOZ MIGLUSTAT | 100MG | Sandoz Canada Incorporated | Resolved | 2023-04-04 | 31 | Manufacturing distruption | 188660 |
752 | G04CA04 | SANDOZ SILODOSIN | 8MG | Sandoz Canada Incorporated | Resolved | 2023-04-04 | 101 | Manufacturing distruption | 188665 |
753 | G03AB09 | TRI-CIRA 21 | 0.035MG 0.25MG 0.035MG 0.215MG 0.035MG 0.18MG | Apotex Inc | Resolved | 2023-04-04 | 126 | Manufacturing distruption | 188979 |
754 | APO-MELOXICAM | 1.5G | Apotex Inc | Resolved | 2023-04-04 | 101 | Manufacturing distruption | 188982 | |
731 | M01CC01 | CUPRIMINE | 250MG | Bausch Health, Canada Inc. | Avoided | 2023-04-03 | 25 | Other | 186886 |
732 | J01FA10 | ZITHROMAX | 250MG | Pfizer Canada Ulc | Resolved | 2023-04-03 | Manufacturing distruption | 188567 | |
733 | C07AB07 | SANDOZ BISOPROLOL TABLETS | 5MG | Sandoz Canada Incorporated | Resolved | 2023-04-03 | 4 | Manufacturing practices | 188637 |
730 | L04AE01 | MYLAN-FINGOLIMOD | 0.5MG | Mylan Pharmaceuticals Ulc | Resolved | 2023-04-02 | Ingredient shortage | 187551 | |
728 | J01DD04 | CEFTRIAXONE SODIUM FOR INJECTI... | 1G | Pfizer Canada Ulc | Resolved | 2023-04-01 | Manufacturing distruption | 188239 | |
729 | M05BA03 | PAMIDRONATE DISODIUM FOR INJEC... | 6MG | Fresenius Kabi Canada Ltd | Resolved | 2023-04-01 | 37 | Manufacturing distruption | 181145 |
720 | A09AA02 | CREON MINIMICROSPHERES 25 | 1600UNIT 25500UNIT 25000UNIT | Bgp Pharma Ulc | Resolved | 2023-03-31 | 24 | Other | 188613 |
721 | H03AA01 | LEVOTHYROXINE SODIUM FOR INJEC... | 500MCG | Fresenius Kabi Canada Ltd | Resolved | 2023-03-31 | 76 | Manufacturing distruption | 187645 |
722 | J01MA02 | SANDOZ CIPROFLOXACIN | 500MG | Sandoz Canada Incorporated | Resolved | 2023-03-31 | 21 | Demand increase | 188611 |
723 | L04AC14 | KEVZARA | 200MG | Sanofi-Aventis Canada Inc | Resolved | 2023-03-31 | 10 | Demand increase | 188465 |
724 | B05XA01 | POTASSIUM CHLORIDE FOR INJECTI... | 200mEq | Omega Laboratories Limited | Resolved | 2023-03-31 | 61 | Demand increase | 188487 |
725 | V07AB | STERILE WATER FOR IRRIGATION, ... | 100% | Baxter Corporation | Resolved | 2023-03-31 | 489 | Demand increase | 188299 |
726 | L01AA09 | BENDAMUSTINE HYDROCHLORIDE FOR... | 25MG | Auro Pharma Inc | Resolved | 2023-03-31 | Other | 229835 | |
727 | L01AA09 | BENDAMUSTINE HYDROCHLORIDE FOR... | 100MG | Auro Pharma Inc | Resolved | 2023-03-31 | Other | 229842 | |
714 | N04AC01 | VPI-BENZTROPINE | 2MG | Vpi Pharmaceuticals Inc | Active | 2023-03-30 | Manufacturing distruption | 201890 | |
718 | A10BD20 | SYNJARDY | 1000MG 12.5MG | Boehringer Ingelheim (Canada) Ltd Ltee | Avoided | 2023-03-30 | 0 | Other | 187800 |
715 | A02BB01 | MISOPROSTOL | 100MCG | Aa Pharma Inc | Resolved | 2023-03-30 | 57 | Manufacturing distruption | 188329 |
716 | S01BC05 | KETOROLAC | 0.5% | Aa Pharma Inc | Resolved | 2023-03-30 | 78 | Manufacturing distruption | 188326 |
717 | A10BD20 | SYNJARDY | 500MG 12.5MG | Boehringer Ingelheim (Canada) Ltd Ltee | Resolved | 2023-03-30 | 11 | Other | 187797 |
719 | N06BA04 | FOQUEST | 55MG | Elvium Life Sciences | Resolved | 2023-03-30 | 15 | Shipping delay | 188286 |
706 | C08DB01 | DILTIAZEM HYDROCHLORIDE INJECT... | 5MG | Omega Laboratories Limited | Resolved | 2023-03-29 | 9 | Demand increase | 187972 |
707 | H02AB01 | CELESTONE SOLUSPAN | 3MG 3MG | Organon Canada Inc. | Resolved | 2023-03-29 | 233 | Manufacturing distruption | 182292 |
708 | G03AA05 | BREVICON 1/35 TABLETS (21-DAY ... | 0.035MG 1MG | Pfizer Canada Ulc | Resolved | 2023-03-29 | 27 | Manufacturing distruption | 188193 |
709 | L01XA02 | CARBOPLATIN INJECTION BP | 10MG | Pfizer Canada Ulc | Resolved | 2023-03-29 | Manufacturing distruption | 187124 | |
710 | A10BA02 | TEVA-METFORMIN | 850MG | Teva Canada Limited | Resolved | 2023-03-29 | 368 | Manufacturing distruption | 209675 |
711 | A10BA02 | TEVA-METFORMIN | 850MG | Teva Canada Limited | Resolved | 2023-03-29 | 490 | Manufacturing distruption | 206389 |
712 | S01ED51 | COSOPT PRESERVATIVE-FREE | 5MG 20MG | Elvium Life Sciences | Resolved | 2023-03-29 | 24 | Shipping delay | 188222 |
713 | H02AB02 | DEXAMETHASONE OMEGA UNIDOSE | 10MG | Omega Laboratories Limited | Resolved | 2023-03-29 | Demand increase | 187964 | |
698 | R05DA04 | CODEINE CONTIN 150MG CONTROLLE... | 150MG | Purdue Pharma | Resolved | 2023-03-28 | 101 | Shipping delay | 188181 |
699 | V04CD | L-ARGININE HYDROCHLORIDE INJEC... | 250MG | Sandoz Canada Incorporated | Resolved | 2023-03-28 | 325 | Shipping delay | 188188 |
700 | N05CF01 | APO-ZOPICLONE | 7.5MG | Apotex Inc | Resolved | 2023-03-28 | 59 | Manufacturing distruption | 188421 |
701 | H02AB07 | APO PREDNISONE TAB 50MG | 50MG | Apotex Inc | Resolved | 2023-03-28 | 73 | Manufacturing distruption | 188418 |
702 | A02BC05 | APO-ESOMEPRAZOLE | 40MG | Apotex Inc | Resolved | 2023-03-28 | 150 | Manufacturing distruption | 188427 |
703 | M04AA01 | APO-ALLOPURINOL | 200MG | Apotex Inc | Resolved | 2023-03-28 | 59 | Manufacturing distruption | 188424 |
704 | A10BH01 | APO-SITAGLIPTIN MALATE | 50MG | Apotex Inc | Resolved | 2023-03-28 | 15 | Demand increase | 188415 |
705 | A10BH01 | APO-SITAGLIPTIN MALATE | 100MG | Apotex Inc | Resolved | 2023-03-28 | 18 | Demand increase | 188411 |
681 | S01BC03 | MINT-DICLOFENAC | 0.1% | Mint Pharmaceuticals Inc | Active | 2023-03-27 | 1010 | Manufacturing distruption | 188042 |
682 | S01BC03 | MINT-DICLOFENAC | 0.1% | Mint Pharmaceuticals Inc | Active | 2023-03-27 | 1010 | Manufacturing distruption | 188045 |
686 | J04AB02 | ROFACT | 300MG | Bausch Health, Canada Inc. | Avoided | 2023-03-27 | 7 | Other | 186883 |
683 | N01AX03 | KETALAR | 10MG | Erfa Canada 2012 Inc | Resolved | 2023-03-27 | 193 | Ingredient shortage | 186132 |
684 | N01AX03 | KETALAR | 50MG | Erfa Canada 2012 Inc | Resolved | 2023-03-27 | Ingredient shortage | 186135 | |
685 | A07EA06 | ENTOCORT ENEMA | 115ML 2.3MG | Tillotts Pharma Gmbh | Resolved | 2023-03-27 | 19 | Shipping delay | 187609 |
687 | M01AB01 | SANDOZ INDOMETHACIN | 100MG | Sandoz Canada Incorporated | Resolved | 2023-03-27 | Manufacturing distruption | 188073 | |
688 | S01FA06 | ODAN-TROPICAMIDE | 1% | Odan Laboratories Ltd | Resolved | 2023-03-27 | 126 | Demand increase | 188095 |
689 | A02BB01 | MISOPROSTOL | 200MCG | Aa Pharma Inc | Resolved | 2023-03-27 | 60 | Manufacturing distruption | 186520 |
690 | A02BC04 | SANDOZ RABEPRAZOLE | 20MG | Sandoz Canada Incorporated | Resolved | 2023-03-27 | 11 | Manufacturing distruption | 188067 |
691 | N06DA03 | SANDOZ RIVASTIGMINE | 1.5MG | Sandoz Canada Incorporated | Resolved | 2023-03-27 | 4 | Shipping delay | 188070 |
692 | C09CA06 | SANDOZ CANDESARTAN | 8MG | Sandoz Canada Incorporated | Resolved | 2023-03-27 | 32 | Manufacturing distruption | 188055 |
693 | V09GA01 | KIT FOR THE PREPARATION OF TEC... | 1MG | Curium Canada Inc | Resolved | 2023-03-27 | 8 | Shipping delay | 187969 |
694 | C09DA06 | SANDOZ CANDESARTAN PLUS | 25MG 32MG | Sandoz Canada Incorporated | Resolved | 2023-03-27 | 18 | Shipping delay | 188052 |
695 | N03AX14 | SANDOZ LEVETIRACETAM | 750MG | Sandoz Canada Incorporated | Resolved | 2023-03-27 | 81 | Manufacturing distruption | 188058 |
696 | A04AA01 | ONDANSETRON ODT | 4MG | Sandoz Canada Incorporated | Resolved | 2023-03-27 | 39 | Manufacturing distruption | 188061 |
697 | J01CR02 | AMOXICILLIN SODIUM AND POTASSI... | 1000MG 200MG | Sandoz Canada Incorporated | Resolved | 2023-03-27 | 81 | Manufacturing distruption | 188048 |
680 | A10BB09 | GLICLAZIDE MR | 60MG | Sanis Health Inc | Active | 2023-03-26 | 919 | Demand increase | 223453 |
679 | N01BB51 | SENSORCAINE WITH EPINEPHRINE | 2.5MG 5MCG | Aspen Pharmacare Canada Inc. | Avoided | 2023-03-25 | 2 | Manufacturing distruption | 174087 |
674 | S01EC03 | TRUSOPT | 2% | Elvium Life Sciences | Resolved | 2023-03-24 | 49 | Shipping delay | 187945 |
675 | N05AB04 | PROCHLORAZINE | 10MG | Aa Pharma Inc | Resolved | 2023-03-24 | 56 | Manufacturing distruption | 186507 |
676 | C01BD01 | AMIODARONE HYDROCHLORIDE FOR I... | 50MG | Sandoz Canada Incorporated | Resolved | 2023-03-24 | 63 | Manufacturing distruption | 187811 |
677 | N01AX03 | KETAMINE HYDROCHLORIDE INJECTI... | 50MG | Sandoz Canada Incorporated | Resolved | 2023-03-24 | 112 | Manufacturing distruption | 187803 |
678 | C07AB12 | BYSTOLIC | 10MG | Abbvie Corporation | Resolved | 2023-03-24 | 133 | Shipping delay | 187625 |
670 | A10BF01 | GLUCOBAY | 50MG | Bayer Inc | Resolved | 2023-03-23 | Other | 156826 | |
671 | B05XA08 | SODIUM ACETATE-OMEGA | 328MG | Omega Laboratories Limited | Resolved | 2023-03-23 | Demand increase | 187387 | |
672 | S01BC05 | KETOROLAC | 0.5% | Aa Pharma Inc | Resolved | 2023-03-23 | 85 | Manufacturing distruption | 186515 |
673 | R01AX03 | IPRAVENT | 42MCG | Aa Pharma Inc | Resolved | 2023-03-23 | 34 | Manufacturing distruption | 186512 |
669 | R03BA05 | FLOVENT HFA | 125MCG | Glaxosmithkline Inc | Resolved | 2023-03-22 | 21 | Manufacturing distruption | 188090 |
659 | B05CB01 | SODIUM CHLORIDE IRRIGATION USP | 9MG | Icu Medical Canada Inc | Resolved | 2023-03-21 | 17 | Manufacturing distruption | 185509 |
660 | N04BA02 | APO-LEVOCARB-TAB 25MG/100MG | 100MG 25MG | Apotex Inc | Resolved | 2023-03-21 | 16 | Manufacturing distruption | 187718 |
661 | N06AB04 | APO-CITALOPRAM | 40MG | Apotex Inc | Resolved | 2023-03-21 | 45 | Manufacturing distruption | 187721 |
662 | C01BD01 | APO-AMIODARONE TABLETS | 200MG | Apotex Inc | Resolved | 2023-03-21 | 45 | Manufacturing distruption | 187727 |
663 | N06BA04 | APO-METHYLPHENIDATE | 10MG | Apotex Inc | Resolved | 2023-03-21 | 45 | Manufacturing distruption | 187724 |
664 | N06BA04 | BIPHENTIN | 40MG | Elvium Life Sciences | Resolved | 2023-03-21 | 15 | Shipping delay | 187628 |
665 | C10AA07 | APO-ROSUVASTATIN | 40MG | Apotex Inc | Resolved | 2023-03-21 | 38 | Manufacturing distruption | 187730 |
666 | N06BA04 | FOQUEST | 70MG | Elvium Life Sciences | Resolved | 2023-03-21 | 24 | Shipping delay | 187631 |
667 | N07BC51 | SUBOXONE | 0.5MG 2MG | Indivior Uk Limited | Resolved | 2023-03-21 | 40 | Demand increase | 186034 |
668 | G03AB09 | TRI-CIRA 28 | 0.035MG 0.25MG 0.035MG 0.215MG 0.035MG 0.18MG | Apotex Inc | Resolved | 2023-03-21 | 140 | Manufacturing distruption | 187715 |
643 | G01AF01 | NIDAGEL | 0.75% | Bausch Health, Canada Inc. | Resolved | 2023-03-20 | 102 | Ingredient shortage | 183891 |
644 | N02AA03 | HYDROMORPHONE HYDROCHLORIDE IN... | 2MG | Sandoz Canada Incorporated | Resolved | 2023-03-20 | 25 | Manufacturing distruption | 187433 |
645 | H02AB02 | PMS DEXAMETHASONE TAB 0.5MG US... | 0.5MG | Pharmascience Inc | Resolved | 2023-03-20 | 30 | Manufacturing distruption | 187463 |
646 | N05AH01 | LOXAPAC IM | 50MG | Sandoz Canada Incorporated | Resolved | 2023-03-20 | 25 | Demand increase | 187444 |
647 | N03AB05 | CEREBYX | 75MG | Searchlight Pharma Inc | Resolved | 2023-03-20 | 26 | Shipping delay | 187772 |
648 | C07AB03 | PMS-ATENOLOL | 100MG | Pharmascience Inc | Resolved | 2023-03-20 | 93 | Manufacturing distruption | 187472 |
649 | N02CC04 | MAXALT RPD | 10MG | Organon Canada Inc. | Resolved | 2023-03-20 | 25 | Shipping delay | 187527 |
650 | R03AK06 | ADVAIR 500 DISKUS | 500MCG 50MCG | Glaxosmithkline Inc | Resolved | 2023-03-20 | 32 | Manufacturing distruption | 187763 |
651 | C07AB03 | PMS-ATENOLOL | 25MG | Pharmascience Inc | Resolved | 2023-03-20 | 84 | Manufacturing distruption | 187482 |
652 | C09AA02 | SANDOZ ENALAPRIL | 16MG | Sandoz Canada Incorporated | Resolved | 2023-03-20 | Demand increase | 187485 | |
653 | M03AC09 | ROCURONIUM BROMIDE INJECTION | 10MG | Sandoz Canada Incorporated | Resolved | 2023-03-20 | 25 | Manufacturing practices | 187451 |
654 | C09AA02 | TARO-ENALAPRIL | 4MG | Sun Pharma Canada Inc | Resolved | 2023-03-20 | 151 | Manufacturing distruption | 202128 |
655 | N02CC03 | SANDOZ ZOLMITRIPTAN ODT | 2.5MG | Sandoz Canada Incorporated | Resolved | 2023-03-20 | 193 | Manufacturing distruption | 187457 |
656 | J02AC01 | FLUCONAZOLE INJECTION SDZ | 2MG | Sandoz Canada Incorporated | Resolved | 2023-03-20 | 32 | Shipping delay | 187430 |
657 | C10AX09 | SANDOZ EZETIMIBE | 10MG | Sandoz Canada Incorporated | Resolved | 2023-03-20 | 4 | Manufacturing distruption | 187427 |
658 | C10AA03 | ACH-PRAVASTATIN | 10MG | Accord Healthcare Inc | Resolved | 2023-03-20 | 100 | Manufacturing distruption | 187454 |
640 | N06AB05 | PAXIL CR | 25MG | Glaxosmithkline Inc | Resolved | 2023-03-17 | 28 | Manufacturing distruption | 187361 |
641 | N03AX14 | ACH-LEVETIRACETAM | 250MG | Accord Healthcare Inc | Resolved | 2023-03-17 | Shipping delay | 187460 | |
642 | A10BJ06 | OZEMPIC | 1MG | Novo Nordisk Canada Inc | Resolved | 2023-03-17 | 7 | Other | 187390 |
635 | H04AA01 | GLUCAGON | 1MG | Eli Lilly Canada Inc | Resolved | 2023-03-16 | 25 | Demand increase | 187074 |
636 | A09AA02 | COTAZYM | 35000UNIT 40000UNIT 10000UNIT | Organon Canada Inc. | Resolved | 2023-03-16 | 50 | Shipping delay | 186649 |
637 | N06AX23 | PRISTIQ | 50MG | Pfizer Canada Ulc | Resolved | 2023-03-16 | 15 | Manufacturing distruption | 177973 |
638 | H05BX01 | MYLAN-CINACALCET | 60MG | Mylan Pharmaceuticals Ulc | Resolved | 2023-03-16 | 40 | Manufacturing distruption | 183765 |
639 | C07AB03 | ATENOLOL | 100MG | Pro Doc Limitee | Resolved | 2023-03-16 | 107 | Shipping delay | 187253 |
632 | G04BE09 | MYLAN-VARDENAFIL | 10MG | Mylan Pharmaceuticals Ulc | Avoided | 2023-03-15 | 6 | Manufacturing distruption | 186414 |
627 | B05BA03 | 5% DEXTROSE INJECTION, USP | 5G | Baxter Corporation | Resolved | 2023-03-15 | 15 | Manufacturing distruption | 187084 |
628 | N03AG04 | SABRIL | 500MG | Lundbeck Pharmaceuticals Llc | Resolved | 2023-03-15 | 397 | Manufacturing practices | 178697 |
629 | G03CA57 | PREMARIN INTRAVENOUS | 25MG | Pfizer Canada Ulc | Resolved | 2023-03-15 | 77 | Demand increase | 186629 |
630 | H02AB01 | CELESTONE SOLUSPAN | 3MG 3MG | Organon Canada Inc. | Resolved | 2023-03-15 | 254 | Manufacturing distruption | 182289 |
631 | A10BD07 | JANUMET | 1000MG 50MG | Merck Canada Inc | Resolved | 2023-03-15 | 5 | Demand increase | 187097 |
633 | N02AA03 | HYDROMORPHONE HYDROCHLORIDE IN... | 10MG | Fresenius Kabi Canada Ltd | Resolved | 2023-03-15 | 61 | Other | 181142 |
634 | N02AA03 | HYDROMORPHONE HYDROCHLORIDE IN... | 2MG | Fresenius Kabi Canada Ltd | Resolved | 2023-03-15 | 47 | Manufacturing distruption | 181139 |
615 | G04BD04 | APO-OXYBUTYNIN | 5MG | Apotex Inc | Resolved | 2023-03-14 | 45 | Manufacturing distruption | 187229 |
616 | A11DA01 | THIAMIJECT INJECTION - LIQ IM... | 100MG | Omega Laboratories Limited | Resolved | 2023-03-14 | 59 | Demand increase | 186796 |
617 | N03AG01 | APO-DIVALPROEX | 500MG | Apotex Inc | Resolved | 2023-03-14 | 10 | Manufacturing distruption | 187226 |
618 | M01AC01 | APO PIROXICAM CAP 20MG | 20MG | Apotex Inc | Resolved | 2023-03-14 | 10 | Manufacturing distruption | 187232 |
619 | H01AB01 | THYROGEN | 0.9MG | Sanofi Genzyme, A Division Of Sanofi-Aventis Canada Inc | Resolved | 2023-03-14 | 38 | Other | 187119 |
620 | C07AG02 | APO-CARVEDILOL | 12.5MG | Apotex Inc | Resolved | 2023-03-14 | 45 | Manufacturing distruption | 187223 |
621 | A10AE04 | LANTUS | 100UNIT | Sanofi-Aventis Canada Inc | Resolved | 2023-03-14 | 15 | Other | 187015 |
622 | N02CC01 | APO-SUMATRIPTAN | 50MG | Apotex Inc | Resolved | 2023-03-14 | 17 | Manufacturing distruption | 187235 |
623 | N02BF02 | LYRICA | 75MG | Upjohn Canada Ulc | Resolved | 2023-03-14 | Manufacturing distruption | 184559 | |
624 | R03DC03 | APO-MONTELUKAST | 10MG | Apotex Inc | Resolved | 2023-03-14 | 17 | Manufacturing distruption | 187241 |
625 | N04BD02 | APO-RASAGILINE | 1MG | Apotex Inc | Resolved | 2023-03-14 | 45 | Manufacturing distruption | 187244 |
626 | N06AX23 | APO-DESVENLAFAXINE EXTENDED-RE... | 50MG | Apotex Inc | Resolved | 2023-03-14 | 24 | Manufacturing distruption | 187238 |
599 | N02AA03 | HYDROMORPHONE HP 10 | 10MG | Sandoz Canada Incorporated | Resolved | 2023-03-13 | 32 | Manufacturing distruption | 186963 |
600 | G03CA03 | ESTRING | 2MG | Pfizer Canada Ulc | Resolved | 2023-03-13 | 50 | Manufacturing distruption | 185649 |
601 | B05XA02 | SODIUM BICARBONATE INJECTION U... | 75MG | Pfizer Canada Ulc | Resolved | 2023-03-13 | Manufacturing distruption | 180722 | |
602 | S01ED01 | TIMOLOL MALEATE-EX | 0.25% | Sandoz Canada Incorporated | Resolved | 2023-03-13 | 60 | Manufacturing distruption | 186993 |
603 | R05CB01 | ACETYLCYSTEINE SOLUTION | 200MG | Sandoz Canada Incorporated | Resolved | 2023-03-13 | 25 | Manufacturing distruption | 186913 |
604 | L04AD01 | SANDOZ CYCLOSPORINE | 25MG | Sandoz Canada Incorporated | Resolved | 2023-03-13 | 53 | Manufacturing distruption | 186956 |
605 | A10BB12 | SANDOZ GLIMEPIRIDE | 4MG | Sandoz Canada Incorporated | Resolved | 2023-03-13 | 39 | Manufacturing distruption | 186959 |
606 | N06DA03 | SANDOZ RIVASTIGMINE | 3MG | Sandoz Canada Incorporated | Resolved | 2023-03-13 | 18 | Manufacturing distruption | 186981 |
607 | C09DA04 | SANDOZ IRBESARTAN HCT | 12.5MG 150MG | Sandoz Canada Incorporated | Resolved | 2023-03-13 | 32 | Manufacturing distruption | 186967 |
608 | C09DA04 | SANDOZ IRBESARTAN HCT | 12.5MG 150MG | Sandoz Canada Incorporated | Resolved | 2023-03-13 | 53 | Manufacturing distruption | 186971 |
609 | C03CA01 | FUROSEMIDE | 20MG | Sanis Health Inc | Resolved | 2023-03-13 | 109 | Manufacturing distruption | 187311 |
610 | C09CA07 | SANDOZ TELMISARTAN | 80MG | Sandoz Canada Incorporated | Resolved | 2023-03-13 | 11 | Shipping delay | 186990 |
611 | N02BF02 | SANDOZ PREGABALIN | 150MG | Sandoz Canada Incorporated | Resolved | 2023-03-13 | 67 | Manufacturing distruption | 186975 |
612 | G04BD08 | SANDOZ SOLIFENACIN | 10MG | Sandoz Canada Incorporated | Resolved | 2023-03-13 | 18 | Manufacturing distruption | 186985 |
613 | N06AA12 | SINEQUAN | 10MG | Aa Pharma Inc | Resolved | 2023-03-13 | 50 | Manufacturing distruption | 185698 |
614 | S02CA06 | SANDOZ CIPROFLOXACIN / DEXAMET... | 0.1% 0.3% | Sandoz Canada Incorporated | Resolved | 2023-03-13 | 11 | Demand increase | 186952 |
598 | D10AF51 | BENZACLIN | 5% 1% | Bausch Health, Canada Inc. | Avoided | 2023-03-12 | 18 | Demand increase | 179119 |
596 | B05XA08 | SODIUM ACETATE INJECTION, USP | 328MG | Fresenius Kabi Canada Ltd | Resolved | 2023-03-10 | 82 | Other | 151507 |
597 | C01DA02 | NITROLINGUAL PUMPSPRAY | 0.4MG | Sanofi-Aventis Canada Inc | Resolved | 2023-03-10 | 478 | Demand increase | 186615 |
593 | D07AC13 | ELOCOM | 0.1% | Organon Canada Inc. | Resolved | 2023-03-09 | 78 | Shipping delay | 179909 |
594 | C02AB02 | METHYLDOPA | 500MG | Aa Pharma Inc | Resolved | 2023-03-09 | 46 | Manufacturing distruption | 186504 |
595 | V04CX | FLUORESCITE | 10% | Alcon Canada Inc | Resolved | 2023-03-09 | 22 | Shipping delay | 186428 |
589 | C01DA02 | NITROLINGUAL PUMPSPRAY | 0.4MG | Sanofi-Aventis Canada Inc | Resolved | 2023-03-08 | 480 | Demand increase | 186618 |
590 | S01FA04 | ODAN-CYCLOPENTOLATE | 1% | Odan Laboratories Ltd | Resolved | 2023-03-08 | 144 | Demand increase | 186465 |
591 | M01AE02 | PRO-NAPROXEN EC | 500MG | Pro Doc Limitee | Resolved | 2023-03-08 | 56 | Shipping delay | 186493 |
592 | A07DA01 | LOMOTIL | .025MG 2.5MG | Pfizer Canada Ulc | Resolved | 2023-03-08 | 224 | Manufacturing distruption | 185710 |
584 | C09BA04 | APO-PERINDOPRIL-INDAPAMIDE | 8MG 2.5MG | Apotex Inc | Avoided | 2023-03-07 | 199 | Manufacturing distruption | 186580 |
581 | G01AF01 | FLAGYL | 10% | Sanofi-Aventis Canada Inc | Resolved | 2023-03-07 | 54 | Other | 186612 |
582 | C07AA07 | APO-SOTALOL | 160MG | Apotex Inc | Resolved | 2023-03-07 | 115 | Manufacturing distruption | 186569 |
583 | L02BG04 | APO-LETROZOLE | 2.5MG | Apotex Inc | Resolved | 2023-03-07 | 17 | Manufacturing distruption | 186589 |
585 | C09BA04 | APO-PERINDOPRIL-INDAPAMIDE | 8MG 2.5MG | Apotex Inc | Resolved | 2023-03-07 | 199 | Manufacturing distruption | 186583 |
586 | M05BB03 | APO-ALENDRONATE/VITAMIN D3 | 2800UNIT 70MG | Apotex Inc | Resolved | 2023-03-07 | 68 | Manufacturing distruption | 186572 |
587 | A10BA02 | APO-METFORMIN ER | 1000MG | Apotex Inc | Resolved | 2023-03-07 | 30 | Manufacturing distruption | 186575 |
588 | N05AH04 | APO-QUETIAPINE FUMARATE | 25MG | Apotex Inc | Resolved | 2023-03-07 | 38 | Manufacturing distruption | 186586 |
573 | G03BA03 | PMS-TESTOSTERONE | 40MG | Pharmascience Inc | Active | 2023-03-06 | Manufacturing distruption | 188961 | |
565 | B05XA03 | SODIUM CHLORIDE INJECTION USP | 9MG | Icu Medical Canada Inc | Avoided | 2023-03-06 | Manufacturing distruption | 182677 | |
569 | J01MA02 | CIPRO ORAL SUSPENSION | 500MG | Bayer Inc | Avoided | 2023-03-06 | 4 | Other | 180743 |
564 | J07AP03 | TYPHIM VI | 25MCG | Sanofi Pasteur Limited | Resolved | 2023-03-06 | 239 | Demand increase | 186004 |
566 | B03BA01 | VITAMIN B12 | 1000MCG | Sandoz Canada Incorporated | Resolved | 2023-03-06 | 25 | Manufacturing distruption | 186307 |
567 | J01FF01 | CLINDAMYCIN INJECTION USP | 150MG | Sandoz Canada Incorporated | Resolved | 2023-03-06 | 74 | Manufacturing practices | 186246 |
568 | N01BB52 | XYLOCAINE 1% W EPINEPHRINE 1:1... | 0.01MG 10MG | Aspen Pharmacare Canada Inc. | Resolved | 2023-03-06 | 117 | Manufacturing distruption | 174078 |
570 | R03BA01 | QVAR | 100MCG | Bausch Health, Canada Inc. | Resolved | 2023-03-06 | 18 | Other | 177248 |
571 | N03AX14 | PMS-LEVETIRACETAM | 250MG | Pharmascience Inc | Resolved | 2023-03-06 | 119 | Manufacturing distruption | 186250 |
572 | N03AX14 | PMS-LEVETIRACETAM | 750MG | Pharmascience Inc | Resolved | 2023-03-06 | 119 | Manufacturing distruption | 186253 |
574 | N06DA03 | SANDOZ RIVASTIGMINE | 1.5MG | Sandoz Canada Incorporated | Resolved | 2023-03-06 | 25 | Shipping delay | 186300 |
575 | C09DA06 | SANDOZ CANDESARTAN PLUS | 12.5MG 16MG | Sandoz Canada Incorporated | Resolved | 2023-03-06 | 25 | Manufacturing distruption | 186277 |
576 | C09DA04 | SANDOZ IRBESARTAN HCT | 12.5MG 300MG | Sandoz Canada Incorporated | Resolved | 2023-03-06 | 25 | Shipping delay | 186285 |
577 | C10AA07 | SANDOZ ROSUVASTATIN | 20MG | Sandoz Canada Incorporated | Resolved | 2023-03-06 | 165 | Manufacturing distruption | 186303 |
578 | N02BF02 | SANDOZ PREGABALIN | 25MG | Sandoz Canada Incorporated | Resolved | 2023-03-06 | 67 | Manufacturing distruption | 186289 |
579 | N02BF02 | SANDOZ PREGABALIN | 150MG | Sandoz Canada Incorporated | Resolved | 2023-03-06 | 74 | Manufacturing practices | 186297 |
580 | J07BC01 | ENGERIX-B | 10MCG | Glaxosmithkline Inc | Resolved | 2023-03-06 | 56 | Shipping delay | 186642 |
553 | V07AB | BACTERIOSTATIC SODIUM CHLORIDE... | 9MG | Pfizer Canada Ulc | Resolved | 2023-03-03 | Manufacturing distruption | 181448 | |
554 | B03BA01 | CYANOCOBALAMIN INJECTION USP | 1000MCG | Sterimax Inc | Resolved | 2023-03-03 | 10 | Shipping delay | 186103 |
555 | H02AB02 | DEXAMETHASONE-OMEGA | 4MG | Omega Laboratories Limited | Resolved | 2023-03-03 | 8 | Demand increase | 185098 |
556 | J01FF01 | CLINDAMYCIN INJECTION USP | 150MG | Sandoz Canada Incorporated | Resolved | 2023-03-03 | 77 | Manufacturing distruption | 186218 |
557 | J01CE02 | PEN-VK | 300MG | Aa Pharma Inc | Resolved | 2023-03-03 | 77 | Manufacturing distruption | 185690 |
558 | N06AX11 | REMERON RD | 45MG | Organon Canada Inc. | Resolved | 2023-03-03 | 14 | Demand increase | 186446 |
559 | V09AX01 | INDIUM DTPA IN 111 | 37MBq | Ge Healthcare Canada Inc | Resolved | 2023-03-03 | 14 | Other | 186110 |
560 | N02BA01 | SNS-ASA EC | 80MG | Sanis Health Inc | Resolved | 2023-03-03 | Manufacturing distruption | 187303 | |
561 | N06AX21 | SANDOZ DULOXETINE | 30MG | Sandoz Canada Incorporated | Resolved | 2023-03-03 | 7 | Shipping delay | 186281 |
562 | A10BD07 | APO-SITAGLIPTIN MALATE / METFO... | 500MG 50MG | Apotex Inc | Resolved | 2023-03-03 | 154 | Demand increase | 185948 |
563 | A10BD07 | APO-SITAGLIPTIN MALATE / METFO... | 850MG 50MG | Apotex Inc | Resolved | 2023-03-03 | 217 | Demand increase | 185951 |
541 | H02AB02 | DEXAMETHASONE-OMEGA | 4MG | Omega Laboratories Limited | Resolved | 2023-03-02 | 16 | Demand increase | 185091 |
542 | N06AX11 | MYLAN-MIRTAZAPINE | 30MG | Mylan Pharmaceuticals Ulc | Resolved | 2023-03-02 | 124 | Manufacturing distruption | 182205 |
543 | A10BD07 | APO-SITAGLIPTIN/METFORMIN XR | 500MG 50MG | Apotex Inc | Resolved | 2023-03-02 | 335 | Demand increase | 185970 |
544 | A10BD07 | APO-SITAGLIPTIN/METFORMIN XR | 1000MG 50MG | Apotex Inc | Resolved | 2023-03-02 | 335 | Demand increase | 185973 |
545 | A10BD07 | APO-SITAGLIPTIN/METFORMIN XR | 1000MG 50MG | Apotex Inc | Resolved | 2023-03-02 | 335 | Demand increase | 185976 |
546 | A10BD07 | APO-SITAGLIPTIN/METFORMIN XR | 1000MG 50MG | Apotex Inc | Resolved | 2023-03-02 | 335 | Demand increase | 185982 |
547 | A10BD07 | APO-SITAGLIPTIN/METFORMIN XR | 1000MG 100MG | Apotex Inc | Resolved | 2023-03-02 | 335 | Demand increase | 185967 |
548 | A10BD07 | APO-SITAGLIPTIN/METFORMIN XR | 1000MG 100MG | Apotex Inc | Resolved | 2023-03-02 | 335 | Demand increase | 185985 |
549 | A10BD07 | APO-SITAGLIPTIN MALATE / METFO... | 850MG 50MG | Apotex Inc | Resolved | 2023-03-02 | 218 | Demand increase | 185954 |
550 | A10BD07 | APO-SITAGLIPTIN MALATE / METFO... | 1000MG 50MG | Apotex Inc | Resolved | 2023-03-02 | 155 | Demand increase | 185957 |
551 | A10BD07 | APO-SITAGLIPTIN MALATE / METFO... | 1000MG 50MG | Apotex Inc | Resolved | 2023-03-02 | 155 | Demand increase | 185961 |
552 | A10BD07 | APO-SITAGLIPTIN MALATE / METFO... | 1000MG 50MG | Apotex Inc | Resolved | 2023-03-02 | 155 | Demand increase | 185964 |
533 | N05AC01 | NEULEPTIL | 10MG | Searchlight Pharma Inc | Resolved | 2023-03-01 | 167 | Ingredient shortage | 187371 |
534 | B05XA06 | POTASSIUM PHOSPHATES INJECTION... | 236MG 224MG | Fresenius Kabi Canada Ltd | Resolved | 2023-03-01 | 61 | Manufacturing distruption | 159355 |
535 | J01XA01 | VANCOMYCIN HYDROCHLORIDE FOR I... | 5G | Fresenius Kabi Canada Ltd | Resolved | 2023-03-01 | 43 | Manufacturing distruption | 177097 |
536 | N07BC02 | METADOL-D | 10MG | Paladin Labs Inc. | Resolved | 2023-03-01 | 12 | Shipping delay | 185821 |
537 | C10BX03 | CADUET | 10MG 10MG | Upjohn Canada Ulc | Resolved | 2023-03-01 | 6 | Manufacturing distruption | 184556 |
538 | J05AB14 | TEVA-VALGANCICLOVIR | 450MG | Teva Canada Limited | Resolved | 2023-03-01 | 233 | Manufacturing distruption | 204769 |
539 | N05AE04 | AURO-ZIPRASIDONE | 80MG | Auro Pharma Inc | Resolved | 2023-03-01 | 131 | Demand increase | 187479 |
540 | H03AA01 | LEVOTHYROXINE SODIUM FOR INJEC... | 500MCG | Avir Pharma Inc. | Resolved | 2023-03-01 | 2 | Shipping delay | 183509 |
519 | V08AB02 | OMNIPAQUE 240 | 518MG | Ge Healthcare Canada Inc | Avoided | 2023-02-28 | 15 | Ingredient shortage | 176387 |
517 | C02CA01 | APO-PRAZO TAB 5MG | 5MG | Apotex Inc | Resolved | 2023-02-28 | Ingredient shortage | 185924 | |
518 | V03AF02 | ZINECARD | 250MG | Pfizer Canada Ulc | Resolved | 2023-02-28 | Manufacturing distruption | 185721 | |
520 | M01AE02 | APO-NAPROXEN | 500MG | Apotex Inc | Resolved | 2023-02-28 | 59 | Manufacturing distruption | 185942 |
521 | N05AA02 | METHOPRAZINE | 5MG | Aa Pharma Inc | Resolved | 2023-02-28 | 15 | Manufacturing distruption | 161409 |
522 | J01CE02 | PEN-VK | 300MG | Aa Pharma Inc | Resolved | 2023-02-28 | 80 | Manufacturing distruption | 185687 |
523 | J01EA01 | TRIMETHOPRIM TABLETS | 100MG | Aa Pharma Inc | Resolved | 2023-02-28 | 41 | Manufacturing distruption | 185693 |
524 | A02BC02 | APO-PANTOPRAZOLE | 20MG | Apotex Inc | Resolved | 2023-02-28 | 59 | Manufacturing distruption | 185936 |
525 | S01EC01 | ACETAZOLAMIDE FOR INJECTION, U... | 500MG | Sterimax Inc | Resolved | 2023-02-28 | 6 | Demand increase | 185664 |
526 | N05AH03 | APO-OLANZAPINE ODT | 15MG | Apotex Inc | Resolved | 2023-02-28 | 92 | Manufacturing distruption | 185930 |
527 | G03AA07 | OVIMA 28 | 30MCG 150MCG | Apotex Inc | Resolved | 2023-02-28 | 31 | Manufacturing distruption | 185933 |
528 | C09DA07 | TELMISARTAN HCTZ | 25MG 80MG | Sivem Pharmaceuticals Ulc | Resolved | 2023-02-28 | 310 | Shipping delay | 183206 |
529 | N05BA06 | LORAZEPAM SUBLINGUAL | 0.5MG | Aa Pharma Inc | Resolved | 2023-02-28 | 51 | Manufacturing distruption | 183599 |
530 | N05BA06 | LORAZEPAM SUBLINGUAL | 1MG | Aa Pharma Inc | Resolved | 2023-02-28 | 56 | Manufacturing distruption | 185682 |
531 | J01DB01 | APO-CEPHALEX | 250MG | Apotex Inc | Resolved | 2023-02-28 | 45 | Manufacturing distruption | 185939 |
532 | N06BA04 | APO-METHYLPHENIDATE ER | 27MG | Apotex Inc | Resolved | 2023-02-28 | 59 | Manufacturing distruption | 185927 |
512 | J01MA02 | CIPROFLOXACIN | 500MG | Sanis Health Inc | Active | 2023-02-27 | Manufacturing distruption | 211200 | |
516 | C10AA03 | M-PRAVASTATIN | 20MG | Mantra Pharma Inc | Active | 2023-02-27 | 854 | Shipping delay | 225548 |
513 | N05CM05 | SCOPOLAMINE HYDROBROMIDE INJEC... | 0.6MG | Omega Laboratories Limited | Avoided | 2023-02-27 | 7 | Demand increase | 185103 |
514 | C03CA01 | FUROSEMIDE | 80MG | Sanis Health Inc | Resolved | 2023-02-27 | 128 | Manufacturing distruption | 187306 |
515 | G03XB51 | MIFEGYMISO | 200MCG 200MG | Linepharma International Limited | Resolved | 2023-02-27 | 9 | Other | 182763 |
511 | S01BA | DUREZOL | 0.05% | Novartis Pharmaceuticals Canada Inc | Resolved | 2023-02-25 | Manufacturing distruption | 152583 | |
506 | N03AX11 | ACH-TOPIRAMATE | 100MG | Accord Healthcare Inc | Active | 2023-02-24 | Manufacturing distruption | 185598 | |
497 | N05AD01 | HALOPERIDOL INJ 5MG/ML USP | 5MG | Sandoz Canada Incorporated | Resolved | 2023-02-24 | 35 | Manufacturing distruption | 186163 |
498 | A03AB02 | GLYCOPYRROLATE INJECTION USP | 0.2MG | Sandoz Canada Incorporated | Resolved | 2023-02-24 | 49 | Manufacturing distruption | 186160 |
499 | J01GB03 | GENTAMICIN(E) | 1.6MG | Baxter Corporation | Resolved | 2023-02-24 | 31 | Demand increase | 185563 |
500 | C08DA01 | VERAPAMIL HYDROCHLORIDE INJECT... | 2.5MG | Sandoz Canada Incorporated | Resolved | 2023-02-24 | 56 | Manufacturing distruption | 186176 |
501 | J01EE01 | SULFATRIM DS | 160MG 800MG | Aa Pharma Inc | Resolved | 2023-02-24 | 35 | Manufacturing distruption | 183596 |
502 | C08DB01 | DILTIAZEM HYDROCHLORIDE INJECT... | 5MG | Sandoz Canada Incorporated | Resolved | 2023-02-24 | 70 | Ingredient shortage | 186152 |
503 | C09CA06 | ACH-CANDESARTAN | 16MG | Accord Healthcare Inc | Resolved | 2023-02-24 | Demand increase | 185595 | |
504 | N04BX02 | SANDOZ ENTACAPONE | 200MG | Sandoz Canada Incorporated | Resolved | 2023-02-24 | 56 | Manufacturing practices | 186157 |
505 | N05AH04 | QUETIAPINE TABLETS | 200MG | Accord Healthcare Inc | Resolved | 2023-02-24 | 188 | Manufacturing distruption | 185592 |
507 | C10AA07 | ACH-ROSUVASTATIN | 20MG | Accord Healthcare Inc | Resolved | 2023-02-24 | Shipping delay | 185581 | |
508 | S01BC03 | SANDOZ DICLOFENAC OPHTHA | 0.1% | Sandoz Canada Incorporated | Resolved | 2023-02-24 | 98 | Ingredient shortage | 186181 |
509 | B01AF03 | LIXIANA | 60MG | Servier Canada Inc | Resolved | 2023-02-24 | 14 | Shipping delay | 185707 |
510 | N06BA12 | VYVANSE | 40MG | Takeda Canada Inc | Resolved | 2023-02-24 | 21 | Shipping delay | 185609 |
493 | N02CC04 | MAXALT RPD | 5MG | Organon Canada Inc. | Resolved | 2023-02-23 | 92 | Demand increase | 185520 |
494 | J01FA09 | BIAXIN | 250MG | Bgp Pharma Ulc | Resolved | 2023-02-23 | 36 | Demand increase | 182226 |
495 | C10BX03 | CADUET | 20MG 10MG | Upjohn Canada Ulc | Resolved | 2023-02-23 | 110 | Demand increase | 187500 |
496 | N01BB20 | ORAQIX | 2.5% 2.5% | Dentsply Canada Limited | Resolved | 2023-02-23 | 59 | Shipping delay | 185659 |
490 | N06AB03 | APO-FLUOXETINE | 10MG | Apotex Inc | Resolved | 2023-02-22 | 9 | Manufacturing distruption | 185456 |
491 | J07BD52 | PRIORIX | 0.5ML 1000CCID50 1000CCID50 10000CCID50 | Glaxosmithkline Inc | Resolved | 2023-02-22 | 23 | Manufacturing distruption | 185638 |
492 | N05BB01 | HYDROXYZINE | 10MG | Aa Pharma Inc | Resolved | 2023-02-22 | 113 | Manufacturing distruption | 186480 |
467 | C08DA01 | APO-VERAP TAB 80MG | 80MG | Apotex Inc | Resolved | 2023-02-21 | 10 | Manufacturing distruption | 185462 |
468 | R03BA05 | APO-FLUTICASONE HFA | 125MCG | Apotex Inc | Resolved | 2023-02-21 | 17 | Manufacturing distruption | 185486 |
469 | C07AB04 | APO-ACEBUTOLOL | 200MG | Apotex Inc | Resolved | 2023-02-21 | 24 | Manufacturing distruption | 185448 |
470 | M01AE02 | APO-NAPROXEN | 500MG | Apotex Inc | Resolved | 2023-02-21 | 73 | Manufacturing distruption | 185459 |
471 | C07AB03 | PMS-ATENOLOL | 50MG | Pharmascience Inc | Resolved | 2023-02-21 | 120 | Manufacturing distruption | 185233 |
472 | C02CA04 | APO-DOXAZOSIN | 2MG | Apotex Inc | Resolved | 2023-02-21 | 31 | Manufacturing distruption | 185451 |
473 | J01CR02 | APO-AMOXI CLAV | 125MG 250MG | Apotex Inc | Resolved | 2023-02-21 | 31 | Manufacturing distruption | 185483 |
474 | C07AG01 | APO-LABETALOL | 200MG | Apotex Inc | Resolved | 2023-02-21 | 10 | Manufacturing distruption | 185489 |
475 | N05CC01 | CHLORAL HYDRATE SYRUP ODAN | 500MG | Odan Laboratories Ltd | Resolved | 2023-02-21 | 38 | Manufacturing distruption | 185263 |
476 | N04BC05 | APO-PRAMIPEXOLE | 0.5MG | Apotex Inc | Resolved | 2023-02-21 | 52 | Manufacturing distruption | 185465 |
477 | N05AH03 | PMS-OLANZAPINE | 10MG | Pharmascience Inc | Resolved | 2023-02-21 | 149 | Manufacturing distruption | 185238 |
478 | J01MA12 | APO-LEVOFLOXACIN | 750MG | Apotex Inc | Resolved | 2023-02-21 | Manufacturing distruption | 185468 | |
479 | C01BB01 | LIDOCAINE HYDROCHLORIDE INJECT... | 20MG | Pfizer Canada Ulc | Resolved | 2023-02-21 | Manufacturing distruption | 180719 | |
480 | S01ED51 | GD-LATANOPROST/TIMOLOL | 50MCG 5MG | Upjohn Canada Ulc | Resolved | 2023-02-21 | Manufacturing distruption | 181289 | |
481 | M01AH01 | APO-CELECOXIB | 200MG | Apotex Inc | Resolved | 2023-02-21 | 10 | Manufacturing distruption | 185471 |
482 | J01DB01 | APO-CEPHALEX | 500MG | Apotex Inc | Resolved | 2023-02-21 | 10 | Manufacturing distruption | 185480 |
483 | C10AA03 | ACH-PRAVASTATIN | 10MG | Accord Healthcare Inc | Resolved | 2023-02-21 | Manufacturing distruption | 185589 | |
484 | M01AE52 | MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 500MG | Mylan Pharmaceuticals Ulc | Resolved | 2023-02-21 | 30 | Manufacturing distruption | 184568 |
485 | A09AA02 | CREON MINIMICROSPHERES MICRO | 320UNIT 5100UNIT 5000UNIT | Bgp Pharma Ulc | Resolved | 2023-02-21 | 21 | Manufacturing distruption | 184582 |
486 | N06BA01 | APO-AMPHETAMINE XR | 10MG | Apotex Inc | Resolved | 2023-02-21 | 31 | Manufacturing distruption | 185474 |
487 | C09CA08 | ACH-OLMESARTAN | 40MG | Accord Healthcare Inc | Resolved | 2023-02-21 | Demand increase | 185586 | |
488 | B01AE07 | APO-DABIGATRAN | 150MG | Apotex Inc | Resolved | 2023-02-21 | 31 | Manufacturing distruption | 185492 |
489 | N05AX12 | APO-ARIPIPRAZOLE | 10MG | Apotex Inc | Resolved | 2023-02-21 | 38 | Manufacturing distruption | 185477 |
464 | B05XA09 | SODIUM PHOSPHATES INJECTION US... | 268MG 276MG | Sandoz Canada Incorporated | Resolved | 2023-02-20 | 42 | Manufacturing distruption | 168559 |
465 | L01XX24 | ONCASPAR | 750UNIT | Servier Canada Inc | Resolved | 2023-02-20 | 374 | Manufacturing distruption | 181357 |
466 | N02AA01 | MORPHINE SULFATE INJECTION EPI... | 0.5MG | Sterimax Inc | Resolved | 2023-02-20 | 88 | Shipping delay | 185528 |
450 | H02AB02 | DEXAMETHASONE SOD PHOSPH INJ 1... | 10MG | Sandoz Canada Incorporated | Resolved | 2023-02-17 | 133 | Manufacturing distruption | 186053 |
451 | J01GB03 | GENTAMICIN INJECTION USP | 40MG | Sandoz Canada Incorporated | Resolved | 2023-02-17 | Manufacturing distruption | 186057 | |
452 | A03FA01 | METOCLOPRAMIDE OMEGA | 5MG | Omega Laboratories Limited | Resolved | 2023-02-17 | Demand increase | 183623 | |
453 | A02BA03 | FAMOTIDINE OMEGA -(WITHOUT PR... | 10MG | Omega Laboratories Limited | Resolved | 2023-02-17 | 32 | Demand increase | 184429 |
454 | L01DB03 | EPIRUBICIN FOR INJECTION | 2MG | Teva Canada Limited | Resolved | 2023-02-17 | 52 | Manufacturing distruption | 185077 |
455 | C09CA04 | SANDOZ IRBESARTAN | 75MG | Sandoz Canada Incorporated | Resolved | 2023-02-17 | 105 | Manufacturing distruption | 186061 |
456 | G04CA02 | SANDOZ TAMSULOSIN CR | 0.4MG | Sandoz Canada Incorporated | Resolved | 2023-02-17 | 28 | Manufacturing distruption | 186077 |
457 | N06AX11 | MIRTAZAPINE | 30MG | Sanis Health Inc | Resolved | 2023-02-17 | 72 | Manufacturing distruption | 187300 |
458 | B02AA02 | TRANEXAMIC ACID INJECTION | 100MG | Omega Laboratories Limited | Resolved | 2023-02-17 | Demand increase | 183628 | |
459 | B02AA02 | TRANEXAMIC ACID INJECTION | 100MG | Omega Laboratories Limited | Resolved | 2023-02-17 | 59 | Demand increase | 184432 |
460 | R01AD09 | SANDOZ MOMETASONE | 50MCG | Sandoz Canada Incorporated | Resolved | 2023-02-17 | 28 | Manufacturing distruption | 186067 |
461 | N06BA04 | FOQUEST | 55MG | Elvium Life Sciences | Resolved | 2023-02-17 | 39 | Shipping delay | 185068 |
462 | G04CA04 | SANDOZ SILODOSIN | 8MG | Sandoz Canada Incorporated | Resolved | 2023-02-17 | 28 | Manufacturing distruption | 186073 |
463 | A04AA01 | ONDANSETRON ODT | 8MG | Sandoz Canada Incorporated | Resolved | 2023-02-17 | 140 | Ingredient shortage | 186070 |
447 | N02CC01 | IMITREX | 6MG | Glaxosmithkline Inc | Resolved | 2023-02-16 | 48 | Demand increase | 185059 |
448 | D10AF01 | TARO-CLINDAMYCIN | 1% | Taro Pharmaceuticals Inc | Resolved | 2023-02-16 | 155 | Manufacturing distruption | 185326 |
449 | H03BB02 | MAR-METHIMAZOLE | 5MG | Marcan Pharmaceuticals Inc | Resolved | 2023-02-16 | 22 | Ingredient shortage | 184738 |
442 | V03AF03 | LEUCOVORIN CALCIUM INJECTION | 10MG | Teva Canada Limited | Resolved | 2023-02-15 | 28 | Demand increase | 184317 |
443 | R01AB01 | SOFRAMYCIN NASAL SPRAY | 0.05MG 12.5MG 2.5MG | Searchlight Pharma Inc | Resolved | 2023-02-15 | 257 | Ingredient shortage | 187368 |
444 | R03BA02 | PULMICORT NEBUAMP 0.125 MG/ML | 0.125MG | Astrazeneca Canada Inc | Resolved | 2023-02-15 | 49 | Demand increase | 184729 |
445 | N02AX06 | NUCYNTA IR | 50MG | Endo Ventures Ltd. | Resolved | 2023-02-15 | 5 | Shipping delay | 179899 |
446 | V03AE01 | ODAN-SODIUM POLYSTYRENE SULFON... | 250MG | Odan Laboratories Ltd | Resolved | 2023-02-15 | 43 | Demand increase | 184792 |
402 | N05BA01 | DIASTAT | 15MG | Bausch Health, Canada Inc. | Resolved | 2023-02-14 | 339 | Demand increase | 177261 |
403 | A02BX02 | TEVA-SUCRALFATE | 1G | Teva Canada Limited | Resolved | 2023-02-14 | 105 | Manufacturing distruption | 184934 |
404 | C02AC01 | TEVA-CLONIDINE | 0.2MG | Teva Canada Limited | Resolved | 2023-02-14 | 218 | Manufacturing distruption | 184946 |
405 | L01CB01 | ETOPOSIDE INJECTION | 20MG | Teva Canada Limited | Resolved | 2023-02-14 | 136 | Manufacturing distruption | 184937 |
406 | A10BA02 | GLUCOPHAGE | 500MG | Sanofi-Aventis Canada Inc | Resolved | 2023-02-14 | 136 | Other | 184615 |
407 | A10BA02 | GLUCOPHAGE | 500MG | Sanofi-Aventis Canada Inc | Resolved | 2023-02-14 | 136 | Other | 184642 |
408 | J05AB06 | CYTOVENE | 500MG | Cheplapharm Arzneimittel Gmbh | Resolved | 2023-02-14 | 411 | Manufacturing distruption | 184528 |
409 | C03CA01 | LASIX SPECIAL | 500MG | Sanofi-Aventis Canada Inc | Resolved | 2023-02-14 | 45 | Other | 184721 |
410 | N02CC01 | IMITREX | 5MG | Glaxosmithkline Inc | Resolved | 2023-02-14 | 10 | Demand increase | 185082 |
411 | J01XE01 | TEVA-NITROFURANTOIN | 100MG | Teva Canada Limited | Resolved | 2023-02-14 | 34 | Manufacturing distruption | 184916 |
412 | N06AB06 | APO-SERTRALINE | 50MG | Apotex Inc | Resolved | 2023-02-14 | 38 | Manufacturing distruption | 185004 |
413 | G03FA01 | ESTALIS 140/50 MCG | 140MCG 50MCG | Sandoz Canada Incorporated | Resolved | 2023-02-14 | 17 | Shipping delay | 184628 |
414 | L04AK01 | ARAVA | 20MG | Sanofi-Aventis Canada Inc | Resolved | 2023-02-14 | 136 | Other | 184712 |
415 | H02AB02 | DEXAMETHASONE SODIUM PHOSPHATE... | 4MG | Sandoz Canada Incorporated | Resolved | 2023-02-14 | 108 | Manufacturing distruption | 184624 |
416 | C04AB01 | PHENTOLAMINE MESYLATE INJECTIO... | 5MG | Sandoz Canada Incorporated | Resolved | 2023-02-14 | 10 | Manufacturing distruption | 184636 |
417 | D07AD01 | TARO-CLOBETASOL TOPICAL SOLUTI... | 0.05% | Taro Pharmaceuticals Inc | Resolved | 2023-02-14 | 73 | Manufacturing distruption | 185335 |
418 | J01CR02 | APO-AMOXI CLAV | 125MG 875MG | Apotex Inc | Resolved | 2023-02-14 | 38 | Manufacturing distruption | 185039 |
419 | C09AA04 | COVERSYL | 8MG | Servier Canada Inc | Resolved | 2023-02-14 | 10 | Shipping delay | 184472 |
420 | N01AX03 | KETAMINE HYDROCHLORIDE INJECTI... | 50MG | Sandoz Canada Incorporated | Resolved | 2023-02-14 | 150 | Manufacturing distruption | 184644 |
421 | C07AA05 | TEVA-PROPRANOLOL | 20MG | Teva Canada Limited | Resolved | 2023-02-14 | 146 | Manufacturing distruption | 184949 |
422 | J01MA12 | APO-LEVOFLOXACIN | 250MG | Apotex Inc | Resolved | 2023-02-14 | Manufacturing distruption | 185010 | |
423 | J01MA12 | APO-LEVOFLOXACIN | 500MG | Apotex Inc | Resolved | 2023-02-14 | Manufacturing distruption | 185007 | |
424 | N06AX11 | APO-MIRTAZAPINE | 15MG | Apotex Inc | Resolved | 2023-02-14 | 38 | Manufacturing distruption | 185013 |
425 | S01ED51 | APO-DORZO-TIMOP | 5MG 20MG | Apotex Inc | Resolved | 2023-02-14 | 17 | Manufacturing distruption | 185036 |
426 | A02BC04 | SANDOZ RABEPRAZOLE | 10MG | Sandoz Canada Incorporated | Resolved | 2023-02-14 | 17 | Manufacturing distruption | 184639 |
427 | N06BA04 | APO-METHYLPHENIDATE ER | 54MG | Apotex Inc | Resolved | 2023-02-14 | 94 | Manufacturing distruption | 185019 |
428 | C09DA04 | SANDOZ IRBESARTAN HCT | 25MG 300MG | Sandoz Canada Incorporated | Resolved | 2023-02-14 | 45 | Manufacturing distruption | 184632 |
429 | S01AE03 | SANDOZ CIPROFLOXACIN | 0.3% | Sandoz Canada Incorporated | Resolved | 2023-02-14 | 52 | Ingredient shortage | 184619 |
430 | L01AX03 | TEVA-TEMOZOLOMIDE | 20MG | Teva Canada Limited | Resolved | 2023-02-14 | 45 | Manufacturing distruption | 184940 |
431 | M04AA01 | APO-ALLOPURINOL | 200MG | Apotex Inc | Resolved | 2023-02-14 | 101 | Manufacturing distruption | 185028 |
432 | C10BX03 | APO-AMLODIPINE-ATORVASTATIN | 20MG 5MG | Apotex Inc | Resolved | 2023-02-14 | 14 | Manufacturing distruption | 185022 |
433 | C10BX03 | APO-AMLODIPINE-ATORVASTATIN | 80MG 10MG | Apotex Inc | Resolved | 2023-02-14 | 14 | Manufacturing distruption | 185025 |
434 | C08DB01 | TEVA-DILTIAZEM XC | 180MG | Teva Canada Limited | Resolved | 2023-02-14 | 34 | Manufacturing distruption | 184919 |
435 | C08DB01 | TEVA-DILTIAZEM XC | 240MG | Teva Canada Limited | Resolved | 2023-02-14 | 34 | Manufacturing distruption | 184922 |
436 | C08DB01 | TEVA-DILTIAZEM XC | 300MG | Teva Canada Limited | Resolved | 2023-02-14 | 34 | Manufacturing distruption | 184925 |
437 | G04BE08 | TEVA-TADALAFIL | 10MG | Teva Canada Limited | Resolved | 2023-02-14 | 55 | Manufacturing distruption | 184943 |
438 | R01AD08 | TEVA-FLUTICASONE | 50MCG | Teva Canada Limited | Resolved | 2023-02-14 | 34 | Manufacturing distruption | 184928 |
439 | M05BB03 | APO-ALENDRONATE/VITAMIN D3 | 5600UNIT 70MG | Apotex Inc | Resolved | 2023-02-14 | 89 | Manufacturing distruption | 185033 |
440 | S01XA18 | TEVA-CYCLOSPORINE | 0.05% | Teva Canada Limited | Resolved | 2023-02-14 | 166 | Manufacturing distruption | 184931 |
441 | APO-MELOXICAM | 1.5G | Apotex Inc | Resolved | 2023-02-14 | 106 | Manufacturing distruption | 185042 | |
396 | S03BA01 | DEXAMETHASONE | 0.1% | Pharma Stulln Inc. | Resolved | 2023-02-13 | 106 | Shipping delay | 184454 |
397 | R05DA04 | CODEINE CONTIN 100MG CONTROLLE... | 100MG | Purdue Pharma | Resolved | 2023-02-13 | 123 | Shipping delay | 184496 |
398 | N02CC07 | FROVA | 2.5MG | Endo Pharmaceuticals Inc. | Resolved | 2023-02-13 | Manufacturing distruption | 192129 | |
399 | N06BA04 | BIPHENTIN | 10MG | Elvium Life Sciences | Resolved | 2023-02-13 | 4 | Shipping delay | 184493 |
400 | N05AH04 | QUETIAPINE | 100MG | Sivem Pharmaceuticals Ulc | Resolved | 2023-02-13 | 121 | Shipping delay | 190322 |
401 | B01AC04 | M-CLOPIDOGREL | 75MG | Mantra Pharma Inc | Resolved | 2023-02-13 | 15 | Shipping delay | 185130 |
387 | B05BB02 | DEXTROSE 5% AND 0.9% SOD CHLOR... | 900MG 5G | Baxter Corporation | Resolved | 2023-02-10 | 33 | Manufacturing distruption | 184314 |
388 | N05CM05 | SCOPOLAMINE HYDROBROMIDE INJEC... | 0.4MG | Omega Laboratories Limited | Resolved | 2023-02-10 | 28 | Demand increase | 184426 |
389 | R05CB01 | ACETYLCYSTEINE SOLUTION | 200MG | Sandoz Canada Incorporated | Resolved | 2023-02-10 | 259 | Demand increase | 174949 |
390 | A11GA01 | VITAMIN C | 500MG | Mylan Pharmaceuticals Ulc | Resolved | 2023-02-10 | 18 | Demand increase | 184576 |
391 | N05BB01 | HYDROXYZINE | 50MG | Aa Pharma Inc | Resolved | 2023-02-10 | 161 | Manufacturing distruption | 176660 |
392 | P01BC01 | PRO-QUININE - 200 | 200MG | Pro Doc Limitee | Resolved | 2023-02-10 | 131 | Shipping delay | 184330 |
393 | G04CB01 | TEVA-FINASTERIDE | 5MG | Teva Canada Limited | Resolved | 2023-02-10 | 59 | Manufacturing distruption | 184210 |
394 | D10AF51 | TARO-BENZOYL PEROXIDE / CLINDA... | 5% 1% | Taro Pharmaceuticals Inc | Resolved | 2023-02-10 | Manufacturing distruption | 185303 | |
395 | S01XA18 | RESTASIS MULTIDOSE | 0.05% | Abbvie Corporation | Resolved | 2023-02-10 | 21 | Demand increase | 184397 |
382 | N02AA01 | SANDOZ MORPHINE SR | 15MG | Sandoz Canada Incorporated | Resolved | 2023-02-09 | 18 | Manufacturing distruption | 184255 |
383 | J02AC03 | VFEND | 200MG | Pfizer Canada Ulc | Resolved | 2023-02-09 | Manufacturing distruption | 184244 | |
384 | B01AB01 | HEPARIN SODIUM INJECTION USP ... | 1000UNIT | Sandoz Canada Incorporated | Resolved | 2023-02-09 | 547 | Manufacturing distruption | 182837 |
385 | N02AA03 | DILAUDID | 8MG | Purdue Pharma | Resolved | 2023-02-09 | 43 | Shipping delay | 184279 |
386 | N06BA04 | FOQUEST | 45MG | Elvium Life Sciences | Resolved | 2023-02-09 | 8 | Shipping delay | 184298 |
380 | J05AF07 | MYLAN-TENOFOVIR DISOPROXIL | 300MG | Mylan Pharmaceuticals Ulc | Avoided | 2023-02-08 | 62 | Ingredient shortage | 177336 |
376 | N05CD08 | MIDAZOLAM INJECTION | 5MG | Sandoz Canada Incorporated | Resolved | 2023-02-08 | 23 | Manufacturing distruption | 184251 |
377 | B02AA02 | TRANEXAMIC ACID INJECTION BP | 100MG | Sandoz Canada Incorporated | Resolved | 2023-02-08 | 16 | Manufacturing distruption | 184263 |
378 | N03AA02 | PHENOBARBITAL SODIUM INJECTION... | 30MG | Sandoz Canada Incorporated | Resolved | 2023-02-08 | 23 | Manufacturing distruption | 184259 |
379 | G04CB02 | TEVA-DUTASTERIDE | 0.5MG | Teva Canada Limited | Resolved | 2023-02-08 | 478 | Manufacturing distruption | 184216 |
381 | J01DB01 | LUPIN-CEPHALEXIN | 250MG | Lupin Pharma Canada Limited | Resolved | 2023-02-08 | 81 | Demand increase | 181214 |
343 | A03FA03 | TEVA-DOMPERIDONE | 10MG | Teva Canada Limited | Resolved | 2023-02-07 | 102 | Manufacturing distruption | 184183 |
344 | N06AB06 | ZOLOFT | 25MG | Upjohn Canada Ulc | Resolved | 2023-02-07 | 35 | Manufacturing distruption | 184552 |
345 | N05BE01 | APO-BUSPIRONE | 10MG | Apotex Inc | Resolved | 2023-02-07 | 101 | Manufacturing distruption | 184072 |
346 | C03CA01 | TEVA-FUROSEMIDE | 40MG | Teva Canada Limited | Resolved | 2023-02-07 | 133 | Manufacturing distruption | 184174 |
347 | C07AA05 | TEVA-PROPRANOLOL | 10MG | Teva Canada Limited | Resolved | 2023-02-07 | 173 | Manufacturing distruption | 184177 |
348 | C07AA05 | TEVA-PROPRANOLOL | 40MG | Teva Canada Limited | Resolved | 2023-02-07 | 153 | Manufacturing distruption | 184180 |
349 | C01BB02 | TEVA-MEXILETINE | 200MG | Teva Canada Limited | Resolved | 2023-02-07 | 92 | Manufacturing distruption | 184186 |
350 | B01AB05 | LOVENOX WITH PRESERVATIVE 300M... | 100MG | Sanofi-Aventis Canada Inc | Resolved | 2023-02-07 | 113 | Other | 184402 |
351 | C02CA04 | APO-DOXAZOSIN | 1MG | Apotex Inc | Resolved | 2023-02-07 | 45 | Manufacturing distruption | 184077 |
352 | N02BF01 | TEVA-GABAPENTIN | 400MG | Teva Canada Limited | Resolved | 2023-02-07 | 62 | Manufacturing distruption | 184189 |
353 | D07XC01 | RATIO-TOPISALIC | 20MG 0.5MG | Teva Canada Limited | Resolved | 2023-02-07 | 163 | Manufacturing distruption | 184192 |
354 | C10AA01 | APO-SIMVASTATIN | 40MG | Apotex Inc | Resolved | 2023-02-07 | 10 | Manufacturing distruption | 184080 |
355 | D01BA02 | ACT TERBINAFINE | 250MG | Teva Canada Limited | Resolved | 2023-02-07 | 204 | Manufacturing distruption | 184195 |
356 | N07CA01 | TEVA-BETAHISTINE | 16MG | Teva Canada Limited | Resolved | 2023-02-07 | 102 | Manufacturing distruption | 184198 |
357 | N07CA01 | TEVA-BETAHISTINE | 24MG | Teva Canada Limited | Resolved | 2023-02-07 | 143 | Manufacturing distruption | 184201 |
358 | N05AH03 | APO-OLANZAPINE | 10MG | Apotex Inc | Resolved | 2023-02-07 | 115 | Manufacturing distruption | 184083 |
359 | A02BC02 | APO-PANTOPRAZOLE | 40MG | Apotex Inc | Resolved | 2023-02-07 | 15 | Manufacturing distruption | 184106 |
360 | A02BC03 | APO-LANSOPRAZOLE | 30MG | Apotex Inc | Resolved | 2023-02-07 | 45 | Manufacturing distruption | 184089 |
361 | C08CA01 | ACT AMLODIPINE | 5MG | Teva Canada Limited | Resolved | 2023-02-07 | 41 | Manufacturing distruption | 184204 |
362 | C09BA04 | APO-PERINDOPRIL-INDAPAMIDE | 1.25MG 4MG | Apotex Inc | Resolved | 2023-02-07 | 227 | Manufacturing distruption | 184092 |
363 | N02CC02 | TEVA-NARATRIPTAN | 2.5MG | Teva Canada Limited | Resolved | 2023-02-07 | 31 | Manufacturing distruption | 184207 |
364 | C09CA07 | TEVA-TELMISARTAN | 40MG | Teva Canada Limited | Resolved | 2023-02-07 | 31 | Manufacturing distruption | 184171 |
365 | N05AH03 | APO-OLANZAPINE | 20MG | Apotex Inc | Resolved | 2023-02-07 | 115 | Manufacturing distruption | 184097 |
366 | N02CC04 | TEVA-RIZATRIPTAN ODT | 10MG | Teva Canada Limited | Resolved | 2023-02-07 | 31 | Manufacturing distruption | 184213 |
367 | G04BE08 | APO-TADALAFIL | 5MG | Apotex Inc | Resolved | 2023-02-07 | 15 | Manufacturing distruption | 184109 |
368 | N06BA01 | TEVA-AMPHETAMINE XR | 5MG | Teva Canada Limited | Resolved | 2023-02-07 | 173 | Manufacturing distruption | 184219 |
369 | N06BA01 | TEVA-AMPHETAMINE XR | 25MG | Teva Canada Limited | Resolved | 2023-02-07 | 296 | Manufacturing distruption | 184222 |
370 | N06BA01 | APO-AMPHETAMINE XR | 25MG | Apotex Inc | Resolved | 2023-02-07 | 59 | Manufacturing distruption | 184103 |
371 | N06BA02 | ACT DEXTROAMPHETAMINE SR | 15MG | Teva Canada Limited | Resolved | 2023-02-07 | 102 | Manufacturing distruption | 184225 |
372 | N05BA06 | PMS-LORAZEPAM | 0.5MG | Pharmascience Inc | Resolved | 2023-02-07 | 43 | Manufacturing distruption | 183870 |
373 | C08CA02 | APO-FELODIPINE | 2.5MG | Apotex Inc | Resolved | 2023-02-07 | 24 | Manufacturing distruption | 184086 |
374 | A10BA02 | APO-METFORMIN ER | 1000MG | Apotex Inc | Resolved | 2023-02-07 | 17 | Manufacturing distruption | 184100 |
375 | A10BH01 | APO-SITAGLIPTIN MALATE | 25MG | Apotex Inc | Resolved | 2023-02-07 | 63 | Demand increase | 184112 |
324 | V07AB | STERILE WATER FOR IRRIGATION U... | 100% | Icu Medical Canada Inc | Active | 2023-02-06 | Manufacturing distruption | 172849 | |
332 | A10BG03 | JAMP PIOGLITAZONE | 15MG | Jamp Pharma Corporation | Active | 2023-02-06 | 312 | Manufacturing distruption | 183744 |
315 | N06AB05 | JAMP-PAROXETINE | 30MG | Jamp Pharma Corporation | Resolved | 2023-02-06 | 1059 | Other | 183775 |
316 | M05BA04 | JAMP-ALENDRONATE | 70MG | Jamp Pharma Corporation | Resolved | 2023-02-06 | 1059 | Other | 183760 |
317 | C10AA07 | JAMP-ROSUVASTATIN | 20MG | Jamp Pharma Corporation | Resolved | 2023-02-06 | 1059 | Other | 183778 |
318 | C10AA07 | JAMP-ROSUVASTATIN | 20MG | Jamp Pharma Corporation | Resolved | 2023-02-06 | 1059 | Other | 183781 |
319 | N06AX16 | VENLAFAXINE XR | 37.5MG | Jamp Pharma Corporation | Resolved | 2023-02-06 | 740 | Manufacturing distruption | 183708 |
320 | N06AX16 | VENLAFAXINE XR | 37.5MG | Jamp Pharma Corporation | Resolved | 2023-02-06 | 740 | Manufacturing distruption | 183728 |
321 | N06AX16 | VENLAFAXINE XR | 75MG | Jamp Pharma Corporation | Resolved | 2023-02-06 | 561 | Manufacturing distruption | 183733 |
322 | N06AX16 | VENLAFAXINE XR | 75MG | Jamp Pharma Corporation | Resolved | 2023-02-06 | 676 | Manufacturing distruption | 183736 |
323 | N06AB06 | ZOLOFT | 25MG | Upjohn Canada Ulc | Resolved | 2023-02-06 | 22 | Manufacturing distruption | 181295 |
325 | B01AC04 | PLAVIX | 75MG | Sanofi-Aventis Canada Inc | Resolved | 2023-02-06 | 28 | Other | 184405 |
326 | C01DA02 | RHO-NITRO PUMPSPRAY | 0.4MG | Sandoz Canada Incorporated | Resolved | 2023-02-06 | 102 | Demand increase | 183701 |
327 | G04BD07 | DETROL | 2MG | Bgp Pharma Ulc | Resolved | 2023-02-06 | Manufacturing distruption | 204811 | |
328 | J05AB01 | MYLAN-ACYCLOVIR | 200MG | Mylan Pharmaceuticals Ulc | Resolved | 2023-02-06 | 36 | Demand increase | 182969 |
329 | C10AA03 | JAMP-PRAVASTATIN | 40MG | Jamp Pharma Corporation | Resolved | 2023-02-06 | 63 | Demand increase | 183677 |
330 | C02KX | REVATIO | 0.8MG | Upjohn Canada Ulc | Resolved | 2023-02-06 | 50 | Manufacturing distruption | 181292 |
331 | L01EX04 | CAPRELSA | 100MG | Sanofi Genzyme, A Division Of Sanofi-Aventis Canada Inc | Resolved | 2023-02-06 | 11 | Other | 182714 |
333 | B02BD02 | ELOCTATE | 2000UNIT | Sanofi-Aventis Canada Inc | Resolved | 2023-02-06 | 37 | Demand increase | 183909 |
334 | N06AB04 | CITALOPRAM | 40MG | Jamp Pharma Corporation | Resolved | 2023-02-06 | 63 | Manufacturing distruption | 183756 |
335 | A10AE04 | TOUJEO SOLOSTAR | 300UNIT | Sanofi-Aventis Canada Inc | Resolved | 2023-02-06 | 29 | Other | 184409 |
336 | N06AX05 | JAMP TRAZODONE | 50MG | Jamp Pharma Corporation | Resolved | 2023-02-06 | 236 | Manufacturing distruption | 183725 |
337 | N06AX05 | JAMP TRAZODONE | 100MG | Jamp Pharma Corporation | Resolved | 2023-02-06 | 236 | Manufacturing distruption | 183705 |
338 | N06AX05 | JAMP TRAZODONE | 150MG | Jamp Pharma Corporation | Resolved | 2023-02-06 | 236 | Manufacturing distruption | 183720 |
339 | S01ED51 | JAMP DORZOLAMIDE-TIMOLOL | 5MG 20MG | Jamp Pharma Corporation | Resolved | 2023-02-06 | 32 | Demand increase | 183655 |
340 | C09CA08 | JAMP OLMESARTAN | 40MG | Jamp Pharma Corporation | Resolved | 2023-02-06 | 32 | Demand increase | 183674 |
341 | L01EA01 | JAMP IMATINIB | 100MG | Jamp Pharma Corporation | Resolved | 2023-02-06 | 1059 | Other | 183671 |
342 | C10AA05 | JAMP ATORVASTATIN CALCIUM | 40MG | Jamp Pharma Corporation | Resolved | 2023-02-06 | 32 | Demand increase | 183651 |
314 | N03AG01 | MYLAN-DIVALPROEX | 125MG | Mylan Pharmaceuticals Ulc | Resolved | 2023-02-04 | 6 | Demand increase | 182986 |
302 | R06AA02 | DIPHENIST 50MG/ML | 50MG | Omega Laboratories Limited | Resolved | 2023-02-03 | 46 | Demand increase | 183620 |
303 | S01EC01 | ACETAZOLAMIDE | 250MG | Aa Pharma Inc | Resolved | 2023-02-03 | 70 | Manufacturing distruption | 183593 |
304 | N05AA02 | METHOPRAZINE | 2MG | Aa Pharma Inc | Resolved | 2023-02-03 | 40 | Manufacturing distruption | 183864 |
305 | A03AA05 | TRIMEBUTINE | 100MG | Aa Pharma Inc | Resolved | 2023-02-03 | 70 | Manufacturing distruption | 183589 |
306 | G03CA03 | SANDOZ ESTRADIOL DERM 50 | 50MCG | Sandoz Canada Incorporated | Resolved | 2023-02-03 | 35 | Manufacturing distruption | 184240 |
307 | C09AA02 | SANDOZ ENALAPRIL | 8MG | Sandoz Canada Incorporated | Resolved | 2023-02-03 | 28 | Shipping delay | 184236 |
308 | J01FA10 | SANDOZ AZITHROMYCIN | 200MG | Sandoz Canada Incorporated | Resolved | 2023-02-03 | 14 | Demand increase | 184233 |
309 | N02AE01 | BUTRANS 20 | 20MCG | Purdue Pharma | Resolved | 2023-02-03 | 35 | Shipping delay | 183517 |
310 | N02AE01 | BUTRANS 20 | 20MCG | Purdue Pharma | Resolved | 2023-02-03 | 56 | Shipping delay | 183519 |
311 | N06BA09 | SANDOZ ATOMOXETINE | 40MG | Sandoz Canada Incorporated | Resolved | 2023-02-03 | 14 | Manufacturing distruption | 184230 |
312 | J01DB04 | CEFAZOLIN FOR INJECTION | 1G | Sterimax Inc | Resolved | 2023-02-03 | 91 | Shipping delay | 183209 |
313 | J01MA14 | MOXIFLOXACIN | 400MG | Pro Doc Limitee | Resolved | 2023-02-03 | 103 | Shipping delay | 183506 |
300 | N06BA04 | FOQUEST | 35MG | Elvium Life Sciences | Avoided | 2023-02-02 | 15 | Shipping delay | 183530 |
291 | B05XA02 | SODIUM BICARBONATE INJECTION U... | 84MG | Pfizer Canada Ulc | Resolved | 2023-02-02 | Manufacturing distruption | 182109 | |
292 | B05XA05 | MAGNESIUM SULFATE INJ 20% USP | 200MG | Sandoz Canada Incorporated | Resolved | 2023-02-02 | 169 | Manufacturing distruption | 184959 |
293 | N06BA04 | BIPHENTIN | 50MG | Elvium Life Sciences | Resolved | 2023-02-02 | 62 | Shipping delay | 183524 |
294 | N06BA04 | BIPHENTIN | 60MG | Elvium Life Sciences | Resolved | 2023-02-02 | 62 | Shipping delay | 183527 |
295 | A10BD07 | JANUMET | 1000MG 50MG | Merck Canada Inc | Resolved | 2023-02-02 | 4 | Demand increase | 183220 |
296 | N05CD08 | MIDAZOLAM INJECTION USP | 1MG | Pfizer Canada Ulc | Resolved | 2023-02-02 | Manufacturing distruption | 180728 | |
297 | N05CD08 | MIDAZOLAM INJECTION USP | 5MG | Pfizer Canada Ulc | Resolved | 2023-02-02 | Manufacturing distruption | 178370 | |
298 | N02AA03 | HYDROMORPHONE HYDROCHLORIDE IN... | 10MG | Pfizer Canada Ulc | Resolved | 2023-02-02 | Manufacturing distruption | 178359 | |
299 | G04CB02 | DUTASTERIDE | 0.5MG | Sivem Pharmaceuticals Ulc | Resolved | 2023-02-02 | 72 | Shipping delay | 183173 |
301 | N06BA04 | FOQUEST | 85MG | Elvium Life Sciences | Resolved | 2023-02-02 | 15 | Shipping delay | 183533 |
285 | N01BB52 | XYLOCAINE 2% W EPINEPHRINE 1:2... | 5MCG 20MG | Aspen Pharmacare Canada Inc. | Avoided | 2023-02-01 | 27 | Manufacturing distruption | 174084 |
283 | H01AC01 | NORDITROPIN NORDIFLEX | 10MG | Novo Nordisk Canada Inc | Resolved | 2023-02-01 | Demand increase | 178312 | |
284 | B05XA02 | SODIUM BICARBONATE INJECTION U... | 84MG | Jamp Pharma Corporation | Resolved | 2023-02-01 | 37 | Demand increase | 182958 |
286 | B01AC07 | PERSANTINE | 5MG | Glenwood Gmbh Pharmazeutische Erzeugnisse | Resolved | 2023-02-01 | 365 | Manufacturing distruption | 181380 |
287 | C01CE02 | MILRINONE LACTATE INJECTION, U... | 1MG | Fresenius Kabi Canada Ltd | Resolved | 2023-02-01 | 58 | Other | 173929 |
288 | J01MA02 | TARO-CIPROFLOX | 250MG | Sun Pharma Canada Inc | Resolved | 2023-02-01 | 408 | Manufacturing distruption | 183077 |
289 | J01MA02 | TARO-CIPROFLOX | 750MG | Sun Pharma Canada Inc | Resolved | 2023-02-01 | 408 | Manufacturing distruption | 183082 |
290 | N06AX23 | PRISTIQ | 100MG | Pfizer Canada Ulc | Resolved | 2023-02-01 | 54 | Manufacturing distruption | 177970 |
260 | R03DA05 | AMINOPHYLLINE INJECTION USP | 25MG | Pfizer Canada Ulc | Resolved | 2023-01-31 | Manufacturing distruption | 178367 | |
261 | L04AX01 | AZATHIOPRINE-50 | 50MG | Pro Doc Limitee | Resolved | 2023-01-31 | 64 | Other | 178536 |
262 | G04BD04 | APO-OXYBUTYNIN | 5MG | Apotex Inc | Resolved | 2023-01-31 | 87 | Manufacturing distruption | 183474 |
263 | R03AC02 | AIROMIR | 100MCG | Bausch Health, Canada Inc. | Resolved | 2023-01-31 | Other | 211577 | |
264 | J01DC02 | APO-CEFUROXIME | 250MG | Apotex Inc | Resolved | 2023-01-31 | 17 | Manufacturing distruption | 183495 |
265 | N06DA03 | EXELON | 2MG | Knight Therapeutics Inc. | Resolved | 2023-01-31 | 273 | Manufacturing distruption | 178295 |
266 | L01XX05 | APO-HYDROXYUREA | 500MG | Apotex Inc | Resolved | 2023-01-31 | 17 | Manufacturing distruption | 183489 |
267 | N03AX14 | APO-LEVETIRACETAM | 750MG | Apotex Inc | Resolved | 2023-01-31 | 143 | Manufacturing distruption | 183477 |
268 | N04BC05 | APO-PRAMIPEXOLE | 0.25MG | Apotex Inc | Resolved | 2023-01-31 | 73 | Manufacturing distruption | 183483 |
269 | A02BC02 | APO-PANTOPRAZOLE | 40MG | Apotex Inc | Resolved | 2023-01-31 | 22 | Manufacturing distruption | 183492 |
270 | A02BC03 | APO-LANSOPRAZOLE | 15MG | Apotex Inc | Resolved | 2023-01-31 | 52 | Manufacturing distruption | 183480 |
271 | L04AA06 | SANDOZ MYCOPHENOLATE MOFETIL | 500MG | Sandoz Canada Incorporated | Resolved | 2023-01-31 | 31 | Ingredient shortage | 182816 |
272 | C09CA06 | SANDOZ CANDESARTAN | 4MG | Sandoz Canada Incorporated | Resolved | 2023-01-31 | 73 | Manufacturing distruption | 182805 |
273 | C10AA07 | SANDOZ ROSUVASTATIN | 20MG | Sandoz Canada Incorporated | Resolved | 2023-01-31 | 122 | Manufacturing distruption | 182820 |
274 | D11AX10 | SANDOZ FINASTERIDE A | 1MG | Sandoz Canada Incorporated | Resolved | 2023-01-31 | 31 | Manufacturing distruption | 182812 |
275 | C10AC04 | LODALIS | 625MG | Bausch Health, Canada Inc. | Resolved | 2023-01-31 | 38 | Other | 180700 |
276 | B01AF01 | XARELTO | 15MG | Bayer Inc | Resolved | 2023-01-31 | 10 | Shipping delay | 182739 |
277 | J01FF01 | CLINDAMYCIN IV INFUSION | 12MG | Sandoz Canada Incorporated | Resolved | 2023-01-31 | Manufacturing practices | 182824 | |
278 | J01FF01 | CLINDAMYCIN IV INFUSION | 18MG | Sandoz Canada Incorporated | Resolved | 2023-01-31 | 234 | Manufacturing practices | 182829 |
279 | C10BX03 | APO-AMLODIPINE-ATORVASTATIN | 10MG 10MG | Apotex Inc | Resolved | 2023-01-31 | 28 | Manufacturing distruption | 183486 |
280 | J01DB04 | CEFAZOLIN FOR INJECTION | 10G | Sterimax Inc | Resolved | 2023-01-31 | 150 | Shipping delay | 182608 |
281 | J01DD02 | CEFTAZIDIME FOR INJECTION BP | 1G | Sterimax Inc | Resolved | 2023-01-31 | 59 | Shipping delay | 182605 |
282 | S02CA06 | SANDOZ CIPROFLOXACIN / DEXAMET... | 0.1% 0.3% | Sandoz Canada Incorporated | Resolved | 2023-01-31 | 24 | Demand increase | 182808 |
237 | M01AE02 | NAPROSYN | 500MG | Atnahs Pharma Uk Limited | Active | 2023-01-30 | 426 | Demand increase | 185677 |
231 | L02BG06 | TEVA-EXEMESTANE | 25MG | Teva Canada Limited | Resolved | 2023-01-30 | 49 | Manufacturing distruption | 183416 |
232 | B05BA03 | DEXTROSE INJECTION | 50% | Omega Laboratories Limited | Resolved | 2023-01-30 | Demand increase | 182591 | |
233 | D07CB01 | TEVA-TRIACOMB | 0.25MG 2.5MG 100000UNIT 1MG | Teva Canada Limited | Resolved | 2023-01-30 | 181 | Manufacturing distruption | 183374 |
234 | B05XA18 | MICRO ZN | 1MG | Sandoz Canada Incorporated | Resolved | 2023-01-30 | 60 | Manufacturing distruption | 182494 |
235 | C02AC01 | TEVA-CLONIDINE | 0.1MG | Teva Canada Limited | Resolved | 2023-01-30 | 39 | Manufacturing distruption | 183364 |
236 | J01CA04 | NOVAMOXIN | 250MG | Teva Canada Limited | Resolved | 2023-01-30 | 161 | Manufacturing distruption | 183361 |
238 | B05XA03 | SODIUM CHLORIDE INJECTION USP | 9MG | Icu Medical Canada Inc | Resolved | 2023-01-30 | 14 | Manufacturing distruption | 182674 |
239 | N02AJ17 | TEVA-OXYCOCET | 325MG 5MG | Teva Canada Limited | Resolved | 2023-01-30 | 120 | Manufacturing distruption | 183377 |
240 | R06AB04 | TEVA-PHENIRAM | 4MG | Teva Canada Limited | Resolved | 2023-01-30 | 110 | Manufacturing distruption | 183371 |
241 | C02CA04 | TEVA-DOXAZOSIN | 2MG | Teva Canada Limited | Resolved | 2023-01-30 | 70 | Manufacturing distruption | 183367 |
242 | N02BF01 | TEVA-GABAPENTIN | 100MG | Teva Canada Limited | Resolved | 2023-01-30 | 39 | Manufacturing distruption | 183422 |
243 | N05CF01 | TEVA-ZOPICLONE | 5MG | Teva Canada Limited | Resolved | 2023-01-30 | Manufacturing distruption | 183386 | |
244 | N05AH03 | TEVA-OLANZAPINE | 5MG | Teva Canada Limited | Resolved | 2023-01-30 | 49 | Manufacturing distruption | 183389 |
245 | J02AC01 | ACT FLUCONAZOLE | 100MG | Teva Canada Limited | Resolved | 2023-01-30 | 376 | Manufacturing distruption | 183392 |
246 | C09AA02 | ACT ENALAPRIL | 16MG | Teva Canada Limited | Resolved | 2023-01-30 | 161 | Manufacturing distruption | 183395 |
247 | C09BA03 | TEVA-LISINOPRIL/HCTZ (TYPE Z) | 25MG 20MG | Teva Canada Limited | Resolved | 2023-01-30 | 39 | Manufacturing distruption | 183398 |
248 | A10BH01 | JANUVIA | 100MG | Merck Canada Inc | Resolved | 2023-01-30 | 22 | Demand increase | 182687 |
249 | A06AD11 | TEVA-LACTULOSE | 667MG | Teva Canada Limited | Resolved | 2023-01-30 | 60 | Manufacturing distruption | 183401 |
250 | L02BG04 | TEVA-LETROZOLE | 2.5MG | Teva Canada Limited | Resolved | 2023-01-30 | 273 | Manufacturing distruption | 183404 |
251 | N02AJ13 | TEVA-TRAMADOL/ACETAMINOPHEN | 37.5MG 325MG | Teva Canada Limited | Resolved | 2023-01-30 | 141 | Manufacturing distruption | 183407 |
252 | C10AA07 | TEVA-ROSUVASTATIN | 40MG | Teva Canada Limited | Resolved | 2023-01-30 | 29 | Manufacturing distruption | 183425 |
253 | N05AH03 | TEVA-OLANZAPINE | 20MG | Teva Canada Limited | Resolved | 2023-01-30 | 39 | Manufacturing distruption | 183410 |
254 | C09CA06 | TEVA-CANDESARTAN | 16MG | Teva Canada Limited | Resolved | 2023-01-30 | 90 | Manufacturing distruption | 183413 |
255 | L01DB06 | IDARUBICIN | 1MG | Pfizer Canada Ulc | Resolved | 2023-01-30 | Manufacturing distruption | 176929 | |
256 | N06BA01 | TEVA-AMPHETAMINE XR | 30MG | Teva Canada Limited | Resolved | 2023-01-30 | 212 | Manufacturing distruption | 183419 |
257 | N03AF01 | TEVA-CARBAMAZEPINE | 200MG | Teva Canada Limited | Resolved | 2023-01-30 | 49 | Manufacturing distruption | 183380 |
258 | C07AB02 | TEVA-METOPROLOL | 50MG | Teva Canada Limited | Resolved | 2023-01-30 | 202 | Manufacturing distruption | 183383 |
259 | B02BA01 | VITAMIN K1 INJ 10MG/ML USP | 10MG | Sandoz Canada Incorporated | Resolved | 2023-01-30 | 116 | Manufacturing distruption | 182486 |
230 | J01FA10 | ZITHROMAX - PWS ORL 100MG/5ML | 100MG | Pfizer Canada Ulc | Active | 2023-01-29 | Manufacturing distruption | 176316 | |
225 | N06AB05 | PAXIL TAB 20MG | 20MG | Glaxosmithkline Inc | Resolved | 2023-01-27 | 21 | Manufacturing distruption | 182602 |
226 | N03AG01 | DEPAKENE | 250MG | Bgp Pharma Ulc | Resolved | 2023-01-27 | 60 | Manufacturing distruption | 181316 |
227 | A11DA01 | THIAMIJECT INJECTION - LIQ IM... | 100MG | Omega Laboratories Limited | Resolved | 2023-01-27 | 27 | Demand increase | 182152 |
228 | N03AF02 | TRILEPTAL 600 MG | 600MG | Novartis Pharmaceuticals Canada Inc | Resolved | 2023-01-27 | 4 | Manufacturing distruption | 175429 |
229 | H02AB02 | DEXAMETHASONE OMEGA UNIDOSE | 10MG | Omega Laboratories Limited | Resolved | 2023-01-27 | 14 | Demand increase | 182149 |
219 | H03AA02 | CYTOMEL | 25MCG | Pfizer Canada Ulc | Resolved | 2023-01-26 | 125 | Manufacturing distruption | 180924 |
220 | S01ED51 | COSOPT PRESERVATIVE-FREE | 5MG 20MG | Elvium Life Sciences | Resolved | 2023-01-26 | 50 | Shipping delay | 182432 |
221 | N05AH03 | OLANZAPINE ODT | 10MG | Pro Doc Limitee | Resolved | 2023-01-26 | 28 | Shipping delay | 182306 |
222 | C09CA06 | TARO-CANDESARTAN | 16MG | Sun Pharma Canada Inc | Resolved | 2023-01-26 | 243 | Manufacturing distruption | 183064 |
223 | D07CB01 | VIADERM KC CRM | 100000UNIT 0.25MG 2.5MG 1MG | Taro Pharmaceuticals Inc | Resolved | 2023-01-26 | 29 | Manufacturing distruption | 182999 |
224 | V07AB | STERILE WATER FOR IRRIGATION, ... | 100% | Baxter Corporation | Resolved | 2023-01-26 | 11 | Shipping delay | 182408 |
218 | B02AA02 | TRANEXAMIC ACID INJECTION | 100MG | Omega Laboratories Limited | Avoided | 2023-01-25 | 6 | Demand increase | 180133 |
206 | J01FA09 | PMS-CLARITHROMYCIN | 250MG | Pharmascience Inc | Resolved | 2023-01-25 | 118 | Manufacturing distruption | 183867 |
207 | N05AE05 | SANDOZ LURASIDONE | 60MG | Sandoz Canada Incorporated | Resolved | 2023-01-25 | 30 | Demand increase | 182567 |
208 | N02AA03 | HYDROMORPHONE HYDROCHLORIDE IN... | 2MG | Sandoz Canada Incorporated | Resolved | 2023-01-25 | 23 | Manufacturing distruption | 182563 |
209 | S01BA07 | SANDOZ FLUOROMETHOLONE | 0.1% | Sandoz Canada Incorporated | Resolved | 2023-01-25 | 37 | Manufacturing distruption | 182559 |
210 | G03CA03 | SANDOZ ESTRADIOL DERM 75 | 75MCG | Sandoz Canada Incorporated | Resolved | 2023-01-25 | 44 | Manufacturing distruption | 182553 |
211 | N05AX08 | SANDOZ RISPERIDONE | 2MG | Sandoz Canada Incorporated | Resolved | 2023-01-25 | 51 | Manufacturing distruption | 182578 |
212 | N05AH03 | SANDOZ OLANZAPINE | 10.0MG | Sandoz Canada Incorporated | Resolved | 2023-01-25 | 9 | Ingredient shortage | 182571 |
213 | C09CA06 | SANDOZ CANDESARTAN | 4MG | Sandoz Canada Incorporated | Resolved | 2023-01-25 | 30 | Manufacturing distruption | 182538 |
214 | C09CA06 | SANDOZ CANDESARTAN | 8MG | Sandoz Canada Incorporated | Resolved | 2023-01-25 | 51 | Manufacturing distruption | 182541 |
215 | C09CA06 | SANDOZ CANDESARTAN | 16MG | Sandoz Canada Incorporated | Resolved | 2023-01-25 | 23 | Manufacturing distruption | 182547 |
216 | G04CA02 | SANDOZ TAMSULOSIN CR | 0.4MG | Sandoz Canada Incorporated | Resolved | 2023-01-25 | 30 | Manufacturing distruption | 182582 |
217 | J02AC01 | FLUCONAZOLE INJECTION SDZ | 2MG | Sandoz Canada Incorporated | Resolved | 2023-01-25 | 51 | Manufacturing distruption | 182556 |
195 | M01AB05 | APO-DICLO | 50MG | Apotex Inc | Resolved | 2023-01-24 | 87 | Manufacturing distruption | 182361 |
196 | N04BA02 | APO-LEVOCARB-TAB 25MG/100MG | 100MG 25MG | Apotex Inc | Resolved | 2023-01-24 | 66 | Manufacturing distruption | 182364 |
197 | A09AA02 | COTAZYM ECS 8 | 45000UNIT 42000UNIT 10800UNIT | Organon Canada Inc. | Resolved | 2023-01-24 | 87 | Shipping delay | 182256 |
198 | J07AE01 | DUKORAL | 31250000000CELLS 31250000000CELLS 31250000000CELLS 1MG 31250000000CELLS | Valneva Sweden Ab | Resolved | 2023-01-24 | 111 | Demand increase | 182277 |
199 | N05AH03 | APO-OLANZAPINE | 7.5MG | Apotex Inc | Resolved | 2023-01-24 | 10 | Manufacturing distruption | 182367 |
200 | A10BB09 | APO-GLICLAZIDE MR | 30MG | Apotex Inc | Resolved | 2023-01-24 | 31 | Manufacturing distruption | 182382 |
201 | N05AX12 | APO-ARIPIPRAZOLE | 2MG | Apotex Inc | Resolved | 2023-01-24 | 66 | Manufacturing distruption | 182370 |
202 | N05AX12 | APO-ARIPIPRAZOLE | 5MG | Apotex Inc | Resolved | 2023-01-24 | 72 | Manufacturing distruption | 182373 |
203 | N05AX12 | APO-ARIPIPRAZOLE | 15MG | Apotex Inc | Resolved | 2023-01-24 | 45 | Manufacturing distruption | 182376 |
204 | N05AX12 | APO-ARIPIPRAZOLE | 20MG | Apotex Inc | Resolved | 2023-01-24 | 45 | Manufacturing distruption | 182379 |
205 | D07AD01 | ODAN CLOBETASOL SPRAY | 0.05% | Odan Laboratories Ltd | Resolved | 2023-01-24 | 22 | Manufacturing distruption | 182246 |
187 | B05BB01 | LACTATED RINGER'S INJECTION | 3.1MG 0.2MG 0.3MG 6MG | Icu Medical Canada Inc | Resolved | 2023-01-23 | 21 | Manufacturing distruption | 180326 |
188 | H02AB09 | CORTEF | 20MG | Pfizer Canada Ulc | Resolved | 2023-01-23 | Manufacturing distruption | 178292 | |
189 | A10AE04 | LANTUS | 100UNIT | Sanofi-Aventis Canada Inc | Resolved | 2023-01-23 | 18 | Other | 182411 |
190 | J01FA10 | PMS-AZITHROMYCIN | 600MG | Pharmascience Inc | Resolved | 2023-01-23 | 119 | Manufacturing distruption | 182160 |
191 | C09DA07 | TELMISARTAN HCTZ | 25MG 80MG | Sivem Pharmaceuticals Ulc | Resolved | 2023-01-23 | 346 | Shipping delay | 183176 |
192 | M05BA07 | RISEDRONATE-35 | 35MG | Sivem Pharmaceuticals Ulc | Resolved | 2023-01-23 | 389 | Manufacturing distruption | 190325 |
193 | C09DA07 | ACH-TELMISARTAN HCTZ | 12.5MG 80MG | Accord Healthcare Inc | Resolved | 2023-01-23 | 60 | Manufacturing distruption | 182634 |
194 | C10AA07 | ACH-ROSUVASTATIN | 10MG | Accord Healthcare Inc | Resolved | 2023-01-23 | Manufacturing distruption | 182631 | |
179 | C01DA02 | MYLAN-NITRO SUBLINGUAL SPRAY | 0.4MG | Mylan Pharmaceuticals Ulc | Resolved | 2023-01-20 | Other | 181369 | |
180 | G03BA03 | DELATESTRYL | 200MG | Bausch Health, Canada Inc. | Resolved | 2023-01-20 | 98 | Demand increase | 181436 |
181 | N07AA01 | NEOSTIGMINE OMEGA | 1MG | Omega Laboratories Limited | Resolved | 2023-01-20 | 32 | Demand increase | 182155 |
182 | A11CC03 | ONE-ALPHA | 2MCG | Cheplapharm Arzneimittel Gmbh | Resolved | 2023-01-20 | 161 | Manufacturing distruption | 180961 |
183 | G03AA07 | INDAYO | 0.03MG 0.15MG | Mylan Pharmaceuticals Ulc | Resolved | 2023-01-20 | Other | 181311 | |
184 | A04AA01 | ONDANSETRON INJECTION USP | 2MG | Sterimax Inc | Resolved | 2023-01-20 | 52 | Shipping delay | 181875 |
185 | A03AB02 | GLYCOPYRROLATE INJECTION USP | 0.4MG | Sterimax Inc | Resolved | 2023-01-20 | 84 | Shipping delay | 181847 |
186 | C01CA06 | PHENYLEPHRINE HYDROCHLORIDE IN... | 10MG | Sterimax Inc | Resolved | 2023-01-20 | 39 | Shipping delay | 181836 |
174 | N06BA02 | DEXEDRINE SPANSULE SRC 15MG | 15MG | Paladin Labs Inc. | Resolved | 2023-01-19 | 68 | Demand increase | 181744 |
175 | M01AE02 | NAPROSYN | 750MG | Atnahs Pharma Uk Limited | Resolved | 2023-01-19 | Other | 181466 | |
176 | N03AF02 | TRILEPTAL 300 MG | 300MG | Novartis Pharmaceuticals Canada Inc | Resolved | 2023-01-19 | 12 | Manufacturing distruption | 175426 |
177 | L01XX05 | MYLAN-HYDROXYUREA | 500MG | Mylan Pharmaceuticals Ulc | Resolved | 2023-01-19 | 61 | Manufacturing distruption | 180346 |
178 | B01AB05 | LOVENOX | 60MG | Sanofi-Aventis Canada Inc | Resolved | 2023-01-19 | 22 | Other | 182116 |
130 | B03BB01 | SANDOZ FOLIC ACID | 5MG | Sandoz Canada Incorporated | Resolved | 2023-01-18 | Manufacturing practices | 181566 | |
131 | N06AX21 | CYMBALTA | 60MG | Eli Lilly Canada Inc | Resolved | 2023-01-18 | 35 | Shipping delay | 181402 |
132 | C01CA02 | ISOPROTERENOL HYDROCHLORIDE IN... | 0.2MG | Sandoz Canada Incorporated | Resolved | 2023-01-18 | 51 | Ingredient shortage | 179784 |
133 | D07AD01 | TEVA-CLOBETASOL | 0.05% | Teva Canada Limited | Resolved | 2023-01-18 | 41 | Manufacturing distruption | 181611 |
134 | N02AA01 | MORPHINE LP EPIDURAL | 1MG | Sandoz Canada Incorporated | Resolved | 2023-01-18 | 58 | Manufacturing distruption | 181700 |
135 | A09AA02 | COTAZYM | 35000UNIT 40000UNIT 10000UNIT | Organon Canada Inc. | Resolved | 2023-01-18 | 30 | Shipping delay | 181463 |
136 | V03AB15 | NALOXONE HCL INJECTION - 1MG/M... | 1MG | Sandoz Canada Incorporated | Resolved | 2023-01-18 | 58 | Demand increase | 181704 |
137 | S01ED01 | SANDOZ TIMOLOL | 0.25% | Sandoz Canada Incorporated | Resolved | 2023-01-18 | 100 | Manufacturing distruption | 181729 |
138 | A03FA01 | METOCLOPRAMIDE HYDROCHLORIDE I... | 5MG | Sandoz Canada Incorporated | Resolved | 2023-01-18 | 30 | Manufacturing distruption | 181692 |
139 | B05XA05 | MAGNESIUM SULFATE INJ 20% USP | 200MG | Sandoz Canada Incorporated | Resolved | 2023-01-18 | 16 | Manufacturing distruption | 181990 |
140 | C07AA05 | TEVA-PROPRANOLOL | 80MG | Teva Canada Limited | Resolved | 2023-01-18 | 61 | Manufacturing distruption | 181623 |
141 | J01FF01 | CLINDAMYCIN INJECTION USP | 150MG | Sandoz Canada Incorporated | Resolved | 2023-01-18 | 121 | Ingredient shortage | 181671 |
142 | J01FF01 | CLINDAMYCIN INJECTION USP | 150MG | Sandoz Canada Incorporated | Resolved | 2023-01-18 | 23 | Ingredient shortage | 181674 |
143 | R06AA02 | DIPHENHYDRAMINE HYDROCHLORIDE ... | 50MG | Sandoz Canada Incorporated | Resolved | 2023-01-18 | 58 | Manufacturing distruption | 181679 |
144 | N05CD08 | MIDAZOLAM INJECTION | 1MG | Sandoz Canada Incorporated | Resolved | 2023-01-18 | 30 | Manufacturing distruption | 181696 |
145 | J01GB03 | GENTAMICIN INJECTION USP | 40MG | Sandoz Canada Incorporated | Resolved | 2023-01-18 | 9 | Manufacturing distruption | 181682 |
146 | B03AC | FERRLECIT | 12.5MG | Sanofi-Aventis Canada Inc | Resolved | 2023-01-18 | 72 | Other | 181813 |
147 | N02BF01 | TEVA-GABAPENTIN | 400MG | Teva Canada Limited | Resolved | 2023-01-18 | 82 | Manufacturing distruption | 181617 |
148 | V03AF07 | FASTURTEC | 1.5MG | Sanofi-Aventis Canada Inc | Resolved | 2023-01-18 | 33 | Other | 179050 |
149 | A10BA02 | ACT METFORMIN | 850MG | Teva Canada Limited | Resolved | 2023-01-18 | 72 | Manufacturing distruption | 181594 |
150 | J01CR05 | PIPERACILLIN AND TAZOBACTAM FO... | 0.25G 2G | Sandoz Canada Incorporated | Resolved | 2023-01-18 | 58 | Ingredient shortage | 181707 |
151 | J01CR05 | PIPERACILLIN AND TAZOBACTAM FO... | 0.375G 3G | Sandoz Canada Incorporated | Resolved | 2023-01-18 | 58 | Ingredient shortage | 181710 |
152 | B01AB01 | HEPARIN SODIUM INJECTION USP ... | 1000UNIT | Sandoz Canada Incorporated | Resolved | 2023-01-18 | 23 | Manufacturing distruption | 181686 |
153 | N06DX01 | ACT MEMANTINE | 10MG | Teva Canada Limited | Resolved | 2023-01-18 | 33 | Manufacturing distruption | 181588 |
154 | C10AA05 | SANDOZ ATORVASTATIN | 10MG | Sandoz Canada Incorporated | Resolved | 2023-01-18 | 16 | Manufacturing distruption | 181658 |
155 | C10AA05 | SANDOZ ATORVASTATIN | 40MG | Sandoz Canada Incorporated | Resolved | 2023-01-18 | 23 | Manufacturing distruption | 181662 |
156 | J01FA10 | SANDOZ AZITHROMYCIN | 200MG | Sandoz Canada Incorporated | Resolved | 2023-01-18 | 9 | Demand increase | 181665 |
157 | C10AA07 | SANDOZ ROSUVASTATIN | 5MG | Sandoz Canada Incorporated | Resolved | 2023-01-18 | 23 | Manufacturing distruption | 181719 |
158 | C10AA07 | SANDOZ ROSUVASTATIN | 40MG | Sandoz Canada Incorporated | Resolved | 2023-01-18 | 58 | Manufacturing distruption | 181716 |
159 | C09CA03 | SANDOZ VALSARTAN | 160MG | Sandoz Canada Incorporated | Resolved | 2023-01-18 | 23 | Shipping delay | 181733 |
160 | C09CA06 | TEVA-CANDESARTAN | 16MG | Teva Canada Limited | Resolved | 2023-01-18 | 193 | Manufacturing distruption | 181599 |
161 | C09CA06 | TEVA-CANDESARTAN | 32MG | Teva Canada Limited | Resolved | 2023-01-18 | 33 | Manufacturing distruption | 181605 |
162 | C09CA07 | SANDOZ TELMISARTAN | 40MG | Sandoz Canada Incorporated | Resolved | 2023-01-18 | 9 | Shipping delay | 181722 |
163 | C09CA07 | SANDOZ TELMISARTAN | 80MG | Sandoz Canada Incorporated | Resolved | 2023-01-18 | 30 | Shipping delay | 181726 |
164 | N02BF02 | SANDOZ PREGABALIN | 25MG | Sandoz Canada Incorporated | Resolved | 2023-01-18 | 23 | Manufacturing distruption | 181713 |
165 | J01XA01 | VANCOMYCIN HYDROCHLORIDE FOR I... | 5G | Sandoz Canada Incorporated | Resolved | 2023-01-18 | 30 | Manufacturing distruption | 181736 |
166 | L01AX03 | TEVA-TEMOZOLOMIDE | 250MG | Teva Canada Limited | Resolved | 2023-01-18 | 72 | Manufacturing distruption | 181628 |
167 | M05BA08 | ZOLEDRONIC ACID - Z | 4MG | Sandoz Canada Incorporated | Resolved | 2023-01-18 | 9 | Demand increase | 181739 |
168 | J01CA04 | JAMP-AMOXICILLIN | 250MG | Jamp Pharma Corporation | Resolved | 2023-01-18 | 51 | Demand increase | 181443 |
169 | J01CA04 | JAMP-AMOXICILLIN | 250MG | Jamp Pharma Corporation | Resolved | 2023-01-18 | 117 | Other | 181446 |
170 | J01DB01 | LUPIN-CEPHALEXIN | 250MG | Lupin Pharma Canada Limited | Resolved | 2023-01-18 | 76 | Demand increase | 181400 |
171 | L01CD04 | CABAZITAXEL FOR INJECTION | 45MG | Sandoz Canada Incorporated | Resolved | 2023-01-18 | 16 | Demand increase | 181668 |
172 | B05CB01 | 0.9% SODIUM CHLORIDE IRRIGATIO... | 900MG | Baxter Corporation | Resolved | 2023-01-18 | 71 | Manufacturing distruption | 181393 |
173 | L04AB04 | HULIO | 40MG | Bgp Pharma Ulc | Resolved | 2023-01-18 | 15 | Manufacturing distruption | 183002 |
124 | B01AB01 | HEPARIN LEO INJ 1000UNIT/ML | 1000UNIT | Leo Pharma Inc | Resolved | 2023-01-17 | 10 | Other | 181252 |
125 | C02CA01 | APO-PRAZO TAB 1MG | 1MG | Apotex Inc | Resolved | 2023-01-17 | Manufacturing distruption | 181967 | |
126 | J07AH08 | MENACTRA | 4.0MCG 4.0MCG 4.0MCG 4.0MCG | Sanofi Pasteur Limited | Resolved | 2023-01-17 | 15 | Demand increase | 181343 |
127 | A02BC03 | APO-LANSOPRAZOLE | 30MG | Apotex Inc | Resolved | 2023-01-17 | 16 | Manufacturing distruption | 181970 |
128 | N02BE01 | ACETAMINOPHEN TABLETS USP 325 ... | 325MG | Apotex Inc | Resolved | 2023-01-17 | 38 | Manufacturing distruption | 181973 |
129 | L04AC14 | KEVZARA | 150MG | Sanofi-Aventis Canada Inc | Resolved | 2023-01-17 | 57 | Other | 181429 |
115 | N07CA01 | M-BETAHISTINE | 16MG | Mantra Pharma Inc | Resolved | 2023-01-16 | 63 | Shipping delay | 182169 |
116 | N03AB02 | DILANTIN | 30MG | Upjohn Canada Ulc | Resolved | 2023-01-16 | 57 | Manufacturing distruption | 176202 |
117 | B05XA06 | POTASSIUM PHOSPHATES | 236MG 224MG | Sandoz Canada Incorporated | Resolved | 2023-01-16 | 119 | Manufacturing practices | 168553 |
118 | H01BB02 | OXYTOCIN INJECTION USP | 10UNIT | Pfizer Canada Ulc | Resolved | 2023-01-16 | Manufacturing distruption | 169271 | |
119 | D07AC01 | BETADERM LOTION 0.1% | 0.1% | Taro Pharmaceuticals Inc | Resolved | 2023-01-16 | 81 | Manufacturing distruption | 182907 |
120 | N06AX16 | M-VENLAFAXINE XR | 150MG | Mantra Pharma Inc | Resolved | 2023-01-16 | 318 | Shipping delay | 185133 |
121 | N06AX16 | M-VENLAFAXINE XR | 150MG | Mantra Pharma Inc | Resolved | 2023-01-16 | 318 | Shipping delay | 182171 |
122 | B05CB01 | 0.9% SODIUM CHLORIDE IRRIGATIO... | 900MG | Baxter Corporation | Resolved | 2023-01-16 | 73 | Manufacturing distruption | 181191 |
123 | D10AD53 | TARO-ADAPALENE/BENZOYL PEROXID... | 2.5% 0.3% | Taro Pharmaceuticals Inc | Resolved | 2023-01-16 | Manufacturing distruption | 185300 | |
113 | M01AE02 | NAPROSYN | 500MG | Atnahs Pharma Uk Limited | Resolved | 2023-01-15 | 36 | Shipping delay | 179465 |
114 | N05CD08 | MIDAZOLAM INJECTION | 5MG | Fresenius Kabi Canada Ltd | Resolved | 2023-01-15 | 76 | Manufacturing distruption | 179688 |
103 | J01CR02 | CLAVULIN 875 | 125MG 875MG | Glaxosmithkline Inc | Resolved | 2023-01-13 | 77 | Demand increase | 180938 |
104 | L04AH01 | RAPAMUNE | 1MG | Pfizer Canada Ulc | Resolved | 2023-01-13 | 42 | Manufacturing distruption | 181170 |
105 | A02BA03 | FAMOTIDINE OMEGA -(WITH PRES... | 10MG | Omega Laboratories Limited | Resolved | 2023-01-13 | 95 | Demand increase | 181052 |
106 | N06BA04 | BIPHENTIN | 30MG | Elvium Life Sciences | Resolved | 2023-01-13 | 14 | Shipping delay | 180941 |
107 | N05AH04 | QUETIAPINE TABLETS | 100MG | Accord Healthcare Inc | Resolved | 2023-01-13 | Manufacturing distruption | 181045 | |
108 | N02BF01 | GABAPENTIN CAPSULES USP | 400MG | Accord Healthcare Inc | Resolved | 2023-01-13 | 56 | Manufacturing distruption | 181036 |
109 | C08CA01 | ACH-AMLODIPINE | 2.5MG | Accord Healthcare Inc | Resolved | 2023-01-13 | Manufacturing distruption | 181030 | |
110 | C08CA01 | ACH-AMLODIPINE | 5MG | Accord Healthcare Inc | Resolved | 2023-01-13 | 77 | Manufacturing distruption | 181033 |
111 | L04AX03 | METHOTREXATE SUBCUTANEOUS | 15MG | Accord Healthcare Inc | Resolved | 2023-01-13 | 91 | Manufacturing distruption | 181027 |
112 | L04AX03 | METHOTREXATE SUBCUTANEOUS | 20MG | Accord Healthcare Inc | Resolved | 2023-01-13 | Manufacturing distruption | 181024 | |
100 | B01AA03 | TARO-WARFARIN | 1MG | Taro Pharmaceuticals Inc | Resolved | 2023-01-12 | 29 | Manufacturing distruption | 182004 |
101 | J01MA02 | TARO-CIPROFLOX | 500MG | Sun Pharma Canada Inc | Resolved | 2023-01-12 | 197 | Manufacturing distruption | 182031 |
102 | C10AX14 | PRALUENT | 150MG | Sanofi-Aventis Canada Inc | Resolved | 2023-01-12 | 36 | Other | 181300 |
95 | N03AB02 | DILANTIN INFATABS | 50MG | Upjohn Canada Ulc | Resolved | 2023-01-11 | 125 | Demand increase | 181283 |
96 | H02AB04 | SOLU-MEDROL | 125MG | Pfizer Canada Ulc | Resolved | 2023-01-11 | Manufacturing distruption | 180725 | |
97 | D07AC01 | BETADERM CRM 0.1% | 0.1% | Taro Pharmaceuticals Inc | Resolved | 2023-01-11 | 86 | Manufacturing distruption | 181808 |
98 | D07CB01 | VIADERM KC CRM | 100000UNIT 0.25MG 2.5MG 1MG | Taro Pharmaceuticals Inc | Resolved | 2023-01-11 | 44 | Manufacturing distruption | 182001 |
99 | A11CC04 | TARO-CALCITRIOL | 0.25MCG | Taro Pharmaceuticals Inc | Resolved | 2023-01-11 | 23 | Manufacturing distruption | 181833 |
76 | A04AA02 | JAMP GRANISETRON | 1MG | Jamp Pharma Corporation | Active | 2023-01-10 | Manufacturing distruption | 181452 | |
77 | H04AA01 | GLUCAGON | 1MG | Eli Lilly Canada Inc | Resolved | 2023-01-10 | 27 | Demand increase | 180461 |
78 | N05BA12 | TEVA-ALPRAZOLAM | 0.5MG | Teva Canada Limited | Resolved | 2023-01-10 | 59 | Manufacturing distruption | 180897 |
79 | M01AB55 | ARTHROTEC 50 | 200MCG 50MG | Pfizer Canada Ulc | Resolved | 2023-01-10 | 38 | Demand increase | 180648 |
80 | C07AB03 | TEVA-ATENOLOL | 50MG | Teva Canada Limited | Resolved | 2023-01-10 | 273 | Manufacturing distruption | 180900 |
81 | R05FA02 | CALMYLIN | 125MG 12.5MG 3.33MG | Teva Canada Limited | Resolved | 2023-01-10 | 243 | Manufacturing distruption | 180888 |
82 | C02CA04 | TEVA-DOXAZOSIN | 4MG | Teva Canada Limited | Resolved | 2023-01-10 | 49 | Manufacturing distruption | 180903 |
83 | C10AA01 | TEVA-SIMVASTATIN | 40MG | Teva Canada Limited | Resolved | 2023-01-10 | 171 | Manufacturing distruption | 180912 |
84 | C10AA01 | TEVA-SIMVASTATIN | 80MG | Teva Canada Limited | Resolved | 2023-01-10 | 151 | Manufacturing distruption | 180915 |
85 | N06AB08 | ACT FLUVOXAMINE | 50MG | Teva Canada Limited | Resolved | 2023-01-10 | 201 | Manufacturing distruption | 180878 |
86 | N02AB03 | TEVA-FENTANYL | 12MCG | Teva Canada Limited | Resolved | 2023-01-10 | 130 | Manufacturing distruption | 180909 |
87 | N05AH04 | ACT QUETIAPINE | 25MG | Teva Canada Limited | Resolved | 2023-01-10 | 31 | Manufacturing distruption | 180881 |
88 | N06AB10 | TEVA-ESCITALOPRAM | 20MG | Teva Canada Limited | Resolved | 2023-01-10 | 90 | Manufacturing distruption | 180906 |
89 | M01AB55 | GD-DICLOFENAC/MISOPROSTOL 50 | 200MCG 50MG | Genmed A Division Of Pfizer Canada Ulc | Resolved | 2023-01-10 | 31 | Demand increase | 180226 |
90 | S01XA18 | RESTASIS | 0.05% | Abbvie Corporation | Resolved | 2023-01-10 | 17 | Demand increase | 180339 |
91 | L01DB01 | DOXORUBICIN HYDROCHLORIDE INJE... | 2MG | Teva Canada Limited | Resolved | 2023-01-10 | 273 | Manufacturing distruption | 180891 |
92 | L01BA04 | TARO-PEMETREXED | 500MG | Taro Pharmaceuticals Inc | Resolved | 2023-01-10 | Manufacturing distruption | 181893 | |
93 | N02CC05 | TEVA-ALMOTRIPTAN | 12.5MG | Teva Canada Limited | Resolved | 2023-01-10 | 171 | Manufacturing distruption | 180894 |
94 | N03AG01 | MYLAN-DIVALPROEX | 250MG | Mylan Pharmaceuticals Ulc | Resolved | 2023-01-10 | 7 | Demand increase | 181324 |
63 | C01BB01 | 0.4% LIDOCAINE HYDROCHLORIDE A... | 50MG 4MG | Baxter Corporation | Resolved | 2023-01-09 | 35 | Demand increase | 179915 |
64 | J01GB03 | GENTAMICIN(E) | 1.6MG | Baxter Corporation | Resolved | 2023-01-09 | 28 | Demand increase | 179918 |
65 | M05BA03 | PAMIDRONATE DISODIUM FOR INJEC... | 9MG | Fresenius Kabi Canada Ltd | Resolved | 2023-01-09 | 81 | Other | 181148 |
66 | G03DA02 | APO-MEDROXY | 10MG | Apotex Inc | Resolved | 2023-01-09 | 221 | Ingredient shortage | 181101 |
67 | G03XC01 | APO-RALOXIFENE | 60MG | Apotex Inc | Resolved | 2023-01-09 | 109 | Manufacturing distruption | 181104 |
68 | J05AR01 | APO-LAMIVUDINE-ZIDOVUDINE | 300MG 150MG | Apotex Inc | Resolved | 2023-01-09 | 11 | Manufacturing distruption | 181110 |
69 | C09DA07 | ACH-TELMISARTAN HCTZ | 25MG 80MG | Accord Healthcare Inc | Resolved | 2023-01-09 | Demand increase | 181042 | |
70 | A10AE04 | TOUJEO SOLOSTAR | 300UNIT | Sanofi-Aventis Canada Inc | Resolved | 2023-01-09 | 21 | Other | 181005 |
71 | H05BX01 | APO-CINACALCET | 30MG | Apotex Inc | Resolved | 2023-01-09 | 32 | Manufacturing distruption | 181113 |
72 | N06BA04 | APO-METHYLPHENIDATE ER | 18MG | Apotex Inc | Resolved | 2023-01-09 | 123 | Manufacturing distruption | 181107 |
73 | C10AX14 | PRALUENT | 75MG | Sanofi-Aventis Canada Inc | Resolved | 2023-01-09 | 37 | Other | 181002 |
74 | C10AA05 | ACH-ATORVASTATIN CALCIUM | 40MG | Accord Healthcare Inc | Resolved | 2023-01-09 | Demand increase | 181039 | |
75 | M01AE52 | MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 375MG | Mylan Pharmaceuticals Ulc | Resolved | 2023-01-09 | 32 | Manufacturing distruption | 180349 |
62 | J07BD54 | PROQUAD | 3.00Log10 TCID50 4.30Log10 TCID50 3.00Log10 TCID50 3.99Log10 PFU | Merck Canada Inc | Avoided | 2023-01-07 | 24 | Demand increase | 177230 |
61 | N05AE04 | ZELDOX | 20MG | Upjohn Canada Ulc | Resolved | 2023-01-07 | 24 | Manufacturing distruption | 176218 |
55 | B05CB01 | SODIUM CHLORIDE IRRIGATION USP | 9MG | Icu Medical Canada Inc | Active | 2023-01-06 | Manufacturing distruption | 172846 | |
54 | B05XA07 | CALCIJECT INJ 100MG/ML | 100MG | Omega Laboratories Limited | Resolved | 2023-01-06 | 12 | Demand increase | 180130 |
56 | B05XA01 | POTASSIUM CHLORIDE FOR INJECTI... | 20mEq | Omega Laboratories Limited | Resolved | 2023-01-06 | Demand increase | 180063 | |
57 | H01AC01 | HUMATROPE | 6MG 3.15ML | Eli Lilly Canada Inc | Resolved | 2023-01-06 | 137 | Manufacturing distruption | 169492 |
58 | A02BA03 | FAMOTIDINE OMEGA -(WITHOUT PR... | 10MG | Omega Laboratories Limited | Resolved | 2023-01-06 | 25 | Demand increase | 179338 |
59 | R05DA03 | PDP-HYDROCODONE | 5MG | Pendopharm Division Of Pharmascience Inc | Resolved | 2023-01-06 | 145 | Manufacturing distruption | 180653 |
60 | N02BF02 | TARO-PREGABALIN | 75MG | Sun Pharma Canada Inc | Resolved | 2023-01-06 | 28 | Manufacturing distruption | 180584 |
42 | C08DB01 | DILTIAZEM HYDROCHLORIDE INJECT... | 5MG | Omega Laboratories Limited | Resolved | 2023-01-05 | 49 | Demand increase | 179329 |
43 | D01AE14 | LOPROX | 1% | Bausch Health, Canada Inc. | Resolved | 2023-01-05 | 61 | Demand increase | 179123 |
44 | N02AA05 | OXY.IR | 5MG | Purdue Pharma | Resolved | 2023-01-05 | 71 | Shipping delay | 179931 |
45 | H01CB02 | OCTREOTIDE ACETATE OMEGA | 500MCG | Omega Laboratories Limited | Resolved | 2023-01-05 | 26 | Demand increase | 179341 |
46 | S01ED51 | COSOPT PRESERVATIVE-FREE | 5MG 20MG | Elvium Life Sciences | Resolved | 2023-01-05 | 22 | Shipping delay | 179950 |
47 | N06BA04 | BIPHENTIN | 40MG | Elvium Life Sciences | Resolved | 2023-01-05 | 43 | Shipping delay | 179939 |
48 | B01AB01 | HEPARIN SODIUM INJECTION, USP | 10000UNIT | Fresenius Kabi Canada Ltd | Resolved | 2023-01-05 | 55 | Other | 158765 |
49 | B02BD04 | ALPROLIX | 3000UNIT | Sanofi-Aventis Canada Inc | Resolved | 2023-01-05 | 26 | Demand increase | 180122 |
50 | R03BA07 | ASMANEX TWISTHALER | 100MCG | Organon Canada Inc. | Resolved | 2023-01-05 | 85 | Demand increase | 179906 |
51 | B05BA03 | DEXTROSE INJECTION USP | 500MG | Pfizer Canada Ulc | Resolved | 2023-01-05 | Manufacturing distruption | 179912 | |
52 | N06BA04 | FOQUEST | 55MG | Elvium Life Sciences | Resolved | 2023-01-05 | 43 | Shipping delay | 179942 |
53 | N06BA04 | FOQUEST | 70MG | Elvium Life Sciences | Resolved | 2023-01-05 | 4 | Shipping delay | 179946 |
37 | H01BB02 | OXYTOCIN INJECTION USP | 10UNIT | Pfizer Canada Ulc | Active | 2023-01-04 | 656 | Manufacturing distruption | 174201 |
36 | B05XA01 | POTASSIUM CHLORIDE FOR INJECTI... | 20mEq | Omega Laboratories Limited | Avoided | 2023-01-04 | Demand increase | 178573 | |
34 | B05BC01 | MANNITOL INJECTION USP | 25% | Pfizer Canada Ulc | Resolved | 2023-01-04 | Manufacturing distruption | 178356 | |
35 | H02AB04 | DEPO-MEDROL (WITH PRESERVATIVE... | 20MG | Pfizer Canada Ulc | Resolved | 2023-01-04 | Manufacturing distruption | 166933 | |
38 | N02CC01 | IMITREX | 6MG | Glaxosmithkline Inc | Resolved | 2023-01-04 | 117 | Demand increase | 179840 |
39 | C01CA24 | EPIPEN JR | 0.15MG | Mylan Specialty Lp | Resolved | 2023-01-04 | 23 | Manufacturing distruption | 179966 |
40 | A10BH01 | JANUVIA | 100MG | Merck Canada Inc | Resolved | 2023-01-04 | 23 | Demand increase | 179856 |
41 | N02BF02 | TARO-PREGABALIN | 25MG | Sun Pharma Canada Inc | Resolved | 2023-01-04 | 541 | Manufacturing distruption | 180578 |
27 | V03AC01 | DEFEROXAMINE MESYLATE FOR INJE... | 2G | Pfizer Canada Ulc | Avoided | 2023-01-03 | Manufacturing distruption | 172596 | |
24 | R03BA02 | PULMICORT NEBUAMP 0.25 MG/ML | 0.25MG | Astrazeneca Canada Inc | Resolved | 2023-01-03 | 28 | Demand increase | 178796 |
25 | N02AA01 | MS.IR | 20MG | Purdue Pharma | Resolved | 2023-01-03 | 23 | Shipping delay | 179934 |
26 | R01AD01 | MYLAN-BECLO AQ | 50MCG | Mylan Pharmaceuticals Ulc | Resolved | 2023-01-03 | 414 | Manufacturing distruption | 203100 |
28 | J07AX | BOOSTRIX | 2.5MCG 8MCG 8MCG 20UNIT 2UNIT | Glaxosmithkline Inc | Resolved | 2023-01-03 | 133 | Shipping delay | 179831 |
29 | A04AA02 | GRANISETRON HYDROCHLORIDE INJE... | 1MG | Omega Laboratories Limited | Resolved | 2023-01-03 | Demand increase | 179332 | |
30 | J01DB01 | LUPIN-CEPHALEXIN | 125MG | Lupin Pharma Canada Limited | Resolved | 2023-01-03 | 209 | Demand increase | 179775 |
31 | J01DB01 | LUPIN-CEPHALEXIN | 125MG | Lupin Pharma Canada Limited | Resolved | 2023-01-03 | 209 | Demand increase | 181417 |
32 | H05AA02 | OSNUVO | 250MCG | Avir Pharma Inc. | Resolved | 2023-01-03 | 73 | Shipping delay | 180223 |
33 | A09AA02 | COTAZYM ECS 20 | 100000UNIT 100000UNIT 25000UNIT | Organon Canada Inc. | Resolved | 2023-01-03 | 87 | Shipping delay | 179772 |
14 | C07AA07 | APO-SOTALOL | 160MG | Apotex Inc | Resolved | 2023-01-02 | 46 | Manufacturing distruption | 180093 |
15 | C07AA07 | APO-SOTALOL | 80MG | Apotex Inc | Resolved | 2023-01-02 | 46 | Manufacturing distruption | 180086 |
16 | B05CX10 | SORBITOL MANNITOL IRRIGATION | 5.4MG 27MG | Icu Medical Canada Inc | Resolved | 2023-01-02 | 21 | Manufacturing distruption | 180329 |
17 | M01AE01 | APO-IBUPROFEN | 400MG | Apotex Inc | Resolved | 2023-01-02 | 53 | Manufacturing distruption | 180109 |
18 | N03AG01 | APO-DIVALPROEX | 250MG | Apotex Inc | Resolved | 2023-01-02 | 18 | Manufacturing distruption | 180081 |
19 | M01AE02 | APO-NAPROXEN EC | 500MG | Apotex Inc | Resolved | 2023-01-02 | 60 | Manufacturing distruption | 180113 |
20 | J05AB09 | APO-FAMCICLOVIR | 250MG | Apotex Inc | Resolved | 2023-01-02 | 39 | Manufacturing distruption | 180116 |
21 | N07BB04 | APO-NALTREXONE | 50MG | Apotex Inc | Resolved | 2023-01-02 | 88 | Manufacturing distruption | 180119 |
22 | C08DA01 | APO-VERAP TABLET 120MG | 120MG | Apotex Inc | Resolved | 2023-01-02 | 60 | Manufacturing distruption | 180106 |
23 | A10BD07 | APO-SITAGLIPTIN MALATE / METFO... | 500MG 50MG | Apotex Inc | Resolved | 2023-01-02 | 214 | Demand increase | 180124 |
10 | C05BB04 | TROMBOJECT 3% | 30MG | Omega Laboratories Limited | Active | 2023-01-01 | Manufacturing distruption | 206240 | |
1 | G03CA03 | OESCLIM | 50MCG | Searchlight Pharma Inc | Resolved | 2023-01-01 | Other | 179065 | |
2 | B05XA03 | SODIUM CHLORIDE INJECTION, USP | 234MG | Fresenius Kabi Canada Ltd | Resolved | 2023-01-01 | 19 | Shipping delay | 179693 |
3 | C03CA01 | TEVA-FUROSEMIDE | 20MG | Teva Canada Limited | Resolved | 2023-01-01 | 383 | Manufacturing distruption | 207497 |
4 | J01CA04 | NOVAMOXIN | 250MG | Teva Canada Limited | Resolved | 2023-01-01 | 455 | Manufacturing distruption | 207503 |
5 | J01XE01 | TEVA-NITROFURANTOIN | 100MG | Teva Canada Limited | Resolved | 2023-01-01 | 333 | Manufacturing distruption | 206380 |
6 | J01XA01 | VANCOMYCIN HYDROCHLORIDE FOR I... | 10G | Fresenius Kabi Canada Ltd | Resolved | 2023-01-01 | 89 | Other | 181151 |
7 | N05CF01 | TEVA-ZOPICLONE | 7.5MG | Teva Canada Limited | Resolved | 2023-01-01 | 313 | Manufacturing distruption | 206386 |
8 | B01AC07 | DIPYRIDAMOLE INJECTION, USP | 5MG | Fresenius Kabi Canada Ltd | Resolved | 2023-01-01 | 89 | Other | 170977 |
9 | N05AX08 | TARO-RISPERIDONE | 0.25MG | Sun Pharma Canada Inc | Resolved | 2023-01-01 | 287 | Manufacturing distruption | 199143 |
11 | N01BB09 | ROPIVACAINE HYDROCHLORIDE INJE... | 10MG | Fresenius Kabi Canada Ltd | Resolved | 2023-01-01 | 90 | Demand increase | 181154 |
12 | N01BB09 | ROPIVACAINE HYDROCHLORIDE INJE... | 10MG | Fresenius Kabi Canada Ltd | Resolved | 2023-01-01 | 318 | Manufacturing distruption | 181157 |
13 | M04AA03 | TEVA-FEBUXOSTAT | 80MG | Teva Canada Limited | Resolved | 2023-01-01 | 405 | Manufacturing distruption | 206434 |
Hello. I am Jon Pipitone, resident in Psychiatry at Queen’s University, Kingston, Ontario, Canada. This dashboard is my attempt to show interesting trends and summaries of Canadian drug shortage reports. Code for this website can be found on github. This work is licensed under a Creative Commons Attribution 4.0 International License.
Much of this work has been done in collaboration with Dr. Jacalyn Duffin, who has a her own site dedicated to analysis of the canadian drug shortages: https://canadadrugshortage.com.
We published a peer-reviwed paper in 2018 on this issue:
I also keep a blog and I sometimes discuss drug shortages.
Questions, comments, requests? Please send email to drugshortages@pipitone.ca.
Why are there different totals listed under “active shortages” and on the “drugs in shortage” graph?
In short, it’s because there is missing or incorrect data in some of the shortage reports that means they get excluded from historical counts. I’ve written a blog post about it.
How often is the dashboard updated?
Daily. It was last updated 2025-04-04 00:17:10.
Database of shortage and discontinuation reports. Active from March 2017 to present. Manufacturers are required to report.
Last updated: 2025-04-04 00:17:10
Database of historical records of drug products in Canada. Maintained by Health Canada.
Last updated: 2025-04-04 00:17:10
---
title: "Assessing Canada’s Drug Shortage Problem"
output:
flexdashboard::flex_dashboard:
orientation: rows
source_code: embed
self_contained: false
---
```{r setup, include=FALSE}
options(tidyverse.quiet=T)
library(flexdashboard)
library(tidyverse)
library(lubridate, warn.conflicts=F)
library(devtools, quietly=T)
library(rdrugshortages) # devtools::install_github('pipitone/rdrugshortages')
library(kableExtra, warn.conflicts=F)
library(plotly, warn.conflicts=F)
# settings
DATA_DIR = 'data/' # Load the Health Canada Drug Product Database
DPD_DOWNLOAD = getOption('dpd_download', default=F) # download the latest drug product database dataset
DSC_DOWNLOAD = getOption('dsc_download', default=F) # download latest DSC database
DSC_PATH = 'data/dsc.csv'
DSC_START = ymd("2018-01-01", tz="")
FAR_FUTURE = ymd("2100-12-31", tz="")
FAR_PAST = origin
theme_set(theme_minimal())
caption = list(labs(caption = paste(
paste(
"source: drugshortagescanada.ca, last updated:", as_date(file.info(DSC_PATH)$ctime)),
"source: Health Canada Drug Product Database",
"jon.pipitone.ca/research/drug-shortages",
sep="\n")))
# load data
if (DSC_DOWNLOAD) {
dsc = dsc_search() %>%
select_if(~ !is.list(.x)) %>%
write_csv(DSC_PATH)
}
dsc.orig = read_csv(DSC_PATH, trim_ws = T, col_types = cols(
status = col_factor(),
drug.company.post_office_box = col_character(),
hc_en_comments = col_character(),
hc_fr_comments = col_character(),
shortage_reason.en_reason = col_factor()
)) %>%
select(-matches("^fr_|\\.fr_|_fr")) %>%
mutate(
reason = fct_recode(shortage_reason.en_reason,
"Demand increase" = "Demand increase for the drug.",
"Manufacturing distruption" = "Disruption of the manufacture of the drug.",
"Ingredient shortage" = "Shortage of an active ingredient.",
"Ingredient shortage" = "Shortage of an inactive ingredient or component.",
"Manufacturing practices" = "Requirements related to complying with good manufacturing practices.",
"Other" = "Other (Please describe in comments)",
"Shipping delay" = "Delay in shipping of the drug."
)
) %>%
mutate(
end_date_no_na = coalesce(actual_end_date, FAR_FUTURE))
## Parsual EML
# https://dx.doi.org/10.9778%2Fcmajo.20160122
eml = read_csv('data/cleanmeds.csv', trim_ws=T, col_types = cols()) %>%
select(category, medication, ATC)
## DPD
dpd = dpd_load(DATA_DIR, download=DPD_DOWNLOAD)
## Add the DPD ATC number to the DSC data
dsc = inner_join(dpd$drug, dpd$ther, by="DRUG_CODE") %>%
select(din = DRUG_IDENTIFICATION_NUMBER, dpd_atc_number = TC_ATC_NUMBER, TC_ATC) %>%
distinct(din, .keep_all = TRUE) %>%
right_join(dsc.orig, by=c("din"))
dsc.shortages = dsc %>% filter(type.label == "shortage")
dsc.discontinuations = dsc %>% filter(type.label == "discontinuance")
this_year = interval(floor_date(now(), "year"), ceiling_date(now(), "year"))
week_start = floor_date(now(), "week")
this_week = interval(week_start, week_start + dweeks(1))
next_week = int_shift(this_week, by = dweeks(1))
```
Shortages
==========
Row {data-height=125}
--------------------------------
### Active shortages
```{r}
valueBox(dsc %>% filter(status == "active_confirmed") %>% count() %>% pull(),
icon="fa-capsules",
color = "warning")
```
### New shortages expected this week
```{r}
.shortages_this_week = dsc.shortages %>%
filter(
status %in% c("active_confirmed", "anticipated_shortage"),
coalesce(actual_start_date, anticipated_start_date) %within% this_week)
valueBox(nrow(.shortages_this_week),icon="fa-needle")
```
### New discontinuations this week
```{r}
.active_disconts = dsc.discontinuations %>%
filter(
status == "discontinued",
discontinuation_date %within% this_week)
valueBox(nrow(.active_disconts), icon="fa-ban")
```
### Shortages of Essential Medicines this year
```{r}
.emls_with_shortages = dsc.shortages %>%
filter(actual_start_date %within% this_year) %>%
right_join(eml, by=c("dpd_atc_number" = "ATC")) %>%
filter(!is.na(din)) %>%
group_by(category, medication, dpd_atc_number)
valueBox(nrow(.emls_with_shortages), icon="fa-ambulance")
```
Row
----------------------------------
### Drugs in shortage
```{r}
weeks = tibble(
week.start = seq(as_date(floor_date(DSC_START, "week")),
as_date(floor_date(now(), "week")), by = "1 week"),
i = 1
)
p = dsc.shortages %>%
mutate(i = 1) %>%
full_join(weeks, by = "i") %>%
filter(week.start %within% interval(actual_start_date, end_date_no_na))%>%
group_by(week.start) %>%
summarize(n = n()) %>%
mutate(week = week.start) %>%
ggplot( aes(x = week, y = n)) +
geom_line() +
scale_x_date(date_minor_breaks = "1 month",
date_labels="%b %Y") +
labs(x = NULL, y = NULL)
ggplotly(p)
```
### Causes of drug shortages this year {.no-padding}
```{r, fig.height=4, asp=0.6}
p = dsc.shortages %>%
transmute(started = as_date(floor_date(actual_start_date, "month")),
reason = reason) %>%
filter(started >= ymd('2019-10-01'), started < now()) %>%
count(started, reason) %>%
group_by(started) %>%
mutate(percent = round(n / sum(n) * 100, 1)) %>%
transmute(month = started, percent, reason) %>%
ggplot(aes(x = month, y = percent, fill=reason)) +
geom_bar(stat='identity') +
scale_x_date(date_breaks="1 month",
date_labels="%b %Y") +
labs(x=NULL, y="% of total") +
theme(legend.position="bottom")
ggplotly(p) %>% layout(legend = list(orientation = 'h', x=0, y=-.1))
```
Row
-----------------------------------------------------------------------
### New shortages per week since 2018
```{r}
p = dsc.shortages %>%
mutate(week = as_date(floor_date(actual_start_date, "week"))) %>%
filter(week >= ymd('2018-01-01'), week < now()) %>%
count(week) %>%
ggplot(aes(x=week, y=n)) +
geom_bar(stat='identity') +
scale_x_date(date_minor_breaks = "1 month",
date_labels = "%b %Y") +
labs(x=NULL, y=NULL)
ggplotly(p)
```
### Shortage durations
```{r}
p = dsc.shortages %>%
filter(actual_start_date >= ymd("2018-01-01")) %>%
mutate(duration = (actual_end_date - coalesce(actual_start_date, estimated_end_date))/dweeks(1),
month_str=floor_date(actual_start_date, unit="year")) %>%
filter(!is.na(duration), duration > 0) %>%
ggplot(aes(x=duration)) +
geom_histogram(binwidth=4) +
facet_wrap(~factor(month_str), nrow=1, labeller = as_labeller(function(x) format.Date(x, "%Y"))) +
labs(x="Duration (weeks)", y="# of shortages")
ggplotly(p)
```
COVID-19 {data-orientation=columns}
=======================================
```{r}
.dpd_status_ordered = dpd$status %>%
group_by(DRUG_CODE) %>%
arrange(HISTORY_DATE, .by_group = T) %>%
mutate(.curr = 1:n(), .prev = .curr-1, .last = n()) %>%
ungroup()
# complex join so that LHS has FROM status and RHS has TO status
# Also includes pair when LHS is the most recent status and then RHS is ignored
dpd_status_intervals = inner_join(.dpd_status_ordered, .dpd_status_ordered, by="DRUG_CODE") %>%
select(-starts_with("CURRENT"), -starts_with("LOT"), -starts_with("EXP")) %>%
filter(.prev.y == .curr.x | (.curr.x == .last.x & .curr.x == .curr.y)) %>%
transmute(
DRUG_CODE = DRUG_CODE,
start_date = HISTORY_DATE.x,
end_date = if_else(.curr.x == .last.x, as_date(FAR_FUTURE), HISTORY_DATE.y),
status = STATUS.x)
# Map ATC code to NAME
atc_codes = dpd$ther %>% transmute(dpd_atc_number = TC_ATC_NUMBER, atc_name = TC_ATC) %>% distinct()
# date range to show
FROM = floor_date(ymd("2019-11-01"), "week")
TO = as_date(now())
BY = "1 week" # warning: if the FROM-TO range is large (e.g. > 20 years), change BY to something larger, e.g. 3 months
# now, for each month, let's compute the total number of drugs marketed, for each ATC code
dpd.months = tibble(month.date = seq(FROM, TO, by=BY), n = 1)
dpd_num_marketed_by_atc = dpd_status_intervals %>% mutate(n=1) %>%
inner_join(dpd.months, by="n") %>%
filter(month.date %within% interval(start_date, end_date)) %>%
select(DRUG_CODE, status, month.date) %>%
inner_join(select(dpd$ther, DRUG_CODE, TC_ATC_NUMBER), by = "DRUG_CODE") %>%
group_by(month.date, TC_ATC_NUMBER) %>%
summarize(marketed = sum(status == "MARKETED"))
dsc_num_shortages_by_atc = dsc.shortages %>%
mutate(n=1) %>%
inner_join(dpd.months, by="n") %>%
filter(month.date %within% interval(actual_start_date, end_date_no_na)) %>%
distinct(month.date, dpd_atc_number, din) %>%
group_by(month.date, dpd_atc_number) %>%
summarize(shortages = n())
atc_plot = function(atc) {
shortages = dsc_num_shortages_by_atc %>%
filter(str_starts(dpd_atc_number, atc))
marketed = dpd_num_marketed_by_atc %>%
filter(str_starts(TC_ATC_NUMBER, atc))
right_join(shortages, marketed,
by = c("month.date" = "month.date", "dpd_atc_number" = "TC_ATC_NUMBER")) %>%
ungroup() %>%
mutate(shortages = replace_na(shortages, 0)) %>%
mutate(available = marketed - shortages) %>%
group_by(month.date) %>%
summarize(Available = sum(available), Marketed = sum(marketed)) %>%
pivot_longer(cols = Available:Marketed, names_to = "status", values_to = "count") %>%
ggplot(aes(x = week, y = count, linetype = fct_rev(status))) +
geom_line() +
labs(x=NULL, y = "# of DINs",
linetype = NULL) +
expand_limits(y=0) +
theme(legend.position="bottom")
}
integer_breaks <- function(n = 5, ...) {
function(x) {
breaks = floor(pretty(x, n, ...))
names(breaks) = attr(breaks, "labels")
breaks
}
}
atc_group_plot = function(atcs) {
atc = paste(atcs, collapse="|")
shortages = dsc_num_shortages_by_atc %>%
filter(str_starts(dpd_atc_number, atc))
marketed = dpd_num_marketed_by_atc %>%
filter(str_starts(TC_ATC_NUMBER, atc))
right_join(shortages, marketed,
by = c("month.date" = "month.date", "dpd_atc_number" = "TC_ATC_NUMBER")) %>%
ungroup() %>%
mutate(shortages = replace_na(shortages, 0)) %>%
mutate(available = marketed - shortages) %>%
group_by(month.date, dpd_atc_number) %>%
summarize(Available = sum(available), Marketed = sum(marketed)) %>%
ungroup() %>%
group_by(dpd_atc_number) %>%
filter(sum(Marketed-Available) > 0, Available > 0) %>%
mutate(percent_available = Available/max(Available)*100) %>%
mutate(week = month.date) %>%
left_join(atc_codes, by="dpd_atc_number") %>%
mutate(name_and_atc = paste0(atc_name, ' [', dpd_atc_number, ']')) %>%
ggplot(aes(x = week, y = Available, fill=name_and_atc)) +
geom_area() +
scale_x_date(date_breaks="2 month",
date_labels="%b %Y",
minor_breaks=NULL) +
scale_y_continuous(breaks=integer_breaks(3)) +
facet_wrap(~name_and_atc, ncol=2, strip.position = "right", scales="free_y") +
theme(legend.position="none",
strip.text.y = element_text(angle=0)
)
}
```
Column {data-width=150}
-------------------------------------
### COVID-19 Indicator Medicines
We are tracking the following list of medications (and groups of medications) to
assess for COVID-related shortages:
```{r}
# To add: propofol, rocuronium, cisatracurium, ketamine, midazolam, norepinephrine, phenylephrine, fentanyl
covid_meds = tribble(
~ATC, ~Type, ~Description,
"N01A", "Anesthetic use", "Anesthetics (includes opioid, ketamines)",
"M03AC", "Anesthetic use", "Muscle relaxants (e.g. paralytics)",
"M03AB01", "Anesthetic use", "Succinylcholine (suxamethonium)",
"N05CD", "Anesthetic use", "Benzodiazepines",
"C01CA", "Anesthetic use", "Adrenergics",
"N05CM18", "Anesthetic use", "Dexmedetomidine",
"H01BA", "Anesthetic use", "Vasopressin and analogues",
"R03AC", "Other", "Respiratory Beta Agonists",
"R01AA04", "Other", "Phenylephrine (nasal)",
"C03CA01", "Other", "Furosemide",
"C01BD01", "Other", "Amiodarone",
"J05AR10", "Other", "Kaletra (anti-viral)",
"P01BA02", "Other", "Hydroxychloroquine",
"N02BE01", "Other", "Acetaminophen (Paracetamol)",
)
kable(covid_meds %>% arrange(Type, ATC) %>% select(-Type)) %>%
kable_styling(
bootstrap_options = c("striped", "hover", "condensed", "responsive"),
full_width=T)
```
The following charts shows the availability of COVID-19 indicator medications since November 2019.
Only medications (by ATC code) that have had a shortages will be shown.
Column {.tabset}
-----------------------------------------------------
### Anesthetic Use {data-padding=30}
```{r}
p = atc_group_plot(filter(covid_meds, Type == "Anesthetic use")$ATC)
p1 = p +
geom_vline(xintercept=as.numeric(ymd("2020-01-15")), linetype=1) +
geom_vline(xintercept=as.numeric(ymd("2020-03-09")), linetype=1, colour="red") +
labs(x=NULL, y = "# DIN available")
p1_ly = ggplotly(p1) %>%
layout(annotations = list(x = 1, y = -0.06, xref="paper", yref="paper",
xanchor="right", yanchor="bottom", xshift=0, yshift=0,
font=list(size=10), showarrow=F,
text="Black line indicates first COVID-19 case in canada, red line indicates first death"))
p1_ly
```
### Other Use {data-padding=30}
```{r}
p = atc_group_plot(filter(covid_meds, Type == "Other")$ATC)
p1 = p +
geom_vline(xintercept=as.numeric(ymd("2020-01-15")), linetype=1) +
geom_vline(xintercept=as.numeric(ymd("2020-03-09")), linetype=1, colour="red") +
labs(x=NULL, y = "# DIN available")
p1_ly = ggplotly(p1) %>%
layout(annotations = list(x = 1, y = -0.06, xref="paper", yref="paper",
xanchor="right", yanchor="bottom", xshift=0, yshift=0,
font=list(size=10), showarrow=F,
text="Black line indicates first COVID-19 case in canada, red line indicates first death"))
p1_ly
```
Search
======
Row
-------------------------------------
### Searchable list of shortage reports since January, 2023
```{r}
dsc.shortages %>%
mutate(start_date = date(coalesce(actual_start_date, anticipated_start_date)),) %>%
filter(start_date %within% interval(ymd("2023-01-01"), now()+dweeks(4))) %>%
arrange(start_date) %>%
mutate(drug_name = if_else(str_length(en_drug_brand_name) > 30, paste0(substring(en_drug_brand_name, 0, 30), '...'), en_drug_brand_name),
company_name = str_to_title(company_name),
duration = round((start_date %--% estimated_end_date)/days(1)),
status = fct_recode(status,
"Active" = "active_confirmed",
"Anticipated" = "anticipated_shortage",
"Avoided" = "avoided_shortage",
"Resolved" = "resolved"),
link = text_spec(id, link=paste0("https://www.drugshortagescanada.ca/shortage/", id))) %>%
select(dpd_atc_number, drug_name, drug_strength, company_name, status, start_date, duration, reason, link) %>%
DT::datatable(escape=F,
filter="top",
rownames=T,
options = list(bPaginate = FALSE,
autoWidth = T,
rowid = F,
search = list(regex = T),
order=list(list(6, "desc"), list(5,"asc"))),
colnames = c("ATC", "Drug Name", "Dose", "Company", "Status", "Start", "Duration (days)", "Reason", "View report")) %>%
DT::formatStyle("start_date", "white-space"="nowrap") %>%
DT::formatStyle("drug_name", "white-space"="nowrap") %>%
DT::formatStyle("reason", "white-space"="nowrap") %>%
DT::formatStyle('status', color = DT::styleEqual(c('Anticipated', 'Active'), c('blue', 'green')))
```
About
=====
Column
------
### About this website
Hello. I am Jon Pipitone, resident in Psychiatry at Queen's University, Kingston,
Ontario, Canada. This dashboard is my attempt to show interesting trends and
summaries of Canadian drug shortage reports. Code for this website can be found
on [github](https://github.com/pipitone/drug-shortages-dashboard). This work is
licensed under a <a rel="license"
href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution
4.0 International License</a>.
Much of this work has been done in collaboration with [Dr. Jacalyn
Duffin](https://jacalynduffin.ca/), who has a her own site dedicated to
analysis of the canadian drug shortages: https://canadadrugshortage.com.
We published a peer-reviwed paper in 2018 on this issue:
* Donelle, Jessy, Jacalyn Duffin, Jonathan Pipitone, and Brian White-Guay.
“Assessing Canada’s Drug Shortage Problem.” CD Howe Institute Commentary 515, 2018. https://doi.org/10.2139/ssrn.3192558
I also keep [a blog](https://jon.pipitone.ca/blog) and I sometimes discuss drug
shortages.
Questions, comments, requests? Please send email to drugshortages@pipitone.ca.
### FAQ
1. Why are there different totals listed under "active shortages" and on the "drugs in shortage" graph?
In short, it's because there is missing or incorrect data in some of the
shortage reports that means they get excluded from historical counts. I've
written [a blog post about it](https://jon.pipitone.ca/blog/2020-04-18-how-many-drug-shortages-are-there/).
1. How often is the dashboard updated?
Daily. It was last updated `r now()`.
Column {data-width=100}
----------------------------
### Data sources
##### [drugshortagescanada.ca](https://www.drugshortagescanada.ca)
Database of shortage and discontinuation reports. Active from March 2017 to
present. Manufacturers are required to report.
Last updated: `r now()`
##### [Drug Product Database](https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html)
Database of historical records of drug products in Canada. Maintained by Health Canada.
Last updated: `r now()`
##### [CLEANMeds Essential Medicines List](https://cleanmeds.ca)